Id,Name,Type,VectorableProperty
2,HOMAIR,Phenotype,HOMAIR
19,HDL,Phenotype,HDL
22,Homair Adj Bmi,Phenotype,Homair Adj Bmi
29,Fasting Blood Glucose,Phenotype,Fasting Blood Glucose
59,T2D,Phenotype,T2D
65,Insulin Fold Change Adj Bmi,Phenotype,Insulin Fold Change Adj Bmi
68,BMI,Phenotype,BMI
72,LDL,Phenotype,LDL
77,Fasting Blood Insulin,Phenotype,Fasting Blood Insulin
200,Schizophrenia,Phenotype,Schizophrenia
671,T2D 2024,Phenotype,T2D 2024
950,Glutamine Fructose-6-Phosphate Amidotransferase Adj Bmi,Phenotype,Glutamine Fructose-6-Phosphate Amidotransferase Adj Bmi
1164,Handedness,Phenotype,Handedness
1239,T1D,Phenotype,T1D
1479,Insulin Sensitivity Index Adj Bmi,Phenotype,Insulin Sensitivity Index Adj Bmi
1603,vatAsatRatio,Phenotype,vatAsatRatio
1680,HbA1c,Phenotype,HbA1c
1682,FastingInsulin,Phenotype,FastingInsulin
1709,Coronary Artery Disease,Phenotype,Coronary Artery Disease
2193,Abdominal Subcutaneous Adipose Tissue Adj Bmi,Phenotype,Abdominal Subcutaneous Adipose Tissue Adj Bmi
2326,Waist-Hip Ratio Adj Bmi,Phenotype,Waist-Hip Ratio Adj Bmi
2327,VATadjBMI,Phenotype,VATadjBMI
2331,Proinsulin,Phenotype,Proinsulin
2332,SHBG_LpA,Phenotype,SHBG_LpA
2333,Beta_Cell_2,Phenotype,Beta_Cell_2
2334,Obesity,Phenotype,Obesity
2335,Lipodystrophy_1,Phenotype,Lipodystrophy_1
2336,Bilirubin,Phenotype,Bilirubin
2337,Liver_Lipid,Phenotype,Liver_Lipid
2338,Lipodystrophy_2,Phenotype,Lipodystrophy_2
2339,Hyper_Insulin,Phenotype,Hyper_Insulin
2340,ALP_Neg,Phenotype,ALP_Neg
2341,Total Cholesterol,Phenotype,Total Cholesterol
2342,Beta_Cell_1,Phenotype,Beta_Cell_1
3595,Type 2 Diabetes Mellitus,Phenotype,Type 2 Diabetes Mellitus
5273,Fasting Glucose Magic,Phenotype,Fasting Glucose Magic
5764,Hba1C Magic,Phenotype,Hba1C Magic
6204,Glutamine Fructose-6-Phosphate Amidotransferase (Gfat),Phenotype,Glutamine Fructose-6-Phosphate Amidotransferase (Gfat)
11899,Fasting Insulin Magic,Phenotype,Fasting Insulin Magic
12450,Hba1C Hm3,Phenotype,Hba1C Hm3
12701,Type 1 Diabetes Mellitus,Phenotype,Type 1 Diabetes Mellitus
15974,Hip Circumference Adjusted For Bmi,Phenotype,Hip Circumference Adjusted For Bmi
15986,Waist Circumference,Phenotype,Waist Circumference
15989,Waist-Hip Ratio,Phenotype,Waist-Hip Ratio
15999,Hip Circumference,Phenotype,Hip Circumference
16010,Response To Homoharringtonine (Cytotoxicity),Phenotype,Response To Homoharringtonine (Cytotoxicity)
16021,Thrombomodulin Levels In Ischemic Stroke,Phenotype,Thrombomodulin Levels In Ischemic Stroke
16023,Creatinine Levels In Ischemic Stroke,Phenotype,Creatinine Levels In Ischemic Stroke
16027,Prothrombin Fragments F1+2 Levels In Ischemic Stroke,Phenotype,Prothrombin Fragments F1+2 Levels In Ischemic Stroke
16033,Clozapine-Induced Cytotoxicity,Phenotype,Clozapine-Induced Cytotoxicity
16038,Waist Circumference Adjusted For Body Mass Index,Phenotype,Waist Circumference Adjusted For Body Mass Index
16044,Trans Fatty Acid Levels,Phenotype,Trans Fatty Acid Levels
16047,Response To Inhaled Glucocorticoid Treatment In Asthma (Change In Fev1),Phenotype,Response To Inhaled Glucocorticoid Treatment In Asthma (Change In Fev1)
16049,Change In Intraocular Pressure In Response To Steroid Treatment (Triamcinolone Acetonide),Phenotype,Change In Intraocular Pressure In Response To Steroid Treatment (Triamcinolone Acetonide)
16051,Subcortical Brain Region Volumes,Phenotype,Subcortical Brain Region Volumes
16067,Bipolar Disorder,Phenotype,Bipolar Disorder
16070,Cutaneous Psoriasis,Phenotype,Cutaneous Psoriasis
16074,Psoriasis Vulgaris,Phenotype,Psoriasis Vulgaris
16080,Psoriatic Arthritis,Phenotype,Psoriatic Arthritis
16083,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Linoleic Acid),Phenotype,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Linoleic Acid)
16086,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Docosahexaenoic Acid),Phenotype,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Docosahexaenoic Acid)
16088,Plasma Omega-3 Polyunsaturated Fatty Acid Level (Eicosapentaenoic Acid),Phenotype,Plasma Omega-3 Polyunsaturated Fatty Acid Level (Eicosapentaenoic Acid)
16093,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Gamma-Linolenic Acid),Phenotype,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Gamma-Linolenic Acid)
16096,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Arachidonic Acid),Phenotype,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Arachidonic Acid)
16100,Delta-5 Desaturase Activity,Phenotype,Delta-5 Desaturase Activity
16103,Waist-To-Hip Ratio Adjusted For Body Mass Index,Phenotype,Waist-To-Hip Ratio Adjusted For Body Mass Index
16108,Verbal Declarative Memory,Phenotype,Verbal Declarative Memory
16110,Peanut Allergy,Phenotype,Peanut Allergy
16112,Egg Allergy,Phenotype,Egg Allergy
16115,Qt Interval,Phenotype,Qt Interval
16120,Celiac Disease,Phenotype,Celiac Disease
16124,Beta-2 Microglubulin Plasma Levels,Phenotype,Beta-2 Microglubulin Plasma Levels
16131,Rheumatoid Arthritis,Phenotype,Rheumatoid Arthritis
16136,Asymmetrical Dimethylarginine Levels,Phenotype,Asymmetrical Dimethylarginine Levels
16140,Symmetrical Dimethylarginine Levels,Phenotype,Symmetrical Dimethylarginine Levels
16142,Serum Dimethylarginine Levels (Asymmetric/Symetric Ratio),Phenotype,Serum Dimethylarginine Levels (Asymmetric/Symetric Ratio)
16149,Lipid Metabolism Phenotypes,Phenotype,Lipid Metabolism Phenotypes
16154,Type 2 Diabetes,Phenotype,Type 2 Diabetes
16156,Complement C3 And C4 Levels,Phenotype,Complement C3 And C4 Levels
16165,Metabolite Levels,Phenotype,Metabolite Levels
16171,Systemic Lupus Erythematosus And Systemic Sclerosis,Phenotype,Systemic Lupus Erythematosus And Systemic Sclerosis
16179,Colorectal Cancer,Phenotype,Colorectal Cancer
16181,Alzheimer'S Disease (Apoe E4 Interaction),Phenotype,Alzheimer'S Disease (Apoe E4 Interaction)
16183,Alzheimer'S Disease In Apoe E4+ Carriers,Phenotype,Alzheimer'S Disease In Apoe E4+ Carriers
16189,Antibody Level In Response To Infection,Phenotype,Antibody Level In Response To Infection
16191,Maximal Oxygen Uptake Response,Phenotype,Maximal Oxygen Uptake Response
16193,Hdl Cholesterol In Hiv-Infection,Phenotype,Hdl Cholesterol In Hiv-Infection
16195,Magnesium Levels,Phenotype,Magnesium Levels
16197,Cutaneous Lupus Erythematosus,Phenotype,Cutaneous Lupus Erythematosus
16205,Vein Graft Stenosis In Coronary Artery Bypass Grafting,Phenotype,Vein Graft Stenosis In Coronary Artery Bypass Grafting
16209,Sasang Constitutional Medicine Type (So-Eum),Phenotype,Sasang Constitutional Medicine Type (So-Eum)
16211,Psoriasis,Phenotype,Psoriasis
16215,Diisocyanate-Induced Asthma,Phenotype,Diisocyanate-Induced Asthma
16219,Type 1 Diabetes And Autoimmune Thyroid Diseases,Phenotype,Type 1 Diabetes And Autoimmune Thyroid Diseases
16227,Leishmaniasis (Visceral),Phenotype,Leishmaniasis (Visceral)
16229,Breast Cancer (Estrogen-Receptor Negative-- Progesterone-Receptor Negative-- And Human Epidermal Growth Factor-Receptor Negative),Phenotype,Breast Cancer (Estrogen-Receptor Negative-- Progesterone-Receptor Negative-- And Human Epidermal Growth Factor-Receptor Negative)
16231,Brugada Syndrome,Phenotype,Brugada Syndrome
16233,Obesity (Early Onset Extreme),Phenotype,Obesity (Early Onset Extreme)
16234,Gray Matter Volume (Schizophrenia Interaction),Phenotype,Gray Matter Volume (Schizophrenia Interaction)
16236,Chronic Hepatitis C Infection,Phenotype,Chronic Hepatitis C Infection
16238,Ulcerative Colitis,Phenotype,Ulcerative Colitis
16243,Plasma Plasminogen Levels,Phenotype,Plasma Plasminogen Levels
16247,Mammographic Density,Phenotype,Mammographic Density
16249,Thiazide-Induced Adverse Metabolic Effects In Hypertensive Patients,Phenotype,Thiazide-Induced Adverse Metabolic Effects In Hypertensive Patients
16258,Response To Chemotherapy In Breast Cancer Hypertensive Cases (Cumulative Dose) (Bevacizumab),Phenotype,Response To Chemotherapy In Breast Cancer Hypertensive Cases (Cumulative Dose) (Bevacizumab)
16261,Sickle Cell Anemia (Haemolysis),Phenotype,Sickle Cell Anemia (Haemolysis)
16269,Red Blood Cell Traits,Phenotype,Red Blood Cell Traits
16277,Stroke (Ischemic),Phenotype,Stroke (Ischemic)
16279,Febrile Seizures (Mmr Vaccine-Related),Phenotype,Febrile Seizures (Mmr Vaccine-Related)
16282,Rheumatoid Arthritis (Acpa-Negative),Phenotype,Rheumatoid Arthritis (Acpa-Negative)
16285,Multiple Cancers (Lung Cancer-- Gastric Cancer-- And Squamous Cell Carcinoma),Phenotype,Multiple Cancers (Lung Cancer-- Gastric Cancer-- And Squamous Cell Carcinoma)
16287,Very Long-Chain Saturated Fatty Acid Levels (Fatty Acid 20:0),Phenotype,Very Long-Chain Saturated Fatty Acid Levels (Fatty Acid 20:0)
16290,Heschl'S Gyrus Morphology,Phenotype,Heschl'S Gyrus Morphology
16293,Crohn'S Disease,Phenotype,Crohn'S Disease
16298,Age-Related Nuclear Cataracts,Phenotype,Age-Related Nuclear Cataracts
16301,Pulmonary Function In Asthmatics,Phenotype,Pulmonary Function In Asthmatics
16303,Response To Thiopurine Immunosuppressants In Inflammatory Bowel Disease (Pancreatitis) (Azathioprine And Mercaptopurine),Phenotype,Response To Thiopurine Immunosuppressants In Inflammatory Bowel Disease (Pancreatitis) (Azathioprine And Mercaptopurine)
16305,Schizophrenia (Inflammation And Infection Response Interaction),Phenotype,Schizophrenia (Inflammation And Infection Response Interaction)
16307,Nonsyndromic Cleft Lip With Or Without Cleft Palate,Phenotype,Nonsyndromic Cleft Lip With Or Without Cleft Palate
16309,Number Of Pregnancies,Phenotype,Number Of Pregnancies
16311,Spontaneous Preterm Birth (Preterm Birth),Phenotype,Spontaneous Preterm Birth (Preterm Birth)
16314,Psychotic Symptoms And Prion Disease,Phenotype,Psychotic Symptoms And Prion Disease
16316,Behavioral Disturbance Or Psychiatric Symptoms In Prion Disease,Phenotype,Behavioral Disturbance Or Psychiatric Symptoms In Prion Disease
16318,Response To Serotonin Reuptake Inhibitors In Major Depressive Disorder,Phenotype,Response To Serotonin Reuptake Inhibitors In Major Depressive Disorder
16322,Prostate Cancer,Phenotype,Prostate Cancer
16329,Serum Total Protein Levels,Phenotype,Serum Total Protein Levels
16331,Dental Caries,Phenotype,Dental Caries
16333,Iron Status Biomarkers (Ferritin Levels),Phenotype,Iron Status Biomarkers (Ferritin Levels)
16335,Iron Status Biomarkers (Transferrin Saturation),Phenotype,Iron Status Biomarkers (Transferrin Saturation)
16336,Iron Status Biomarkers (Iron Levels),Phenotype,Iron Status Biomarkers (Iron Levels)
16337,Iron Status Biomarkers (Transferrin Levels),Phenotype,Iron Status Biomarkers (Transferrin Levels)
16338,Vogt-Koyanagi-Harada Syndrome,Phenotype,Vogt-Koyanagi-Harada Syndrome
16341,Nasopharyngeal Carcinoma (Snp X Snp Interaction),Phenotype,Nasopharyngeal Carcinoma (Snp X Snp Interaction)
16356,Gastritis,Phenotype,Gastritis
16358,Platelet Count,Phenotype,Platelet Count
16360,Melanoma,Phenotype,Melanoma
16363,Response To Efavirenz-Containing Treatment In Hiv 1 Infection (Virologic Failure),Phenotype,Response To Efavirenz-Containing Treatment In Hiv 1 Infection (Virologic Failure)
16367,Response To Abacavir-Containing Treatment In Hiv-1 Infection (Virologic Failure),Phenotype,Response To Abacavir-Containing Treatment In Hiv-1 Infection (Virologic Failure)
16372,Sleep Time,Phenotype,Sleep Time
16374,Sleep Quality,Phenotype,Sleep Quality
16376,Sleep Duration,Phenotype,Sleep Duration
16379,Allergic Sensitization,Phenotype,Allergic Sensitization
16387,Pancreatic Cancer,Phenotype,Pancreatic Cancer
16389,Cardiac Troponin-T Levels,Phenotype,Cardiac Troponin-T Levels
16392,Multiple Sclerosis,Phenotype,Multiple Sclerosis
16394,Body Mass Index (Change Over Time),Phenotype,Body Mass Index (Change Over Time)
16396,Hodgkin'S Lymphoma,Phenotype,Hodgkin'S Lymphoma
16399,Follicular Lymphoma,Phenotype,Follicular Lymphoma
16401,Red Wine Liking,Phenotype,Red Wine Liking
16403,White Wine Liking,Phenotype,White Wine Liking
16404,Chronic Hepatitis B Infection,Phenotype,Chronic Hepatitis B Infection
16416,Number Of Children (6+ Vs. 0 Or 1),Phenotype,Number Of Children (6+ Vs. 0 Or 1)
16420,Number Of Children,Phenotype,Number Of Children
16423,Survival In Microsatellite Instability Low/Stable Colorectal Cancer,Phenotype,Survival In Microsatellite Instability Low/Stable Colorectal Cancer
16426,Survival In Rectal Cancer,Phenotype,Survival In Rectal Cancer
16428,Sitting Height Ratio,Phenotype,Sitting Height Ratio
16431,Information Processing Speed,Phenotype,Information Processing Speed
16438,Polychlorinated Biphenyl Levels,Phenotype,Polychlorinated Biphenyl Levels
16440,Myeloproliferative Neoplasms,Phenotype,Myeloproliferative Neoplasms
16447,Blood Pressure,Phenotype,Blood Pressure
16451,Food Antigen Igg Levels,Phenotype,Food Antigen Igg Levels
16453,Diffuse Large B Cell Lymphoma,Phenotype,Diffuse Large B Cell Lymphoma
16457,Plasma Plasminogen Activator Levels,Phenotype,Plasma Plasminogen Activator Levels
16459,Hepatitis,Phenotype,Hepatitis
16466,Bladder Cancer (Smoking Interaction),Phenotype,Bladder Cancer (Smoking Interaction)
16469,Telomere Length,Phenotype,Telomere Length
16471,Carotid Intima Media Thickness,Phenotype,Carotid Intima Media Thickness
16473,Cytomegalovirus Antibody Response,Phenotype,Cytomegalovirus Antibody Response
16475,Sarcoidosis,Phenotype,Sarcoidosis
16477,Menarche (Age At Onset),Phenotype,Menarche (Age At Onset)
16496,Lipoprotein (A) - Cholesterol Levels,Phenotype,Lipoprotein (A) - Cholesterol Levels
16511,Urate Levels In Lean Individuals,Phenotype,Urate Levels In Lean Individuals
16514,Urate Levels In Overweight Individuals,Phenotype,Urate Levels In Overweight Individuals
16529,Adamts13 Activity,Phenotype,Adamts13 Activity
16531,Recalcitrant Atopic Dermatitis,Phenotype,Recalcitrant Atopic Dermatitis
16533,Serum Ige Levels,Phenotype,Serum Ige Levels
16536,Chronic Obstructive Pulmonary Disease-Related Biomarkers,Phenotype,Chronic Obstructive Pulmonary Disease-Related Biomarkers
16544,Cataracts In Type 2 Diabetes,Phenotype,Cataracts In Type 2 Diabetes
16547,Coronary Heart Disease,Phenotype,Coronary Heart Disease
16549,Alcohol Dependence,Phenotype,Alcohol Dependence
16551,Facial Pigmentation,Phenotype,Facial Pigmentation
16559,Behavioural Disinhibition (Generation Interaction),Phenotype,Behavioural Disinhibition (Generation Interaction)
16562,Lipid Traits,Phenotype,Lipid Traits
16563,Acne (Severe),Phenotype,Acne (Severe)
16565,Anger,Phenotype,Anger
16571,Adiponectin Levels,Phenotype,Adiponectin Levels
16573,Chronic Lymphocytic Leukemia,Phenotype,Chronic Lymphocytic Leukemia
16578,Preschool Internalizing Problems,Phenotype,Preschool Internalizing Problems
16580,Glycated Hemoglobin Levels,Phenotype,Glycated Hemoglobin Levels
16584,Endometrial Cancer,Phenotype,Endometrial Cancer
16587,Antinuclear Antibody Levels,Phenotype,Antinuclear Antibody Levels
16591,Interferon Alpha Levels In Systemic Lupus Erythematosus,Phenotype,Interferon Alpha Levels In Systemic Lupus Erythematosus
16593,Thyroid Peroxidase Antibody Positivity,Phenotype,Thyroid Peroxidase Antibody Positivity
16595,Immune Response To Measles-Mumps-Rubella Vaccine,Phenotype,Immune Response To Measles-Mumps-Rubella Vaccine
16597,Systemic Lupus Erythematosus,Phenotype,Systemic Lupus Erythematosus
16602,General Cognitive Ability,Phenotype,General Cognitive Ability
16606,Enteric Fever,Phenotype,Enteric Fever
16608,Parkinson'S Disease,Phenotype,Parkinson'S Disease
16611,Breast Cancer (Menopausal Hormone Therapy Interaction),Phenotype,Breast Cancer (Menopausal Hormone Therapy Interaction)
16613,Political Ideology,Phenotype,Political Ideology
16615,Serum Uric Acid Levels,Phenotype,Serum Uric Acid Levels
16616,Birth Weight,Phenotype,Birth Weight
16618,Hdl Cholesterol,Phenotype,Hdl Cholesterol
16619,Bronchopulmonary Dysplasia,Phenotype,Bronchopulmonary Dysplasia
16622,Puberty Onset (Genital Enlargement),Phenotype,Puberty Onset (Genital Enlargement)
16623,Puberty Onset (Breast Development),Phenotype,Puberty Onset (Breast Development)
16625,Puberty Onset,Phenotype,Puberty Onset
16627,Response To Statins (Ldl Cholesterol Change),Phenotype,Response To Statins (Ldl Cholesterol Change)
16631,Tourette'S Syndrome Or Obsessive-Compulsive Disorder,Phenotype,Tourette'S Syndrome Or Obsessive-Compulsive Disorder
16634,Chemerin Levels,Phenotype,Chemerin Levels
16636,Hypospadias,Phenotype,Hypospadias
16643,Breastfeeding Duration,Phenotype,Breastfeeding Duration
16645,Hyperopia,Phenotype,Hyperopia
16648,Myopia,Phenotype,Myopia
16650,Iron Status Biomarkers,Phenotype,Iron Status Biomarkers
16652,Serum Thyroid-Stimulating Hormone Levels,Phenotype,Serum Thyroid-Stimulating Hormone Levels
16654,Bone Mineral Density,Phenotype,Bone Mineral Density
16658,Vitiligo,Phenotype,Vitiligo
16661,Vertical Cup-Disc Ratio,Phenotype,Vertical Cup-Disc Ratio
16665,Bipolar Disorder (Body Mass Index Interaction),Phenotype,Bipolar Disorder (Body Mass Index Interaction)
16674,Kidney Function Decline Traits,Phenotype,Kidney Function Decline Traits
16676,Airway Responsiveness In Chronic Obstructive Pulmonary Disease,Phenotype,Airway Responsiveness In Chronic Obstructive Pulmonary Disease
16680,Cognitive Function,Phenotype,Cognitive Function
16682,Cervical Artery Dissection,Phenotype,Cervical Artery Dissection
16691,Non-Alcoholic Fatty Liver Disease Histology (Other),Phenotype,Non-Alcoholic Fatty Liver Disease Histology (Other)
16694,Multiple Myeloma,Phenotype,Multiple Myeloma
16696,Alzheimer'S Disease,Phenotype,Alzheimer'S Disease
16698,Educational Attainment,Phenotype,Educational Attainment
16705,Acute Anterior Uveitis (With Or Without Ankylosing Spondylitis),Phenotype,Acute Anterior Uveitis (With Or Without Ankylosing Spondylitis)
16712,Acute Anterior Uveitis In Ankylosing Spondylitis,Phenotype,Acute Anterior Uveitis In Ankylosing Spondylitis
16715,Refractive Astigmatism,Phenotype,Refractive Astigmatism
16717,Social Autistic-Like Traits,Phenotype,Social Autistic-Like Traits
16721,Lung Cancer (Dna Repair Capacity),Phenotype,Lung Cancer (Dna Repair Capacity)
16724,Fibrinogen,Phenotype,Fibrinogen
16726,Systolic Blood Pressure (Alcohol Consumption Interaction),Phenotype,Systolic Blood Pressure (Alcohol Consumption Interaction)
16729,Autoimmune Hepatitis Type-1,Phenotype,Autoimmune Hepatitis Type-1
16731,Mitochondrial Dna Levels,Phenotype,Mitochondrial Dna Levels
16734,Breast Cancer,Phenotype,Breast Cancer
16737,Breast Cancer (Early Onset),Phenotype,Breast Cancer (Early Onset)
16741,Plasma Homocysteine Levels (Post-Methionine Load Test),Phenotype,Plasma Homocysteine Levels (Post-Methionine Load Test)
16743,Central Corneal Thickness,Phenotype,Central Corneal Thickness
16745,Periodontal Disease-Related Phenotype (Socransky),Phenotype,Periodontal Disease-Related Phenotype (Socransky)
16747,Response To Inhaled Corticosteroid Treatment In Asthma (Change In Fev1),Phenotype,Response To Inhaled Corticosteroid Treatment In Asthma (Change In Fev1)
16749,Response To Antipsychotic Therapy (Extrapyramidal Side Effects),Phenotype,Response To Antipsychotic Therapy (Extrapyramidal Side Effects)
16751,Fetal Hemoglobin Levels In Sickle Cell Anemia,Phenotype,Fetal Hemoglobin Levels In Sickle Cell Anemia
16756,Methotrexate Pharmacokinetics (Acute Lymphoblastic Leukemia),Phenotype,Methotrexate Pharmacokinetics (Acute Lymphoblastic Leukemia)
16761,Glaucoma,Phenotype,Glaucoma
16767,Ossification Of The Posterior Longitudinal Ligament Of The Spine,Phenotype,Ossification Of The Posterior Longitudinal Ligament Of The Spine
16770,Schizophrenia Or Bipolar Disorder,Phenotype,Schizophrenia Or Bipolar Disorder
16772,Mixed Cryoglobulinemia Vasculitis In Chronic Hepatitis C Infection,Phenotype,Mixed Cryoglobulinemia Vasculitis In Chronic Hepatitis C Infection
16775,Diabetic Retinopathy In Type 2 Diabetes,Phenotype,Diabetic Retinopathy In Type 2 Diabetes
16779,Asthma And Hay Fever,Phenotype,Asthma And Hay Fever
16782,Cervical Cancer,Phenotype,Cervical Cancer
16785,Tuberculosis,Phenotype,Tuberculosis
16793,Laryngeal Squamous Cell Carcinoma,Phenotype,Laryngeal Squamous Cell Carcinoma
16796,Breast Cancer (Survival),Phenotype,Breast Cancer (Survival)
16798,Electroencephalogram Traits,Phenotype,Electroencephalogram Traits
16804,Obesity-Related Traits,Phenotype,Obesity-Related Traits
16806,Illicit Drug Use,Phenotype,Illicit Drug Use
16808,Non-Substance Related Behavioral Disinhibition,Phenotype,Non-Substance Related Behavioral Disinhibition
16809,Asthma (Sex Interaction),Phenotype,Asthma (Sex Interaction)
16813,Acute Urticaria And Angioedema (Non-Steroidal Anti-Inflammatory Drug-Induced),Phenotype,Acute Urticaria And Angioedema (Non-Steroidal Anti-Inflammatory Drug-Induced)
16819,Lupus Nephritis In Systemic Lupus Erythematosus,Phenotype,Lupus Nephritis In Systemic Lupus Erythematosus
16825,Bone Mineral Density (Paediatric-- Upper Limb),Phenotype,Bone Mineral Density (Paediatric-- Upper Limb)
16827,Bone Mineral Density (Paediatric-- Skull),Phenotype,Bone Mineral Density (Paediatric-- Skull)
16831,Bone Mineral Density (Paediatric-- Total Body Less Head),Phenotype,Bone Mineral Density (Paediatric-- Total Body Less Head)
16833,Reading Disability Or Specific Language Impairment (Pleiotropy),Phenotype,Reading Disability Or Specific Language Impairment (Pleiotropy)
16835,Reading Disability Or Specific Language Impairment Adjusted For Intelligence Quotient (Pleiotropy),Phenotype,Reading Disability Or Specific Language Impairment Adjusted For Intelligence Quotient (Pleiotropy)
16836,Colorectal Cancer (Calcium Intake Interaction),Phenotype,Colorectal Cancer (Calcium Intake Interaction)
16838,Psychosis (Atypical),Phenotype,Psychosis (Atypical)
16841,Height Adjusted Bmi,Phenotype,Height Adjusted Bmi
16842,Response To Cytadine Analogues (Cytosine Arabinoside),Phenotype,Response To Cytadine Analogues (Cytosine Arabinoside)
16844,Barrett'S Esophagus,Phenotype,Barrett'S Esophagus
16847,Neuroblastoma,Phenotype,Neuroblastoma
16851,C-Reactive Protein,Phenotype,C-Reactive Protein
16854,Aids Progression,Phenotype,Aids Progression
16858,Smoking Quantity,Phenotype,Smoking Quantity
16861,Smoking Initiation,Phenotype,Smoking Initiation
16865,C-Reactive Protein Levels,Phenotype,C-Reactive Protein Levels
16867,Hypertension,Phenotype,Hypertension
16869,Birth Length,Phenotype,Birth Length
16871,Infant Length,Phenotype,Infant Length
16874,Systolic Blood Pressure,Phenotype,Systolic Blood Pressure
16876,Diastolic Blood Pressure,Phenotype,Diastolic Blood Pressure
16877,Alzheimer'S Disease (Age Of Onset),Phenotype,Alzheimer'S Disease (Age Of Onset)
16880,Age-Related Hearing Impairment (Snp X Snp Interaction),Phenotype,Age-Related Hearing Impairment (Snp X Snp Interaction)
16897,Age-Related Hearing Impairment,Phenotype,Age-Related Hearing Impairment
16904,Ige Levels,Phenotype,Ige Levels
16907,Iga Nephropathy,Phenotype,Iga Nephropathy
16919,Thyroid Peroxidase Antibody Levels,Phenotype,Thyroid Peroxidase Antibody Levels
16923,Response To Taxane Treatment (Paclitaxel),Phenotype,Response To Taxane Treatment (Paclitaxel)
16925,Response To Antipsychotic Treatment,Phenotype,Response To Antipsychotic Treatment
16933,Myopia (Pathological),Phenotype,Myopia (Pathological)
16940,Resting Heart Rate,Phenotype,Resting Heart Rate
16942,Asthma,Phenotype,Asthma
16944,Amyotrophic Lateral Sclerosis,Phenotype,Amyotrophic Lateral Sclerosis
16946,Narcolepsy (Onset Before 2009 H1N1 Influenza Pandemic),Phenotype,Narcolepsy (Onset Before 2009 H1N1 Influenza Pandemic)
16949,Narcolepsy (Age Of Onset),Phenotype,Narcolepsy (Age Of Onset)
16953,Ige Levels In Asthmatics (D.F. Specific),Phenotype,Ige Levels In Asthmatics (D.F. Specific)
16955,Hepatitis B Vaccine Response,Phenotype,Hepatitis B Vaccine Response
16958,Lung Function (Forced Vital Capacity),Phenotype,Lung Function (Forced Vital Capacity)
16961,Endometriosis,Phenotype,Endometriosis
16969,Mammographic Density (Dense Area),Phenotype,Mammographic Density (Dense Area)
16971,Mammographic Density (Non-Dense Area),Phenotype,Mammographic Density (Non-Dense Area)
16973,Overweight Status,Phenotype,Overweight Status
16975,Educational Attainment (Years Of Education),Phenotype,Educational Attainment (Years Of Education)
16977,Educational Attainment (College Completion),Phenotype,Educational Attainment (College Completion)
16983,Nonsyndromic Cleft Lip With Cleft Palate,Phenotype,Nonsyndromic Cleft Lip With Cleft Palate
16986,Post Bronchodilator Fev1/Fvc Ratio,Phenotype,Post Bronchodilator Fev1/Fvc Ratio
16999,Antithyroid Drug-Induced Agranulocytosis,Phenotype,Antithyroid Drug-Induced Agranulocytosis
17001,Hematocrit,Phenotype,Hematocrit
17021,Mean Corpuscular Hemoglobin Concentration,Phenotype,Mean Corpuscular Hemoglobin Concentration
17042,Presence Of Antiphospholipid Antibodies,Phenotype,Presence Of Antiphospholipid Antibodies
17044,Eosinophil Counts,Phenotype,Eosinophil Counts
17058,Loneliness (Multivariate Analysis),Phenotype,Loneliness (Multivariate Analysis)
17061,Loneliness,Phenotype,Loneliness
17063,Loneliness (Linear Analysis),Phenotype,Loneliness (Linear Analysis)
17070,Inflammatory Bowel Disease,Phenotype,Inflammatory Bowel Disease
17071,Drug-Induced Liver Injury,Phenotype,Drug-Induced Liver Injury
17073,Spherical Equivalent (Joint Analysis Main Effects And Education Interaction),Phenotype,Spherical Equivalent (Joint Analysis Main Effects And Education Interaction)
17077,Oppositional Defiant Disorder Dimensions In Attention-Deficit Hyperactivity Disorder,Phenotype,Oppositional Defiant Disorder Dimensions In Attention-Deficit Hyperactivity Disorder
17080,Aggressiveness In Attention Deficit Hyperactivity Disorder,Phenotype,Aggressiveness In Attention Deficit Hyperactivity Disorder
17083,Diastolic Blood Pressure Response To Hydrochlorothiazide In Hypertension,Phenotype,Diastolic Blood Pressure Response To Hydrochlorothiazide In Hypertension
17085,Systolic Blood Pressure Response To Hydrochlorothiazide In Hypertension,Phenotype,Systolic Blood Pressure Response To Hydrochlorothiazide In Hypertension
17100,Lung Cancer,Phenotype,Lung Cancer
17102,Smoking Status (Current Vs Former),Phenotype,Smoking Status (Current Vs Former)
17104,Bone Mineral Density (Ward'S Triangle Area),Phenotype,Bone Mineral Density (Ward'S Triangle Area)
17108,Clozapine-Induced Agranulocytosis/Granulocytopenia In Treatment-Resistant Schizophrenia,Phenotype,Clozapine-Induced Agranulocytosis/Granulocytopenia In Treatment-Resistant Schizophrenia
17113,Eosinophil Percentage Of White Cells,Phenotype,Eosinophil Percentage Of White Cells
17117,Response To Paclitaxel In Ovarian Cancer (Caspase 3/7 Ec50),Phenotype,Response To Paclitaxel In Ovarian Cancer (Caspase 3/7 Ec50)
17119,Glaucoma (Primary Open-Angle),Phenotype,Glaucoma (Primary Open-Angle)
17121,Mean Corpuscular Volume,Phenotype,Mean Corpuscular Volume
17131,Midgestational Circulating Levels Of Pcbs (Fetal Genetic Effect),Phenotype,Midgestational Circulating Levels Of Pcbs (Fetal Genetic Effect)
17133,Midgestational Circulating Levels Of Pbdes,Phenotype,Midgestational Circulating Levels Of Pbdes
17135,Midgestational Circulating Levels Of Pbdes (Fetal Genetic Effect),Phenotype,Midgestational Circulating Levels Of Pbdes (Fetal Genetic Effect)
17137,Midgestational Circulating Levels Of Pcbs,Phenotype,Midgestational Circulating Levels Of Pcbs
17142,Cerebrospinal P-Tau181P Levels,Phenotype,Cerebrospinal P-Tau181P Levels
17144,C-Reactive Protein Levels Or Hdl-Cholesterol Levels (Pleiotropy),Phenotype,C-Reactive Protein Levels Or Hdl-Cholesterol Levels (Pleiotropy)
17147,C-Reactive Protein Levels Or Ldl-Cholesterol Levels (Pleiotropy),Phenotype,C-Reactive Protein Levels Or Ldl-Cholesterol Levels (Pleiotropy)
17150,C-Reactive Protein Levels Or Total Cholesterol Levels (Pleiotropy),Phenotype,C-Reactive Protein Levels Or Total Cholesterol Levels (Pleiotropy)
17153,Cerebrospinal Fluid Ab1-42 Levels,Phenotype,Cerebrospinal Fluid Ab1-42 Levels
17156,C-Reactive Protein Levels Or Triglyceride Levels (Pleiotropy),Phenotype,C-Reactive Protein Levels Or Triglyceride Levels (Pleiotropy)
17164,Red Blood Cell Count,Phenotype,Red Blood Cell Count
17169,Hemoglobin Levels,Phenotype,Hemoglobin Levels
17175,Ischemic Stroke,Phenotype,Ischemic Stroke
17177,Small Vessel Stroke,Phenotype,Small Vessel Stroke
17179,Caffeine Metabolism (Plasma 1--7-Dimethylxanthine (Paraxanthine) Level),Phenotype,Caffeine Metabolism (Plasma 1--7-Dimethylxanthine (Paraxanthine) Level)
17181,Neuroticism,Phenotype,Neuroticism
17199,Non-Response To Antidepressants And Depression,Phenotype,Non-Response To Antidepressants And Depression
17201,Response To Citalopram Or Escitalopram In Depression,Phenotype,Response To Citalopram Or Escitalopram In Depression
17203,Non-Response To Citalopram Or Escitalopram And Depression,Phenotype,Non-Response To Citalopram Or Escitalopram And Depression
17205,Gout,Phenotype,Gout
17208,Renal Underexcretion Gout,Phenotype,Renal Underexcretion Gout
17209,Core Binding Factor Acute Myeloid Leukemia,Phenotype,Core Binding Factor Acute Myeloid Leukemia
17282,Sleep Traits (Multi-Trait Analysis),Phenotype,Sleep Traits (Multi-Trait Analysis)
17284,Insomnia,Phenotype,Insomnia
17286,Monocyte Count,Phenotype,Monocyte Count
17288,Mathematical Ability,Phenotype,Mathematical Ability
17311,Cerebrospinal T-Tau Levels,Phenotype,Cerebrospinal T-Tau Levels
17313,Chronic Inflammatory Diseases (Ankylosing Spondylitis-- Crohn'S Disease-- Psoriasis-- Primary Sclerosing Cholangitis-- Ulcerative Colitis) (Pleiotropy),Phenotype,Chronic Inflammatory Diseases (Ankylosing Spondylitis-- Crohn'S Disease-- Psoriasis-- Primary Sclerosing Cholangitis-- Ulcerative Colitis) (Pleiotropy)
17324,Mean Corpuscular Hemoglobin,Phenotype,Mean Corpuscular Hemoglobin
17327,Optic Cup Area,Phenotype,Optic Cup Area
17331,Granulocyte Percentage Of Myeloid White Cells,Phenotype,Granulocyte Percentage Of Myeloid White Cells
17349,Pulse Pressure,Phenotype,Pulse Pressure
17358,Post Bronchodilator Fev1,Phenotype,Post Bronchodilator Fev1
17363,Cholesterol-- Total,Phenotype,Cholesterol-- Total
17366,Body Fat Percentage,Phenotype,Body Fat Percentage
17367,Height,Phenotype,Height
17398,Bortezomib-Induced Peripheral Neuropathy In Multiple Myeloma,Phenotype,Bortezomib-Induced Peripheral Neuropathy In Multiple Myeloma
17405,Monocyte Percentage Of White Cells,Phenotype,Monocyte Percentage Of White Cells
17420,Migraine,Phenotype,Migraine
17427,Hypothyroidism,Phenotype,Hypothyroidism
17434,Breast Size,Phenotype,Breast Size
17441,Monobrow,Phenotype,Monobrow
17443,Vasculitis Associated With Antineutrophil Cytoplasmic Antibody Reactive To Myeloperoxidase,Phenotype,Vasculitis Associated With Antineutrophil Cytoplasmic Antibody Reactive To Myeloperoxidase
17445,Antineutrophil Cytoplasmic Antibody-Associated Vasculitis,Phenotype,Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
17449,Lung Function (Fev1/Fvc) In Asthma (Dust Mite Allergen Exposure Interaction),Phenotype,Lung Function (Fev1/Fvc) In Asthma (Dust Mite Allergen Exposure Interaction)
17451,White Blood Cell Count,Phenotype,White Blood Cell Count
17470,Male-Pattern Baldness,Phenotype,Male-Pattern Baldness
17487,Plateletcrit,Phenotype,Plateletcrit
17514,Venous Thromboembolism Adjusted For Sickle Cell Variant Rs77121243-T,Phenotype,Venous Thromboembolism Adjusted For Sickle Cell Variant Rs77121243-T
17527,Carotid Plaque Burden,Phenotype,Carotid Plaque Burden
17535,Clopidogrel Active Metabolite Levels,Phenotype,Clopidogrel Active Metabolite Levels
17545,Tonsillectomy,Phenotype,Tonsillectomy
17554,Age At Voice Drop,Phenotype,Age At Voice Drop
17562,Optic Disc Area,Phenotype,Optic Disc Area
17569,Sepsis In Extremely Premature Infants,Phenotype,Sepsis In Extremely Premature Infants
17590,Allergy,Phenotype,Allergy
17593,Photic Sneeze Reflex,Phenotype,Photic Sneeze Reflex
17602,Childhood Ear Infection,Phenotype,Childhood Ear Infection
17606,Chin Dimples,Phenotype,Chin Dimples
17610,Prostate-Specific Antigen Levels,Phenotype,Prostate-Specific Antigen Levels
17615,Nose Size,Phenotype,Nose Size
17621,Joint Mobility (Beighton Score),Phenotype,Joint Mobility (Beighton Score)
17629,Prostate-Specific Antigen Levels (Conditioned On Lead Snps),Phenotype,Prostate-Specific Antigen Levels (Conditioned On Lead Snps)
17633,Response To Paliperidone In Schizophrenia (Positive Marder Score),Phenotype,Response To Paliperidone In Schizophrenia (Positive Marder Score)
17635,Response To Paliperidone In Schizophrenia (Negative Marder Score),Phenotype,Response To Paliperidone In Schizophrenia (Negative Marder Score)
17640,Parental Longevity (Mother'S Age At Death),Phenotype,Parental Longevity (Mother'S Age At Death)
17644,Parental Longevity (Combined Parental Age At Death),Phenotype,Parental Longevity (Combined Parental Age At Death)
17647,Cannabis Dependence Symptom Count,Phenotype,Cannabis Dependence Symptom Count
17653,Anti-Thyroid Drug Induced Agranulocytosis,Phenotype,Anti-Thyroid Drug Induced Agranulocytosis
17656,Non-Chemotherapy Drug Induced Agranulocytosis,Phenotype,Non-Chemotherapy Drug Induced Agranulocytosis
17659,Celiac Disease And Rheumatoid Arthritis,Phenotype,Celiac Disease And Rheumatoid Arthritis
17664,Liver Fibrosis Severity In Hiv/Hepatitis C Co-Infection,Phenotype,Liver Fibrosis Severity In Hiv/Hepatitis C Co-Infection
17667,Collagenous Colitis,Phenotype,Collagenous Colitis
17670,Migraine Without Aura,Phenotype,Migraine Without Aura
17677,Endometrial Endometrioid Carcinoma,Phenotype,Endometrial Endometrioid Carcinoma
17690,Response To Antidepressants And Depression,Phenotype,Response To Antidepressants And Depression
17692,Posterior Cortical Atrophy And Alzheimer'S Disease,Phenotype,Posterior Cortical Atrophy And Alzheimer'S Disease
17696,Cancer (Pleiotropy),Phenotype,Cancer (Pleiotropy)
17701,Cancer,Phenotype,Cancer
17908,Hdl Cholesterol Levels,Phenotype,Hdl Cholesterol Levels
17911,Platelet Distribution Width,Phenotype,Platelet Distribution Width
17913,Eosinophil Percentage Of Granulocytes,Phenotype,Eosinophil Percentage Of Granulocytes
17919,Atrial Fibrillation,Phenotype,Atrial Fibrillation
17928,White Blood Cell Count (Basophil),Phenotype,White Blood Cell Count (Basophil)
17936,Reticulocyte Fraction Of Red Cells,Phenotype,Reticulocyte Fraction Of Red Cells
17967,Sum Basophil Neutrophil Counts,Phenotype,Sum Basophil Neutrophil Counts
17973,Isovolumetric Relaxation Time,Phenotype,Isovolumetric Relaxation Time
17975,Aortic Root Size,Phenotype,Aortic Root Size
17977,Left Atrial Antero-Posterior Diameter,Phenotype,Left Atrial Antero-Posterior Diameter
17981,Left Ventricle Wall Thickness,Phenotype,Left Ventricle Wall Thickness
17984,Red Cell Distribution Width,Phenotype,Red Cell Distribution Width
18002,Left Ventricular Fractional Shortening,Phenotype,Left Ventricular Fractional Shortening
18004,Essential Tremor,Phenotype,Essential Tremor
18006,Liver Injury In Anti-Tuberculosis Drug Treatment,Phenotype,Liver Injury In Anti-Tuberculosis Drug Treatment
18019,Daytime Sleep Phenotypes,Phenotype,Daytime Sleep Phenotypes
18029,Night Sleep Phenotypes,Phenotype,Night Sleep Phenotypes
18045,High Light Scatter Reticulocyte Count,Phenotype,High Light Scatter Reticulocyte Count
18056,Response To Paliperidone In Schizophrenia (Cgi-S Score),Phenotype,Response To Paliperidone In Schizophrenia (Cgi-S Score)
18058,Gut Microbiota (Beta Diversity),Phenotype,Gut Microbiota (Beta Diversity)
18061,Sum Neutrophil Eosinophil Counts,Phenotype,Sum Neutrophil Eosinophil Counts
18062,Exhaled Nitric Oxide Output,Phenotype,Exhaled Nitric Oxide Output
18064,Exhaled Nitric Oxide Levels,Phenotype,Exhaled Nitric Oxide Levels
18066,Body Mass Index (Change Over Time) In Cancer Or Chronic Obstructive Pulmonary Disease,Phenotype,Body Mass Index (Change Over Time) In Cancer Or Chronic Obstructive Pulmonary Disease
18068,Body Mass Index (Change Over Time) In Lung Cancer,Phenotype,Body Mass Index (Change Over Time) In Lung Cancer
18070,Body Mass Index (Change Over Time) In Cancer,Phenotype,Body Mass Index (Change Over Time) In Cancer
18071,Granulocyte Count,Phenotype,Granulocyte Count
18072,Skin Pigmentation,Phenotype,Skin Pigmentation
18075,Age-Related Diseases-- Mortality And Associated Endophenotypes,Phenotype,Age-Related Diseases-- Mortality And Associated Endophenotypes
18077,Age-Related Diseases And Mortality,Phenotype,Age-Related Diseases And Mortality
18079,Incident Atrial Fibrillation,Phenotype,Incident Atrial Fibrillation
18081,Age-Related Disease Endophenotypes,Phenotype,Age-Related Disease Endophenotypes
18084,Hemoglobin Concentration,Phenotype,Hemoglobin Concentration
18088,Prevalent Atrial Fibrillation,Phenotype,Prevalent Atrial Fibrillation
18095,Response To Paliperidone In Schizophrenia (Panss Score),Phenotype,Response To Paliperidone In Schizophrenia (Panss Score)
18106,Immune Response To Measles Vaccine (Measles-Induced Ifn Gamma),Phenotype,Immune Response To Measles Vaccine (Measles-Induced Ifn Gamma)
18108,Gut Microbiota (Bacterial Taxa),Phenotype,Gut Microbiota (Bacterial Taxa)
18111,Gut Microbiota (Functional Units),Phenotype,Gut Microbiota (Functional Units)
18116,Systemic Sclerosis,Phenotype,Systemic Sclerosis
18118,Rr Interval (Tricyclic/Tetracyclic Antidepressant Use Interaction),Phenotype,Rr Interval (Tricyclic/Tetracyclic Antidepressant Use Interaction)
18121,High Light Scatter Reticulocyte Percentage Of Red Cells,Phenotype,High Light Scatter Reticulocyte Percentage Of Red Cells
18125,Total Cholesterol Levels,Phenotype,Total Cholesterol Levels
18129,Ldl Cholesterol Levels,Phenotype,Ldl Cholesterol Levels
18158,Triglyceride Levels,Phenotype,Triglyceride Levels
18171,Sum Eosinophil Basophil Counts,Phenotype,Sum Eosinophil Basophil Counts
18174,Otitis Media,Phenotype,Otitis Media
18176,Otitis Media (Recurrent),Phenotype,Otitis Media (Recurrent)
18177,Hepcidin/Ferritin Ratio,Phenotype,Hepcidin/Ferritin Ratio
18207,Lung Function (Fvc),Phenotype,Lung Function (Fvc)
18209,Myeloid White Cell Count,Phenotype,Myeloid White Cell Count
18395,Lung Function (Fev1),Phenotype,Lung Function (Fev1)
18399,Lung Function (Fev1/Fvc),Phenotype,Lung Function (Fev1/Fvc)
18445,Chronic Obstructive Pulmonary Disease,Phenotype,Chronic Obstructive Pulmonary Disease
18455,Lymphocyte Count,Phenotype,Lymphocyte Count
18463,Reticulocyte Count,Phenotype,Reticulocyte Count
18495,Pre-Treatment Pain In Head And Neck Squamous Cell Carcinoma,Phenotype,Pre-Treatment Pain In Head And Neck Squamous Cell Carcinoma
18499,Neutrophil Percentage Of Granulocytes,Phenotype,Neutrophil Percentage Of Granulocytes
18506,Qrs Duration,Phenotype,Qrs Duration
18509,Qrs Complex (Cornell),Phenotype,Qrs Complex (Cornell)
18511,Qrs Complex (Sokolow-Lyon),Phenotype,Qrs Complex (Sokolow-Lyon)
18515,Chronic Kidney Disease (Chronic Kidney Disease Vs Normal Or Mildly Reduced Egfr) In Type 1 Diabetes,Phenotype,Chronic Kidney Disease (Chronic Kidney Disease Vs Normal Or Mildly Reduced Egfr) In Type 1 Diabetes
18517,Qrs Complex (12-Leadsum),Phenotype,Qrs Complex (12-Leadsum)
18538,Response To Platinum-Based Neoadjuvant Chemotherapy In Cervical Cancer,Phenotype,Response To Platinum-Based Neoadjuvant Chemotherapy In Cervical Cancer
18540,Immature Fraction Of Reticulocytes,Phenotype,Immature Fraction Of Reticulocytes
18544,Hiv Progression (Cd4 And Viral Load),Phenotype,Hiv Progression (Cd4 And Viral Load)
18547,Rheumatoid Arthritis (Rheumatoid Factor And/Or Anti-Cyclic Citrullinated Peptide Seropositive),Phenotype,Rheumatoid Arthritis (Rheumatoid Factor And/Or Anti-Cyclic Citrullinated Peptide Seropositive)
18548,Acute-On-Chronic Liver Failure In Hepatitis B,Phenotype,Acute-On-Chronic Liver Failure In Hepatitis B
18660,Neutrophil Count,Phenotype,Neutrophil Count
18666,Ldl Cholesterol,Phenotype,Ldl Cholesterol
18667,Response To Fenofibrate (Hdl Cholesterol Levels),Phenotype,Response To Fenofibrate (Hdl Cholesterol Levels)
18669,Parental Extreme Longevity (95 Years And Older),Phenotype,Parental Extreme Longevity (95 Years And Older)
18677,Middle Facial Morphology Traits (Quantitative Measurement),Phenotype,Middle Facial Morphology Traits (Quantitative Measurement)
18679,Facial Morphology Traits (Multivariate Analysis),Phenotype,Facial Morphology Traits (Multivariate Analysis)
18680,Pathological Gambling,Phenotype,Pathological Gambling
18682,Gestational Age At Birth (Maternal Effect),Phenotype,Gestational Age At Birth (Maternal Effect)
18684,Gestational Age At Birth In Labor-Initiated Deliveries (Child Effect),Phenotype,Gestational Age At Birth In Labor-Initiated Deliveries (Child Effect)
18686,Gestational Age At Birth In Labor-Initiated Deliveries (Maternal Effect),Phenotype,Gestational Age At Birth In Labor-Initiated Deliveries (Maternal Effect)
18688,Egfr Mutation-Positive Lung Adenocarcinoma,Phenotype,Egfr Mutation-Positive Lung Adenocarcinoma
18704,Alcohol Consumption (Heavy Vs. Light/Non-Drinkers),Phenotype,Alcohol Consumption (Heavy Vs. Light/Non-Drinkers)
18707,Extraversion,Phenotype,Extraversion
18709,Positive Affect,Phenotype,Positive Affect
18711,Depression,Phenotype,Depression
18713,Subjective Well-Being,Phenotype,Subjective Well-Being
18716,Life Satisfaction,Phenotype,Life Satisfaction
18717,Systemic Juvenile Idiopathic Arthritis,Phenotype,Systemic Juvenile Idiopathic Arthritis
18723,Jt Interval (Sulfonylurea Treatment Interaction),Phenotype,Jt Interval (Sulfonylurea Treatment Interaction)
18725,Qrs Interval (Sulfonylurea Treatment Interaction),Phenotype,Qrs Interval (Sulfonylurea Treatment Interaction)
18751,Bone Mineral Density (Spine),Phenotype,Bone Mineral Density (Spine)
18753,Age At First Birth,Phenotype,Age At First Birth
18755,Bipolar Disorder (Age Of Onset <21) Or Attention Deficit Hyperactivity Disorder,Phenotype,Bipolar Disorder (Age Of Onset <21) Or Attention Deficit Hyperactivity Disorder
18757,Bipolar Disorder Or Attention Deficit Hyperactivity Disorder,Phenotype,Bipolar Disorder Or Attention Deficit Hyperactivity Disorder
18769,Excessive Daytime Sleepiness,Phenotype,Excessive Daytime Sleepiness
18771,Childhood Body Mass Index,Phenotype,Childhood Body Mass Index
18775,Membranous Nephropathy,Phenotype,Membranous Nephropathy
18777,Triglycerides,Phenotype,Triglycerides
18779,Stroke,Phenotype,Stroke
18781,Gastroesophageal Reflux Disease,Phenotype,Gastroesophageal Reflux Disease
18783,Severity Of Facial Solar Lentigines,Phenotype,Severity Of Facial Solar Lentigines
18786,Subcutaneous Adipose Tissue,Phenotype,Subcutaneous Adipose Tissue
18788,Visceral Adipose Tissue Adjusted For Bmi,Phenotype,Visceral Adipose Tissue Adjusted For Bmi
18790,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio,Phenotype,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio
18792,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio Adjusted For Bmi,Phenotype,Visceral Adipose Tissue/Subcutaneous Adipose Tissue Ratio Adjusted For Bmi
18799,Subcutaneous Adipose Tissue Attenuation (Hounsfield Unit Scale),Phenotype,Subcutaneous Adipose Tissue Attenuation (Hounsfield Unit Scale)
18801,Visceral Adipose Tissue Attenuation (Hounslow Unit Scale),Phenotype,Visceral Adipose Tissue Attenuation (Hounslow Unit Scale)
18802,Asparaginase-Induced Acute Pancreatitis In Acute Lymphoblastic Leukemia (Onset Time),Phenotype,Asparaginase-Induced Acute Pancreatitis In Acute Lymphoblastic Leukemia (Onset Time)
18815,Developmental Language Disorder,Phenotype,Developmental Language Disorder
18817,Developmental Language Disorder (Linguistic Errors),Phenotype,Developmental Language Disorder (Linguistic Errors)
18819,Breast Cancer (Estrogen-Receptor Negative),Phenotype,Breast Cancer (Estrogen-Receptor Negative)
18929,Protein C Levels,Phenotype,Protein C Levels
18931,B-Cell Malignancies (Chronic Lymphocytic Leukemia-- Hodgkin Lymphoma Or Multiple Myeloma) (Pleiotropy),Phenotype,B-Cell Malignancies (Chronic Lymphocytic Leukemia-- Hodgkin Lymphoma Or Multiple Myeloma) (Pleiotropy)
18941,Takotsubo Syndrome,Phenotype,Takotsubo Syndrome
18943,Plasma T-Tau Levels,Phenotype,Plasma T-Tau Levels
18945,Fibrinogen Levels,Phenotype,Fibrinogen Levels
18956,Methadone Dose In Opioid Dependence,Phenotype,Methadone Dose In Opioid Dependence
18970,Basophil Percentage Of White Cells,Phenotype,Basophil Percentage Of White Cells
18972,Lymphocyte Percentage Of White Cells,Phenotype,Lymphocyte Percentage Of White Cells
18978,Neutrophil Percentage Of White Cells,Phenotype,Neutrophil Percentage Of White Cells
18990,Pediatric Bone Mineral Density (Spine),Phenotype,Pediatric Bone Mineral Density (Spine)
18992,Pediatric Bone Mineral Content (Femoral Neck),Phenotype,Pediatric Bone Mineral Content (Femoral Neck)
18996,Pediatric Bone Mineral Density (Femoral Neck),Phenotype,Pediatric Bone Mineral Density (Femoral Neck)
18998,Pediatric Bone Mineral Density (Hip),Phenotype,Pediatric Bone Mineral Density (Hip)
18999,Pediatric Bone Mineral Content (Radius),Phenotype,Pediatric Bone Mineral Content (Radius)
19001,Pediatric Bone Mineral Content (Spine),Phenotype,Pediatric Bone Mineral Content (Spine)
19003,Basophil Percentage Of Granulocytes,Phenotype,Basophil Percentage Of Granulocytes
19005,Mean Platelet Volume,Phenotype,Mean Platelet Volume
19021,Ldl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Ldl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
19025,Ldl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),Phenotype,Ldl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df)
19035,Triglyceride Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),Phenotype,Triglyceride Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df)
19038,Longevity,Phenotype,Longevity
19041,Parental Longevity (Father'S Age At Death),Phenotype,Parental Longevity (Father'S Age At Death)
19052,Microalbuminuria In Type 1 Diabetes,Phenotype,Microalbuminuria In Type 1 Diabetes
19054,Dental Caries (Decayed-- Missing And Filled Teeth),Phenotype,Dental Caries (Decayed-- Missing And Filled Teeth)
19057,Dental Caries (Decayed And Filled Deciduous Tooth Surfaces),Phenotype,Dental Caries (Decayed And Filled Deciduous Tooth Surfaces)
19059,Dental Caries (Decayed-- Missing And Filled Tooth Surfaces),Phenotype,Dental Caries (Decayed-- Missing And Filled Tooth Surfaces)
19060,Blood Protein Levels,Phenotype,Blood Protein Levels
19068,Resistant Hypertension,Phenotype,Resistant Hypertension
19071,Heel Bone Mineral Density,Phenotype,Heel Bone Mineral Density
19080,Epigenetic Age Acceleration In Alcohol Use Disorder,Phenotype,Epigenetic Age Acceleration In Alcohol Use Disorder
19082,Phenylephrine Infusion Rate During Anesthesia,Phenotype,Phenylephrine Infusion Rate During Anesthesia
19085,High Density Lipoprotein Cholesterol Levels,Phenotype,High Density Lipoprotein Cholesterol Levels
19089,Low Density Lipoprotein Cholesterol Levels,Phenotype,Low Density Lipoprotein Cholesterol Levels
19092,Plasma Anti-Thyroglobulin And Anti-Thyroid Peroxidase Levels (Bivariate Analysis),Phenotype,Plasma Anti-Thyroglobulin And Anti-Thyroid Peroxidase Levels (Bivariate Analysis)
19094,Plasma Anti-Thyroglobulin Levels,Phenotype,Plasma Anti-Thyroglobulin Levels
19097,Plasma Anti-Thyroid Peroxidase Levels,Phenotype,Plasma Anti-Thyroid Peroxidase Levels
19103,Triglyceride Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Triglyceride Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
19104,Adolescent Idiopathic Scoliosis,Phenotype,Adolescent Idiopathic Scoliosis
19110,Waist-To-Hip Ratio Adjusted For Bmi,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi
19117,Hdl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df),Phenotype,Hdl Cholesterol Levels X Alcohol Consumption (Regular Vs Non-Regular Drinkers) Interaction (2Df)
19122,Stress Sensitivity (Neuroticism Score X Major Depressive Disorder Status Interaction),Phenotype,Stress Sensitivity (Neuroticism Score X Major Depressive Disorder Status Interaction)
19127,Peripheral Artery Disease,Phenotype,Peripheral Artery Disease
19130,Minimum Ankle–Brachial Index,Phenotype,Minimum Ankle–Brachial Index
19133,Age-Related Cognitive Decline (Memory) (Slope Of Z-Scores),Phenotype,Age-Related Cognitive Decline (Memory) (Slope Of Z-Scores)
19136,Age-Related Cognitive Decline (Visuospatial Skill) (Slope Of Z-Scores),Phenotype,Age-Related Cognitive Decline (Visuospatial Skill) (Slope Of Z-Scores)
19138,Age-Related Cognitive Decline (Attention/Processing Speed) (Slope Of Z-Scores),Phenotype,Age-Related Cognitive Decline (Attention/Processing Speed) (Slope Of Z-Scores)
19140,Age-Related Cognitive Decline (Language) (Slope Of Z-Scores),Phenotype,Age-Related Cognitive Decline (Language) (Slope Of Z-Scores)
19143,End-Stage Kidney Disease,Phenotype,End-Stage Kidney Disease
19146,Mild To Moderate Chronic Kidney Disease,Phenotype,Mild To Moderate Chronic Kidney Disease
19152,Predicted Visceral Adipose Tissue,Phenotype,Predicted Visceral Adipose Tissue
19162,Mosaic Loss Of Chromosome Y (Y Chromosome Dosage),Phenotype,Mosaic Loss Of Chromosome Y (Y Chromosome Dosage)
19168,Serum Platinum Levels After Completion Of Cisplatin Chemotherapy,Phenotype,Serum Platinum Levels After Completion Of Cisplatin Chemotherapy
19172,T Wave Morphology Restitution During Exercise (Mtag),Phenotype,T Wave Morphology Restitution During Exercise (Mtag)
19174,T Wave Morphology Restitution During Exercise,Phenotype,T Wave Morphology Restitution During Exercise
19175,Microalbuminuria,Phenotype,Microalbuminuria
19178,Urinary Albumin-To-Creatinine Ratio,Phenotype,Urinary Albumin-To-Creatinine Ratio
19193,Basal Metabolic Rate,Phenotype,Basal Metabolic Rate
19200,Post-Traumatic Stress Disorder,Phenotype,Post-Traumatic Stress Disorder
19204,Metabolic Syndrome,Phenotype,Metabolic Syndrome
19255,Skin Aging Measurement,Phenotype,Skin Aging Measurement
19259,Asthma (Childhood Onset),Phenotype,Asthma (Childhood Onset)
19261,Asthma And Attention Deficit Hyperactivity Disorder,Phenotype,Asthma And Attention Deficit Hyperactivity Disorder
19263,Asthma And Major Depressive Disorder,Phenotype,Asthma And Major Depressive Disorder
19276,Corneal Resistance Factor,Phenotype,Corneal Resistance Factor
19278,Corneal Hysteresis,Phenotype,Corneal Hysteresis
19279,Cytokine Levels,Phenotype,Cytokine Levels
19282,Cytokine Network Levels (Multivariate Analysis),Phenotype,Cytokine Network Levels (Multivariate Analysis)
19286,Rate Of Ventricular Enlargement,Phenotype,Rate Of Ventricular Enlargement
19294,Response To Ketamine In Bipolar Disorder Or Major Depression (Antidepressant Effects),Phenotype,Response To Ketamine In Bipolar Disorder Or Major Depression (Antidepressant Effects)
19296,Red Vs. Brown/Black Hair Color,Phenotype,Red Vs. Brown/Black Hair Color
19328,Blond Vs. Brown/Black Hair Color,Phenotype,Blond Vs. Brown/Black Hair Color
19332,Childhood Steroid-Sensitive Nephrotic Syndrome,Phenotype,Childhood Steroid-Sensitive Nephrotic Syndrome
19348,Longevity (Age >90Th Survival Percentile),Phenotype,Longevity (Age >90Th Survival Percentile)
19349,Gut Microbiota Relative Abundance (Bacterial Taxa),Phenotype,Gut Microbiota Relative Abundance (Bacterial Taxa)
19352,Parental Longevity (Father'S Age At Death Or Father'S Attained Age),Phenotype,Parental Longevity (Father'S Age At Death Or Father'S Attained Age)
19362,Asthma (Time To Onset),Phenotype,Asthma (Time To Onset)
19365,Cognitive Performance (Processing Speed),Phenotype,Cognitive Performance (Processing Speed)
19368,Parental Longevity (Mother'S Age At Death Or Mother'S Attained Age),Phenotype,Parental Longevity (Mother'S Age At Death Or Mother'S Attained Age)
19382,Working Memory,Phenotype,Working Memory
19387,Lung Adenocarcinoma,Phenotype,Lung Adenocarcinoma
19390,Non-Small Cell Lung Cancer,Phenotype,Non-Small Cell Lung Cancer
19393,High Chromosomal Aberration Frequency (Chromosome Type),Phenotype,High Chromosomal Aberration Frequency (Chromosome Type)
19396,Chromosomal Aberration Frequency (Chromosome Type),Phenotype,Chromosomal Aberration Frequency (Chromosome Type)
19397,High Chromosomal Aberration Frequency (Total),Phenotype,High Chromosomal Aberration Frequency (Total)
19399,High Chromosomal Aberration Frequency (Chromatid Type),Phenotype,High Chromosomal Aberration Frequency (Chromatid Type)
19448,Gestational Age At Birth (Child Effect),Phenotype,Gestational Age At Birth (Child Effect)
19451,Pulmonary Arterial Hypertension,Phenotype,Pulmonary Arterial Hypertension
19453,Right Planum Temporale Grey Matter Volume,Phenotype,Right Planum Temporale Grey Matter Volume
19455,Urinary Sodium Excretion,Phenotype,Urinary Sodium Excretion
19465,Urinary Potassium Excretion,Phenotype,Urinary Potassium Excretion
19467,Non-Lobar Intracerebral Hemorrhage (Mtag),Phenotype,Non-Lobar Intracerebral Hemorrhage (Mtag)
19469,Emotional Recognition,Phenotype,Emotional Recognition
19471,Face Memory,Phenotype,Face Memory
19473,Abstraction And Mental Flexibility,Phenotype,Abstraction And Mental Flexibility
19476,Spatial Memory,Phenotype,Spatial Memory
19481,Joint Damage In Rheumatoid Arthritis,Phenotype,Joint Damage In Rheumatoid Arthritis
19498,White Coat Effect (Clinic Systolic Blood Pressure Minus Ambulatory Systolic Blood Pressure),Phenotype,White Coat Effect (Clinic Systolic Blood Pressure Minus Ambulatory Systolic Blood Pressure)
19501,White Coat Effect (Clinic Diastolic Blood Pressure Minus Ambulatory Diastolic Blood Pressure),Phenotype,White Coat Effect (Clinic Diastolic Blood Pressure Minus Ambulatory Diastolic Blood Pressure)
19504,Maximum Retinal Arteriolar Tortuosity,Phenotype,Maximum Retinal Arteriolar Tortuosity
19507,Uveal Melanoma,Phenotype,Uveal Melanoma
19509,Uveal Melanoma With Any Chromosomal Aberration,Phenotype,Uveal Melanoma With Any Chromosomal Aberration
19511,Hydrolysed Wheat Protein Allergy,Phenotype,Hydrolysed Wheat Protein Allergy
19514,Recurrence Of Mild Malaria Attacks,Phenotype,Recurrence Of Mild Malaria Attacks
19517,Body Fat Percentage Variance,Phenotype,Body Fat Percentage Variance
19519,Body Mass Index Variance,Phenotype,Body Mass Index Variance
19520,Waist Circumference Variance,Phenotype,Waist Circumference Variance
19521,Basal Metabolic Rate Variance,Phenotype,Basal Metabolic Rate Variance
19523,Hip Circumference Variance,Phenotype,Hip Circumference Variance
19524,Heel Bone Mineral Density Variance,Phenotype,Heel Bone Mineral Density Variance
19526,Chronic Lymphocytic Leukemia Or Multiple Sclerosis,Phenotype,Chronic Lymphocytic Leukemia Or Multiple Sclerosis
19529,Marginal Zone Lymphoma Or Rheumatoid Arthritis,Phenotype,Marginal Zone Lymphoma Or Rheumatoid Arthritis
19531,Marginal Zone Lymphoma Or Systemic Lupus Erythematosus,Phenotype,Marginal Zone Lymphoma Or Systemic Lupus Erythematosus
19537,Prepulse Inhibition Of The Startle Response,Phenotype,Prepulse Inhibition Of The Startle Response
19540,Degraded Stimulus Continuous Performance Test Score,Phenotype,Degraded Stimulus Continuous Performance Test Score
19542,Spatial Processing,Phenotype,Spatial Processing
19545,California Verbal Learning Test Score,Phenotype,California Verbal Learning Test Score
19547,Antisaccade Task Score,Phenotype,Antisaccade Task Score
19550,Neuroblastoma Or Malignant Cutaneous Melanoma,Phenotype,Neuroblastoma Or Malignant Cutaneous Melanoma
19579,Suicide,Phenotype,Suicide
19590,Numerical Cognitive Ability,Phenotype,Numerical Cognitive Ability
19593,Figural/Spatial Cognitive Ability,Phenotype,Figural/Spatial Cognitive Ability
19595,Tendinopathy,Phenotype,Tendinopathy
19597,Ankle-Brachial Index,Phenotype,Ankle-Brachial Index
19599,Peripheral Artery Disease (Borderline),Phenotype,Peripheral Artery Disease (Borderline)
19612,Number Of Decayed-- Missing And Filled Tooth Surfaces Or Use Of Dentures,Phenotype,Number Of Decayed-- Missing And Filled Tooth Surfaces Or Use Of Dentures
19617,Dentures,Phenotype,Dentures
19627,Nicotine Dependence Symptom Count,Phenotype,Nicotine Dependence Symptom Count
19680,White Matter Microstructure (Radial Diusivities),Phenotype,White Matter Microstructure (Radial Diusivities)
19685,Spontaneous Adipocyte Lipolysis,Phenotype,Spontaneous Adipocyte Lipolysis
19688,Stimulated Adipocyte Lipolysis,Phenotype,Stimulated Adipocyte Lipolysis
19692,Cortical Surface Area,Phenotype,Cortical Surface Area
19702,White Matter Microstructure (Mode Of Anisotropy),Phenotype,White Matter Microstructure (Mode Of Anisotropy)
19724,Modic Changes,Phenotype,Modic Changes
19726,Frequency Of Relapse In Mepolizumab-Treated Eosinophilic Granulomatosis With Polyangiitis,Phenotype,Frequency Of Relapse In Mepolizumab-Treated Eosinophilic Granulomatosis With Polyangiitis
19728,Average Oral Glucocorticoid Dose In Mepolizumab-Treated Eosinophilic Granulomatosis With Polyangiitis,Phenotype,Average Oral Glucocorticoid Dose In Mepolizumab-Treated Eosinophilic Granulomatosis With Polyangiitis
19788,Pelvic Organ Prolapse,Phenotype,Pelvic Organ Prolapse
19791,Follicle Stimulating Hormone Levels,Phenotype,Follicle Stimulating Hormone Levels
19793,Follicle Stimulating Hormone In Healthy Women,Phenotype,Follicle Stimulating Hormone In Healthy Women
19795,Luteinizing Hormone Levels In Healthy Women,Phenotype,Luteinizing Hormone Levels In Healthy Women
19811,White Matter Microstructure (Fractional Anisotropy),Phenotype,White Matter Microstructure (Fractional Anisotropy)
19814,White Matter Microstructure (Axial Diusivities),Phenotype,White Matter Microstructure (Axial Diusivities)
19825,Behcet'S Disease,Phenotype,Behcet'S Disease
19893,Erythrocyte Methylated 6-Mercaptopurine Metabolite Concentration In 6-Mercaptopurine-Treated Acute Lymphoblastic Leukaemia,Phenotype,Erythrocyte Methylated 6-Mercaptopurine Metabolite Concentration In 6-Mercaptopurine-Treated Acute Lymphoblastic Leukaemia
19895,Dna-Incorporated Thioguanine Levels In 6-Mercaptopurine-Treated Acute Lymphoblastic Leukaemia,Phenotype,Dna-Incorporated Thioguanine Levels In 6-Mercaptopurine-Treated Acute Lymphoblastic Leukaemia
19897,Erythrocyte Thioguanine Concentration In 6-Mercaptopurine-Treated Acute Lymphoblastic Leukaemia,Phenotype,Erythrocyte Thioguanine Concentration In 6-Mercaptopurine-Treated Acute Lymphoblastic Leukaemia
19906,Breast Cancer (Estrogen-Receptor Positive),Phenotype,Breast Cancer (Estrogen-Receptor Positive)
19952,Lean Mass Index,Phenotype,Lean Mass Index
19996,Cortical Thickness,Phenotype,Cortical Thickness
19997,Ocular Sarcoidosis,Phenotype,Ocular Sarcoidosis
20055,Brown Vs. Black Hair Color,Phenotype,Brown Vs. Black Hair Color
20064,Factor Viii Levels,Phenotype,Factor Viii Levels
20066,Vwf Levels,Phenotype,Vwf Levels
20084,Automobile Speeding Propensity,Phenotype,Automobile Speeding Propensity
20089,Alcohol Consumption (Drinks Per Week),Phenotype,Alcohol Consumption (Drinks Per Week)
20095,Fat-Free Mass,Phenotype,Fat-Free Mass
20106,Smoking Status (Ever Vs Never Smokers),Phenotype,Smoking Status (Ever Vs Never Smokers)
20119,Risk-Taking Tendency (4-Domain Principal Component Model),Phenotype,Risk-Taking Tendency (4-Domain Principal Component Model)
20125,General Risk Tolerance (Mtag),Phenotype,General Risk Tolerance (Mtag)
20129,Brain Region Volumes,Phenotype,Brain Region Volumes
20151,Vertical Cup-Disc Ratio (Adjusted For Vertical Disc Diameter),Phenotype,Vertical Cup-Disc Ratio (Adjusted For Vertical Disc Diameter)
20154,Vertical Cup-Disc Ratio (Multi-Trait Analysis),Phenotype,Vertical Cup-Disc Ratio (Multi-Trait Analysis)
20165,Intraocular Pressure,Phenotype,Intraocular Pressure
20176,Hdl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df),Phenotype,Hdl Cholesterol Levels X Alcohol Consumption (Drinkers Vs Non-Drinkers) Interaction (2Df)
20183,Gut Microbiota (Alpha Diversity),Phenotype,Gut Microbiota (Alpha Diversity)
20188,Accommodative Esotropia,Phenotype,Accommodative Esotropia
20190,Amblyopia,Phenotype,Amblyopia
20206,Early Cardiac Repolarization,Phenotype,Early Cardiac Repolarization
20215,Moderate-To-Late Spontaneous Preterm Birth,Phenotype,Moderate-To-Late Spontaneous Preterm Birth
20217,Spontaneous Preterm Birth With Premature Rupture Of Membranes,Phenotype,Spontaneous Preterm Birth With Premature Rupture Of Membranes
20219,Spontaneous Preterm Birth Without Premature Rupture Of Membranes,Phenotype,Spontaneous Preterm Birth Without Premature Rupture Of Membranes
20223,Uterine Fibroids,Phenotype,Uterine Fibroids
20227,Subpleural-Predominant Interstitial Lung Abnormalities,Phenotype,Subpleural-Predominant Interstitial Lung Abnormalities
20230,Interstitial Lung Abnormalities,Phenotype,Interstitial Lung Abnormalities
20265,Adventurousness,Phenotype,Adventurousness
20327,Thoracic Aortic Calcification Levels,Phenotype,Thoracic Aortic Calcification Levels
20331,Cocaine Use Disorder X Household Tobacco Use Interaction,Phenotype,Cocaine Use Disorder X Household Tobacco Use Interaction
20334,Apolipoprotein B Levels,Phenotype,Apolipoprotein B Levels
20336,Otu97_108 (Phascolarctobacterium) Abundance,Phenotype,Otu97_108 (Phascolarctobacterium) Abundance
20338,Otu97_117 (Ruminococcus) Abundance,Phenotype,Otu97_117 (Ruminococcus) Abundance
20340,Otu97_101 (Sutterella) Abundance,Phenotype,Otu97_101 (Sutterella) Abundance
20342,Otu97_17 (Parabacteroides) Abundance,Phenotype,Otu97_17 (Parabacteroides) Abundance
20345,Otu97_150 (Bacteroides) Abundance,Phenotype,Otu97_150 (Bacteroides) Abundance
20347,Otu97_126 (Prevotella) Abundance,Phenotype,Otu97_126 (Prevotella) Abundance
20349,Age At Adiposity Rebound,Phenotype,Age At Adiposity Rebound
20350,C_Clostridia Abundance,Phenotype,C_Clostridia Abundance
20353,F_Lachnospiraceae Abundance,Phenotype,F_Lachnospiraceae Abundance
20358,Heart Failure,Phenotype,Heart Failure
20362,Otu97_23 (Faecalibacterium) Abundance,Phenotype,Otu97_23 (Faecalibacterium) Abundance
20364,G_Bacteroidetes Abundance,Phenotype,G_Bacteroidetes Abundance
20366,G_Barnesiella Abundance,Phenotype,G_Barnesiella Abundance
20368,Otu97_51 (Barnesiella) Abundance,Phenotype,Otu97_51 (Barnesiella) Abundance
20369,Otu97_354 (Alloprevotella) Abundance,Phenotype,Otu97_354 (Alloprevotella) Abundance
20371,Otu97_39 (Proteobacteria) Abundance,Phenotype,Otu97_39 (Proteobacteria) Abundance
20379,Otu99_34 (Holdemanella) Abundance,Phenotype,Otu99_34 (Holdemanella) Abundance
20382,Otu99_40 (Proteobacteria) Abundance,Phenotype,Otu99_40 (Proteobacteria) Abundance
20383,Otu99_45 (Faecalibacterium) Abundance,Phenotype,Otu99_45 (Faecalibacterium) Abundance
20385,Otu99_54 (Holdemanella) Abundance,Phenotype,Otu99_54 (Holdemanella) Abundance
20388,Type 2 Diabetes (Adjusted For Bmi),Phenotype,Type 2 Diabetes (Adjusted For Bmi)
20393,G_Parasutterella Abundance,Phenotype,G_Parasutterella Abundance
20398,Anxiety,Phenotype,Anxiety
20400,G_Ruminococcus Abundance,Phenotype,G_Ruminococcus Abundance
20403,O_Clostridiales Abundance,Phenotype,O_Clostridiales Abundance
20404,G_Prevotella Abundance,Phenotype,G_Prevotella Abundance
20406,G_Sutterella Abundance,Phenotype,G_Sutterella Abundance
20408,Otu99_2 (Bacteroides) Prevalence,Phenotype,Otu99_2 (Bacteroides) Prevalence
20410,Otu99_23 (Faecalibacterium) Prevalence,Phenotype,Otu99_23 (Faecalibacterium) Prevalence
20414,Otu99_40 (Proteobacteria) Prevalence,Phenotype,Otu99_40 (Proteobacteria) Prevalence
20416,Otu99_45 (Faecalibacterium) Prevalence,Phenotype,Otu99_45 (Faecalibacterium) Prevalence
20418,Otu99_39 (Alphaproteobacteria) Prevalence,Phenotype,Otu99_39 (Alphaproteobacteria) Prevalence
20420,Otu99_558 (Bacteroidales) Prevalence,Phenotype,Otu99_558 (Bacteroidales) Prevalence
20422,Otu99_47 (Prevotella) Prevalence,Phenotype,Otu99_47 (Prevotella) Prevalence
20435,Testasv_12 (Bacteroides) Prevalence,Phenotype,Testasv_12 (Bacteroides) Prevalence
20437,Testasv_14 (Lachnospiraceae) Prevalence,Phenotype,Testasv_14 (Lachnospiraceae) Prevalence
20439,Otu99_65 (Sutterellaceae) Prevalence,Phenotype,Otu99_65 (Sutterellaceae) Prevalence
20441,Gamma Glutamyl Transferase Levels In Excessive Alcohol Consumption,Phenotype,Gamma Glutamyl Transferase Levels In Excessive Alcohol Consumption
20443,Alanine Aminotransferase Levels In Excessive Alcohol Consumption,Phenotype,Alanine Aminotransferase Levels In Excessive Alcohol Consumption
20450,Erectile Dysfunction,Phenotype,Erectile Dysfunction
20458,Gamma Glutamyl Transferase Levels In Low Alcohol Consumption,Phenotype,Gamma Glutamyl Transferase Levels In Low Alcohol Consumption
20461,Hepatitis C (Spontaneous Viral Clearance),Phenotype,Hepatitis C (Spontaneous Viral Clearance)
20492,Number Of Sexual Partners,Phenotype,Number Of Sexual Partners
20548,Testasv_15 (Bacteroides) Prevalence,Phenotype,Testasv_15 (Bacteroides) Prevalence
20558,Crohn'S Disease (Time To Progression),Phenotype,Crohn'S Disease (Time To Progression)
20560,Crohn'S Disease (Time To First Abdominal Surgery),Phenotype,Crohn'S Disease (Time To First Abdominal Surgery)
20564,Intracranial Volume,Phenotype,Intracranial Volume
20566,Attention Deficit Hyperactivity Disorder Or Intracranial Volume (Pleiotropy),Phenotype,Attention Deficit Hyperactivity Disorder Or Intracranial Volume (Pleiotropy)
20612,Peak Expiratory Flow,Phenotype,Peak Expiratory Flow
20619,Hemoglobin,Phenotype,Hemoglobin
20672,FEV1,Phenotype,FEV1
20695,Serum Urea Levels,Phenotype,Serum Urea Levels
20699,Morningness,Phenotype,Morningness
20728,Crohn'S Disease Or Systemic Sclerosis,Phenotype,Crohn'S Disease Or Systemic Sclerosis
20736,Autism Spectrum Disorder,Phenotype,Autism Spectrum Disorder
20745,Autism And Major Depressive Disorder (Mtag),Phenotype,Autism And Major Depressive Disorder (Mtag)
20747,Autism And Schizophrenia (Mtag),Phenotype,Autism And Schizophrenia (Mtag)
20748,Autism And Educational Attainment (Mtag),Phenotype,Autism And Educational Attainment (Mtag)
20749,Thiopurine-Induced Myelosuppression In Inflammatory Bowel Disease,Phenotype,Thiopurine-Induced Myelosuppression In Inflammatory Bowel Disease
20832,Daytime Nap,Phenotype,Daytime Nap
20834,Ease Of Getting Up In The Morning,Phenotype,Ease Of Getting Up In The Morning
20845,Snoring,Phenotype,Snoring
20869,Igg N-Glycosylation Phenotypes (Multivariate Analysis),Phenotype,Igg N-Glycosylation Phenotypes (Multivariate Analysis)
20871,Intracranial Aneurysm,Phenotype,Intracranial Aneurysm
20876,Insomnia Symptoms (Never/Rarely Vs. Sometimes/Usually),Phenotype,Insomnia Symptoms (Never/Rarely Vs. Sometimes/Usually)
20880,Triiodothyronine Levels,Phenotype,Triiodothyronine Levels
20882,Creativity,Phenotype,Creativity
20887,Calcific Aortic Valve Stenosis,Phenotype,Calcific Aortic Valve Stenosis
20917,Tourette Syndrome,Phenotype,Tourette Syndrome
20990,Carotid Intima Media Thickness X Smoking Interaction,Phenotype,Carotid Intima Media Thickness X Smoking Interaction
21049,Bladder Cancer,Phenotype,Bladder Cancer
21051,Polycystic Ovary Syndrome,Phenotype,Polycystic Ovary Syndrome
21072,Alzheimer'S Disease (Late Onset),Phenotype,Alzheimer'S Disease (Late Onset)
21095,Insomnia Symptoms (Never/Rarely Vs. Usually),Phenotype,Insomnia Symptoms (Never/Rarely Vs. Usually)
21104,Weight Gain In Amisulpride-Treated First-Episode Psychosis,Phenotype,Weight Gain In Amisulpride-Treated First-Episode Psychosis
21124,Endometriosis Or Migraine,Phenotype,Endometriosis Or Migraine
21145,Adverse Response To Inhaled Corticosteroid Treatment X Age Interaction In Asthma,Phenotype,Adverse Response To Inhaled Corticosteroid Treatment X Age Interaction In Asthma
21194,Venous Thromboembolism,Phenotype,Venous Thromboembolism
21205,Trauma Exposure In Major Depressive Disorder-Negative Individuals,Phenotype,Trauma Exposure In Major Depressive Disorder-Negative Individuals
21210,Trauma Exposure,Phenotype,Trauma Exposure
21212,Trauma Exposure In Major Depressive Disorder,Phenotype,Trauma Exposure In Major Depressive Disorder
21229,Postoperative Acute Renal Failure After Cardiac Surgery,Phenotype,Postoperative Acute Renal Failure After Cardiac Surgery
21231,Spontaneous Coronary Artery Dissection,Phenotype,Spontaneous Coronary Artery Dissection
21278,Attention Deficit Hyperactivity Disorder,Phenotype,Attention Deficit Hyperactivity Disorder
21280,Attention Deficit Hyperactivity Disorder (Persistent),Phenotype,Attention Deficit Hyperactivity Disorder (Persistent)
21289,Attention Deficit Hyperactivity Disorder (Childhood),Phenotype,Attention Deficit Hyperactivity Disorder (Childhood)
21297,Lactate Dehydrogenase Levels,Phenotype,Lactate Dehydrogenase Levels
21320,Major Depressive Disorder In Trauma Exposed Individuals,Phenotype,Major Depressive Disorder In Trauma Exposed Individuals
21323,Major Depressive Disorder In Trauma-Unexposed Individuals,Phenotype,Major Depressive Disorder In Trauma-Unexposed Individuals
21326,Major Depressive Disorder,Phenotype,Major Depressive Disorder
21345,Drug-Induced Liver Injury (Flucloxacillin),Phenotype,Drug-Induced Liver Injury (Flucloxacillin)
21347,Recurrence Of Clostridium Difficile Infection X Bezlotuxumab Treatment Interaction (2Df Test),Phenotype,Recurrence Of Clostridium Difficile Infection X Bezlotuxumab Treatment Interaction (2Df Test)
21350,Chronic Rhinosinusitis,Phenotype,Chronic Rhinosinusitis
21352,Nasal Polyps,Phenotype,Nasal Polyps
21353,Obese Vs. Thin,Phenotype,Obese Vs. Thin
21356,Obesity (Extreme),Phenotype,Obesity (Extreme)
21465,Essential Hypertension (Time To Event),Phenotype,Essential Hypertension (Time To Event)
21467,Hyperlipidemia (Time To Event),Phenotype,Hyperlipidemia (Time To Event)
21469,Asthma (Time To Event),Phenotype,Asthma (Time To Event)
21471,Cataract (Time To Event),Phenotype,Cataract (Time To Event)
21541,Chronotype (Smeq Score),Phenotype,Chronotype (Smeq Score)
21543,Evening Vs. Morning Chronotype (Smeq Score),Phenotype,Evening Vs. Morning Chronotype (Smeq Score)
21545,Evening Vs. Morning Chronotype (Self-Assessed),Phenotype,Evening Vs. Morning Chronotype (Self-Assessed)
21564,Brain Amyloid Deposition (Pet Imaging),Phenotype,Brain Amyloid Deposition (Pet Imaging)
21588,Gut Microbiota (Bacterial Taxa-- Hurdle Binary Method),Phenotype,Gut Microbiota (Bacterial Taxa-- Hurdle Binary Method)
21595,Depressive Symptoms X Herpes Simplex 1 Infection Interaction,Phenotype,Depressive Symptoms X Herpes Simplex 1 Infection Interaction
21598,Depression X Herpes Simplex 1 Infection Interaction,Phenotype,Depression X Herpes Simplex 1 Infection Interaction
21635,Idiopathic Membranous Nephropathy,Phenotype,Idiopathic Membranous Nephropathy
21662,Immunoglobulin A,Phenotype,Immunoglobulin A
21664,Hepatocellular Carcinoma,Phenotype,Hepatocellular Carcinoma
21666,Caudate Nucleus Volume,Phenotype,Caudate Nucleus Volume
21668,Lipoprotein-Associated Phospholipase A2 Activity Change In Response To Statin Therapy,Phenotype,Lipoprotein-Associated Phospholipase A2 Activity Change In Response To Statin Therapy
21669,Lipoprotein-Associated Phospholipase A2 Activity And Mass,Phenotype,Lipoprotein-Associated Phospholipase A2 Activity And Mass
21672,Response To Hepatitis C Treatment,Phenotype,Response To Hepatitis C Treatment
21676,Hepatitis C Induced Liver Cirrhosis,Phenotype,Hepatitis C Induced Liver Cirrhosis
21683,Menopause (Age At Onset),Phenotype,Menopause (Age At Onset)
21686,Waist Circumference And Related Phenotypes,Phenotype,Waist Circumference And Related Phenotypes
21687,Infantile Hypertrophic Pyloric Stenosis,Phenotype,Infantile Hypertrophic Pyloric Stenosis
21690,Menarche And Menopause (Age At Onset),Phenotype,Menarche And Menopause (Age At Onset)
21693,Bone Mineral Density (Hip),Phenotype,Bone Mineral Density (Hip)
21696,Response To Citalopram Treatment,Phenotype,Response To Citalopram Treatment
21704,Primary Biliary Cholangitis,Phenotype,Primary Biliary Cholangitis
21708,Warfarin Maintenance Dose,Phenotype,Warfarin Maintenance Dose
21711,Nasopharyngeal Carcinoma,Phenotype,Nasopharyngeal Carcinoma
21715,Type 1 Diabetes,Phenotype,Type 1 Diabetes
21723,Inflammatory Bowel Disease (Early Onset),Phenotype,Inflammatory Bowel Disease (Early Onset)
21724,Lumiracoxib-Related Liver Injury,Phenotype,Lumiracoxib-Related Liver Injury
21726,Bipolar Disorder Or Major Depressive Disorder,Phenotype,Bipolar Disorder Or Major Depressive Disorder
21734,Response To Statin Therapy,Phenotype,Response To Statin Therapy
21735,Pulmonary Function,Phenotype,Pulmonary Function
21743,Malaria,Phenotype,Malaria
21749,Heart Rate,Phenotype,Heart Rate
21754,Hiv-1 Control,Phenotype,Hiv-1 Control
21769,Monocyte Early Outgrowth Colony Forming Units,Phenotype,Monocyte Early Outgrowth Colony Forming Units
21771,Major Depressive Disorder (Broad),Phenotype,Major Depressive Disorder (Broad)
21775,Platelet Aggregation,Phenotype,Platelet Aggregation
21780,Renal Cell Carcinoma,Phenotype,Renal Cell Carcinoma
21787,Electrocardiographic Traits,Phenotype,Electrocardiographic Traits
21795,Calcium Levels,Phenotype,Calcium Levels
21799,Response To Treatment For Acute Lymphoblastic Leukemia,Phenotype,Response To Treatment For Acute Lymphoblastic Leukemia
21807,Smoking Behavior,Phenotype,Smoking Behavior
21809,Age-Related Macular Degeneration,Phenotype,Age-Related Macular Degeneration
21813,Dupuytren'S Disease,Phenotype,Dupuytren'S Disease
21815,Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis (Sjs-Ten),Phenotype,Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis (Sjs-Ten)
21817,Bipolar Disorder And Schizophrenia,Phenotype,Bipolar Disorder And Schizophrenia
21823,Renal Function-Related Traits (Bun),Phenotype,Renal Function-Related Traits (Bun)
21826,Renal Function-Related Traits (Scr),Phenotype,Renal Function-Related Traits (Scr)
21829,Renal Function-Related Traits (Egrfcrea),Phenotype,Renal Function-Related Traits (Egrfcrea)
21836,Renal Function-Related Traits (Urea),Phenotype,Renal Function-Related Traits (Urea)
21838,Lentiform Nucleus Volume,Phenotype,Lentiform Nucleus Volume
21840,End-Stage Coagulation,Phenotype,End-Stage Coagulation
21846,Pit-And-Fissure Caries,Phenotype,Pit-And-Fissure Caries
21847,Circulating Vasoactive Peptide Levels,Phenotype,Circulating Vasoactive Peptide Levels
21849,Refractive Error,Phenotype,Refractive Error
21856,Blood Trace Element (Se Levels),Phenotype,Blood Trace Element (Se Levels)
21858,Blood Trace Element (Cu Levels),Phenotype,Blood Trace Element (Cu Levels)
21860,Acute Lymphoblastic Leukemia (Childhood),Phenotype,Acute Lymphoblastic Leukemia (Childhood)
21869,Uric Acid Levels,Phenotype,Uric Acid Levels
21872,Hematological Parameters,Phenotype,Hematological Parameters
21874,Ovarian Reserve,Phenotype,Ovarian Reserve
21881,Apolipoprotein A1 Levels,Phenotype,Apolipoprotein A1 Levels
21882,Cognitive Performance,Phenotype,Cognitive Performance
21889,Ileal Carcinoids,Phenotype,Ileal Carcinoids
21893,Ankylosing Spondylitis,Phenotype,Ankylosing Spondylitis
21897,Protein Quantitative Trait Loci,Phenotype,Protein Quantitative Trait Loci
21905,Ige Grass Sensitization,Phenotype,Ige Grass Sensitization
21908,Allergic Rhinitis,Phenotype,Allergic Rhinitis
21910,Pubertal Anthropometrics,Phenotype,Pubertal Anthropometrics
21916,Attention Deficit Hyperactivity Disorder And Conduct Disorder,Phenotype,Attention Deficit Hyperactivity Disorder And Conduct Disorder
21924,Response To Tnf Antagonist Treatment,Phenotype,Response To Tnf Antagonist Treatment
21926,Response To Anti-Tnf Alpha Therapy In Inflammatory Bowel Disease,Phenotype,Response To Anti-Tnf Alpha Therapy In Inflammatory Bowel Disease
21928,Attention Deficit Hyperactivity Disorder Symptoms (Maternal Expressed Emotions Interaction),Phenotype,Attention Deficit Hyperactivity Disorder Symptoms (Maternal Expressed Emotions Interaction)
21930,Conduct Disorder (Maternal Expressed Emotions Interaction),Phenotype,Conduct Disorder (Maternal Expressed Emotions Interaction)
21933,Black Vs. Blond Hair Color,Phenotype,Black Vs. Blond Hair Color
21934,Black Vs. Red Hair Color,Phenotype,Black Vs. Red Hair Color
21940,Cardiovascular Disease Risk Factors,Phenotype,Cardiovascular Disease Risk Factors
21942,Interstitial Lung Disease,Phenotype,Interstitial Lung Disease
21947,Hematology Traits,Phenotype,Hematology Traits
21949,Relative Hand Skill In Reading Disability,Phenotype,Relative Hand Skill In Reading Disability
21954,Hematological And Biochemical Traits,Phenotype,Hematological And Biochemical Traits
21958,Response To Dabigatran Etexilate Treatment,Phenotype,Response To Dabigatran Etexilate Treatment
21961,Ulcerative Colitis Or Crohn'S Disease,Phenotype,Ulcerative Colitis Or Crohn'S Disease
21963,Immune Response To Anthrax Vaccine,Phenotype,Immune Response To Anthrax Vaccine
21965,Activated Partial Thromboplastin Time,Phenotype,Activated Partial Thromboplastin Time
21974,Electroencephalographic Traits In Alcoholism,Phenotype,Electroencephalographic Traits In Alcoholism
21977,Basal Cell Carcinoma,Phenotype,Basal Cell Carcinoma
21981,Depression (Quantitative Trait),Phenotype,Depression (Quantitative Trait)
21983,Response To Antipsychotic Treatment In Schizophrenia (Working Memory),Phenotype,Response To Antipsychotic Treatment In Schizophrenia (Working Memory)
21985,Response To Antipsychotic Treatment In Schizophrenia (Reasoning),Phenotype,Response To Antipsychotic Treatment In Schizophrenia (Reasoning)
21988,Renal Sinus Fat,Phenotype,Renal Sinus Fat
21990,Airflow Obstruction,Phenotype,Airflow Obstruction
21993,Femoral Neck Bone Geometry,Phenotype,Femoral Neck Bone Geometry
21995,Nodular Sclerosis Hodgkin Lymphoma,Phenotype,Nodular Sclerosis Hodgkin Lymphoma
21999,Clozapine-Induced Agranulocytosis,Phenotype,Clozapine-Induced Agranulocytosis
22002,Homocysteine Levels,Phenotype,Homocysteine Levels
22010,Axial Length,Phenotype,Axial Length
22012,Body Mass Index In Non-Asthmatics,Phenotype,Body Mass Index In Non-Asthmatics
22014,Metabolite Levels (Hva),Phenotype,Metabolite Levels (Hva)
22016,Metabolite Levels (5-Hiaa),Phenotype,Metabolite Levels (5-Hiaa)
22018,Metabolite Levels (Hva-5-Hiaa Factor Score),Phenotype,Metabolite Levels (Hva-5-Hiaa Factor Score)
22019,Metabolite Levels (Hva/5-Hiaa Ratio),Phenotype,Metabolite Levels (Hva/5-Hiaa Ratio)
22027,Metabolite Levels (Hva/Mhpg Ratio),Phenotype,Metabolite Levels (Hva/Mhpg Ratio)
22031,Metabolite Levels (Mhpg),Phenotype,Metabolite Levels (Mhpg)
22036,Metabolite Levels (5-Hiaa/ Mhpg Ratio),Phenotype,Metabolite Levels (5-Hiaa/ Mhpg Ratio)
22038,Response To Fenofibrate (Adiponectin Levels),Phenotype,Response To Fenofibrate (Adiponectin Levels)
22052,Obsessive-Compulsive Disorder,Phenotype,Obsessive-Compulsive Disorder
22054,Breast Cancer (Male),Phenotype,Breast Cancer (Male)
22060,Orofacial Clefts,Phenotype,Orofacial Clefts
22071,Disc Degeneration (Lumbar),Phenotype,Disc Degeneration (Lumbar)
22093,Partial Epilepsies,Phenotype,Partial Epilepsies
22096,Non-Obstructive Azoospermia,Phenotype,Non-Obstructive Azoospermia
22100,Hpv Seropositivity,Phenotype,Hpv Seropositivity
22101,Progressive Supranuclear Palsy,Phenotype,Progressive Supranuclear Palsy
22102,Aging,Phenotype,Aging
22107,Neonatal Lupus,Phenotype,Neonatal Lupus
22111,Autism,Phenotype,Autism
22113,Chronic Kidney Disease And Serum Creatinine Levels,Phenotype,Chronic Kidney Disease And Serum Creatinine Levels
22115,Testicular Germ Cell Tumor,Phenotype,Testicular Germ Cell Tumor
22124,Pr Interval,Phenotype,Pr Interval
22133,Breast Cancer In Brca1 Mutation Carriers,Phenotype,Breast Cancer In Brca1 Mutation Carriers
22134,Response To Fenofibrate,Phenotype,Response To Fenofibrate
22136,Sunburns,Phenotype,Sunburns
22137,Hair Color,Phenotype,Hair Color
22138,Non-Melanoma Skin Cancer,Phenotype,Non-Melanoma Skin Cancer
22140,Tanning,Phenotype,Tanning
22141,Periodontal Microbiota,Phenotype,Periodontal Microbiota
22145,Caffeine Consumption,Phenotype,Caffeine Consumption
22148,Circulating Myeloperoxidase Levels (Serum),Phenotype,Circulating Myeloperoxidase Levels (Serum)
22150,Dengue Shock Syndrome,Phenotype,Dengue Shock Syndrome
22154,Liver Enzyme Levels (Alkaline Phosphatase),Phenotype,Liver Enzyme Levels (Alkaline Phosphatase)
22156,Liver Enzyme Levels (Gamma-Glutamyl Transferase),Phenotype,Liver Enzyme Levels (Gamma-Glutamyl Transferase)
22160,White Blood Cell Types,Phenotype,White Blood Cell Types
22164,Brain Connectivity,Phenotype,Brain Connectivity
22167,Sex Hormone-Binding Globulin Levels,Phenotype,Sex Hormone-Binding Globulin Levels
22169,Hepatocellular Carcinoma In Hepatitis B Infection,Phenotype,Hepatocellular Carcinoma In Hepatitis B Infection
22171,Periodontitis,Phenotype,Periodontitis
22173,Qt Interval (Drug Interaction),Phenotype,Qt Interval (Drug Interaction)
22177,Attention Deficit Hyperactivity Disorder (Combined Symptoms),Phenotype,Attention Deficit Hyperactivity Disorder (Combined Symptoms)
22179,Attention Deficit Hyperactivity Disorder (Inattention Symptoms),Phenotype,Attention Deficit Hyperactivity Disorder (Inattention Symptoms)
22196,Hba2 Levels,Phenotype,Hba2 Levels
22197,Atopic Dermatitis,Phenotype,Atopic Dermatitis
22202,Venous Thromboembolism (Snp X Snp Interaction),Phenotype,Venous Thromboembolism (Snp X Snp Interaction)
22220,Response To Amphetamines,Phenotype,Response To Amphetamines
22228,Urate Levels,Phenotype,Urate Levels
22236,Adiposity,Phenotype,Adiposity
22240,Lung Cancer (Asbestos Exposure Interaction),Phenotype,Lung Cancer (Asbestos Exposure Interaction)
22242,Cannabis Use (Initiation),Phenotype,Cannabis Use (Initiation)
22245,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (All Anthracycline-Based Drugs),Phenotype,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (All Anthracycline-Based Drugs)
22247,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Cyclophosphamide),Phenotype,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Cyclophosphamide)
22249,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (All Antimicrotubule Drugs),Phenotype,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (All Antimicrotubule Drugs)
22253,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Paclitaxel),Phenotype,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Paclitaxel)
22254,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Docetaxel),Phenotype,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Docetaxel)
22256,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Camptothecin),Phenotype,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Camptothecin)
22258,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Carboplatin),Phenotype,Adverse Response To Chemotherapy (Neutropenia/Leucopenia) (Carboplatin)
22261,Preeclampsia,Phenotype,Preeclampsia
22263,Type 2 Diabetes (Dietary Heme Iron Intake Interaction),Phenotype,Type 2 Diabetes (Dietary Heme Iron Intake Interaction)
22264,Palmitic Acid (16:0) Levels,Phenotype,Palmitic Acid (16:0) Levels
22266,Palmitoleic Acid (16:1N-7) Levels,Phenotype,Palmitoleic Acid (16:1N-7) Levels
22269,Oleic Acid (18:1N-9) Levels,Phenotype,Oleic Acid (18:1N-9) Levels
22276,Visceral Fat,Phenotype,Visceral Fat
22287,Age-Related Macular Degeneration (Choroidal Neovascularisation),Phenotype,Age-Related Macular Degeneration (Choroidal Neovascularisation)
22290,Age-Related Macular Degeneration (Geographic Atrophy),Phenotype,Age-Related Macular Degeneration (Geographic Atrophy)
22292,Esophageal Cancer (Squamous Cell),Phenotype,Esophageal Cancer (Squamous Cell)
22294,Lifetime Average Cigarettes Per Day In Chronic Obstructive Pulmonary Disease,Phenotype,Lifetime Average Cigarettes Per Day In Chronic Obstructive Pulmonary Disease
22296,Sexual Dysfunction (Female),Phenotype,Sexual Dysfunction (Female)
22298,Age At Smoking Initiation In Chronic Obstructive Pulmonary Disease,Phenotype,Age At Smoking Initiation In Chronic Obstructive Pulmonary Disease
22303,Capecitabine Sensitivity,Phenotype,Capecitabine Sensitivity
22313,Esophageal Cancer,Phenotype,Esophageal Cancer
22315,Aspirin Exacerbated Respiratory Disease In Asthmatics,Phenotype,Aspirin Exacerbated Respiratory Disease In Asthmatics
22324,Cystic Fibrosis Severity,Phenotype,Cystic Fibrosis Severity
22327,Hypertension (Snp X Snp Interaction),Phenotype,Hypertension (Snp X Snp Interaction)
22332,Scoliosis,Phenotype,Scoliosis
22341,Response To Anti-Depressant Treatment In Major Depressive Disorder,Phenotype,Response To Anti-Depressant Treatment In Major Depressive Disorder
22349,Adverse Response To Carbamazepine,Phenotype,Adverse Response To Carbamazepine
22357,Gambling,Phenotype,Gambling
22390,Molar-Incisor Hypomineralization,Phenotype,Molar-Incisor Hypomineralization
22398,Epstein-Barr Virus Immune Response (Ebna-1),Phenotype,Epstein-Barr Virus Immune Response (Ebna-1)
22399,Myasthenia Gravis,Phenotype,Myasthenia Gravis
22402,Anxiety In Major Depressive Disorder,Phenotype,Anxiety In Major Depressive Disorder
22404,Anxiety And Major Depressive Disorder,Phenotype,Anxiety And Major Depressive Disorder
22406,Multiple Sclerosis (Ocb Status),Phenotype,Multiple Sclerosis (Ocb Status)
22408,Femoral Neck Bone Mineral Density,Phenotype,Femoral Neck Bone Mineral Density
22409,Lumbar Spine Bone Mineral Density,Phenotype,Lumbar Spine Bone Mineral Density
22415,Alcohol And Nicotine Co-Dependence,Phenotype,Alcohol And Nicotine Co-Dependence
22419,Drug-Induced Stevens-Johnson Syndrome Or Toxic Epidermal Necrolysis (Sjs/Ten),Phenotype,Drug-Induced Stevens-Johnson Syndrome Or Toxic Epidermal Necrolysis (Sjs/Ten)
22429,C-Reactive Protein And White Blood Cell Count,Phenotype,C-Reactive Protein And White Blood Cell Count
22431,Thyroid Hormone Levels,Phenotype,Thyroid Hormone Levels
22443,Retinopathy In Non-Diabetics,Phenotype,Retinopathy In Non-Diabetics
22445,Alzheimer'S Disease (Cognitive Decline),Phenotype,Alzheimer'S Disease (Cognitive Decline)
22471,Periodontitis (Mean Pal),Phenotype,Periodontitis (Mean Pal)
22476,Periodontitis (Pal4Q3),Phenotype,Periodontitis (Pal4Q3)
22478,Periodontitis (Cdc/Aap),Phenotype,Periodontitis (Cdc/Aap)
22482,Response To Tocilizumab In Rheumatoid Arthritis,Phenotype,Response To Tocilizumab In Rheumatoid Arthritis
22484,Thyroid Function,Phenotype,Thyroid Function
22485,Thyroid Peroxidase Autoantibody Levels In Type 1 Diabetes,Phenotype,Thyroid Peroxidase Autoantibody Levels In Type 1 Diabetes
22487,Bilirubin Levels,Phenotype,Bilirubin Levels
22489,Autism Spectrum Disorder-- Attention Deficit-Hyperactivity Disorder-- Bipolar Disorder-- Major Depressive Disorder-- And Schizophrenia (Combined),Phenotype,Autism Spectrum Disorder-- Attention Deficit-Hyperactivity Disorder-- Bipolar Disorder-- Major Depressive Disorder-- And Schizophrenia (Combined)
22498,Electrocardiographic Conduction Measures,Phenotype,Electrocardiographic Conduction Measures
22506,Economic And Political Preferences,Phenotype,Economic And Political Preferences
22508,Economic And Political Preferences (Environmentalism),Phenotype,Economic And Political Preferences (Environmentalism)
22510,Crohn'S Disease And Celiac Disease,Phenotype,Crohn'S Disease And Celiac Disease
22512,Response To Angiotensin Ii Receptor Blocker Therapy,Phenotype,Response To Angiotensin Ii Receptor Blocker Therapy
22516,Economic And Political Preferences (Immigration/Crime),Phenotype,Economic And Political Preferences (Immigration/Crime)
22520,Nephropathy,Phenotype,Nephropathy
22522,White Matter Integrity,Phenotype,White Matter Integrity
22524,Hepatitis B (Viral Clearance),Phenotype,Hepatitis B (Viral Clearance)
22532,Dietary Macronutrient Intake,Phenotype,Dietary Macronutrient Intake
22537,Haptoglobin Levels,Phenotype,Haptoglobin Levels
22538,Restless Legs Syndrome,Phenotype,Restless Legs Syndrome
22541,Drug-Induced Liver Injury (Amoxicillin-Clavulanate),Phenotype,Drug-Induced Liver Injury (Amoxicillin-Clavulanate)
22544,Dialysis-Related Mortality,Phenotype,Dialysis-Related Mortality
22549,Antipsychotic Drug-Induced Qtc Interval Prolongation,Phenotype,Antipsychotic Drug-Induced Qtc Interval Prolongation
22551,Metabolic Traits,Phenotype,Metabolic Traits
22559,Immune Reponse To Smallpox (Secreted Il-2),Phenotype,Immune Reponse To Smallpox (Secreted Il-2)
22561,Immune Reponse To Smallpox (Secreted Il-10),Phenotype,Immune Reponse To Smallpox (Secreted Il-10)
22563,Immune Reponse To Smallpox (Secreted Il-12P40),Phenotype,Immune Reponse To Smallpox (Secreted Il-12P40)
22566,Immune Response To Smallpox Vaccine (Il-6),Phenotype,Immune Response To Smallpox Vaccine (Il-6)
22569,Immune Reponse To Smallpox (Secreted Ifn-Alpha),Phenotype,Immune Reponse To Smallpox (Secreted Ifn-Alpha)
22572,Response To Mtor Inhibitor (Everolimus),Phenotype,Response To Mtor Inhibitor (Everolimus)
22574,Response To Mtor Inhibitor (Rapamycin),Phenotype,Response To Mtor Inhibitor (Rapamycin)
22576,Primary Tooth Development (Number Of Teeth),Phenotype,Primary Tooth Development (Number Of Teeth)
22578,Primary Tooth Development (Time To First Tooth Eruption),Phenotype,Primary Tooth Development (Time To First Tooth Eruption)
22584,Coronary Artery Calcification,Phenotype,Coronary Artery Calcification
22594,Response To Gemcitabine In Pancreatic Cancer,Phenotype,Response To Gemcitabine In Pancreatic Cancer
22597,Crohn'S Disease And Psoriasis,Phenotype,Crohn'S Disease And Psoriasis
22599,Treatment Response For Severe Sepsis,Phenotype,Treatment Response For Severe Sepsis
22602,Osteoarthritis,Phenotype,Osteoarthritis
22606,Phospholipid Levels (Plasma),Phenotype,Phospholipid Levels (Plasma)
22611,Sphingolipid Levels,Phenotype,Sphingolipid Levels
22613,Response To Tnf-Alpha Inhibitors In Rheumatoid Arthritis,Phenotype,Response To Tnf-Alpha Inhibitors In Rheumatoid Arthritis
22616,Lp (A) Levels,Phenotype,Lp (A) Levels
22619,Paget'S Disease,Phenotype,Paget'S Disease
22621,Weight Loss (Gastric Bypass Surgery),Phenotype,Weight Loss (Gastric Bypass Surgery)
22628,Sexual Dimorphism In Anthropometric Traits,Phenotype,Sexual Dimorphism In Anthropometric Traits
22630,Adverse Response To Chemotherapy In Breast Cancer (Alopecia) (Cyclophosphamide+Doxorubicin+/-5Fu),Phenotype,Adverse Response To Chemotherapy In Breast Cancer (Alopecia) (Cyclophosphamide+Doxorubicin+/-5Fu)
22632,Adverse Response To Chemotherapy In Breast Cancer (Alopecia) (Paclitaxel),Phenotype,Adverse Response To Chemotherapy In Breast Cancer (Alopecia) (Paclitaxel)
22634,Kawasaki Disease,Phenotype,Kawasaki Disease
22636,Vwf And Fviii Levels,Phenotype,Vwf And Fviii Levels
22638,Alopecia Areata,Phenotype,Alopecia Areata
22640,Hepatitis B,Phenotype,Hepatitis B
22642,Nevirapine-Induced Rash,Phenotype,Nevirapine-Induced Rash
22651,Hiv-1 Viral Setpoint,Phenotype,Hiv-1 Viral Setpoint
22655,Graves' Disease,Phenotype,Graves' Disease
22681,Multiple Myeloma (Igh Translocation),Phenotype,Multiple Myeloma (Igh Translocation)
22688,Hiv-1 Susceptibility,Phenotype,Hiv-1 Susceptibility
22691,Bulimia Nervosa,Phenotype,Bulimia Nervosa
22693,Anorexia Nervosa,Phenotype,Anorexia Nervosa
22697,Eating Disorders,Phenotype,Eating Disorders
22700,Metabolite Levels (Pyroglutamine),Phenotype,Metabolite Levels (Pyroglutamine)
22703,Metabolite Levels  (X-11787),Phenotype,Metabolite Levels  (X-11787)
22706,Metabolite Levels (Dihydroxy Docosatrienoic Acid),Phenotype,Metabolite Levels (Dihydroxy Docosatrienoic Acid)
22709,Tetralogy Of Fallot,Phenotype,Tetralogy Of Fallot
22716,D-Dimer Levels,Phenotype,D-Dimer Levels
22730,Erectile Dysfunction In Type 1 Diabetes,Phenotype,Erectile Dysfunction In Type 1 Diabetes
22735,Corneal Astigmatism,Phenotype,Corneal Astigmatism
22739,Homeostasis Model Assessment Of Beta-Cell Function (Dietary Factor Interaction),Phenotype,Homeostasis Model Assessment Of Beta-Cell Function (Dietary Factor Interaction)
22742,Fasting Insulin (Dietary Factor Interaction),Phenotype,Fasting Insulin (Dietary Factor Interaction)
22745,Homeostasis Model Assessment Of Insulin Resistance (Dietary Factor Interaction),Phenotype,Homeostasis Model Assessment Of Insulin Resistance (Dietary Factor Interaction)
22747,Liver Enzyme Levels (Alanine Transaminase),Phenotype,Liver Enzyme Levels (Alanine Transaminase)
22749,Insulin Resistance/Response,Phenotype,Insulin Resistance/Response
22751,Orthostatic Hypotension,Phenotype,Orthostatic Hypotension
22772,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Alphalinolenic Acid),Phenotype,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Alphalinolenic Acid)
22775,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Docosapentaenoic Acid),Phenotype,Plasma Omega-3 Polyunsaturated Fatty Acid Levels (Docosapentaenoic Acid)
22789,Fasting Blood Insulin (Bmi Interaction),Phenotype,Fasting Blood Insulin (Bmi Interaction)
22791,Fasting Blood Glucose (Bmi Interaction),Phenotype,Fasting Blood Glucose (Bmi Interaction)
22806,Retinal Vascular Caliber,Phenotype,Retinal Vascular Caliber
22814,Igg Glycosylation,Phenotype,Igg Glycosylation
22833,Hemostatic Factors And Hematological Phenotypes,Phenotype,Hemostatic Factors And Hematological Phenotypes
22842,Arthritis (Juvenile Idiopathic),Phenotype,Arthritis (Juvenile Idiopathic)
22853,Brain Structure (Hippocampal Volume),Phenotype,Brain Structure (Hippocampal Volume)
22855,Corneal Structure,Phenotype,Corneal Structure
22859,Crohn'S Disease (Time To Surgery),Phenotype,Crohn'S Disease (Time To Surgery)
22861,F-Cell Distribution,Phenotype,F-Cell Distribution
22862,Select Biomarker Traits,Phenotype,Select Biomarker Traits
22865,Skin Sensitivity To Sun,Phenotype,Skin Sensitivity To Sun
22866,Red Vs Non-Red Hair Color,Phenotype,Red Vs Non-Red Hair Color
22867,Freckles,Phenotype,Freckles
22869,Blond Vs. Brown Hair Color,Phenotype,Blond Vs. Brown Hair Color
22880,Diabetes (Gestational),Phenotype,Diabetes (Gestational)
22881,Metabolic Syndrome (Bivariate Traits),Phenotype,Metabolic Syndrome (Bivariate Traits)
22883,Hdl Cholesterol - Triglycerides (Hdlc-Tg),Phenotype,Hdl Cholesterol - Triglycerides (Hdlc-Tg)
22885,Other Erythrocyte Phenotypes,Phenotype,Other Erythrocyte Phenotypes
22890,Prostate Cancer (Snp X Snp Interaction),Phenotype,Prostate Cancer (Snp X Snp Interaction)
22895,Anthropometric Traits,Phenotype,Anthropometric Traits
22908,Non-Alcoholic Fatty Liver Disease Histology (Ast),Phenotype,Non-Alcoholic Fatty Liver Disease Histology (Ast)
22912,Rr Interval (Heart Rate),Phenotype,Rr Interval (Heart Rate)
22919,Alcoholism (Alcohol Use Disorder Factor Score),Phenotype,Alcoholism (Alcohol Use Disorder Factor Score)
22921,Alcoholism (Alcohol Dependence Factor Score),Phenotype,Alcoholism (Alcohol Dependence Factor Score)
22922,Alzheimer'S Disease Biomarkers,Phenotype,Alzheimer'S Disease Biomarkers
22924,F-Cell Distribution In Sickle Cell Anaemia,Phenotype,F-Cell Distribution In Sickle Cell Anaemia
22927,Freckling,Phenotype,Freckling
22928,Common Traits (Other),Phenotype,Common Traits (Other)
22930,Eye Color,Phenotype,Eye Color
22935,Biomedical Quantitative Traits,Phenotype,Biomedical Quantitative Traits
22939,Liver Enzyme Levels,Phenotype,Liver Enzyme Levels
22941,Brain Imaging In Schizophrenia (Dorsolateral Prefrontal Cortex Interaction),Phenotype,Brain Imaging In Schizophrenia (Dorsolateral Prefrontal Cortex Interaction)
22944,Quantitative Traits,Phenotype,Quantitative Traits
22947,Type 2 Diabetes Nephropathy,Phenotype,Type 2 Diabetes Nephropathy
22964,Optic Disc Parameters,Phenotype,Optic Disc Parameters
22967,Inattentive Symptoms,Phenotype,Inattentive Symptoms
22970,Hyperactive-Impulsive Symptoms,Phenotype,Hyperactive-Impulsive Symptoms
22975,Age-Related Macular Degeneration (Smoking Status Interaction),Phenotype,Age-Related Macular Degeneration (Smoking Status Interaction)
22977,Age-Related Macular Degeneration (Extreme Sampling),Phenotype,Age-Related Macular Degeneration (Extreme Sampling)
22980,Brain Structure,Phenotype,Brain Structure
22991,Attention Deficit Hyperactivity Disorder (Time To Onset),Phenotype,Attention Deficit Hyperactivity Disorder (Time To Onset)
22993,Beta Thalassemia/Hemoglobin E Disease,Phenotype,Beta Thalassemia/Hemoglobin E Disease
22994,Response To Interferon Beta Therapy,Phenotype,Response To Interferon Beta Therapy
22996,Panic Disorder,Phenotype,Panic Disorder
22999,Folate Pathway Vitamin Levels,Phenotype,Folate Pathway Vitamin Levels
23011,Cognitive Test Performance,Phenotype,Cognitive Test Performance
23013,Echocardiographic Traits,Phenotype,Echocardiographic Traits
23017,Optic Nerve Measurement (Rim Area),Phenotype,Optic Nerve Measurement (Rim Area)
23019,Smooth-Surface Caries,Phenotype,Smooth-Surface Caries
23031,Carotenoid And Tocopherol Levels,Phenotype,Carotenoid And Tocopherol Levels
23033,Insulin-Like Growth Factors,Phenotype,Insulin-Like Growth Factors
23035,Thyroid Stimulating Hormone Levels,Phenotype,Thyroid Stimulating Hormone Levels
23038,Major Cvd,Phenotype,Major Cvd
23040,Leprosy,Phenotype,Leprosy
23044,Hip Geometry,Phenotype,Hip Geometry
23049,Tonometry,Phenotype,Tonometry
23058,Lymphoma,Phenotype,Lymphoma
23069,Myocardial Infarction (Early Onset),Phenotype,Myocardial Infarction (Early Onset)
23073,Brain Lesion Load,Phenotype,Brain Lesion Load
23075,Multiple Sclerosis (Severity),Phenotype,Multiple Sclerosis (Severity)
23078,Normalized Brain Volume,Phenotype,Normalized Brain Volume
23079,Weight,Phenotype,Weight
23081,Morbidity-Free Survival,Phenotype,Morbidity-Free Survival
23084,Hearing Impairment,Phenotype,Hearing Impairment
23086,Cardiovascular Risk Factors,Phenotype,Cardiovascular Risk Factors
23102,Cardiac Structure And Function,Phenotype,Cardiac Structure And Function
23107,Osteosarcoma,Phenotype,Osteosarcoma
23109,Pulmonary Function (Smoking Interaction),Phenotype,Pulmonary Function (Smoking Interaction)
23126,Diabetic Retinopathy,Phenotype,Diabetic Retinopathy
23141,Biochemical Measures,Phenotype,Biochemical Measures
23145,Sudden Cardiac Arrest,Phenotype,Sudden Cardiac Arrest
23149,Orofacial Clefts (Maternal Alcohol Consumption Interaction),Phenotype,Orofacial Clefts (Maternal Alcohol Consumption Interaction)
23151,Alcohol Consumption (Transferrin Glycosylation),Phenotype,Alcohol Consumption (Transferrin Glycosylation)
23158,Body Mass In Chronic Obstructive Pulmonary Disease,Phenotype,Body Mass In Chronic Obstructive Pulmonary Disease
23177,Cardiac Hypertrophy,Phenotype,Cardiac Hypertrophy
23194,Vitiligo (Non-Segmental),Phenotype,Vitiligo (Non-Segmental)
23196,Chronic Kidney Disease,Phenotype,Chronic Kidney Disease
23200,Radiation Response,Phenotype,Radiation Response
23208,Hoarding,Phenotype,Hoarding
23214,Anti-Cyclic Citrullinated Peptide Antibody,Phenotype,Anti-Cyclic Citrullinated Peptide Antibody
23222,Systolic Blood Pressure In Sickle Cell Anemia,Phenotype,Systolic Blood Pressure In Sickle Cell Anemia
23227,Hepatitis C Induced Liver Fibrosis,Phenotype,Hepatitis C Induced Liver Fibrosis
23234,Response To Anti-Retroviral Therapy (Ddi/D4T) In Hiv-1 Infection (Grade 3 Peripheral Neuropathy),Phenotype,Response To Anti-Retroviral Therapy (Ddi/D4T) In Hiv-1 Infection (Grade 3 Peripheral Neuropathy)
23240,Response To Anti-Retroviral Therapy (Ddi/D4T) In Hiv-1 Infection (Grade 2 Peripheral Neuropathy),Phenotype,Response To Anti-Retroviral Therapy (Ddi/D4T) In Hiv-1 Infection (Grade 2 Peripheral Neuropathy)
23247,Sjögren'S Syndrome,Phenotype,Sjögren'S Syndrome
23262,Electrodermal Activity,Phenotype,Electrodermal Activity
23275,Bone Properties (Heel),Phenotype,Bone Properties (Heel)
23281,Serum Metabolite Levels,Phenotype,Serum Metabolite Levels
23284,Esophageal Squamous Cell Carcinoma,Phenotype,Esophageal Squamous Cell Carcinoma
23287,Urinary Uromodulin Levels,Phenotype,Urinary Uromodulin Levels
23291,Bipolar Disorder With Mood-Incongruent Psychosis,Phenotype,Bipolar Disorder With Mood-Incongruent Psychosis
23298,Hashimoto Thyroiditis Versus Graves' Disease,Phenotype,Hashimoto Thyroiditis Versus Graves' Disease
23303,Marginal Zone Lymphoma,Phenotype,Marginal Zone Lymphoma
23306,Sensory Disturbances After Bilateral Sagittal Split Ramus Osteotomy,Phenotype,Sensory Disturbances After Bilateral Sagittal Split Ramus Osteotomy
23308,Amyotrophic Lateral Sclerosis (Sporadic),Phenotype,Amyotrophic Lateral Sclerosis (Sporadic)
23319,Social Communication Problems,Phenotype,Social Communication Problems
23327,Schizophrenia-- Schizoaffective Disorder Or Bipolar Disorder,Phenotype,Schizophrenia-- Schizoaffective Disorder Or Bipolar Disorder
23331,Large Artery Stroke,Phenotype,Large Artery Stroke
23333,Coronary Artery Disease Or Ischemic Stroke,Phenotype,Coronary Artery Disease Or Ischemic Stroke
23338,Coronary Artery Disease Or Large Artery Stroke,Phenotype,Coronary Artery Disease Or Large Artery Stroke
23341,Pr Interval In Tripanosoma Cruzi Seropositivity,Phenotype,Pr Interval In Tripanosoma Cruzi Seropositivity
23343,Qt Interval In Tripanosoma Cruzi Seropositivity,Phenotype,Qt Interval In Tripanosoma Cruzi Seropositivity
23346,Ejection Fraction In Tripanosoma Cruzi Seropositivity,Phenotype,Ejection Fraction In Tripanosoma Cruzi Seropositivity
23360,Self-Reported Allergy,Phenotype,Self-Reported Allergy
23366,Aortic-Valve Calcification,Phenotype,Aortic-Valve Calcification
23370,Narcolepsy,Phenotype,Narcolepsy
23372,Body Mass Index  (Smoking Years Interaction),Phenotype,Body Mass Index  (Smoking Years Interaction)
23387,Thyroid Volume,Phenotype,Thyroid Volume
23390,Epilepsy (Remission After Treatment),Phenotype,Epilepsy (Remission After Treatment)
23397,Migraine - Clinic-Based,Phenotype,Migraine - Clinic-Based
23406,Response To Irinotecan And Platinum-Based Chemotherapy In Non-Small-Cell Lung Cancer,Phenotype,Response To Irinotecan And Platinum-Based Chemotherapy In Non-Small-Cell Lung Cancer
23409,Job-Related Exhaustion,Phenotype,Job-Related Exhaustion
23416,Body Mass Index (Snp X Snp Interaction),Phenotype,Body Mass Index (Snp X Snp Interaction)
23417,Vascular Endothelial Growth Factor Levels,Phenotype,Vascular Endothelial Growth Factor Levels
23420,Response To Platinum-Based Agents,Phenotype,Response To Platinum-Based Agents
23425,Eosinophilic Esophagitis (Pediatric),Phenotype,Eosinophilic Esophagitis (Pediatric)
23436,Wegener'S Granulomatosis,Phenotype,Wegener'S Granulomatosis
23450,Hepcidin Levels,Phenotype,Hepcidin Levels
23454,Creatinine Levels,Phenotype,Creatinine Levels
23457,Digit Length Ratio,Phenotype,Digit Length Ratio
23460,Personality Dimensions,Phenotype,Personality Dimensions
23462,Knee Osteoarthritis,Phenotype,Knee Osteoarthritis
23464,Qrs Duration In Tripanosoma Cruzi Seropositivity,Phenotype,Qrs Duration In Tripanosoma Cruzi Seropositivity
23467,Chagas Cardiomyopathy In Tripanosoma Cruzi Seropositivity,Phenotype,Chagas Cardiomyopathy In Tripanosoma Cruzi Seropositivity
23474,Antibody Status In Tripanosoma Cruzi Seropositivity,Phenotype,Antibody Status In Tripanosoma Cruzi Seropositivity
23476,Parasitemia In Tripanosoma Cruzi Seropositivity,Phenotype,Parasitemia In Tripanosoma Cruzi Seropositivity
23484,Blood Pressure Measurement (High Sodium And Potassium Intervention),Phenotype,Blood Pressure Measurement (High Sodium And Potassium Intervention)
23487,Blood Pressure Measurement (Low Sodium Intervention),Phenotype,Blood Pressure Measurement (Low Sodium Intervention)
23490,Blood Pressure Measurement (High Sodium Intervention),Phenotype,Blood Pressure Measurement (High Sodium Intervention)
23499,Chronic Myeloid Leukemia,Phenotype,Chronic Myeloid Leukemia
23502,Glycemic Traits,Phenotype,Glycemic Traits
23504,Migraine With Aura,Phenotype,Migraine With Aura
23519,Word Reading,Phenotype,Word Reading
23521,Reading And Spelling,Phenotype,Reading And Spelling
23523,Non-Word Repetition,Phenotype,Non-Word Repetition
23525,Phosphorus Levels,Phenotype,Phosphorus Levels
23530,Response To Platinum-Based Chemotherapy (Carboplatin),Phenotype,Response To Platinum-Based Chemotherapy (Carboplatin)
23534,Response To Platinum-Based Chemotherapy (Cisplatin),Phenotype,Response To Platinum-Based Chemotherapy (Cisplatin)
23539,Response To Antidepressants,Phenotype,Response To Antidepressants
23554,Inflammatory Skin Disease,Phenotype,Inflammatory Skin Disease
23559,Blood Pressure (Smoking Interaction),Phenotype,Blood Pressure (Smoking Interaction)
23566,Response To Dalcetrapib Treatment In Acute Coronary Syndrome,Phenotype,Response To Dalcetrapib Treatment In Acute Coronary Syndrome
23573,Congenital Left-Sided Heart Lesions,Phenotype,Congenital Left-Sided Heart Lesions
23575,Epithelial Ovarian Cancer,Phenotype,Epithelial Ovarian Cancer
23578,Allergic Rhinitis In Non-Asthmatics,Phenotype,Allergic Rhinitis In Non-Asthmatics
23585,Red Blood Cell Fatty Acid Levels,Phenotype,Red Blood Cell Fatty Acid Levels
23589,Frontotemporal Dementia,Phenotype,Frontotemporal Dementia
23605,L-Arginine Levels,Phenotype,L-Arginine Levels
23607,Shingles,Phenotype,Shingles
23609,Glucose Homeostasis Traits,Phenotype,Glucose Homeostasis Traits
23615,Glaucoma (High Intraocular Pressure),Phenotype,Glaucoma (High Intraocular Pressure)
23626,White Matter Microstructure (Global Fractional Anisotropy),Phenotype,White Matter Microstructure (Global Fractional Anisotropy)
23627,Conduct Disorder (Symptom Count),Phenotype,Conduct Disorder (Symptom Count)
23635,Renal Function And Chronic Kidney Disease,Phenotype,Renal Function And Chronic Kidney Disease
23636,Asthma (Corticosteroid Response),Phenotype,Asthma (Corticosteroid Response)
23643,Esophageal Adenocarcinoma,Phenotype,Esophageal Adenocarcinoma
23646,Digestive System Disease (Barrett'S Esophagus And Esophageal Adenocarcinoma Combined),Phenotype,Digestive System Disease (Barrett'S Esophagus And Esophageal Adenocarcinoma Combined)
23647,Response To Radiotherapy In Cancer (Late Toxicity),Phenotype,Response To Radiotherapy In Cancer (Late Toxicity)
23649,Autism Spectrum Disorder-Related Traits,Phenotype,Autism Spectrum Disorder-Related Traits
23651,Cd4:Cd8 Lymphocyte Ratio,Phenotype,Cd4:Cd8 Lymphocyte Ratio
23653,Cd8-Positive T-Lymphocyte Count,Phenotype,Cd8-Positive T-Lymphocyte Count
23654,Fasting Plasma Glucose,Phenotype,Fasting Plasma Glucose
23659,Longevity (90 Years And Older),Phenotype,Longevity (90 Years And Older)
23662,Age-Related Cataracts,Phenotype,Age-Related Cataracts
23667,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Adrenic Acid),Phenotype,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Adrenic Acid)
23674,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Dihomo-Gamma-Linolenic Acid),Phenotype,Plasma Omega-6 Polyunsaturated Fatty Acid Levels (Dihomo-Gamma-Linolenic Acid)
23682,Sepsis From Pneumonia (Survival),Phenotype,Sepsis From Pneumonia (Survival)
23684,White Matter Hyperintensity Volume (Adjusted For Hypertension),Phenotype,White Matter Hyperintensity Volume (Adjusted For Hypertension)
23692,Parkinson'S Disease Progression (Composite),Phenotype,Parkinson'S Disease Progression (Composite)
23694,Response To Selenium Supplementation (Change In Plasma Selenium Concentration),Phenotype,Response To Selenium Supplementation (Change In Plasma Selenium Concentration)
23767,Nonalcoholic Fatty Liver Disease,Phenotype,Nonalcoholic Fatty Liver Disease
23770,Percent Liver Fat,Phenotype,Percent Liver Fat
23771,Liver Fibrosis And Steatohepatitis Severity (Mri Ct1 Measure),Phenotype,Liver Fibrosis And Steatohepatitis Severity (Mri Ct1 Measure)
23774,Problematic Alcohol Use (Mtag),Phenotype,Problematic Alcohol Use (Mtag)
23780,Diffuse Plaques (Snp X Snp Interaction),Phenotype,Diffuse Plaques (Snp X Snp Interaction)
23798,Schizophrenia (Mtag),Phenotype,Schizophrenia (Mtag)
23801,Bipolar Disorder (Mtag),Phenotype,Bipolar Disorder (Mtag)
23822,Homeostasis Model Assessment Of Insulin Resistance,Phenotype,Homeostasis Model Assessment Of Insulin Resistance
23824,Fasting Glucose,Phenotype,Fasting Glucose
23827,Parental Lifespan,Phenotype,Parental Lifespan
23830,Caffeine Consumption From Coffee,Phenotype,Caffeine Consumption From Coffee
23832,Caffeine Consumption From Tea,Phenotype,Caffeine Consumption From Tea
23837,Caffeine Consumption From Coffee Or Tea,Phenotype,Caffeine Consumption From Coffee Or Tea
23889,Septic Shock,Phenotype,Septic Shock
23908,Autism Spectrum Disorder (Mtag),Phenotype,Autism Spectrum Disorder (Mtag)
23909,Depressive Symptoms (Mtag),Phenotype,Depressive Symptoms (Mtag)
23934,White Matter Hyperintensity Volume,Phenotype,White Matter Hyperintensity Volume
23988,Help-Seeking From A Gp,Phenotype,Help-Seeking From A Gp
23990,Help-Seeking From A Psychiatrist,Phenotype,Help-Seeking From A Psychiatrist
23996,Help-Seeking From A Gp (Without Major Depressive Disorder Symptoms),Phenotype,Help-Seeking From A Gp (Without Major Depressive Disorder Symptoms)
23999,Major Depressive Disorder (Lifetime),Phenotype,Major Depressive Disorder (Lifetime)
24009,Alcohol Use Disorder,Phenotype,Alcohol Use Disorder
24057,Response To Antiepileptic Mood-Stabilizing Treatment In Bipolar Disorder,Phenotype,Response To Antiepileptic Mood-Stabilizing Treatment In Bipolar Disorder
24059,Gut Microbiota (Bacterial Taxa-- Rank Normal Transformation Method),Phenotype,Gut Microbiota (Bacterial Taxa-- Rank Normal Transformation Method)
24062,Parent Of Origin Effect On Receptive Language Ability (Paternal),Phenotype,Parent Of Origin Effect On Receptive Language Ability (Paternal)
24066,Parent Of Origin Effect On Receptive Language Ability (Maternal),Phenotype,Parent Of Origin Effect On Receptive Language Ability (Maternal)
24082,Preeclampsia (Maternal Genotype Effect),Phenotype,Preeclampsia (Maternal Genotype Effect)
24085,Triglyceride Levels In Hiv Infection,Phenotype,Triglyceride Levels In Hiv Infection
24088,Macrovascular Complications In Type 2 Diabetes,Phenotype,Macrovascular Complications In Type 2 Diabetes
24124,Neuritic Plaques (Snp X Snp Interaction),Phenotype,Neuritic Plaques (Snp X Snp Interaction)
24131,Problematic Alcohol Use,Phenotype,Problematic Alcohol Use
24153,Alcohol Consumption (Drinks Per Week) (Mtag),Phenotype,Alcohol Consumption (Drinks Per Week) (Mtag)
24158,Attention Deficit Hyperactivity Disorder (Mtag),Phenotype,Attention Deficit Hyperactivity Disorder (Mtag)
24159,Depressive Symptoms,Phenotype,Depressive Symptoms
24163,Rate Of Cognitive Decline In Alzheimer'S Disease,Phenotype,Rate Of Cognitive Decline In Alzheimer'S Disease
24270,Ldl Cholesterol Levels In Hiv Infection,Phenotype,Ldl Cholesterol Levels In Hiv Infection
24275,Peak Hip Bone Mineral Content,Phenotype,Peak Hip Bone Mineral Content
24290,Cv-A6-Associated Hand-- Foot-- And Mouth Disease (Severe Vs Mild),Phenotype,Cv-A6-Associated Hand-- Foot-- And Mouth Disease (Severe Vs Mild)
24292,Migraine With Aura And/Or Diastolic Blood Pressure,Phenotype,Migraine With Aura And/Or Diastolic Blood Pressure
24293,Migraine With Aura And/Or Systolic Blood Pressure,Phenotype,Migraine With Aura And/Or Systolic Blood Pressure
24295,Migraine With Aura And/Or Pulse Pressure,Phenotype,Migraine With Aura And/Or Pulse Pressure
24296,Migraine Without Aura And/Or Diastolic Blood Pressure,Phenotype,Migraine Without Aura And/Or Diastolic Blood Pressure
24298,Migraine Without Aura And/Or Systolic Blood Pressure,Phenotype,Migraine Without Aura And/Or Systolic Blood Pressure
24300,Migraine Without Aura And/Or Pulse Pressure,Phenotype,Migraine Without Aura And/Or Pulse Pressure
24301,Migraine And/Or Diastolic Blood Pressure,Phenotype,Migraine And/Or Diastolic Blood Pressure
24302,Migraine And/Or Pulse Pressure,Phenotype,Migraine And/Or Pulse Pressure
24304,Migraine And/Or Systolic Blood Pressure,Phenotype,Migraine And/Or Systolic Blood Pressure
24311,Deliberate Self-Harm,Phenotype,Deliberate Self-Harm
24320,Thrombosis In Response To Liver Transplant,Phenotype,Thrombosis In Response To Liver Transplant
24326,Autoimmune Thyroid Disease,Phenotype,Autoimmune Thyroid Disease
24364,Cognitive Function In Depression,Phenotype,Cognitive Function In Depression
24373,Tumor Necrosis Factor Beta Levels,Phenotype,Tumor Necrosis Factor Beta Levels
24376,Rheumatic Heart Disease,Phenotype,Rheumatic Heart Disease
24380,Response To Radiotherapy In Nasopharyngeal Carcinoma (Acute Oral Mucositis),Phenotype,Response To Radiotherapy In Nasopharyngeal Carcinoma (Acute Oral Mucositis)
24426,Attention Deficit Hyperactivity Disorder (Hyperactivity-Impulsivity Symptoms),Phenotype,Attention Deficit Hyperactivity Disorder (Hyperactivity-Impulsivity Symptoms)
24460,Estrogen Level Change In Anastrozole-Treated Breast Cancer,Phenotype,Estrogen Level Change In Anastrozole-Treated Breast Cancer
24473,Sepsis (Hospital Admission),Phenotype,Sepsis (Hospital Admission)
24475,Sepsis (90-Day Mortality),Phenotype,Sepsis (90-Day Mortality)
24489,L-Selectin Levels,Phenotype,L-Selectin Levels
24495,Cardiovascular Death Or Myocardial Infarction In Response To Clopidogrel Treatment,Phenotype,Cardiovascular Death Or Myocardial Infarction In Response To Clopidogrel Treatment
24497,Cardiovascular Death-- Myocardial Infarction Or Stroke In Response To Clopidogrel Treatment,Phenotype,Cardiovascular Death-- Myocardial Infarction Or Stroke In Response To Clopidogrel Treatment
24499,Stent Thrombosis In Response To Clopidogrel Treatment,Phenotype,Stent Thrombosis In Response To Clopidogrel Treatment
24501,Platelet Reactivity In Response To Clopidogrel Treatment,Phenotype,Platelet Reactivity In Response To Clopidogrel Treatment
24504,Nontraumatic Osteonecrosis Of The Femoral Head,Phenotype,Nontraumatic Osteonecrosis Of The Femoral Head
24508,White Matter Hyperintensity Volume X Hypertension Interaction (2Df),Phenotype,White Matter Hyperintensity Volume X Hypertension Interaction (2Df)
24509,Hdl Cholesterol Levels In Hiv Infection,Phenotype,Hdl Cholesterol Levels In Hiv Infection
24515,Periventricular White Matter Hyperintensities,Phenotype,Periventricular White Matter Hyperintensities
24518,Total Phf-Tau (Snp X Snp Interaction),Phenotype,Total Phf-Tau (Snp X Snp Interaction)
24536,Autoimmune Traits,Phenotype,Autoimmune Traits
24539,Cardiovascular Disease,Phenotype,Cardiovascular Disease
24588,Tumor Necrosis Factor Levels,Phenotype,Tumor Necrosis Factor Levels
24618,Pancreatic Beta-Cell Glucose Sensitivity,Phenotype,Pancreatic Beta-Cell Glucose Sensitivity
24627,Myocardial Fractal Dimension (Slice 5),Phenotype,Myocardial Fractal Dimension (Slice 5)
24630,Myocardial Fractal Dimension (Slice 7),Phenotype,Myocardial Fractal Dimension (Slice 7)
24632,Myocardial Fractal Dimension (Slice 6),Phenotype,Myocardial Fractal Dimension (Slice 6)
24633,Myocardial Fractal Dimension (Slice 4),Phenotype,Myocardial Fractal Dimension (Slice 4)
24640,Myocardial Fractal Dimension (Slice 8),Phenotype,Myocardial Fractal Dimension (Slice 8)
24641,Shoulder Impingement Syndrome,Phenotype,Shoulder Impingement Syndrome
24682,Sensory Peripheral Neuropathy In Microtubule Targeting Agent-Treated Breast Cancer,Phenotype,Sensory Peripheral Neuropathy In Microtubule Targeting Agent-Treated Breast Cancer
24686,Leukoderma In Response To Rhododendrol,Phenotype,Leukoderma In Response To Rhododendrol
24744,Eczema,Phenotype,Eczema
24757,Mastocytosis,Phenotype,Mastocytosis
24761,Systemic Mastocytosis,Phenotype,Systemic Mastocytosis
24766,Cutaneous Mastocytosis,Phenotype,Cutaneous Mastocytosis
24769,Facial Morphology Traits (59 Nscl/P Endophenotypic Segments),Phenotype,Facial Morphology Traits (59 Nscl/P Endophenotypic Segments)
24799,Residual Cognitive Resilience,Phenotype,Residual Cognitive Resilience
24801,Combined Resilience (Covariance Of Educational Attainment With Residual Cognitive Resilience),Phenotype,Combined Resilience (Covariance Of Educational Attainment With Residual Cognitive Resilience)
24803,Vaginal Microbiome Composition (Shannon Diversity Index),Phenotype,Vaginal Microbiome Composition (Shannon Diversity Index)
24892,Gastric Cancer,Phenotype,Gastric Cancer
24902,Neonatal White Matter Microstructure,Phenotype,Neonatal White Matter Microstructure
24907,Adult Onset Asthma Or Type 2 Diabetes,Phenotype,Adult Onset Asthma Or Type 2 Diabetes
24910,Adult Onset Asthma And/Or Bmi,Phenotype,Adult Onset Asthma And/Or Bmi
24912,Nonatopic Asthma And/Or Bmi,Phenotype,Nonatopic Asthma And/Or Bmi
24914,Asthma (Adult Onset),Phenotype,Asthma (Adult Onset)
24948,Aging Traits (Healthspan-- Parental Lifespan Or Longevity) (Multivariate Analysis),Phenotype,Aging Traits (Healthspan-- Parental Lifespan Or Longevity) (Multivariate Analysis)
24952,Electrocardiographic Traits (Multivariate),Phenotype,Electrocardiographic Traits (Multivariate)
24961,Brain Morphology (Mostest),Phenotype,Brain Morphology (Mostest)
25002,Motor Fluctuations In Levodopa Treated Parkinson'S Disease,Phenotype,Motor Fluctuations In Levodopa Treated Parkinson'S Disease
25004,Levodopa-Induced Dyskinesia In Levodopa Treated Parkinson'S Disease,Phenotype,Levodopa-Induced Dyskinesia In Levodopa Treated Parkinson'S Disease
25013,Response To Esketamine In Treatment Resistant Depression,Phenotype,Response To Esketamine In Treatment Resistant Depression
25017,Response To Esketamine (Responder Status) In Treatment Resistant Depression,Phenotype,Response To Esketamine (Responder Status) In Treatment Resistant Depression
25033,Anti-Epstein-Barr Virus Nuclear Antigen (Ebna) Igg Levels,Phenotype,Anti-Epstein-Barr Virus Nuclear Antigen (Ebna) Igg Levels
25059,Cortical Thickness (Mostest),Phenotype,Cortical Thickness (Mostest)
25065,Subcortical Volume (Mostest),Phenotype,Subcortical Volume (Mostest)
25093,Arterial Stiffness (Brachial-Femoral Pulse Wave Velocity),Phenotype,Arterial Stiffness (Brachial-Femoral Pulse Wave Velocity)
25095,Total Carotid Plaque Area (Excess Vs Minimal Atherosclerosis),Phenotype,Total Carotid Plaque Area (Excess Vs Minimal Atherosclerosis)
25099,Circulating Leptin Levels Adjusted For Bmi,Phenotype,Circulating Leptin Levels Adjusted For Bmi
25101,Circulating Leptin Levels,Phenotype,Circulating Leptin Levels
25108,Glucocorticoid Receptor Gene Expression In B-Cell Precursor Acute Lymphoblastic Leukaemia,Phenotype,Glucocorticoid Receptor Gene Expression In B-Cell Precursor Acute Lymphoblastic Leukaemia
25202,Percent Mammographic Density,Phenotype,Percent Mammographic Density
25203,Cerebrospinal Fluid T-Tau:Ab1-42 Ratio,Phenotype,Cerebrospinal Fluid T-Tau:Ab1-42 Ratio
25219,Restless Legs Syndrome In Migraine Without Aura,Phenotype,Restless Legs Syndrome In Migraine Without Aura
25235,Deep White Matter Hyperintensities,Phenotype,Deep White Matter Hyperintensities
25257,Childhood All/Lbl (Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma) Treatment-Related Venous Thromboembolism,Phenotype,Childhood All/Lbl (Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma) Treatment-Related Venous Thromboembolism
25283,Respiratory Diseases,Phenotype,Respiratory Diseases
25344,Age At Menopause,Phenotype,Age At Menopause
25394,Neuroblastoma (Pediatric),Phenotype,Neuroblastoma (Pediatric)
25401,Allergic Disease (Asthma-- Hay Fever And/Or Eczema) (Age Of Onset),Phenotype,Allergic Disease (Asthma-- Hay Fever And/Or Eczema) (Age Of Onset)
25406,Allergic Disease (Asthma-- Hay Fever And/Or Eczema) (Multivariate Analysis),Phenotype,Allergic Disease (Asthma-- Hay Fever And/Or Eczema) (Multivariate Analysis)
25450,Brain Morphology (Min-P),Phenotype,Brain Morphology (Min-P)
25452,Cortical Surface Area (Mostest),Phenotype,Cortical Surface Area (Mostest)
25499,Cortical Surface Area (Min-P),Phenotype,Cortical Surface Area (Min-P)
25503,Subcortical Volume (Min-P),Phenotype,Subcortical Volume (Min-P)
25505,Cortical Thickness (Min-P),Phenotype,Cortical Thickness (Min-P)
25532,Oral Cavity Cancer,Phenotype,Oral Cavity Cancer
25534,Oropharynx Cancer,Phenotype,Oropharynx Cancer
25537,Head And Neck Squamous Cell Carcinoma,Phenotype,Head And Neck Squamous Cell Carcinoma
25540,Ceramide Levels (C24:0),Phenotype,Ceramide Levels (C24:0)
25542,Ceramide Levels (C22:0),Phenotype,Ceramide Levels (C22:0)
25544,Waist-To-Hip Ratio Adjusted For Bmi In Non-Smokers,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi In Non-Smokers
25545,Body Fat Mass,Phenotype,Body Fat Mass
25551,Skin Aging (Microtopography Measurement),Phenotype,Skin Aging (Microtopography Measurement)
25576,Dehydroepiandrosterone Sulphate Levels,Phenotype,Dehydroepiandrosterone Sulphate Levels
25578,Chronic Periodontitis (Mean Interproximal Clinical Attachment Level),Phenotype,Chronic Periodontitis (Mean Interproximal Clinical Attachment Level)
25581,Barrett'S Esophagus  Or Esophageal Adenocarcinoma,Phenotype,Barrett'S Esophagus  Or Esophageal Adenocarcinoma
25584,Survival In Pancreatic Cancer,Phenotype,Survival In Pancreatic Cancer
25589,Glomerular Filtration Rate,Phenotype,Glomerular Filtration Rate
25592,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis For Main Effect And Physical Activity Interaction),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis For Main Effect And Physical Activity Interaction)
25600,Total Cholesterol Change In Response To Fenofibrate In Statin-Treated Type 2 Diabetes,Phenotype,Total Cholesterol Change In Response To Fenofibrate In Statin-Treated Type 2 Diabetes
25606,Triglyceride Change In Response To Fenofibrate In Statin-Treated Type 2 Diabetes,Phenotype,Triglyceride Change In Response To Fenofibrate In Statin-Treated Type 2 Diabetes
25612,Body Mass Index (Joint Analysis Main Effects And Physical Activity Interaction),Phenotype,Body Mass Index (Joint Analysis Main Effects And Physical Activity Interaction)
25616,Modified Stumvoll Insulin Sensitivity Index (Bmi Interaction),Phenotype,Modified Stumvoll Insulin Sensitivity Index (Bmi Interaction)
25626,Psychosis Proneness (Hypomanic Personality Scale),Phenotype,Psychosis Proneness (Hypomanic Personality Scale)
25628,Psychosis Proneness (Perceptual Aberration Scale),Phenotype,Psychosis Proneness (Perceptual Aberration Scale)
25630,Psychosis Proneness (Hypomanic Personality Scale And Revised Physical Anhedonia Scale),Phenotype,Psychosis Proneness (Hypomanic Personality Scale And Revised Physical Anhedonia Scale)
25635,Acute Graft Versus Host Disease In Bone Marrow Transplantation (Recipient Effect),Phenotype,Acute Graft Versus Host Disease In Bone Marrow Transplantation (Recipient Effect)
25638,Acute Graft Versus Host Disease In Bone Marrow Transplantation (Donor Effect),Phenotype,Acute Graft Versus Host Disease In Bone Marrow Transplantation (Donor Effect)
25641,Response To Statins (Hdl Cholesterol Change),Phenotype,Response To Statins (Hdl Cholesterol Change)
25646,Early Onset Atrial Fibrillation,Phenotype,Early Onset Atrial Fibrillation
25651,Alcoholic Chronic Pancreatitis,Phenotype,Alcoholic Chronic Pancreatitis
25653,Left Ventricular Obstructive Tract Defect (Inherited Effect),Phenotype,Left Ventricular Obstructive Tract Defect (Inherited Effect)
25656,Left Ventricular Obstructive Tract Defect (Maternal Effect),Phenotype,Left Ventricular Obstructive Tract Defect (Maternal Effect)
25658,Congenital Heart Disease (Inherited Effect),Phenotype,Congenital Heart Disease (Inherited Effect)
25660,Congenital Heart Disease (Maternal Effect),Phenotype,Congenital Heart Disease (Maternal Effect)
25662,Conotruncal Heart Defects (Maternal Effects),Phenotype,Conotruncal Heart Defects (Maternal Effects)
25674,Appendicular Lean Mass,Phenotype,Appendicular Lean Mass
25676,Lean Body Mass,Phenotype,Lean Body Mass
25686,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Physical Activity Interaction),Phenotype,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Physical Activity Interaction)
25713,Plantar Warts,Phenotype,Plantar Warts
25737,Bacterial Meningitis,Phenotype,Bacterial Meningitis
25744,Fear Of Minor Pain,Phenotype,Fear Of Minor Pain
25754,Fear Of Medical Pain (Dental),Phenotype,Fear Of Medical Pain (Dental)
25756,Fear Of Pain,Phenotype,Fear Of Pain
25757,Igg Galactosylation Phenotypes (Multivariate Analysis),Phenotype,Igg Galactosylation Phenotypes (Multivariate Analysis)
25759,Rubella,Phenotype,Rubella
25762,Mononucleosis,Phenotype,Mononucleosis
25795,Insomnia Complaints,Phenotype,Insomnia Complaints
25800,Peripheral Arterial Disease (Traffic-Related Air Pollution Interaction),Phenotype,Peripheral Arterial Disease (Traffic-Related Air Pollution Interaction)
25808,Facial Morphology (Factor 16),Phenotype,Facial Morphology (Factor 16)
25810,Facial Morphology (Factor 17-- Height Of Vermillion Upper Lip),Phenotype,Facial Morphology (Factor 17-- Height Of Vermillion Upper Lip)
25812,Facial Morphology (Factor 15-- Philtrum Width),Phenotype,Facial Morphology (Factor 15-- Philtrum Width)
25816,Autism Spectrum Disorder Or Schizophrenia,Phenotype,Autism Spectrum Disorder Or Schizophrenia
25852,Urinary Tract Infection Frequency,Phenotype,Urinary Tract Infection Frequency
25859,Chronic Sinus Infection,Phenotype,Chronic Sinus Infection
25865,Number Of Common Colds,Phenotype,Number Of Common Colds
25871,Hepatitis A,Phenotype,Hepatitis A
25874,Rheumatic Fever,Phenotype,Rheumatic Fever
25882,Pneumonia,Phenotype,Pneumonia
25893,Scarlet Fever,Phenotype,Scarlet Fever
25917,Small Cell Lung Carcinoma,Phenotype,Small Cell Lung Carcinoma
25933,Squamous Cell Lung Carcinoma,Phenotype,Squamous Cell Lung Carcinoma
25988,Facial Morphology (Factor 12-- Vertical Position Of Sublabial Sulcus Relative To Central Midface),Phenotype,Facial Morphology (Factor 12-- Vertical Position Of Sublabial Sulcus Relative To Central Midface)
25991,Facial Morphology (Factor 4-- Facial Height Related To Vertical Position Of Gnathion),Phenotype,Facial Morphology (Factor 4-- Facial Height Related To Vertical Position Of Gnathion)
25993,Facial Morphology (Factor 9-- Facial Height Related To Vertical Position Of Nasion),Phenotype,Facial Morphology (Factor 9-- Facial Height Related To Vertical Position Of Nasion)
25995,Facial Morphology (Factor 7-- Width Of Cartilaginous Portion Of Nose),Phenotype,Facial Morphology (Factor 7-- Width Of Cartilaginous Portion Of Nose)
25998,Facial Morphology (Factor 8-- Orbital Inclination Due To Vertical And Horizontal Position Of Exocanthion),Phenotype,Facial Morphology (Factor 8-- Orbital Inclination Due To Vertical And Horizontal Position Of Exocanthion)
26000,Facial Morphology (Factor 6-- Height Of Vermillion Lower Lip),Phenotype,Facial Morphology (Factor 6-- Height Of Vermillion Lower Lip)
26004,Facial Morphology (Factor 11-- Projection Of The Nose),Phenotype,Facial Morphology (Factor 11-- Projection Of The Nose)
26043,Obstetric Antiphospholipid Syndrome,Phenotype,Obstetric Antiphospholipid Syndrome
26047,Chickenpox,Phenotype,Chickenpox
26069,Cold Sores,Phenotype,Cold Sores
26091,Mumps,Phenotype,Mumps
26141,Lipoprotein(A) Levels Adjusted For Apolipoprotein(A) Isoforms,Phenotype,Lipoprotein(A) Levels Adjusted For Apolipoprotein(A) Isoforms
26163,Lipoprotein (A) Levels,Phenotype,Lipoprotein (A) Levels
26218,Lung Cancer In Ever Smokers,Phenotype,Lung Cancer In Ever Smokers
26249,Lung Cancer In Never Smokers,Phenotype,Lung Cancer In Never Smokers
26260,Facial Morphology (Factor 2-- Vertical Position Of Orbits Relative To Midface),Phenotype,Facial Morphology (Factor 2-- Vertical Position Of Orbits Relative To Midface)
26266,Facial Morphology (Factor 18),Phenotype,Facial Morphology (Factor 18)
26268,Facial Morphology (Factor 19),Phenotype,Facial Morphology (Factor 19)
26291,Trunk Fat Mass,Phenotype,Trunk Fat Mass
26316,Verbal Memory Performance (Immediate Recall Change),Phenotype,Verbal Memory Performance (Immediate Recall Change)
26318,Verbal Memory Performance (Residualized Delayed Recall Level),Phenotype,Verbal Memory Performance (Residualized Delayed Recall Level)
26320,Hepatocellular Carcinoma In Hepatitis C Infection,Phenotype,Hepatocellular Carcinoma In Hepatitis C Infection
26332,Strep Throat,Phenotype,Strep Throat
26353,Subjective Well-Being (Mtag),Phenotype,Subjective Well-Being (Mtag)
26356,Neuroticism (Mtag),Phenotype,Neuroticism (Mtag)
26360,Cerebral Blood Flow,Phenotype,Cerebral Blood Flow
26362,Resistance To Mycobacterium Tuberculosis In Hiv-Positive Individuals Measured By A Negative Tuberculin Skin Test (Dichotomous),Phenotype,Resistance To Mycobacterium Tuberculosis In Hiv-Positive Individuals Measured By A Negative Tuberculin Skin Test (Dichotomous)
26364,Red Blood Cell Density In Sickle Cell Anemia,Phenotype,Red Blood Cell Density In Sickle Cell Anemia
26366,Heart Rate Variability Traits (Sdnn),Phenotype,Heart Rate Variability Traits (Sdnn)
26368,Heart Rate Variability Traits (Rmssd),Phenotype,Heart Rate Variability Traits (Rmssd)
26376,Heart Rate Variability Traits (Pvrsa/Hf),Phenotype,Heart Rate Variability Traits (Pvrsa/Hf)
26421,Hiv-Associated Neurocognitive Disorder (Mild Neurocognitive Disorder Or Asymptomatic Neurocognitive Impairment),Phenotype,Hiv-Associated Neurocognitive Disorder (Mild Neurocognitive Disorder Or Asymptomatic Neurocognitive Impairment)
26423,Hiv-Associated Neurocognitive Disorder (Asymptomatic Neurocogntive Impairment),Phenotype,Hiv-Associated Neurocognitive Disorder (Asymptomatic Neurocogntive Impairment)
26459,Monocyte Chemoattractant Protein-1 Levels,Phenotype,Monocyte Chemoattractant Protein-1 Levels
26461,Interleukin-12P70 Levels,Phenotype,Interleukin-12P70 Levels
26468,Rantes Levels,Phenotype,Rantes Levels
26470,Platelet-Derived Growth Factor Bb Levels,Phenotype,Platelet-Derived Growth Factor Bb Levels
26479,Stem Cell Factor Levels,Phenotype,Stem Cell Factor Levels
26482,Macrophage Inflammatory Protein 1B Levels,Phenotype,Macrophage Inflammatory Protein 1B Levels
26490,Prudent Dietary Pattern,Phenotype,Prudent Dietary Pattern
26494,Western Dietary Pattern,Phenotype,Western Dietary Pattern
26503,Primary Vesicoureteric Reflux,Phenotype,Primary Vesicoureteric Reflux
26505,Anti-Saccade Response,Phenotype,Anti-Saccade Response
26507,Pursuit Maintenance Gain,Phenotype,Pursuit Maintenance Gain
26519,Initial Pursuit Acceleration In Psychotic Disorders,Phenotype,Initial Pursuit Acceleration In Psychotic Disorders
26524,Cold Medicine-Related Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Sjs/Ten) With Severe Ocular Complications,Phenotype,Cold Medicine-Related Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Sjs/Ten) With Severe Ocular Complications
26527,Macrophage Inflammatory Protein 1A Levels,Phenotype,Macrophage Inflammatory Protein 1A Levels
26532,Monokine Induced By Gamma Interferon Levels,Phenotype,Monokine Induced By Gamma Interferon Levels
26537,Macrophage Colony Stimulating Factor Levels,Phenotype,Macrophage Colony Stimulating Factor Levels
26549,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test)
26551,Diastolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (1Df Test),Phenotype,Diastolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (1Df Test)
26556,Diastolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Smoking Status (Current Vs Non-Current) Interaction (2Df Test)
26558,Post Bronchodilator Fev1/Fvc Ratio In Copd,Phenotype,Post Bronchodilator Fev1/Fvc Ratio In Copd
26578,Acpa-Positive Rheumatoid Arthritis (Smoking Interaction),Phenotype,Acpa-Positive Rheumatoid Arthritis (Smoking Interaction)
26591,Milk Allergy (Maternal Genetic Effects),Phenotype,Milk Allergy (Maternal Genetic Effects)
26593,Coronary Atherosclerosis (Increased Number Of Diseased Vessels) (Traffic Exposure Interaction),Phenotype,Coronary Atherosclerosis (Increased Number Of Diseased Vessels) (Traffic Exposure Interaction)
26596,Limited Cutaneous Systemic Scleroderma,Phenotype,Limited Cutaneous Systemic Scleroderma
26597,Blood Osmolality (Transformed Sodium),Phenotype,Blood Osmolality (Transformed Sodium)
26599,Neuritic Plaques Or Neurofibrillary Tangles (Pleiotropy),Phenotype,Neuritic Plaques Or Neurofibrillary Tangles (Pleiotropy)
26606,Initial Pursuit Acceleration,Phenotype,Initial Pursuit Acceleration
26616,Cleft Palate,Phenotype,Cleft Palate
26619,Primary Sclerosing Cholangitis,Phenotype,Primary Sclerosing Cholangitis
26621,Multiple System Atrophy,Phenotype,Multiple System Atrophy
26638,Ovarian Disease With Few Adhesions,Phenotype,Ovarian Disease With Few Adhesions
26640,Deep Ovarian And/Or Rectovaginal Disease With Dense Adhesions,Phenotype,Deep Ovarian And/Or Rectovaginal Disease With Dense Adhesions
26642,Opioid Dependence,Phenotype,Opioid Dependence
26646,Systolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test)
26651,Lipoprotein-Associated Phospholipase A2 Activity Change In Response To Darapladib Treatment In Cardiovascular Disease,Phenotype,Lipoprotein-Associated Phospholipase A2 Activity Change In Response To Darapladib Treatment In Cardiovascular Disease
26653,Diarrhoea In Darapladib-Treated Cardiovascular Disease (Time To Event),Phenotype,Diarrhoea In Darapladib-Treated Cardiovascular Disease (Time To Event)
26656,Major Coronary Event In Cardiovascular Disease (Time To Event) (Darapladib Treatment Interaction),Phenotype,Major Coronary Event In Cardiovascular Disease (Time To Event) (Darapladib Treatment Interaction)
26657,Lipoprotein Phospholipase A2 Activity In Cardiovascular Disease,Phenotype,Lipoprotein Phospholipase A2 Activity In Cardiovascular Disease
26659,Moderate Or Severe Diarrhoea In Darapladib-Treated Cardiovascular Disease (Time To Event),Phenotype,Moderate Or Severe Diarrhoea In Darapladib-Treated Cardiovascular Disease (Time To Event)
26661,Glp-1 Levels In Response To Oral Glucose Tolerance Test (Fasting),Phenotype,Glp-1 Levels In Response To Oral Glucose Tolerance Test (Fasting)
26663,Gip Levels In Response To Oral Glucose Tolerance Test (120 Minutes),Phenotype,Gip Levels In Response To Oral Glucose Tolerance Test (120 Minutes)
26668,Nicotine Dependence,Phenotype,Nicotine Dependence
26687,Mean Arterial Pressure,Phenotype,Mean Arterial Pressure
26691,Obsessive-Compulsive Disorder Or Autism Spectrum Disorder,Phenotype,Obsessive-Compulsive Disorder Or Autism Spectrum Disorder
26694,Huntington'S Disease Progression,Phenotype,Huntington'S Disease Progression
26701,Immunoglobulin A Vasculitis,Phenotype,Immunoglobulin A Vasculitis
26703,Intelligence (Mtag),Phenotype,Intelligence (Mtag)
26727,Adult Asthma,Phenotype,Adult Asthma
26739,Coenzyme Q10 Levels,Phenotype,Coenzyme Q10 Levels
26747,Plasma Kynurenine Levels In Major Depressive Disorder,Phenotype,Plasma Kynurenine Levels In Major Depressive Disorder
26749,Follicle Stimulating Hormone Levels In Polycystic Ovary Syndrome,Phenotype,Follicle Stimulating Hormone Levels In Polycystic Ovary Syndrome
26751,Testosterone Levels In Polycystic Ovary Syndrome,Phenotype,Testosterone Levels In Polycystic Ovary Syndrome
26753,Sarcoidosis (Non-Lofgren'S Syndrome),Phenotype,Sarcoidosis (Non-Lofgren'S Syndrome)
26755,Sarcoidosis (Non-Lofgren'S Syndrome Without Extrapulmonary Manifestations),Phenotype,Sarcoidosis (Non-Lofgren'S Syndrome Without Extrapulmonary Manifestations)
26758,Sarcoidosis (Lofgren'S Syndrome Vs Non-Lofgren'S Syndrome),Phenotype,Sarcoidosis (Lofgren'S Syndrome Vs Non-Lofgren'S Syndrome)
26773,Thrombin-Activatable Fibrinolysis Inhibitor Activation Peptide,Phenotype,Thrombin-Activatable Fibrinolysis Inhibitor Activation Peptide
26780,Sarcoidosis (Lofgren'S Syndrome),Phenotype,Sarcoidosis (Lofgren'S Syndrome)
26781,Epstein-Barr Virus Copy Number In Lymphoblastoid Cell Lines,Phenotype,Epstein-Barr Virus Copy Number In Lymphoblastoid Cell Lines
26791,Serum Uric Acid Levels In Response To Allopurinol In Gout,Phenotype,Serum Uric Acid Levels In Response To Allopurinol In Gout
26794,Lower Body Strength,Phenotype,Lower Body Strength
26811,Brain Volume In Infants (White Matter),Phenotype,Brain Volume In Infants (White Matter)
26814,Brain Volume In Infants (Cerebrospinal Fluid),Phenotype,Brain Volume In Infants (Cerebrospinal Fluid)
26816,Brain Volume In Infants (Grey Matter),Phenotype,Brain Volume In Infants (Grey Matter)
26820,Opioid Requirements During Laparoscopic-Assisted Colectomy,Phenotype,Opioid Requirements During Laparoscopic-Assisted Colectomy
26829,Total Cholesterol Levels In Hdl,Phenotype,Total Cholesterol Levels In Hdl
26831,Docetaxel-Induced Peripheral Neuropathy In Metastatic Castrate-Resistant Prostate Cancer,Phenotype,Docetaxel-Induced Peripheral Neuropathy In Metastatic Castrate-Resistant Prostate Cancer
26850,Recurrent Major Depressive Disorder,Phenotype,Recurrent Major Depressive Disorder
26855,Disease Progression In Age-Related Macular Degeneration,Phenotype,Disease Progression In Age-Related Macular Degeneration
26860,Disease Progression To Choroidal Neovascularization Form In Age-Related Macular Degeneration,Phenotype,Disease Progression To Choroidal Neovascularization Form In Age-Related Macular Degeneration
26862,Disease Progression In Age-Related Macular Degeneration (Adjusted For Baseline),Phenotype,Disease Progression In Age-Related Macular Degeneration (Adjusted For Baseline)
26915,Coronary Artery Disease (Myocardial Infarction-- Percutaneous Transluminal Coronary Angioplasty-- Coronary Artery Bypass Grafting-- Angina Or Chromic Ischemic Heart Disease),Phenotype,Coronary Artery Disease (Myocardial Infarction-- Percutaneous Transluminal Coronary Angioplasty-- Coronary Artery Bypass Grafting-- Angina Or Chromic Ischemic Heart Disease)
26920,Forced Expiratory Volume In 1 Second (Environmental Tobacco Smoke Interaction),Phenotype,Forced Expiratory Volume In 1 Second (Environmental Tobacco Smoke Interaction)
26931,Response To Metformin (Ic50),Phenotype,Response To Metformin (Ic50)
26955,6-Month Creatinine Clearance Change Response To Tenofovir Treatment In Hiv Infection (Treatment Arm Interaction),Phenotype,6-Month Creatinine Clearance Change Response To Tenofovir Treatment In Hiv Infection (Treatment Arm Interaction)
26966,Nevirapine-Induced Hypersensitivity In Hiv (Stevens-Johnson Syndrome Or Toxic Epidermal Necrosis),Phenotype,Nevirapine-Induced Hypersensitivity In Hiv (Stevens-Johnson Syndrome Or Toxic Epidermal Necrosis)
26968,Nevirapine-Induced Hypersensitivity In Hiv,Phenotype,Nevirapine-Induced Hypersensitivity In Hiv
26973,Itch Intensity From Mosquito Bite,Phenotype,Itch Intensity From Mosquito Bite
26986,Itch Intensity From Mosquito Bite Adjusted By Bite Size,Phenotype,Itch Intensity From Mosquito Bite Adjusted By Bite Size
26988,Tenofovir Clearance In Hiv Infection,Phenotype,Tenofovir Clearance In Hiv Infection
26996,Blood Pressure Traits (Multi-Trait Analysis),Phenotype,Blood Pressure Traits (Multi-Trait Analysis)
27010,Waist Circumference Adjusted For Bmi (Adjusted For Smoking Behaviour),Phenotype,Waist Circumference Adjusted For Bmi (Adjusted For Smoking Behaviour)
27013,Waist-To-Hip Ratio Adjusted For Bmi (Adjusted For Smoking Behaviour),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Adjusted For Smoking Behaviour)
27025,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Smoking Interaction),Phenotype,Waist Circumference Adjusted For Bmi (Joint Analysis Main Effects And Smoking Interaction)
27026,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis Main Effects And Smoking Interaction),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Joint Analysis Main Effects And Smoking Interaction)
27042,Body Mass Index (Adult),Phenotype,Body Mass Index (Adult)
27067,Intelligence,Phenotype,Intelligence
27078,Mosquito Bite Size,Phenotype,Mosquito Bite Size
27095,Perceived Unattractiveness To Mosquitoes,Phenotype,Perceived Unattractiveness To Mosquitoes
27099,Bmi (Adjusted For Smoking Behaviour),Phenotype,Bmi (Adjusted For Smoking Behaviour)
27100,Body Mass Index (Joint Analysis Main Effects And Smoking Interaction),Phenotype,Body Mass Index (Joint Analysis Main Effects And Smoking Interaction)
27105,Pre Bronchodilator Fev1/Fvc Ratio In Never-Smokers,Phenotype,Pre Bronchodilator Fev1/Fvc Ratio In Never-Smokers
27107,Late-Onset Alzheimer'S Disease,Phenotype,Late-Onset Alzheimer'S Disease
27133,Dermatomyositis,Phenotype,Dermatomyositis
27135,Hip Minimal Joint Space Width,Phenotype,Hip Minimal Joint Space Width
27138,Insulin Levels,Phenotype,Insulin Levels
27140,Insulin Levels Adjusted For Bmi,Phenotype,Insulin Levels Adjusted For Bmi
27141,Insulin Disposition Index,Phenotype,Insulin Disposition Index
27142,Incremental Insulin,Phenotype,Incremental Insulin
27143,Corrected Insulin Response,Phenotype,Corrected Insulin Response
27144,Corrected Insulin Response Adjusted For Insulin Sensitivity Index,Phenotype,Corrected Insulin Response Adjusted For Insulin Sensitivity Index
27153,Bipolar Disorder Lithium Response (Continuous) Or Schizophrenia,Phenotype,Bipolar Disorder Lithium Response (Continuous) Or Schizophrenia
27155,Bipolar Disorder Lithium Response (Categorical) Or Schizophrenia,Phenotype,Bipolar Disorder Lithium Response (Categorical) Or Schizophrenia
27163,Response To Mepolizumab In Severe Asthma,Phenotype,Response To Mepolizumab In Severe Asthma
27169,Moyamoya Disease,Phenotype,Moyamoya Disease
27192,Alcohol Dependence Symptom Count,Phenotype,Alcohol Dependence Symptom Count
27198,Selective Iga Deficiency,Phenotype,Selective Iga Deficiency
27202,Thiopurine S-Methyltransferase Activity,Phenotype,Thiopurine S-Methyltransferase Activity
27207,Oral Cavity And Pharyngeal Cancer,Phenotype,Oral Cavity And Pharyngeal Cancer
27212,Mortality In Sepsis,Phenotype,Mortality In Sepsis
27215,Food Addiction,Phenotype,Food Addiction
27217,Depression In Response To Interferon-Based Therapy In Chronic Hepatitis C,Phenotype,Depression In Response To Interferon-Based Therapy In Chronic Hepatitis C
27228,Inhibitory Control,Phenotype,Inhibitory Control
27236,Dementia With Lewy Bodies,Phenotype,Dementia With Lewy Bodies
27246,Chronic Rhinosinusitis With Nasal Polyps,Phenotype,Chronic Rhinosinusitis With Nasal Polyps
27258,Sulfasalazine-Induced Agranulocytosis,Phenotype,Sulfasalazine-Induced Agranulocytosis
27292,Heart Rate Response To Exercise,Phenotype,Heart Rate Response To Exercise
27293,Heart Rate Response To Recovery Post Exercise,Phenotype,Heart Rate Response To Recovery Post Exercise
27296,Systemic Sclerosis (Anti-Centromere-Positive),Phenotype,Systemic Sclerosis (Anti-Centromere-Positive)
27299,Diffuse Cutaneous Systemic Sclerosis,Phenotype,Diffuse Cutaneous Systemic Sclerosis
27301,Systemic Sclerosis (Anti-Topoisomerase-Positive),Phenotype,Systemic Sclerosis (Anti-Topoisomerase-Positive)
27303,Total Body Bone Mineral Density,Phenotype,Total Body Bone Mineral Density
27313,Epstein Barr Virus Nuclear Antigen 1 Igg Levels,Phenotype,Epstein Barr Virus Nuclear Antigen 1 Igg Levels
27314,Epstein Barr Virus Nuclear Antigen 1 Igg Seropositivity,Phenotype,Epstein Barr Virus Nuclear Antigen 1 Igg Seropositivity
27315,Epstein-Barr Virus Immune Response (Multivariate Analysis),Phenotype,Epstein-Barr Virus Immune Response (Multivariate Analysis)
27316,Giant Cell Arteritis,Phenotype,Giant Cell Arteritis
27317,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies)
27319,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Mean Antibody Levels),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Mean Antibody Levels)
27321,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Area Under The Curve For The First Two Years),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Area Under The Curve For The First Two Years)
27322,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Maximum Antibody Levels),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Maximum Antibody Levels)
27327,Total Body Bone Mineral Density (Age 30-45),Phenotype,Total Body Bone Mineral Density (Age 30-45)
27329,Total Body Bone Mineral Density (Age 45-60),Phenotype,Total Body Bone Mineral Density (Age 45-60)
27330,Total Body Bone Mineral Density (Age Over 60),Phenotype,Total Body Bone Mineral Density (Age Over 60)
27332,Alzheimer'S Disease Or Family History Of Alzheimer'S Disease,Phenotype,Alzheimer'S Disease Or Family History Of Alzheimer'S Disease
27338,Stimulated C-Peptide Levels In Type I Diabetes,Phenotype,Stimulated C-Peptide Levels In Type I Diabetes
27340,Random C-Peptide Levels In Type I Diabetes,Phenotype,Random C-Peptide Levels In Type I Diabetes
27342,C-Peptide Levels In Type I Diabetes,Phenotype,C-Peptide Levels In Type I Diabetes
27403,Low Tan Response,Phenotype,Low Tan Response
27423,Neuromyelitis Optica,Phenotype,Neuromyelitis Optica
27425,Neuromyelitis Optica (Aqp4-Igg-Positive),Phenotype,Neuromyelitis Optica (Aqp4-Igg-Positive)
27426,Spherical Equivalent Or Myopia (Age Of Diagnosis),Phenotype,Spherical Equivalent Or Myopia (Age Of Diagnosis)
27428,Myopia (Age Of Diagnosis),Phenotype,Myopia (Age Of Diagnosis)
27432,Allergic Disease (Asthma-- Hay Fever Or Eczema),Phenotype,Allergic Disease (Asthma-- Hay Fever Or Eczema)
27440,Thyroid Autoantibody Positivity (Anti-Thyroglobulin (Tgab) And/Or Anti-Thyroid Peroxidase  (Tpoab) Levels),Phenotype,Thyroid Autoantibody Positivity (Anti-Thyroglobulin (Tgab) And/Or Anti-Thyroid Peroxidase  (Tpoab) Levels)
27443,Optic Disc Size,Phenotype,Optic Disc Size
27450,Bone Mineral Density (Total Hip),Phenotype,Bone Mineral Density (Total Hip)
27452,Menstruation Quality Of Life Impact (Loss Of Concentration),Phenotype,Menstruation Quality Of Life Impact (Loss Of Concentration)
27454,Vaginal Discharge (Itching),Phenotype,Vaginal Discharge (Itching)
27541,Exacerbations Requiring Hospitalisation In Asthma,Phenotype,Exacerbations Requiring Hospitalisation In Asthma
27546,Cannabis Use (Age At Onset),Phenotype,Cannabis Use (Age At Onset)
27550,Reaction Time,Phenotype,Reaction Time
27583,Coronary Artery Disease In Diabetes,Phenotype,Coronary Artery Disease In Diabetes
27594,Plasma Proprotein Convertase Subtilisin/Kexin Type 9 Levels In Stable Coronary Artery Disease,Phenotype,Plasma Proprotein Convertase Subtilisin/Kexin Type 9 Levels In Stable Coronary Artery Disease
27597,Executive Function In Adhd,Phenotype,Executive Function In Adhd
27599,Spherical Equivalent,Phenotype,Spherical Equivalent
27613,Optic Nerve Head Parameters (Multi-Trait Analysis),Phenotype,Optic Nerve Head Parameters (Multi-Trait Analysis)
27619,Cognitive Decline (Age-Related),Phenotype,Cognitive Decline (Age-Related)
27623,Behavioural Changes In Frontotemporal Lobe Dementia,Phenotype,Behavioural Changes In Frontotemporal Lobe Dementia
27627,Anti-Chlamydia Trachomatis Igg Seropositivity,Phenotype,Anti-Chlamydia Trachomatis Igg Seropositivity
27645,Blood Glucose Levels,Phenotype,Blood Glucose Levels
27649,Myocardial Infarction,Phenotype,Myocardial Infarction
27661,Coffee Consumption,Phenotype,Coffee Consumption
27663,Neonatal Total 25-Hydroxyvitamin D Levels (Maternal Genetic Effect),Phenotype,Neonatal Total 25-Hydroxyvitamin D Levels (Maternal Genetic Effect)
27665,Cervical Cancer (Mtag),Phenotype,Cervical Cancer (Mtag)
27709,Gynecologic Disease (Multivariate Analysis),Phenotype,Gynecologic Disease (Multivariate Analysis)
27723,Atopic Asthma,Phenotype,Atopic Asthma
27733,Dermatomyositis Or Juvenile Dermatomyositis,Phenotype,Dermatomyositis Or Juvenile Dermatomyositis
27735,Polymyositis,Phenotype,Polymyositis
27736,Idiopathic Inflammatory Myopathy,Phenotype,Idiopathic Inflammatory Myopathy
27737,Age At Loss Of Ambulation In Duchenne Muscular Dystrophy,Phenotype,Age At Loss Of Ambulation In Duchenne Muscular Dystrophy
27782,Non-Glioblastoma Glioma,Phenotype,Non-Glioblastoma Glioma
27783,Glioma,Phenotype,Glioma
27784,Worry,Phenotype,Worry
27833,Rosacea Symptom Severity,Phenotype,Rosacea Symptom Severity
27866,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index-- Change Over Time),Phenotype,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index-- Change Over Time)
27869,Delta-5 Desaturase Activity Response To N3-Polyunsaturated Fat Supplement,Phenotype,Delta-5 Desaturase Activity Response To N3-Polyunsaturated Fat Supplement
27871,End Stage Renal Disease X Apol1 Genotype Interaction,Phenotype,End Stage Renal Disease X Apol1 Genotype Interaction
27873,Menstruation Quality Of Life Impact (Dysmenorrhea),Phenotype,Menstruation Quality Of Life Impact (Dysmenorrhea)
27875,Menstruation Quality Of Life Impact (Acne),Phenotype,Menstruation Quality Of Life Impact (Acne)
27877,Menstruation Quality Of Life Impact (Fever),Phenotype,Menstruation Quality Of Life Impact (Fever)
27936,Blood Protein Levels In Cardiovascular Risk,Phenotype,Blood Protein Levels In Cardiovascular Risk
27950,Serum Polyunsaturated Fatty Acid Concentration X Mediterranean Diet Adherence Interaction In Metabolic Syndrome,Phenotype,Serum Polyunsaturated Fatty Acid Concentration X Mediterranean Diet Adherence Interaction In Metabolic Syndrome
27971,Longitudinal Brain Connectivity Change (Louvain Modularity),Phenotype,Longitudinal Brain Connectivity Change (Louvain Modularity)
27977,Serum 25-Hydroxyvitamin D Levels,Phenotype,Serum 25-Hydroxyvitamin D Levels
27990,Nonatopic Asthma,Phenotype,Nonatopic Asthma
28001,Response To Ketogenic Dietary Therapies In Epilepsy,Phenotype,Response To Ketogenic Dietary Therapies In Epilepsy
28008,Depressed Affect,Phenotype,Depressed Affect
28015,Response To (Pegylated) Interferon In Hbeag-Negative Hepatitis B,Phenotype,Response To (Pegylated) Interferon In Hbeag-Negative Hepatitis B
28017,Response To (Pegylated) Interferon In Hbeag-Positive Hepatitis B,Phenotype,Response To (Pegylated) Interferon In Hbeag-Positive Hepatitis B
28019,Intrinsic Epigenetic Age Acceleration,Phenotype,Intrinsic Epigenetic Age Acceleration
28023,Total Body Bone Mineral Density (Mtag),Phenotype,Total Body Bone Mineral Density (Mtag)
28026,Heel Bone Mineral Density (Mtag),Phenotype,Heel Bone Mineral Density (Mtag)
28034,Gynecologic Disease,Phenotype,Gynecologic Disease
28055,Ovarian Cancer (Mtag),Phenotype,Ovarian Cancer (Mtag)
28065,Alcohol-Associated Liver Disease In Light Drinkers,Phenotype,Alcohol-Associated Liver Disease In Light Drinkers
28067,Rapidly Progressive Alzheimer'S Disease (Clinical Vs Typical) (Case-Control Set 2),Phenotype,Rapidly Progressive Alzheimer'S Disease (Clinical Vs Typical) (Case-Control Set 2)
28069,Rapidly Progressive Alzheimer'S Disease (Typical) (Case-Control Set 2),Phenotype,Rapidly Progressive Alzheimer'S Disease (Typical) (Case-Control Set 2)
28071,Rapidly Progressive Alzheimer'S Disease (Pathologically-Confirmed Vs Typical) (Case-Control Set 3),Phenotype,Rapidly Progressive Alzheimer'S Disease (Pathologically-Confirmed Vs Typical) (Case-Control Set 3)
28074,Rapidly Progressive Alzheimer'S Disease (Typical) (Case-Control Set 1),Phenotype,Rapidly Progressive Alzheimer'S Disease (Typical) (Case-Control Set 1)
28076,Rapidly Progressive Alzheimer'S Disease (Clinical Vs Typical) (Case-Control Set 1),Phenotype,Rapidly Progressive Alzheimer'S Disease (Clinical Vs Typical) (Case-Control Set 1)
28077,Rapidly Progressive Alzheimer'S Disease (Clinical) (Case-Control Set 3),Phenotype,Rapidly Progressive Alzheimer'S Disease (Clinical) (Case-Control Set 3)
28080,Rapidly Progressive Alzheimer'S Disease (Clinical Vs Typical) (Case-Control Set 3),Phenotype,Rapidly Progressive Alzheimer'S Disease (Clinical Vs Typical) (Case-Control Set 3)
28105,Prostate Cancer (Early Onset),Phenotype,Prostate Cancer (Early Onset)
28111,Diabetes Mellitus,Phenotype,Diabetes Mellitus
28113,Non-Del(5Q) Myelodysplastic Syndromes,Phenotype,Non-Del(5Q) Myelodysplastic Syndromes
28118,Bone Mineral Content,Phenotype,Bone Mineral Content
28120,Maternal Nondisjunction Of Chromosome 21 (Mothers Vs Fathers),Phenotype,Maternal Nondisjunction Of Chromosome 21 (Mothers Vs Fathers)
28123,Maternal Nondisjunction Of Chromosome 21 (Mi Error Vs Fathers),Phenotype,Maternal Nondisjunction Of Chromosome 21 (Mi Error Vs Fathers)
28139,Cryptosporidiosis,Phenotype,Cryptosporidiosis
28141,Serum Omega-3 Polyunsaturated Fatty Acid Concentration In Metabolic Syndrome,Phenotype,Serum Omega-3 Polyunsaturated Fatty Acid Concentration In Metabolic Syndrome
28145,Serum Docosahexaenoic Fatty Acid Concentration In Metabolic Syndrome,Phenotype,Serum Docosahexaenoic Fatty Acid Concentration In Metabolic Syndrome
28150,Severe Aplastic Anemia,Phenotype,Severe Aplastic Anemia
28152,Uterine Fibroids (Mtag),Phenotype,Uterine Fibroids (Mtag)
28158,Endometrial Cancer (Mtag),Phenotype,Endometrial Cancer (Mtag)
28159,Ovarian Cancer,Phenotype,Ovarian Cancer
28193,Red Blood Cell Traits (Multivariate Analysis),Phenotype,Red Blood Cell Traits (Multivariate Analysis)
28263,Nash Resolution In Nonalcoholic Steatohepatitis,Phenotype,Nash Resolution In Nonalcoholic Steatohepatitis
28277,Cutaneous Squamous Cell Carcinoma,Phenotype,Cutaneous Squamous Cell Carcinoma
28280,Response To Statins (Ldl Cholesterol Percent Change),Phenotype,Response To Statins (Ldl Cholesterol Percent Change)
28281,Low Density Lipoprotein Cholesterol Levels (On Statin Treatment),Phenotype,Low Density Lipoprotein Cholesterol Levels (On Statin Treatment)
28295,Alcohol-Associated Liver Disease In Non Drinkers,Phenotype,Alcohol-Associated Liver Disease In Non Drinkers
28337,Maximum Cranial Length,Phenotype,Maximum Cranial Length
28341,Prostate Cancer (Advanced),Phenotype,Prostate Cancer (Advanced)
28346,Cerebellum Growth,Phenotype,Cerebellum Growth
28369,Cardioembolic Stroke (Ccsp Classification),Phenotype,Cardioembolic Stroke (Ccsp Classification)
28371,Cardioembolic Stroke (Toast Classification),Phenotype,Cardioembolic Stroke (Toast Classification)
28372,Cardioembolic Stroke (Ccs And Toast Classification),Phenotype,Cardioembolic Stroke (Ccs And Toast Classification)
28373,Cardioembolic Stroke (Ccs Or Toast Classification),Phenotype,Cardioembolic Stroke (Ccs Or Toast Classification)
28374,Cardioembolic Stroke (Ccsc Classification),Phenotype,Cardioembolic Stroke (Ccsc Classification)
28376,Lipoprotein (A) Levels In Response To Niacin In Statin-Treated Individuals,Phenotype,Lipoprotein (A) Levels In Response To Niacin In Statin-Treated Individuals
28377,Hdl Cholesterol Change In Response To Niacin In Statin-Treated Individuals,Phenotype,Hdl Cholesterol Change In Response To Niacin In Statin-Treated Individuals
28399,Gastrointestinal Infection,Phenotype,Gastrointestinal Infection
28405,Glycosuria In Pregnancy (Maternal Genotype Effect),Phenotype,Glycosuria In Pregnancy (Maternal Genotype Effect)
28407,Glycosuria In Pregnancy (Offspring Genotype Effect),Phenotype,Glycosuria In Pregnancy (Offspring Genotype Effect)
28411,Glycosuria In Pregnancy (Maternal And Offspring Genotype Effect),Phenotype,Glycosuria In Pregnancy (Maternal And Offspring Genotype Effect)
28412,Neck Pain Or Shoulder Pain,Phenotype,Neck Pain Or Shoulder Pain
28419,Hallux Valgus,Phenotype,Hallux Valgus
28425,Gout (Normal Type),Phenotype,Gout (Normal Type)
28443,Externalizing Behaviour Score,Phenotype,Externalizing Behaviour Score
28445,Parkinson'S Disease Or First Degree Relation To Individual With Parkinson'S Disease,Phenotype,Parkinson'S Disease Or First Degree Relation To Individual With Parkinson'S Disease
28458,Occipital Lobe Volume,Phenotype,Occipital Lobe Volume
28460,Lung Function In Never Smokers (High Fev1 Vs Average Fev1),Phenotype,Lung Function In Never Smokers (High Fev1 Vs Average Fev1)
28462,Lung Function In Never Smokers (Low Fev1 Vs Average Fev1),Phenotype,Lung Function In Never Smokers (Low Fev1 Vs Average Fev1)
28464,Smoking Status (Heavy Vs Never),Phenotype,Smoking Status (Heavy Vs Never)
28466,Lung Function (Low Fev1 Vs High Fev1),Phenotype,Lung Function (Low Fev1 Vs High Fev1)
28470,Lung Function In Never Smokers (Low Fev1 Vs High Fev1),Phenotype,Lung Function In Never Smokers (Low Fev1 Vs High Fev1)
28473,Lung Function (Low Fev1 Vs High Fev1) X Smoking Interaction,Phenotype,Lung Function (Low Fev1 Vs High Fev1) X Smoking Interaction
28475,Cerebrospinal Fluid Strem-2 Levels,Phenotype,Cerebrospinal Fluid Strem-2 Levels
28513,Hdl Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test),Phenotype,Hdl Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test)
28520,Idiopathic Pulmonary Fibrosis,Phenotype,Idiopathic Pulmonary Fibrosis
28521,Hospital Contact For Infections,Phenotype,Hospital Contact For Infections
28553,Testasv_38 (Ruminococcus) Abundance,Phenotype,Testasv_38 (Ruminococcus) Abundance
28554,Otu97_31 (Prevotella) Prevalence,Phenotype,Otu97_31 (Prevotella) Prevalence
28556,Otu97_2 (Bacteroides) Prevalence,Phenotype,Otu97_2 (Bacteroides) Prevalence
28557,Otu97_21 (Parasutterella) Prevalence,Phenotype,Otu97_21 (Parasutterella) Prevalence
28559,Otu97_354 (Alloprevotella) Prevalence,Phenotype,Otu97_354 (Alloprevotella) Prevalence
28561,Otu97_38 (Alphaproteobacteria) Prevalence,Phenotype,Otu97_38 (Alphaproteobacteria) Prevalence
28563,Otu99_124 (Paraprevotella) Prevalence,Phenotype,Otu99_124 (Paraprevotella) Prevalence
28568,Otu99_132 (Bacteroidales) Prevalence,Phenotype,Otu99_132 (Bacteroidales) Prevalence
28577,Urinary Metabolite Levels In Chronic Kidney Disease,Phenotype,Urinary Metabolite Levels In Chronic Kidney Disease
28600,Fish- And Plant-Related Diet,Phenotype,Fish- And Plant-Related Diet
28609,Oily Fish Consumption,Phenotype,Oily Fish Consumption
28616,Non-Oily Fish Consumption,Phenotype,Non-Oily Fish Consumption
28618,Lamb Consumption,Phenotype,Lamb Consumption
28624,Beef Consumption,Phenotype,Beef Consumption
28643,Hdl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test),Phenotype,Hdl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test)
28649,Kidney Stones,Phenotype,Kidney Stones
28686,Trunk Fat Mass Adjusted For Trunk Lean Mass,Phenotype,Trunk Fat Mass Adjusted For Trunk Lean Mass
28688,Femoral Neck Bone Mineral Density And Trunk Fat Mass Adjusted By Trunk Lean Mass,Phenotype,Femoral Neck Bone Mineral Density And Trunk Fat Mass Adjusted By Trunk Lean Mass
28689,Serum Alkaline Phosphatase Levels,Phenotype,Serum Alkaline Phosphatase Levels
28692,Hemoglobin A1C Levels,Phenotype,Hemoglobin A1C Levels
28705,Parkinson'S Disease (Age Of Onset),Phenotype,Parkinson'S Disease (Age Of Onset)
28708,Birth Weight (Mtag),Phenotype,Birth Weight (Mtag)
28709,Birth Length (Mtag),Phenotype,Birth Length (Mtag)
28711,Infant Head Circumference (Mtag),Phenotype,Infant Head Circumference (Mtag)
28714,Skin Pigmentation (Conditioned On Rs1426654 And Rs35397),Phenotype,Skin Pigmentation (Conditioned On Rs1426654 And Rs35397)
28731,Facial Morphology,Phenotype,Facial Morphology
28748,Serum Metabolite Levels (Cms),Phenotype,Serum Metabolite Levels (Cms)
28754,Café-Au-Lait Macule Number In Neurofibromatosis Type1,Phenotype,Café-Au-Lait Macule Number In Neurofibromatosis Type1
28757,Basophil Count,Phenotype,Basophil Count
28783,Household Income (Mtag),Phenotype,Household Income (Mtag)
28832,Excessive Sweating,Phenotype,Excessive Sweating
28854,Self-Reported Risk-Taking Behaviour,Phenotype,Self-Reported Risk-Taking Behaviour
28877,Mucinous Adenocarcinoma In Colorectal Cancer,Phenotype,Mucinous Adenocarcinoma In Colorectal Cancer
28885,Cerebrospinal Fluid Α-Synuclein Levels,Phenotype,Cerebrospinal Fluid Α-Synuclein Levels
28915,Cleft Lip With Or Without Cleft Palate X Maternal Periconceptional Vitamin Use Interaction (Parent Of Origin Effect),Phenotype,Cleft Lip With Or Without Cleft Palate X Maternal Periconceptional Vitamin Use Interaction (Parent Of Origin Effect)
28931,Type 1 Diabetes In High Risk Hla Genotype Individuals (Time To Event),Phenotype,Type 1 Diabetes In High Risk Hla Genotype Individuals (Time To Event)
28933,Type 1 Diabetes Autoantibodies In High Risk Hla Genotype Individuals (Time To Event),Phenotype,Type 1 Diabetes Autoantibodies In High Risk Hla Genotype Individuals (Time To Event)
28953,White Matter Microstructure (Mean Diusivities),Phenotype,White Matter Microstructure (Mean Diusivities)
28955,Leukocyte Telomere Length,Phenotype,Leukocyte Telomere Length
28961,Serum Cancer Antigen 125 (Ca 125) Levels,Phenotype,Serum Cancer Antigen 125 (Ca 125) Levels
28996,Osteoarthritis Of The Hand,Phenotype,Osteoarthritis Of The Hand
29011,Household Income,Phenotype,Household Income
29017,Osteoporosis-Related Phenotypes (Mtag),Phenotype,Osteoporosis-Related Phenotypes (Mtag)
29027,Urinary Calcium Excretion,Phenotype,Urinary Calcium Excretion
29029,Urinary Magnesium Excretion,Phenotype,Urinary Magnesium Excretion
29033,Urinary Volume,Phenotype,Urinary Volume
29045,Hay Fever And/Or Eczema,Phenotype,Hay Fever And/Or Eczema
29079,Insulin-Related Traits (Multivariate Analysis),Phenotype,Insulin-Related Traits (Multivariate Analysis)
29146,Clozapine-Induced Myocarditis In Schizophrenia,Phenotype,Clozapine-Induced Myocarditis In Schizophrenia
29232,Testasv_33 (Paraprevotella) Prevalence,Phenotype,Testasv_33 (Paraprevotella) Prevalence
29234,Testasv_30 (Paraprevotella) Prevalence,Phenotype,Testasv_30 (Paraprevotella) Prevalence
29238,Testasv_48 (Sutterella) Abundance,Phenotype,Testasv_48 (Sutterella) Abundance
29240,Testasv_42 (Alphaproteobacteria) Abundance,Phenotype,Testasv_42 (Alphaproteobacteria) Abundance
29241,Testasv_39 (Bacteroides) Abundance,Phenotype,Testasv_39 (Bacteroides) Abundance
29243,Testasv_44 (Parasutterella) Abundance,Phenotype,Testasv_44 (Parasutterella) Abundance
29245,Testasv_46 (Sutterella) Abundance,Phenotype,Testasv_46 (Sutterella) Abundance
29247,Bipolar Disorder Or Body Mass Index,Phenotype,Bipolar Disorder Or Body Mass Index
29249,Otu97_58 (Sutterellaceae) Prevalence,Phenotype,Otu97_58 (Sutterellaceae) Prevalence
29250,Otu97_6 (Sutterella) Prevalence,Phenotype,Otu97_6 (Sutterella) Prevalence
29252,Otu97_39 (Proteobacteria) Prevalence,Phenotype,Otu97_39 (Proteobacteria) Prevalence
29253,Otu97_51 (Barnesiella) Prevalence,Phenotype,Otu97_51 (Barnesiella) Prevalence
29256,Testasv_6 (Subdoligranulum) Prevalence,Phenotype,Testasv_6 (Subdoligranulum) Prevalence
29258,Testasv_47 (Parasutterella) Prevalence,Phenotype,Testasv_47 (Parasutterella) Prevalence
29269,Low Hdl-Cholesterol Levels,Phenotype,Low Hdl-Cholesterol Levels
29278,Graft Survival Time In Renal Transplantation (Donor Effect),Phenotype,Graft Survival Time In Renal Transplantation (Donor Effect)
29281,Graft Survival Time In Renal Transplantation (Donor Effect) X Apol1 Genotype Interaction,Phenotype,Graft Survival Time In Renal Transplantation (Donor Effect) X Apol1 Genotype Interaction
29284,Angioedema In Response To Angiotensin-Converting Enzyme Inhibitor And/Or Angiotensin Receptor Blocker,Phenotype,Angioedema In Response To Angiotensin-Converting Enzyme Inhibitor And/Or Angiotensin Receptor Blocker
29296,Fruit Consumption,Phenotype,Fruit Consumption
29310,Fractures,Phenotype,Fractures
29321,Testasv_2 (Bacteroides) Abundance,Phenotype,Testasv_2 (Bacteroides) Abundance
29323,Testasv_20 (Phascolarctobacterium) Abundance,Phenotype,Testasv_20 (Phascolarctobacterium) Abundance
29325,Testasv_21 (Ruminococcaceae) Abundance,Phenotype,Testasv_21 (Ruminococcaceae) Abundance
29327,Testasv_24 (Bacteroides) Abundance,Phenotype,Testasv_24 (Bacteroides) Abundance
29331,Otu97_80 (Ruminococcus) Prevalence,Phenotype,Otu97_80 (Ruminococcus) Prevalence
29333,Otu99_106 (Barnesiella) Prevalence,Phenotype,Otu99_106 (Barnesiella) Prevalence
29335,Otu99_108 (Cytophagales) Prevalence,Phenotype,Otu99_108 (Cytophagales) Prevalence
29337,Otu97_95 (Cytophagales) Prevalence,Phenotype,Otu97_95 (Cytophagales) Prevalence
29339,Survival In Breast Cancer (Estrogen-Receptor Positive),Phenotype,Survival In Breast Cancer (Estrogen-Receptor Positive)
29342,Suicidal Or Self-Harm Ideation,Phenotype,Suicidal Or Self-Harm Ideation
29351,Compulsion Score In Obsessive Compulsive Disorder,Phenotype,Compulsion Score In Obsessive Compulsive Disorder
29353,Meat-Related Diet,Phenotype,Meat-Related Diet
29354,Pork Consumption,Phenotype,Pork Consumption
29355,Coronary Artery Disease In Type 1 Diabetes,Phenotype,Coronary Artery Disease In Type 1 Diabetes
29363,Testasv_10 (Parabacteroides) Abundance,Phenotype,Testasv_10 (Parabacteroides) Abundance
29365,Otu99_92 (Ruminococcus) Abundance,Phenotype,Otu99_92 (Ruminococcus) Abundance
29367,Testasv_16 (Bacteroides) Abundance,Phenotype,Testasv_16 (Bacteroides) Abundance
29369,Otu99_84 (Prevotella) Abundance,Phenotype,Otu99_84 (Prevotella) Abundance
29373,G_Coprococcus Prevalence,Phenotype,G_Coprococcus Prevalence
29376,G_Parasutterella Prevalence,Phenotype,G_Parasutterella Prevalence
29378,G_Prevotella Prevalence,Phenotype,G_Prevotella Prevalence
29379,G_Bacteroidales Prevalence,Phenotype,G_Bacteroidales Prevalence
29381,G_Catenibacterium Prevalence,Phenotype,G_Catenibacterium Prevalence
29386,Otu97_137 (Catenibacterium) Prevalence,Phenotype,Otu97_137 (Catenibacterium) Prevalence
29387,Otu97_138 (Oscillibacter) Prevalence,Phenotype,Otu97_138 (Oscillibacter) Prevalence
29389,Otu97_150 (Bacteroides) Prevalence,Phenotype,Otu97_150 (Bacteroides) Prevalence
29391,Otu97_16 (Faecalibacterium) Prevalence,Phenotype,Otu97_16 (Faecalibacterium) Prevalence
29393,Otu97_13 (Subdoligranulum) Prevalence,Phenotype,Otu97_13 (Subdoligranulum) Prevalence
29395,Lung Function,Phenotype,Lung Function
29399,Hypertriglyceridemia,Phenotype,Hypertriglyceridemia
29410,Urinary Metabolite Modules (Eigenmetabolites) In Chronic Kidney Disease,Phenotype,Urinary Metabolite Modules (Eigenmetabolites) In Chronic Kidney Disease
29415,Serum Immune Biomarker Levels,Phenotype,Serum Immune Biomarker Levels
29420,Cerebrospinal Fluid Immune Biomarker Levels,Phenotype,Cerebrospinal Fluid Immune Biomarker Levels
29449,Epilepsy,Phenotype,Epilepsy
29451,Juvenile Myoclonic Epilepsy,Phenotype,Juvenile Myoclonic Epilepsy
29453,Focal Epilepsy (With Hippocampal Sclerosis),Phenotype,Focal Epilepsy (With Hippocampal Sclerosis)
29455,Generalized Epilepsy,Phenotype,Generalized Epilepsy
29459,Taste Perception (Total Score Including Phenylthiocarbamide) In Obesity With Metabolic Syndrome,Phenotype,Taste Perception (Total Score Including Phenylthiocarbamide) In Obesity With Metabolic Syndrome
29463,Aspartate Aminotransferase Levels In Low Alcohol Consumption,Phenotype,Aspartate Aminotransferase Levels In Low Alcohol Consumption
29477,Blood Metabolite Levels,Phenotype,Blood Metabolite Levels
29514,Youthful Appearance (Self-Reported),Phenotype,Youthful Appearance (Self-Reported)
29516,White Matter Hyperintensities,Phenotype,White Matter Hyperintensities
29518,White Matter Integrity (Fractional Anisotropy),Phenotype,White Matter Integrity (Fractional Anisotropy)
29529,White Matter Integrity (Mean Diffusivity),Phenotype,White Matter Integrity (Mean Diffusivity)
29531,Cutaneous Malignant Melanoma,Phenotype,Cutaneous Malignant Melanoma
29536,Cutaneous Melanoma Or Hair Colour,Phenotype,Cutaneous Melanoma Or Hair Colour
29555,Nevus Count Or Cutaneous Melanoma,Phenotype,Nevus Count Or Cutaneous Melanoma
29577,Neuropathologic Traits (Pleiotropy),Phenotype,Neuropathologic Traits (Pleiotropy)
29580,Microscopic Brain Infarct,Phenotype,Microscopic Brain Infarct
29582,Macroscopic Brain Infarct,Phenotype,Macroscopic Brain Infarct
29586,Neuritic Plaque,Phenotype,Neuritic Plaque
29589,Diffuse Plaques,Phenotype,Diffuse Plaques
29591,Neurofibrillary Tangles,Phenotype,Neurofibrillary Tangles
29594,Covid-19 (Critical Illness Vs Population),Phenotype,Covid-19 (Critical Illness Vs Population)
29596,Jt Interval,Phenotype,Jt Interval
29597,Sleep (1/2-Day Periodicity),Phenotype,Sleep (1/2-Day Periodicity)
29599,Sleep Activity Levels,Phenotype,Sleep Activity Levels
29601,Sleep Start Time,Phenotype,Sleep Start Time
29605,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test),Phenotype,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (2Df Test)
29606,Triglyceride Levels X Long Total Sleep Time Interaction (2Df Test),Phenotype,Triglyceride Levels X Long Total Sleep Time Interaction (2Df Test)
29609,Triglyceride Levels X Short Total Sleep Time Interaction (2Df Test),Phenotype,Triglyceride Levels X Short Total Sleep Time Interaction (2Df Test)
29612,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (1Df Test),Phenotype,Ldl Cholesterol Levels X Short Total Sleep Time Interaction (1Df Test)
29614,Ldl Cholesterol Levels X Loop Diuretics Use Interaction,Phenotype,Ldl Cholesterol Levels X Loop Diuretics Use Interaction
29616,Triglyceride Levels X Loop Diuretics Use Interaction,Phenotype,Triglyceride Levels X Loop Diuretics Use Interaction
29621,Brainstem Volume,Phenotype,Brainstem Volume
29625,Putamen Volume,Phenotype,Putamen Volume
29628,Cortical Surface Area (Visual Pc2),Phenotype,Cortical Surface Area (Visual Pc2)
29631,Cortical Surface Area (Global Pc1),Phenotype,Cortical Surface Area (Global Pc1)
29638,Response To Lamotrigine And Valproic Acid In Genetic Generalized Epilepsy,Phenotype,Response To Lamotrigine And Valproic Acid In Genetic Generalized Epilepsy
29656,Leisure Sedentary Behaviour (Television Watching),Phenotype,Leisure Sedentary Behaviour (Television Watching)
29665,Bone Mineral Density (Hip) And Hip Bone Size,Phenotype,Bone Mineral Density (Hip) And Hip Bone Size
29671,Leisure Sedentary Behaviour (Computer Use),Phenotype,Leisure Sedentary Behaviour (Computer Use)
29681,Complement Factor H Binding To Malondialdehyde,Phenotype,Complement Factor H Binding To Malondialdehyde
29687,Ldl Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test),Phenotype,Ldl Cholesterol Levels X Long Total Sleep Time Interaction (2Df Test)
29695,Circulating Leptin Levels In High Cardiovascular Risk,Phenotype,Circulating Leptin Levels In High Cardiovascular Risk
29743,Mhc Class I Polypeptide-Related Sequence A Levels,Phenotype,Mhc Class I Polypeptide-Related Sequence A Levels
29745,Ccl19 Levels,Phenotype,Ccl19 Levels
29751,Protein Level Change In Low Calorie Diet Obesity Intervention,Phenotype,Protein Level Change In Low Calorie Diet Obesity Intervention
29756,Protein Levels In Obesity,Phenotype,Protein Levels In Obesity
29802,High Myopia,Phenotype,High Myopia
29804,Retinal Detachment Or Retinal Break,Phenotype,Retinal Detachment Or Retinal Break
29805,Cataracts (Operation),Phenotype,Cataracts (Operation)
29807,Buruli Ulcer (Age At Onset),Phenotype,Buruli Ulcer (Age At Onset)
29809,Hip Bone Size,Phenotype,Hip Bone Size
29826,Primary Biliary Cirrhosis,Phenotype,Primary Biliary Cirrhosis
29840,Adipose Morphology,Phenotype,Adipose Morphology
29844,Vascular Endothelial Growth Factor Levels In Major Depressive Disorder,Phenotype,Vascular Endothelial Growth Factor Levels In Major Depressive Disorder
29853,Glaucoma (Multi-Trait Analysis),Phenotype,Glaucoma (Multi-Trait Analysis)
29858,Relative Fat Intake,Phenotype,Relative Fat Intake
29859,Relative Carbohydrate Intake,Phenotype,Relative Carbohydrate Intake
29860,Relative Sugar Intake,Phenotype,Relative Sugar Intake
29862,Carotid Intima Media Thickness (Mean),Phenotype,Carotid Intima Media Thickness (Mean)
29864,Carotid Intima Media Thickness (Mean-Maximum),Phenotype,Carotid Intima Media Thickness (Mean-Maximum)
29907,Ebbinghaus Illusion (Underestimation),Phenotype,Ebbinghaus Illusion (Underestimation)
29911,Ebbinghaus Illusion (Overestimation),Phenotype,Ebbinghaus Illusion (Overestimation)
29956,Otu97_86 (Phascolarctobacterium) Abundance,Phenotype,Otu97_86 (Phascolarctobacterium) Abundance
29958,Tpe Interval (Resting),Phenotype,Tpe Interval (Resting)
29975,Otu99_116 (Sutterella) Abundance,Phenotype,Otu99_116 (Sutterella) Abundance
29978,Systemic Seropositive Rheumatic Diseases (Systemic Sclerosis Or Systemic Lupus Erythematosus Or Rheumatoid Arthritis Or Idiopathic Inflammatory Myopathies),Phenotype,Systemic Seropositive Rheumatic Diseases (Systemic Sclerosis Or Systemic Lupus Erythematosus Or Rheumatoid Arthritis Or Idiopathic Inflammatory Myopathies)
29986,Pepsinogen I/Ii Ratio,Phenotype,Pepsinogen I/Ii Ratio
30014,Eosinophilic Esophagitis,Phenotype,Eosinophilic Esophagitis
30050,Lifetime Smoking Index,Phenotype,Lifetime Smoking Index
30056,Otu99_23 (Faecalibacterium) Abundance,Phenotype,Otu99_23 (Faecalibacterium) Abundance
30058,Otu99_132 (Bacteroidales) Abundance,Phenotype,Otu99_132 (Bacteroidales) Abundance
30060,Otu99_137 (Ruminococcus) Abundance,Phenotype,Otu99_137 (Ruminococcus) Abundance
30061,Otu99_150 (Prevotella) Abundance,Phenotype,Otu99_150 (Prevotella) Abundance
30062,Childhood Obesity,Phenotype,Childhood Obesity
30103,Proliferative Diabetic Retinopathy,Phenotype,Proliferative Diabetic Retinopathy
30108,Bipolar I Disorder,Phenotype,Bipolar I Disorder
30129,Age-Related Hearing Impairment (High Frequency),Phenotype,Age-Related Hearing Impairment (High Frequency)
30152,Eosinophilic Granulomatosis With Polyangiitis (Mpo-Anca Positive),Phenotype,Eosinophilic Granulomatosis With Polyangiitis (Mpo-Anca Positive)
30154,Eosinophilic Granulomatosis With Polyangiitis (Anca Negative),Phenotype,Eosinophilic Granulomatosis With Polyangiitis (Anca Negative)
30156,Eosinophilic Granulomatosis With Polyangiitis,Phenotype,Eosinophilic Granulomatosis With Polyangiitis
30177,Smoking Status (Current Vs Never),Phenotype,Smoking Status (Current Vs Never)
30185,Bmi In Adult Survivors Of Childhood Acute Lymphoblastic Leukemia,Phenotype,Bmi In Adult Survivors Of Childhood Acute Lymphoblastic Leukemia
30188,Response To Norepinephrine-Dopamine Reuptake Inhibitors (Responders Vs Non-Responders),Phenotype,Response To Norepinephrine-Dopamine Reuptake Inhibitors (Responders Vs Non-Responders)
30190,Response To Antidepressants (Non-Treatment-Resistant Vs Treatment-Resistant Depression),Phenotype,Response To Antidepressants (Non-Treatment-Resistant Vs Treatment-Resistant Depression)
30192,Mastocytosis (Kit D816V Positive),Phenotype,Mastocytosis (Kit D816V Positive)
30198,Fasting Insulin,Phenotype,Fasting Insulin
30200,Plasma Free Amino Acid Levels (Adjusted For Twenty Other Pfaas),Phenotype,Plasma Free Amino Acid Levels (Adjusted For Twenty Other Pfaas)
30202,Eye Color (Brightness),Phenotype,Eye Color (Brightness)
30203,Plasma Free Amino Acid Levels (Adjusted For One Other Pfaa),Phenotype,Plasma Free Amino Acid Levels (Adjusted For One Other Pfaa)
30204,Skin-- Hair And Eye Pigmentation (Multivariate Analysis),Phenotype,Skin-- Hair And Eye Pigmentation (Multivariate Analysis)
30205,Plasma Free Amino Acid Levels,Phenotype,Plasma Free Amino Acid Levels
30206,Body Fat Distribution (Arm Fat Ratio),Phenotype,Body Fat Distribution (Arm Fat Ratio)
30208,Glucagon Levels In Response To Oral Glucose Tolerance Test (30 Minutes),Phenotype,Glucagon Levels In Response To Oral Glucose Tolerance Test (30 Minutes)
30213,Glucagon Levels In Response To Oral Glucose Tolerance Test (Decremental Area Under The Curve For 0-30 Minutes),Phenotype,Glucagon Levels In Response To Oral Glucose Tolerance Test (Decremental Area Under The Curve For 0-30 Minutes)
30215,Glucagon Levels In Response To Oral Glucose Tolerance Test (Decremental Area Under The Curve For 0-120 Minutes),Phenotype,Glucagon Levels In Response To Oral Glucose Tolerance Test (Decremental Area Under The Curve For 0-120 Minutes)
30218,Glucagon Levels In Response To Oral Glucose Tolerance Test (Fasting),Phenotype,Glucagon Levels In Response To Oral Glucose Tolerance Test (Fasting)
30223,Glucagon Levels In Response To Oral Glucose Tolerance Test (120 Minutes),Phenotype,Glucagon Levels In Response To Oral Glucose Tolerance Test (120 Minutes)
30225,Body Fat Distribution (Leg Fat Ratio),Phenotype,Body Fat Distribution (Leg Fat Ratio)
30230,Hdl Cholesterol X Physical Activity Interaction (2Df Test),Phenotype,Hdl Cholesterol X Physical Activity Interaction (2Df Test)
30232,Ldl Cholesterol X Physical Activity Interaction (2Df Test),Phenotype,Ldl Cholesterol X Physical Activity Interaction (2Df Test)
30233,Triglycerides X Physical Activity Interaction (2Df Test),Phenotype,Triglycerides X Physical Activity Interaction (2Df Test)
30235,Body Fat Distribution (Trunk Fat Ratio),Phenotype,Body Fat Distribution (Trunk Fat Ratio)
30267,Staphylococcus Aureus Nasal Carriage (Intermittent),Phenotype,Staphylococcus Aureus Nasal Carriage (Intermittent)
30269,Pediatric Autoimmune Diseases,Phenotype,Pediatric Autoimmune Diseases
30296,Postoperative Atrial Fibrillation In Coronary Artery Bypass Grafting Surgery,Phenotype,Postoperative Atrial Fibrillation In Coronary Artery Bypass Grafting Surgery
30298,Rotator Cuff Tears,Phenotype,Rotator Cuff Tears
30302,Influenza A (H1N1) Infection,Phenotype,Influenza A (H1N1) Infection
30307,Mild Influenza (H1N1) Infection,Phenotype,Mild Influenza (H1N1) Infection
30310,Severe Influenza A (H1N1) Infection,Phenotype,Severe Influenza A (H1N1) Infection
30314,Urinary Metabolites,Phenotype,Urinary Metabolites
30317,Bone Mineral Density (Hip) And Age At Menarche,Phenotype,Bone Mineral Density (Hip) And Age At Menarche
30319,Scalp Hair Shape,Phenotype,Scalp Hair Shape
30321,Eyebrow Thickness,Phenotype,Eyebrow Thickness
30323,Monobrow Thickness,Phenotype,Monobrow Thickness
30325,Beard Thickness,Phenotype,Beard Thickness
30327,Hair Greying,Phenotype,Hair Greying
30328,Gut Microbiome Composition (Winter),Phenotype,Gut Microbiome Composition (Winter)
30332,Gut Microbiome Composition (Summer),Phenotype,Gut Microbiome Composition (Summer)
30339,Thrombosis,Phenotype,Thrombosis
30341,Squamous Cell Carcinoma,Phenotype,Squamous Cell Carcinoma
30344,Low High Density Lipoprotein Cholesterol Levels,Phenotype,Low High Density Lipoprotein Cholesterol Levels
30345,Advanced Age-Related Macular Degeneration,Phenotype,Advanced Age-Related Macular Degeneration
30355,Cerebral Amyloid Deposition In Apoee4 Non-Carriers (Pet Imaging),Phenotype,Cerebral Amyloid Deposition In Apoee4 Non-Carriers (Pet Imaging)
30359,Cognitive Decline Rate In Late Mild Cognitive Impairment,Phenotype,Cognitive Decline Rate In Late Mild Cognitive Impairment
30366,Glomerular Filtration Rate In Non Diabetics (Creatinine),Phenotype,Glomerular Filtration Rate In Non Diabetics (Creatinine)
30367,Glomerular Filtration Rate In Diabetics (Creatinine),Phenotype,Glomerular Filtration Rate In Diabetics (Creatinine)
30369,Glomerular Filtration Rate (Creatinine),Phenotype,Glomerular Filtration Rate (Creatinine)
30371,Myositis,Phenotype,Myositis
30388,Parkinson Disease And Lewy Body Pathology,Phenotype,Parkinson Disease And Lewy Body Pathology
30392,Oligoclonal Band Status In Multiple Sclerosis,Phenotype,Oligoclonal Band Status In Multiple Sclerosis
30394,Immunoglobulin G Index Levels In Multiple Sclerosis,Phenotype,Immunoglobulin G Index Levels In Multiple Sclerosis
30395,Motion Sickness,Phenotype,Motion Sickness
30397,Depressive Symptoms (Ssri Exposure Interaction),Phenotype,Depressive Symptoms (Ssri Exposure Interaction)
30402,Exudative Age-Related Macular Degeneration,Phenotype,Exudative Age-Related Macular Degeneration
30409,Takayasu Arteritis,Phenotype,Takayasu Arteritis
30437,Adenocarcinoma,Phenotype,Adenocarcinoma
30441,Ischemic Stroke (Cardioembolic),Phenotype,Ischemic Stroke (Cardioembolic)
30442,Ischemic Stroke (Undetermined Subtype),Phenotype,Ischemic Stroke (Undetermined Subtype)
30453,Cerebral Amyloid Deposition (Pet Imaging),Phenotype,Cerebral Amyloid Deposition (Pet Imaging)
30457,Antipsychotic Drug Dosage In Schizophrenia Or Schizoaffective Disorder,Phenotype,Antipsychotic Drug Dosage In Schizophrenia Or Schizoaffective Disorder
30460,Alzheimer Disease And Age Of Onset,Phenotype,Alzheimer Disease And Age Of Onset
30462,Morning Vs. Evening Chronotype,Phenotype,Morning Vs. Evening Chronotype
30467,Chronotype,Phenotype,Chronotype
30468,Obstructive Sleep Apnea (Average Oxygen Saturation During Sleep),Phenotype,Obstructive Sleep Apnea (Average Oxygen Saturation During Sleep)
30470,Obstructive Sleep Apnea Trait (Average Respiratory Event Duration),Phenotype,Obstructive Sleep Apnea Trait (Average Respiratory Event Duration)
30472,Post Bronchodilator Fev1 In Copd,Phenotype,Post Bronchodilator Fev1 In Copd
30477,Gut Microbiome Composition (Summer And Winter),Phenotype,Gut Microbiome Composition (Summer And Winter)
30485,Bone Mineral Density (Femoral Neck),Phenotype,Bone Mineral Density (Femoral Neck)
30486,Entorhinal Cortical Volume,Phenotype,Entorhinal Cortical Volume
30488,Total Ventricular Volume,Phenotype,Total Ventricular Volume
30490,Entorhinal Cortical Volume (Alzheimer'S Disease Interaction),Phenotype,Entorhinal Cortical Volume (Alzheimer'S Disease Interaction)
30493,Body Mass Index (Age Interaction),Phenotype,Body Mass Index (Age Interaction)
30494,Exploratory Eye Movement Dysfunction In Schizophrenia (Mean Eye Scanning Length),Phenotype,Exploratory Eye Movement Dysfunction In Schizophrenia (Mean Eye Scanning Length)
30496,Exploratory Eye Movement Dysfunction In Schizophrenia (Number Of Eye Fixations),Phenotype,Exploratory Eye Movement Dysfunction In Schizophrenia (Number Of Eye Fixations)
30500,Exploratory Eye Movement Dysfunction In Schizophrenia (Responsive Search Score),Phenotype,Exploratory Eye Movement Dysfunction In Schizophrenia (Responsive Search Score)
30503,Early Childhood Aggressive Behavior,Phenotype,Early Childhood Aggressive Behavior
30505,Childhood And Early Adolescence Aggressive Behavior,Phenotype,Childhood And Early Adolescence Aggressive Behavior
30508,Exploratory Eye Movement Dysfunction In Schizophrenia (Cognitive Search Score),Phenotype,Exploratory Eye Movement Dysfunction In Schizophrenia (Cognitive Search Score)
30509,Systolic Blood Pressure (Cigarette Smoking Interaction),Phenotype,Systolic Blood Pressure (Cigarette Smoking Interaction)
30512,Response To Anti-Tnf Therapy In Rheumatoid Arthritis,Phenotype,Response To Anti-Tnf Therapy In Rheumatoid Arthritis
30552,Manic Episodes In Bipolar Disorder,Phenotype,Manic Episodes In Bipolar Disorder
30554,Depressive Episodes In Bipolar Disorder,Phenotype,Depressive Episodes In Bipolar Disorder
30557,Depressive And Manic Episodes In Bipolar Disorder,Phenotype,Depressive And Manic Episodes In Bipolar Disorder
30558,Glucocorticoid-Induced Osteonecrosis,Phenotype,Glucocorticoid-Induced Osteonecrosis
30560,Incident Coronary Heart Disease,Phenotype,Incident Coronary Heart Disease
30562,Incident Myocardial Infarction,Phenotype,Incident Myocardial Infarction
30565,Urinary Albumin-To-Creatinine Ratio In Non-Diabetics,Phenotype,Urinary Albumin-To-Creatinine Ratio In Non-Diabetics
30568,Progression Free Survival In Metastatic Colorectal Cancer (Capox-B Vs Capox-B Plus Cetuximab),Phenotype,Progression Free Survival In Metastatic Colorectal Cancer (Capox-B Vs Capox-B Plus Cetuximab)
30570,Emphysema Imaging Phenotypes,Phenotype,Emphysema Imaging Phenotypes
30573,Percentage Gas Trapping,Phenotype,Percentage Gas Trapping
30579,Hippocampal Sclerosis,Phenotype,Hippocampal Sclerosis
30581,Cerebral Amyloid Angiopathy,Phenotype,Cerebral Amyloid Angiopathy
30583,Narcolepsy With Cataplexy,Phenotype,Narcolepsy With Cataplexy
30591,3-Hydroxypropylmercapturic Acid Levels In Smokers,Phenotype,3-Hydroxypropylmercapturic Acid Levels In Smokers
30597,Asparaginase Hypersensitivity In Acute Lymphoblastic Leukemia,Phenotype,Asparaginase Hypersensitivity In Acute Lymphoblastic Leukemia
30602,3-Hydroxy-1-Methylpropylmercapturic Acid Levels In Smokers,Phenotype,3-Hydroxy-1-Methylpropylmercapturic Acid Levels In Smokers
30613,Multiple Myeloma And Monoclonal Gammopathy,Phenotype,Multiple Myeloma And Monoclonal Gammopathy
30620,Sex Hormone Levels,Phenotype,Sex Hormone Levels
30627,Response To Simvastatin Treatment (Pcsk9 Protein Level Change),Phenotype,Response To Simvastatin Treatment (Pcsk9 Protein Level Change)
30633,Yu-Zhi Constitution Type In Type 2 Diabetes,Phenotype,Yu-Zhi Constitution Type In Type 2 Diabetes
30641,Multiple Myeloma (Survival),Phenotype,Multiple Myeloma (Survival)
30653,Colorectal Or Endometrial Cancer,Phenotype,Colorectal Or Endometrial Cancer
30670,Glomerular Filtration Rate In Chronic Kidney Disease,Phenotype,Glomerular Filtration Rate In Chronic Kidney Disease
30673,Proteinuria In Chronic Kidney Disease,Phenotype,Proteinuria In Chronic Kidney Disease
30676,Dementia And Core Alzheimer'S Disease Neuropathologic Changes,Phenotype,Dementia And Core Alzheimer'S Disease Neuropathologic Changes
30693,Lachrymal/Salivary Gland Lesion In Type 1 Autoimmune Pancreatitis,Phenotype,Lachrymal/Salivary Gland Lesion In Type 1 Autoimmune Pancreatitis
30695,Skin Colour Saturation,Phenotype,Skin Colour Saturation
30697,Perceived Skin Darkness,Phenotype,Perceived Skin Darkness
30698,Forced Expiratory Volume In 1 Second (Occupational Environmental Exposures Interaction),Phenotype,Forced Expiratory Volume In 1 Second (Occupational Environmental Exposures Interaction)
30709,Classic Bladder Exstrophy,Phenotype,Classic Bladder Exstrophy
30727,Response To Zileuton Treatment In Asthma (Fev1 Change Interaction),Phenotype,Response To Zileuton Treatment In Asthma (Fev1 Change Interaction)
30731,Bone Mineral Accretion In Asthma (Oral Corticosteroid Dose Interaction),Phenotype,Bone Mineral Accretion In Asthma (Oral Corticosteroid Dose Interaction)
30734,Erythema Nodosum In Inflammatory Bowel Disease,Phenotype,Erythema Nodosum In Inflammatory Bowel Disease
30736,Peak Creatinine Levels In Vancomycin Therapy,Phenotype,Peak Creatinine Levels In Vancomycin Therapy
30738,Epilepsy And Lamotrigine-Induced Maculopapular Eruptions,Phenotype,Epilepsy And Lamotrigine-Induced Maculopapular Eruptions
30747,Blond Vs Non-Blond Hair Color,Phenotype,Blond Vs Non-Blond Hair Color
30748,Brown Vs. Non-Brown Hair Color,Phenotype,Brown Vs. Non-Brown Hair Color
30751,Light Vs. Dark Hair Color,Phenotype,Light Vs. Dark Hair Color
30753,Black Vs. Non-Black Hair Color,Phenotype,Black Vs. Non-Black Hair Color
30764,Trichloroethylene-Induced Hypersensitivity Syndrome,Phenotype,Trichloroethylene-Induced Hypersensitivity Syndrome
30772,Attention Function In Attention Deficit Hyperactive Disorder,Phenotype,Attention Function In Attention Deficit Hyperactive Disorder
30774,Postprandial Triglyceride Response To High Fat Diet Meal,Phenotype,Postprandial Triglyceride Response To High Fat Diet Meal
30776,Left Superior Temporal Gyrus Thickness (Schizophrenia Interaction),Phenotype,Left Superior Temporal Gyrus Thickness (Schizophrenia Interaction)
30780,Diabetic Kidney Disease,Phenotype,Diabetic Kidney Disease
30789,Mitral Valve Prolapse,Phenotype,Mitral Valve Prolapse
30792,Antipsychotic Drug-Induced Weight Gain,Phenotype,Antipsychotic Drug-Induced Weight Gain
30794,Antipsychotic Drug-Induced Weight Gain (Time Interaction),Phenotype,Antipsychotic Drug-Induced Weight Gain (Time Interaction)
30795,White Matter Lesion Progression (Adjusted For White Matter Lesion Burden At Baseline),Phenotype,White Matter Lesion Progression (Adjusted For White Matter Lesion Burden At Baseline)
30797,Eating Disorder In Bipolar Disorder,Phenotype,Eating Disorder In Bipolar Disorder
30799,Bipolar Disorder And Eating Disorder,Phenotype,Bipolar Disorder And Eating Disorder
30800,Lung Disease Severity In Cystic Fibrosis,Phenotype,Lung Disease Severity In Cystic Fibrosis
30802,Staphylococcus Aureus Infection,Phenotype,Staphylococcus Aureus Infection
30805,Skin And Soft Tissue Staphylococcus Aureus Infection,Phenotype,Skin And Soft Tissue Staphylococcus Aureus Infection
30806,Soluble Receptor For Advanced Glycation End-Product Levels,Phenotype,Soluble Receptor For Advanced Glycation End-Product Levels
30811,Ear Morphology,Phenotype,Ear Morphology
30813,Lobe Size,Phenotype,Lobe Size
30814,Lobe Attachment,Phenotype,Lobe Attachment
30815,Cerebrospinal Fluid Clusterin Levels,Phenotype,Cerebrospinal Fluid Clusterin Levels
30818,Plasma Clusterin Levels,Phenotype,Plasma Clusterin Levels
30820,Response To Pazopanib In Cancer (Hepatotoxicity),Phenotype,Response To Pazopanib In Cancer (Hepatotoxicity)
30821,Cardiovascular Disease In Hypertension (Calcium Channel Blocker Interaction),Phenotype,Cardiovascular Disease In Hypertension (Calcium Channel Blocker Interaction)
30823,Atopic March,Phenotype,Atopic March
30825,Setpoint Viral Load In Hiv-1 Infection,Phenotype,Setpoint Viral Load In Hiv-1 Infection
30828,Pelvic Organ Prolapse (Moderate/Severe),Phenotype,Pelvic Organ Prolapse (Moderate/Severe)
30833,Late-Onset Myasthenia Gravis,Phenotype,Late-Onset Myasthenia Gravis
30840,Ldl Peak Particle Diameter (Total Fat Intake Interaction),Phenotype,Ldl Peak Particle Diameter (Total Fat Intake Interaction)
30845,Dysphagia,Phenotype,Dysphagia
30849,Plasma Homocysteine Levels,Phenotype,Plasma Homocysteine Levels
30852,Non-Cardia Gastric Cancer,Phenotype,Non-Cardia Gastric Cancer
30855,Thionamide-Induced Agranulocytosis In Graves' Disease,Phenotype,Thionamide-Induced Agranulocytosis In Graves' Disease
30864,Response To Lithium Treatment In Bipolar Disorder (Dichotomous Phenotype),Phenotype,Response To Lithium Treatment In Bipolar Disorder (Dichotomous Phenotype)
30868,Survival In Colorectal Cancer (Distant Metastatic),Phenotype,Survival In Colorectal Cancer (Distant Metastatic)
30870,Sense Of Smell,Phenotype,Sense Of Smell
30874,Osteoarthritis (Hip),Phenotype,Osteoarthritis (Hip)
30881,Tetanus Toxoid Igg Concentrations Post Childhood Immunization,Phenotype,Tetanus Toxoid Igg Concentrations Post Childhood Immunization
30884,Lipoprotein (A) Levels In Coronary Artery Disease (Percutaneous Coronary Intervention),Phenotype,Lipoprotein (A) Levels In Coronary Artery Disease (Percutaneous Coronary Intervention)
30887,Osteoarthritis Of The Hip Or Knee,Phenotype,Osteoarthritis Of The Hip Or Knee
30893,3-Indolepropionic Acid To L-Valine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Valine Ratio In Coronary Artery Disease
30895,3-Indolepropionic Acid Levels In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid Levels In Coronary Artery Disease
30897,L-Histidine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Histidine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30899,3-Indolepropionic Acid To Lysopc 16:0 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 16:0 Ratio In Coronary Artery Disease
30900,3-Indolepropionic Acid To Lysopc 18:1 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 18:1 Ratio In Coronary Artery Disease
30901,L-Thyroxine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Thyroxine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30902,Hydrocinnamic Acid Levels In Coronary Artery Disease,Phenotype,Hydrocinnamic Acid Levels In Coronary Artery Disease
30903,3-Indolepropionic Acid To Trimethylamine N-Oxide Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Trimethylamine N-Oxide Ratio In Coronary Artery Disease
30904,3-Indolepropionic Acid To Sarcosine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Sarcosine Ratio In Coronary Artery Disease
30905,3-Indolepropionic Acid To L-Lysine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Lysine Ratio In Coronary Artery Disease
30906,L-Glutamic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Glutamic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30907,3-Indolepropionic Acid To Adenine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Adenine Ratio In Coronary Artery Disease
30908,3-Indolepropionic Acid To L-Methionine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Methionine Ratio In Coronary Artery Disease
30909,L-Phenylalanine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Phenylalanine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30910,3-Indolepropionic Acid To L-Tyrosine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Tyrosine Ratio In Coronary Artery Disease
30911,3-Indolepropionic Acid To Phenylpyruvic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Phenylpyruvic Acid Ratio In Coronary Artery Disease
30912,3-Indolepropionic Acid To L-Ornithine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Ornithine Ratio In Coronary Artery Disease
30913,L-Glutamine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Glutamine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30914,3-Indolepropionic Acid To Taurocholic Acid Sodium Salt Hydrate Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Taurocholic Acid Sodium Salt Hydrate Ratio In Coronary Artery Disease
30915,Asp-Phe To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,Asp-Phe To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30917,3-Indolepropionic Acid To 3--3'--5-Triiodo-L-Thyronine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 3--3'--5-Triiodo-L-Thyronine Ratio In Coronary Artery Disease
30918,D-Arabinose To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,D-Arabinose To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30919,L-Threonine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Threonine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30920,3-Indolepropionic Acid To N6-Acetyl-L-Lysine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To N6-Acetyl-L-Lysine Ratio In Coronary Artery Disease
30921,L-Aspartic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Aspartic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30922,3-Indolepropionic Acid To Uric Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Uric Acid Ratio In Coronary Artery Disease
30923,3-Indolepropionic Acid To D-Fructose Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To D-Fructose Ratio In Coronary Artery Disease
30924,L-Tryptophan To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Tryptophan To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30925,3-Indolepropionic Acid To Choline Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Choline Ratio In Coronary Artery Disease
30926,3-Indolepropionic Acid To Uridine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Uridine Ratio In Coronary Artery Disease
30927,L-Serine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Serine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30928,3-Indolepropionic Acid To S-(5-Adenosy) -L-Homocysteine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To S-(5-Adenosy) -L-Homocysteine Ratio In Coronary Artery Disease
30929,3-Indolepropionic Acid To D-2-Aminobutyric Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To D-2-Aminobutyric Acid Ratio In Coronary Artery Disease
30930,3-Indolepropionic Acid To Lysopc 16:1 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 16:1 Ratio In Coronary Artery Disease
30931,3-Indolepropionic Acid To Hippuric Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Hippuric Acid Ratio In Coronary Artery Disease
30932,3-Indolepropionic Acid To Pipecolinic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Pipecolinic Acid Ratio In Coronary Artery Disease
30933,L-Citrulline To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Citrulline To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
30934,Response To Treatment In Irritable Bowel Syndrome (Symptom Severity),Phenotype,Response To Treatment In Irritable Bowel Syndrome (Symptom Severity)
30936,Asthma (Moderate Or Severe),Phenotype,Asthma (Moderate Or Severe)
30947,Protein Quantitative Trait Loci (Liver),Phenotype,Protein Quantitative Trait Loci (Liver)
30950,Circulating Fibroblast Growth Factor 23 Levels,Phenotype,Circulating Fibroblast Growth Factor 23 Levels
30952,Amygdala Volume Change Rate X Age Interaction (1Df),Phenotype,Amygdala Volume Change Rate X Age Interaction (1Df)
30954,Cerebellum Cortex Volume Change Rate X Age Interaction (1Df),Phenotype,Cerebellum Cortex Volume Change Rate X Age Interaction (1Df)
30956,Lateral Ventricle Volume Change Rate X Age Interaction (1Df),Phenotype,Lateral Ventricle Volume Change Rate X Age Interaction (1Df)
30958,Cerebellum White Matter Volume Change Rate X Age Interaction (1Df),Phenotype,Cerebellum White Matter Volume Change Rate X Age Interaction (1Df)
30960,Cerebral White Matter Volume Change Rate X Age Interaction (1Df),Phenotype,Cerebral White Matter Volume Change Rate X Age Interaction (1Df)
30963,Cortex Volume Change Rate X Age Interaction (1Df),Phenotype,Cortex Volume Change Rate X Age Interaction (1Df)
30965,Brain Surface Area Change Rate X Age Interaction (1Df),Phenotype,Brain Surface Area Change Rate X Age Interaction (1Df)
30967,Thalamus Volume Change Rate X Age Interaction (1Df),Phenotype,Thalamus Volume Change Rate X Age Interaction (1Df)
30969,Thalamus Volume Change Rate,Phenotype,Thalamus Volume Change Rate
30971,Total Brain Volume Change Rate,Phenotype,Total Brain Volume Change Rate
30973,Putamen Volume Change Rate,Phenotype,Putamen Volume Change Rate
30975,Pallidum Volume Change Rate X Age Interaction (1Df),Phenotype,Pallidum Volume Change Rate X Age Interaction (1Df)
30977,Putamen Volume Change Rate X Age Interaction (1Df),Phenotype,Putamen Volume Change Rate X Age Interaction (1Df)
30982,Gut Microbiota Alpha Diversity (Shannon Index),Phenotype,Gut Microbiota Alpha Diversity (Shannon Index)
30984,Carbamazepine-Induced Serious Cutaneous Adverse Reaction,Phenotype,Carbamazepine-Induced Serious Cutaneous Adverse Reaction
30991,Total Amyloid (Snp X Snp Interaction),Phenotype,Total Amyloid (Snp X Snp Interaction)
30994,Neurofibrillary Tangles (Snp X Snp Interaction),Phenotype,Neurofibrillary Tangles (Snp X Snp Interaction)
31024,Mean Spheric Corpuscular Volume,Phenotype,Mean Spheric Corpuscular Volume
31054,Corneal Endothelial Cell Size Variation Coefficient,Phenotype,Corneal Endothelial Cell Size Variation Coefficient
31065,Impulsivity (Non-Planning),Phenotype,Impulsivity (Non-Planning)
31067,Lack Of Premeditation,Phenotype,Lack Of Premeditation
31069,Negative Urgency,Phenotype,Negative Urgency
31071,Sweet Beverage Consumption,Phenotype,Sweet Beverage Consumption
31072,Sugar-Sweetened Beverage Consumption,Phenotype,Sugar-Sweetened Beverage Consumption
31073,Artificially Sweetened Beverage Consumption,Phenotype,Artificially Sweetened Beverage Consumption
31075,Pure Non-Grapefruit Juice Consumption,Phenotype,Pure Non-Grapefruit Juice Consumption
31079,Tea Consumption,Phenotype,Tea Consumption
31084,Grapefruit Juice Consumption,Phenotype,Grapefruit Juice Consumption
31088,Lack Of Perseverance,Phenotype,Lack Of Perseverance
31090,Impulsivity (Attentional),Phenotype,Impulsivity (Attentional)
31095,Aspartate Aminotransferase Levels In Non-Alcoholic Fatty Liver Disease,Phenotype,Aspartate Aminotransferase Levels In Non-Alcoholic Fatty Liver Disease
31098,Alanine Aminotransferase Levels In Non-Alcoholic Fatty Liver Disease,Phenotype,Alanine Aminotransferase Levels In Non-Alcoholic Fatty Liver Disease
31104,Priapism In Sickle Cell Disease,Phenotype,Priapism In Sickle Cell Disease
31106,Cerebellum White Matter Volume Change Rate X Age Interaction (2Df),Phenotype,Cerebellum White Matter Volume Change Rate X Age Interaction (2Df)
31108,Cerebral White Matter Volume Change Rate X Age Interaction (2Df),Phenotype,Cerebral White Matter Volume Change Rate X Age Interaction (2Df)
31109,Cortical Thickness Change Rate X Age Interaction (2Df),Phenotype,Cortical Thickness Change Rate X Age Interaction (2Df)
31111,Short-Term Memory (Digit-Span Task),Phenotype,Short-Term Memory (Digit-Span Task)
31114,Rapid Automised Naming Of Digits,Phenotype,Rapid Automised Naming Of Digits
31120,Rapid Automised Naming Of Pictures,Phenotype,Rapid Automised Naming Of Pictures
31144,Post-Traumatic Stress Disorder (Re-Experiencing Symptoms),Phenotype,Post-Traumatic Stress Disorder (Re-Experiencing Symptoms)
31160,Toxicity Response To Radiotherapy In Prostate Cancer (Hematuria) (Time To Event),Phenotype,Toxicity Response To Radiotherapy In Prostate Cancer (Hematuria) (Time To Event)
31175,Percentage Of Invited Food Questionnaires Completed,Phenotype,Percentage Of Invited Food Questionnaires Completed
31178,Acceptance Of An Invitation To Participate In A Mental Health Questionnaire,Phenotype,Acceptance Of An Invitation To Participate In A Mental Health Questionnaire
31192,Blood Cell Traits (Multivariate Analysis),Phenotype,Blood Cell Traits (Multivariate Analysis)
31195,Emphysema Annual Change Measurement In Smokers (Adjusted Lung Density),Phenotype,Emphysema Annual Change Measurement In Smokers (Adjusted Lung Density)
31199,Emphysema Annual Change Measurement In Smokers (Percent Low Attenuation Area),Phenotype,Emphysema Annual Change Measurement In Smokers (Percent Low Attenuation Area)
31210,Bitter Non-Alcoholic Beverage Consumption,Phenotype,Bitter Non-Alcoholic Beverage Consumption
31213,Bitter Alcoholic Beverage Consumption,Phenotype,Bitter Alcoholic Beverage Consumption
31267,Estimated Glomerular Filtration Rate,Phenotype,Estimated Glomerular Filtration Rate
31268,Response To Treatment In Irritable Bowel Syndrome (Pain Frequency),Phenotype,Response To Treatment In Irritable Bowel Syndrome (Pain Frequency)
31271,Response To Treatment In Irritable Bowel Syndrome (Pain Severity),Phenotype,Response To Treatment In Irritable Bowel Syndrome (Pain Severity)
31280,3-Indolepropionic Acid To L-Pipecolic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Pipecolic Acid Ratio In Coronary Artery Disease
31281,3-Indolepropionic Acid To 3-Hydroxybutyrate Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 3-Hydroxybutyrate Ratio In Coronary Artery Disease
31282,3-Indolepropionic Acid To (S)-(-)-2-Hydroxyisocaproic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To (S)-(-)-2-Hydroxyisocaproic Acid Ratio In Coronary Artery Disease
31283,3-Indolepropionic Acid To Creatinine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Creatinine Ratio In Coronary Artery Disease
31284,L-Pyroglutamic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Pyroglutamic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31285,3-Indolepropionic Acid To Gamma-Linolenic Acid (C18:3N6) Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Gamma-Linolenic Acid (C18:3N6) Ratio In Coronary Artery Disease
31286,3-Indolepropionic Acid To N--N-Dimethylglycine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To N--N-Dimethylglycine Ratio In Coronary Artery Disease
31287,3-Indolepropionic Acid To Subericacid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Subericacid Ratio In Coronary Artery Disease
31288,3-Indolepropionic Acid To 2-(Dimethylamino) Guanosine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 2-(Dimethylamino) Guanosine Ratio In Coronary Artery Disease
31289,3-Indolepropionic Acid To Lysopc 14:0 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 14:0 Ratio In Coronary Artery Disease
31290,3-Indolepropionic Acid To 4-Hydroxybenzaldehyde Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 4-Hydroxybenzaldehyde Ratio In Coronary Artery Disease
31291,3-Indolepropionic Acid To Azelaic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Azelaic Acid Ratio In Coronary Artery Disease
31292,3-Indolepropionic Acid To Cis-5--8--11--14--17-Eicosapentaenoic Acid (C20:5N3) Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Cis-5--8--11--14--17-Eicosapentaenoic Acid (C20:5N3) Ratio In Coronary Artery Disease
31293,3-Indolepropionic Acid To Hypoxanthine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Hypoxanthine Ratio In Coronary Artery Disease
31294,L-Proline To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Proline To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31295,D-Trehalose To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,D-Trehalose To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31296,3-Indolepropionic Acid To Methylmalonic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Methylmalonic Acid Ratio In Coronary Artery Disease
31297,3-Indolepropionic Acid To Alpha-Linolenic Acid (C18:3N3) Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Alpha-Linolenic Acid (C18:3N3) Ratio In Coronary Artery Disease
31298,3-Indolepropionic Acid To S-Sulfo-L-Cysteine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To S-Sulfo-L-Cysteine Ratio In Coronary Artery Disease
31299,3-Indolepropionic Acid To Lysopc 20:0 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 20:0 Ratio In Coronary Artery Disease
31300,3-Indolepropionic Acid To Beta-Pseudouridine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Beta-Pseudouridine Ratio In Coronary Artery Disease
31301,Dulcitol To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,Dulcitol To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31302,3-Indolepropionic Acid To 4-Nitrophenol Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 4-Nitrophenol Ratio In Coronary Artery Disease
31303,3-Indolepropionic Acid To Indole-5-Carboxylic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Indole-5-Carboxylic Acid Ratio In Coronary Artery Disease
31304,Pantothenate To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,Pantothenate To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31305,3-Indolepropionic Acid To L-Saccharopine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Saccharopine Ratio In Coronary Artery Disease
31306,3-Indolepropionic Acid To 5-Oxoproline Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 5-Oxoproline Ratio In Coronary Artery Disease
31307,L-Asparagine Anhydrous To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Asparagine Anhydrous To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31308,3-Indolepropionic Acid To Kinurenine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Kinurenine Ratio In Coronary Artery Disease
31309,3-Indolepropionic Acid To Lysopc 18:0 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 18:0 Ratio In Coronary Artery Disease
31310,3-Indolepropionic Acid To L-2-Aminobutyric Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-2-Aminobutyric Acid Ratio In Coronary Artery Disease
31311,3-Indolepropionic Acid To 2-Picolinic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 2-Picolinic Acid Ratio In Coronary Artery Disease
31312,3-Indolepropionic Acid To 2-Methylsuccinic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 2-Methylsuccinic Acid Ratio In Coronary Artery Disease
31313,3-Indolepropionic Acid To Lysopc 20:2 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 20:2 Ratio In Coronary Artery Disease
31314,3-Indolepropionic Acid To 4-Guanidinobutyric Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 4-Guanidinobutyric Acid Ratio In Coronary Artery Disease
31315,3-Indolepropionic Acid To Isonicotinamide Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Isonicotinamide Ratio In Coronary Artery Disease
31316,5-Methyluridine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,5-Methyluridine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31317,3-Indolepropionic Acid To N-Acetylglycine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To N-Acetylglycine Ratio In Coronary Artery Disease
31318,3-Indolepropionic Acid To N-Acetyl-L-Tyrosine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To N-Acetyl-L-Tyrosine Ratio In Coronary Artery Disease
31319,L-Cystine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,L-Cystine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31320,3-Indolepropionic Acid To Cyclic Amp Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Cyclic Amp Ratio In Coronary Artery Disease
31321,3-Indolepropionic Acid To L-Carnitine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Carnitine Ratio In Coronary Artery Disease
31322,3-Indolepropionic Acid To 1--4-Dihydro-1-Methyl-4-Oxo-3-Pyridinecarboxamide Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 1--4-Dihydro-1-Methyl-4-Oxo-3-Pyridinecarboxamide Ratio In Coronary Artery Disease
31323,3-Indolepropionic Acid To Creatine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Creatine Ratio In Coronary Artery Disease
31324,3-Indolepropionic Acid To Dodecanedioic Aicd Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Dodecanedioic Aicd Ratio In Coronary Artery Disease
31325,3-Indolepropionic Acid To Lysopc 20:1 Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lysopc 20:1 Ratio In Coronary Artery Disease
31326,3-Indolepropionic Acid To L-Arginine Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To L-Arginine Ratio In Coronary Artery Disease
31327,3-Indolepropionic Acid To Kynurenic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Kynurenic Acid Ratio In Coronary Artery Disease
31328,3-Indolepropionic Acid To 2-Hydroxyisocaproic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 2-Hydroxyisocaproic Acid Ratio In Coronary Artery Disease
31329,3-Indolepropionic Acid To 4-Pyridoxic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To 4-Pyridoxic Acid Ratio In Coronary Artery Disease
31330,3-Indolepropionic Acid To Lauric Acid/Dodecanoic Acid (C12:0) Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Lauric Acid/Dodecanoic Acid (C12:0) Ratio In Coronary Artery Disease
31331,3-Indolepropionic Acid To Homovanillic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Homovanillic Acid Ratio In Coronary Artery Disease
31332,N-Acetyl-L-Leucine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,N-Acetyl-L-Leucine To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31333,3-Indolepropionic Acid To Myoinositol Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Myoinositol Ratio In Coronary Artery Disease
31334,3-Indolepropionic Acid To Urocanic Acid Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Urocanic Acid Ratio In Coronary Artery Disease
31335,Riboflavin To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,Riboflavin To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31336,3-Indolepropionic Acid To Maltose Ratio In Coronary Artery Disease,Phenotype,3-Indolepropionic Acid To Maltose Ratio In Coronary Artery Disease
31337,D-Malic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,D-Malic Acid To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31338,D-Sucrose To 3-Indolepropionic Acid Ratio In Coronary Artery Disease,Phenotype,D-Sucrose To 3-Indolepropionic Acid Ratio In Coronary Artery Disease
31342,Caudate Volume Change Rate,Phenotype,Caudate Volume Change Rate
31345,Lateral Ventricle Volume Change Rate,Phenotype,Lateral Ventricle Volume Change Rate
31347,Pallidum Volume Change Rate,Phenotype,Pallidum Volume Change Rate
31350,Cortex Volume Change Rate,Phenotype,Cortex Volume Change Rate
31352,Cortical Thickness Change Rate,Phenotype,Cortical Thickness Change Rate
31354,Thalamus Volume Change Rate X Age Interaction (2Df),Phenotype,Thalamus Volume Change Rate X Age Interaction (2Df)
31356,Lateral Ventricle Volume Change Rate X Age Interaction (2Df),Phenotype,Lateral Ventricle Volume Change Rate X Age Interaction (2Df)
31357,Pallidum Volume Change Rate X Age Interaction (2Df),Phenotype,Pallidum Volume Change Rate X Age Interaction (2Df)
31360,Putamen Volume Change Rate X Age Interaction (2Df),Phenotype,Putamen Volume Change Rate X Age Interaction (2Df)
31375,Mortality In Covid-19,Phenotype,Mortality In Covid-19
31389,Alanine Aminotransferase Levels,Phenotype,Alanine Aminotransferase Levels
31403,Corneal Curvature,Phenotype,Corneal Curvature
31411,Gut Microbiota Relative Abundance (Sutterella),Phenotype,Gut Microbiota Relative Abundance (Sutterella)
31413,Gut Microbiota Relative Abundance (Faecalibacterium),Phenotype,Gut Microbiota Relative Abundance (Faecalibacterium)
31416,Gut Microbiota Relative Abundance (Oscillospira),Phenotype,Gut Microbiota Relative Abundance (Oscillospira)
31419,Gut Microbiota Relative Abundance (Eubacterium Belonging To Family Erysipelotrichaceae),Phenotype,Gut Microbiota Relative Abundance (Eubacterium Belonging To Family Erysipelotrichaceae)
31421,Gut Microbiota Alpha Diversity (Chao1 Index),Phenotype,Gut Microbiota Alpha Diversity (Chao1 Index)
31425,Gut Microbiota Relative Abundance (Ruminococcus Belonging To Family Lachnospiraceae),Phenotype,Gut Microbiota Relative Abundance (Ruminococcus Belonging To Family Lachnospiraceae)
31432,Cognitive Function (Generalized Correlation Coefficient),Phenotype,Cognitive Function (Generalized Correlation Coefficient)
31438,Body Mass Index And Systolic Blood Pressure (Bivariate Analysis),Phenotype,Body Mass Index And Systolic Blood Pressure (Bivariate Analysis)
31441,Body Mass Index And Diastolic Blood Pressure (Bivariate Analysis),Phenotype,Body Mass Index And Diastolic Blood Pressure (Bivariate Analysis)
31448,Systolic Blood Pressure And Diastolic Blood Pressure (Bivariate Analysis),Phenotype,Systolic Blood Pressure And Diastolic Blood Pressure (Bivariate Analysis)
31462,Mean Reticulocyte Volume,Phenotype,Mean Reticulocyte Volume
31478,Gut Microbiota Relative Abundance (Prevotella),Phenotype,Gut Microbiota Relative Abundance (Prevotella)
31480,Gut Microbiota Relative Abundance (Streptococcus),Phenotype,Gut Microbiota Relative Abundance (Streptococcus)
31487,Atorvastatin-Induced Myopathy,Phenotype,Atorvastatin-Induced Myopathy
31489,Self-Rated Health,Phenotype,Self-Rated Health
31493,Bone Mineral Density Or Leg Lean Mass (Pleiotropy),Phenotype,Bone Mineral Density Or Leg Lean Mass (Pleiotropy)
31494,Leg Lean Mass,Phenotype,Leg Lean Mass
31511,Anorectal Malformation,Phenotype,Anorectal Malformation
31526,Iron Status Biomarkers (Total Iron Binding Capacity),Phenotype,Iron Status Biomarkers (Total Iron Binding Capacity)
31550,First Fracture In Long-Term Childhood Cancer Survivors (Time To Event),Phenotype,First Fracture In Long-Term Childhood Cancer Survivors (Time To Event)
31552,Cortical Volume,Phenotype,Cortical Volume
31556,Helicobacter Pylori Omp Antibody Levels,Phenotype,Helicobacter Pylori Omp Antibody Levels
31558,Chlamydia Trachomatis Porb Antibody Levels,Phenotype,Chlamydia Trachomatis Porb Antibody Levels
31560,Epstein-Barr Virus Ea-D Antibody Levels,Phenotype,Epstein-Barr Virus Ea-D Antibody Levels
31562,Epstein-Barr Virus Vca P18 Antibody Levels,Phenotype,Epstein-Barr Virus Vca P18 Antibody Levels
31564,Epstein-Barr Virus Zebra Antibody Levels,Phenotype,Epstein-Barr Virus Zebra Antibody Levels
31565,Merkel Cell Polyomavirus Vp1 Antibody Levels,Phenotype,Merkel Cell Polyomavirus Vp1 Antibody Levels
31567,Anti-Human Herpes Virus 6 Ie1A Igg Seropositivity,Phenotype,Anti-Human Herpes Virus 6 Ie1A Igg Seropositivity
31569,Human Herpes Virus 6 Ie1A Antibody Levels,Phenotype,Human Herpes Virus 6 Ie1A Antibody Levels
31571,Varicella Zoster Virus Glycoproteins E And I Antibody Levels,Phenotype,Varicella Zoster Virus Glycoproteins E And I Antibody Levels
31575,Helicobacter Pylori Urea Antibody Levels,Phenotype,Helicobacter Pylori Urea Antibody Levels
31577,Anti-Polyomavirus 2 Igg Seropositivity,Phenotype,Anti-Polyomavirus 2 Igg Seropositivity
31579,Polyomavirus 2  Jc Vp1 Antibody Levels,Phenotype,Polyomavirus 2  Jc Vp1 Antibody Levels
31581,Epstein-Barr Virus Ebna-1 Antibody Levels,Phenotype,Epstein-Barr Virus Ebna-1 Antibody Levels
31582,Anti-Merkel Cell Polyomavirus Igg Seropositivity,Phenotype,Anti-Merkel Cell Polyomavirus Igg Seropositivity
31588,Human Herpes Virus 7 U14 Antibody Levels,Phenotype,Human Herpes Virus 7 U14 Antibody Levels
31590,Anti-Varicella Zoster Virus Igg Seropositivity,Phenotype,Anti-Varicella Zoster Virus Igg Seropositivity
31599,Opioid Use Disorder,Phenotype,Opioid Use Disorder
31607,Gut Microbiota Relative Abundance (Unclassified Genus Belonging To Family Lachnospiraceae),Phenotype,Gut Microbiota Relative Abundance (Unclassified Genus Belonging To Family Lachnospiraceae)
31608,Gut Microbiota Relative Abundance (Blautia),Phenotype,Gut Microbiota Relative Abundance (Blautia)
31612,Gut Microbiota Relative Abundance (Unclassified Genus Belonging To Family Ruminococcaceae),Phenotype,Gut Microbiota Relative Abundance (Unclassified Genus Belonging To Family Ruminococcaceae)
31614,Gut Microbiota Relative Abundance (Dorea),Phenotype,Gut Microbiota Relative Abundance (Dorea)
31635,Urolithiasis,Phenotype,Urolithiasis
31636,Arrhythmia,Phenotype,Arrhythmia
31648,Simvastatin-Induced Myopathy,Phenotype,Simvastatin-Induced Myopathy
31666,Chronic Kidney Disease X Type 2 Diabetes Interaction,Phenotype,Chronic Kidney Disease X Type 2 Diabetes Interaction
31669,Obsessive-Compulsive Traits,Phenotype,Obsessive-Compulsive Traits
31676,Interleukin-6 Levels,Phenotype,Interleukin-6 Levels
31684,Mitochondrial Dna Copy Number,Phenotype,Mitochondrial Dna Copy Number
31687,Mitochondrial Dna Copy Number (White Blood Cells),Phenotype,Mitochondrial Dna Copy Number (White Blood Cells)
31689,Factor Vii Activity,Phenotype,Factor Vii Activity
31701,Lean Nonalcoholic Fatty Liver Disease,Phenotype,Lean Nonalcoholic Fatty Liver Disease
31702,Nonsyndromic Cleft Palate,Phenotype,Nonsyndromic Cleft Palate
31772,Differentiated Thyroid Cancer,Phenotype,Differentiated Thyroid Cancer
31777,Aspartate Aminotransferase Levels,Phenotype,Aspartate Aminotransferase Levels
31803,Beta-2-Microglobulin Levels,Phenotype,Beta-2-Microglobulin Levels
31805,C-C Motif Chemokine 22 Levels,Phenotype,C-C Motif Chemokine 22 Levels
31807,C-C Motif Chemokine 17 Levels,Phenotype,C-C Motif Chemokine 17 Levels
31809,Ubiquitin-Conjugating Enzyme E2 G2 Levels,Phenotype,Ubiquitin-Conjugating Enzyme E2 G2 Levels
31814,Ubiquitin Carboxyl-Terminal Hydrolase 25 Levels,Phenotype,Ubiquitin Carboxyl-Terminal Hydrolase 25 Levels
31853,Post-Traumatic Stress Disorder (Mtag),Phenotype,Post-Traumatic Stress Disorder (Mtag)
31855,Non-Hdl Cholesterol Levels,Phenotype,Non-Hdl Cholesterol Levels
31882,Tryptase Beta-2 Levels,Phenotype,Tryptase Beta-2 Levels
31895,Gdnf Family Receptor Alpha-1 Levels,Phenotype,Gdnf Family Receptor Alpha-1 Levels
31897,Heparin Cofactor 2 Levels,Phenotype,Heparin Cofactor 2 Levels
31900,Thrombospondin-2 Levels,Phenotype,Thrombospondin-2 Levels
31949,Hazardous Alcohol Drinking,Phenotype,Hazardous Alcohol Drinking
31956,Rectal Cancer,Phenotype,Rectal Cancer
31959,Colorectal Cancer Vs Inflammatory Bowel Disease,Phenotype,Colorectal Cancer Vs Inflammatory Bowel Disease
31962,Colorectal Cancer Vs Inflammatory Bowel Disease Or Controls,Phenotype,Colorectal Cancer Vs Inflammatory Bowel Disease Or Controls
31966,Right Colon Cancer,Phenotype,Right Colon Cancer
31968,Left Colon Cancer,Phenotype,Left Colon Cancer
31977,Hdl Cholesterol Levels In Type 2 Diabetes,Phenotype,Hdl Cholesterol Levels In Type 2 Diabetes
31978,Total Cholesterol Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Total Cholesterol Levels In Chylomicrons And Extremely Large Vldl
31980,Cholesteryl Esters To Total Lipids Ratio In Medium Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Medium Vldl
31981,Free Cholesterol To Total Lipids Ratio In Medium Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Medium Vldl
31983,Free Cholesterol In Medium Vldl,Phenotype,Free Cholesterol In Medium Vldl
31985,Cholesterol Esters In Medium Vldl,Phenotype,Cholesterol Esters In Medium Vldl
31986,Total Cholesterol Levels In Small Hdl,Phenotype,Total Cholesterol Levels In Small Hdl
31987,Total Cholesterol To Total Lipids Ratio In Small Hdl,Phenotype,Total Cholesterol To Total Lipids Ratio In Small Hdl
31989,Ratio Of Saturated Fatty Acids To Total Fatty Acids,Phenotype,Ratio Of Saturated Fatty Acids To Total Fatty Acids
31991,Saturated Fatty Acids,Phenotype,Saturated Fatty Acids
31995,Serum Total Triglyceride Levels,Phenotype,Serum Total Triglyceride Levels
31996,Free Cholesterol To Total Lipids Ratio In Small Ldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Small Ldl
31998,Concentration Of Small Ldl Particles,Phenotype,Concentration Of Small Ldl Particles
32000,Total Lipids In Small Ldl,Phenotype,Total Lipids In Small Ldl
32004,Ischemic Stroke (Large Artery Atherosclerosis),Phenotype,Ischemic Stroke (Large Artery Atherosclerosis)
32005,Ischemic Stroke (Small-Vessel),Phenotype,Ischemic Stroke (Small-Vessel)
32006,Apolipoprotein A-I Levels,Phenotype,Apolipoprotein A-I Levels
32009,Systolic Blood Pressure (Bmi Adjusted),Phenotype,Systolic Blood Pressure (Bmi Adjusted)
32012,Systolic Blood Pressure (Bmi Unadjusted),Phenotype,Systolic Blood Pressure (Bmi Unadjusted)
32015,Total Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
32017,Cholesteryl Ester Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Cholesteryl Ester Levels In Chylomicrons And Extremely Large Vldl
32018,Triglycerides To Total Lipids Ratio In Very Small Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Very Small Vldl
32019,Triglycerides In Very Small Vldl,Phenotype,Triglycerides In Very Small Vldl
32020,Phospholipids In Very Small Vldl,Phenotype,Phospholipids In Very Small Vldl
32032,Serum Total Cholesterol Levels,Phenotype,Serum Total Cholesterol Levels
32034,Polyunsaturated Fatty Acids,Phenotype,Polyunsaturated Fatty Acids
32035,Remnant Cholesterol (Non-Hdl-- Non-Ldl -Cholesterol),Phenotype,Remnant Cholesterol (Non-Hdl-- Non-Ldl -Cholesterol)
32037,Ratio Of Polyunsaturated Fatty Acids To Total Fatty Acids,Phenotype,Ratio Of Polyunsaturated Fatty Acids To Total Fatty Acids
32039,Pyruvate Levels,Phenotype,Pyruvate Levels
32041,Phenylalanine Levels,Phenotype,Phenylalanine Levels
32044,Cholesterol Esters In Small Ldl,Phenotype,Cholesterol Esters In Small Ldl
32046,Total Cholesterol To Total Lipids Ratio In Small Ldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Small Ldl
32048,Total Cholesterol In Small Ldl,Phenotype,Total Cholesterol In Small Ldl
32049,Hashimoto Thyroiditis,Phenotype,Hashimoto Thyroiditis
32052,Ratio Of Apolipoprotein B To Apolipoprotein A1 Levels,Phenotype,Ratio Of Apolipoprotein B To Apolipoprotein A1 Levels
32053,Diastolic Blood Pressure (Bmi Unadjusted),Phenotype,Diastolic Blood Pressure (Bmi Unadjusted)
32058,Coronary Artery Disease Or Von Willebrand Factor Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Von Willebrand Factor Levels (Pleiotropy)
32059,Coronary Artery Disease Or Factor Xi Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Factor Xi Levels (Pleiotropy)
32066,Unstable Angina Pectoris,Phenotype,Unstable Angina Pectoris
32068,Acne Vulgaris,Phenotype,Acne Vulgaris
32074,Breast Cancer Subtype (Triple Negative Vs Luminal A-Like),Phenotype,Breast Cancer Subtype (Triple Negative Vs Luminal A-Like)
32075,Serum Albumin Levels,Phenotype,Serum Albumin Levels
32080,Ratio Of Triglycerides To Phosphoglycerides,Phenotype,Ratio Of Triglycerides To Phosphoglycerides
32082,Triglycerides To Total Lipids Ratio In Small Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Small Vldl
32084,Triglycerides In Small Vldl,Phenotype,Triglycerides In Small Vldl
32085,Acute Radiotoxicity In Head And Neck Cancer,Phenotype,Acute Radiotoxicity In Head And Neck Cancer
32087,Acute Radiotoxicity In Lung Cancer,Phenotype,Acute Radiotoxicity In Lung Cancer
32098,Phospholipids In Very Large Vldl,Phenotype,Phospholipids In Very Large Vldl
32104,Neovascular Age-Related Macular Degeneration,Phenotype,Neovascular Age-Related Macular Degeneration
32108,Cholesteryl Esters To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
32110,Free Cholesterol Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Free Cholesterol Levels In Chylomicrons And Extremely Large Vldl
32111,Free Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
32112,Total Lipid Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Total Lipid Levels In Chylomicrons And Extremely Large Vldl
32113,Phospholipid Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Phospholipid Levels In Chylomicrons And Extremely Large Vldl
32114,Phospholipids To Total Lipids Ratio In Medium Ldl,Phenotype,Phospholipids To Total Lipids Ratio In Medium Ldl
32116,Concentration Of Chylomicrons And Extremely Large Vldl Particles,Phenotype,Concentration Of Chylomicrons And Extremely Large Vldl Particles
32117,Cholesterol Esters In Small Hdl,Phenotype,Cholesterol Esters In Small Hdl
32118,Cholesteryl Esters To Total Lipids Ratio In Small Hdl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Small Hdl
32119,Free Cholesterol To Total Lipids Ratio In Small Hdl,Phenotype,Free Cholesterol To Total Lipids Ratio In Small Hdl
32120,Free Cholesterol In Small Hdl,Phenotype,Free Cholesterol In Small Hdl
32123,Total Lipids In Small Hdl,Phenotype,Total Lipids In Small Hdl
32125,Waist-Hip Index,Phenotype,Waist-Hip Index
32146,Phospholipids To Total Lipids Ratio In Small Ldl,Phenotype,Phospholipids To Total Lipids Ratio In Small Ldl
32147,Phospholipids In Small Ldl,Phenotype,Phospholipids In Small Ldl
32148,Triglycerides In Small Ldl,Phenotype,Triglycerides In Small Ldl
32153,3-Hydroxybutyrate Levels,Phenotype,3-Hydroxybutyrate Levels
32154,Conjugated Linoleic Acid,Phenotype,Conjugated Linoleic Acid
32160,Diastolic Blood Pressure (Bmi Adjusted),Phenotype,Diastolic Blood Pressure (Bmi Adjusted)
32163,Nonalcoholic Fatty Liver Disease (Imputed),Phenotype,Nonalcoholic Fatty Liver Disease (Imputed)
32169,Uterine Prolapse,Phenotype,Uterine Prolapse
32170,Uveitis,Phenotype,Uveitis
32172,Coronary Artery Disease Or Fibrinogen Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Fibrinogen Levels (Pleiotropy)
32185,Varicose Veins,Phenotype,Varicose Veins
32205,Dry Eye Disease,Phenotype,Dry Eye Disease
32224,Phospholipids To Total Lipids Ratio In Very Large Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Very Large Hdl
32225,Phospholipids In Very Large Hdl,Phenotype,Phospholipids In Very Large Hdl
32233,Severe Covid-19 Infection (Severe Vs Non-Severe),Phenotype,Severe Covid-19 Infection (Severe Vs Non-Severe)
32235,Free Cholesterol To Total Lipids Ratio In Very Small Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Very Small Vldl
32238,Free Cholesterol In Very Small Vldl,Phenotype,Free Cholesterol In Very Small Vldl
32239,Concentration Of Very Small Vldl Particles,Phenotype,Concentration Of Very Small Vldl Particles
32241,Total Lipids In Very Small Vldl,Phenotype,Total Lipids In Very Small Vldl
32242,Total Fatty Acids,Phenotype,Total Fatty Acids
32243,Total Phosphoglycerides Levels,Phenotype,Total Phosphoglycerides Levels
32246,Tyrosine Levels,Phenotype,Tyrosine Levels
32248,Estimated Degree Of Unsaturation,Phenotype,Estimated Degree Of Unsaturation
32249,Total Cholines Levels,Phenotype,Total Cholines Levels
32251,Cholesterol Esters In Very Small Vldl,Phenotype,Cholesterol Esters In Very Small Vldl
32253,Total Cholesterol To Total Lipids Ratio In Very Small Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Very Small Vldl
32254,Cholesteryl Esters To Total Lipids Ratio In Very Small Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Very Small Vldl
32255,Triglycerides To Total Lipids Ratio In Very Large Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Very Large Vldl
32256,Triglycerides In Very Large Vldl,Phenotype,Triglycerides In Very Large Vldl
32257,Total Cholesterol In Very Small Vldl,Phenotype,Total Cholesterol In Very Small Vldl
32258,Triglycerides To Total Lipids Ratio In Medium Ldl,Phenotype,Triglycerides To Total Lipids Ratio In Medium Ldl
32260,Triglycerides In Medium Ldl,Phenotype,Triglycerides In Medium Ldl
32262,Monounsaturated Fatty Acids (16:1-- 18:1) Levels,Phenotype,Monounsaturated Fatty Acids (16:1-- 18:1) Levels
32263,Ratio Of Monounsaturated Fatty Acids To Total Fatty Acids,Phenotype,Ratio Of Monounsaturated Fatty Acids To Total Fatty Acids
32266,Triglycerides To Total Lipids Ratio In Medium Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Medium Vldl
32267,Phospholipids To Total Lipids Ratio In Medium Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Medium Vldl
32268,Triglycerides In Medium Vldl,Phenotype,Triglycerides In Medium Vldl
32269,Phosphatidylcholine And Other Choline Levels,Phenotype,Phosphatidylcholine And Other Choline Levels
32270,Phospholipids In Medium Vldl,Phenotype,Phospholipids In Medium Vldl
32271,Cholesteryl Esters To Total Lipids Ratio In Small Ldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Small Ldl
32272,Free Cholesterol In Small Ldl,Phenotype,Free Cholesterol In Small Ldl
32273,Phospholipids To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
32275,Triglyceride Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Triglyceride Levels In Chylomicrons And Extremely Large Vldl
32277,Triglycerides To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
32278,Acetate Levels,Phenotype,Acetate Levels
32280,Total Cholesterol In Small Vldl,Phenotype,Total Cholesterol In Small Vldl
32281,Alanine Levels,Phenotype,Alanine Levels
32286,Omega-3 Fatty Acids Levels,Phenotype,Omega-3 Fatty Acids Levels
32287,Ratio Of Omega-3 Fatty Acids To Total Fatty Acids,Phenotype,Ratio Of Omega-3 Fatty Acids To Total Fatty Acids
32288,Omega-6 Fatty Acids Levels,Phenotype,Omega-6 Fatty Acids Levels
32290,Mean Arterial Pressure (Bmi Adjusted),Phenotype,Mean Arterial Pressure (Bmi Adjusted)
32291,Coronary Artery Disease Or Factor Vii Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Factor Vii Levels (Pleiotropy)
32292,Coronary Artery Disease Or Tissue Plasminogen Activator Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Tissue Plasminogen Activator Levels (Pleiotropy)
32308,Total Cholesterol In Very Large Vldl,Phenotype,Total Cholesterol In Very Large Vldl
32309,Cholesterol Esters In Very Large Vldl,Phenotype,Cholesterol Esters In Very Large Vldl
32310,Total Cholesterol To Total Lipids Ratio In Very Large Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Very Large Vldl
32311,Cholesteryl Esters To Total Lipids Ratio In Very Large Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Very Large Vldl
32312,Free Cholesterol In Very Large Vldl,Phenotype,Free Cholesterol In Very Large Vldl
32334,Angina,Phenotype,Angina
32337,Ratio Of Omega-6 Fatty Acids To Total Fatty Acids,Phenotype,Ratio Of Omega-6 Fatty Acids To Total Fatty Acids
32338,Glucose Levels,Phenotype,Glucose Levels
32339,Retinal Venular Tortuosity,Phenotype,Retinal Venular Tortuosity
32341,Retinal Venular Width,Phenotype,Retinal Venular Width
32354,Electrocardiogram Morphology (Amplitude At Temporal Datapoints),Phenotype,Electrocardiogram Morphology (Amplitude At Temporal Datapoints)
32356,Urine Heptanoylglutamine Levels In Chronic Kidney Disease,Phenotype,Urine Heptanoylglutamine Levels In Chronic Kidney Disease
32357,Plasma Hexanoylglutamine Levels In Chronic Kidney Disease,Phenotype,Plasma Hexanoylglutamine Levels In Chronic Kidney Disease
32359,Urine Gamma-Cehc Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine Gamma-Cehc Sulfate Levels In Chronic Kidney Disease
32360,Plasma Butyrylcarnitine (C4) Levels In Chronic Kidney Disease,Phenotype,Plasma Butyrylcarnitine (C4) Levels In Chronic Kidney Disease
32361,Plasma Carotene Diol (1) Levels In Chronic Kidney Disease,Phenotype,Plasma Carotene Diol (1) Levels In Chronic Kidney Disease
32363,Plasma Carotene Diol (2) Levels In Chronic Kidney Disease,Phenotype,Plasma Carotene Diol (2) Levels In Chronic Kidney Disease
32364,Plasma Carotene Diol (3) Levels In Chronic Kidney Disease,Phenotype,Plasma Carotene Diol (3) Levels In Chronic Kidney Disease
32366,Plasma Cerotoylcarnitine (C26)* Levels In Chronic Kidney Disease,Phenotype,Plasma Cerotoylcarnitine (C26)* Levels In Chronic Kidney Disease
32367,Plasma Ethylmalonate Levels In Chronic Kidney Disease,Phenotype,Plasma Ethylmalonate Levels In Chronic Kidney Disease
32369,Urine Ethylmalonate Levels In Chronic Kidney Disease,Phenotype,Urine Ethylmalonate Levels In Chronic Kidney Disease
32370,Plasma Ferulic Acid 4-Sulfate Levels In Chronic Kidney Disease,Phenotype,Plasma Ferulic Acid 4-Sulfate Levels In Chronic Kidney Disease
32371,Urine Ferulic Acid 4-Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine Ferulic Acid 4-Sulfate Levels In Chronic Kidney Disease
32372,Plasma Furaneol Sulfate Levels In Chronic Kidney Disease,Phenotype,Plasma Furaneol Sulfate Levels In Chronic Kidney Disease
32373,Urine Furaneol Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine Furaneol Sulfate Levels In Chronic Kidney Disease
32374,Urine Hexanoylglutamine Levels In Chronic Kidney Disease,Phenotype,Urine Hexanoylglutamine Levels In Chronic Kidney Disease
32375,Plasma Ergothioneine Levels In Chronic Kidney Disease,Phenotype,Plasma Ergothioneine Levels In Chronic Kidney Disease
32377,Autoimmune Neurological Syndromes With Anti-Gad65 Autoantibodies,Phenotype,Autoimmune Neurological Syndromes With Anti-Gad65 Autoantibodies
32384,Vertex-Wise Cortical Thickness,Phenotype,Vertex-Wise Cortical Thickness
32387,Urinary Uromodulin Levels (Raw),Phenotype,Urinary Uromodulin Levels (Raw)
32396,Urinary Uromodulin Levels (Indexed To Creatinine),Phenotype,Urinary Uromodulin Levels (Indexed To Creatinine)
32401,Fasting Plasma Glucose Change,Phenotype,Fasting Plasma Glucose Change
32404,Covid-19 (Critical Illness Vs Population Or Mild Symptoms),Phenotype,Covid-19 (Critical Illness Vs Population Or Mild Symptoms)
32408,Estimated Glomerular Filtration Rate (Creatinine),Phenotype,Estimated Glomerular Filtration Rate (Creatinine)
32410,Predicted Developmental Stuttering,Phenotype,Predicted Developmental Stuttering
32423,Vaginal Microbiome Metacyc Pathway (P163-Pwy|L-Lysine Fermentation To Acetate And Butanoate),Phenotype,Vaginal Microbiome Metacyc Pathway (P163-Pwy|L-Lysine Fermentation To Acetate And Butanoate)
32426,Vaginal Microbiome Metacyc Pathway (P562-Pwy|Myo-Inositol Degradation I),Phenotype,Vaginal Microbiome Metacyc Pathway (P562-Pwy|Myo-Inositol Degradation I)
32430,Vaginal Microbiome Metacyc Pathway (Polyamsyn-Pwy|Superpathway Of Polyamine Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Polyamsyn-Pwy|Superpathway Of Polyamine Biosynthesis I)
32432,Vaginal Microbiome Metacyc Pathway (Ppgppmet-Pwy|Ppgpp Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Ppgppmet-Pwy|Ppgpp Biosynthesis)
32434,Vaginal Microbiome Metacyc Pathway (P381-Pwy|Adenosylcobalamin Biosynthesis Ii (Late Cobalt Incorporation)),Phenotype,Vaginal Microbiome Metacyc Pathway (P381-Pwy|Adenosylcobalamin Biosynthesis Ii (Late Cobalt Incorporation))
32438,Vaginal Microbiome Metacyc Pathway (P164-Pwy|Purine Nucleobases Degradation I (Anaerobic)),Phenotype,Vaginal Microbiome Metacyc Pathway (P164-Pwy|Purine Nucleobases Degradation I (Anaerobic))
32441,Vaginal Microbiome Metacyc Pathway (P221-Pwy|Octane Oxidation),Phenotype,Vaginal Microbiome Metacyc Pathway (P221-Pwy|Octane Oxidation)
32444,Vertex-Wise Cortical Surface Area,Phenotype,Vertex-Wise Cortical Surface Area
32445,Vertex-Wise Sulcal Depth,Phenotype,Vertex-Wise Sulcal Depth
32457,Orofacial Cleft X Maternal Vitamin Supplementation Interaction (2Df),Phenotype,Orofacial Cleft X Maternal Vitamin Supplementation Interaction (2Df)
32460,Plasma Ascorbic Acid 2-Sulfate Levels In Chronic Kidney Disease,Phenotype,Plasma Ascorbic Acid 2-Sulfate Levels In Chronic Kidney Disease
32462,Plasma Ascorbic Acid 3-Sulfate* Levels In Chronic Kidney Disease,Phenotype,Plasma Ascorbic Acid 3-Sulfate* Levels In Chronic Kidney Disease
32464,Urine Azelate (C9-Dc) Levels In Chronic Kidney Disease,Phenotype,Urine Azelate (C9-Dc) Levels In Chronic Kidney Disease
32465,Plasma 5-Methylthioadenosine (Mta) Levels In Chronic Kidney Disease,Phenotype,Plasma 5-Methylthioadenosine (Mta) Levels In Chronic Kidney Disease
32467,Plasma Acisoga Levels In Chronic Kidney Disease,Phenotype,Plasma Acisoga Levels In Chronic Kidney Disease
32468,Urine Glutamine Conjugate Of C10H16O2 (2)* Levels In Chronic Kidney Disease,Phenotype,Urine Glutamine Conjugate Of C10H16O2 (2)* Levels In Chronic Kidney Disease
32469,Urine Glutamine Conjugate Of C8H12O2 (3)* Levels In Chronic Kidney Disease,Phenotype,Urine Glutamine Conjugate Of C8H12O2 (3)* Levels In Chronic Kidney Disease
32471,Urine Glutamine Conjugate Of C8H12O4 (1)* Levels In Chronic Kidney Disease,Phenotype,Urine Glutamine Conjugate Of C8H12O4 (1)* Levels In Chronic Kidney Disease
32472,Urine Glutamine Conjugate Of C9H16O2 (1)* Levels In Chronic Kidney Disease,Phenotype,Urine Glutamine Conjugate Of C9H16O2 (1)* Levels In Chronic Kidney Disease
32473,Plasma Glutarylcarnitine (C5-Dc) Levels In Chronic Kidney Disease,Phenotype,Plasma Glutarylcarnitine (C5-Dc) Levels In Chronic Kidney Disease
32474,Urine Glutarylcarnitine (C5-Dc) Levels In Chronic Kidney Disease,Phenotype,Urine Glutarylcarnitine (C5-Dc) Levels In Chronic Kidney Disease
32475,Urine Alpha-Cehc Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine Alpha-Cehc Sulfate Levels In Chronic Kidney Disease
32476,Plasma Arachidonoylcarnitine (C20:4) Levels In Chronic Kidney Disease,Phenotype,Plasma Arachidonoylcarnitine (C20:4) Levels In Chronic Kidney Disease
32477,Plasma Argininate* Levels In Chronic Kidney Disease,Phenotype,Plasma Argininate* Levels In Chronic Kidney Disease
32478,Urine Argininate* Levels In Chronic Kidney Disease,Phenotype,Urine Argininate* Levels In Chronic Kidney Disease
32479,Urine Acisoga Levels In Chronic Kidney Disease,Phenotype,Urine Acisoga Levels In Chronic Kidney Disease
32480,Urine Adenosine 3'--5'-Cyclic Monophosphate (Camp) Levels In Chronic Kidney Disease,Phenotype,Urine Adenosine 3'--5'-Cyclic Monophosphate (Camp) Levels In Chronic Kidney Disease
32482,Urine Adenosine Levels In Chronic Kidney Disease,Phenotype,Urine Adenosine Levels In Chronic Kidney Disease
32483,Plasma Adipoylcarnitine (C6-Dc) Levels In Chronic Kidney Disease,Phenotype,Plasma Adipoylcarnitine (C6-Dc) Levels In Chronic Kidney Disease
32484,Urine Adipoylcarnitine (C6-Dc) Levels In Chronic Kidney Disease,Phenotype,Urine Adipoylcarnitine (C6-Dc) Levels In Chronic Kidney Disease
32558,Vaginal Microbiome Metacyc Pathway (Pwy-5121|Superpathway Of Geranylgeranyl Diphosphate Biosynthesis Ii (Via Mep)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5121|Superpathway Of Geranylgeranyl Diphosphate Biosynthesis Ii (Via Mep))
32560,Vaginal Microbiome Metacyc Pathway (Pwy-5177|Glutaryl-Coa Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5177|Glutaryl-Coa Degradation)
32563,Vaginal Microbiome Metacyc Pathway (Pwy-5182|Toluene Degradation Ii (Aerobic) (Via 4-Methylcatechol)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5182|Toluene Degradation Ii (Aerobic) (Via 4-Methylcatechol))
32567,Vaginal Microbiome Metacyc Pathway (Pwy-5180|Toluene Degradation I (Aerobic) (Via O-Cresol)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5180|Toluene Degradation I (Aerobic) (Via O-Cresol))
32580,Urine 3-Formylindole Levels In Chronic Kidney Disease,Phenotype,Urine 3-Formylindole Levels In Chronic Kidney Disease
32582,Urine 3-Hydroxycinnamate Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine 3-Hydroxycinnamate Sulfate Levels In Chronic Kidney Disease
32583,Plasma 3-Hydroxydecanoylcarnitine Levels In Chronic Kidney Disease,Phenotype,Plasma 3-Hydroxydecanoylcarnitine Levels In Chronic Kidney Disease
32585,Urine 3-Hydroxydodecanedioate* Levels In Chronic Kidney Disease,Phenotype,Urine 3-Hydroxydodecanedioate* Levels In Chronic Kidney Disease
32587,Plasma 3-Hydroxyhexanoate Levels In Chronic Kidney Disease,Phenotype,Plasma 3-Hydroxyhexanoate Levels In Chronic Kidney Disease
32589,Urine 3-Hydroxyindolin-2-One Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine 3-Hydroxyindolin-2-One Sulfate Levels In Chronic Kidney Disease
32591,Plasma 3-Hydroxyoctanoylcarnitine (1) Levels In Chronic Kidney Disease,Phenotype,Plasma 3-Hydroxyoctanoylcarnitine (1) Levels In Chronic Kidney Disease
32592,Plasma 3-Hydroxyoctanoylcarnitine (2) Levels In Chronic Kidney Disease,Phenotype,Plasma 3-Hydroxyoctanoylcarnitine (2) Levels In Chronic Kidney Disease
32593,Urine 3-Hydroxysebacate Levels In Chronic Kidney Disease,Phenotype,Urine 3-Hydroxysebacate Levels In Chronic Kidney Disease
32595,Urine 21-Hydroxypregnenolone Disulfate Levels In Chronic Kidney Disease,Phenotype,Urine 21-Hydroxypregnenolone Disulfate Levels In Chronic Kidney Disease
32596,Urine 3-(3-Hydroxyphenyl)Propionate Levels In Chronic Kidney Disease,Phenotype,Urine 3-(3-Hydroxyphenyl)Propionate Levels In Chronic Kidney Disease
32597,Plasma 3-Decenoylcarnitine Levels In Chronic Kidney Disease,Phenotype,Plasma 3-Decenoylcarnitine Levels In Chronic Kidney Disease
32599,Urine 4-Hydroxycinnamate Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine 4-Hydroxycinnamate Sulfate Levels In Chronic Kidney Disease
32600,Urine 4-Hydroxyphenylacetylglutamine Levels In Chronic Kidney Disease,Phenotype,Urine 4-Hydroxyphenylacetylglutamine Levels In Chronic Kidney Disease
32602,Urine 4-Hydroxyphenylpyruvate Levels In Chronic Kidney Disease,Phenotype,Urine 4-Hydroxyphenylpyruvate Levels In Chronic Kidney Disease
32603,Urine 4-Methylhexanoylglutamine Levels In Chronic Kidney Disease,Phenotype,Urine 4-Methylhexanoylglutamine Levels In Chronic Kidney Disease
32605,Urine 5-Hydroxyindole Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine 5-Hydroxyindole Sulfate Levels In Chronic Kidney Disease
32658,Vaginal Microbiome Metacyc Pathway (P124-Pwy|Bifidobacterium Shunt),Phenotype,Vaginal Microbiome Metacyc Pathway (P124-Pwy|Bifidobacterium Shunt)
32660,Vaginal Microbiome Metacyc Pathway (Nad-Biosynthesis-Ii|Nad Salvage Pathway Ii),Phenotype,Vaginal Microbiome Metacyc Pathway (Nad-Biosynthesis-Ii|Nad Salvage Pathway Ii)
32663,Vaginal Microbiome Metacyc Pathway (Meth-Acetate-Pwy|Methanogenesis From Acetate),Phenotype,Vaginal Microbiome Metacyc Pathway (Meth-Acetate-Pwy|Methanogenesis From Acetate)
32668,Vaginal Microbiome Metacyc Pathway (P125-Pwy|Superpathway Of (R--R)-Butanediol Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (P125-Pwy|Superpathway Of (R--R)-Butanediol Biosynthesis)
32684,Urine 2-Hydroxysebacate Levels In Chronic Kidney Disease,Phenotype,Urine 2-Hydroxysebacate Levels In Chronic Kidney Disease
32685,Plasma 2--3-Dihydroxy-5-Methylthio-4-Pentenoate (Dmtpa)* Levels In Chronic Kidney Disease,Phenotype,Plasma 2--3-Dihydroxy-5-Methylthio-4-Pentenoate (Dmtpa)* Levels In Chronic Kidney Disease
32687,Plasma Phenylacetylglutamate Levels In Chronic Kidney Disease,Phenotype,Plasma Phenylacetylglutamate Levels In Chronic Kidney Disease
32689,Urine Phenylacetylglutamate Levels In Chronic Kidney Disease,Phenotype,Urine Phenylacetylglutamate Levels In Chronic Kidney Disease
32690,Plasma Phenyllactate (Pla) Levels In Chronic Kidney Disease,Phenotype,Plasma Phenyllactate (Pla) Levels In Chronic Kidney Disease
32692,Urine Phenyllactate (Pla) Levels In Chronic Kidney Disease,Phenotype,Urine Phenyllactate (Pla) Levels In Chronic Kidney Disease
32693,Plasma Picolinate Levels In Chronic Kidney Disease,Phenotype,Plasma Picolinate Levels In Chronic Kidney Disease
32695,Plasma 1--2-Dipalmitoyl-Gpc (16:0/16:0) Levels In Chronic Kidney Disease,Phenotype,Plasma 1--2-Dipalmitoyl-Gpc (16:0/16:0) Levels In Chronic Kidney Disease
32696,Urine Pterin Levels In Chronic Kidney Disease,Phenotype,Urine Pterin Levels In Chronic Kidney Disease
32697,Urine Pyridoxal Levels In Chronic Kidney Disease,Phenotype,Urine Pyridoxal Levels In Chronic Kidney Disease
32698,Plasma S-Adenosylhomocysteine (Sah) Levels In Chronic Kidney Disease,Phenotype,Plasma S-Adenosylhomocysteine (Sah) Levels In Chronic Kidney Disease
32700,Urine S-Adenosylhomocysteine (Sah) Levels In Chronic Kidney Disease,Phenotype,Urine S-Adenosylhomocysteine (Sah) Levels In Chronic Kidney Disease
32702,Urine Sebacate (C10-Dc) Levels In Chronic Kidney Disease,Phenotype,Urine Sebacate (C10-Dc) Levels In Chronic Kidney Disease
32704,Urine Picolinate Levels In Chronic Kidney Disease,Phenotype,Urine Picolinate Levels In Chronic Kidney Disease
32706,Plasma Picolinoylglycine Levels In Chronic Kidney Disease,Phenotype,Plasma Picolinoylglycine Levels In Chronic Kidney Disease
32707,Plasma Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc) Levels In Chronic Kidney Disease,Phenotype,Plasma Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc) Levels In Chronic Kidney Disease
32708,Urine Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc) Levels In Chronic Kidney Disease,Phenotype,Urine Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc) Levels In Chronic Kidney Disease
32709,Urine Pregnenediol Disulfate (C21H34O8S2)* Levels In Chronic Kidney Disease,Phenotype,Urine Pregnenediol Disulfate (C21H34O8S2)* Levels In Chronic Kidney Disease
32710,Urine Prolylglycine Levels In Chronic Kidney Disease,Phenotype,Urine Prolylglycine Levels In Chronic Kidney Disease
32712,Plasma Propionylcarnitine (C3) Levels In Chronic Kidney Disease,Phenotype,Plasma Propionylcarnitine (C3) Levels In Chronic Kidney Disease
32713,Plasma Stearoylcarnitine (C18) Levels In Chronic Kidney Disease,Phenotype,Plasma Stearoylcarnitine (C18) Levels In Chronic Kidney Disease
32714,Urine Suberate (C8-Dc) Levels In Chronic Kidney Disease,Phenotype,Urine Suberate (C8-Dc) Levels In Chronic Kidney Disease
32716,Plasma Suberoylcarnitine (C8-Dc) Levels In Chronic Kidney Disease,Phenotype,Plasma Suberoylcarnitine (C8-Dc) Levels In Chronic Kidney Disease
32728,Fasting Plasma Glucose In Prediabetes,Phenotype,Fasting Plasma Glucose In Prediabetes
32730,Body Mass Index In Prediabetes,Phenotype,Body Mass Index In Prediabetes
32762,Vaginal Microbiome Metacyc Pathway (Pwy-1861|Formaldehyde Assimilation Ii (Rump Cycle)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-1861|Formaldehyde Assimilation Ii (Rump Cycle))
32764,Vaginal Microbiome Metacyc Pathway (Pwy-4984|Urea Cycle),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-4984|Urea Cycle)
32766,Vaginal Microbiome Metacyc Pathway (Protocatechuate-Ortho-Cleavage-Pwy|Protocatechuate Degradation Ii (Ortho-Cleavage Pathway)),Phenotype,Vaginal Microbiome Metacyc Pathway (Protocatechuate-Ortho-Cleavage-Pwy|Protocatechuate Degradation Ii (Ortho-Cleavage Pathway))
32768,Vaginal Microbiome Metacyc Pathway (Pwy-1622|Formaldehyde Assimilation I (Serine Pathway)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-1622|Formaldehyde Assimilation I (Serine Pathway))
32795,Breast Cancer Or Lung Cancer (Pleiotropy),Phenotype,Breast Cancer Or Lung Cancer (Pleiotropy)
32800,Lung Cancer Or Head/Neck Cancer (Pleiotropy),Phenotype,Lung Cancer Or Head/Neck Cancer (Pleiotropy)
32802,Breast Cancer Or Ovarian Cancer (Pleiotropy),Phenotype,Breast Cancer Or Ovarian Cancer (Pleiotropy)
32805,Retinal Arteriolar Tortuosity,Phenotype,Retinal Arteriolar Tortuosity
32812,Urine Nicotinamide Riboside Levels In Chronic Kidney Disease,Phenotype,Urine Nicotinamide Riboside Levels In Chronic Kidney Disease
32813,Plasma Oleoylcarnitine (C18:1) Levels In Chronic Kidney Disease,Phenotype,Plasma Oleoylcarnitine (C18:1) Levels In Chronic Kidney Disease
32814,Plasma Palmitoylcarnitine (C16) Levels In Chronic Kidney Disease,Phenotype,Plasma Palmitoylcarnitine (C16) Levels In Chronic Kidney Disease
32815,Plasma X-11381 Levels In Chronic Kidney Disease,Phenotype,Plasma X-11381 Levels In Chronic Kidney Disease
32816,Plasma X-11470 Levels In Chronic Kidney Disease,Phenotype,Plasma X-11470 Levels In Chronic Kidney Disease
32818,Urine X-11470 Levels In Chronic Kidney Disease,Phenotype,Urine X-11470 Levels In Chronic Kidney Disease
32819,Plasma X-11478 Levels In Chronic Kidney Disease,Phenotype,Plasma X-11478 Levels In Chronic Kidney Disease
32820,Urine X-12097 Levels In Chronic Kidney Disease,Phenotype,Urine X-12097 Levels In Chronic Kidney Disease
32822,Plasma X-12100 Levels In Chronic Kidney Disease,Phenotype,Plasma X-12100 Levels In Chronic Kidney Disease
32824,Urine X-12100 Levels In Chronic Kidney Disease,Phenotype,Urine X-12100 Levels In Chronic Kidney Disease
32826,Urine X-12124 Levels In Chronic Kidney Disease,Phenotype,Urine X-12124 Levels In Chronic Kidney Disease
32828,Plasma X-12689 Levels In Chronic Kidney Disease,Phenotype,Plasma X-12689 Levels In Chronic Kidney Disease
32830,Urine X-12704 Levels In Chronic Kidney Disease,Phenotype,Urine X-12704 Levels In Chronic Kidney Disease
32831,Urine X-12707 Levels In Chronic Kidney Disease,Phenotype,Urine X-12707 Levels In Chronic Kidney Disease
32852,Central Serous Chorioretinopathy,Phenotype,Central Serous Chorioretinopathy
32863,Vaginal Microbiome Metacyc Pathway (Fasyn-Initial-Pwy|Superpathway Of Fatty Acid Biosynthesis Initiation (E. Coli)),Phenotype,Vaginal Microbiome Metacyc Pathway (Fasyn-Initial-Pwy|Superpathway Of Fatty Acid Biosynthesis Initiation (E. Coli))
32866,Vaginal Microbiome Metacyc Pathway (Fuc-Rhamcat-Pwy|Superpathway Of Fucose And Rhamnose Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Fuc-Rhamcat-Pwy|Superpathway Of Fucose And Rhamnose Degradation)
32868,Vaginal Microbiome Metacyc Pathway (Centferm-Pwy|Pyruvate Fermentation To Butanoate),Phenotype,Vaginal Microbiome Metacyc Pathway (Centferm-Pwy|Pyruvate Fermentation To Butanoate)
32873,Vaginal Microbiome Metacyc Pathway (Entbacsyn-Pwy|Enterobactin Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Entbacsyn-Pwy|Enterobactin Biosynthesis)
32876,Vaginal Microbiome Metacyc Pathway (Fuccat-Pwy|Fucose Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Fuccat-Pwy|Fucose Degradation)
32881,Vaginal Microbiome Metacyc Pathway (Fao-Pwy|Fatty Acid Beta;-Oxidation I),Phenotype,Vaginal Microbiome Metacyc Pathway (Fao-Pwy|Fatty Acid Beta;-Oxidation I)
32902,Plasma 1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0)* Levels In Chronic Kidney Disease,Phenotype,Plasma 1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0)* Levels In Chronic Kidney Disease
32903,Plasma 1-Methylnicotinamide Levels In Chronic Kidney Disease,Phenotype,Plasma 1-Methylnicotinamide Levels In Chronic Kidney Disease
32904,Age At Menarche,Phenotype,Age At Menarche
32905,Urine Diacetylspermidine* Levels In Chronic Kidney Disease,Phenotype,Urine Diacetylspermidine* Levels In Chronic Kidney Disease
32906,Plasma Dihomo-Linolenoylcarnitine (C20:3N3 Or 6)* Levels In Chronic Kidney Disease,Phenotype,Plasma Dihomo-Linolenoylcarnitine (C20:3N3 Or 6)* Levels In Chronic Kidney Disease
32907,Plasma Dihomo-Linoleoylcarnitine (C20:2)* Levels In Chronic Kidney Disease,Phenotype,Plasma Dihomo-Linoleoylcarnitine (C20:2)* Levels In Chronic Kidney Disease
32908,Urine Dihydroferulic Acid Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine Dihydroferulic Acid Sulfate Levels In Chronic Kidney Disease
32909,Urine Isoxanthopterin Levels In Chronic Kidney Disease,Phenotype,Urine Isoxanthopterin Levels In Chronic Kidney Disease
32910,Plasma Kynurenine Levels In Chronic Kidney Disease,Phenotype,Plasma Kynurenine Levels In Chronic Kidney Disease
32911,Urine Kynurenine Levels In Chronic Kidney Disease,Phenotype,Urine Kynurenine Levels In Chronic Kidney Disease
32913,Plasma Levulinoylcarnitine Levels In Chronic Kidney Disease,Phenotype,Plasma Levulinoylcarnitine Levels In Chronic Kidney Disease
32914,Plasma Linolenoylcarnitine (C18:3)* Levels In Chronic Kidney Disease,Phenotype,Plasma Linolenoylcarnitine (C18:3)* Levels In Chronic Kidney Disease
32915,Plasma Linoleoylcarnitine (C18:2)* Levels In Chronic Kidney Disease,Phenotype,Plasma Linoleoylcarnitine (C18:2)* Levels In Chronic Kidney Disease
32916,Plasma Lysine Levels In Chronic Kidney Disease,Phenotype,Plasma Lysine Levels In Chronic Kidney Disease
32917,Urine Cyclo(Leu-Asp)* Levels In Chronic Kidney Disease,Phenotype,Urine Cyclo(Leu-Asp)* Levels In Chronic Kidney Disease
32918,Plasma Cys-Gly-- Oxidized Levels In Chronic Kidney Disease,Phenotype,Plasma Cys-Gly-- Oxidized Levels In Chronic Kidney Disease
32920,Plasma Cysteinylglycine Disulfide* Levels In Chronic Kidney Disease,Phenotype,Plasma Cysteinylglycine Disulfide* Levels In Chronic Kidney Disease
32922,Urine Cysteinylglycine Disulfide* Levels In Chronic Kidney Disease,Phenotype,Urine Cysteinylglycine Disulfide* Levels In Chronic Kidney Disease
32923,Plasma Cysteinylglycine Levels In Chronic Kidney Disease,Phenotype,Plasma Cysteinylglycine Levels In Chronic Kidney Disease
32924,Urine Cysteinylglycine Levels In Chronic Kidney Disease,Phenotype,Urine Cysteinylglycine Levels In Chronic Kidney Disease
32925,Urine Glucuronide Of C10H18O2 (10)* Levels In Chronic Kidney Disease,Phenotype,Urine Glucuronide Of C10H18O2 (10)* Levels In Chronic Kidney Disease
32927,Plasma Imidazole Lactate Levels In Chronic Kidney Disease,Phenotype,Plasma Imidazole Lactate Levels In Chronic Kidney Disease
32929,Urine Imidazole Lactate Levels In Chronic Kidney Disease,Phenotype,Urine Imidazole Lactate Levels In Chronic Kidney Disease
32930,Plasma Indoleacetoylcarnitine* Levels In Chronic Kidney Disease,Phenotype,Plasma Indoleacetoylcarnitine* Levels In Chronic Kidney Disease
32931,Urine Indoleacetoylcarnitine* Levels In Chronic Kidney Disease,Phenotype,Urine Indoleacetoylcarnitine* Levels In Chronic Kidney Disease
32932,Plasma Indoleacetylglutamine Levels In Chronic Kidney Disease,Phenotype,Plasma Indoleacetylglutamine Levels In Chronic Kidney Disease
32933,Urine Indoleacetylglutamine Levels In Chronic Kidney Disease,Phenotype,Urine Indoleacetylglutamine Levels In Chronic Kidney Disease
32934,Urine Indoleacetylglycine Levels In Chronic Kidney Disease,Phenotype,Urine Indoleacetylglycine Levels In Chronic Kidney Disease
32935,Urine Indolelactate Levels In Chronic Kidney Disease,Phenotype,Urine Indolelactate Levels In Chronic Kidney Disease
32936,Plasma Indolepropionate Levels In Chronic Kidney Disease,Phenotype,Plasma Indolepropionate Levels In Chronic Kidney Disease
32937,Plasma Isobutyrylcarnitine (C4) Levels In Chronic Kidney Disease,Phenotype,Plasma Isobutyrylcarnitine (C4) Levels In Chronic Kidney Disease
32938,Urine Isobutyrylcarnitine (C4) Levels In Chronic Kidney Disease,Phenotype,Urine Isobutyrylcarnitine (C4) Levels In Chronic Kidney Disease
32939,Urine Isocaproylglutamine Levels In Chronic Kidney Disease,Phenotype,Urine Isocaproylglutamine Levels In Chronic Kidney Disease
32940,Plasma 1-Palmitoyl-2-Dihomo-Linolenoyl-Gpc (16:0/20:3N3 Or 6)* Levels In Chronic Kidney Disease,Phenotype,Plasma 1-Palmitoyl-2-Dihomo-Linolenoyl-Gpc (16:0/20:3N3 Or 6)* Levels In Chronic Kidney Disease
32944,Total Bilirubin Levels,Phenotype,Total Bilirubin Levels
32949,Chronic Sputum Production,Phenotype,Chronic Sputum Production
32987,Vaginal Microbiome Metacyc Pathway (Arg+Polyamine-Syn|Superpathway Of Arginine And Polyamine Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Arg+Polyamine-Syn|Superpathway Of Arginine And Polyamine Biosynthesis)
32989,Vaginal Microbiome Metacyc Pathway (Catechol-Ortho-Cleavage-Pwy|Catechol Degradation To Beta;-Ketoadipate),Phenotype,Vaginal Microbiome Metacyc Pathway (Catechol-Ortho-Cleavage-Pwy|Catechol Degradation To Beta;-Ketoadipate)
32994,Vaginal Microbiome Metacyc Pathway (All-Chorismate-Pwy|Superpathway Of Chorismate Metabolism),Phenotype,Vaginal Microbiome Metacyc Pathway (All-Chorismate-Pwy|Superpathway Of Chorismate Metabolism)
33002,Triglycerides (54:7)B Levels,Phenotype,Triglycerides (54:7)B Levels
33006,Phosphatidylcholines (42:5) Levels,Phenotype,Phosphatidylcholines (42:5) Levels
33012,Fornix Volume,Phenotype,Fornix Volume
33014,Brain Age (Difference Between Predicted And Chronological Age),Phenotype,Brain Age (Difference Between Predicted And Chronological Age)
33015,Plasma Methylsuccinoylcarnitine Levels In Chronic Kidney Disease,Phenotype,Plasma Methylsuccinoylcarnitine Levels In Chronic Kidney Disease
33017,Urine Methylsuccinoylcarnitine Levels In Chronic Kidney Disease,Phenotype,Urine Methylsuccinoylcarnitine Levels In Chronic Kidney Disease
33018,Urine Myo-Inositol Levels In Chronic Kidney Disease,Phenotype,Urine Myo-Inositol Levels In Chronic Kidney Disease
33019,Urine N-Lactoyl Leucine Levels In Chronic Kidney Disease,Phenotype,Urine N-Lactoyl Leucine Levels In Chronic Kidney Disease
33021,Urine N-Lactoyl Phenylalanine Levels In Chronic Kidney Disease,Phenotype,Urine N-Lactoyl Phenylalanine Levels In Chronic Kidney Disease
33022,Urine N-Lactoyl Tyrosine Levels In Chronic Kidney Disease,Phenotype,Urine N-Lactoyl Tyrosine Levels In Chronic Kidney Disease
33024,Urine N-Lactoyl Valine Levels In Chronic Kidney Disease,Phenotype,Urine N-Lactoyl Valine Levels In Chronic Kidney Disease
33025,Urine N-Octanoylglutamine Levels In Chronic Kidney Disease,Phenotype,Urine N-Octanoylglutamine Levels In Chronic Kidney Disease
33026,Urine Suberoylcarnitine (C8-Dc) Levels In Chronic Kidney Disease,Phenotype,Urine Suberoylcarnitine (C8-Dc) Levels In Chronic Kidney Disease
33027,Plasma Maltol Sulfate Levels In Chronic Kidney Disease,Phenotype,Plasma Maltol Sulfate Levels In Chronic Kidney Disease
33028,Urine Maltol Sulfate Levels In Chronic Kidney Disease,Phenotype,Urine Maltol Sulfate Levels In Chronic Kidney Disease
33029,Plasma N-Acetyl-Isoputreanine Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetyl-Isoputreanine Levels In Chronic Kidney Disease
33030,Urine N-Acetyl-Met-Phe Levels In Chronic Kidney Disease,Phenotype,Urine N-Acetyl-Met-Phe Levels In Chronic Kidney Disease
33031,Plasma N-Acetylcarnosine Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetylcarnosine Levels In Chronic Kidney Disease
33033,Urine N-Acetylcarnosine Levels In Chronic Kidney Disease,Phenotype,Urine N-Acetylcarnosine Levels In Chronic Kidney Disease
33034,Plasma N-Acetylphenylalanine Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetylphenylalanine Levels In Chronic Kidney Disease
33035,Plasma N-Acetyltryptophan Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetyltryptophan Levels In Chronic Kidney Disease
33037,Plasma N-Acetylglucosamine/N-Acetylgalactosamine Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetylglucosamine/N-Acetylgalactosamine Levels In Chronic Kidney Disease
33039,Urine N-Acetylglucosamine/N-Acetylgalactosamine Levels In Chronic Kidney Disease,Phenotype,Urine N-Acetylglucosamine/N-Acetylgalactosamine Levels In Chronic Kidney Disease
33040,Plasma N-Acetylglucosaminylasparagine Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetylglucosaminylasparagine Levels In Chronic Kidney Disease
33041,Urine N-Acetylglucosaminylasparagine Levels In Chronic Kidney Disease,Phenotype,Urine N-Acetylglucosaminylasparagine Levels In Chronic Kidney Disease
33042,Plasma N-Acetylkynurenine (2) Levels In Chronic Kidney Disease,Phenotype,Plasma N-Acetylkynurenine (2) Levels In Chronic Kidney Disease
33071,Phosphatidylcholines (38:2) Levels,Phenotype,Phosphatidylcholines (38:2) Levels
33083,Urine X-21829 Levels In Chronic Kidney Disease,Phenotype,Urine X-21829 Levels In Chronic Kidney Disease
33084,Urine X-21841 Levels In Chronic Kidney Disease,Phenotype,Urine X-21841 Levels In Chronic Kidney Disease
33085,Urine X-23518 Levels In Chronic Kidney Disease,Phenotype,Urine X-23518 Levels In Chronic Kidney Disease
33086,Plasma X-24422 Levels In Chronic Kidney Disease,Phenotype,Plasma X-24422 Levels In Chronic Kidney Disease
33087,Urine X-24470 Levels In Chronic Kidney Disease,Phenotype,Urine X-24470 Levels In Chronic Kidney Disease
33091,Urine X-17328 Levels In Chronic Kidney Disease,Phenotype,Urine X-17328 Levels In Chronic Kidney Disease
33092,Urine X-17674 Levels In Chronic Kidney Disease,Phenotype,Urine X-17674 Levels In Chronic Kidney Disease
33093,Urine X-18888 Levels In Chronic Kidney Disease,Phenotype,Urine X-18888 Levels In Chronic Kidney Disease
33094,Urine X-13837 Levels In Chronic Kidney Disease,Phenotype,Urine X-13837 Levels In Chronic Kidney Disease
33095,Plasma X-13846 Levels In Chronic Kidney Disease,Phenotype,Plasma X-13846 Levels In Chronic Kidney Disease
33096,Urine X-13846 Levels In Chronic Kidney Disease,Phenotype,Urine X-13846 Levels In Chronic Kidney Disease
33097,Plasma X-13866 Levels In Chronic Kidney Disease,Phenotype,Plasma X-13866 Levels In Chronic Kidney Disease
33099,Urine X-13866 Levels In Chronic Kidney Disease,Phenotype,Urine X-13866 Levels In Chronic Kidney Disease
33100,Urine X-13874 Levels In Chronic Kidney Disease,Phenotype,Urine X-13874 Levels In Chronic Kidney Disease
33101,Urine X-15806 Levels In Chronic Kidney Disease,Phenotype,Urine X-15806 Levels In Chronic Kidney Disease
33102,Plasma X-17304 Levels In Chronic Kidney Disease,Phenotype,Plasma X-17304 Levels In Chronic Kidney Disease
33103,Plasma X-17323 Levels In Chronic Kidney Disease,Phenotype,Plasma X-17323 Levels In Chronic Kidney Disease
33104,Urine X-17323 Levels In Chronic Kidney Disease,Phenotype,Urine X-17323 Levels In Chronic Kidney Disease
33105,Plasma X-19141 Levels In Chronic Kidney Disease,Phenotype,Plasma X-19141 Levels In Chronic Kidney Disease
33106,Urine X-24515 Levels In Chronic Kidney Disease,Phenotype,Urine X-24515 Levels In Chronic Kidney Disease
33107,Plasma X-24556 Levels In Chronic Kidney Disease,Phenotype,Plasma X-24556 Levels In Chronic Kidney Disease
33108,Urine X-12714 Levels In Chronic Kidney Disease,Phenotype,Urine X-12714 Levels In Chronic Kidney Disease
33109,Plasma X-12798 Levels In Chronic Kidney Disease,Phenotype,Plasma X-12798 Levels In Chronic Kidney Disease
33111,Plasma X-12822 Levels In Chronic Kidney Disease,Phenotype,Plasma X-12822 Levels In Chronic Kidney Disease
33112,Urine X-12822 Levels In Chronic Kidney Disease,Phenotype,Urine X-12822 Levels In Chronic Kidney Disease
33114,Urine X-12839 Levels In Chronic Kidney Disease,Phenotype,Urine X-12839 Levels In Chronic Kidney Disease
33115,Plasma X-13684 Levels In Chronic Kidney Disease,Phenotype,Plasma X-13684 Levels In Chronic Kidney Disease
33117,Urine X-13684 Levels In Chronic Kidney Disease,Phenotype,Urine X-13684 Levels In Chronic Kidney Disease
33118,Urine X-23787 Levels In Chronic Kidney Disease,Phenotype,Urine X-23787 Levels In Chronic Kidney Disease
33120,Plasma X-23983 Levels In Chronic Kidney Disease,Phenotype,Plasma X-23983 Levels In Chronic Kidney Disease
33122,Urine X-24339 Levels In Chronic Kidney Disease,Phenotype,Urine X-24339 Levels In Chronic Kidney Disease
33125,Urine X-24345 Levels In Chronic Kidney Disease,Phenotype,Urine X-24345 Levels In Chronic Kidney Disease
33131,Cardiovascular Delta Age (Difference Between Ecg-Predicted And Chronological Age),Phenotype,Cardiovascular Delta Age (Difference Between Ecg-Predicted And Chronological Age)
33140,Blood Urea Nitrogen Levels,Phenotype,Blood Urea Nitrogen Levels
33167,Vaginal Microbiome Metacyc Pathway (Glucose1Pmetab-Pwy|Glucose And Glucose-1-Phosphate Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Glucose1Pmetab-Pwy|Glucose And Glucose-1-Phosphate Degradation)
33169,Vaginal Microbiome Metacyc Pathway (Glucurocat-Pwy|Superpathway Of Beta;-D-Glucuronide And D-Glucuronate Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Glucurocat-Pwy|Superpathway Of Beta;-D-Glucuronide And D-Glucuronate Degradation)
33171,Vaginal Microbiome Metacyc Pathway (Hisdeg-Pwy|L-Histidine Degradation I),Phenotype,Vaginal Microbiome Metacyc Pathway (Hisdeg-Pwy|L-Histidine Degradation I)
33175,Vaginal Microbiome Metacyc Pathway (Galact-Glucurocat-Pwy|Superpathway Of Hexuronide And Hexuronate Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Galact-Glucurocat-Pwy|Superpathway Of Hexuronide And Hexuronate Degradation)
33176,Vaginal Microbiome Metacyc Pathway (Kdo-Naglipasyn-Pwy|Superpathway Of (Kdo)2-Lipid A Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Kdo-Naglipasyn-Pwy|Superpathway Of (Kdo)2-Lipid A Biosynthesis)
33180,Vaginal Microbiome Metacyc Pathway (Pwy-5265|Peptidoglycan Biosynthesis Ii (Staphylococci)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5265|Peptidoglycan Biosynthesis Ii (Staphylococci))
33183,Ascending Thoracic Aortic Diameter,Phenotype,Ascending Thoracic Aortic Diameter
33188,Rheumatoid Arthritis Or Multiple Sclerosis,Phenotype,Rheumatoid Arthritis Or Multiple Sclerosis
33191,Rheumatoid Arthritis Or Irritable Bowel Disease,Phenotype,Rheumatoid Arthritis Or Irritable Bowel Disease
33205,Rheumatoid Arthritis Or Type 1 Diabetes,Phenotype,Rheumatoid Arthritis Or Type 1 Diabetes
33222,Orange Juice Liking,Phenotype,Orange Juice Liking
33224,Oranges Liking,Phenotype,Oranges Liking
33225,Plum Liking,Phenotype,Plum Liking
33229,F-Meat Liking (Derived Food-Liking Factor),Phenotype,F-Meat Liking (Derived Food-Liking Factor)
33230,Milky Sweets Liking,Phenotype,Milky Sweets Liking
33232,F-Oily Fish Liking (Derived Food-Liking Factor),Phenotype,F-Oily Fish Liking (Derived Food-Liking Factor)
33234,Liver Liking,Phenotype,Liver Liking
33235,Salad Dressing Liking,Phenotype,Salad Dressing Liking
33237,Salami Liking,Phenotype,Salami Liking
33238,Mackerel Liking,Phenotype,Mackerel Liking
33240,Porridge Liking,Phenotype,Porridge Liking
33241,Raw Carrot Liking,Phenotype,Raw Carrot Liking
33242,Red Meat Liking,Phenotype,Red Meat Liking
33243,F-Acquired Taste Liking (Derived Food-Liking Factor),Phenotype,F-Acquired Taste Liking (Derived Food-Liking Factor)
33245,F-Fatty Food Liking (Derived Food-Liking Factor),Phenotype,F-Fatty Food Liking (Derived Food-Liking Factor)
33246,F-Fish Liking (Derived Food-Liking Factor),Phenotype,F-Fish Liking (Derived Food-Liking Factor)
33247,F-Chocolate/Coffee Liking (Derived Food-Liking Factor),Phenotype,F-Chocolate/Coffee Liking (Derived Food-Liking Factor)
33249,F-Coffee/Alcohol Liking (Derived Food-Liking Factor),Phenotype,F-Coffee/Alcohol Liking (Derived Food-Liking Factor)
33250,F-Cooking Vegetables Liking (Derived Food-Liking Factor),Phenotype,F-Cooking Vegetables Liking (Derived Food-Liking Factor)
33252,Coriander Liking,Phenotype,Coriander Liking
33254,Crisps Liking,Phenotype,Crisps Liking
33256,Coffee Difference Liking,Phenotype,Coffee Difference Liking
33258,Coffee Max Liking,Phenotype,Coffee Max Liking
33259,F-Cooking Flavour Liking (Derived Food-Liking Factor),Phenotype,F-Cooking Flavour Liking (Derived Food-Liking Factor)
33261,Croissant Liking,Phenotype,Croissant Liking
33263,Curry Liking,Phenotype,Curry Liking
33264,F-Deep Fried Food Liking (Derived Food-Liking Factor),Phenotype,F-Deep Fried Food Liking (Derived Food-Liking Factor)
33267,Fruit Liking,Phenotype,Fruit Liking
33269,Dried Fruit Liking,Phenotype,Dried Fruit Liking
33270,F-Fatty/Salty Food Liking (Derived Food-Liking Factor),Phenotype,F-Fatty/Salty Food Liking (Derived Food-Liking Factor)
33271,Capers Liking,Phenotype,Capers Liking
33273,F-Capsicum Liking (Derived Food-Liking Factor),Phenotype,F-Capsicum Liking (Derived Food-Liking Factor)
33275,F-Cheese Liking (Derived Food-Liking Factor),Phenotype,F-Cheese Liking (Derived Food-Liking Factor)
33351,F-Fruit Liking (Derived Food-Liking Factor),Phenotype,F-Fruit Liking (Derived Food-Liking Factor)
33352,Fruit Juice Liking,Phenotype,Fruit Juice Liking
33353,Globe Artichoke Liking,Phenotype,Globe Artichoke Liking
33354,Serum Uromodulin Concentration,Phenotype,Serum Uromodulin Concentration
33428,Small Intestine Neuroendocrine Tumor,Phenotype,Small Intestine Neuroendocrine Tumor
33479,F-Vegetarian Liking (Derived Food-Liking Factor),Phenotype,F-Vegetarian Liking (Derived Food-Liking Factor)
33480,White Bread Liking,Phenotype,White Bread Liking
33482,F-Whole Food Liking (Derived Food-Liking Factor),Phenotype,F-Whole Food Liking (Derived Food-Liking Factor)
33484,Whole Grain Cereal Liking,Phenotype,Whole Grain Cereal Liking
33485,F-Strong Vegetable Liking (Derived Food-Liking Factor),Phenotype,F-Strong Vegetable Liking (Derived Food-Liking Factor)
33486,Smoked Fish Liking,Phenotype,Smoked Fish Liking
33487,F-Sodas Liking (Derived Food-Liking Factor),Phenotype,F-Sodas Liking (Derived Food-Liking Factor)
33488,Soft Cheese Liking,Phenotype,Soft Cheese Liking
33490,Soy Sauce Liking,Phenotype,Soy Sauce Liking
33492,Soya Milk Liking,Phenotype,Soya Milk Liking
33494,Spicy Food Liking,Phenotype,Spicy Food Liking
33496,Strawberries Liking,Phenotype,Strawberries Liking
33498,F-Sweet Food Liking (Derived Food-Liking Factor),Phenotype,F-Sweet Food Liking (Derived Food-Liking Factor)
33500,Tea Difference Liking,Phenotype,Tea Difference Liking
33501,Tea With Sugar Liking,Phenotype,Tea With Sugar Liking
33504,F-Strong Flavour Liking (Derived Food-Liking Factor),Phenotype,F-Strong Flavour Liking (Derived Food-Liking Factor)
33507,Alcohol Liking,Phenotype,Alcohol Liking
33509,Aniseed Liking,Phenotype,Aniseed Liking
33512,Apple Juice Liking,Phenotype,Apple Juice Liking
33520,Longitudinal Peak Diastolic Strain Rate,Phenotype,Longitudinal Peak Diastolic Strain Rate
33521,Radial Peak Diastolic Strain Rate,Phenotype,Radial Peak Diastolic Strain Rate
33559,Phosphatidylethanolamine (36:2) Levels,Phenotype,Phosphatidylethanolamine (36:2) Levels
33568,Plasma X-25244 Levels In Chronic Kidney Disease,Phenotype,Plasma X-25244 Levels In Chronic Kidney Disease
33569,Plasma X-25371 Levels In Chronic Kidney Disease,Phenotype,Plasma X-25371 Levels In Chronic Kidney Disease
33571,Plasma Xanthurenate Levels In Chronic Kidney Disease,Phenotype,Plasma Xanthurenate Levels In Chronic Kidney Disease
33572,Plasma Ximenoylcarnitine (C26:1)* Levels In Chronic Kidney Disease,Phenotype,Plasma Ximenoylcarnitine (C26:1)* Levels In Chronic Kidney Disease
33585,Vaginal Microbiome Beta Diversity (Unweighted Unifrac),Phenotype,Vaginal Microbiome Beta Diversity (Unweighted Unifrac)
33587,Vaginal Microbiome Beta Diversity (Bray-Curtis Dissimilarity),Phenotype,Vaginal Microbiome Beta Diversity (Bray-Curtis Dissimilarity)
33589,Vaginal Microbiome Dominance (S_Lactobacillus Iners),Phenotype,Vaginal Microbiome Dominance (S_Lactobacillus Iners)
33591,Vaginal Microbiome Metacyc Pathway (1Cmet2-Pwy|N10-Formyl-Tetrahydrofolate Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (1Cmet2-Pwy|N10-Formyl-Tetrahydrofolate Biosynthesis)
33596,Descending Thoracic Aortic Diameter,Phenotype,Descending Thoracic Aortic Diameter
33604,Malignant Vs Benign Glioma,Phenotype,Malignant Vs Benign Glioma
33631,Haddock Liking,Phenotype,Haddock Liking
33632,F-Healthy Food Liking (Derived Food-Liking Factor),Phenotype,F-Healthy Food Liking (Derived Food-Liking Factor)
33634,F-Healthy Breakfast Food Liking (Derived Food-Liking Factor),Phenotype,F-Healthy Breakfast Food Liking (Derived Food-Liking Factor)
33635,Goat Cheese Liking,Phenotype,Goat Cheese Liking
33642,Herring Liking,Phenotype,Herring Liking
33647,F-Highly Palatable Foods Liking (Derived Food-Liking Factor),Phenotype,F-Highly Palatable Foods Liking (Derived Food-Liking Factor)
33649,Kiwi Liking,Phenotype,Kiwi Liking
33651,Lager Liking,Phenotype,Lager Liking
33653,Horseradish Liking,Phenotype,Horseradish Liking
33655,Honey Liking,Phenotype,Honey Liking
33656,F-Bitter Food Liking (Derived Food-Liking Factor),Phenotype,F-Bitter Food Liking (Derived Food-Liking Factor)
33657,Broad Bean Liking,Phenotype,Broad Bean Liking
33661,Beans Liking,Phenotype,Beans Liking
33663,Beef/Steak Liking,Phenotype,Beef/Steak Liking
33664,Beetroot Liking,Phenotype,Beetroot Liking
33666,F-Caffeinated/Sweet Liking (Derived Food-Liking Factor),Phenotype,F-Caffeinated/Sweet Liking (Derived Food-Liking Factor)
33667,F-Cake/Biscuits Liking (Derived Food-Liking Factor),Phenotype,F-Cake/Biscuits Liking (Derived Food-Liking Factor)
33668,Avocado Liking,Phenotype,Avocado Liking
33671,Baked/Steamed Fish Liking,Phenotype,Baked/Steamed Fish Liking
33672,Butternut Squash Liking,Phenotype,Butternut Squash Liking
33678,Obstructive Heart Defect,Phenotype,Obstructive Heart Defect
33680,Obstructive Heart Defect (Maternal Genotype Effect),Phenotype,Obstructive Heart Defect (Maternal Genotype Effect)
33688,Hormone-Sensitive Cancer,Phenotype,Hormone-Sensitive Cancer
33702,Vaginal Microbiome Metacyc Pathway (Pwy-6507|4-Deoxy-L-Threo-Hex-4-Enopyranuronate Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6507|4-Deoxy-L-Threo-Hex-4-Enopyranuronate Degradation)
33704,Vaginal Microbiome Metacyc Pathway (Pwy-6519|8-Amino-7-Oxononanoate Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6519|8-Amino-7-Oxononanoate Biosynthesis I)
33707,Vaginal Microbiome Metacyc Pathway (Pwy-6383|Mono-Trans-- Poly-Cis Decaprenyl Phosphate Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6383|Mono-Trans-- Poly-Cis Decaprenyl Phosphate Biosynthesis)
33709,Vaginal Microbiome Metacyc Pathway (Pwy-6562|Norspermidine Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6562|Norspermidine Biosynthesis)
33711,Vaginal Microbiome Relative Abundance (F_Mycoplasmataceae),Phenotype,Vaginal Microbiome Relative Abundance (F_Mycoplasmataceae)
33714,Vaginal Microbiome Relative Abundance (O_Bacteroidales),Phenotype,Vaginal Microbiome Relative Abundance (O_Bacteroidales)
33715,Vaginal Microbiome Relative Abundance (G_Dialister),Phenotype,Vaginal Microbiome Relative Abundance (G_Dialister)
33719,Vaginal Microbiome Relative Abundance (G_Megasphaera),Phenotype,Vaginal Microbiome Relative Abundance (G_Megasphaera)
33721,Vaginal Microbiome Relative Abundance (G_Anaerococcus),Phenotype,Vaginal Microbiome Relative Abundance (G_Anaerococcus)
33723,Vaginal Microbiome Relative Abundance (O_Campylobacterales),Phenotype,Vaginal Microbiome Relative Abundance (O_Campylobacterales)
33726,Vaginal Microbiome Relative Abundance (G_Peptoniphilus),Phenotype,Vaginal Microbiome Relative Abundance (G_Peptoniphilus)
33729,Vaginal Microbiome Relative Abundance (G_Prevotella),Phenotype,Vaginal Microbiome Relative Abundance (G_Prevotella)
33730,Vaginal Microbiome Relative Abundance (G_Streptococcus),Phenotype,Vaginal Microbiome Relative Abundance (G_Streptococcus)
33732,Vaginal Microbiome Relative Abundance (P_Proteobacteria),Phenotype,Vaginal Microbiome Relative Abundance (P_Proteobacteria)
33734,Medication Use (Vasodilators Used In Cardiac Diseases),Phenotype,Medication Use (Vasodilators Used In Cardiac Diseases)
33737,Medication Use (Antihypertensives),Phenotype,Medication Use (Antihypertensives)
33739,Medication Use (Antithrombotic Agents),Phenotype,Medication Use (Antithrombotic Agents)
33743,Medication Use (Beta Blocking Agents),Phenotype,Medication Use (Beta Blocking Agents)
33751,Medication Use (Diuretics),Phenotype,Medication Use (Diuretics)
33758,Actinic Keratosis,Phenotype,Actinic Keratosis
33794,Vaginal Microbiome Metacyc Pathway (Pwy-6708|Ubiquinol-8 Biosynthesis (Prokaryotic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6708|Ubiquinol-8 Biosynthesis (Prokaryotic))
33795,Vaginal Microbiome Metacyc Pathway (Pwy-6749|Cmp-Legionaminate Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6749|Cmp-Legionaminate Biosynthesis I)
33798,Vaginal Microbiome Metacyc Pathway (Pwy-6590|Superpathway Of Clostridium Acetobutylicum Acidogenic Fermentation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6590|Superpathway Of Clostridium Acetobutylicum Acidogenic Fermentation)
33799,Vaginal Microbiome Metacyc Pathway (Pwy-6608|Guanosine Nucleotides Degradation Iii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6608|Guanosine Nucleotides Degradation Iii)
33821,Vaginal Microbiome Metacyc Pathway (Pwy-6609|Adenine And Adenosine Salvage Iii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6609|Adenine And Adenosine Salvage Iii)
33822,Vaginal Microbiome Relative Abundance (S_Lactobacillus Crispatus),Phenotype,Vaginal Microbiome Relative Abundance (S_Lactobacillus Crispatus)
33824,Vaginal Microbiome Relative Abundance (S_Lactobacillus Jensenii),Phenotype,Vaginal Microbiome Relative Abundance (S_Lactobacillus Jensenii)
33827,Vaginal Microbiome Relative Abundance (S_Dialister Micraerophilus),Phenotype,Vaginal Microbiome Relative Abundance (S_Dialister Micraerophilus)
33828,Vaginal Microbiome Relative Abundance (S_Dialister Propionicifaciens),Phenotype,Vaginal Microbiome Relative Abundance (S_Dialister Propionicifaciens)
33830,Vaginal Microbiome Relative Abundance (S_Aerococcus Christensenii),Phenotype,Vaginal Microbiome Relative Abundance (S_Aerococcus Christensenii)
33837,Vaginal Microbiome Relative Abundance (S_Lactobacillus Reuteri),Phenotype,Vaginal Microbiome Relative Abundance (S_Lactobacillus Reuteri)
33842,Facial Skin Hydration,Phenotype,Facial Skin Hydration
33845,Facial Wrinkles,Phenotype,Facial Wrinkles
33847,Serum Creatinine Levels,Phenotype,Serum Creatinine Levels
33859,Medication Use (Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease),Phenotype,Medication Use (Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease)
33860,Medication Use (Drugs Used In Diabetes),Phenotype,Medication Use (Drugs Used In Diabetes)
33863,Bmi At 8 Months Old,Phenotype,Bmi At 8 Months Old
33865,Bmi At 1 Year Old,Phenotype,Bmi At 1 Year Old
33871,Bmi At 2 Years Old,Phenotype,Bmi At 2 Years Old
33872,Bmi At 3 Years Old,Phenotype,Bmi At 3 Years Old
33873,Bmi At 7 Years Old,Phenotype,Bmi At 7 Years Old
33874,Bmi At 1.5 Years Old,Phenotype,Bmi At 1.5 Years Old
33875,Bmi At 8 Years Old,Phenotype,Bmi At 8 Years Old
33876,Medication Use (Immunosuppressants),Phenotype,Medication Use (Immunosuppressants)
33879,Medication Use (Anti-Inflammatory And Antirheumatic Products-- Non-Steroids),Phenotype,Medication Use (Anti-Inflammatory And Antirheumatic Products-- Non-Steroids)
33882,Medication Use (Drugs Affecting Bone Structure And Mineralization),Phenotype,Medication Use (Drugs Affecting Bone Structure And Mineralization)
33884,Medication Use (Salicylic Acid And Derivatives),Phenotype,Medication Use (Salicylic Acid And Derivatives)
33887,Medication Use (Anilides),Phenotype,Medication Use (Anilides)
33888,Medication Use (Antimigraine Preparations),Phenotype,Medication Use (Antimigraine Preparations)
33891,Medication Use (Thyroid Preparations),Phenotype,Medication Use (Thyroid Preparations)
33894,Executive Function (Longitudinal),Phenotype,Executive Function (Longitudinal)
33896,Executive Function,Phenotype,Executive Function
33901,Cognitive Performance (Visuoconstruction) (Longitudinal),Phenotype,Cognitive Performance (Visuoconstruction) (Longitudinal)
33905,Cognitive Performance (Visuoconstruction),Phenotype,Cognitive Performance (Visuoconstruction)
33928,Vaginal Microbiome Metacyc Pathway (Pwy-5507|Adenosylcobalamin Biosynthesis I (Early Cobalt Insertion)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5507|Adenosylcobalamin Biosynthesis I (Early Cobalt Insertion))
33930,Vaginal Microbiome Metacyc Pathway (Pwy-5856|Ubiquinol-9 Biosynthesis (Prokaryotic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5856|Ubiquinol-9 Biosynthesis (Prokaryotic))
33932,Vaginal Microbiome Metacyc Pathway (Pwy-5857|Ubiquinol-10 Biosynthesis (Prokaryotic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5857|Ubiquinol-10 Biosynthesis (Prokaryotic))
33933,Vaginal Microbiome Metacyc Pathway (Pwy-5415|Catechol Degradation I (Meta-Cleavage Pathway)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5415|Catechol Degradation I (Meta-Cleavage Pathway))
33939,Vaginal Microbiome Metacyc Pathway (Pwy-5705|Allantoin Degradation To Glyoxylate Iii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5705|Allantoin Degradation To Glyoxylate Iii)
33943,Vaginal Microbiome Metacyc Pathway (Pwy-5741|Ethylmalonyl-Coa Pathway),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5741|Ethylmalonyl-Coa Pathway)
33946,Vaginal Microbiome Metacyc Pathway (Pwy-5860|Superpathway Of Demethylmenaquinol-6 Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5860|Superpathway Of Demethylmenaquinol-6 Biosynthesis I)
33947,Vaginal Microbiome Metacyc Pathway (Pwy-5861|Superpathway Of Demethylmenaquinol-8 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5861|Superpathway Of Demethylmenaquinol-8 Biosynthesis)
33948,Vaginal Microbiome Metacyc Pathway (Pwy-5845|Superpathway Of Menaquinol-9 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5845|Superpathway Of Menaquinol-9 Biosynthesis)
33950,Vaginal Microbiome Metacyc Pathway (Pwy-5850|Superpathway Of Menaquinol-6 Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5850|Superpathway Of Menaquinol-6 Biosynthesis I)
33951,Vaginal Microbiome Metacyc Pathway (Pwy-5855|Ubiquinol-7 Biosynthesis (Prokaryotic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5855|Ubiquinol-7 Biosynthesis (Prokaryotic))
33952,Vaginal Microbiome Metacyc Pathway (Pwy-5862|Superpathway Of Demethylmenaquinol-9 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5862|Superpathway Of Demethylmenaquinol-9 Biosynthesis)
33953,Estimated Glomerular Filtration Rate (Cystatin C),Phenotype,Estimated Glomerular Filtration Rate (Cystatin C)
33955,Vaginal Microbiome Metacyc Pathway (Pwy0-1241|Adp-L-Glycero-Beta;-D-Manno-Heptose Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-1241|Adp-L-Glycero-Beta;-D-Manno-Heptose Biosynthesis)
33957,Vaginal Microbiome Metacyc Pathway (Pwy0-1261|Anhydromuropeptides Recycling),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-1261|Anhydromuropeptides Recycling)
33958,Vaginal Microbiome Metacyc Pathway (Pwy0-1298|Superpathway Of Pyrimidine Deoxyribonucleosides Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-1298|Superpathway Of Pyrimidine Deoxyribonucleosides Degradation)
33959,Vaginal Microbiome Metacyc Pathway (Pwy0-1533|Methylphosphonate Degradation I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-1533|Methylphosphonate Degradation I)
33960,Vaginal Microbiome Metacyc Pathway (Pwy0-162|Superpathway Of Pyrimidine Ribonucleotides De Novo Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-162|Superpathway Of Pyrimidine Ribonucleotides De Novo Biosynthesis)
33962,Vaginal Microbiome Metacyc Pathway (Pwy0-166|Superpathway Of Pyrimidine Deoxyribonucleotides De Novo Biosynthesis (E. Coli)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-166|Superpathway Of Pyrimidine Deoxyribonucleotides De Novo Biosynthesis (E. Coli))
33967,Vaginal Microbiome Metacyc Pathway (Pwy0-1479|Trna Processing),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-1479|Trna Processing)
33998,Vaginal Microbiome Relative Abundance (S_Megasphaera Genomosp Type 1),Phenotype,Vaginal Microbiome Relative Abundance (S_Megasphaera Genomosp Type 1)
34001,Vaginal Microbiome Relative Abundance (S_Prevotella Bivia),Phenotype,Vaginal Microbiome Relative Abundance (S_Prevotella Bivia)
34002,Vaginal Microbiome Relative Abundance (S_Peptoniphilus Vaginalis),Phenotype,Vaginal Microbiome Relative Abundance (S_Peptoniphilus Vaginalis)
34004,Vaginal Microbiome Relative Abundance (Pleiotropy),Phenotype,Vaginal Microbiome Relative Abundance (Pleiotropy)
34006,Bmi At 6 Months Old,Phenotype,Bmi At 6 Months Old
34015,Bmi At Birth,Phenotype,Bmi At Birth
34016,Bmi At 3 Months Old,Phenotype,Bmi At 3 Months Old
34017,Myalgic Encephalomyelitis / Chronic Fatigue Syndrome,Phenotype,Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
34019,Log White Blood Cell Count In Acute Lymphoblastic Leukemia,Phenotype,Log White Blood Cell Count In Acute Lymphoblastic Leukemia
34021,Spline Residuals Of Log White Blood Cell Count In Acute Lymphoblastic Leukemia,Phenotype,Spline Residuals Of Log White Blood Cell Count In Acute Lymphoblastic Leukemia
34024,Cognitive Performance (Attention) (Longitudinal),Phenotype,Cognitive Performance (Attention) (Longitudinal)
34030,Medication Use (Hmg Coa Reductase Inhibitors),Phenotype,Medication Use (Hmg Coa Reductase Inhibitors)
34057,Breast Cancer X Tp53 Mutation Interaction,Phenotype,Breast Cancer X Tp53 Mutation Interaction
34059,Breast Cancer X Tp53 Gain Of Function Mutation Interaction,Phenotype,Breast Cancer X Tp53 Gain Of Function Mutation Interaction
34069,Depression (Age Of Onset),Phenotype,Depression (Age Of Onset)
34072,Vaginal Microbiome Metacyc Pathway (Pwy-7159|Chlorophyllide A Biosynthesis Iii (Aerobic-- Light Independent)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7159|Chlorophyllide A Biosynthesis Iii (Aerobic-- Light Independent))
34073,Vaginal Microbiome Metacyc Pathway (Pwy-7013|L-1--2-Propanediol Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7013|L-1--2-Propanediol Degradation)
34075,Vaginal Microbiome Metacyc Pathway (Pwy-7094|Fatty Acid Salvage),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7094|Fatty Acid Salvage)
34076,Vaginal Microbiome Metacyc Pathway (Teichoicacid-Pwy|Teichoic Acid (Poly-Glycerol) Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Teichoicacid-Pwy|Teichoic Acid (Poly-Glycerol) Biosynthesis)
34078,Vaginal Microbiome Metacyc Pathway (Rump-Pwy|Formaldehyde Oxidation I),Phenotype,Vaginal Microbiome Metacyc Pathway (Rump-Pwy|Formaldehyde Oxidation I)
34080,Vaginal Microbiome Metacyc Pathway (Pyridoxsyn-Pwy|Pyridoxal 5'-Phosphate Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pyridoxsyn-Pwy|Pyridoxal 5'-Phosphate Biosynthesis I)
34082,Cutaneous Melanoma (Mtag),Phenotype,Cutaneous Melanoma (Mtag)
34089,Medication Use (Agents Acting On The Renin-Angiotensin System),Phenotype,Medication Use (Agents Acting On The Renin-Angiotensin System)
34122,Regional Cortical Thickness (Medialorbitofrontal),Phenotype,Regional Cortical Thickness (Medialorbitofrontal)
34123,Regional Cortical Thickness (Parahippocampal),Phenotype,Regional Cortical Thickness (Parahippocampal)
34124,Regional Cortical Thickness (Inferiorparietal),Phenotype,Regional Cortical Thickness (Inferiorparietal)
34126,Regional Cortical Thickness (Lingual),Phenotype,Regional Cortical Thickness (Lingual)
34128,Regional Cortical Thickness (Lateraloccipital),Phenotype,Regional Cortical Thickness (Lateraloccipital)
34129,Vaginal Microbiome Metacyc Pathway (Pwy-6151|S-Adenosyl-L-Methionine Cycle I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6151|S-Adenosyl-L-Methionine Cycle I)
34131,Vaginal Microbiome Metacyc Pathway (Pwy-621|Sucrose Degradation Iii (Sucrose Invertase)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-621|Sucrose Degradation Iii (Sucrose Invertase))
34132,Vaginal Microbiome Metacyc Pathway (Pwy-6123|Inosine-5'-Phosphate Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6123|Inosine-5'-Phosphate Biosynthesis I)
34134,Vaginal Microbiome Metacyc Pathway (Pwy-6125|Superpathway Of Guanosine Nucleotides De Novo Biosynthesis Ii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6125|Superpathway Of Guanosine Nucleotides De Novo Biosynthesis Ii)
34135,Vaginal Microbiome Metacyc Pathway (Pwy-6700|Queuosine Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6700|Queuosine Biosynthesis)
34136,Vaginal Microbiome Metacyc Pathway (Pwy-6277|Superpathway Of 5-Aminoimidazole Ribonucleotide Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-6277|Superpathway Of 5-Aminoimidazole Ribonucleotide Biosynthesis)
34138,Vaginal Microbiome Metacyc Pathway (Pwy-5863|Superpathway Of Phylloquinol Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5863|Superpathway Of Phylloquinol Biosynthesis)
34140,Vaginal Microbiome Metacyc Pathway (Pwy-5896|Superpathway Of Menaquinol-10 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5896|Superpathway Of Menaquinol-10 Biosynthesis)
34141,Vaginal Microbiome Metacyc Pathway (Pwy-5897|Superpathway Of Menaquinol-11 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5897|Superpathway Of Menaquinol-11 Biosynthesis)
34142,Vaginal Microbiome Metacyc Pathway (Pwy-5899|Superpathway Of Menaquinol-13 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5899|Superpathway Of Menaquinol-13 Biosynthesis)
34143,Vaginal Microbiome Metacyc Pathway (Pwy490-3|Nitrate Reduction Vi (Assimilatory)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy490-3|Nitrate Reduction Vi (Assimilatory))
34145,Vaginal Microbiome Metacyc Pathway (Pyridnucsal-Pwy|Nad Salvage Pathway I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pyridnucsal-Pwy|Nad Salvage Pathway I)
34146,Vaginal Microbiome Metacyc Pathway (Pyridnucsyn-Pwy|Nad Biosynthesis I (From Aspartate)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pyridnucsyn-Pwy|Nad Biosynthesis I (From Aspartate))
34147,Vaginal Microbiome Metacyc Pathway (Pwy0-321|Phenylacetate Degradation I (Aerobic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-321|Phenylacetate Degradation I (Aerobic))
34159,Vaginal Microbiome Metacyc Pathway (Pwy0-42|2-Methylcitrate Cycle I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-42|2-Methylcitrate Cycle I)
34161,Vaginal Microbiome Metacyc Pathway (Pwy0-862|(5Z)-Dodec-5-Enoate Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy0-862|(5Z)-Dodec-5-Enoate Biosynthesis)
34163,Vaginal Microbiome Metacyc Pathway (Pwy1G-0|Mycothiol Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy1G-0|Mycothiol Biosynthesis)
34167,Pseudouridine Levels,Phenotype,Pseudouridine Levels
34169,Medication Use (Calcium Channel Blockers),Phenotype,Medication Use (Calcium Channel Blockers)
34176,High-Density Lipoprotein Mediated Cholesterol Efflux Capacity,Phenotype,High-Density Lipoprotein Mediated Cholesterol Efflux Capacity
34177,White Matter Lesions (Fazekas Score),Phenotype,White Matter Lesions (Fazekas Score)
34180,Left Hippocampal Volume,Phenotype,Left Hippocampal Volume
34183,Global Cognition (Mini Mental State Examination) (Longitudinal),Phenotype,Global Cognition (Mini Mental State Examination) (Longitudinal)
34194,Facial Wrinkles (Under Eye),Phenotype,Facial Wrinkles (Under Eye)
34197,Sib-Shared Facial Trait 757; Facial Segment 37; 3D Morphology Of The Philtrium,Phenotype,Sib-Shared Facial Trait 757; Facial Segment 37; 3D Morphology Of The Philtrium
34199,Sib-Shared Facial Trait 782; Facial Segment 40; 3D Morphology Of The Nose Sides,Phenotype,Sib-Shared Facial Trait 782; Facial Segment 40; 3D Morphology Of The Nose Sides
34201,Sib-Shared Facial Trait 788; Facial Segment 42; 3D Morphology Of The Nose Sides,Phenotype,Sib-Shared Facial Trait 788; Facial Segment 42; 3D Morphology Of The Nose Sides
34202,Sib-Shared Facial Trait 823; Facial Segment 44; 3D Morphology Of The Nose Apex,Phenotype,Sib-Shared Facial Trait 823; Facial Segment 44; 3D Morphology Of The Nose Apex
34204,Sib-Shared Facial Trait 835; Facial Segment 45; 3D Morphology Of The Nose Alae,Phenotype,Sib-Shared Facial Trait 835; Facial Segment 45; 3D Morphology Of The Nose Alae
34206,Sib-Shared Facial Trait 869; Facial Segment 50; 3D Morphology Of The Cheeks,Phenotype,Sib-Shared Facial Trait 869; Facial Segment 50; 3D Morphology Of The Cheeks
34208,Inosine Levels,Phenotype,Inosine Levels
34209,Isobutyrylcarnitine (C4) Levels,Phenotype,Isobutyrylcarnitine (C4) Levels
34210,Ornithine Levels (Metabolon Platform),Phenotype,Ornithine Levels (Metabolon Platform)
34212,Regional Cortical Thickness (Frontalpole),Phenotype,Regional Cortical Thickness (Frontalpole)
34214,Regional Cortical Thickness (Insula),Phenotype,Regional Cortical Thickness (Insula)
34215,Vaginal Microbiome Metacyc Pathway (Pwy-5837|1--4-Dihydroxy-2-Naphthoate Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5837|1--4-Dihydroxy-2-Naphthoate Biosynthesis I)
34217,Vaginal Microbiome Metacyc Pathway (Pwy-5838|Superpathway Of Menaquinol-8 Biosynthesis I),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5838|Superpathway Of Menaquinol-8 Biosynthesis I)
34221,Vaginal Microbiome Metacyc Pathway (Pwy-5840|Superpathway Of Menaquinol-7 Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5840|Superpathway Of Menaquinol-7 Biosynthesis)
34226,Vaginal Microbiome Metacyc Pathway (Pwy-5747|2-Methylcitrate Cycle Ii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5747|2-Methylcitrate Cycle Ii)
34228,Vaginal Microbiome Metacyc Pathway (Pwy-5695|Urate Biosynthesis/Inosine 5'-Phosphate Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-5695|Urate Biosynthesis/Inosine 5'-Phosphate Degradation)
34234,Vaginal Microbiome Metacyc Pathway (Pwy-7539|6-Hydroxymethyl-Dihydropterin Diphosphate Biosynthesis Iii (Chlamydia)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7539|6-Hydroxymethyl-Dihydropterin Diphosphate Biosynthesis Iii (Chlamydia))
34236,Vaginal Microbiome Metacyc Pathway (Pwy-7664|Oleate Biosynthesis Iv (Anaerobic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7664|Oleate Biosynthesis Iv (Anaerobic))
34238,Vaginal Microbiome Metacyc Pathway (Pwy-7373|Superpathway Of Demethylmenaquinol-6 Biosynthesis Ii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7373|Superpathway Of Demethylmenaquinol-6 Biosynthesis Ii)
34274,Medication Use (Adrenergics-- Inhalants),Phenotype,Medication Use (Adrenergics-- Inhalants)
34277,Cognitive Performance (Language Ability) (Longitudinal),Phenotype,Cognitive Performance (Language Ability) (Longitudinal)
34280,Medication Use (Antihistamines For Systemic Use),Phenotype,Medication Use (Antihistamines For Systemic Use)
34281,Medication Use (Antiglaucoma Preparations And Miotics),Phenotype,Medication Use (Antiglaucoma Preparations And Miotics)
34282,Cognitive Function (Delayed Memory) (Longitudinal),Phenotype,Cognitive Function (Delayed Memory) (Longitudinal)
34284,Cognitive Function (Delayed Memory),Phenotype,Cognitive Function (Delayed Memory)
34288,Cognitive Function (Immediate Memory),Phenotype,Cognitive Function (Immediate Memory)
34293,Medication Use (Glucocorticoids),Phenotype,Medication Use (Glucocorticoids)
34305,Regional Cortical Thickness (Entorhinal),Phenotype,Regional Cortical Thickness (Entorhinal)
34306,Regional Cortical Thickness (Fusiform),Phenotype,Regional Cortical Thickness (Fusiform)
34307,Regional Cortical Thickness (Caudalmiddlefrontal),Phenotype,Regional Cortical Thickness (Caudalmiddlefrontal)
34309,Global Cortical Thickness (Globalmeanmean),Phenotype,Global Cortical Thickness (Globalmeanmean)
34312,Tyrosine Levels (Biocrates Platform),Phenotype,Tyrosine Levels (Biocrates Platform)
34314,Threonine Levels (Metabolon Platform),Phenotype,Threonine Levels (Metabolon Platform)
34316,Oleoylcarnitine Levels (Metabolon Platform),Phenotype,Oleoylcarnitine Levels (Metabolon Platform)
34318,1-Palmitoleoylglycerophosphocholine Levels (Metabolon Platform),Phenotype,1-Palmitoleoylglycerophosphocholine Levels (Metabolon Platform)
34320,X-11469 Levels,Phenotype,X-11469 Levels
34322,X-12798 Levels,Phenotype,X-12798 Levels
34323,X-13435 Levels,Phenotype,X-13435 Levels
34325,X-14086 Levels,Phenotype,X-14086 Levels
34327,Sib-Shared Facial Trait 891; Facial Segment 52; 3D Morphology Of The Outer Cheeks,Phenotype,Sib-Shared Facial Trait 891; Facial Segment 52; 3D Morphology Of The Outer Cheeks
34329,Sib-Shared Facial Trait 920; Facial Segment 56; 3D Morphology Of The Middle Forehead,Phenotype,Sib-Shared Facial Trait 920; Facial Segment 56; 3D Morphology Of The Middle Forehead
34331,Sib-Shared Facial Trait 1000; Facial Segment 60; 3D Morphology Of The Eye Sockets,Phenotype,Sib-Shared Facial Trait 1000; Facial Segment 60; 3D Morphology Of The Eye Sockets
34333,Elevated Alanine Aminotransferase And Aspartate Aminotransferase Levels In Acute Lymphoblastic Leukemia,Phenotype,Elevated Alanine Aminotransferase And Aspartate Aminotransferase Levels In Acute Lymphoblastic Leukemia
34353,Vaginal Microbiome Metacyc Pathway (Pwy-7328|Superpathway Of Udp-Glucose-Derived O-Antigen Building Blocks Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7328|Superpathway Of Udp-Glucose-Derived O-Antigen Building Blocks Biosynthesis)
34355,Vaginal Microbiome Metacyc Pathway (Pwy-7237|Myo--- Chiro- And Scillo-Inositol Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7237|Myo--- Chiro- And Scillo-Inositol Degradation)
34357,Vaginal Microbiome Metacyc Pathway (Pwy-7242|D-Fructuronate Degradation),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7242|D-Fructuronate Degradation)
34358,Vaginal Microbiome Metacyc Pathway (Pwy-7219|Adenosine Ribonucleotides De Novo Biosynthesis),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7219|Adenosine Ribonucleotides De Novo Biosynthesis)
34360,Vaginal Microbiome Metacyc Pathway (Pwy-7220|Adenosine Deoxyribonucleotides De Novo Biosynthesis Ii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7220|Adenosine Deoxyribonucleotides De Novo Biosynthesis Ii)
34362,Vaginal Microbiome Metacyc Pathway (Pwy-7222|Guanosine Deoxyribonucleotides De Novo Biosynthesis Ii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7222|Guanosine Deoxyribonucleotides De Novo Biosynthesis Ii)
34363,Vaginal Microbiome Metacyc Pathway (Pwy-7371|1--4-Dihydroxy-6-Naphthoate Biosynthesis Ii),Phenotype,Vaginal Microbiome Metacyc Pathway (Pwy-7371|1--4-Dihydroxy-6-Naphthoate Biosynthesis Ii)
34367,Vaginal Microbiome Metacyc Pathway (Ubisyn-Pwy|Superpathway Of Ubiquinol-8 Biosynthesis (Prokaryotic)),Phenotype,Vaginal Microbiome Metacyc Pathway (Ubisyn-Pwy|Superpathway Of Ubiquinol-8 Biosynthesis (Prokaryotic))
34368,Vaginal Microbiome Presence (C_Actinobacteria),Phenotype,Vaginal Microbiome Presence (C_Actinobacteria)
34371,Vaginal Microbiome Presence (S_Dialister Micraerophilus),Phenotype,Vaginal Microbiome Presence (S_Dialister Micraerophilus)
34372,Vaginal Microbiome Presence (S_Lactobacillus Mulieris),Phenotype,Vaginal Microbiome Presence (S_Lactobacillus Mulieris)
34374,Vaginal Microbiome Presence (F_Mycoplasmataceae),Phenotype,Vaginal Microbiome Presence (F_Mycoplasmataceae)
34375,Vaginal Microbiome Presence (G_Dialister),Phenotype,Vaginal Microbiome Presence (G_Dialister)
34376,Vaginal Microbiome Presence (G_Megasphaera),Phenotype,Vaginal Microbiome Presence (G_Megasphaera)
34377,Vaginal Microbiome Presence (P_Proteobacteria),Phenotype,Vaginal Microbiome Presence (P_Proteobacteria)
34378,Vaginal Microbiome Presence (S_Aerococcus Christensenii),Phenotype,Vaginal Microbiome Presence (S_Aerococcus Christensenii)
34380,Vaginal Microbiome Relative Abundance (F_Lachnospiraceae),Phenotype,Vaginal Microbiome Relative Abundance (F_Lachnospiraceae)
34384,Vaginal Microbiome Relative Abundance (C_Gammaproteobacteria),Phenotype,Vaginal Microbiome Relative Abundance (C_Gammaproteobacteria)
34385,Vaginal Microbiome Relative Abundance (F_Aerococcaceae),Phenotype,Vaginal Microbiome Relative Abundance (F_Aerococcaceae)
34409,Facial Skin Elasticity,Phenotype,Facial Skin Elasticity
34412,Facial Skin Melanin,Phenotype,Facial Skin Melanin
34414,Facial Skin Gloss,Phenotype,Facial Skin Gloss
34421,Biological Age (Phenoage),Phenotype,Biological Age (Phenoage)
34430,Global Cognition (Mini Mental State Examination),Phenotype,Global Cognition (Mini Mental State Examination)
34435,Cognitive Function (Immediate Memory) (Longitudinal),Phenotype,Cognitive Function (Immediate Memory) (Longitudinal)
34453,Regional Cortical Thickness (Superiorfrontal),Phenotype,Regional Cortical Thickness (Superiorfrontal)
34454,Sib-Shared Facial Trait 524; Facial Segment 18; 3D Morphology Of The Philtrium,Phenotype,Sib-Shared Facial Trait 524; Facial Segment 18; 3D Morphology Of The Philtrium
34456,Sib-Shared Facial Trait 528; Facial Segment 18; 3D Morphology Of The Philtrium,Phenotype,Sib-Shared Facial Trait 528; Facial Segment 18; 3D Morphology Of The Philtrium
34458,Sib-Shared Facial Trait 232; Facial Segment 5; 3D Morphology Of The Nose,Phenotype,Sib-Shared Facial Trait 232; Facial Segment 5; 3D Morphology Of The Nose
34460,Sib-Shared Facial Trait 25; Facial Segment 1; 3D Morphology Of The Full Face,Phenotype,Sib-Shared Facial Trait 25; Facial Segment 1; 3D Morphology Of The Full Face
34462,Sib-Shared Facial Trait 247; Facial Segment 6; 3D Morphology Of The Lower Face,Phenotype,Sib-Shared Facial Trait 247; Facial Segment 6; 3D Morphology Of The Lower Face
34464,Sib-Shared Facial Trait 263; Facial Segment 6; 3D Morphology Of The Lower Face,Phenotype,Sib-Shared Facial Trait 263; Facial Segment 6; 3D Morphology Of The Lower Face
34466,Sib-Shared Facial Trait 283; Facial Segment 7; 3D Morphology Of The Upper Face,Phenotype,Sib-Shared Facial Trait 283; Facial Segment 7; 3D Morphology Of The Upper Face
34468,Sib-Shared Facial Trait 347; Facial Segment 9; 3D Morphology Of The Upper Lip,Phenotype,Sib-Shared Facial Trait 347; Facial Segment 9; 3D Morphology Of The Upper Lip
34470,Sib-Shared Facial Trait 159; Facial Segment 3; 3D Morphology Of The Upper And Lower Face-- Excluding The Nose,Phenotype,Sib-Shared Facial Trait 159; Facial Segment 3; 3D Morphology Of The Upper And Lower Face-- Excluding The Nose
34472,Sib-Shared Facial Trait 84; Facial Segment 1; 3D Morphology Of The Full Face,Phenotype,Sib-Shared Facial Trait 84; Facial Segment 1; 3D Morphology Of The Full Face
34474,Sib-Shared Facial Trait 290; Facial Segment 7; 3D Morphology Of The Upper Face,Phenotype,Sib-Shared Facial Trait 290; Facial Segment 7; 3D Morphology Of The Upper Face
34476,Regional Cortical Thickness (Superiorparietal),Phenotype,Regional Cortical Thickness (Superiorparietal)
34477,Sib-Shared Facial Trait 531; Facial Segment 19; 3D Morphology Of The Upper Vermillion,Phenotype,Sib-Shared Facial Trait 531; Facial Segment 19; 3D Morphology Of The Upper Vermillion
34480,Regional Cortical Thickness (Rostralanteriorcingulate),Phenotype,Regional Cortical Thickness (Rostralanteriorcingulate)
34482,Regional Cortical Thickness (Rostralmiddlefrontal),Phenotype,Regional Cortical Thickness (Rostralmiddlefrontal)
34483,Regional Cortical Thickness (Superiortemporal),Phenotype,Regional Cortical Thickness (Superiortemporal)
34485,Regional Cortical Thickness (Supramarginal),Phenotype,Regional Cortical Thickness (Supramarginal)
34486,Regional Cortical Thickness (Precentral),Phenotype,Regional Cortical Thickness (Precentral)
34487,Regional Cortical Thickness (Precuneus),Phenotype,Regional Cortical Thickness (Precuneus)
34488,Acid Sphingomyelinase-Like Phosphodiesterase 3A Levels,Phenotype,Acid Sphingomyelinase-Like Phosphodiesterase 3A Levels
34490,Vascular Endothelial Growth Factor A-- Isoform 121 Levels,Phenotype,Vascular Endothelial Growth Factor A-- Isoform 121 Levels
34491,Alpha-2-Macroglobulin Receptor-Associated Protein Levels,Phenotype,Alpha-2-Macroglobulin Receptor-Associated Protein Levels
34504,Oxaliplatin-Induced Peripheral Sensory Neuropathy In Colon Cancer,Phenotype,Oxaliplatin-Induced Peripheral Sensory Neuropathy In Colon Cancer
34506,Time To Recovery From Peripheral Sensory Neuropathy In Colon Cancer,Phenotype,Time To Recovery From Peripheral Sensory Neuropathy In Colon Cancer
34509,Oxaliplatin-Induced Allergic Reactions In Colon Cancer,Phenotype,Oxaliplatin-Induced Allergic Reactions In Colon Cancer
34518,Intracranial Germ Cell Tumors,Phenotype,Intracranial Germ Cell Tumors
34529,Advanced Glycosylation End Product-Specific Receptor-- Soluble Levels,Phenotype,Advanced Glycosylation End Product-Specific Receptor-- Soluble Levels
34531,Complement Factor B Levels,Phenotype,Complement Factor B Levels
34533,Cation-Independent Mannose-6-Phosphate Receptor Levels,Phenotype,Cation-Independent Mannose-6-Phosphate Receptor Levels
34540,Plasminogen Levels,Phenotype,Plasminogen Levels
34546,Icd10 K44: Diaphragmatic Hernia,Phenotype,Icd10 K44: Diaphragmatic Hernia
34548,Time To Colon Cancer Recurrence,Phenotype,Time To Colon Cancer Recurrence
34556,Retinoic Acid Receptor Responder Protein 2 Levels,Phenotype,Retinoic Acid Receptor Responder Protein 2 Levels
34586,Stem Cell Growth Factor-Alpha Levels,Phenotype,Stem Cell Growth Factor-Alpha Levels
34588,Brain-Specific Serine Protease 4 Levels,Phenotype,Brain-Specific Serine Protease 4 Levels
34591,Complement C4 Levels,Phenotype,Complement C4 Levels
34616,Cd109 Antigen Levels,Phenotype,Cd109 Antigen Levels
34645,Glycine Levels,Phenotype,Glycine Levels
34647,Glycoprotein Acetyls (Mainly A1-Acid Glycoprotein),Phenotype,Glycoprotein Acetyls (Mainly A1-Acid Glycoprotein)
34648,Mean Diameter Of Vldl Particles,Phenotype,Mean Diameter Of Vldl Particles
34657,Decenoylcarnitine Levels,Phenotype,Decenoylcarnitine Levels
34659,Decanoylcarnitine Levels,Phenotype,Decanoylcarnitine Levels
34661,Butyrylcarnitine Levels,Phenotype,Butyrylcarnitine Levels
34663,Sarcosine Levels,Phenotype,Sarcosine Levels
34665,Dodecanoylcarnitine Levels,Phenotype,Dodecanoylcarnitine Levels
34668,Octanoylcarnitine Levels,Phenotype,Octanoylcarnitine Levels
34669,Propionylcarnitine Levels,Phenotype,Propionylcarnitine Levels
34670,Dodecenoylcarnitine Levels,Phenotype,Dodecenoylcarnitine Levels
34671,Tetradecenoylcarnitine Levels,Phenotype,Tetradecenoylcarnitine Levels
34672,Qtc Interval,Phenotype,Qtc Interval
34689,F-Savour/Caloric Food Liking (Derived Food-Liking Factor),Phenotype,F-Savour/Caloric Food Liking (Derived Food-Liking Factor)
34690,F-Seafood Liking (Derived Food-Liking Factor),Phenotype,F-Seafood Liking (Derived Food-Liking Factor)
34711,F-Savoury Food Liking (Derived Food-Liking Factor),Phenotype,F-Savoury Food Liking (Derived Food-Liking Factor)
34713,Salmon Liking,Phenotype,Salmon Liking
34714,Sardines Liking,Phenotype,Sardines Liking
34721,F-Sharp Flavour Liking (Derived Food-Liking Factor),Phenotype,F-Sharp Flavour Liking (Derived Food-Liking Factor)
34722,F-Small Fish Liking (Derived Food-Liking Factor),Phenotype,F-Small Fish Liking (Derived Food-Liking Factor)
34725,Shellfish Liking,Phenotype,Shellfish Liking
34750,Oral Corticosteroid Burst In Asthma,Phenotype,Oral Corticosteroid Burst In Asthma
34759,Asthma Exacerbations In Inhaled Corticosteroid Treatment,Phenotype,Asthma Exacerbations In Inhaled Corticosteroid Treatment
34769,Germline Telomere Length In Neuroblastoma,Phenotype,Germline Telomere Length In Neuroblastoma
34771,Serum Uromodulin Levels (Antibody-Based Assay),Phenotype,Serum Uromodulin Levels (Antibody-Based Assay)
34773,Serum Uromodulin Levels (Aptamer-Based Assay),Phenotype,Serum Uromodulin Levels (Aptamer-Based Assay)
34785,Covid-19 (Hospitalized Vs Population),Phenotype,Covid-19 (Hospitalized Vs Population)
34786,Sars-Cov-2 Infection,Phenotype,Sars-Cov-2 Infection
34788,Environmental Pollutants Exposure (Ac50 Low),Phenotype,Environmental Pollutants Exposure (Ac50 Low)
34791,Environmental Pollutants Exposure (Ac50 High),Phenotype,Environmental Pollutants Exposure (Ac50 High)
34794,Cadmium Chloride Levels,Phenotype,Cadmium Chloride Levels
34795,Chlorpyrifos Levels,Phenotype,Chlorpyrifos Levels
34796,Di-N-Butyl Phthalate Levels,Phenotype,Di-N-Butyl Phthalate Levels
34797,Diazinon Levels,Phenotype,Diazinon Levels
34798,Nickel Levels,Phenotype,Nickel Levels
34799,Pentachlorophenol Levels,Phenotype,Pentachlorophenol Levels
34800,Parathion Levels,Phenotype,Parathion Levels
34802,Ideal Cardiovascular Health Score (Clinical And Behavioral),Phenotype,Ideal Cardiovascular Health Score (Clinical And Behavioral)
34804,Ideal Cardiovascular Health (Clinical And Behavioral),Phenotype,Ideal Cardiovascular Health (Clinical And Behavioral)
34805,Alpha-Aminoadipic Acid Levels,Phenotype,Alpha-Aminoadipic Acid Levels
34809,Environmental Pollutants Exposure (Pod High),Phenotype,Environmental Pollutants Exposure (Pod High)
34810,Environmental Pollutants Exposure (Pod Low),Phenotype,Environmental Pollutants Exposure (Pod Low)
34816,Environmental Pollutants Exposure (Expo High),Phenotype,Environmental Pollutants Exposure (Expo High)
34817,Endrin Levels,Phenotype,Endrin Levels
34818,Ethion Levels,Phenotype,Ethion Levels
34819,Endosulfan Levels,Phenotype,Endosulfan Levels
34824,Heptachlor Levels,Phenotype,Heptachlor Levels
34826,Environmental Pollutants Exposure (Expo Low),Phenotype,Environmental Pollutants Exposure (Expo Low)
34829,Lithium Clearance,Phenotype,Lithium Clearance
34831,Heptachlor Epoxide Levels,Phenotype,Heptachlor Epoxide Levels
34832,Mercuric Chloride Levels,Phenotype,Mercuric Chloride Levels
34833,Methoxychlor Levels,Phenotype,Methoxychlor Levels
34834,Mercuric Chloride-2 Levels,Phenotype,Mercuric Chloride-2 Levels
34835,Cardioembolic Stroke (Mtag),Phenotype,Cardioembolic Stroke (Mtag)
34841,2--4--5-Trichlorophenol Levels,Phenotype,2--4--5-Trichlorophenol Levels
34844,Aldrin Levels,Phenotype,Aldrin Levels
34845,Azinphos Methyl Levels,Phenotype,Azinphos Methyl Levels
34847,Ddt Metabolite (Ddd P-P') Levels,Phenotype,Ddt Metabolite (Ddd P-P') Levels
34848,Ddt Metabolite (Ddt O-P') Levels,Phenotype,Ddt Metabolite (Ddt O-P') Levels
34849,Ddt Metabolite (Ddt P-P') Levels,Phenotype,Ddt Metabolite (Ddt P-P') Levels
34852,4--6-Dinitro-O-Cresol Levels,Phenotype,4--6-Dinitro-O-Cresol Levels
34853,2--4--5-Trichlorophenol-2 Levels,Phenotype,2--4--5-Trichlorophenol-2 Levels
34857,Cobalt Levels,Phenotype,Cobalt Levels
34859,Disulfoton Levels,Phenotype,Disulfoton Levels
34860,Dieldrin Levels,Phenotype,Dieldrin Levels
34861,Dicofol Levels,Phenotype,Dicofol Levels
34869,Potassium Chromate Levels,Phenotype,Potassium Chromate Levels
34870,Atrial Fibrillation (Mtag),Phenotype,Atrial Fibrillation (Mtag)
34877,Environmental Pollutants Exposure (Rfd High),Phenotype,Environmental Pollutants Exposure (Rfd High)
34878,Environmental Pollutants Exposure (Rfd Low),Phenotype,Environmental Pollutants Exposure (Rfd Low)
34895,A Body Shape Index,Phenotype,A Body Shape Index
34921,Sex Hormone-Binding Globulin Levels Adjusted For Bmi,Phenotype,Sex Hormone-Binding Globulin Levels Adjusted For Bmi
34934,Coffee Consumption (Cups Per Day),Phenotype,Coffee Consumption (Cups Per Day)
34940,Gastroesophageal Reflux Disease-- Peptic Ulcer Disease And/Or Corresponding Medications And Treatment,Phenotype,Gastroesophageal Reflux Disease-- Peptic Ulcer Disease And/Or Corresponding Medications And Treatment
34941,Irritable Bowel Syndrome,Phenotype,Irritable Bowel Syndrome
34968,Mouth Ulcers,Phenotype,Mouth Ulcers
34978,Total Testosterone Levels,Phenotype,Total Testosterone Levels
35001,Digit Length Ratio (Right Hand),Phenotype,Digit Length Ratio (Right Hand)
35004,Digit Length Ratio (Left Hand),Phenotype,Digit Length Ratio (Left Hand)
35005,Cerebrospinal Fluid P-Tau181P:Ab1-42 Ratio,Phenotype,Cerebrospinal Fluid P-Tau181P:Ab1-42 Ratio
35007,Adult Body Size,Phenotype,Adult Body Size
35024,Igm Levels,Phenotype,Igm Levels
35026,Igg Levels,Phenotype,Igg Levels
35028,Diverticular Disease,Phenotype,Diverticular Disease
35035,Anti-Sp100 Seropositivity In Primary Biliary Cholangitis,Phenotype,Anti-Sp100 Seropositivity In Primary Biliary Cholangitis
35040,Cognitive Function In Longevity,Phenotype,Cognitive Function In Longevity
35043,Systolic Blood Pressure (Baseline),Phenotype,Systolic Blood Pressure (Baseline)
35045,Systolic Blood Pressure Change Trajectory,Phenotype,Systolic Blood Pressure Change Trajectory
35047,Autoimmune Pulmonary Alveolar Proteinosis,Phenotype,Autoimmune Pulmonary Alveolar Proteinosis
35051,Well-Being Spectrum (Multivariate Analysis),Phenotype,Well-Being Spectrum (Multivariate Analysis)
35070,Triiodothyronine Levels And Thyroxine Levels,Phenotype,Triiodothyronine Levels And Thyroxine Levels
35072,Carpal Tunnel Syndrome,Phenotype,Carpal Tunnel Syndrome
35080,Hand Grip Strength,Phenotype,Hand Grip Strength
35091,Cognitive Impairment Test Score,Phenotype,Cognitive Impairment Test Score
35108,Diastolic Blood Pressure Change Trajectory,Phenotype,Diastolic Blood Pressure Change Trajectory
35112,Academic Attainment (Maths),Phenotype,Academic Attainment (Maths)
35127,Cirrhosis (Alcohol Related),Phenotype,Cirrhosis (Alcohol Related)
35150,Diastolic Blood Pressure (Long-Term Average),Phenotype,Diastolic Blood Pressure (Long-Term Average)
35158,Academic Attainment (Science),Phenotype,Academic Attainment (Science)
35166,Metabolically Unhealthy In Obesity,Phenotype,Metabolically Unhealthy In Obesity
35167,Metabolically Unhealthy In Normal Weight,Phenotype,Metabolically Unhealthy In Normal Weight
35176,Cutaneous Leishmaniasis,Phenotype,Cutaneous Leishmaniasis
35242,Joint Destruction In Rheumatoid Arthritis (Rapid Vs Slow),Phenotype,Joint Destruction In Rheumatoid Arthritis (Rapid Vs Slow)
35245,Hypertrophic Cardiomyopathy,Phenotype,Hypertrophic Cardiomyopathy
35248,Lack Of Behavioral Control,Phenotype,Lack Of Behavioral Control
35251,Frontal Fibrosing Alopecia,Phenotype,Frontal Fibrosing Alopecia
35279,Alcohol Use Disorder (Consumption Score),Phenotype,Alcohol Use Disorder (Consumption Score)
35283,Serum Urate Levels In Chronic Kidney Disease,Phenotype,Serum Urate Levels In Chronic Kidney Disease
35305,Ferritin Levels,Phenotype,Ferritin Levels
35308,Declining Hemoglobin Trajectory In Blood Donors,Phenotype,Declining Hemoglobin Trajectory In Blood Donors
35343,Brca1/2-Negative High-Risk Breast Cancer,Phenotype,Brca1/2-Negative High-Risk Breast Cancer
35347,Hip Shape (Dxa Scan),Phenotype,Hip Shape (Dxa Scan)
35357,Addison'S Disease,Phenotype,Addison'S Disease
35373,Vesicoureteral Reflux,Phenotype,Vesicoureteral Reflux
35390,Early Age-Related Macular Degeneration,Phenotype,Early Age-Related Macular Degeneration
35394,Facial Pigmentation Measurement (Uv Light),Phenotype,Facial Pigmentation Measurement (Uv Light)
35395,Facial Pigmentation Measurement (Polar Light),Phenotype,Facial Pigmentation Measurement (Polar Light)
35396,Response To Tofacitinib Treatment In Rheumatoid Arthritis (Herpes Zoster)(Time To Event),Phenotype,Response To Tofacitinib Treatment In Rheumatoid Arthritis (Herpes Zoster)(Time To Event)
35399,Response To Tofacitinib Treatment In Psoriasis (Herpes Zoster)(Time To Event),Phenotype,Response To Tofacitinib Treatment In Psoriasis (Herpes Zoster)(Time To Event)
35401,Response To Tofacitinib Treatment In Rheumatoid Arthritis (Herpes Zoster),Phenotype,Response To Tofacitinib Treatment In Rheumatoid Arthritis (Herpes Zoster)
35402,Response To Tofacitinib Treatment In Psoriasis (Herpes Zoster),Phenotype,Response To Tofacitinib Treatment In Psoriasis (Herpes Zoster)
35403,Response To Tofacitinib Treatment (Herpes Zoster)(Time To Event),Phenotype,Response To Tofacitinib Treatment (Herpes Zoster)(Time To Event)
35404,Response To Tofacitinib Treatment (Herpes Zoster),Phenotype,Response To Tofacitinib Treatment (Herpes Zoster)
35413,Ulna And Radius Bone Mineral Density,Phenotype,Ulna And Radius Bone Mineral Density
35421,Post-Bronchodilator Fev1 X Air Pollution (Co) Interaction In Childhood Asthma,Phenotype,Post-Bronchodilator Fev1 X Air Pollution (Co) Interaction In Childhood Asthma
35425,Severe Carbamazepine- Or Oxcarbazepine-Induced Hyponatremia In Epilepsy,Phenotype,Severe Carbamazepine- Or Oxcarbazepine-Induced Hyponatremia In Epilepsy
35427,Carbamazepine Metabolism (Carbamazepine-10--11-Diol To Carbamazepine Ratio) In Epilepsy,Phenotype,Carbamazepine Metabolism (Carbamazepine-10--11-Diol To Carbamazepine Ratio) In Epilepsy
35440,Asthma With Severe Exacerbations,Phenotype,Asthma With Severe Exacerbations
35442,Diverticulitis,Phenotype,Diverticulitis
35453,Bipolar Disorder Or Ulcerative Colitis (Mtag),Phenotype,Bipolar Disorder Or Ulcerative Colitis (Mtag)
35457,Bipolar Disorder Or Inflammatory Bowel Disease (Mtag),Phenotype,Bipolar Disorder Or Inflammatory Bowel Disease (Mtag)
35459,2-Hydroxyadipate Levels,Phenotype,2-Hydroxyadipate Levels
35461,Eukaryotic Elongation Factor 2 Kinase Levels,Phenotype,Eukaryotic Elongation Factor 2 Kinase Levels
35463,Tapasin Levels,Phenotype,Tapasin Levels
35465,Proteasome Subunit Beta Type-1 Levels,Phenotype,Proteasome Subunit Beta Type-1 Levels
35467,Nad-Dependent Protein Deacylase Sirtuin-5-- Mitochondrial Levels,Phenotype,Nad-Dependent Protein Deacylase Sirtuin-5-- Mitochondrial Levels
35472,Chloride Intracellular Channel Protein 5 Levels,Phenotype,Chloride Intracellular Channel Protein 5 Levels
35474,Integrin Beta-2 Levels,Phenotype,Integrin Beta-2 Levels
35475,Histone Deacetylase Complex Subunit Sap30 Levels,Phenotype,Histone Deacetylase Complex Subunit Sap30 Levels
35486,Migraine With Aura (Age At Onset),Phenotype,Migraine With Aura (Age At Onset)
35488,Interleukin-17B (Analyte X3499.77) Levels,Phenotype,Interleukin-17B (Analyte X3499.77) Levels
35492,Epididymis-Specific Alpha-Mannosidase Levels,Phenotype,Epididymis-Specific Alpha-Mannosidase Levels
35493,Triggering Receptor Expressed On Myeloid Cells 1 Levels,Phenotype,Triggering Receptor Expressed On Myeloid Cells 1 Levels
35495,Cation-Independent Mannose-6-Phosphate Receptor (Analyte X3676.15) Levels,Phenotype,Cation-Independent Mannose-6-Phosphate Receptor (Analyte X3676.15) Levels
35496,Membrane Frizzled-Related Protein Levels,Phenotype,Membrane Frizzled-Related Protein Levels
35499,Butyrophilin Subfamily 2 Member A1 Levels,Phenotype,Butyrophilin Subfamily 2 Member A1 Levels
35503,N-Acetylglucosamine-6-Sulfatase (Analyte X3616.3) Levels,Phenotype,N-Acetylglucosamine-6-Sulfatase (Analyte X3616.3) Levels
35506,Lymphocyte Antigen 86 Levels,Phenotype,Lymphocyte Antigen 86 Levels
35510,Slam Family Member 5 (Analyte X3642.4) Levels,Phenotype,Slam Family Member 5 (Analyte X3642.4) Levels
35512,Thrombospondin-2 (Analyte X3339.33) Levels,Phenotype,Thrombospondin-2 (Analyte X3339.33) Levels
35514,Tryptase Beta-2 (Analyte X3403.1) Levels,Phenotype,Tryptase Beta-2 (Analyte X3403.1) Levels
35516,Granzyme A (Analyte X3440.7) Levels,Phenotype,Granzyme A (Analyte X3440.7) Levels
35518,Severe Coronary Stenosis (Family History Of Cad Interaction),Phenotype,Severe Coronary Stenosis (Family History Of Cad Interaction)
35520,Severe Coronary Stenosis,Phenotype,Severe Coronary Stenosis
35526,Lung Adenocarcinoma (Conditioned On Cigarettes Per Day),Phenotype,Lung Adenocarcinoma (Conditioned On Cigarettes Per Day)
35527,Squamous Cell Lung Carcinoma (Conditioned On Cigarettes Per Day),Phenotype,Squamous Cell Lung Carcinoma (Conditioned On Cigarettes Per Day)
35528,Lung Cancer (Conditioned On Cigarettes Per Day),Phenotype,Lung Cancer (Conditioned On Cigarettes Per Day)
35530,Methazolamide-Induced Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis,Phenotype,Methazolamide-Induced Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis
35546,Fad-Linked Sulfhydryl Oxidase Alr Levels,Phenotype,Fad-Linked Sulfhydryl Oxidase Alr Levels
35548,Otoraplin Levels,Phenotype,Otoraplin Levels
35550,Neuregulin-1-- Sensory And Motor Neuron-Derived Factor Isoform Levels,Phenotype,Neuregulin-1-- Sensory And Motor Neuron-Derived Factor Isoform Levels
35551,5'-Nucleotidase (Analyte X15452.5) Levels,Phenotype,5'-Nucleotidase (Analyte X15452.5) Levels
35553,T-Cell Surface Glycoprotein Cd8 Alpha Chain (Analyte X15462.28) Levels,Phenotype,T-Cell Surface Glycoprotein Cd8 Alpha Chain (Analyte X15462.28) Levels
35554,Collagen Alpha-1(Ix) Chain (Analyte X15466.30) Levels,Phenotype,Collagen Alpha-1(Ix) Chain (Analyte X15466.30) Levels
35556,Low-Density Lipoprotein Receptor-Related Protein 11 (Analyte X15472.16) Levels,Phenotype,Low-Density Lipoprotein Receptor-Related Protein 11 (Analyte X15472.16) Levels
35558,Vascular Non-Inflammatory Molecule 2 (Analyte X15480.2) Levels,Phenotype,Vascular Non-Inflammatory Molecule 2 (Analyte X15480.2) Levels
35560,Cation-Independent Mannose-6-Phosphate Receptor (Analyte X16057.6) Levels,Phenotype,Cation-Independent Mannose-6-Phosphate Receptor (Analyte X16057.6) Levels
35562,Nidogen-2 (Analyte X16060.99) Levels,Phenotype,Nidogen-2 (Analyte X16060.99) Levels
35564,Triggering Receptor Expressed On Myeloid Cells 2 (Analyte X16300.4) Levels,Phenotype,Triggering Receptor Expressed On Myeloid Cells 2 (Analyte X16300.4) Levels
35565,Syndecan-3 Levels,Phenotype,Syndecan-3 Levels
35567,Ephrin Type-A Receptor 7 (Analyte X15580.2) Levels,Phenotype,Ephrin Type-A Receptor 7 (Analyte X15580.2) Levels
35569,Myelin-Oligodendrocyte Glycoprotein Levels,Phenotype,Myelin-Oligodendrocyte Glycoprotein Levels
35571,Prostasin (Analyte X15513.108) Levels,Phenotype,Prostasin (Analyte X15513.108) Levels
35573,M.Tuberculosis Induced Tnf-A Level,Phenotype,M.Tuberculosis Induced Tnf-A Level
35575,S.Typhi Induced Il-10 Level,Phenotype,S.Typhi Induced Il-10 Level
35578,S.Typhi Induced Il-1B Level,Phenotype,S.Typhi Induced Il-1B Level
35580,S.Pneumoniae Induced Il-1B Level,Phenotype,S.Pneumoniae Induced Il-1B Level
35582,S.Pneumoniae Induced Il-6 Level,Phenotype,S.Pneumoniae Induced Il-6 Level
35584,S.Pneumoniae Induced Tnf-A Level,Phenotype,S.Pneumoniae Induced Tnf-A Level
35586,Lps Induced Il-1B Level,Phenotype,Lps Induced Il-1B Level
35588,S.Enteritidis Induced Ifn-G Level,Phenotype,S.Enteritidis Induced Ifn-G Level
35590,Protein Disulfide-Isomerase A3 (Analyte X7832.181) Levels,Phenotype,Protein Disulfide-Isomerase A3 (Analyte X7832.181) Levels
35592,S-Arrestin Levels,Phenotype,S-Arrestin Levels
35594,Double C2-Like Domain-Containing Protein Beta Levels,Phenotype,Double C2-Like Domain-Containing Protein Beta Levels
35596,Glycoprotein Endo-Alpha-1--2-Mannosidase Levels,Phenotype,Glycoprotein Endo-Alpha-1--2-Mannosidase Levels
35598,Ferritin-- Mitochondrial Levels,Phenotype,Ferritin-- Mitochondrial Levels
35599,N-Acetylated-Alpha-Linked Acidic Dipeptidase 2 Levels,Phenotype,N-Acetylated-Alpha-Linked Acidic Dipeptidase 2 Levels
35600,Chronic Obstructive Pulmonary Disease In Non-Current Smokers,Phenotype,Chronic Obstructive Pulmonary Disease In Non-Current Smokers
35602,Schizophrenia Vs Bipolar Disorder (Ordinary Least Squares (Ols)),Phenotype,Schizophrenia Vs Bipolar Disorder (Ordinary Least Squares (Ols))
35604,Schizophrenia Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols)),Phenotype,Schizophrenia Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols))
35606,Neuferricin Levels,Phenotype,Neuferricin Levels
35607,39S Ribosomal Protein L55-- Mitochondrial Levels,Phenotype,39S Ribosomal Protein L55-- Mitochondrial Levels
35609,P-Selectin Glycoprotein Ligand 1:Extracellular Domain Levels,Phenotype,P-Selectin Glycoprotein Ligand 1:Extracellular Domain Levels
35612,Collagen Alpha-2(Xi) Chain Levels,Phenotype,Collagen Alpha-2(Xi) Chain Levels
35614,Cyclic Amp-Responsive Element-Binding Protein 3-Like Protein 4 Levels,Phenotype,Cyclic Amp-Responsive Element-Binding Protein 3-Like Protein 4 Levels
35618,Cyclic Amp-Dependent Transcription Factor Atf-6 Beta Levels,Phenotype,Cyclic Amp-Dependent Transcription Factor Atf-6 Beta Levels
35620,Hepatitis A Virus Cellular Receptor 2 (Analyte X11481.25) Levels,Phenotype,Hepatitis A Virus Cellular Receptor 2 (Analyte X11481.25) Levels
35622,Signal Peptide-- Cub And Egf-Like Domain-Containing Protein 3 Levels,Phenotype,Signal Peptide-- Cub And Egf-Like Domain-Containing Protein 3 Levels
35624,Sphingomyelin Phosphodiesterase Levels,Phenotype,Sphingomyelin Phosphodiesterase Levels
35626,Secretagogin (Analyte X10894.25) Levels,Phenotype,Secretagogin (Analyte X10894.25) Levels
35628,N-Acetylglucosamine-1-Phosphodiester Alpha-N-Acetylglucosaminidase Levels,Phenotype,N-Acetylglucosamine-1-Phosphodiester Alpha-N-Acetylglucosaminidase Levels
35630,Thioredoxin Domain-Containing Protein 5 Levels,Phenotype,Thioredoxin Domain-Containing Protein 5 Levels
35632,Zymogen Granule Protein 16 Homolog B Levels,Phenotype,Zymogen Granule Protein 16 Homolog B Levels
35634,Low-Density Lipoprotein Receptor-Related Protein 11 (Analyte X8330.1) Levels,Phenotype,Low-Density Lipoprotein Receptor-Related Protein 11 (Analyte X8330.1) Levels
35635,Uronyl 2-Sulfotransferase Levels,Phenotype,Uronyl 2-Sulfotransferase Levels
35637,Allograft Inflammatory Factor 1 Levels,Phenotype,Allograft Inflammatory Factor 1 Levels
35639,Olfactomedin-Like Protein 3 (Analyte X8660.33) Levels,Phenotype,Olfactomedin-Like Protein 3 (Analyte X8660.33) Levels
35641,Dipeptidase 1 (Analyte X8794.13) Levels,Phenotype,Dipeptidase 1 (Analyte X8794.13) Levels
35643,Myeloid Cell Surface Antigen Cd33 Levels,Phenotype,Myeloid Cell Surface Antigen Cd33 Levels
35645,Natural Cytotoxicity Triggering Receptor 3 Levels,Phenotype,Natural Cytotoxicity Triggering Receptor 3 Levels
35646,Agouti-Related Protein Levels,Phenotype,Agouti-Related Protein Levels
35648,Delta-Like Protein 1 (Analyte X8264.43) Levels,Phenotype,Delta-Like Protein 1 (Analyte X8264.43) Levels
35650,Alpha-L-Iduronidase Levels,Phenotype,Alpha-L-Iduronidase Levels
35651,Lysosomal Protective Protein Levels,Phenotype,Lysosomal Protective Protein Levels
35652,Complement C2 Levels,Phenotype,Complement C2 Levels
35654,Wap-- Kazal-- Immunoglobulin-- Kunitz And Ntr Domain-Containing Protein 1 Levels,Phenotype,Wap-- Kazal-- Immunoglobulin-- Kunitz And Ntr Domain-Containing Protein 1 Levels
35656,Melanoma-Derived Growth Regulatory Protein Levels,Phenotype,Melanoma-Derived Growth Regulatory Protein Levels
35658,Nkg2D Ligand 3 Levels,Phenotype,Nkg2D Ligand 3 Levels
35663,Inguinal Hernia,Phenotype,Inguinal Hernia
35666,Bipolar Disorder Or Crohn'S Disease (Mtag),Phenotype,Bipolar Disorder Or Crohn'S Disease (Mtag)
35672,Intestinal Permeability Measurement,Phenotype,Intestinal Permeability Measurement
35674,Creutzfeldt-Jakob Disease (Sporadic),Phenotype,Creutzfeldt-Jakob Disease (Sporadic)
35676,Schizophrenia Vs Autism Spectrum Disorder (Ordinary Least Squares (Ols)),Phenotype,Schizophrenia Vs Autism Spectrum Disorder (Ordinary Least Squares (Ols))
35678,Diphosphomevalonate Decarboxylase (Analyte X19748.3) Levels,Phenotype,Diphosphomevalonate Decarboxylase (Analyte X19748.3) Levels
35680,Acylpyruvase Fahd1-- Mitochondrial Levels,Phenotype,Acylpyruvase Fahd1-- Mitochondrial Levels
35682,Charged Multivesicular Body Protein 1A Levels,Phenotype,Charged Multivesicular Body Protein 1A Levels
35683,Hydroxyacylglutathione Hydrolase-- Mitochondrial Levels,Phenotype,Hydroxyacylglutathione Hydrolase-- Mitochondrial Levels
35685,Enoyl-Coa Delta Isomerase 1-- Mitochondrial Levels,Phenotype,Enoyl-Coa Delta Isomerase 1-- Mitochondrial Levels
35687,Retinoic Acid Early Transcript 1L Protein (Analyte X20526.3) Levels,Phenotype,Retinoic Acid Early Transcript 1L Protein (Analyte X20526.3) Levels
35689,Nuclear Apoptosis-Inducing Factor 1 Levels,Phenotype,Nuclear Apoptosis-Inducing Factor 1 Levels
35691,Desmoglein-2 (Analyte X20517.1) Levels,Phenotype,Desmoglein-2 (Analyte X20517.1) Levels
35693,Gastric Intrinsic Factor Levels,Phenotype,Gastric Intrinsic Factor Levels
35695,Tripeptidyl-Peptidase 1 Levels,Phenotype,Tripeptidyl-Peptidase 1 Levels
35697,Butyrophilin Subfamily 3 Member A3 (Analyte X17692.2) Levels,Phenotype,Butyrophilin Subfamily 3 Member A3 (Analyte X17692.2) Levels
35700,Microtubule-Associated Proteins 1A/1B Light Chain 3A Levels,Phenotype,Microtubule-Associated Proteins 1A/1B Light Chain 3A Levels
35701,Succinate-Semialdehyde Dehydrogenase-- Mitochondrial Levels,Phenotype,Succinate-Semialdehyde Dehydrogenase-- Mitochondrial Levels
35703,Phosphomannomutase 2 Levels,Phenotype,Phosphomannomutase 2 Levels
35705,Valacyclovir Hydrolase Levels,Phenotype,Valacyclovir Hydrolase Levels
35707,Glycerol-3-Phosphate Phosphatase Levels,Phenotype,Glycerol-3-Phosphate Phosphatase Levels
35709,Promotilin Levels,Phenotype,Promotilin Levels
35711,Triggering Receptor Expressed On Myeloid Cells 2 (Analyte X5635.66) Levels,Phenotype,Triggering Receptor Expressed On Myeloid Cells 2 (Analyte X5635.66) Levels
35712,Chymotrypsinogen B2 Levels,Phenotype,Chymotrypsinogen B2 Levels
35715,Endophilin-A3 (Analyte X23029.3) Levels,Phenotype,Endophilin-A3 (Analyte X23029.3) Levels
35717,An1-Type Zinc Finger Protein 2B Levels,Phenotype,An1-Type Zinc Finger Protein 2B Levels
35718,Vasorin Levels,Phenotype,Vasorin Levels
35719,Cysteine-Rich Secretory Protein Lccl Domain-Containing 2 Levels,Phenotype,Cysteine-Rich Secretory Protein Lccl Domain-Containing 2 Levels
35721,Tenascin-X Levels,Phenotype,Tenascin-X Levels
35723,Trem-Like Transcript 2 Protein Levels,Phenotype,Trem-Like Transcript 2 Protein Levels
35724,Colipase Levels,Phenotype,Colipase Levels
35726,T-Cell Surface Glycoprotein Cd8 Alpha Chain (Analyte X5992.50) Levels,Phenotype,T-Cell Surface Glycoprotein Cd8 Alpha Chain (Analyte X5992.50) Levels
35727,Paraneoplastic Antigen Ma2 Levels,Phenotype,Paraneoplastic Antigen Ma2 Levels
35734,Glutathione S-Transferase A2 Levels,Phenotype,Glutathione S-Transferase A2 Levels
35767,Suicide Attempt Severity In Mood Disorders,Phenotype,Suicide Attempt Severity In Mood Disorders
35770,Suicidality In Mood Disorders,Phenotype,Suicidality In Mood Disorders
35784,Serpin B9 Levels,Phenotype,Serpin B9 Levels
35786,Alpha-L-Fucoside Fucohydrolase Levels,Phenotype,Alpha-L-Fucoside Fucohydrolase Levels
35787,L-Dopachrome Tautomerase Levels,Phenotype,L-Dopachrome Tautomerase Levels
35788,Shadow Of Prion Protein Levels,Phenotype,Shadow Of Prion Protein Levels
35790,Killer Cell Immunoglobulin-Like Receptor 2Ds2 Levels,Phenotype,Killer Cell Immunoglobulin-Like Receptor 2Ds2 Levels
35792,Apolipoprotein M (Analyte X10445.20) Levels,Phenotype,Apolipoprotein M (Analyte X10445.20) Levels
35794,Interleukin-18 Receptor Accessory Protein (Analyte X10457.3) Levels,Phenotype,Interleukin-18 Receptor Accessory Protein (Analyte X10457.3) Levels
35796,Splicing Factor U2Af 65 Kda Subunit Levels,Phenotype,Splicing Factor U2Af 65 Kda Subunit Levels
35798,Rac Gtpase-Activating Protein 1 Levels,Phenotype,Rac Gtpase-Activating Protein 1 Levels
35802,Plexin Domain-Containing Protein 2:Extracellular Domain Levels,Phenotype,Plexin Domain-Containing Protein 2:Extracellular Domain Levels
35804,Retinoic Acid Early Transcript 1L Protein (Analyte X10589.7) Levels,Phenotype,Retinoic Acid Early Transcript 1L Protein (Analyte X10589.7) Levels
35806,Protein Mdm4 Levels,Phenotype,Protein Mdm4 Levels
35808,N-Acetylglucosamine-1-Phosphotransferase Subunit Gamma Levels,Phenotype,N-Acetylglucosamine-1-Phosphotransferase Subunit Gamma Levels
35810,Leukocyte Elastase Inhibitor Levels,Phenotype,Leukocyte Elastase Inhibitor Levels
35815,Immunoglobulin D Levels,Phenotype,Immunoglobulin D Levels
35817,Neuropeptide W Levels,Phenotype,Neuropeptide W Levels
35819,Protein Fam110A (Analyte X22371.46) Levels,Phenotype,Protein Fam110A (Analyte X22371.46) Levels
35821,Acid Sphingomyelinase-Like Phosphodiesterase 3A (Analyte X4771.10) Levels,Phenotype,Acid Sphingomyelinase-Like Phosphodiesterase 3A (Analyte X4771.10) Levels
35822,Cd83 Antigen Levels,Phenotype,Cd83 Antigen Levels
35824,Mhc Class I Polypeptide-Related Sequence B Levels,Phenotype,Mhc Class I Polypeptide-Related Sequence B Levels
35830,Reticulon-4 Receptor Levels,Phenotype,Reticulon-4 Receptor Levels
35831,Platelet-Activating Factor Acetylhydrolase Levels,Phenotype,Platelet-Activating Factor Acetylhydrolase Levels
35833,Lactoylglutathione Lyase Levels,Phenotype,Lactoylglutathione Lyase Levels
35835,Peptidyl-Prolyl Cis-Trans Isomerase-Like 1 Levels,Phenotype,Peptidyl-Prolyl Cis-Trans Isomerase-Like 1 Levels
35837,Unconventional Myosin-Vi Levels,Phenotype,Unconventional Myosin-Vi Levels
35839,Complement C4B Levels,Phenotype,Complement C4B Levels
35842,Ras Association Domain-Containing Protein 2 Levels,Phenotype,Ras Association Domain-Containing Protein 2 Levels
35844,Delta-Like Protein 1 (Analyte X5349.69) Levels,Phenotype,Delta-Like Protein 1 (Analyte X5349.69) Levels
35850,Bipolar Disorder Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols)),Phenotype,Bipolar Disorder Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols))
35851,Anorexia Nervosa Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols)),Phenotype,Anorexia Nervosa Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols))
35852,Autism Spectrum Disorder Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols)),Phenotype,Autism Spectrum Disorder Vs Tourette'S Syndrome And Other Tic Disorders (Ordinary Least Squares (Ols))
35853,Adhd Vs Anorexia Nervosa (Ordinary Least Squares (Ols)),Phenotype,Adhd Vs Anorexia Nervosa (Ordinary Least Squares (Ols))
35855,Ultradistal Forearm Bone Mineral Density,Phenotype,Ultradistal Forearm Bone Mineral Density
35862,Laminin-2 Levels,Phenotype,Laminin-2 Levels
35864,C4A Anaphylatoxin Levels,Phenotype,C4A Anaphylatoxin Levels
35868,Interleukin-17B (Analyte X14022.17) Levels,Phenotype,Interleukin-17B (Analyte X14022.17) Levels
35869,Fibroblast Growth Factor 7 (Analyte X14031.18) Levels,Phenotype,Fibroblast Growth Factor 7 (Analyte X14031.18) Levels
35870,Interleukin-15 Receptor Subunit Alpha (Analyte X14054.17) Levels,Phenotype,Interleukin-15 Receptor Subunit Alpha (Analyte X14054.17) Levels
35872,Acid Sphingomyelinase-Like Phosphodiesterase 3A (Analyte X14086.11) Levels,Phenotype,Acid Sphingomyelinase-Like Phosphodiesterase 3A (Analyte X14086.11) Levels
35874,Thrombospondin-2 (Analyte X14111.15) Levels,Phenotype,Thrombospondin-2 (Analyte X14111.15) Levels
35876,Tumor Necrosis Factor Receptor Superfamily Member 10D Levels,Phenotype,Tumor Necrosis Factor Receptor Superfamily Member 10D Levels
35878,Apolipoprotein M (Analyte X14125.5) Levels,Phenotype,Apolipoprotein M (Analyte X14125.5) Levels
35880,Interleukin-36 Alpha Levels,Phenotype,Interleukin-36 Alpha Levels
35884,Homeobox Protein Six6 Levels,Phenotype,Homeobox Protein Six6 Levels
35885,Uncharacterized Metallophosphoesterase Cstp1 Levels,Phenotype,Uncharacterized Metallophosphoesterase Cstp1 Levels
35887,Adhesion G-Protein Coupled Receptor G1 Levels,Phenotype,Adhesion G-Protein Coupled Receptor G1 Levels
35889,Tryptase Beta-2 (Analyte X14696.45) Levels,Phenotype,Tryptase Beta-2 (Analyte X14696.45) Levels
35891,Secretagogin (Analyte X15305.7) Levels,Phenotype,Secretagogin (Analyte X15305.7) Levels
35893,Thioredoxin-Like Protein 4B Levels,Phenotype,Thioredoxin-Like Protein 4B Levels
35894,Prolyl Endopeptidase Levels,Phenotype,Prolyl Endopeptidase Levels
35896,Ras-Related Protein Rab-14 Levels,Phenotype,Ras-Related Protein Rab-14 Levels
35898,Stromal Cell-Derived Factor 2-Like Protein 1 Levels,Phenotype,Stromal Cell-Derived Factor 2-Like Protein 1 Levels
35901,Protein G6B:Isoform A-- Extracellular Domain Levels,Phenotype,Protein G6B:Isoform A-- Extracellular Domain Levels
35905,Igf-Like Family Receptor 1 Levels,Phenotype,Igf-Like Family Receptor 1 Levels
35908,Protein-Methionine Sulfoxide Oxidase Mical1 Levels,Phenotype,Protein-Methionine Sulfoxide Oxidase Mical1 Levels
35909,Nodal Modulator 2 Levels,Phenotype,Nodal Modulator 2 Levels
35911,Hla Class Ii Histocompatibility Antigen-- Dq Alpha 2 Chain Levels,Phenotype,Hla Class Ii Histocompatibility Antigen-- Dq Alpha 2 Chain Levels
35916,Dnaj Homolog Subfamily B Member 11 Levels,Phenotype,Dnaj Homolog Subfamily B Member 11 Levels
35918,C->U-Editing Enzyme Apobec-2 Levels,Phenotype,C->U-Editing Enzyme Apobec-2 Levels
35919,Inactive Pancreatic Lipase-Related Protein 1 Levels,Phenotype,Inactive Pancreatic Lipase-Related Protein 1 Levels
35921,Low-Density Lipoprotein Receptor-Related Protein 11 (Analyte X6713.4) Levels,Phenotype,Low-Density Lipoprotein Receptor-Related Protein 11 (Analyte X6713.4) Levels
35923,Hemoglobin Subunit Zeta Levels,Phenotype,Hemoglobin Subunit Zeta Levels
35925,Gdnf Family Receptor Alpha-Like Levels,Phenotype,Gdnf Family Receptor Alpha-Like Levels
35927,Procollagen-Lysine--2-Oxoglutarate 5-Dioxygenase 2 Levels,Phenotype,Procollagen-Lysine--2-Oxoglutarate 5-Dioxygenase 2 Levels
35928,Hepatitis A Virus Cellular Receptor 2 (Analyte X7152.5) Levels,Phenotype,Hepatitis A Virus Cellular Receptor 2 (Analyte X7152.5) Levels
35929,Gdh/6Pgl Endoplasmic Bifunctional Protein Levels,Phenotype,Gdh/6Pgl Endoplasmic Bifunctional Protein Levels
35932,Liver Carboxylesterase 1 (Analyte X7182.1) Levels,Phenotype,Liver Carboxylesterase 1 (Analyte X7182.1) Levels
35933,Leucine-Rich Repeat And Fibronectin Type-Iii Domain-Containing Protein 2 Levels,Phenotype,Leucine-Rich Repeat And Fibronectin Type-Iii Domain-Containing Protein 2 Levels
35935,Tuberoinfundibular Peptide Of 39 Residues Levels,Phenotype,Tuberoinfundibular Peptide Of 39 Residues Levels
35936,Cadherin-1 (Analyte X2501.51) Levels,Phenotype,Cadherin-1 (Analyte X2501.51) Levels
35938,Nadp-Dependent Malic Enzyme Levels,Phenotype,Nadp-Dependent Malic Enzyme Levels
35956,Sun-Seeking Behavior,Phenotype,Sun-Seeking Behavior
35958,Crohn'S Disease Vs Rheumatoid Arthritis (Ordinary Least Squares (Ols)),Phenotype,Crohn'S Disease Vs Rheumatoid Arthritis (Ordinary Least Squares (Ols))
35960,Acetyl-Coa Acetyltransferase-- Cytosolic Levels,Phenotype,Acetyl-Coa Acetyltransferase-- Cytosolic Levels
35962,Mam Domain-Containing Glycosylphosphatidylinositol Anchor Protein 1 Levels,Phenotype,Mam Domain-Containing Glycosylphosphatidylinositol Anchor Protein 1 Levels
35964,Killer Cell Immunoglobulin-Like Receptor 2Dl3 Levels,Phenotype,Killer Cell Immunoglobulin-Like Receptor 2Dl3 Levels
35966,Lysosome-Associated Membrane Glycoprotein 1 Levels,Phenotype,Lysosome-Associated Membrane Glycoprotein 1 Levels
35967,Ribonuclease T2 Levels,Phenotype,Ribonuclease T2 Levels
35969,Gmp Reductase 1 Levels,Phenotype,Gmp Reductase 1 Levels
35971,Daily Alcohol Intake X Rs671 Interaction (2Df),Phenotype,Daily Alcohol Intake X Rs671 Interaction (2Df)
35973,Alcohol Drinking Status X Rs671 Interaction (2Df),Phenotype,Alcohol Drinking Status X Rs671 Interaction (2Df)
35974,Butyrophilin Subfamily 3 Member A2 Levels,Phenotype,Butyrophilin Subfamily 3 Member A2 Levels
35981,Transcription Initiation Factor Iia Subunit 2 Levels,Phenotype,Transcription Initiation Factor Iia Subunit 2 Levels
35982,Butyrophilin Subfamily 3 Member A3 (Analyte X22950.6) Levels,Phenotype,Butyrophilin Subfamily 3 Member A3 (Analyte X22950.6) Levels
35986,Nkg2D Ligand 2 (Analyte X22583.47) Levels,Phenotype,Nkg2D Ligand 2 (Analyte X22583.47) Levels
35987,Butyrophilin Subfamily 2 Member A2 Levels,Phenotype,Butyrophilin Subfamily 2 Member A2 Levels
35991,N-Acetylgalactosamine-6-Sulfatase Levels,Phenotype,N-Acetylgalactosamine-6-Sulfatase Levels
35993,Glutamate Carboxypeptidase 2 (Analyte X5478.50) Levels,Phenotype,Glutamate Carboxypeptidase 2 (Analyte X5478.50) Levels
35995,Clinical Depression,Phenotype,Clinical Depression
36003,Angiostatin Levels,Phenotype,Angiostatin Levels
36004,Heat Shock 70 Kda Protein 1A (Analyte X4124.24) Levels,Phenotype,Heat Shock 70 Kda Protein 1A (Analyte X4124.24) Levels
36007,Methyltransferase-Like Protein 24 Levels,Phenotype,Methyltransferase-Like Protein 24 Levels
36009,Desmoglein-2 (Analyte X9484.75) Levels,Phenotype,Desmoglein-2 (Analyte X9484.75) Levels
36012,72 Kda Type Iv Collagenase Levels,Phenotype,72 Kda Type Iv Collagenase Levels
36014,Cysteine-Rich Secretory Protein 2 Levels,Phenotype,Cysteine-Rich Secretory Protein 2 Levels
36017,Peptidyl-Prolyl Cis-Trans Isomerase Fkbp7 Levels,Phenotype,Peptidyl-Prolyl Cis-Trans Isomerase Fkbp7 Levels
36021,Fibroblast Growth Factor 7 (Analyte X4487.1) Levels,Phenotype,Fibroblast Growth Factor 7 (Analyte X4487.1) Levels
36022,Interleukin-34 Levels,Phenotype,Interleukin-34 Levels
36024,Carbohydrate Sulfotransferase 6 Levels,Phenotype,Carbohydrate Sulfotransferase 6 Levels
36028,Ribosyldihydronicotinamide Dehydrogenase [Quinone] Levels,Phenotype,Ribosyldihydronicotinamide Dehydrogenase [Quinone] Levels
36030,Wap Four-Disulfide Core Domain Protein 1 Levels,Phenotype,Wap Four-Disulfide Core Domain Protein 1 Levels
36032,Protein Eyes Shut Homolog Levels,Phenotype,Protein Eyes Shut Homolog Levels
36034,Tryptase Beta-1 Levels,Phenotype,Tryptase Beta-1 Levels
36035,Nad(P)H Dehydrogenase [Quinone] 1 Levels,Phenotype,Nad(P)H Dehydrogenase [Quinone] 1 Levels
36038,Hla-C Levels,Phenotype,Hla-C Levels
36044,Crohn'S Disease Vs Ulcerative Colitis (Ordinary Least Squares (Ols)),Phenotype,Crohn'S Disease Vs Ulcerative Colitis (Ordinary Least Squares (Ols))
36045,Major Depressive Disorder Vs Adhd (Ordinary Least Squares (Ols)),Phenotype,Major Depressive Disorder Vs Adhd (Ordinary Least Squares (Ols))
36047,Psoriasis Or Type 2 Diabetes (Trans-Disease Meta-Analysis),Phenotype,Psoriasis Or Type 2 Diabetes (Trans-Disease Meta-Analysis)
36049,Psoriasis Or Type 2 Diabetes (Trans-Disease Meta-Analysis)(Opposite Effect),Phenotype,Psoriasis Or Type 2 Diabetes (Trans-Disease Meta-Analysis)(Opposite Effect)
36052,Childhood Aggressive Behavior,Phenotype,Childhood Aggressive Behavior
36056,Stomatin-Like Protein 2-- Mitochondrial Levels,Phenotype,Stomatin-Like Protein 2-- Mitochondrial Levels
36058,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 5 Levels,Phenotype,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 5 Levels
36060,Tolloid-Like Protein 1 Levels,Phenotype,Tolloid-Like Protein 1 Levels
36062,Upf0705 Protein C11Orf49 (Analyte X23767.1) Levels,Phenotype,Upf0705 Protein C11Orf49 (Analyte X23767.1) Levels
36063,Aspartate Aminotransferase-- Mitochondrial (Analyte X23903.3) Levels,Phenotype,Aspartate Aminotransferase-- Mitochondrial (Analyte X23903.3) Levels
36065,Sh2 Domain-Containing Adapter Protein D Levels,Phenotype,Sh2 Domain-Containing Adapter Protein D Levels
36067,Prosaposin Levels,Phenotype,Prosaposin Levels
36068,Adhesion G Protein-Coupled Receptor F5 Levels,Phenotype,Adhesion G Protein-Coupled Receptor F5 Levels
36070,Prenylcysteine Oxidase 1 Levels,Phenotype,Prenylcysteine Oxidase 1 Levels
36072,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 4 Levels,Phenotype,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 4 Levels
36094,Symptomatic Extra- And Intra-Cranial Atherosclerotic Stenosis,Phenotype,Symptomatic Extra- And Intra-Cranial Atherosclerotic Stenosis
36097,Phosphatidylcholine-O_18:0_[M+H]1+/Lysophosphatidylethanolamine_21:0_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_18:0_[M+H]1+/Lysophosphatidylethanolamine_21:0_[M+H]1+ Levels
36099,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ Levels
36101,Gamma Glutamyl Transferase Levels,Phenotype,Gamma Glutamyl Transferase Levels
36105,Phosphatidylcholine(36:3)_[M+H]1+/Phosphatidylethanolamine(39:3)_[M+H]1+/Phosphatidate(41:4)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(36:3)_[M+H]1+/Phosphatidylethanolamine(39:3)_[M+H]1+/Phosphatidate(41:4)_[M+Nh4]1+ Levels
36107,Node-Level Brain Connectivity (Multivariate Analysis),Phenotype,Node-Level Brain Connectivity (Multivariate Analysis)
36111,Serum Urate Levels,Phenotype,Serum Urate Levels
36153,Phosphatidylcholine_38:3_[M+H]1+/Phosphatidylethanolamine_41:3_[M+H]1+/Phosphatidate_43:4_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_38:3_[M+H]1+/Phosphatidylethanolamine_41:3_[M+H]1+/Phosphatidate_43:4_[M+Nh4]1+ Levels
36160,Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+Nh4]1+ Levels
36190,Serum Phosphate Levels,Phenotype,Serum Phosphate Levels
36221,Gut Bacterial Pathway Abundance (Glycocat.Pwy..Glycogen.Degradation.I..Bacterial.),Phenotype,Gut Bacterial Pathway Abundance (Glycocat.Pwy..Glycogen.Degradation.I..Bacterial.)
36223,Gut Bacterial Pathway Abundance (Pwy.5088..L.Glutamate.Degradation.Viii..To.Propanoate.),Phenotype,Gut Bacterial Pathway Abundance (Pwy.5088..L.Glutamate.Degradation.Viii..To.Propanoate.)
36257,Phosphatidylcholine(38:3)_[M+H]1+/Phosphatidylethanolamine(41:3)_[M+H]1+/Phosphatidate(43:4)_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine(38:3)_[M+H]1+/Phosphatidylethanolamine(41:3)_[M+H]1+/Phosphatidate(43:4)_[M+Nh4]1+ Levels
36267,White Blood Cell Count (Neutrophil),Phenotype,White Blood Cell Count (Neutrophil)
36270,Phosphatidylcholine(38:3)_[M+Oac]1-/Phosphatidylserine(42:2)_[M-H]1- Levels,Phenotype,Phosphatidylcholine(38:3)_[M+Oac]1-/Phosphatidylserine(42:2)_[M-H]1- Levels
36282,Phosphatidylethanolamine(40:2)_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine(40:2)_[M-H]1- Levels
36302,Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ Levels,Phenotype,Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ Levels
36317,Insulin-Like Growth Factor 1 Levels,Phenotype,Insulin-Like Growth Factor 1 Levels
36319,Phosphatidylcholine(38:2)_[M+H]1+/Phosphatidylethanolamine(41:2)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine(38:2)_[M+H]1+/Phosphatidylethanolamine(41:2)_[M+H]1+ Levels
36320,Heel Bone Mineral Density T Score,Phenotype,Heel Bone Mineral Density T Score
36322,Direct Bilirubin Levels,Phenotype,Direct Bilirubin Levels
36324,12-Lead Ecg Morphology Phenotype,Phenotype,12-Lead Ecg Morphology Phenotype
36332,Depressive Symptoms X Dependent Stressful Life Events Interaction (1Df Test),Phenotype,Depressive Symptoms X Dependent Stressful Life Events Interaction (1Df Test)
36334,Depressive Symptoms X Independent Stressful Life Events Interaction (2Df Test),Phenotype,Depressive Symptoms X Independent Stressful Life Events Interaction (2Df Test)
36336,Depressive Symptoms X Dependent Stressful Life Events Interaction (2Df Test),Phenotype,Depressive Symptoms X Dependent Stressful Life Events Interaction (2Df Test)
36337,Depressive Symptoms X Stressful Life Events Interaction (1Df Test),Phenotype,Depressive Symptoms X Stressful Life Events Interaction (1Df Test)
36338,Depressive Symptoms X Stressful Life Events Interaction (2Df Test),Phenotype,Depressive Symptoms X Stressful Life Events Interaction (2Df Test)
36339,Depressive Symptoms X Independent Stressful Life Events Interaction (1Df Test),Phenotype,Depressive Symptoms X Independent Stressful Life Events Interaction (1Df Test)
36359,Edge-Level Brain Connectivity (Multivariate Analysis),Phenotype,Edge-Level Brain Connectivity (Multivariate Analysis)
36363,Schizophrenia Or Breast Cancer (Pleiotropy),Phenotype,Schizophrenia Or Breast Cancer (Pleiotropy)
36365,Schizophrenia Or Er Positive Breast Cancer (Pleiotropy),Phenotype,Schizophrenia Or Er Positive Breast Cancer (Pleiotropy)
36370,White Blood Cell Count (Lymphocyte),Phenotype,White Blood Cell Count (Lymphocyte)
36373,White Blood Cell Count (Monocyte),Phenotype,White Blood Cell Count (Monocyte)
36396,Phosphatidylcholine_37:3_[M+Oac]1-/Phosphatidylserine_41:2_[M-H]1- Levels,Phenotype,Phosphatidylcholine_37:3_[M+Oac]1-/Phosphatidylserine_41:2_[M-H]1- Levels
36397,Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ Levels
36398,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ Levels
36401,Lung Function (Fvc) And Body Mass Index,Phenotype,Lung Function (Fvc) And Body Mass Index
36412,Mean Sphered Cell Volume,Phenotype,Mean Sphered Cell Volume
36422,Phosphatidylcholine(40:6)_[M+H]1+/Phosphatidylethanolamine(43:6)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine(40:6)_[M+H]1+/Phosphatidylethanolamine(43:6)_[M+H]1+ Levels
36424,Phosphatidylethanolamine_38:3_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine_38:3_[M-H]1- Levels
36432,Risky Substance Use,Phenotype,Risky Substance Use
36434,Phosphatidylcholine_36:3_[M+H]1+/Phosphatidylethanolamine_39:3_[M+H]1+/Phosphatidate_41:4_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_36:3_[M+H]1+/Phosphatidylethanolamine_39:3_[M+H]1+/Phosphatidate_41:4_[M+Nh4]1+ Levels
36435,Phosphatidylcholine-O(34:3)_[M+H]1+/Phosphatidylethanolamine-P(37:2)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine-O(34:3)_[M+H]1+/Phosphatidylethanolamine-P(37:2)_[M+H]1+ Levels
36459,Lung Function (Fev1) And Body Mass Index,Phenotype,Lung Function (Fev1) And Body Mass Index
36463,Cystatin C Levels,Phenotype,Cystatin C Levels
36470,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ Levels,Phenotype,Phosphatidylcholine(38:6)_[M+H]1+/Phosphatidylethanolamine(41:6)_[M+H]1+ Levels
36515,Cholesteryl Ester(20:3)_[M+Nh4]1+ Levels,Phenotype,Cholesteryl Ester(20:3)_[M+Nh4]1+ Levels
36559,Early-Onset Myasthenia Gravis,Phenotype,Early-Onset Myasthenia Gravis
36562,Diacylglycerol_38:5_[M+H-H2O]1+ Levels,Phenotype,Diacylglycerol_38:5_[M+H-H2O]1+ Levels
36578,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ Levels,Phenotype,Phosphatidylcholine_38:2_[M+H]1+/Phosphatidylethanolamine_41:2_[M+H]1+ Levels
36581,Go Reaction Time Variability,Phenotype,Go Reaction Time Variability
36609,Cholesteryl Ester_18:3_[M+Nh4]1+ Levels,Phenotype,Cholesteryl Ester_18:3_[M+Nh4]1+ Levels
36610,Cholesteryl Ester_20:3_[M+Nh4]1+ Levels,Phenotype,Cholesteryl Ester_20:3_[M+Nh4]1+ Levels
36612,Cholesteryl Ester_22:6_[M+Nh4]1+ Levels,Phenotype,Cholesteryl Ester_22:6_[M+Nh4]1+ Levels
36613,Phosphatidylethanolamine_38:5_[M-H]1- Levels,Phenotype,Phosphatidylethanolamine_38:5_[M-H]1- Levels
36625,Fatty Acid(20:3)_[M-H]1- Levels,Phenotype,Fatty Acid(20:3)_[M-H]1- Levels
36643,Acute Myeloid Leukemia Or Myelodysplastic Syndrome (Pleiotropy),Phenotype,Acute Myeloid Leukemia Or Myelodysplastic Syndrome (Pleiotropy)
36661,Externalizing Behaviour (Multivariate Analysis),Phenotype,Externalizing Behaviour (Multivariate Analysis)
36672,Osteoarthritis Of The Hip Or Knee (With Total Joint Replacement),Phenotype,Osteoarthritis Of The Hip Or Knee (With Total Joint Replacement)
36698,Body Mass Index And Bone Mineral Density (Pleiotropy),Phenotype,Body Mass Index And Bone Mineral Density (Pleiotropy)
36735,Kidney Cancer,Phenotype,Kidney Cancer
36746,Response To Erlotinib,Phenotype,Response To Erlotinib
36749,Response To Trametinib,Phenotype,Response To Trametinib
36752,Response To Arsenic Trioxide,Phenotype,Response To Arsenic Trioxide
36755,Response To Vemurafenib,Phenotype,Response To Vemurafenib
36757,Response To Paclitaxel And Epirubicin,Phenotype,Response To Paclitaxel And Epirubicin
36760,Response To Vinblastine,Phenotype,Response To Vinblastine
36762,Hydroxycholesterol_[M+H-2H2O]1+ Levels,Phenotype,Hydroxycholesterol_[M+H-2H2O]1+ Levels
36764,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ Levels,Phenotype,Lysophosphatidylcholine_16:0_[M+H]1+/Lysophosphatidylethanolamine_19:0_[M+H]1+ Levels
36772,Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+Nh4]1+ Levels
36796,Clear Cell Renal Cell Carcinoma,Phenotype,Clear Cell Renal Cell Carcinoma
36803,Osteoarthritis (With Total Hip Replacement),Phenotype,Osteoarthritis (With Total Hip Replacement)
36807,Finger Osteoarthritis,Phenotype,Finger Osteoarthritis
36811,Change In High-Sensitivity Cardiac Troponin I Concentration,Phenotype,Change In High-Sensitivity Cardiac Troponin I Concentration
36813,High-Sensitivity Cardiac Troponin I Concentration,Phenotype,High-Sensitivity Cardiac Troponin I Concentration
36827,Phosphatidylinositol(40:6)_[M-H]1- Levels,Phenotype,Phosphatidylinositol(40:6)_[M-H]1- Levels
36838,Delayed Neurodevelopment,Phenotype,Delayed Neurodevelopment
36872,Sleepwalking,Phenotype,Sleepwalking
36877,Idiopathic Achalasia,Phenotype,Idiopathic Achalasia
36881,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+Nh4]1+ Levels
36882,Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+Nh4]1+ Levels
36883,Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+Nh4]1+ Levels
36895,Physical Activity,Phenotype,Physical Activity
36898,Suicide Attempt,Phenotype,Suicide Attempt
36902,Cardiorespiratory Fitness (Vo2 Max),Phenotype,Cardiorespiratory Fitness (Vo2 Max)
36905,Vitamin D-Binding Protein Levels (Adjusted For Gc Haplotype),Phenotype,Vitamin D-Binding Protein Levels (Adjusted For Gc Haplotype)
36909,Lysophosphatidylethanolamine_18:0_[M-H]1- Levels,Phenotype,Lysophosphatidylethanolamine_18:0_[M-H]1- Levels
36910,Lysophosphatidylethanolamine_20:0_[M-H]1- Levels,Phenotype,Lysophosphatidylethanolamine_20:0_[M-H]1- Levels
36911,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+Nh4]1+ Levels
36912,Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+Nh4]1+ Levels,Phenotype,Phosphatidylcholine_34:3_[M+H]1+/Phosphatidylethanolamine_37:3_[M+H]1+/Phosphatidate_39:4_[M+Nh4]1+ Levels
36934,Human Papilloma Virus 16 Negative Oropharyngeal Cancer,Phenotype,Human Papilloma Virus 16 Negative Oropharyngeal Cancer
36936,Human Papilloma Virus 16 Positive Oropharyngeal Cancer,Phenotype,Human Papilloma Virus 16 Positive Oropharyngeal Cancer
36940,Oropharynx Cancer And Human Papilloma Virus 16 Negative Oropharyngeal Cancer,Phenotype,Oropharynx Cancer And Human Papilloma Virus 16 Negative Oropharyngeal Cancer
36952,Breast Cancer And/Or Colorectal Cancer,Phenotype,Breast Cancer And/Or Colorectal Cancer
36956,Educational Attainment (Mtag),Phenotype,Educational Attainment (Mtag)
36957,Pre-Treatment Viral Load In Hiv-1 Infection,Phenotype,Pre-Treatment Viral Load In Hiv-1 Infection
36965,Velopharyngeal Dysfunction,Phenotype,Velopharyngeal Dysfunction
36969,Cognitive Empathy,Phenotype,Cognitive Empathy
36995,Anorexia Nervosa-- Attention-Deficit/Hyperactivity Disorder-- Autism Spectrum Disorder-- Bipolar Disorder-- Major Depression-- Obsessive-Compulsive Disorder-- Schizophrenia-- Or Tourette Syndrome (Pleiotropy),Phenotype,Anorexia Nervosa-- Attention-Deficit/Hyperactivity Disorder-- Autism Spectrum Disorder-- Bipolar Disorder-- Major Depression-- Obsessive-Compulsive Disorder-- Schizophrenia-- Or Tourette Syndrome (Pleiotropy)
37009,Hypertrophic Cardiomyopathy (Sarcomere Positive),Phenotype,Hypertrophic Cardiomyopathy (Sarcomere Positive)
37011,Hypertrophic Cardiomyopathy (Sarcomere Negative),Phenotype,Hypertrophic Cardiomyopathy (Sarcomere Negative)
37014,Self-Reported Math Ability (Mtag),Phenotype,Self-Reported Math Ability (Mtag)
37025,T Cell Lymphocyte Profile Difference,Phenotype,T Cell Lymphocyte Profile Difference
37028,Childhood Body Fatness,Phenotype,Childhood Body Fatness
37029,Self-Reported Math Ability,Phenotype,Self-Reported Math Ability
37043,Aerodigestive Squamous Cell Cancer (Pleiotropy),Phenotype,Aerodigestive Squamous Cell Cancer (Pleiotropy)
37044,Shigella-Associated Diarrhea,Phenotype,Shigella-Associated Diarrhea
37049,Systolic Blood Pressure (Education Interaction),Phenotype,Systolic Blood Pressure (Education Interaction)
37050,Diastolic Blood Pressure (Education Interaction),Phenotype,Diastolic Blood Pressure (Education Interaction)
37075,Adverse Response To Benznidazole In Chagas Disease,Phenotype,Adverse Response To Benznidazole In Chagas Disease
37084,Bmi X Environmental Factors (Including Physical Activity) Interaction,Phenotype,Bmi X Environmental Factors (Including Physical Activity) Interaction
37086,Bmi X  Environmental Factors (Excluding Physical Activity) Interaction,Phenotype,Bmi X  Environmental Factors (Excluding Physical Activity) Interaction
37102,Fever In Mesalamine-Treated Irritable Bowel Disease,Phenotype,Fever In Mesalamine-Treated Irritable Bowel Disease
37104,Fever And Diarrhea In Mesalamine-Treated Irritable Bowel Disease,Phenotype,Fever And Diarrhea In Mesalamine-Treated Irritable Bowel Disease
37146,Macular Thickness,Phenotype,Macular Thickness
37148,Childhood Onset Ulcerative Colitis,Phenotype,Childhood Onset Ulcerative Colitis
37151,Fulminant Type 1 Diabetes,Phenotype,Fulminant Type 1 Diabetes
37162,Facial Morphology Traits (63 Three-Dimensional Facial Segments),Phenotype,Facial Morphology Traits (63 Three-Dimensional Facial Segments)
37180,B Cell Lymphocyte Profile Difference,Phenotype,B Cell Lymphocyte Profile Difference
37195,Cognitive Performance (Mtag),Phenotype,Cognitive Performance (Mtag)
37210,Sum Of Carotid Plaque Area,Phenotype,Sum Of Carotid Plaque Area
37212,Carotid Plaque Maximum Area,Phenotype,Carotid Plaque Maximum Area
37213,Mean Area Of Carotid Plaque,Phenotype,Mean Area Of Carotid Plaque
37215,Maximum Stenosis,Phenotype,Maximum Stenosis
37216,Mean Degree Of Stenosis,Phenotype,Mean Degree Of Stenosis
37221,Adiponectin Levels X Mediterranean Diet Adherence Interaction,Phenotype,Adiponectin Levels X Mediterranean Diet Adherence Interaction
37225,Post-Traumatic Stress Disorder (Mental Health Questionnaire Or Predicted),Phenotype,Post-Traumatic Stress Disorder (Mental Health Questionnaire Or Predicted)
37228,Generalized Anxiety Disorder (Phenotype Risk Score),Phenotype,Generalized Anxiety Disorder (Phenotype Risk Score)
37230,Post-Traumatic Stress Disorder (Phenotype Risk Score),Phenotype,Post-Traumatic Stress Disorder (Phenotype Risk Score)
37263,Autoimmune Traits (Pleiotropy),Phenotype,Autoimmune Traits (Pleiotropy)
37267,Left-handedness,Phenotype,Left-handedness
37274,Breast Cancer In Brca2 Mutation Carriers,Phenotype,Breast Cancer In Brca2 Mutation Carriers
37276,Extranodal Natural Killer T-Cell Lymphoma (Nasal Type),Phenotype,Extranodal Natural Killer T-Cell Lymphoma (Nasal Type)
37278,Metastasis In Stage I-Iii Microsatellite Instability Low/Stable Colorectal Cancer (Time To Event),Phenotype,Metastasis In Stage I-Iii Microsatellite Instability Low/Stable Colorectal Cancer (Time To Event)
37280,Cellular Nuclear Factor (Erythroid-Derived 2)-Like 2 Levels,Phenotype,Cellular Nuclear Factor (Erythroid-Derived 2)-Like 2 Levels
37282,Heart Rate In Heart Failure With Reduced Ejection Fraction,Phenotype,Heart Rate In Heart Failure With Reduced Ejection Fraction
37318,Sero-Negative Rheumatoid Arthritis,Phenotype,Sero-Negative Rheumatoid Arthritis
37321,Carotid Plaque,Phenotype,Carotid Plaque
37344,Sum Of Stenosis,Phenotype,Sum Of Stenosis
37345,Urinary Albumin Excretion,Phenotype,Urinary Albumin Excretion
37347,Poor Prognosis In Crohn'S Disease,Phenotype,Poor Prognosis In Crohn'S Disease
37352,Macular Telangiectasia Type 2,Phenotype,Macular Telangiectasia Type 2
37354,Cannabis Smoking Or Cigarette Smoking Or Schizophrenia,Phenotype,Cannabis Smoking Or Cigarette Smoking Or Schizophrenia
37357,Hypo-HDL-cholesterolemia,Phenotype,Hypo-HDL-cholesterolemia
37362,Bmi At 5 Years Old,Phenotype,Bmi At 5 Years Old
37364,Adult Hearing Difficulty,Phenotype,Adult Hearing Difficulty
37367,Alzheimer'S Disease With Memory Domain Impairment,Phenotype,Alzheimer'S Disease With Memory Domain Impairment
37369,Alzheimer'S Disease With Visuospatial Domain Impairment,Phenotype,Alzheimer'S Disease With Visuospatial Domain Impairment
37372,Alzheimer'S Disease With Multiple Cognitive Domain Impairments,Phenotype,Alzheimer'S Disease With Multiple Cognitive Domain Impairments
37374,Alzheimer'S Disease With No Specific Cognitive Domain Impairment,Phenotype,Alzheimer'S Disease With No Specific Cognitive Domain Impairment
37379,Health Literacy,Phenotype,Health Literacy
37384,Response To Cognitive-Behavioural Therapy In Anxiety Disorder,Phenotype,Response To Cognitive-Behavioural Therapy In Anxiety Disorder
37387,Response To Cognitive-Behavioural Therapy In Major Depressive Disorder,Phenotype,Response To Cognitive-Behavioural Therapy In Major Depressive Disorder
37389,Aromatic Antiseizure Medication-Induced Stevens-Johnson Syndrome Or Toxic Epidermal Necrolysis In Hla-B*15:02 Non-Carriers,Phenotype,Aromatic Antiseizure Medication-Induced Stevens-Johnson Syndrome Or Toxic Epidermal Necrolysis In Hla-B*15:02 Non-Carriers
37399,Candidemia,Phenotype,Candidemia
37400,Response To Hepatitis B Vaccine,Phenotype,Response To Hepatitis B Vaccine
37406,Sensitivity To Environmental Stress And Adversity,Phenotype,Sensitivity To Environmental Stress And Adversity
37450,Sleep (Number Of Episodes),Phenotype,Sleep (Number Of Episodes)
37459,Peginterferon Alfa-2A Treatment Response In Chronic Hepatitis B Infection,Phenotype,Peginterferon Alfa-2A Treatment Response In Chronic Hepatitis B Infection
37498,Major Depressive Episode Treated With Electroconvulsive Therapy,Phenotype,Major Depressive Episode Treated With Electroconvulsive Therapy
37500,Major Depressive Disorder And Major Depressive Episode Treated With Electroconvulsive Therapy,Phenotype,Major Depressive Disorder And Major Depressive Episode Treated With Electroconvulsive Therapy
37505,Carotenoid Levels,Phenotype,Carotenoid Levels
37507,Lipid Or Lipoprotein Levels,Phenotype,Lipid Or Lipoprotein Levels
37508,Iga Levels,Phenotype,Iga Levels
37510,Composite Immunoglobulin Trait (Iga/Igg),Phenotype,Composite Immunoglobulin Trait (Iga/Igg)
37512,Composite Immunoglobulin Trait (Iga/Igm),Phenotype,Composite Immunoglobulin Trait (Iga/Igm)
37516,Composite Immunoglobulin Trait (Iga X Igg X Igm),Phenotype,Composite Immunoglobulin Trait (Iga X Igg X Igm)
37524,Left Ventricular Mass To End-Diastolic Volume Ratio,Phenotype,Left Ventricular Mass To End-Diastolic Volume Ratio
37526,Left Ventricular Global Circumferential Strain,Phenotype,Left Ventricular Global Circumferential Strain
37528,Dilated Cardiomyopathy (Mtag),Phenotype,Dilated Cardiomyopathy (Mtag)
37530,Left Ventricular Global Radial Strain,Phenotype,Left Ventricular Global Radial Strain
37531,Left Ventricular Global Longitudinal Strain,Phenotype,Left Ventricular Global Longitudinal Strain
37533,Hypertrophic Cardiomyopathy (Mtag),Phenotype,Hypertrophic Cardiomyopathy (Mtag)
37535,Sleep Duration (Short Sleep),Phenotype,Sleep Duration (Short Sleep)
37541,Sleep Duration (Long Sleep),Phenotype,Sleep Duration (Long Sleep)
37570,Latent Autoimmune Diabetes,Phenotype,Latent Autoimmune Diabetes
37571,Latent Autoimmune Diabetes Vs. Type 2 Diabetes,Phenotype,Latent Autoimmune Diabetes Vs. Type 2 Diabetes
37572,Latent Autoimmune Diabetes Vs. Type 1 Diabetes,Phenotype,Latent Autoimmune Diabetes Vs. Type 1 Diabetes
37573,Seasonality And Depression,Phenotype,Seasonality And Depression
37580,Hdl Cholesterol And Triglyceride Levels (Pleiotropy),Phenotype,Hdl Cholesterol And Triglyceride Levels (Pleiotropy)
37581,Delayed Reward Discounting,Phenotype,Delayed Reward Discounting
37584,Plasma Renin Activity Levels,Phenotype,Plasma Renin Activity Levels
37586,Diffusing Capacity Of The Lung For Carbon Monoxide Traits,Phenotype,Diffusing Capacity Of The Lung For Carbon Monoxide Traits
37588,Upper Eyelid Sagging Severity,Phenotype,Upper Eyelid Sagging Severity
37592,Initial Alcohol Sensitivity,Phenotype,Initial Alcohol Sensitivity
37626,Waist-To-Hip Ratio Adjusted For Bmi (Additive Genetic Model),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Additive Genetic Model)
37633,Morning Person,Phenotype,Morning Person
37653,Smoking Behaviour (Cigarettes Smoked Per Day),Phenotype,Smoking Behaviour (Cigarettes Smoked Per Day)
37657,Smoking Cessation,Phenotype,Smoking Cessation
37659,Plasma Anastrozole Concentration In Anastrozole-Treated Estrogen Receptor Positive Breast Cancer,Phenotype,Plasma Anastrozole Concentration In Anastrozole-Treated Estrogen Receptor Positive Breast Cancer
37676,Age Of Smoking Initiation (Mtag),Phenotype,Age Of Smoking Initiation (Mtag)
37680,Smoking Initiation (Ever Regular Vs Never Regular) (Mtag),Phenotype,Smoking Initiation (Ever Regular Vs Never Regular) (Mtag)
37693,Thyroglobulin Plasma Levels,Phenotype,Thyroglobulin Plasma Levels
37715,Postoperative Survival Time In Hepatocellular Carcinoma,Phenotype,Postoperative Survival Time In Hepatocellular Carcinoma
37717,Chronic Obstructive Pulmonary Disease Or Resting Heart Rate (Pleiotropy),Phenotype,Chronic Obstructive Pulmonary Disease Or Resting Heart Rate (Pleiotropy)
37745,Lumbar Spine Bone Mineral Density (Trabecular),Phenotype,Lumbar Spine Bone Mineral Density (Trabecular)
37746,Lumbar Spine Bone Mineral Density (Integral),Phenotype,Lumbar Spine Bone Mineral Density (Integral)
37748,Depression In Smokers,Phenotype,Depression In Smokers
37760,Cerebral Amyloid Angiopathy In Apoee4 Non-Carrier Alzheimer’S Disease,Phenotype,Cerebral Amyloid Angiopathy In Apoee4 Non-Carrier Alzheimer’S Disease
37762,Cerebral Amyloid Angiopathy X Sex Interaction In Alzheimer’S Disease,Phenotype,Cerebral Amyloid Angiopathy X Sex Interaction In Alzheimer’S Disease
37764,Cerebral Amyloid Angiopathy X Apoee4 Status Interaction In Alzheimer’S Disease,Phenotype,Cerebral Amyloid Angiopathy X Apoee4 Status Interaction In Alzheimer’S Disease
37769,Cerebral Amyloid Angiopathy In Alzheimer’S Disease,Phenotype,Cerebral Amyloid Angiopathy In Alzheimer’S Disease
37804,Major Adverse Cardiovascular Events In Response To Aspirin And Clopidogrel Treatment,Phenotype,Major Adverse Cardiovascular Events In Response To Aspirin And Clopidogrel Treatment
37819,Lymphocyte-To-Monocyte Ratio,Phenotype,Lymphocyte-To-Monocyte Ratio
37822,Neutrophil-To-Lymphocyte Ratio,Phenotype,Neutrophil-To-Lymphocyte Ratio
37828,Platelet-To-Lymphocyte Ratio,Phenotype,Platelet-To-Lymphocyte Ratio
37835,Corneal Resistance Factor (Mtag),Phenotype,Corneal Resistance Factor (Mtag)
37838,Central Corneal Thickness (Mtag),Phenotype,Central Corneal Thickness (Mtag)
37842,Kawasaki Disease Or Immunoglobulin A Vasculitis (Pleiotropy),Phenotype,Kawasaki Disease Or Immunoglobulin A Vasculitis (Pleiotropy)
37910,Liver Stiffness Changes At Sustained Virological Response Following Antiviral Therapy In Hcv Infection,Phenotype,Liver Stiffness Changes At Sustained Virological Response Following Antiviral Therapy In Hcv Infection
37933,Intracerebral Hemorrhage Stroke,Phenotype,Intracerebral Hemorrhage Stroke
37935,Subcortical Intracerebral Hemorrhage,Phenotype,Subcortical Intracerebral Hemorrhage
37937,Triglyceride To Hdl Cholesterol Ratio,Phenotype,Triglyceride To Hdl Cholesterol Ratio
37939,Sensation Seeking (Measured By Upps At 28 Years),Phenotype,Sensation Seeking (Measured By Upps At 28 Years)
37951,Trunk Lean Mass,Phenotype,Trunk Lean Mass
37952,Gynoid Fat Mass,Phenotype,Gynoid Fat Mass
37954,Android Bone Mass,Phenotype,Android Bone Mass
37956,Right Unilateral Cleft Lip,Phenotype,Right Unilateral Cleft Lip
37959,Left Unilateral Cleft Lip,Phenotype,Left Unilateral Cleft Lip
37961,Right Unilateral Cleft Lip And Palate,Phenotype,Right Unilateral Cleft Lip And Palate
37963,Left Unilateral Cleft Lip And Palate,Phenotype,Left Unilateral Cleft Lip And Palate
37973,Idiopathic Central Precocious Puberty,Phenotype,Idiopathic Central Precocious Puberty
37976,Frailty Index,Phenotype,Frailty Index
37977,Nasal Protrusion,Phenotype,Nasal Protrusion
37979,Neuroticism Conditioned On Cognitive Performance (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Cognitive Performance (Multi-Trait Conditioning And Joint Analysis)
37982,Thoracic Aortic Aneurysms,Phenotype,Thoracic Aortic Aneurysms
37984,Neuroticism Conditioned On Townsend Deprivation Index (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Townsend Deprivation Index (Multi-Trait Conditioning And Joint Analysis)
37991,Neuroticism Conditioned On Average Household Income Before Tax (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Average Household Income Before Tax (Multi-Trait Conditioning And Joint Analysis)
37992,Neuroticism Conditioned On Educational Attainment (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Educational Attainment (Multi-Trait Conditioning And Joint Analysis)
37993,Neuroticism Conditioned On Highest Math Class (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Highest Math Class (Multi-Trait Conditioning And Joint Analysis)
38001,Neuroticism Conditioned On Self-Rated Math Ability (Multi-Trait Conditioning And Joint Analysis),Phenotype,Neuroticism Conditioned On Self-Rated Math Ability (Multi-Trait Conditioning And Joint Analysis)
38006,Childhood Asthma X Sex Interaction,Phenotype,Childhood Asthma X Sex Interaction
38008,Recurrence-Free Survival In Non-Muscle-Invasive Bladder Cancer,Phenotype,Recurrence-Free Survival In Non-Muscle-Invasive Bladder Cancer
38010,Progression-Free Survival In Non-Muscle-Invasive Bladder Cancer,Phenotype,Progression-Free Survival In Non-Muscle-Invasive Bladder Cancer
38022,Hearing Function,Phenotype,Hearing Function
38025,Hearing Function (Left/Right Asymmetry),Phenotype,Hearing Function (Left/Right Asymmetry)
38063,Opioid Dependence (Time To Event),Phenotype,Opioid Dependence (Time To Event)
38075,Htlv-1 Associated Myelopathy,Phenotype,Htlv-1 Associated Myelopathy
38091,Wheat-Dependent Exercise-Induced Anaphylaxis,Phenotype,Wheat-Dependent Exercise-Induced Anaphylaxis
38111,Complement Factor H-Like 1 Protein Levels,Phenotype,Complement Factor H-Like 1 Protein Levels
38143,Complement Factor H Measurement,Phenotype,Complement Factor H Measurement
38152,Complement Factor H-Related Protein 1 Levels,Phenotype,Complement Factor H-Related Protein 1 Levels
38155,Complement Factor H-Related Protein 3 Levels,Phenotype,Complement Factor H-Related Protein 3 Levels
38158,Complement Factor H-Related Protein 2 Levels,Phenotype,Complement Factor H-Related Protein 2 Levels
38222,Pulmonary Mycobacterium Avium Complex Disease,Phenotype,Pulmonary Mycobacterium Avium Complex Disease
38276,Complement Factor H-Related Protein 4 Levels,Phenotype,Complement Factor H-Related Protein 4 Levels
38322,Complement Factor H-Related Protein 5 Levels,Phenotype,Complement Factor H-Related Protein 5 Levels
38335,Switch To Non-Stimulant Treatment In Adhd,Phenotype,Switch To Non-Stimulant Treatment In Adhd
38366,Tinnitus (Chronic-- Bothersome),Phenotype,Tinnitus (Chronic-- Bothersome)
38369,Total Cerebellar Volume (Excluding Crus I Vermis),Phenotype,Total Cerebellar Volume (Excluding Crus I Vermis)
38374,Body Fat Percentage Or Coronary Artery Disease (Mtag),Phenotype,Body Fat Percentage Or Coronary Artery Disease (Mtag)
38375,Body Fat Percentage Or Heart Failure (Mtag),Phenotype,Body Fat Percentage Or Heart Failure (Mtag)
38402,Warfarin Dose Variability,Phenotype,Warfarin Dose Variability
38415,Progesterone Levels,Phenotype,Progesterone Levels
38434,Testosterone To Estradiol Ratio,Phenotype,Testosterone To Estradiol Ratio
38436,Schizophrenia-- Bipolar Disorder Or Recurrent Major Depressive Disorder,Phenotype,Schizophrenia-- Bipolar Disorder Or Recurrent Major Depressive Disorder
38439,Schizophrenia-- Bipolar Disorder Or Recurrent Major Depressive Disorder X Sex Interaction (3Df),Phenotype,Schizophrenia-- Bipolar Disorder Or Recurrent Major Depressive Disorder X Sex Interaction (3Df)
38442,Schizophrenia-- Bipolar Disorder Or Major Depressive Disorder,Phenotype,Schizophrenia-- Bipolar Disorder Or Major Depressive Disorder
38444,Schizophrenia-- Bipolar Disorder Or Major Depressive Disorder X Sex Interaction (3Df),Phenotype,Schizophrenia-- Bipolar Disorder Or Major Depressive Disorder X Sex Interaction (3Df)
38446,Response To Antipsychotic Treatment In Schizophrenia,Phenotype,Response To Antipsychotic Treatment In Schizophrenia
38456,Lipoprotein-Associated Phospholipase A2 Mass,Phenotype,Lipoprotein-Associated Phospholipase A2 Mass
38458,Bisphosphonate-Related Osteonecrosis Of The Jaw,Phenotype,Bisphosphonate-Related Osteonecrosis Of The Jaw
38462,Language Functional Connectivity,Phenotype,Language Functional Connectivity
38480,Schizophrenia X Sex Interaction,Phenotype,Schizophrenia X Sex Interaction
38482,Bipolar Disorder X Sex Interaction,Phenotype,Bipolar Disorder X Sex Interaction
38484,Major Depressive Disorder X Sex Interaction,Phenotype,Major Depressive Disorder X Sex Interaction
38493,Lipoprotein-Associated Phospholipase A2 Activity,Phenotype,Lipoprotein-Associated Phospholipase A2 Activity
38578,Vertigo,Phenotype,Vertigo
38646,Copper Levels,Phenotype,Copper Levels
38658,Negative Urgency (Measured By Upps At 28 Years),Phenotype,Negative Urgency (Measured By Upps At 28 Years)
38662,Sensation Seeking (Measured By Upps At 26 Years),Phenotype,Sensation Seeking (Measured By Upps At 26 Years)
38693,Metabolic Biomarkers (Multivariate Analysis),Phenotype,Metabolic Biomarkers (Multivariate Analysis)
38723,Cognitive Processing Speed,Phenotype,Cognitive Processing Speed
38726,Cognitive Processing Accuracy,Phenotype,Cognitive Processing Accuracy
38734,Dna Methylation-Estimated Plasminogen Activator Inhibitor-1 Levels,Phenotype,Dna Methylation-Estimated Plasminogen Activator Inhibitor-1 Levels
38736,Dna Methylation Phenoage Acceleration,Phenotype,Dna Methylation Phenoage Acceleration
38795,Hemorrhagic Fever With Renal Syndrome,Phenotype,Hemorrhagic Fever With Renal Syndrome
38798,Hemorrhagic Fever With Renal Syndrome (Severe Vs Mild),Phenotype,Hemorrhagic Fever With Renal Syndrome (Severe Vs Mild)
38808,Random Glucose Levels,Phenotype,Random Glucose Levels
38840,Systolic Blood Pressure (Mtag),Phenotype,Systolic Blood Pressure (Mtag)
38875,Dna Methylation Grimage Acceleration,Phenotype,Dna Methylation Grimage Acceleration
38894,Non-Albumin Protein Levels,Phenotype,Non-Albumin Protein Levels
38900,Lipoprotein A Levels (Ukb Data Field 30790),Phenotype,Lipoprotein A Levels (Ukb Data Field 30790)
38908,Alkaline Phosphatase (Ukb Data Field 30610),Phenotype,Alkaline Phosphatase (Ukb Data Field 30610)
38912,Ocular Disease,Phenotype,Ocular Disease
38914,Severe Insulin-Resistant Type 2 Diabetes,Phenotype,Severe Insulin-Resistant Type 2 Diabetes
38916,Severe Insulin-Deficient Type 2 Diabetes,Phenotype,Severe Insulin-Deficient Type 2 Diabetes
38919,Mild Obesity-Related Type 2 Diabetes,Phenotype,Mild Obesity-Related Type 2 Diabetes
38921,Mild Age-Related Type 2 Diabetes,Phenotype,Mild Age-Related Type 2 Diabetes
38923,Severe Autoimmune Type 2 Diabetes,Phenotype,Severe Autoimmune Type 2 Diabetes
38966,Response To Levetiracetam In Focal Epilepsy,Phenotype,Response To Levetiracetam In Focal Epilepsy
38968,Response To Phenytoin In Focal Epilepsy,Phenotype,Response To Phenytoin In Focal Epilepsy
38988,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node1),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node1)
38992,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node25),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node25)
38994,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node26),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node26)
38996,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node27),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node27)
38998,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node29),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node29)
39000,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node42),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node42)
39002,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node2),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node2)
39003,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node3),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node3)
39005,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node5),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node5)
39006,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node17),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node17)
39007,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node9),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node9)
39009,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node11),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node11)
39010,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node14),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node14)
39011,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node20),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node20)
39012,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node21),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net25_Node21)
39013,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node44),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node44)
39014,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node48),Phenotype,Brain Rsfmri Measurement (Amplitude Of Low Frequency Fluctations) (Net100_Node48)
39018,Dna Methylation Hannum Age Acceleration,Phenotype,Dna Methylation Hannum Age Acceleration
39030,Wellbeing Index,Phenotype,Wellbeing Index
39032,Childhood Maltreatment,Phenotype,Childhood Maltreatment
39063,Testosterone Levels,Phenotype,Testosterone Levels
39079,Type 2 Diabetes Or Polycystic Ovary Syndrome (Pleiotropy),Phenotype,Type 2 Diabetes Or Polycystic Ovary Syndrome (Pleiotropy)
39080,Type 2 Diabetes (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy),Phenotype,Type 2 Diabetes (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy)
39082,Fasting Insulin (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy),Phenotype,Fasting Insulin (Adjusted For Bmi) Or Polycystic Ovary Syndrome (Pleiotropy)
39084,Hba1C Or Polycystic Ovary Syndrome (Pleiotropy),Phenotype,Hba1C Or Polycystic Ovary Syndrome (Pleiotropy)
39106,Stimulant Dependence,Phenotype,Stimulant Dependence
39109,Ascending Aorta Diameter,Phenotype,Ascending Aorta Diameter
39114,Neonatal Abstinence Syndrome,Phenotype,Neonatal Abstinence Syndrome
39127,Bisoprolol Clearance In Non-St Elevation Acute Coronary Syndrome,Phenotype,Bisoprolol Clearance In Non-St Elevation Acute Coronary Syndrome
39142,Epigenetic Age Acceleration (Hannum) In Childhood Cancer Survivors,Phenotype,Epigenetic Age Acceleration (Hannum) In Childhood Cancer Survivors
39213,Response To Levetiracetam In Epilepsy,Phenotype,Response To Levetiracetam In Epilepsy
39215,Clostridioides Difficle Infection,Phenotype,Clostridioides Difficle Infection
39310,Primary Dental Caries (Decayed And Filled Teeth),Phenotype,Primary Dental Caries (Decayed And Filled Teeth)
39312,Permanent Dental Caries (Decayed And Filled Teeth),Phenotype,Permanent Dental Caries (Decayed And Filled Teeth)
39322,Albuminuria,Phenotype,Albuminuria
39323,Dyslipidemia,Phenotype,Dyslipidemia
39325,Osteoporosis,Phenotype,Osteoporosis
39328,Carotid Artery Intima-Media Thickness In Type 2 Diabetes,Phenotype,Carotid Artery Intima-Media Thickness In Type 2 Diabetes
39330,Coronary Artery Calcification In Type 2 Diabetes (Excluding Prevalent Cardiovascular Disease),Phenotype,Coronary Artery Calcification In Type 2 Diabetes (Excluding Prevalent Cardiovascular Disease)
39337,Femur Bone Mineral Density X Serum Urate Levels Interaction,Phenotype,Femur Bone Mineral Density X Serum Urate Levels Interaction
39348,Aspartate Aminotransferase To Alanine Aminotransferase Ratio,Phenotype,Aspartate Aminotransferase To Alanine Aminotransferase Ratio
39360,Mean Platelet Volume During First Trimester Of Pregnancy,Phenotype,Mean Platelet Volume During First Trimester Of Pregnancy
39375,Total Protein Levels X Insomnia Interaction,Phenotype,Total Protein Levels X Insomnia Interaction
39377,Mean Platelet Volume During The Postpartum Period,Phenotype,Mean Platelet Volume During The Postpartum Period
39380,Mean Platelet Volume At Delivery,Phenotype,Mean Platelet Volume At Delivery
39385,Fasting Total Lipids In Very Small Vldl,Phenotype,Fasting Total Lipids In Very Small Vldl
39386,Fasting Very Small Vldl Particle Concentration,Phenotype,Fasting Very Small Vldl Particle Concentration
39387,Fasting Phospholipid Levels In Very Large Hdl,Phenotype,Fasting Phospholipid Levels In Very Large Hdl
39388,Fasting Total Cholesterol In Very Small Vldl,Phenotype,Fasting Total Cholesterol In Very Small Vldl
39389,Fasting Cholesterol Esters In Very Small Vldl,Phenotype,Fasting Cholesterol Esters In Very Small Vldl
39390,Fasting Total Cholesterol In Very Large Hdl,Phenotype,Fasting Total Cholesterol In Very Large Hdl
39391,Fasting Cholesterol Esters In Very Large Hdl,Phenotype,Fasting Cholesterol Esters In Very Large Hdl
39392,Parkinson'S Disease Motor Subtype (Tremor Dominant Vs Postural Instability/Gait Difficulty),Phenotype,Parkinson'S Disease Motor Subtype (Tremor Dominant Vs Postural Instability/Gait Difficulty)
39396,Parkinson'S Disease Motor Subtype (Tremor To Postural Instability/Gait Difficulty Score Ratio),Phenotype,Parkinson'S Disease Motor Subtype (Tremor To Postural Instability/Gait Difficulty Score Ratio)
39399,Fasting Tyrosine,Phenotype,Fasting Tyrosine
39403,Fasting Free Cholesterol In Very Large Hdl,Phenotype,Fasting Free Cholesterol In Very Large Hdl
39404,Fasting Total Lipids In Very Large Hdl,Phenotype,Fasting Total Lipids In Very Large Hdl
39405,Fasting Very Large Hdl Particle Concentration,Phenotype,Fasting Very Large Hdl Particle Concentration
39406,Coprococcus Comes,Phenotype,Coprococcus Comes
39408,Chronic Widespread Musculoskeletal Pain,Phenotype,Chronic Widespread Musculoskeletal Pain
39420,Progression Free Survival In Epithelial Ovarian Cancer Treated With Carboplatin And Paclitaxel,Phenotype,Progression Free Survival In Epithelial Ovarian Cancer Treated With Carboplatin And Paclitaxel
39422,Progression Free Survival In Serous Epithelial Ovarian Cancer Treated With Carboplatin And Paclitaxel,Phenotype,Progression Free Survival In Serous Epithelial Ovarian Cancer Treated With Carboplatin And Paclitaxel
39424,Progression Free Survival In Serous Epithelial Ovarian Cancer,Phenotype,Progression Free Survival In Serous Epithelial Ovarian Cancer
39429,Pancreas Volume,Phenotype,Pancreas Volume
39430,Kidney Volume,Phenotype,Kidney Volume
39431,Visceral Adipose Tissue Volume,Phenotype,Visceral Adipose Tissue Volume
39432,Abdominal Subcutaneous Adipose Tissue Volume,Phenotype,Abdominal Subcutaneous Adipose Tissue Volume
39433,Liver Iron Content,Phenotype,Liver Iron Content
39443,Lung Volume,Phenotype,Lung Volume
39450,Pancreas Fat,Phenotype,Pancreas Fat
39458,Jc Polyomavirus Vp1 Antibody Levels,Phenotype,Jc Polyomavirus Vp1 Antibody Levels
39462,Human Polyomavirus 6 Vp1 Antibody Levels,Phenotype,Human Polyomavirus 6 Vp1 Antibody Levels
39464,Anti-Jc Polyomavirus Igg Seropositivity,Phenotype,Anti-Jc Polyomavirus Igg Seropositivity
39485,Covid-19 (Severe Respiratory Symptoms Vs Population),Phenotype,Covid-19 (Severe Respiratory Symptoms Vs Population)
39490,Covid-19 (Covid Respiratory Support Vs Population),Phenotype,Covid-19 (Covid Respiratory Support Vs Population)
39493,Mean Platelet Volume During Third Trimester Of Pregnancy,Phenotype,Mean Platelet Volume During Third Trimester Of Pregnancy
39512,Postprandial Total Cholesterol In Very Large Hdl,Phenotype,Postprandial Total Cholesterol In Very Large Hdl
39513,Postprandial Cholesterol Esters In Very Large Hdl,Phenotype,Postprandial Cholesterol Esters In Very Large Hdl
39514,Postprandial Free Cholesterol In Very Large Hdl,Phenotype,Postprandial Free Cholesterol In Very Large Hdl
39515,Postprandial Cholesterol Esters In Small Vldl,Phenotype,Postprandial Cholesterol Esters In Small Vldl
39516,Postprandial Total Cholesterol In Very Small Vldl,Phenotype,Postprandial Total Cholesterol In Very Small Vldl
39517,Postprandial Cholesterol Esters In Very Small Vldl,Phenotype,Postprandial Cholesterol Esters In Very Small Vldl
39518,Postprandial Total Lipids In Very Small Vldl,Phenotype,Postprandial Total Lipids In Very Small Vldl
39519,Postprandial Very Small Vldl Particle Concentration,Phenotype,Postprandial Very Small Vldl Particle Concentration
39520,Postprandial Total Lipids In Very Large Hdl,Phenotype,Postprandial Total Lipids In Very Large Hdl
39521,Postprandial Very Large Hdl Particle Concentration,Phenotype,Postprandial Very Large Hdl Particle Concentration
39522,Postprandial Phospholipid Levels In Very Large Hdl,Phenotype,Postprandial Phospholipid Levels In Very Large Hdl
39523,Postprandial Tyrosine,Phenotype,Postprandial Tyrosine
39547,25(Oh)D3 Levels In Prediabetes,Phenotype,25(Oh)D3 Levels In Prediabetes
39617,Hearing Function (0.5 Khz),Phenotype,Hearing Function (0.5 Khz)
39619,Hearing Function (1 Khz),Phenotype,Hearing Function (1 Khz)
39621,Hearing Function (4 Khz),Phenotype,Hearing Function (4 Khz)
39623,Hearing Function (8 Khz),Phenotype,Hearing Function (8 Khz)
39627,Accelerated Cognitive Decline,Phenotype,Accelerated Cognitive Decline
39677,Decaffeinated Coffee Consumption Or Major Depression Disorder,Phenotype,Decaffeinated Coffee Consumption Or Major Depression Disorder
39679,Decaffeinated Coffee Consumption And/Or Neuroticism,Phenotype,Decaffeinated Coffee Consumption And/Or Neuroticism
39689,Cholesteryl Ester Levels In Large Hdl,Phenotype,Cholesteryl Ester Levels In Large Hdl
39694,Free Cholesterol Levels In Large Hdl,Phenotype,Free Cholesterol Levels In Large Hdl
39697,Concentration Of Large Hdl Particles,Phenotype,Concentration Of Large Hdl Particles
39699,Gestational Diabetes,Phenotype,Gestational Diabetes
39702,Phospholipids To Total Lipids Ratio In Large Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Large Hdl
39704,Triglyceride Levels In Large Hdl,Phenotype,Triglyceride Levels In Large Hdl
39710,Alanine Aminotransferase Levels X Vegetarianism Interaction,Phenotype,Alanine Aminotransferase Levels X Vegetarianism Interaction
39712,Albumin Levels X Vegetarianism Interaction,Phenotype,Albumin Levels X Vegetarianism Interaction
39715,Alkaline Phosphatase Levels X Vegetarianism Interaction,Phenotype,Alkaline Phosphatase Levels X Vegetarianism Interaction
39717,Apolipoprotein B Levels X Vegetarianism Interaction,Phenotype,Apolipoprotein B Levels X Vegetarianism Interaction
39719,Free Cholesterol Levels In Large Ldl,Phenotype,Free Cholesterol Levels In Large Ldl
39722,Aspartate Aminotransferase Levels X Vegetarianism Interaction,Phenotype,Aspartate Aminotransferase Levels X Vegetarianism Interaction
39724,C Reactive Protein Levels X Vegetarianism Interaction,Phenotype,C Reactive Protein Levels X Vegetarianism Interaction
39727,Calcium Levels X Vegetarianism Interaction,Phenotype,Calcium Levels X Vegetarianism Interaction
39729,Cholesterol Levels X Vegetarianism Interaction,Phenotype,Cholesterol Levels X Vegetarianism Interaction
39732,Hba1C Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Hba1C Levels (Adjusted For Bmi) X Vegetarianism Interaction
39735,Cystatin C Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Cystatin C Levels (Adjusted For Bmi) X Vegetarianism Interaction
39738,Gamma Glutamyltransferase Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Gamma Glutamyltransferase Levels (Adjusted For Bmi) X Vegetarianism Interaction
39741,Insulin-Like Growth Factor 1 Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Insulin-Like Growth Factor 1 Levels (Adjusted For Bmi) X Vegetarianism Interaction
39743,Direct Low Density Lipoprotein Cholesterol Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Direct Low Density Lipoprotein Cholesterol Levels (Adjusted For Bmi) X Vegetarianism Interaction
39745,Concentration Of Large Ldl Particles,Phenotype,Concentration Of Large Ldl Particles
39750,Cholesterol Levels In Large Vldl,Phenotype,Cholesterol Levels In Large Vldl
39759,Hip Index,Phenotype,Hip Index
39767,Phospholipid Levels In Large Vldl,Phenotype,Phospholipid Levels In Large Vldl
39768,Concentration Of Large Vldl Particles,Phenotype,Concentration Of Large Vldl Particles
39769,Ribosyldihydronicotinamide Dehydrogenase [Quinone] Levels (Nqo2.9754.33.3),Phenotype,Ribosyldihydronicotinamide Dehydrogenase [Quinone] Levels (Nqo2.9754.33.3)
39773,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 5 Levels (Enpp5.6556.5.3),Phenotype,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 5 Levels (Enpp5.6556.5.3)
39777,Cholesteryl Ester Levels In Hdl,Phenotype,Cholesteryl Ester Levels In Hdl
39780,Carotid Intima-Media Thickness (Mean Of The Maximum Cimt),Phenotype,Carotid Intima-Media Thickness (Mean Of The Maximum Cimt)
39788,Fractalkine Levels (Cx3Cl1.2827.23.2),Phenotype,Fractalkine Levels (Cx3Cl1.2827.23.2)
39794,Ubiquitin-Like Protein Isg15 Levels (Isg15.14151.4.3),Phenotype,Ubiquitin-Like Protein Isg15 Levels (Isg15.14151.4.3)
39796,Udp-N-Acetylhexosamine Pyrophosphorylase Levels (Uap1.13580.2.3),Phenotype,Udp-N-Acetylhexosamine Pyrophosphorylase Levels (Uap1.13580.2.3)
39797,Phospholipid Levels In Hdl,Phenotype,Phospholipid Levels In Hdl
39800,Ubiquitin Carboxyl-Terminal Hydrolase 25 Levels (Usp25.9215.117.3),Phenotype,Ubiquitin Carboxyl-Terminal Hydrolase 25 Levels (Usp25.9215.117.3)
39814,Concentration Of Hdl Particles,Phenotype,Concentration Of Hdl Particles
39815,Cholesterol Levels In Idl,Phenotype,Cholesterol Levels In Idl
39819,Phospholipid Levels In Idl,Phenotype,Phospholipid Levels In Idl
39821,Melanocyte Protein Pmel Levels (Pmel.6472.40.3),Phenotype,Melanocyte Protein Pmel Levels (Pmel.6472.40.3)
39823,Nad(P)H Dehydrogenase [Quinone] 1 Levels (Nqo1.9837.60.3),Phenotype,Nad(P)H Dehydrogenase [Quinone] 1 Levels (Nqo1.9837.60.3)
39827,Natural Cytotoxicity Triggering Receptor 3 Levels (Ncr3.3003.29.2),Phenotype,Natural Cytotoxicity Triggering Receptor 3 Levels (Ncr3.3003.29.2)
39829,Mhc Class I Polypeptide-Related Sequence B Levels (Micb.5102.55.3),Phenotype,Mhc Class I Polypeptide-Related Sequence B Levels (Micb.5102.55.3)
39836,Vesicle-Fusing Atpase Levels (Nsf.13992.12.3),Phenotype,Vesicle-Fusing Atpase Levels (Nsf.13992.12.3)
39838,Zinc Fingers And Homeoboxes Protein 3 Levels (Zhx3.10036.201.3),Phenotype,Zinc Fingers And Homeoboxes Protein 3 Levels (Zhx3.10036.201.3)
39840,N-Acetylated-Alpha-Linked Acidic Dipeptidase 2 Levels (Naalad2.7986.98.3),Phenotype,N-Acetylated-Alpha-Linked Acidic Dipeptidase 2 Levels (Naalad2.7986.98.3)
39841,N-Acetylglucosamine-1-Phosphodiester Alpha-N-Acetylglucosaminidase Levels (Nagpa.11208.15.3),Phenotype,N-Acetylglucosamine-1-Phosphodiester Alpha-N-Acetylglucosaminidase Levels (Nagpa.11208.15.3)
39842,Cyclic Amp-Dependent Transcription Factor Atf-6 Alpha Levels (Atf6.11277.23.3),Phenotype,Cyclic Amp-Dependent Transcription Factor Atf-6 Alpha Levels (Atf6.11277.23.3)
39843,Polypeptide N-Acetylgalactosaminyltransferase 1 Levels (Galnt1.7090.17.3),Phenotype,Polypeptide N-Acetylgalactosaminyltransferase 1 Levels (Galnt1.7090.17.3)
39847,Glycoprotein Endo-Alpha-1--2-Mannosidase Levels (Manea.8014.359.3),Phenotype,Glycoprotein Endo-Alpha-1--2-Mannosidase Levels (Manea.8014.359.3)
39851,Carotid Intima Media Thickness (Maximum),Phenotype,Carotid Intima Media Thickness (Maximum)
39853,Glutathione S-Transferase A1 Levels (Gsta1.12446.49.3),Phenotype,Glutathione S-Transferase A1 Levels (Gsta1.12446.49.3)
39855,Glycine N-Methyltransferase Levels (Gnmt.14006.36.3),Phenotype,Glycine N-Methyltransferase Levels (Gnmt.14006.36.3)
39860,Free Cholesterol To Total Lipids Ratio In Idl,Phenotype,Free Cholesterol To Total Lipids Ratio In Idl
39876,Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Large Hdl
39881,Phospholipid Levels In Large Hdl,Phenotype,Phospholipid Levels In Large Hdl
39894,Cholesterol To Total Lipids Ratio In Large Ldl,Phenotype,Cholesterol To Total Lipids Ratio In Large Ldl
39897,Albumin Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Albumin Levels (Adjusted For Bmi) X Vegetarianism Interaction
39904,Total Lipid Levels In Large Ldl,Phenotype,Total Lipid Levels In Large Ldl
39906,Free Cholesterol To Total Lipids Ratio In Large Ldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Large Ldl
39908,Estimated Glomerular Filtration Rate X Vegetarianism Interaction,Phenotype,Estimated Glomerular Filtration Rate X Vegetarianism Interaction
39909,Urea Levels X Vegetarianism Interaction,Phenotype,Urea Levels X Vegetarianism Interaction
39911,Vitamin D Levels X Vegetarianism Interaction,Phenotype,Vitamin D Levels X Vegetarianism Interaction
39913,Triglycerides To Total Lipids Ratio In Large Ldl,Phenotype,Triglycerides To Total Lipids Ratio In Large Ldl
39916,Total Lipid Levels In Large Vldl,Phenotype,Total Lipid Levels In Large Vldl
39917,Free Cholesterol To Total Lipids Ratio In Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Large Vldl
39921,Cholesteryl Esters To Total Lipids Ratio In Large Hdl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Large Hdl
39931,Hba1C Levels X Vegetarianism Interaction,Phenotype,Hba1C Levels X Vegetarianism Interaction
39936,Direct Low Density Lipoprotein Cholesterol Levels X Vegetarianism Interaction,Phenotype,Direct Low Density Lipoprotein Cholesterol Levels X Vegetarianism Interaction
39937,Phosphate Levels X Vegetarianism Interaction,Phenotype,Phosphate Levels X Vegetarianism Interaction
39939,Testosterone Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Testosterone Levels (Adjusted For Bmi) X Vegetarianism Interaction
39942,Total Bilirubin Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Total Bilirubin Levels (Adjusted For Bmi) X Vegetarianism Interaction
39945,Lipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Lipoprotein A Levels (Adjusted For Bmi) X Vegetarianism Interaction
39948,Phosphate Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Phosphate Levels (Adjusted For Bmi) X Vegetarianism Interaction
39949,Phospholipid Levels In Large Ldl,Phenotype,Phospholipid Levels In Large Ldl
39951,Cholesterol To Total Lipids Ratio In Large Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Large Vldl
39961,Total Lipid Levels In Large Hdl,Phenotype,Total Lipid Levels In Large Hdl
39962,Insomnia Or Psoriasis (Pleiotropy),Phenotype,Insomnia Or Psoriasis (Pleiotropy)
39988,Cholesteryl Ester Levels In Large Ldl,Phenotype,Cholesteryl Ester Levels In Large Ldl
39990,Cholesteryl Esters To Total Lipids Ratio In Large Ldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Large Ldl
40003,Free Cholesterol Levels In Large Vldl,Phenotype,Free Cholesterol Levels In Large Vldl
40005,Cholesterol Levels In Large Hdl,Phenotype,Cholesterol Levels In Large Hdl
40006,Free Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Free Cholesterol To Total Lipids Ratio In Large Hdl
40024,Cholesterol Levels In Large Ldl,Phenotype,Cholesterol Levels In Large Ldl
40025,Triglycerides To Total Lipids Ratio In Large Hdl,Phenotype,Triglycerides To Total Lipids Ratio In Large Hdl
40027,Cholesterol Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Cholesterol Levels (Adjusted For Bmi) X Vegetarianism Interaction
40028,Aspartate Aminotransferase Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Aspartate Aminotransferase Levels (Adjusted For Bmi) X Vegetarianism Interaction
40030,C Reactive Protein Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,C Reactive Protein Levels (Adjusted For Bmi) X Vegetarianism Interaction
40032,Calcium Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Calcium Levels (Adjusted For Bmi) X Vegetarianism Interaction
40048,Phospholipids To Total Lipids Ratio In Large Ldl,Phenotype,Phospholipids To Total Lipids Ratio In Large Ldl
40054,Estimated Glomerular Filtration Rate (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Estimated Glomerular Filtration Rate (Adjusted For Bmi) X Vegetarianism Interaction
40055,Urea Levels (Adjusted For Bmi) X Vegetarianism Interaction,Phenotype,Urea Levels (Adjusted For Bmi) X Vegetarianism Interaction
40057,Cholesteryl Esters To Total Lipids Ratio In Large Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Large Vldl
40086,Testosterone Levels X Vegetarianism Interaction,Phenotype,Testosterone Levels X Vegetarianism Interaction
40087,Total Bilirubin Levels X Vegetarianism Interaction,Phenotype,Total Bilirubin Levels X Vegetarianism Interaction
40088,Triglyceride Levels X Vegetarianism Interaction,Phenotype,Triglyceride Levels X Vegetarianism Interaction
40093,Triglyceride Levels In Large Ldl,Phenotype,Triglyceride Levels In Large Ldl
40094,Cholesteryl Ester Levels In Large Vldl,Phenotype,Cholesteryl Ester Levels In Large Vldl
40095,Free Cholesterol Levels In Ldl,Phenotype,Free Cholesterol Levels In Ldl
40096,Pediatric Dental Caries (Decayed-- Missing And Filled Teeth >5),Phenotype,Pediatric Dental Caries (Decayed-- Missing And Filled Teeth >5)
40098,Cholesteryl Ester Levels In Medium Hdl,Phenotype,Cholesteryl Ester Levels In Medium Hdl
40101,Cholesterol To Total Lipids Ratio In Medium Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Medium Hdl
40102,Total Lipid Levels In Medium Hdl,Phenotype,Total Lipid Levels In Medium Hdl
40107,Depression Severity  X Hours Spent Watching Television Interaction,Phenotype,Depression Severity  X Hours Spent Watching Television Interaction
40110,Cigarette Consumption X Playing Computer Games Interaction,Phenotype,Cigarette Consumption X Playing Computer Games Interaction
40111,Alcohol Consumption X Playing Computer Games Interaction,Phenotype,Alcohol Consumption X Playing Computer Games Interaction
40114,Anxiety Severity X Hours Spent Watching Television Interaction,Phenotype,Anxiety Severity X Hours Spent Watching Television Interaction
40118,Cholesterol Levels In Medium Ldl,Phenotype,Cholesterol Levels In Medium Ldl
40119,Cholesterol To Total Lipids Ratio In Medium Ldl,Phenotype,Cholesterol To Total Lipids Ratio In Medium Ldl
40124,Phospholipid Levels In Medium Ldl,Phenotype,Phospholipid Levels In Medium Ldl
40129,Testosterone Levels In Premenopausal Women,Phenotype,Testosterone Levels In Premenopausal Women
40133,Omega-3 Fatty Acid Levels,Phenotype,Omega-3 Fatty Acid Levels
40136,Ferritin Levels (Fth1.Ftl.3031.66.1),Phenotype,Ferritin Levels (Fth1.Ftl.3031.66.1)
40137,Er Membrane Protein Complex Subunit 4 Levels (Emc4.13516.46.3),Phenotype,Er Membrane Protein Complex Subunit 4 Levels (Emc4.13516.46.3)
40139,Carotid Intima Media Thickness (Minimum),Phenotype,Carotid Intima Media Thickness (Minimum)
40140,Cholesteryl Esters To Total Lipids Ratio In Idl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Idl
40142,Chronic Elevation Of Alanine Aminotransferase (Calt) Levels,Phenotype,Chronic Elevation Of Alanine Aminotransferase (Calt) Levels
40144,Triglyceride Levels In Idl,Phenotype,Triglyceride Levels In Idl
40150,Mitogen-Activated Protein Kinase 13 Levels (Mapk13.5006.71.1),Phenotype,Mitogen-Activated Protein Kinase 13 Levels (Mapk13.5006.71.1)
40159,Osteocalcin Levels (Bglap.11067.13.3),Phenotype,Osteocalcin Levels (Bglap.11067.13.3)
40161,Nmra-Like Family Domain-Containing Protein 1 Levels (Nmral1.13988.67.3),Phenotype,Nmra-Like Family Domain-Containing Protein 1 Levels (Nmral1.13988.67.3)
40163,Neural Cell Adhesion Molecule 2 Levels (Ncam2.6507.16.3),Phenotype,Neural Cell Adhesion Molecule 2 Levels (Ncam2.6507.16.3)
40165,Neuropeptide W Levels (Npw.9986.14.3),Phenotype,Neuropeptide W Levels (Npw.9986.14.3)
40167,Neutrophil Collagenase Levels (Mmp8.2954.56.2),Phenotype,Neutrophil Collagenase Levels (Mmp8.2954.56.2)
40171,Sparc-Like Protein 1 Levels (Sparcl1.4467.49.2),Phenotype,Sparc-Like Protein 1 Levels (Sparcl1.4467.49.2)
40172,Granulysin Levels (Gnly.3195.50.2),Phenotype,Granulysin Levels (Gnly.3195.50.2)
40174,Gremlin-1 Levels (Grem1.4449.67.3),Phenotype,Gremlin-1 Levels (Grem1.4449.67.3)
40179,Stromal Membrane-Associated Protein 1 Levels (Smap1.11649.3.3),Phenotype,Stromal Membrane-Associated Protein 1 Levels (Smap1.11649.3.3)
40181,Killer Cell Immunoglobulin-Like Receptor 2Ds2 Levels (Kir2Ds2.10428.1.3),Phenotype,Killer Cell Immunoglobulin-Like Receptor 2Ds2 Levels (Kir2Ds2.10428.1.3)
40185,Triglyceride Levels In Hdl,Phenotype,Triglyceride Levels In Hdl
40187,Average Diameter For Hdl Particles,Phenotype,Average Diameter For Hdl Particles
40189,Free Cholesterol Levels In Idl,Phenotype,Free Cholesterol Levels In Idl
40190,Phospholipids To Total Lipids Ratio In Idl,Phenotype,Phospholipids To Total Lipids Ratio In Idl
40195,Vascular Endothelial Growth Factor A Levels (Vegfa.2597.8.3),Phenotype,Vascular Endothelial Growth Factor A Levels (Vegfa.2597.8.3)
40196,Vascular Endothelial Growth Factor A-- Isoform 121 Levels (Vegfa.14032.2.3),Phenotype,Vascular Endothelial Growth Factor A-- Isoform 121 Levels (Vegfa.14032.2.3)
40199,Promotilin Levels (Mln.5631.83.3),Phenotype,Promotilin Levels (Mln.5631.83.3)
40202,T-Cell Surface Protein Tactile Levels (Cd96.9735.44.3),Phenotype,T-Cell Surface Protein Tactile Levels (Cd96.9735.44.3)
40204,Tapasin Levels (Tapbp.12378.71.3),Phenotype,Tapasin Levels (Tapbp.12378.71.3)
40206,Tapasin-Related Protein Levels (Tapbpl.6364.7.3),Phenotype,Tapasin-Related Protein Levels (Tapbpl.6364.7.3)
40207,Hla Class Ii Histocompatibility Antigen-- Dq Alpha 2 Chain Levels (Hla.Dqa2.7757.5.3),Phenotype,Hla Class Ii Histocompatibility Antigen-- Dq Alpha 2 Chain Levels (Hla.Dqa2.7757.5.3)
40213,Tenascin-X Levels (Tnxb.5698.60.3),Phenotype,Tenascin-X Levels (Tnxb.5698.60.3)
40219,Cholesterol To Total Lipids Ratio In Idl,Phenotype,Cholesterol To Total Lipids Ratio In Idl
40225,Total Lipid Levels In Idl,Phenotype,Total Lipid Levels In Idl
40226,Concentration Of Idl Particles,Phenotype,Concentration Of Idl Particles
40228,Triglycerides To Total Lipids Ratio In Idl,Phenotype,Triglycerides To Total Lipids Ratio In Idl
40229,Thioredoxin Domain-Containing Protein 5 Levels (Txndc5.11212.7.3),Phenotype,Thioredoxin Domain-Containing Protein 5 Levels (Txndc5.11212.7.3)
40230,Thrombospondin-2 Levels (Thbs2.3339.33.1),Phenotype,Thrombospondin-2 Levels (Thbs2.3339.33.1)
40234,Inactive Pancreatic Lipase-Related Protein 1 Levels (Pnliprp1.6627.25.3),Phenotype,Inactive Pancreatic Lipase-Related Protein 1 Levels (Pnliprp1.6627.25.3)
40236,Inducible T-Cell Costimulator Levels (Icos.14084.191.3),Phenotype,Inducible T-Cell Costimulator Levels (Icos.14084.191.3)
40238,Total Lipid Levels In Hdl,Phenotype,Total Lipid Levels In Hdl
40242,Cholesteryl Ester Levels In Idl,Phenotype,Cholesteryl Ester Levels In Idl
40243,Radiation-Induced Toxicity (Physician-Rated Acute Dysphagia),Phenotype,Radiation-Induced Toxicity (Physician-Rated Acute Dysphagia)
40245,Radiation-Induced Toxicity (Patient-Rated Acute Xerostomia),Phenotype,Radiation-Induced Toxicity (Patient-Rated Acute Xerostomia)
40246,Radiation-Induced Toxicity (Physician-Rated Acute Xerostomia),Phenotype,Radiation-Induced Toxicity (Physician-Rated Acute Xerostomia)
40249,Radiation-Induced Toxicity (Patient-Rated Acute Sticky Saliva),Phenotype,Radiation-Induced Toxicity (Patient-Rated Acute Sticky Saliva)
40254,Radiation-Induced Toxicity (Standardized Total Average Toxicity_Patient),Phenotype,Radiation-Induced Toxicity (Standardized Total Average Toxicity_Patient)
40256,Free Cholesterol Levels In Small Hdl,Phenotype,Free Cholesterol Levels In Small Hdl
40258,Phospholipids To Total Lipids Ratio In Small Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Small Hdl
40264,Cholesterol Levels In Small Ldl,Phenotype,Cholesterol Levels In Small Ldl
40265,Primary Open Angle Glaucoma (Multi-Trait Analysis),Phenotype,Primary Open Angle Glaucoma (Multi-Trait Analysis)
40279,Cholesterol To Total Lipids Ratio In Small Ldl,Phenotype,Cholesterol To Total Lipids Ratio In Small Ldl
40281,Cholesteryl Ester Levels In Small Vldl,Phenotype,Cholesteryl Ester Levels In Small Vldl
40283,Cholesterol To Total Lipids Ratio In Small Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Small Vldl
40286,Annual Frequency Of Asthma Exacerbations In Non-Smokers,Phenotype,Annual Frequency Of Asthma Exacerbations In Non-Smokers
40288,Annual Frequency Of Asthma Exacerbations In Smokers,Phenotype,Annual Frequency Of Asthma Exacerbations In Smokers
40290,Cholesteryl Esters To Total Lipids Ratio In Small Vldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Small Vldl
40294,Saturated Fatty Acid Levels,Phenotype,Saturated Fatty Acid Levels
40298,Total Lipid Levels In Lipoprotein Particles,Phenotype,Total Lipid Levels In Lipoprotein Particles
40299,Total Concentration Of Lipoprotein Particles,Phenotype,Total Concentration Of Lipoprotein Particles
40300,Total Fatty Acid Levels,Phenotype,Total Fatty Acid Levels
40301,Anti-Hepatitis E Antibody Seropositivity,Phenotype,Anti-Hepatitis E Antibody Seropositivity
40304,Free Cholesterol Levels In Vldl,Phenotype,Free Cholesterol Levels In Vldl
40305,Total Lipid Levels In Vldl,Phenotype,Total Lipid Levels In Vldl
40306,Triglyceride Levels In Vldl,Phenotype,Triglyceride Levels In Vldl
40307,Cholesterol Levels In Very Large Hdl,Phenotype,Cholesterol Levels In Very Large Hdl
40320,Cholesteryl Ester Levels In Very Large Hdl,Phenotype,Cholesteryl Ester Levels In Very Large Hdl
40321,Cholesteryl Esters To Total Lipids Ratio In Very Large Hdl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Very Large Hdl
40327,Free Cholesterol Levels In Very Large Hdl,Phenotype,Free Cholesterol Levels In Very Large Hdl
40330,Free Cholesterol To Total Lipids Ratio In Very Large Hdl,Phenotype,Free Cholesterol To Total Lipids Ratio In Very Large Hdl
40340,Total Lipid Levels In Very Large Hdl,Phenotype,Total Lipid Levels In Very Large Hdl
40341,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; All Treatment Preparations),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; All Treatment Preparations)
40343,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; Ifnβ-1B Subcutaneous),Phenotype,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; Ifnβ-1B Subcutaneous)
40346,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; Ifnβ-1A Subcutaneous And Intramuscular),Phenotype,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; Ifnβ-1A Subcutaneous And Intramuscular)
40349,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; Ifnβ-1A Subcutaneous),Phenotype,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; Ifnβ-1A Subcutaneous)
40351,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; All Treatment Preparations),Phenotype,Binding Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Levels; All Treatment Preparations)
40356,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; Ifnβ-1B Subcutaneous),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; Ifnβ-1B Subcutaneous)
40358,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; Ifnβ-1A Subcutaneous And Intramuscular),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; Ifnβ-1A Subcutaneous And Intramuscular)
40360,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; Ifnβ-1A Subcutaneous),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; Ifnβ-1A Subcutaneous)
40362,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; All Treatment Preparations),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Antibody Titre; All Treatment Preparations)
40363,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; Ifnβ-1B Subcutaneous),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; Ifnβ-1B Subcutaneous)
40365,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; Ifnβ-1A Subcutaneous And Intramuscular),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; Ifnβ-1A Subcutaneous And Intramuscular)
40367,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; Ifnβ-1A Subcutaneous),Phenotype,Neutralising Antibody Response To Interferon Beta Therapy In Multiple Sclerosis (Presence Of Antibodies; Ifnβ-1A Subcutaneous)
40369,Phospholipid Levels In Very Large Hdl,Phenotype,Phospholipid Levels In Very Large Hdl
40376,Triglycerides To Total Lipids Ratio In Very Large Hdl,Phenotype,Triglycerides To Total Lipids Ratio In Very Large Hdl
40377,Cholesterol Levels In Very Large Vldl,Phenotype,Cholesterol Levels In Very Large Vldl
40378,Cholesterol To Total Lipids Ratio In Very Large Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Very Large Vldl
40383,Whole Brain Restricted Isotropic Diffusion (Multivariate Analysis),Phenotype,Whole Brain Restricted Isotropic Diffusion (Multivariate Analysis)
40386,Cholesteryl Ester Levels In Very Large Vldl,Phenotype,Cholesteryl Ester Levels In Very Large Vldl
40389,Concentration Of Medium Hdl Particles,Phenotype,Concentration Of Medium Hdl Particles
40391,Hunner-Type Interstitial Cystitis,Phenotype,Hunner-Type Interstitial Cystitis
40392,Psycho-Cardiometabolic Multimorbidity (Multivariate Analysis),Phenotype,Psycho-Cardiometabolic Multimorbidity (Multivariate Analysis)
40400,Total Lipid Levels In Small Hdl,Phenotype,Total Lipid Levels In Small Hdl
40401,Concentration Of Small Hdl Particles,Phenotype,Concentration Of Small Hdl Particles
40404,Free Cholesterol Levels In Small Ldl,Phenotype,Free Cholesterol Levels In Small Ldl
40407,Phospholipid Levels In Small Ldl,Phenotype,Phospholipid Levels In Small Ldl
40410,Extraintestinal Manifestations In Inflammatory Bowel Disease (Ankylosing Spondylitis And Sacroiliitis),Phenotype,Extraintestinal Manifestations In Inflammatory Bowel Disease (Ankylosing Spondylitis And Sacroiliitis)
40413,Extraintestinal Manifestations In Inflammatory Bowel Disease (Ocular Manifestations),Phenotype,Extraintestinal Manifestations In Inflammatory Bowel Disease (Ocular Manifestations)
40416,Extraintestinal Manifestations In Inflammatory Bowel Disease (Primary Sclerosing Cholangitis),Phenotype,Extraintestinal Manifestations In Inflammatory Bowel Disease (Primary Sclerosing Cholangitis)
40422,Extraintestinal Manifestations In Inflammatory Bowel Disease (Any Of 6 Phenotypes),Phenotype,Extraintestinal Manifestations In Inflammatory Bowel Disease (Any Of 6 Phenotypes)
40424,Free Cholesterol Levels In Small Vldl,Phenotype,Free Cholesterol Levels In Small Vldl
40425,Phospholipids To Total Lipids Ratio In Small Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Small Vldl
40427,Sphingomyelin Levels,Phenotype,Sphingomyelin Levels
40430,Total Triglycerides Levels,Phenotype,Total Triglycerides Levels
40431,Tanner 3 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model),Phenotype,Tanner 3 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model)
40434,Tanner 2 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model),Phenotype,Tanner 2 To Tanner 4 Pubertal Stage Transition (Joint Longitudinal Bmi And Survival Model)
40438,Phospholipid Levels In Vldl,Phenotype,Phospholipid Levels In Vldl
40439,Concentration Of Vldl Particles,Phenotype,Concentration Of Vldl Particles
40452,Triglyceride Levels In Small Hdl,Phenotype,Triglyceride Levels In Small Hdl
40455,Triglyceride Levels In Small Ldl,Phenotype,Triglyceride Levels In Small Ldl
40457,Free Cholesterol To Total Lipids Ratio In Small Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Small Vldl
40460,Cardiorespiratory Fitness,Phenotype,Cardiorespiratory Fitness
40464,Phospholipid Levels In Small Vldl,Phenotype,Phospholipid Levels In Small Vldl
40465,Total Phospholipid Levels In Lipoprotein Particles,Phenotype,Total Phospholipid Levels In Lipoprotein Particles
40468,Cholesterol To Total Lipids Ratio In Very Large Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Very Large Hdl
40471,High General Stress,Phenotype,High General Stress
40475,Concentration Of Very Large Hdl Particles,Phenotype,Concentration Of Very Large Hdl Particles
40488,Triglyceride Levels In Very Large Hdl,Phenotype,Triglyceride Levels In Very Large Hdl
40505,Acetoacetate Levels,Phenotype,Acetoacetate Levels
40509,Acetone Levels,Phenotype,Acetone Levels
40512,Clinical Ldl Cholesterol Levels,Phenotype,Clinical Ldl Cholesterol Levels
40515,Potassium Levels,Phenotype,Potassium Levels
40520,Glycoprotein Acetyls Levels,Phenotype,Glycoprotein Acetyls Levels
40530,Cholesterol Levels In Medium Hdl,Phenotype,Cholesterol Levels In Medium Hdl
40531,Polyunsaturated Fatty Acid Levels,Phenotype,Polyunsaturated Fatty Acid Levels
40540,Alpha-Hydroxyisovalerate Levels In Elite Athletes,Phenotype,Alpha-Hydroxyisovalerate Levels In Elite Athletes
40545,Argininate Levels In Elite Athletes,Phenotype,Argininate Levels In Elite Athletes
40547,Beta-Citrylglutamate Levels In Elite Athletes,Phenotype,Beta-Citrylglutamate Levels In Elite Athletes
40550,Betaine Levels In Elite Athletes,Phenotype,Betaine Levels In Elite Athletes
40553,1-Methylhistidine Levels In Elite Athletes,Phenotype,1-Methylhistidine Levels In Elite Athletes
40556,Periodontal Pocket (Adjusted For Age-- Sex And Smoking Status),Phenotype,Periodontal Pocket (Adjusted For Age-- Sex And Smoking Status)
40558,Periodontal Pocket (Adjusted For Age-- Sex-- Smoking Status  And Plaque),Phenotype,Periodontal Pocket (Adjusted For Age-- Sex-- Smoking Status  And Plaque)
40559,Perfluorooctanesulfonic Acid (Pfos) Levels In Elite Athletes,Phenotype,Perfluorooctanesulfonic Acid (Pfos) Levels In Elite Athletes
40561,Ursodeoxycholate Levels In Elite Athletes,Phenotype,Ursodeoxycholate Levels In Elite Athletes
40565,Tyrosine Levels In Elite Athletes,Phenotype,Tyrosine Levels In Elite Athletes
40567,N-Methylpipecolate Levels In Elite Athletes,Phenotype,N-Methylpipecolate Levels In Elite Athletes
40569,Methyl Glucopyranoside (Alpha + Beta) Levels In Elite Athletes,Phenotype,Methyl Glucopyranoside (Alpha + Beta) Levels In Elite Athletes
40571,Tryptophan Betaine Levels In Elite Athletes,Phenotype,Tryptophan Betaine Levels In Elite Athletes
40573,Tryptophan Levels In Elite Athletes,Phenotype,Tryptophan Levels In Elite Athletes
40574,N-(2-Furoyl)Glycine Levels In Elite Athletes,Phenotype,N-(2-Furoyl)Glycine Levels In Elite Athletes
40576,Tartronate (Hydroxymalonate) Levels In Elite Athletes,Phenotype,Tartronate (Hydroxymalonate) Levels In Elite Athletes
40579,Bilirubin (Z--Z) Levels In Elite Athletes,Phenotype,Bilirubin (Z--Z) Levels In Elite Athletes
40581,Gulonate Levels In Elite Athletes,Phenotype,Gulonate Levels In Elite Athletes
40583,Ribonate Levels In Elite Athletes,Phenotype,Ribonate Levels In Elite Athletes
40585,Xylose Levels In Elite Athletes,Phenotype,Xylose Levels In Elite Athletes
40587,Alpha-Ketoglutarate Levels In Elite Athletes,Phenotype,Alpha-Ketoglutarate Levels In Elite Athletes
40589,1-(1-Enyl-Palmitoyl)-2-Arachidonoyl-Gpe (P-16:0/20:4) Levels In Elite Athletes,Phenotype,1-(1-Enyl-Palmitoyl)-2-Arachidonoyl-Gpe (P-16:0/20:4) Levels In Elite Athletes
40591,Galactonate Levels In Elite Athletes,Phenotype,Galactonate Levels In Elite Athletes
40593,Tyramine O-Sulfate Levels In Elite Athletes,Phenotype,Tyramine O-Sulfate Levels In Elite Athletes
40595,Urea Levels In Elite Athletes,Phenotype,Urea Levels In Elite Athletes
40597,1-(1-Enyl-Palmitoyl)-2-Oleoyl-Gpe (P-16:0/18:1) Levels In Elite Athletes,Phenotype,1-(1-Enyl-Palmitoyl)-2-Oleoyl-Gpe (P-16:0/18:1) Levels In Elite Athletes
40599,1-(1-Enyl-Palmitoyl)-2-Palmitoleoyl-Gpc (P-16:0/16:1) Levels In Elite Athletes,Phenotype,1-(1-Enyl-Palmitoyl)-2-Palmitoleoyl-Gpc (P-16:0/16:1) Levels In Elite Athletes
40601,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels In Elite Athletes,Phenotype,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels In Elite Athletes
40603,1-Palmitoyl-2-Oleoyl-Gpe (16:0/18:1) Levels In Elite Athletes,Phenotype,1-Palmitoyl-2-Oleoyl-Gpe (16:0/18:1) Levels In Elite Athletes
40610,5-Oxoproline Levels In Elite Athletes,Phenotype,5-Oxoproline Levels In Elite Athletes
40612,1-Stearoyl-Gpc (18:0) Levels In Elite Athletes,Phenotype,1-Stearoyl-Gpc (18:0) Levels In Elite Athletes
40616,1-Stearoyl-Gpe (18:0) Levels In Elite Athletes,Phenotype,1-Stearoyl-Gpe (18:0) Levels In Elite Athletes
40617,1-Palmitoyl-Gpi (16:0) Levels In Elite Athletes,Phenotype,1-Palmitoyl-Gpi (16:0) Levels In Elite Athletes
40619,1-Stearoyl-2-Linoleoyl-Gpc (18:0/18:2) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Linoleoyl-Gpc (18:0/18:2) Levels In Elite Athletes
40621,1-Stearoyl-2-Linoleoyl-Gpi (18:0/18:2) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Linoleoyl-Gpi (18:0/18:2) Levels In Elite Athletes
40623,1-Stearoyl-2-Oleoyl-Gpi (18:0/18:1) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Oleoyl-Gpi (18:0/18:1) Levels In Elite Athletes
40625,1-Stearoyl-2-Oleoyl-Gps (18:0/18:1) Levels In Elite Athletes,Phenotype,1-Stearoyl-2-Oleoyl-Gps (18:0/18:1) Levels In Elite Athletes
40628,1-Palmitoyl-2-Stearoyl-Gpc (16:0/18:0) Levels In Elite Athletes,Phenotype,1-Palmitoyl-2-Stearoyl-Gpc (16:0/18:0) Levels In Elite Athletes
40629,1-Palmitoyl-Gpc (16:0) Levels In Elite Athletes,Phenotype,1-Palmitoyl-Gpc (16:0) Levels In Elite Athletes
40630,1-Palmitoyl-Gpe (16:0) Levels In Elite Athletes,Phenotype,1-Palmitoyl-Gpe (16:0) Levels In Elite Athletes
40633,5-Hete Levels In Elite Athletes,Phenotype,5-Hete Levels In Elite Athletes
40636,Cysteine Levels In Elite Athletes,Phenotype,Cysteine Levels In Elite Athletes
40643,Cystathionine Levels In Elite Athletes,Phenotype,Cystathionine Levels In Elite Athletes
40645,5-Hepe Levels In Elite Athletes,Phenotype,5-Hepe Levels In Elite Athletes
40647,4-Hdohe Levels In Elite Athletes,Phenotype,4-Hdohe Levels In Elite Athletes
40649,Cortisone Levels In Elite Athletes,Phenotype,Cortisone Levels In Elite Athletes
40651,3-Hydroxyoctanoate Levels In Elite Athletes,Phenotype,3-Hydroxyoctanoate Levels In Elite Athletes
40653,Chenodeoxycholate Levels In Elite Athletes,Phenotype,Chenodeoxycholate Levels In Elite Athletes
40660,Dehydroisoandrosterone Sulfate (Dhea-S) Levels In Elite Athletes,Phenotype,Dehydroisoandrosterone Sulfate (Dhea-S) Levels In Elite Athletes
40662,Deoxycholate Levels In Elite Athletes,Phenotype,Deoxycholate Levels In Elite Athletes
40665,Dihomo-Linoleate (20:2N6) Levels In Elite Athletes,Phenotype,Dihomo-Linoleate (20:2N6) Levels In Elite Athletes
40667,5Alpha-Pregnan-3Beta--20Beta-Diol Monosulfate (1) Levels In Elite Athletes,Phenotype,5Alpha-Pregnan-3Beta--20Beta-Diol Monosulfate (1) Levels In Elite Athletes
40669,Dimethylglycine Levels In Elite Athletes,Phenotype,Dimethylglycine Levels In Elite Athletes
40671,5Alpha-Pregnan-3(Alpha Or Beta)--20Beta-Diol Disulfate Levels In Elite Athletes,Phenotype,5Alpha-Pregnan-3(Alpha Or Beta)--20Beta-Diol Disulfate Levels In Elite Athletes
40673,5Alpha-Pregnan-3Beta-Ol--20-One Sulfate Levels In Elite Athletes,Phenotype,5Alpha-Pregnan-3Beta-Ol--20-One Sulfate Levels In Elite Athletes
40675,Adipoylcarnitine (C6-Dc) Levels In Elite Athletes,Phenotype,Adipoylcarnitine (C6-Dc) Levels In Elite Athletes
40677,Andro Steroid Monosulfate C19H28O6S (1) Levels In Elite Athletes,Phenotype,Andro Steroid Monosulfate C19H28O6S (1) Levels In Elite Athletes
40679,5Alpha-Pregnan-3Beta--20Alpha-Diol Monosulfate (2) Levels In Elite Athletes,Phenotype,5Alpha-Pregnan-3Beta--20Alpha-Diol Monosulfate (2) Levels In Elite Athletes
40682,Atopic Dermatitis (Moderate To Severe),Phenotype,Atopic Dermatitis (Moderate To Severe)
40686,Glutamine Levels,Phenotype,Glutamine Levels
40690,Docosahexaenoic Acid Levels,Phenotype,Docosahexaenoic Acid Levels
40692,Histidine Levels,Phenotype,Histidine Levels
40694,Isoleucine Levels,Phenotype,Isoleucine Levels
40696,Lactate Levels,Phenotype,Lactate Levels
40697,Linoleic Acid Levels,Phenotype,Linoleic Acid Levels
40704,Total Free Cholesterol Levels,Phenotype,Total Free Cholesterol Levels
40705,4-Hydroxyphenylpyruvate Levels In Elite Athletes,Phenotype,4-Hydroxyphenylpyruvate Levels In Elite Athletes
40707,2-Oxoarginine Levels In Elite Athletes,Phenotype,2-Oxoarginine Levels In Elite Athletes
40709,3-Hydroxy-2-Ethylpropionate Levels In Elite Athletes,Phenotype,3-Hydroxy-2-Ethylpropionate Levels In Elite Athletes
40713,3-Methylglutaconate Levels In Elite Athletes,Phenotype,3-Methylglutaconate Levels In Elite Athletes
40718,2-Hydroxy-3-Methylvalerate Levels In Elite Athletes,Phenotype,2-Hydroxy-3-Methylvalerate Levels In Elite Athletes
40720,1-Methylimidazoleacetate Levels In Elite Athletes,Phenotype,1-Methylimidazoleacetate Levels In Elite Athletes
40722,5-Bromotryptophan Levels In Elite Athletes,Phenotype,5-Bromotryptophan Levels In Elite Athletes
40725,2-Hydroxybutyrate/2-Hydroxyisobutyrate Levels In Elite Athletes,Phenotype,2-Hydroxybutyrate/2-Hydroxyisobutyrate Levels In Elite Athletes
40727,2-Methylbutyrylcarnitine (C5) Levels In Elite Athletes,Phenotype,2-Methylbutyrylcarnitine (C5) Levels In Elite Athletes
40730,2-Methylbutyrylglycine Levels In Elite Athletes,Phenotype,2-Methylbutyrylglycine Levels In Elite Athletes
40734,Taurolithocholate 3-Sulfate Levels In Elite Athletes,Phenotype,Taurolithocholate 3-Sulfate Levels In Elite Athletes
40736,Tetradecanedioate Levels In Elite Athletes,Phenotype,Tetradecanedioate Levels In Elite Athletes
40738,Theobromine Levels In Elite Athletes,Phenotype,Theobromine Levels In Elite Athletes
40740,Cinnamoylglycine Levels In Elite Athletes,Phenotype,Cinnamoylglycine Levels In Elite Athletes
40743,5-Acetylamino-6-Amino-3-Methyluracil Levels In Elite Athletes,Phenotype,5-Acetylamino-6-Amino-3-Methyluracil Levels In Elite Athletes
40745,5-Acetylamino-6-Formylamino-3-Methyluracil Levels In Elite Athletes,Phenotype,5-Acetylamino-6-Formylamino-3-Methyluracil Levels In Elite Athletes
40748,6-Hydroxyindole Sulfate Levels In Elite Athletes,Phenotype,6-Hydroxyindole Sulfate Levels In Elite Athletes
40750,Acesulfame Levels In Elite Athletes,Phenotype,Acesulfame Levels In Elite Athletes
40752,Gluconate Levels In Elite Athletes,Phenotype,Gluconate Levels In Elite Athletes
40755,Stearoylcarnitine (C18) Levels In Elite Athletes,Phenotype,Stearoylcarnitine (C18) Levels In Elite Athletes
40756,Dihydroferulic Acid Levels In Elite Athletes,Phenotype,Dihydroferulic Acid Levels In Elite Athletes
40758,Taurochenodeoxycholate Levels In Elite Athletes,Phenotype,Taurochenodeoxycholate Levels In Elite Athletes
40762,S-Methylmethionine Levels In Elite Athletes,Phenotype,S-Methylmethionine Levels In Elite Athletes
40764,1--3--7-Trimethylurate Levels In Elite Athletes,Phenotype,1--3--7-Trimethylurate Levels In Elite Athletes
40766,1--5-Anhydroglucitol (1--5-Ag) Levels In Elite Athletes,Phenotype,1--5-Anhydroglucitol (1--5-Ag) Levels In Elite Athletes
40768,1--7-Dimethylurate Levels In Elite Athletes,Phenotype,1--7-Dimethylurate Levels In Elite Athletes
40770,Spermidine Levels In Elite Athletes,Phenotype,Spermidine Levels In Elite Athletes
40772,Tiglylcarnitine (C5:1-Dc) Levels In Elite Athletes,Phenotype,Tiglylcarnitine (C5:1-Dc) Levels In Elite Athletes
40774,N-Formylphenylalanine Levels In Elite Athletes,Phenotype,N-Formylphenylalanine Levels In Elite Athletes
40776,N-Trimethyl 5-Aminovalerate Levels In Elite Athletes,Phenotype,N-Trimethyl 5-Aminovalerate Levels In Elite Athletes
40778,N-Acetyltryptophan Levels In Elite Athletes,Phenotype,N-Acetyltryptophan Levels In Elite Athletes
40779,N-Acetylproline Levels In Elite Athletes,Phenotype,N-Acetylproline Levels In Elite Athletes
40782,3-Ureidopropionate Levels In Elite Athletes,Phenotype,3-Ureidopropionate Levels In Elite Athletes
40784,1-Myristoyl-2-Arachidonoyl-Gpc (14:0/20:4) Levels In Elite Athletes,Phenotype,1-Myristoyl-2-Arachidonoyl-Gpc (14:0/20:4) Levels In Elite Athletes
40786,1-Palmitoyl-2-Arachidonoyl-Gpc (16:0/20:4N6) Levels In Elite Athletes,Phenotype,1-Palmitoyl-2-Arachidonoyl-Gpc (16:0/20:4N6) Levels In Elite Athletes
40788,1-Palmitoleoyl-2-Linolenoyl-Gpc (16:1/18:3) Levels In Elite Athletes,Phenotype,1-Palmitoleoyl-2-Linolenoyl-Gpc (16:1/18:3) Levels In Elite Athletes
40790,1-Palmitoleoyl-Gpc (16:1) Levels In Elite Athletes,Phenotype,1-Palmitoleoyl-Gpc (16:1) Levels In Elite Athletes
40792,1-Palmitoleoylglycerol (16:1) Levels In Elite Athletes,Phenotype,1-Palmitoleoylglycerol (16:1) Levels In Elite Athletes
40794,1-Oleoyl-Gpe (18:1) Levels In Elite Athletes,Phenotype,1-Oleoyl-Gpe (18:1) Levels In Elite Athletes
40795,1-Oleoyl-Gpi (18:1) Levels In Elite Athletes,Phenotype,1-Oleoyl-Gpi (18:1) Levels In Elite Athletes
40799,Carnitine Levels In Elite Athletes,Phenotype,Carnitine Levels In Elite Athletes
40801,Biliverdin Levels In Elite Athletes,Phenotype,Biliverdin Levels In Elite Athletes
40803,2-Aminooctanoate Levels In Elite Athletes,Phenotype,2-Aminooctanoate Levels In Elite Athletes
40805,Arginine Levels In Elite Athletes,Phenotype,Arginine Levels In Elite Athletes
40807,Aspartate Levels In Elite Athletes,Phenotype,Aspartate Levels In Elite Athletes
40809,2-Hydroxyadipate Levels In Elite Athletes,Phenotype,2-Hydroxyadipate Levels In Elite Athletes
40811,Caffeic Acid Sulfate Levels In Elite Athletes,Phenotype,Caffeic Acid Sulfate Levels In Elite Athletes
40813,21-Hydroxypregnenolone Disulfate Levels In Elite Athletes,Phenotype,21-Hydroxypregnenolone Disulfate Levels In Elite Athletes
40815,3-Hydroxy-3-Methylglutarate Levels In Elite Athletes,Phenotype,3-Hydroxy-3-Methylglutarate Levels In Elite Athletes
40817,2-Hydroxyoctanoate Levels In Elite Athletes,Phenotype,2-Hydroxyoctanoate Levels In Elite Athletes
40819,2-Linoleoylglycerol (18:2) Levels In Elite Athletes,Phenotype,2-Linoleoylglycerol (18:2) Levels In Elite Athletes
40821,2-Oleoylglycerol (18:1) Levels In Elite Athletes,Phenotype,2-Oleoylglycerol (18:1) Levels In Elite Athletes
40823,2-Palmitoleoyl-Gpc (16:1) Levels In Elite Athletes,Phenotype,2-Palmitoleoyl-Gpc (16:1) Levels In Elite Athletes
40826,3-Hydroxyhexanoate Levels In Elite Athletes,Phenotype,3-Hydroxyhexanoate Levels In Elite Athletes
40828,3-Hydroxymyristate Levels In Elite Athletes,Phenotype,3-Hydroxymyristate Levels In Elite Athletes
40830,Gamma Glutamyl Transpeptidase,Phenotype,Gamma Glutamyl Transpeptidase
40844,Citrate Levels,Phenotype,Citrate Levels
40863,Leucine Levels,Phenotype,Leucine Levels
40865,Total Esterified Cholesterol Levels,Phenotype,Total Esterified Cholesterol Levels
40873,Dopamine 3-O-Sulfate Levels In Elite Athletes,Phenotype,Dopamine 3-O-Sulfate Levels In Elite Athletes
40875,Isobutyrylcarnitine (C4) Levels In Elite Athletes,Phenotype,Isobutyrylcarnitine (C4) Levels In Elite Athletes
40877,4-Hydroxychlorothalonil Levels In Elite Athletes,Phenotype,4-Hydroxychlorothalonil Levels In Elite Athletes
40879,4-Methylcatechol Sulfate Levels In Elite Athletes,Phenotype,4-Methylcatechol Sulfate Levels In Elite Athletes
40882,Stachydrine Levels In Elite Athletes,Phenotype,Stachydrine Levels In Elite Athletes
40884,3-Hydroxyhippurate Levels In Elite Athletes,Phenotype,3-Hydroxyhippurate Levels In Elite Athletes
40886,3-Methoxycatechol Sulfate (2) Levels In Elite Athletes,Phenotype,3-Methoxycatechol Sulfate (2) Levels In Elite Athletes
40888,3-Methyl Catechol Sulfate (1) Levels In Elite Athletes,Phenotype,3-Methyl Catechol Sulfate (1) Levels In Elite Athletes
40890,4-Acetylphenol Sulfate Levels In Elite Athletes,Phenotype,4-Acetylphenol Sulfate Levels In Elite Athletes
40892,4-Allylphenol Sulfate Levels In Elite Athletes,Phenotype,4-Allylphenol Sulfate Levels In Elite Athletes
40895,Guanidinosuccinate Levels In Elite Athletes,Phenotype,Guanidinosuccinate Levels In Elite Athletes
40897,Imidazole Lactate Levels In Elite Athletes,Phenotype,Imidazole Lactate Levels In Elite Athletes
40899,Imidazole Propionate Levels In Elite Athletes,Phenotype,Imidazole Propionate Levels In Elite Athletes
40904,Thioproline Levels In Elite Athletes,Phenotype,Thioproline Levels In Elite Athletes
40906,1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0) Levels In Elite Athletes,Phenotype,1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0) Levels In Elite Athletes
40907,1-(1-Enyl-Palmitoyl)-Gpc (P-16:0) Levels In Elite Athletes,Phenotype,1-(1-Enyl-Palmitoyl)-Gpc (P-16:0) Levels In Elite Athletes
40909,1-(1-Enyl-Stearoyl)-2-Arachidonoyl-Gpe (P-18:0/20:4) Levels In Elite Athletes,Phenotype,1-(1-Enyl-Stearoyl)-2-Arachidonoyl-Gpe (P-18:0/20:4) Levels In Elite Athletes
40910,3-(4-Hydroxyphenyl)Lactate Levels In Elite Athletes,Phenotype,3-(4-Hydroxyphenyl)Lactate Levels In Elite Athletes
40912,3-Aminoisobutyrate Levels In Elite Athletes,Phenotype,3-Aminoisobutyrate Levels In Elite Athletes
40914,3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoate (Cmpf) Levels In Elite Athletes,Phenotype,3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoate (Cmpf) Levels In Elite Athletes
40916,1-(1-Enyl-Stearoyl)-Gpe (P-18:0) Levels In Elite Athletes,Phenotype,1-(1-Enyl-Stearoyl)-Gpe (P-18:0) Levels In Elite Athletes
40918,1-Arachidonoyl-Gpa (20:4) Levels In Elite Athletes,Phenotype,1-Arachidonoyl-Gpa (20:4) Levels In Elite Athletes
40922,1-Linoleoyl-Gpc (18:2) Levels In Elite Athletes,Phenotype,1-Linoleoyl-Gpc (18:2) Levels In Elite Athletes
40924,1-Arachidonoyl-Gpi (20:4) Levels In Elite Athletes,Phenotype,1-Arachidonoyl-Gpi (20:4) Levels In Elite Athletes
40926,1-Dihomo-Linolenylglycerol (20:3) Levels In Elite Athletes,Phenotype,1-Dihomo-Linolenylglycerol (20:3) Levels In Elite Athletes
40929,1-Lignoceroyl-Gpc (24:0) Levels In Elite Athletes,Phenotype,1-Lignoceroyl-Gpc (24:0) Levels In Elite Athletes
40931,1-Linolenoyl-Gpc (18:3) Levels In Elite Athletes,Phenotype,1-Linolenoyl-Gpc (18:3) Levels In Elite Athletes
40933,12--13-Dihome Levels In Elite Athletes,Phenotype,12--13-Dihome Levels In Elite Athletes
40935,14-Hdohe/17-Hdohe Levels In Elite Athletes,Phenotype,14-Hdohe/17-Hdohe Levels In Elite Athletes
40939,1-Stearoyl-Gpg (18:0) Levels In Elite Athletes,Phenotype,1-Stearoyl-Gpg (18:0) Levels In Elite Athletes
40941,Adrenate (22:4N6) Levels In Elite Athletes,Phenotype,Adrenate (22:4N6) Levels In Elite Athletes
40943,Arabinose Levels In Elite Athletes,Phenotype,Arabinose Levels In Elite Athletes
40944,2-Aminoheptanoate Levels In Elite Athletes,Phenotype,2-Aminoheptanoate Levels In Elite Athletes
40946,15-Methylpalmitate Levels In Elite Athletes,Phenotype,15-Methylpalmitate Levels In Elite Athletes
40948,1--2-Dipalmitoyl-Gpe (16:0/16:0) Levels In Elite Athletes,Phenotype,1--2-Dipalmitoyl-Gpe (16:0/16:0) Levels In Elite Athletes
40952,10-Undecenoate (11:1N1) Levels In Elite Athletes,Phenotype,10-Undecenoate (11:1N1) Levels In Elite Athletes
40960,Erythronate Levels In Elite Athletes,Phenotype,Erythronate Levels In Elite Athletes
40961,Eicosapentaenoate (Epa; 20:5N3) Levels In Elite Athletes,Phenotype,Eicosapentaenoate (Epa; 20:5N3) Levels In Elite Athletes
40962,Androstenediol (3Beta--17Beta) Monosulfate (1) Levels In Elite Athletes,Phenotype,Androstenediol (3Beta--17Beta) Monosulfate (1) Levels In Elite Athletes
40964,Gamma-Glutamylglutamate Levels In Elite Athletes,Phenotype,Gamma-Glutamylglutamate Levels In Elite Athletes
40966,Dodecanedioate Levels In Elite Athletes,Phenotype,Dodecanedioate Levels In Elite Athletes
40970,Androstenediol (3Alpha-- 17Alpha) Monosulfate (3) Levels In Elite Athletes,Phenotype,Androstenediol (3Alpha-- 17Alpha) Monosulfate (3) Levels In Elite Athletes
40972,Azelate (Nonanedioate) Levels In Elite Athletes,Phenotype,Azelate (Nonanedioate) Levels In Elite Athletes
40974,Behenoyl Sphingomyelin (D18:1/22:0) Levels In Elite Athletes,Phenotype,Behenoyl Sphingomyelin (D18:1/22:0) Levels In Elite Athletes
40976,Arachidonoylcarnitine (C20:4) Levels In Elite Athletes,Phenotype,Arachidonoylcarnitine (C20:4) Levels In Elite Athletes
40980,Gamma-Glutamylisoleucine Levels In Elite Athletes,Phenotype,Gamma-Glutamylisoleucine Levels In Elite Athletes
40982,Gamma-Glutamylleucine Levels In Elite Athletes,Phenotype,Gamma-Glutamylleucine Levels In Elite Athletes
40984,Ceramide (D18:1/14:0-- D16:1/16:0) Levels In Elite Athletes,Phenotype,Ceramide (D18:1/14:0-- D16:1/16:0) Levels In Elite Athletes
40986,Ceramide (D18:1/20:0-- D16:1/22:0-- D20:1/18:0) Levels In Elite Athletes,Phenotype,Ceramide (D18:1/20:0-- D16:1/22:0-- D20:1/18:0) Levels In Elite Athletes
40988,Ceramide (D16:1/24:1-- D18:1/22:1) Levels In Elite Athletes,Phenotype,Ceramide (D16:1/24:1-- D18:1/22:1) Levels In Elite Athletes
40990,Gamma-Glutamyltyrosine Levels In Elite Athletes,Phenotype,Gamma-Glutamyltyrosine Levels In Elite Athletes
40992,Glutamine Levels In Elite Athletes,Phenotype,Glutamine Levels In Elite Athletes
40994,Glycerate Levels In Elite Athletes,Phenotype,Glycerate Levels In Elite Athletes
40996,Free Cholesterol To Total Lipids Ratio In Very Large Vldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Very Large Vldl
40997,Total Lipid Levels In Very Large Vldl,Phenotype,Total Lipid Levels In Very Large Vldl
40998,Concentration Of Very Large Vldl Particles,Phenotype,Concentration Of Very Large Vldl Particles
41018,Phospholipids To Total Lipids Ratio In Very Large Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Very Large Vldl
41020,Phospholipid Levels In Very Large Vldl,Phenotype,Phospholipid Levels In Very Large Vldl
41021,Triglyceride Levels In Very Large Vldl,Phenotype,Triglyceride Levels In Very Large Vldl
41030,Cholesterol To Total Lipids Ratio In Very Small Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Very Small Vldl
41031,Ascending Aorta Maximum Area,Phenotype,Ascending Aorta Maximum Area
41032,Peripheral Artery Disease In Non Diabetes,Phenotype,Peripheral Artery Disease In Non Diabetes
41033,Ascending Aorta Minimum Area,Phenotype,Ascending Aorta Minimum Area
41037,Whole Brain Restricted Directional Diffusion (Multivariate Analysis),Phenotype,Whole Brain Restricted Directional Diffusion (Multivariate Analysis)
41041,Cholesteryl Ester Levels In Very Small Vldl,Phenotype,Cholesteryl Ester Levels In Very Small Vldl
41050,Gastric Polyp,Phenotype,Gastric Polyp
41054,Hepatic Cancer,Phenotype,Hepatic Cancer
41059,Triglyceride Levels In Very Small Vldl,Phenotype,Triglyceride Levels In Very Small Vldl
41065,Cholesterol Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Cholesterol Levels In Chylomicrons And Extremely Large Vldl
41083,Free Cholesterol Levels In Very Large Vldl,Phenotype,Free Cholesterol Levels In Very Large Vldl
41095,Free Cholesterol Levels In Very Small Vldl,Phenotype,Free Cholesterol Levels In Very Small Vldl
41099,Cirrhosis,Phenotype,Cirrhosis
41100,Angina Pectoris,Phenotype,Angina Pectoris
41104,Chronic Sinusitis,Phenotype,Chronic Sinusitis
41106,Autoimmune Hepatitis,Phenotype,Autoimmune Hepatitis
41109,Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation (Recipients),Phenotype,Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation (Recipients)
41111,Cytomegalovirus High-Level Reactivation After Allogeneic Hematopoietic Cell Transplantation (Donors),Phenotype,Cytomegalovirus High-Level Reactivation After Allogeneic Hematopoietic Cell Transplantation (Donors)
41113,Phospholipids To Total Lipids Ratio In Very Small Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Very Small Vldl
41115,Phospholipid Levels In Very Small Vldl,Phenotype,Phospholipid Levels In Very Small Vldl
41116,Facial Morphology (Segment 7),Phenotype,Facial Morphology (Segment 7)
41117,Facial Morphology (Segment 9),Phenotype,Facial Morphology (Segment 9)
41118,Facial Morphology (Segment 21),Phenotype,Facial Morphology (Segment 21)
41120,Facial Morphology (Segment 22),Phenotype,Facial Morphology (Segment 22)
41122,Facial Morphology (Segment 53),Phenotype,Facial Morphology (Segment 53)
41124,Facial Morphology (Segment 59),Phenotype,Facial Morphology (Segment 59)
41126,Facial Morphology (Segment 2),Phenotype,Facial Morphology (Segment 2)
41128,Atrial Fibrillation/Atrial Flutter,Phenotype,Atrial Fibrillation/Atrial Flutter
41134,Facial Morphology (Segment 62),Phenotype,Facial Morphology (Segment 62)
41136,Whole Brain Free Water Diffusion (Multivariate Analysis),Phenotype,Whole Brain Free Water Diffusion (Multivariate Analysis)
41150,Peripheral Artery Disease In Ever Smokers,Phenotype,Peripheral Artery Disease In Ever Smokers
41152,Facial Morphology (Segment 11),Phenotype,Facial Morphology (Segment 11)
41154,Facial Morphology (Segment 19),Phenotype,Facial Morphology (Segment 19)
41156,Facial Morphology (Segment 23),Phenotype,Facial Morphology (Segment 23)
41158,Facial Morphology (Segment 28),Phenotype,Facial Morphology (Segment 28)
41159,Facial Morphology (Segment 1),Phenotype,Facial Morphology (Segment 1)
41165,Substance Dependence,Phenotype,Substance Dependence
41171,Retinitis Pigmentosa,Phenotype,Retinitis Pigmentosa
41173,Pulmonary Tuberculosis,Phenotype,Pulmonary Tuberculosis
41176,Pollinosis,Phenotype,Pollinosis
41179,Stable Angina Pectoris,Phenotype,Stable Angina Pectoris
41196,Cholesterol Levels In Very Small Vldl,Phenotype,Cholesterol Levels In Very Small Vldl
41198,Total Lipid Levels In Very Small Vldl,Phenotype,Total Lipid Levels In Very Small Vldl
41199,Nephrotic Syndrome,Phenotype,Nephrotic Syndrome
41206,Iritis,Phenotype,Iritis
41217,Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl,Phenotype,Cholesterol To Total Lipids Ratio In Chylomicrons And Extremely Large Vldl
41239,Neuropathic Pain,Phenotype,Neuropathic Pain
41244,Brain-Specific Serine Protease 4 Levels (Prss22.4534.10.2),Phenotype,Brain-Specific Serine Protease 4 Levels (Prss22.4534.10.2)
41246,Beta-Defensin 119 Levels (Defb119.13455.10.3),Phenotype,Beta-Defensin 119 Levels (Defb119.13455.10.3)
41249,C-C Motif Chemokine 17 Levels (Ccl17.3519.3.2),Phenotype,C-C Motif Chemokine 17 Levels (Ccl17.3519.3.2)
41251,C-C Motif Chemokine 19 Levels (Ccl19.4922.13.1),Phenotype,C-C Motif Chemokine 19 Levels (Ccl19.4922.13.1)
41252,C-C Motif Chemokine 21 Levels (Ccl21.2516.57.3),Phenotype,C-C Motif Chemokine 21 Levels (Ccl21.2516.57.3)
41254,C-C Motif Chemokine 22 Levels (Ccl22.3508.78.3),Phenotype,C-C Motif Chemokine 22 Levels (Ccl22.3508.78.3)
41265,Acid Sphingomyelinase-Like Phosphodiesterase 3A Levels (Smpdl3A.14086.11.3),Phenotype,Acid Sphingomyelinase-Like Phosphodiesterase 3A Levels (Smpdl3A.14086.11.3)
41267,Adhesion G Protein-Coupled Receptor F5 Levels (Adgrf5.6409.57.3),Phenotype,Adhesion G Protein-Coupled Receptor F5 Levels (Adgrf5.6409.57.3)
41270,Advanced Glycosylation End Product-Specific Receptor-- Soluble Levels (Ager.4125.52.2),Phenotype,Advanced Glycosylation End Product-Specific Receptor-- Soluble Levels (Ager.4125.52.2)
41271,Agouti-Related Protein Levels (Agrp.2813.11.2),Phenotype,Agouti-Related Protein Levels (Agrp.2813.11.2)
41273,Alpha-2-Macroglobulin Receptor-Associated Protein Levels (Lrpap1.3640.14.3),Phenotype,Alpha-2-Macroglobulin Receptor-Associated Protein Levels (Lrpap1.3640.14.3)
41277,Amelogenin-- X Isoform Levels (Amelx.8578.45.3),Phenotype,Amelogenin-- X Isoform Levels (Amelx.8578.45.3)
41279,Angiostatin Levels (Plg.3710.49.2),Phenotype,Angiostatin Levels (Plg.3710.49.2)
41281,Cerebellin-1 Levels (Cbln1.9313.27.3),Phenotype,Cerebellin-1 Levels (Cbln1.9313.27.3)
41286,Chloride Intracellular Channel Protein 5 Levels (Clic5.12475.48.3),Phenotype,Chloride Intracellular Channel Protein 5 Levels (Clic5.12475.48.3)
41288,Chymotrypsinogen B Levels (Ctrb1.5671.1.3),Phenotype,Chymotrypsinogen B Levels (Ctrb1.5671.1.3)
41291,Atp-Dependent Rna Helicase Dhx8 Levels (Dhx8.11601.26.3),Phenotype,Atp-Dependent Rna Helicase Dhx8 Levels (Dhx8.11601.26.3)
41292,Colipase Levels (Clps.5749.53.3),Phenotype,Colipase Levels (Clps.5749.53.3)
41296,Apolipoprotein L1 Levels (Apol1.9506.10.3),Phenotype,Apolipoprotein L1 Levels (Apol1.9506.10.3)
41297,Apolipoprotein M Levels (Apom.10445.20.3),Phenotype,Apolipoprotein M Levels (Apom.10445.20.3)
41299,Camp-Specific 3'--5'-Cyclic Phosphodiesterase 4D Levels (Pde4D.5255.22.3),Phenotype,Camp-Specific 3'--5'-Cyclic Phosphodiesterase 4D Levels (Pde4D.5255.22.3)
41303,Cation-Independent Mannose-6-Phosphate Receptor Levels (Igf2R.3676.15.3),Phenotype,Cation-Independent Mannose-6-Phosphate Receptor Levels (Igf2R.3676.15.3)
41306,Cd109 Antigen Levels (Cd109.3290.50.2),Phenotype,Cd109 Antigen Levels (Cd109.3290.50.2)
41308,Carboxypeptidase B Levels (Cpb1.6356.3.3),Phenotype,Carboxypeptidase B Levels (Cpb1.6356.3.3)
41311,Intracerebral Hemorrhage,Phenotype,Intracerebral Hemorrhage
41315,Iron Deficiency Anemia,Phenotype,Iron Deficiency Anemia
41317,Juvenile Rheumatoid Arthritis,Phenotype,Juvenile Rheumatoid Arthritis
41323,Streptacidiphilus Abundance In Stool,Phenotype,Streptacidiphilus Abundance In Stool
41325,Treponema D Abundance In Stool,Phenotype,Treponema D Abundance In Stool
41327,Treponemataceae Abundance In Stool,Phenotype,Treponemataceae Abundance In Stool
41329,Rug472 Sp900319345 Abundance In Stool,Phenotype,Rug472 Sp900319345 Abundance In Stool
41331,Rug472 Abundance In Stool,Phenotype,Rug472 Abundance In Stool
41332,Succinivibrio Abundance In Stool,Phenotype,Succinivibrio Abundance In Stool
41334,Uba1066 Sp900317515 Abundance In Stool,Phenotype,Uba1066 Sp900317515 Abundance In Stool
41336,Uba11471 Sp000434215 Abundance In Stool,Phenotype,Uba11471 Sp000434215 Abundance In Stool
41338,Uba11471 Abundance In Stool,Phenotype,Uba11471 Abundance In Stool
41339,Uba1206 Sp000433115 Abundance In Stool,Phenotype,Uba1206 Sp000433115 Abundance In Stool
41341,Uba1448 Sp002329405 Abundance In Stool,Phenotype,Uba1448 Sp002329405 Abundance In Stool
41343,Uba1448 Abundance In Stool,Phenotype,Uba1448 Abundance In Stool
41344,Uba1777 Sp900319835 Abundance In Stool,Phenotype,Uba1777 Sp900319835 Abundance In Stool
41345,Uba2922 Sp900313925 Abundance In Stool,Phenotype,Uba2922 Sp900313925 Abundance In Stool
41347,Uba6398 Sp002451695 Abundance In Stool,Phenotype,Uba6398 Sp002451695 Abundance In Stool
41349,Uba7182 Sp002491115 Abundance In Stool,Phenotype,Uba7182 Sp002491115 Abundance In Stool
41352,Acidobacteriales Abundance In Stool,Phenotype,Acidobacteriales Abundance In Stool
41354,Agathobacter Sp000434275 Abundance In Stool,Phenotype,Agathobacter Sp000434275 Abundance In Stool
41356,Anaeromassilibacillus Sp001305115 Abundance In Stool,Phenotype,Anaeromassilibacillus Sp001305115 Abundance In Stool
41358,Uba7748 Sp900314535 Abundance In Stool,Phenotype,Uba7748 Sp900314535 Abundance In Stool
41360,Uba8517 Abundance In Stool,Phenotype,Uba8517 Abundance In Stool
41362,Achromobacter Abundance In Stool,Phenotype,Achromobacter Abundance In Stool
41364,Borreliaceae Abundance In Stool,Phenotype,Borreliaceae Abundance In Stool
41366,Borreliales Abundance In Stool,Phenotype,Borreliales Abundance In Stool
41369,Neuropathic Bladder,Phenotype,Neuropathic Bladder
41371,Malignant Lymphoma,Phenotype,Malignant Lymphoma
41374,Meniere'S Disease,Phenotype,Meniere'S Disease
41376,Bacillus Ay Abundance In Stool,Phenotype,Bacillus Ay Abundance In Stool
41378,Bifidobacterium Angulatum Abundance In Stool,Phenotype,Bifidobacterium Angulatum Abundance In Stool
41380,Cag-349 Abundance In Stool,Phenotype,Cag-349 Abundance In Stool
41382,Cag-448 Sp000433415 Abundance In Stool,Phenotype,Cag-448 Sp000433415 Abundance In Stool
41384,Cag-170 Sp003516765 Abundance In Stool,Phenotype,Cag-170 Sp003516765 Abundance In Stool
41386,Cag-177 Sp002438685 Abundance In Stool,Phenotype,Cag-177 Sp002438685 Abundance In Stool
41388,Cag-177 Sp002451755 Abundance In Stool,Phenotype,Cag-177 Sp002451755 Abundance In Stool
41389,Cag-177 Sp003514385 Abundance In Stool,Phenotype,Cag-177 Sp003514385 Abundance In Stool
41390,Cag-177 Sp003538135 Abundance In Stool,Phenotype,Cag-177 Sp003538135 Abundance In Stool
41391,Cag-177 Abundance In Stool,Phenotype,Cag-177 Abundance In Stool
41392,Cag-180 Sp000432435 Abundance In Stool,Phenotype,Cag-180 Sp000432435 Abundance In Stool
41393,Cag-269 Sp001915995 Abundance In Stool,Phenotype,Cag-269 Sp001915995 Abundance In Stool
41395,Cag-81 Sp000435795 Abundance In Stool,Phenotype,Cag-81 Sp000435795 Abundance In Stool
41397,Cag-841 Sp002479075 Abundance In Stool,Phenotype,Cag-841 Sp002479075 Abundance In Stool
41399,Cag-882 Sp003486385 Abundance In Stool,Phenotype,Cag-882 Sp003486385 Abundance In Stool
41405,Cag-977 Abundance In Stool,Phenotype,Cag-977 Abundance In Stool
41407,Clostridium Tertium Abundance In Stool,Phenotype,Clostridium Tertium Abundance In Stool
41409,Desulfovibrio Piger Abundance In Stool,Phenotype,Desulfovibrio Piger Abundance In Stool
41412,Cholesterol To Total Lipids Ratio In Small Hdl,Phenotype,Cholesterol To Total Lipids Ratio In Small Hdl
41414,Cholesteryl Ester Levels In Small Hdl,Phenotype,Cholesteryl Ester Levels In Small Hdl
41415,Phospholipid Levels In Small Hdl,Phenotype,Phospholipid Levels In Small Hdl
41416,Triglycerides To Total Lipids Ratio In Small Hdl,Phenotype,Triglycerides To Total Lipids Ratio In Small Hdl
41417,Total Lipid Levels In Small Ldl,Phenotype,Total Lipid Levels In Small Ldl
41418,Triglycerides To Total Lipids Ratio In Small Ldl,Phenotype,Triglycerides To Total Lipids Ratio In Small Ldl
41420,Total Lipid Levels In Small Vldl,Phenotype,Total Lipid Levels In Small Vldl
41421,Triglyceride Levels In Small Vldl,Phenotype,Triglyceride Levels In Small Vldl
41437,Resilience Score,Phenotype,Resilience Score
41439,Vldl Cholesterol Levels,Phenotype,Vldl Cholesterol Levels
41440,Valine Levels,Phenotype,Valine Levels
41450,Saliva Microbiota Abundance (Order Actinomycetales),Phenotype,Saliva Microbiota Abundance (Order Actinomycetales)
41453,Total Concentration Of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),Phenotype,Total Concentration Of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine)
41456,Cholesteryl Ester Levels In Vldl,Phenotype,Cholesteryl Ester Levels In Vldl
41472,Cholesteryl Ester Levels In Small Ldl,Phenotype,Cholesteryl Ester Levels In Small Ldl
41473,Cholesterol Levels In Small Vldl,Phenotype,Cholesterol Levels In Small Vldl
41474,Pulmonary Tuberculosis Resistance,Phenotype,Pulmonary Tuberculosis Resistance
41476,Concentration Of Small Vldl Particles,Phenotype,Concentration Of Small Vldl Particles
41478,Anti-Hepatitis E Antibody Levels,Phenotype,Anti-Hepatitis E Antibody Levels
41485,Degree Of Unsaturation,Phenotype,Degree Of Unsaturation
41499,Average Diameter For Vldl Particles,Phenotype,Average Diameter For Vldl Particles
41506,Lignoceroylcarnitine (C24) Levels In Elite Athletes,Phenotype,Lignoceroylcarnitine (C24) Levels In Elite Athletes
41509,Maleate Levels In Elite Athletes,Phenotype,Maleate Levels In Elite Athletes
41511,Linoleoylcarnitine (C18:2) Levels In Elite Athletes,Phenotype,Linoleoylcarnitine (C18:2) Levels In Elite Athletes
41512,Mannose Levels In Elite Athletes,Phenotype,Mannose Levels In Elite Athletes
41516,Linoleoyl Ethanolamide Levels In Elite Athletes,Phenotype,Linoleoyl Ethanolamide Levels In Elite Athletes
41519,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [1] Levels In Elite Athletes,Phenotype,Linoleoyl-Arachidonoyl-Glycerol (18:2/20:4) [1] Levels In Elite Athletes
41521,Tonsillitis,Phenotype,Tonsillitis
41528,N-Acetylmethionine Levels In Elite Athletes,Phenotype,N-Acetylmethionine Levels In Elite Athletes
41530,N-Acetyltaurine Levels In Elite Athletes,Phenotype,N-Acetyltaurine Levels In Elite Athletes
41532,Palmitoyl Dihydrosphingomyelin (D18:0/16:0) Levels In Elite Athletes,Phenotype,Palmitoyl Dihydrosphingomyelin (D18:0/16:0) Levels In Elite Athletes
41534,Palmitoyl Ethanolamide Levels In Elite Athletes,Phenotype,Palmitoyl Ethanolamide Levels In Elite Athletes
41535,Palmitoyl-Oleoyl-Glycerol (16:0/18:1) [1] Levels In Elite Athletes,Phenotype,Palmitoyl-Oleoyl-Glycerol (16:0/18:1) [1] Levels In Elite Athletes
41538,Viral Variant Gag242N Carrier Status In Hiv Infection,Phenotype,Viral Variant Gag242N Carrier Status In Hiv Infection
41540,Cerebrospinal Fluid Metabolite X-24728 Levels,Phenotype,Cerebrospinal Fluid Metabolite X-24728 Levels
41541,Cerebrospinal Fluid Metabolite X-25948 Levels,Phenotype,Cerebrospinal Fluid Metabolite X-25948 Levels
41543,Cerebrospinal Fluid Adenine Levels,Phenotype,Cerebrospinal Fluid Adenine Levels
41545,Oleoylcarnitine (C18:1) Levels In Elite Athletes,Phenotype,Oleoylcarnitine (C18:1) Levels In Elite Athletes
41546,Sphingomyelin (D18:2/23:0-- D18:1/23:1-- D17:1/24:1) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:2/23:0-- D18:1/23:1-- D17:1/24:1) Levels In Elite Athletes
41548,Sphingomyelin (D18:2/24:1-- D18:1/24:2) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:2/24:1-- D18:1/24:2) Levels In Elite Athletes
41555,Brain 2-Hydroxystearate Levels,Phenotype,Brain 2-Hydroxystearate Levels
41557,Sphingomyelin (D18:2/24:2) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:2/24:2) Levels In Elite Athletes
41559,Sphingosine 1-Phosphate Levels In Elite Athletes,Phenotype,Sphingosine 1-Phosphate Levels In Elite Athletes
41560,Stearoylcholine Levels In Elite Athletes,Phenotype,Stearoylcholine Levels In Elite Athletes
41563,Chronic Heart Failure,Phenotype,Chronic Heart Failure
41568,Bronchiectasis,Phenotype,Bronchiectasis
41574,Dihydroorotate Levels In Elite Athletes,Phenotype,Dihydroorotate Levels In Elite Athletes
41576,Pro-Hydroxy-Pro Levels In Elite Athletes,Phenotype,Pro-Hydroxy-Pro Levels In Elite Athletes
41578,Pyridoxate Levels In Elite Athletes,Phenotype,Pyridoxate Levels In Elite Athletes
41581,Pipecolate Levels In Elite Athletes,Phenotype,Pipecolate Levels In Elite Athletes
41583,2'-O-Methyluridine Levels In Elite Athletes,Phenotype,2'-O-Methyluridine Levels In Elite Athletes
41585,N1-Methylinosine Levels In Elite Athletes,Phenotype,N1-Methylinosine Levels In Elite Athletes
41587,N6-Carbamoylthreonyladenosine Levels In Elite Athletes,Phenotype,N6-Carbamoylthreonyladenosine Levels In Elite Athletes
41588,Orotidine Levels In Elite Athletes,Phenotype,Orotidine Levels In Elite Athletes
41591,Pyruvate Levels In Elite Athletes,Phenotype,Pyruvate Levels In Elite Athletes
41594,Cataracts,Phenotype,Cataracts
41598,Phenylacetylglutamate Levels In Elite Athletes,Phenotype,Phenylacetylglutamate Levels In Elite Athletes
41600,Valylglutamine Levels In Elite Athletes,Phenotype,Valylglutamine Levels In Elite Athletes
41602,Valylglycine Levels In Elite Athletes,Phenotype,Valylglycine Levels In Elite Athletes
41604,1--2--3-Benzenetriol Sulfate (2) Levels In Elite Athletes,Phenotype,1--2--3-Benzenetriol Sulfate (2) Levels In Elite Athletes
41606,2--3-Dihydroxyisovalerate Levels In Elite Athletes,Phenotype,2--3-Dihydroxyisovalerate Levels In Elite Athletes
41607,3-(3-Hydroxyphenyl)Propionate Sulfate Levels In Elite Athletes,Phenotype,3-(3-Hydroxyphenyl)Propionate Sulfate Levels In Elite Athletes
41610,Esophageal Varix,Phenotype,Esophageal Varix
41612,Bell'S Palsy,Phenotype,Bell'S Palsy
41619,Homostachydrine Levels In Elite Athletes,Phenotype,Homostachydrine Levels In Elite Athletes
41622,Hwesasxx Levels In Elite Athletes,Phenotype,Hwesasxx Levels In Elite Athletes
41624,Hypoxanthine Levels In Elite Athletes,Phenotype,Hypoxanthine Levels In Elite Athletes
41626,Glycolithocholate Sulfate Levels In Elite Athletes,Phenotype,Glycolithocholate Sulfate Levels In Elite Athletes
41628,Glycosyl Ceramide (D18:1/23:1-- D17:1/24:1) Levels In Elite Athletes,Phenotype,Glycosyl Ceramide (D18:1/23:1-- D17:1/24:1) Levels In Elite Athletes
41631,Inosine Levels In Elite Athletes,Phenotype,Inosine Levels In Elite Athletes
41636,Chiro-Inositol Levels In Elite Athletes,Phenotype,Chiro-Inositol Levels In Elite Athletes
41639,Eicosenoate (20:1) Levels In Elite Athletes,Phenotype,Eicosenoate (20:1) Levels In Elite Athletes
41640,Etiocholanolone Glucuronide Levels In Elite Athletes,Phenotype,Etiocholanolone Glucuronide Levels In Elite Athletes
41643,Dihomo-Linolenoylcarnitine (20:3N3 Or 6) Levels In Elite Athletes,Phenotype,Dihomo-Linolenoylcarnitine (20:3N3 Or 6) Levels In Elite Athletes
41645,Dihomo-Linoleoylcarnitine (C20:2) Levels In Elite Athletes,Phenotype,Dihomo-Linoleoylcarnitine (C20:2) Levels In Elite Athletes
41646,Docosadienoate (22:2N6) Levels In Elite Athletes,Phenotype,Docosadienoate (22:2N6) Levels In Elite Athletes
41651,Leucine Levels In Elite Athletes,Phenotype,Leucine Levels In Elite Athletes
41660,Lactosyl-N-Nervonoyl-Sphingosine (D18:1/24:1) Levels In Elite Athletes,Phenotype,Lactosyl-N-Nervonoyl-Sphingosine (D18:1/24:1) Levels In Elite Athletes
41662,Kynurenine Levels In Elite Athletes,Phenotype,Kynurenine Levels In Elite Athletes
41665,Glycosyl Ceramide (D18:2/24:1-- D18:1/24:2) Levels In Elite Athletes,Phenotype,Glycosyl Ceramide (D18:2/24:1-- D18:1/24:2) Levels In Elite Athletes
41666,Isoleucine Levels In Elite Athletes,Phenotype,Isoleucine Levels In Elite Athletes
41668,Lactosyl-N-Behenoyl-Sphingosine (D18:1/22:0) Levels In Elite Athletes,Phenotype,Lactosyl-N-Behenoyl-Sphingosine (D18:1/22:0) Levels In Elite Athletes
41671,N-Acetyl-Beta-Alanine Levels In Elite Athletes,Phenotype,N-Acetyl-Beta-Alanine Levels In Elite Athletes
41673,N-Palmitoyltaurine Levels In Elite Athletes,Phenotype,N-Palmitoyltaurine Levels In Elite Athletes
41677,N-Acetylarginine Levels In Elite Athletes,Phenotype,N-Acetylarginine Levels In Elite Athletes
41679,Margaroylcarnitine Levels In Elite Athletes,Phenotype,Margaroylcarnitine Levels In Elite Athletes
41681,Methionine Sulfoxide Levels In Elite Athletes,Phenotype,Methionine Sulfoxide Levels In Elite Athletes
41683,Myristoylcarnitine (C14) Levels In Elite Athletes,Phenotype,Myristoylcarnitine (C14) Levels In Elite Athletes
41684,Octanoylcarnitine (C8) Levels In Elite Athletes,Phenotype,Octanoylcarnitine (C8) Levels In Elite Athletes
41687,Oleoyl Ethanolamide Levels In Elite Athletes,Phenotype,Oleoyl Ethanolamide Levels In Elite Athletes
41689,N-Palmitoyl-Sphingadienine (D18:2/16:0) Levels In Elite Athletes,Phenotype,N-Palmitoyl-Sphingadienine (D18:2/16:0) Levels In Elite Athletes
41691,Sphingomyelin (D18:1/25:0-- D19:0/24:1-- D20:1/23:0-- D19:1/24:0) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:1/25:0-- D19:0/24:1-- D20:1/23:0-- D19:1/24:0) Levels In Elite Athletes
41694,Sphingomyelin (D18:2/21:0-- D16:2/23:0) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:2/21:0-- D16:2/23:0) Levels In Elite Athletes
41696,Nonadecanoate (19:0) Levels In Elite Athletes,Phenotype,Nonadecanoate (19:0) Levels In Elite Athletes
41697,Sphingomyelin (D18:1/20:2-- D18:2/20:1-- D16:1/22:2) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:1/20:2-- D18:2/20:1-- D16:1/22:2) Levels In Elite Athletes
41699,Octadecanedioate Levels In Elite Athletes,Phenotype,Octadecanedioate Levels In Elite Athletes
41701,Sebacate (Decanedioate) Levels In Elite Athletes,Phenotype,Sebacate (Decanedioate) Levels In Elite Athletes
41703,Pregnanediol-3-Glucuronide Levels In Elite Athletes,Phenotype,Pregnanediol-3-Glucuronide Levels In Elite Athletes
41705,Pregnanolone/Allopregnanolone Sulfate Levels In Elite Athletes,Phenotype,Pregnanolone/Allopregnanolone Sulfate Levels In Elite Athletes
41707,Pregnen-Diol Disulfate C21H34O8S2 Levels In Elite Athletes,Phenotype,Pregnen-Diol Disulfate C21H34O8S2 Levels In Elite Athletes
41709,Sphingomyelin (D18:1/22:1-- D18:2/22:0-- D16:1/24:1) Levels In Elite Athletes,Phenotype,Sphingomyelin (D18:1/22:1-- D18:2/22:0-- D16:1/24:1) Levels In Elite Athletes
41711,Brain 2-Hydroxyglutarate Levels,Phenotype,Brain 2-Hydroxyglutarate Levels
41713,Cerebrospinal Fluid Imidazole Lactate Levels,Phenotype,Cerebrospinal Fluid Imidazole Lactate Levels
41714,Cerebrospinal Fluid Xanthosine Levels,Phenotype,Cerebrospinal Fluid Xanthosine Levels
41716,Cerebrospinal Fluid Phenyllactate (Pla) Levels,Phenotype,Cerebrospinal Fluid Phenyllactate (Pla) Levels
41718,Phenylacetate Levels In Elite Athletes,Phenotype,Phenylacetate Levels In Elite Athletes
41720,Phenyllactate (Pla) Levels In Elite Athletes,Phenotype,Phenyllactate (Pla) Levels In Elite Athletes
41722,Phenol Sulfate Levels In Elite Athletes,Phenotype,Phenol Sulfate Levels In Elite Athletes
41724,Cerebrospinal Fluid Ethylmalonate Levels,Phenotype,Cerebrospinal Fluid Ethylmalonate Levels
41726,Cerebrospinal Fluid 5-Methylthioadenosine (Mta) Levels,Phenotype,Cerebrospinal Fluid 5-Methylthioadenosine (Mta) Levels
41728,Cerebrospinal Fluid 3-(4-Hydroxyphenyl)Lactate Levels,Phenotype,Cerebrospinal Fluid 3-(4-Hydroxyphenyl)Lactate Levels
41730,Cerebrospinal Fluid Inosine Levels,Phenotype,Cerebrospinal Fluid Inosine Levels
41731,Cerebrospinal Fluid Methylmalonate (Mma) Levels,Phenotype,Cerebrospinal Fluid Methylmalonate (Mma) Levels
41735,Cerebrospinal Fluid Isobutyrylcarnitine (C4) Levels,Phenotype,Cerebrospinal Fluid Isobutyrylcarnitine (C4) Levels
41737,Leucylalanine Levels In Elite Athletes,Phenotype,Leucylalanine Levels In Elite Athletes
41739,Serine Levels In Elite Athletes,Phenotype,Serine Levels In Elite Athletes
41742,Gamma-Glutamyltryptophan Levels In Elite Athletes,Phenotype,Gamma-Glutamyltryptophan Levels In Elite Athletes
41744,Quinate Levels In Elite Athletes,Phenotype,Quinate Levels In Elite Athletes
41745,4-Hydroxyphenylacetylglutamine Levels In Elite Athletes,Phenotype,4-Hydroxyphenylacetylglutamine Levels In Elite Athletes
41746,Chronic Glomerulonephritis,Phenotype,Chronic Glomerulonephritis
41748,Chronic Renal Failure,Phenotype,Chronic Renal Failure
41750,Chronic Bronchitis,Phenotype,Chronic Bronchitis
41753,Colon Polyp,Phenotype,Colon Polyp
41755,Cystitis,Phenotype,Cystitis
41757,Cholelithiasis,Phenotype,Cholelithiasis
41760,Hearing Loss-- Difficulty In Hearing,Phenotype,Hearing Loss-- Difficulty In Hearing
41763,Hyperthyroidism,Phenotype,Hyperthyroidism
41767,Goiter,Phenotype,Goiter
41779,Body Mass Index In Physically Active Individuals,Phenotype,Body Mass Index In Physically Active Individuals
41780,Waist Circumference Adjusted For Bmi In Active Individuals,Phenotype,Waist Circumference Adjusted For Bmi In Active Individuals
41781,Accelerated Cognitive Decline After Conversion Of Mild Cognitive Impairment To Alzheimer'S Disease (Alzhiemer'S Diagnosis Trajectory Interaction),Phenotype,Accelerated Cognitive Decline After Conversion Of Mild Cognitive Impairment To Alzheimer'S Disease (Alzhiemer'S Diagnosis Trajectory Interaction)
41785,Sporadic Neuroblastoma,Phenotype,Sporadic Neuroblastoma
41786,Body Mass Index In Physically Inactive Individuals,Phenotype,Body Mass Index In Physically Inactive Individuals
41787,Waist Circumference Adjusted For Bmi In Inactive Individuals,Phenotype,Waist Circumference Adjusted For Bmi In Inactive Individuals
41788,Waist-To-Hip Ratio Adjusted For Bmi In Active Individuals,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi In Active Individuals
41789,Foot Ulcer In Diabetes And Neuropathy,Phenotype,Foot Ulcer In Diabetes And Neuropathy
41792,Foot Ulcer And Neuropathy In Diabetes,Phenotype,Foot Ulcer And Neuropathy In Diabetes
41794,Change In Lvef In Response To Paclitaxel And Trastuzumab In Her2+ Breast Cancer,Phenotype,Change In Lvef In Response To Paclitaxel And Trastuzumab In Her2+ Breast Cancer
41828,Psychosis Proneness (Perceptual Aberration Scale And Revised Physical Anhedonia Scale),Phenotype,Psychosis Proneness (Perceptual Aberration Scale And Revised Physical Anhedonia Scale)
41832,Ankylosing Spondylitis (Snp X Snp Interaction),Phenotype,Ankylosing Spondylitis (Snp X Snp Interaction)
41838,Plasma Trimethylamine N-Oxide Levels,Phenotype,Plasma Trimethylamine N-Oxide Levels
41849,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index),Phenotype,Obstructive Sleep Apnea Trait (Apnea Hypopnea Index)
41852,Overall Survival In Serous Epithelial Ovarian Cancer Treated With Paclitaxel And Cisplatin,Phenotype,Overall Survival In Serous Epithelial Ovarian Cancer Treated With Paclitaxel And Cisplatin
41854,Diastolic Blood Pressure X Sodium Interaction (1Df Test),Phenotype,Diastolic Blood Pressure X Sodium Interaction (1Df Test)
41856,Diastolic Blood Pressure X Sodium Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Sodium Interaction (2Df Test)
41861,Colonoscopy-Negative Controls Vs Population Controls,Phenotype,Colonoscopy-Negative Controls Vs Population Controls
41882,Paclitaxel Disposition In Epithelial Ovarian Cancer,Phenotype,Paclitaxel Disposition In Epithelial Ovarian Cancer
41885,Carboplatin Disposition In Epthelial Ovarian Cancer,Phenotype,Carboplatin Disposition In Epthelial Ovarian Cancer
41894,Hepatocyte Growth Factor Levels,Phenotype,Hepatocyte Growth Factor Levels
41896,Interleukin-1-Receptor Antagonist Levels,Phenotype,Interleukin-1-Receptor Antagonist Levels
41898,Interferon Gamma Levels,Phenotype,Interferon Gamma Levels
41902,Interleukin-1-Beta Levels,Phenotype,Interleukin-1-Beta Levels
41905,Interleukin-2 Receptor Antagonist Levels,Phenotype,Interleukin-2 Receptor Antagonist Levels
41907,Interleukin-4 Levels,Phenotype,Interleukin-4 Levels
41910,Interleukin-2 Levels,Phenotype,Interleukin-2 Levels
41915,Stromal-Cell-Derived Factor 1 Alpha Levels,Phenotype,Stromal-Cell-Derived Factor 1 Alpha Levels
41916,Tumor Necrosis Factor Alpha Levels,Phenotype,Tumor Necrosis Factor Alpha Levels
41920,Stem Cell Growth Factor Beta Levels,Phenotype,Stem Cell Growth Factor Beta Levels
41927,Idiopathic Osteonecrosis Of The Femoral Head,Phenotype,Idiopathic Osteonecrosis Of The Femoral Head
41930,Glioblastoma,Phenotype,Glioblastoma
41933,Subclinical Trait Of Interstitial Lung Disease (Basilar Percentage Of High Attenuation Areas On Ct Scan),Phenotype,Subclinical Trait Of Interstitial Lung Disease (Basilar Percentage Of High Attenuation Areas On Ct Scan)
41934,Subclinical Trait Of Interstitial Lung Disease (Basilar Peel-Core Ratio Of High Attentuation Areas On Ct Scan),Phenotype,Subclinical Trait Of Interstitial Lung Disease (Basilar Peel-Core Ratio Of High Attentuation Areas On Ct Scan)
41936,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (2Df Test)
41938,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (1Df Test),Phenotype,Diastolic Blood Pressure X Smoking Status (Ever Vs Never) Interaction (1Df Test)
41962,Lobe Attachment (Rater-Scored Or Self-Reported),Phenotype,Lobe Attachment (Rater-Scored Or Self-Reported)
41965,Iris Color (L* Coordinate),Phenotype,Iris Color (L* Coordinate)
41968,Iris Color (A* Coordinate),Phenotype,Iris Color (A* Coordinate)
42019,Cognitive Ability (Mtag),Phenotype,Cognitive Ability (Mtag)
42020,Cognitive Ability,Phenotype,Cognitive Ability
42026,Lobe Attachment (Rater Scored),Phenotype,Lobe Attachment (Rater Scored)
42028,P Wave Terminal Force,Phenotype,P Wave Terminal Force
42032,Caudate Volume In Trauma-Exposed Individuals,Phenotype,Caudate Volume In Trauma-Exposed Individuals
42034,Nucleus Accumbens Volume In Trauma-Exposed Individuals,Phenotype,Nucleus Accumbens Volume In Trauma-Exposed Individuals
42041,Cardiometabolic And Hematological Traits,Phenotype,Cardiometabolic And Hematological Traits
42044,Branched-Chain Amino Acid Levels (Isoleucine),Phenotype,Branched-Chain Amino Acid Levels (Isoleucine)
42047,Branched-Chain Amino Acid Levels (Valine),Phenotype,Branched-Chain Amino Acid Levels (Valine)
42048,High Altitude Adaptation,Phenotype,High Altitude Adaptation
42050,Common Carotid Intima-Media Thickness In Hiv Negative Individuals,Phenotype,Common Carotid Intima-Media Thickness In Hiv Negative Individuals
42052,Common Carotid Intima-Media Thickness,Phenotype,Common Carotid Intima-Media Thickness
42057,Response To Bronchodilator In Chronic Obstructive Pulmonary Disease (Change In Fev1),Phenotype,Response To Bronchodilator In Chronic Obstructive Pulmonary Disease (Change In Fev1)
42066,Coronary Artery Calcified Atherosclerotic Plaque (130 Hu Threshold) In Type 2 Diabetes,Phenotype,Coronary Artery Calcified Atherosclerotic Plaque (130 Hu Threshold) In Type 2 Diabetes
42073,Coronary Artery Calcified Atherosclerotic Plaque Score In Type 2 Diabetes,Phenotype,Coronary Artery Calcified Atherosclerotic Plaque Score In Type 2 Diabetes
42076,Coronary Artery Calcified Atherosclerotic Plaque (90 Or 130 Hu Threshold) In Type 2 Diabetes,Phenotype,Coronary Artery Calcified Atherosclerotic Plaque (90 Or 130 Hu Threshold) In Type 2 Diabetes
42085,Low Vwf Levels,Phenotype,Low Vwf Levels
42089,Event Free Survival In Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy,Phenotype,Event Free Survival In Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
42091,Response To Radiotherapy In Prostate Cancer (Toxicity-- Urinary Frequency),Phenotype,Response To Radiotherapy In Prostate Cancer (Toxicity-- Urinary Frequency)
42094,Objective Response To Lithium Treatment In Bipolar Disorder,Phenotype,Objective Response To Lithium Treatment In Bipolar Disorder
42097,Interleukin-10 Levels,Phenotype,Interleukin-10 Levels
42102,Fibroblast Growth Factor Basic Levels,Phenotype,Fibroblast Growth Factor Basic Levels
42105,Growth-Regulated Protein Alpha Levels,Phenotype,Growth-Regulated Protein Alpha Levels
42113,Eotaxin Levels,Phenotype,Eotaxin Levels
42125,Rheumatoid Arthritis (Acpa-Positive),Phenotype,Rheumatoid Arthritis (Acpa-Positive)
42126,Waist-To-Hip Ratio Adjusted For Bmi (Age <50),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Age <50)
42128,Waist-To-Hip Ratio Adjusted For Bmi (Age >50),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi (Age >50)
42129,Body Mass Index (Age <50),Phenotype,Body Mass Index (Age <50)
42131,Body Mass Index (Age>50),Phenotype,Body Mass Index (Age>50)
42135,Interferon Gamma-Induced Protein 10 Levels,Phenotype,Interferon Gamma-Induced Protein 10 Levels
42141,Macrophage Migration Inhibitory Factor Levels,Phenotype,Macrophage Migration Inhibitory Factor Levels
42145,Interleukin-18 Levels,Phenotype,Interleukin-18 Levels
42149,Interleukin-17 Levels,Phenotype,Interleukin-17 Levels
42159,Immunoglobulin Light Chain (Al) Amyloidosis,Phenotype,Immunoglobulin Light Chain (Al) Amyloidosis
42161,Trail Levels,Phenotype,Trail Levels
42171,Plasma Thyroid-Stimulating Hormone Levels,Phenotype,Plasma Thyroid-Stimulating Hormone Levels
42173,Heart Rate Response To Beta Blockers (Atenolol Add-On Therapy),Phenotype,Heart Rate Response To Beta Blockers (Atenolol Add-On Therapy)
42175,Heart Rate Response To Beta Blockers,Phenotype,Heart Rate Response To Beta Blockers
42178,Waist-To-Hip Ratio Adjusted For Bmi X Sex X Age Interaction (4Df Test),Phenotype,Waist-To-Hip Ratio Adjusted For Bmi X Sex X Age Interaction (4Df Test)
42179,Waist-To-Hip Ratio Adjusted For Bmi X Sex Interaction,Phenotype,Waist-To-Hip Ratio Adjusted For Bmi X Sex Interaction
42180,Juvenile Idiopathic Arthritis (Oligoarticular Or Rheumatoid Factor-Negative Polyarticular),Phenotype,Juvenile Idiopathic Arthritis (Oligoarticular Or Rheumatoid Factor-Negative Polyarticular)
42183,Yeast Infection,Phenotype,Yeast Infection
42190,Myringotomy,Phenotype,Myringotomy
42192,Measles,Phenotype,Measles
42200,Autoimmune Thyroid Diseases (Graves Disease Or Hashimoto'S Thyroiditis),Phenotype,Autoimmune Thyroid Diseases (Graves Disease Or Hashimoto'S Thyroiditis)
42207,Neuroblastoma (1P Deletion),Phenotype,Neuroblastoma (1P Deletion)
42208,Neuroblastoma (Mycn Amplification),Phenotype,Neuroblastoma (Mycn Amplification)
42228,Borderline Personality Disorder,Phenotype,Borderline Personality Disorder
42253,Facial Morphology (Factor 22),Phenotype,Facial Morphology (Factor 22)
42255,Facial Morphology (Factor 23),Phenotype,Facial Morphology (Factor 23)
42272,Facial Morphology (Factor 14-- Intercanthal Width),Phenotype,Facial Morphology (Factor 14-- Intercanthal Width)
42277,Facial Morphology (Factor 21-- Depth Of Nasal Alae),Phenotype,Facial Morphology (Factor 21-- Depth Of Nasal Alae)
42341,Prevalent Type 2 Diabetes,Phenotype,Prevalent Type 2 Diabetes
42348,Time-Dependent Creatinine Clearance Change Response To Tenofovir Treatment In Hiv Infection (Time And Treatment Arm Interaction),Phenotype,Time-Dependent Creatinine Clearance Change Response To Tenofovir Treatment In Hiv Infection (Time And Treatment Arm Interaction)
42359,Venlafaxine Response In Generalised Anxiety Disorder (Responders Vs Non-Responders After 12 Weeks),Phenotype,Venlafaxine Response In Generalised Anxiety Disorder (Responders Vs Non-Responders After 12 Weeks)
42361,Venlafaxine Response In Generalised Anxiety Disorder (Responders Vs Non-Responders After 24 Weeks),Phenotype,Venlafaxine Response In Generalised Anxiety Disorder (Responders Vs Non-Responders After 24 Weeks)
42365,Waist Circumference Adjusted For Bmi (Smoking Interaction),Phenotype,Waist Circumference Adjusted For Bmi (Smoking Interaction)
42381,Energy Expenditure (24H),Phenotype,Energy Expenditure (24H)
42390,Bone Ultrasound Measurement (Velocity Of Sound),Phenotype,Bone Ultrasound Measurement (Velocity Of Sound)
42392,Bone Ultrasound Measurement (Broadband Ultrasound Attenuation),Phenotype,Bone Ultrasound Measurement (Broadband Ultrasound Attenuation)
42394,Waist Circumference Adjusted For Bmi In Non-Smokers,Phenotype,Waist Circumference Adjusted For Bmi In Non-Smokers
42398,Peak Insulin Response,Phenotype,Peak Insulin Response
42399,Acute Insulin Response,Phenotype,Acute Insulin Response
42400,Insulin Secretion Rate,Phenotype,Insulin Secretion Rate
42401,Bmi In Non-Smokers,Phenotype,Bmi In Non-Smokers
42402,Waist Circumference Adjusted For Bmi In Smokers,Phenotype,Waist Circumference Adjusted For Bmi In Smokers
42412,Bmi In Smokers,Phenotype,Bmi In Smokers
42433,Interleukin-9 Levels,Phenotype,Interleukin-9 Levels
42436,Interleukin-13 Levels,Phenotype,Interleukin-13 Levels
42447,Alcohol Consumption Over The Past Year,Phenotype,Alcohol Consumption Over The Past Year
42453,Severe Malaria (Adjusted For Sickle Cell Variant Rs334),Phenotype,Severe Malaria (Adjusted For Sickle Cell Variant Rs334)
42459,Mixed Cellularity Hodgkin Lymphoma,Phenotype,Mixed Cellularity Hodgkin Lymphoma
42460,Severe Malaria,Phenotype,Severe Malaria
42461,Colorectal Adenoma (Advanced),Phenotype,Colorectal Adenoma (Advanced)
42468,Interleukin-8 Levels,Phenotype,Interleukin-8 Levels
42472,Interleukin-7 Levels,Phenotype,Interleukin-7 Levels
42476,Interleukin-5 Levels,Phenotype,Interleukin-5 Levels
42488,Ctack Levels,Phenotype,Ctack Levels
42490,Beta-Nerve Growth Factor Levels,Phenotype,Beta-Nerve Growth Factor Levels
42507,Diastolic Blood Pressure (Cigarette Smoking Interaction),Phenotype,Diastolic Blood Pressure (Cigarette Smoking Interaction)
42514,Major Depression And Alcohol Dependence,Phenotype,Major Depression And Alcohol Dependence
42542,Facial Emotion Recognition (Angry Faces),Phenotype,Facial Emotion Recognition (Angry Faces)
42544,Facial Emotion Recognition (Fearful Faces),Phenotype,Facial Emotion Recognition (Fearful Faces)
42565,Alcohol Consumption (Max-Drinks),Phenotype,Alcohol Consumption (Max-Drinks)
42567,Response To Alcohol Consumption (Flushing Response),Phenotype,Response To Alcohol Consumption (Flushing Response)
42569,Body Mass Index X Sex X Age Interaction (4Df Test),Phenotype,Body Mass Index X Sex X Age Interaction (4Df Test)
42570,Peanut Allergy (Parent-Of-Origin Effect),Phenotype,Peanut Allergy (Parent-Of-Origin Effect)
42573,Peanut Allergy (Maternal Genetic Effects),Phenotype,Peanut Allergy (Maternal Genetic Effects)
42575,Idiopathic Dilated Cardiomyopathy,Phenotype,Idiopathic Dilated Cardiomyopathy
42582,Heart Rate Response To Recovery Post Exercise (20 Sec),Phenotype,Heart Rate Response To Recovery Post Exercise (20 Sec)
42587,Decline In Glucose Metabolism In Posterior Cingulate Cortex,Phenotype,Decline In Glucose Metabolism In Posterior Cingulate Cortex
42593,Caudate Activity During Reward,Phenotype,Caudate Activity During Reward
42608,Creatine Kinase Levels,Phenotype,Creatine Kinase Levels
42616,Response To Haloperidol In Schizophrenia,Phenotype,Response To Haloperidol In Schizophrenia
42618,Irritable Mood,Phenotype,Irritable Mood
42620,Feeling Miserable,Phenotype,Feeling Miserable
42622,Systemic Lupus Erythematosus Or Rheumatoid Arthritis,Phenotype,Systemic Lupus Erythematosus Or Rheumatoid Arthritis
42625,Carotid Artery External Diameter,Phenotype,Carotid Artery External Diameter
42626,Carotid Artery Internal Diameter,Phenotype,Carotid Artery Internal Diameter
42627,Antipsychotic Drug-Induced Qtc Interval Change In Schizophrenia,Phenotype,Antipsychotic Drug-Induced Qtc Interval Change In Schizophrenia
42632,Thiopurine-Induced Alopecia In Inflammatory Bowel Disease,Phenotype,Thiopurine-Induced Alopecia In Inflammatory Bowel Disease
42640,Virologic Severity In Herpes Simplex Virus Type 2 Infection,Phenotype,Virologic Severity In Herpes Simplex Virus Type 2 Infection
42642,Plantar Fascial Disorders,Phenotype,Plantar Fascial Disorders
42645,Serum Metabolite Concentrations In Chronic Kidney Disease,Phenotype,Serum Metabolite Concentrations In Chronic Kidney Disease
42647,Serum Metabolite Ratios In Chronic Kidney Disease,Phenotype,Serum Metabolite Ratios In Chronic Kidney Disease
42649,Peak Cortisol Response To Low Dose Short Synacthen Test In Corticosteroid Treated Asthma,Phenotype,Peak Cortisol Response To Low Dose Short Synacthen Test In Corticosteroid Treated Asthma
42652,Family History Of Alzheimer'S Disease,Phenotype,Family History Of Alzheimer'S Disease
42654,Fractional Excretion Of Metabolites In Chronic Kidney Disease,Phenotype,Fractional Excretion Of Metabolites In Chronic Kidney Disease
42656,Asthma Or Allergic Disease (Pleiotropy),Phenotype,Asthma Or Allergic Disease (Pleiotropy)
42659,Erosive Tooth Wear (Severe Vs Non-Severe),Phenotype,Erosive Tooth Wear (Severe Vs Non-Severe)
42663,Nonsyndromic Cleft Lip,Phenotype,Nonsyndromic Cleft Lip
42685,Keratinocyte Cancer (Mtag),Phenotype,Keratinocyte Cancer (Mtag)
42703,17-Hydroxyprogesterone (17-Ohp) Levels,Phenotype,17-Hydroxyprogesterone (17-Ohp) Levels
42716,Dheas Levels,Phenotype,Dheas Levels
42721,Smoking Initiation (Ever Regular Vs Never Regular),Phenotype,Smoking Initiation (Ever Regular Vs Never Regular)
42732,Lysophosphatidylcholine Levels,Phenotype,Lysophosphatidylcholine Levels
42742,Suicide Attempts In Major Depressive Disorder Or Bipolar Disorder Or Schizophrenia,Phenotype,Suicide Attempts In Major Depressive Disorder Or Bipolar Disorder Or Schizophrenia
42745,Suicide Attempts In Major Depressive Disorder,Phenotype,Suicide Attempts In Major Depressive Disorder
42749,Mood Instability,Phenotype,Mood Instability
42762,Maximum Habitual Alcohol Consumption,Phenotype,Maximum Habitual Alcohol Consumption
42779,Phosphatidylcholine-Ether Levels,Phenotype,Phosphatidylcholine-Ether Levels
42782,Balding Type 1,Phenotype,Balding Type 1
42824,Alzheimer'S Disease In Hypertension,Phenotype,Alzheimer'S Disease In Hypertension
42834,Smoking Behaviour (Cigarette Pack-Years),Phenotype,Smoking Behaviour (Cigarette Pack-Years)
42838,Subscapular Skin Fold Thickness,Phenotype,Subscapular Skin Fold Thickness
42845,Cholesteryl Ester Levels,Phenotype,Cholesteryl Ester Levels
42850,Peg-Asparaginase Hypersensitivity Without Enzyme Activity In Childhood Acute Lymphoblastic Leukaemia,Phenotype,Peg-Asparaginase Hypersensitivity Without Enzyme Activity In Childhood Acute Lymphoblastic Leukaemia
42872,Chronic Central Serous Retinopathy,Phenotype,Chronic Central Serous Retinopathy
42880,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms (Prostate Cancer Excluded),Phenotype,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms (Prostate Cancer Excluded)
42882,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms,Phenotype,Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms
42885,Fasting Glucose Change (Long-Term),Phenotype,Fasting Glucose Change (Long-Term)
42889,Fasting Glucose Change (Short-Term),Phenotype,Fasting Glucose Change (Short-Term)
42897,Decreased Fine Motor Function In Charcot-Marie-Tooth Disease 1A (Eating With Utensils),Phenotype,Decreased Fine Motor Function In Charcot-Marie-Tooth Disease 1A (Eating With Utensils)
42899,Walking Difficulty In Charcot-Marie-Tooth Disease 1A,Phenotype,Walking Difficulty In Charcot-Marie-Tooth Disease 1A
42903,Diabetic Retinopathy (All Npdr And Pdr),Phenotype,Diabetic Retinopathy (All Npdr And Pdr)
42905,Proliferative Diabetic Retinopathy (Vs No Dr),Phenotype,Proliferative Diabetic Retinopathy (Vs No Dr)
42912,Free Thyroxine Concentration,Phenotype,Free Thyroxine Concentration
42917,Nevus Count,Phenotype,Nevus Count
42919,Infant-- Child And Juvenile Death (Proportion Of Children Died <15 Years),Phenotype,Infant-- Child And Juvenile Death (Proportion Of Children Died <15 Years)
42923,Brain Glucose Metabolism (Fluorodeoxyglucose Uptake),Phenotype,Brain Glucose Metabolism (Fluorodeoxyglucose Uptake)
42927,Suicidality (Suicidal Ideation/Attempts),Phenotype,Suicidality (Suicidal Ideation/Attempts)
42929,Vitiligo (Late Onset),Phenotype,Vitiligo (Late Onset)
42930,Vitiligo (Early Onset),Phenotype,Vitiligo (Early Onset)
42933,Suicide Attempts In Schizophrenia,Phenotype,Suicide Attempts In Schizophrenia
42938,Suicide Attempts In Bipolar Disorder Or Schizophrenia,Phenotype,Suicide Attempts In Bipolar Disorder Or Schizophrenia
42946,Estradiol Levels,Phenotype,Estradiol Levels
42950,Albumin-Globulin Ratio,Phenotype,Albumin-Globulin Ratio
42967,Feeling Worry,Phenotype,Feeling Worry
42970,Feeling Hurt,Phenotype,Feeling Hurt
42973,Feeling Nervous,Phenotype,Feeling Nervous
42989,Cleft Lip With Or Without Cleft Palate (Maternal Periconceptional Vitamin Use Interaction),Phenotype,Cleft Lip With Or Without Cleft Palate (Maternal Periconceptional Vitamin Use Interaction)
42990,Plasma Trimethyllysine Levels,Phenotype,Plasma Trimethyllysine Levels
42993,Urinary Haptoglobin Levels In Type 2 Diabetes,Phenotype,Urinary Haptoglobin Levels In Type 2 Diabetes
42995,Plasma Haptoglobin Levels In Type 2 Diabetes,Phenotype,Plasma Haptoglobin Levels In Type 2 Diabetes
42996,Serum Bilirubin Levels X Mediterranean Diet Adherence Interaction In Metabolic Syndrome,Phenotype,Serum Bilirubin Levels X Mediterranean Diet Adherence Interaction In Metabolic Syndrome
42999,Serum Bilirubin Levels X Sex Interaction In Metabolic Syndrome,Phenotype,Serum Bilirubin Levels X Sex Interaction In Metabolic Syndrome
43002,Cisplatin-Induced Ototoxicity,Phenotype,Cisplatin-Induced Ototoxicity
43011,Ldl Cholesterol Levels In Current Drinkers,Phenotype,Ldl Cholesterol Levels In Current Drinkers
43012,Response To Interferon Treatment In Hepatitis C Virus Genotype 3,Phenotype,Response To Interferon Treatment In Hepatitis C Virus Genotype 3
43014,Response To Direct-Acting Antiviral Treatment In Hepatitis C Virus Genotype 3,Phenotype,Response To Direct-Acting Antiviral Treatment In Hepatitis C Virus Genotype 3
43020,Thiopurine-Induced Leukopenia In Inflammatory Bowel Disease,Phenotype,Thiopurine-Induced Leukopenia In Inflammatory Bowel Disease
43022,Thiopurine Methyltransferase Activity In Acute Lymphoblastic Leukemia Patients Treated With Mercaptopurines,Phenotype,Thiopurine Methyltransferase Activity In Acute Lymphoblastic Leukemia Patients Treated With Mercaptopurines
43023,Neurociticism,Phenotype,Neurociticism
43024,Autoimmune Hepatitis In Primary Sclerosing Cholangitis,Phenotype,Autoimmune Hepatitis In Primary Sclerosing Cholangitis
43025,Liver Transplant-Free Survival In Primary Sclerosing Cholangitis (Time To Event),Phenotype,Liver Transplant-Free Survival In Primary Sclerosing Cholangitis (Time To Event)
43026,Feeling Tense,Phenotype,Feeling Tense
43029,Persistent Hepatitis B Virus Infection,Phenotype,Persistent Hepatitis B Virus Infection
43033,Breast Milk Fatty Acid Composition (Maternal Genotype Effect),Phenotype,Breast Milk Fatty Acid Composition (Maternal Genotype Effect)
43035,Breast Milk Fatty Acid Composition (Infant Genotype Effect),Phenotype,Breast Milk Fatty Acid Composition (Infant Genotype Effect)
43036,Aortic Valve Stenosis,Phenotype,Aortic Valve Stenosis
43037,Age At First Sexual Intercourse,Phenotype,Age At First Sexual Intercourse
43039,Empathy Quotient,Phenotype,Empathy Quotient
43043,Nicotine Withdrawal,Phenotype,Nicotine Withdrawal
43046,Coronary Artery Aneurysm In Kawasaki Disease,Phenotype,Coronary Artery Aneurysm In Kawasaki Disease
43048,Normal Facial Asymmetry (Angle Of Surface Orientation Score),Phenotype,Normal Facial Asymmetry (Angle Of Surface Orientation Score)
43050,Fast Beta Electroencephalogram,Phenotype,Fast Beta Electroencephalogram
43052,Cerebrospinal Fluid Biomarker Levels,Phenotype,Cerebrospinal Fluid Biomarker Levels
43054,Possible Neuropathic Pain In Post Total Joint Replacement Surgery For Osteoarthritis,Phenotype,Possible Neuropathic Pain In Post Total Joint Replacement Surgery For Osteoarthritis
43056,Moderate To Vigorous Physical Activity Levels,Phenotype,Moderate To Vigorous Physical Activity Levels
43060,Vigorous Physical Activity,Phenotype,Vigorous Physical Activity
43068,Strenuous Sports Or Other Exercises,Phenotype,Strenuous Sports Or Other Exercises
43072,Blood Sugar Levels,Phenotype,Blood Sugar Levels
43074,Alanine Transaminase Levels,Phenotype,Alanine Transaminase Levels
43080,Sodium Levels,Phenotype,Sodium Levels
43084,Chloride Levels,Phenotype,Chloride Levels
43104,Osteoarthritis (Self-Reported),Phenotype,Osteoarthritis (Self-Reported)
43106,Broad Depression Or Major Depressive Disorder (Self-Reported),Phenotype,Broad Depression Or Major Depressive Disorder (Self-Reported)
43107,Broad Depression Or Schizophrenia,Phenotype,Broad Depression Or Schizophrenia
43111,Angiotensin-Converting Enzyme Inhibitor Intolerance,Phenotype,Angiotensin-Converting Enzyme Inhibitor Intolerance
43114,Alanine Aminotransferase (Alt) Levels After Remission Induction Therapy In Actute Lymphoblastic Leukemia (All),Phenotype,Alanine Aminotransferase (Alt) Levels After Remission Induction Therapy In Actute Lymphoblastic Leukemia (All)
43126,Cortisol Levels (Saliva),Phenotype,Cortisol Levels (Saliva)
43139,Feeling Fed-Up,Phenotype,Feeling Fed-Up
43141,Feeling Guilty,Phenotype,Feeling Guilty
43144,Experiencing Mood Swings,Phenotype,Experiencing Mood Swings
43153,Worry Too Long After An Embarrassing Experience,Phenotype,Worry Too Long After An Embarrassing Experience
43156,Smoking Behaviour (Maximum Cigarettes In A 24 Hour Period),Phenotype,Smoking Behaviour (Maximum Cigarettes In A 24 Hour Period)
43177,Surgical Necrotising Enterocolitis In Extremely Premature Birth,Phenotype,Surgical Necrotising Enterocolitis In Extremely Premature Birth
43180,Nonobstructive Coronary Artery Disease,Phenotype,Nonobstructive Coronary Artery Disease
43182,Barrett'S Esophagus X Pack-Years Of Smoking Exposure Interaction,Phenotype,Barrett'S Esophagus X Pack-Years Of Smoking Exposure Interaction
43184,Multiple Sclerosis And Systolic Blood Pressure (Pleiotropy),Phenotype,Multiple Sclerosis And Systolic Blood Pressure (Pleiotropy)
43187,Multiple Sclerosis And Body Mass Index (Pleiotropy),Phenotype,Multiple Sclerosis And Body Mass Index (Pleiotropy)
43189,Multiple Sclerosis And Waist-To-Hip-Ratio (Pleiotropy),Phenotype,Multiple Sclerosis And Waist-To-Hip-Ratio (Pleiotropy)
43191,Multiple Sclerosis And Type 2 Diabetes (Pleiotropy),Phenotype,Multiple Sclerosis And Type 2 Diabetes (Pleiotropy)
43193,Type 2 Diabetes (Age Of Onset),Phenotype,Type 2 Diabetes (Age Of Onset)
43197,Cough In Response To Angiotensin-Converting Enzyme Inhibitor Drugs,Phenotype,Cough In Response To Angiotensin-Converting Enzyme Inhibitor Drugs
43200,Liver Disease Severity In Alagille Syndrome,Phenotype,Liver Disease Severity In Alagille Syndrome
43205,Ankle Injury,Phenotype,Ankle Injury
43214,Eye Morphology,Phenotype,Eye Morphology
43216,Headache,Phenotype,Headache
43221,Binge Eating Behaviour And Bipolar Disorder,Phenotype,Binge Eating Behaviour And Bipolar Disorder
43238,Multiple Keratinocyte Cancers,Phenotype,Multiple Keratinocyte Cancers
43243,Gait Speed In Old Age,Phenotype,Gait Speed In Old Age
43263,Rostral Middle Frontal Gyrus Volume,Phenotype,Rostral Middle Frontal Gyrus Volume
43265,Superior Frontal Gyrus Volume,Phenotype,Superior Frontal Gyrus Volume
43267,Superior Parietal Cortex Volume,Phenotype,Superior Parietal Cortex Volume
43269,Pericalcarine Cortex Volume,Phenotype,Pericalcarine Cortex Volume
43272,Lateral Orbital Frontal Cortex Volume,Phenotype,Lateral Orbital Frontal Cortex Volume
43274,Middle Temporal Gyrus Volume,Phenotype,Middle Temporal Gyrus Volume
43277,Parahippocampal Gyrus Volume,Phenotype,Parahippocampal Gyrus Volume
43280,Precuneus Cortex Volume,Phenotype,Precuneus Cortex Volume
43282,Pars Triangularis Volume,Phenotype,Pars Triangularis Volume
43286,Paracentral Lobule Volume,Phenotype,Paracentral Lobule Volume
43290,Pars Opercularis Volume,Phenotype,Pars Opercularis Volume
43292,Medial Orbital Frontal Cortex Volume,Phenotype,Medial Orbital Frontal Cortex Volume
43295,Cortex Volume,Phenotype,Cortex Volume
43298,Cerebral White Matter Volume,Phenotype,Cerebral White Matter Volume
43300,Intake Of Sweets,Phenotype,Intake Of Sweets
43304,Perceived Intensity Of Neohesperidin Dihydrochalcone,Phenotype,Perceived Intensity Of Neohesperidin Dihydrochalcone
43306,Sub-Cortical Grey Matter Volume,Phenotype,Sub-Cortical Grey Matter Volume
43309,Estimated Glomerular Filtration Rate In Diabetes,Phenotype,Estimated Glomerular Filtration Rate In Diabetes
43315,Perceived Intensity Of Sweet Substances,Phenotype,Perceived Intensity Of Sweet Substances
43317,Perceived Sweetness Of Sucrose,Phenotype,Perceived Sweetness Of Sucrose
43320,Colorectal Cancer Or Advanced Adenoma,Phenotype,Colorectal Cancer Or Advanced Adenoma
43324,Familial Lung Adenocarcinoma,Phenotype,Familial Lung Adenocarcinoma
43326,Familial Lung Cancer,Phenotype,Familial Lung Cancer
43330,Response To Antidepressants (Symptom Remission),Phenotype,Response To Antidepressants (Symptom Remission)
43332,Adverse Response To Drug,Phenotype,Adverse Response To Drug
43338,Pneumococcal Meningitis,Phenotype,Pneumococcal Meningitis
43341,Corpus Callosum Central Volume,Phenotype,Corpus Callosum Central Volume
43344,Corpus Callosum Mid-Anterior Volume,Phenotype,Corpus Callosum Mid-Anterior Volume
43346,Lateral Ventricle Volume,Phenotype,Lateral Ventricle Volume
43347,Lateral Ventricle Temporal Horn Volume,Phenotype,Lateral Ventricle Temporal Horn Volume
43349,Third Ventricle Volume,Phenotype,Third Ventricle Volume
43365,Estimated Glomerular Filtration Rate In Non-Diabetics,Phenotype,Estimated Glomerular Filtration Rate In Non-Diabetics
43372,Familial Squamous Cell Lung Carcinoma,Phenotype,Familial Squamous Cell Lung Carcinoma
43383,Metabolite Risk Score For Predicting Weight Gain,Phenotype,Metabolite Risk Score For Predicting Weight Gain
43396,Caudal Anterior-Cingulate Cortex Volume,Phenotype,Caudal Anterior-Cingulate Cortex Volume
43398,Caudal Middle Frontal Gyrus Volume,Phenotype,Caudal Middle Frontal Gyrus Volume
43400,Cuneus Cortex Volume,Phenotype,Cuneus Cortex Volume
43408,Inferior Parietal Cortex Volume,Phenotype,Inferior Parietal Cortex Volume
43410,Isthmus-Cingulate Cortex Volume,Phenotype,Isthmus-Cingulate Cortex Volume
43412,Lateral Occipital Cortex Volume,Phenotype,Lateral Occipital Cortex Volume
43416,Systemising,Phenotype,Systemising
43418,Nucleus Accumbens Volume,Phenotype,Nucleus Accumbens Volume
43420,Choroid Plexus Volume,Phenotype,Choroid Plexus Volume
43422,Frontal Pole Volume,Phenotype,Frontal Pole Volume
43424,Temporal Pole Volume,Phenotype,Temporal Pole Volume
43426,Insular Cortex Volume,Phenotype,Insular Cortex Volume
43428,Pallidum Volume,Phenotype,Pallidum Volume
43430,Hippocampal Volume,Phenotype,Hippocampal Volume
43433,Amygdala Volume,Phenotype,Amygdala Volume
43436,Thalamus Volume,Phenotype,Thalamus Volume
43439,Cerebellum White Matter Volume,Phenotype,Cerebellum White Matter Volume
43442,Whole Brain Grey Matter Density,Phenotype,Whole Brain Grey Matter Density
43446,Intake Of Total Sugars,Phenotype,Intake Of Total Sugars
43449,Perceived Intensity Of Glucose,Phenotype,Perceived Intensity Of Glucose
43453,Superior Temporal Sulcus Banks Volume,Phenotype,Superior Temporal Sulcus Banks Volume
43464,Subjective Response To Placebo Treatment In Childhood Asthma (Change In Cough/Wheeze),Phenotype,Subjective Response To Placebo Treatment In Childhood Asthma (Change In Cough/Wheeze)
43468,Response To Placebo Treatment In Childhood Asthma (Fvc Change),Phenotype,Response To Placebo Treatment In Childhood Asthma (Fvc Change)
43472,Handedness (Non-Right-Handed Vs Right-Handed),Phenotype,Handedness (Non-Right-Handed Vs Right-Handed)
43479,Nose Morphology,Phenotype,Nose Morphology
43482,Upper Eyelid Morphology,Phenotype,Upper Eyelid Morphology
43485,Verbal Intelligence Quotient (Cesarean Section Interaction),Phenotype,Verbal Intelligence Quotient (Cesarean Section Interaction)
43487,Performance Intelligence Quotient (Cesarean Section Interaction),Phenotype,Performance Intelligence Quotient (Cesarean Section Interaction)
43489,Full Scale Intelligence Quotient (Cesarean Section Interaction),Phenotype,Full Scale Intelligence Quotient (Cesarean Section Interaction)
43492,Diastolic Blood Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test)
43494,Bone Mineral Density (Femoral Neck) In Inflammatory Bowel Disease,Phenotype,Bone Mineral Density (Femoral Neck) In Inflammatory Bowel Disease
43497,Systolic Blood Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Alcohol Consumption Interaction (2Df Test)
43499,Cerebrospinal Fluid P-Tau Levels In Normal Cognition,Phenotype,Cerebrospinal Fluid P-Tau Levels In Normal Cognition
43501,Logical Memory (Immediate Recall) In Normal Cognition,Phenotype,Logical Memory (Immediate Recall) In Normal Cognition
43503,Hippocampal Volume In Mild Cognitive Impairment,Phenotype,Hippocampal Volume In Mild Cognitive Impairment
43505,Cerebrospinal Ab1-42 Levels In Alzheimer'S Disease Dementia,Phenotype,Cerebrospinal Ab1-42 Levels In Alzheimer'S Disease Dementia
43507,Hippocampal Volume In Alzheimer'S Disease Dementia,Phenotype,Hippocampal Volume In Alzheimer'S Disease Dementia
43510,Parental Longevity (Mother'S Attained Age),Phenotype,Parental Longevity (Mother'S Attained Age)
43513,Parental Longevity (Father'S Attained Age),Phenotype,Parental Longevity (Father'S Attained Age)
43516,Pulse Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Pulse Pressure X Alcohol Consumption Interaction (2Df Test)
43517,Mean Arterial Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Mean Arterial Pressure X Alcohol Consumption Interaction (2Df Test)
43520,Diastolic Blood Pressure X Alcohol Consumption Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Alcohol Consumption Interaction (2Df Test)
43522,Obsessive-Compulsive Disorder X Sex Interaction,Phenotype,Obsessive-Compulsive Disorder X Sex Interaction
43530,Childhood Dental Caries In Permanent Teeth,Phenotype,Childhood Dental Caries In Permanent Teeth
43532,Parental Longevity (Combined Parental Attained Age-- Martingale Residuals),Phenotype,Parental Longevity (Combined Parental Attained Age-- Martingale Residuals)
43533,Parental Longevity (Both Parents In Top 10%),Phenotype,Parental Longevity (Both Parents In Top 10%)
43537,Cerebrospinal Ab1-42 Levels In Normal Cognition,Phenotype,Cerebrospinal Ab1-42 Levels In Normal Cognition
43543,Logical Memory (Delayed Recall) In Normal Cognition,Phenotype,Logical Memory (Delayed Recall) In Normal Cognition
43545,Systolic Blood Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test)
43550,Mean Arterial Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test),Phenotype,Mean Arterial Pressure X Alcohol Consumption (Light Vs Heavy) Interaction (2Df Test)
43576,Fatty Acid Desaturase Activity (Serum),Phenotype,Fatty Acid Desaturase Activity (Serum)
43579,Asthma X Hispanic Interaction (2Df),Phenotype,Asthma X Hispanic Interaction (2Df)
43583,Hdl Cholesterol Levels In Current Drinkers,Phenotype,Hdl Cholesterol Levels In Current Drinkers
43585,Regular Attendance At A Gym Or Sports Club,Phenotype,Regular Attendance At A Gym Or Sports Club
43587,Regular Attendance At A Pub Or Social Club,Phenotype,Regular Attendance At A Pub Or Social Club
43589,Regular Attendance At A Religious Group,Phenotype,Regular Attendance At A Religious Group
43591,Loneliness (Mtag),Phenotype,Loneliness (Mtag)
43592,Pemphigus,Phenotype,Pemphigus
43594,Pemphigus Vulgaris,Phenotype,Pemphigus Vulgaris
43595,Triglyceride Levels In Current Drinkers,Phenotype,Triglyceride Levels In Current Drinkers
43596,Diabetic Maculopathy In Type 2 Diabetes,Phenotype,Diabetic Maculopathy In Type 2 Diabetes
43599,Mental Health Study Participation (Provided Email Address),Phenotype,Mental Health Study Participation (Provided Email Address)
43602,Mental Health Study Participation (Completed Survey),Phenotype,Mental Health Study Participation (Completed Survey)
43606,Number Of Alcoholic Drinks Required To Feel An Effect (Long-Term Average),Phenotype,Number Of Alcoholic Drinks Required To Feel An Effect (Long-Term Average)
43608,Alzheimer'S Disease Or Gastroesophageal Reflux Disease,Phenotype,Alzheimer'S Disease Or Gastroesophageal Reflux Disease
43611,Urea Levels,Phenotype,Urea Levels
43617,Diastolic Blood Pressure (Mtag),Phenotype,Diastolic Blood Pressure (Mtag)
43647,Pcsk9 Levels,Phenotype,Pcsk9 Levels
43653,Body Mass Index X Pumpkin Consumption Interaction,Phenotype,Body Mass Index X Pumpkin Consumption Interaction
43658,Seropositivity For Rhinovirus B Peptide (Twist_47860),Phenotype,Seropositivity For Rhinovirus B Peptide (Twist_47860)
43659,Seropositivity For Enterovirus Peptide (Agilent_11510),Phenotype,Seropositivity For Enterovirus Peptide (Agilent_11510)
43663,Seropositivity For Enterovirus Peptide (Agilent_6487),Phenotype,Seropositivity For Enterovirus Peptide (Agilent_6487)
43665,Seropositivity For Enterovirus B Peptide (Twist_28808),Phenotype,Seropositivity For Enterovirus B Peptide (Twist_28808)
43666,Seropositivity For Enterovirus Peptide (Agilent_6423),Phenotype,Seropositivity For Enterovirus Peptide (Agilent_6423)
43668,Seropositivity For Escherichia Coli O157:H7 Str. Edl933 Peptide (Agilent_231281),Phenotype,Seropositivity For Escherichia Coli O157:H7 Str. Edl933 Peptide (Agilent_231281)
43670,Seropositivity For Human Adenovirus 12 Peptide (Twist_43231),Phenotype,Seropositivity For Human Adenovirus 12 Peptide (Twist_43231)
43675,Seropositivity For Human Adenovirus 12 Peptide (Twist_55551),Phenotype,Seropositivity For Human Adenovirus 12 Peptide (Twist_55551)
43679,Seropositivity For Human Adenovirus C Peptide (Agilent_42),Phenotype,Seropositivity For Human Adenovirus C Peptide (Agilent_42)
43681,Seropositivity For Human Adenovirus C Peptide (Agilent_2749),Phenotype,Seropositivity For Human Adenovirus C Peptide (Agilent_2749)
43682,Seropositivity For Aegilops Tauschii (Tausch'S Goatgrass) Peptide (Twist_22888),Phenotype,Seropositivity For Aegilops Tauschii (Tausch'S Goatgrass) Peptide (Twist_22888)
43683,Familial Combined Hyperlipidemia Defined By Mexico Criteria,Phenotype,Familial Combined Hyperlipidemia Defined By Mexico Criteria
43685,Seropositivity For Firmicutes Peptide (Agilent_150014),Phenotype,Seropositivity For Firmicutes Peptide (Agilent_150014)
43687,Seropositivity For Haemophilus Influenzae Peptide (Agilent_223654),Phenotype,Seropositivity For Haemophilus Influenzae Peptide (Agilent_223654)
43689,Seropositivity For Haemophilus Influenzae Peptide (Agilent_229777),Phenotype,Seropositivity For Haemophilus Influenzae Peptide (Agilent_229777)
43694,Seropositivity For Haemophilus Influenzae Nontypable Strain 3179B Peptide (Agilent_223905),Phenotype,Seropositivity For Haemophilus Influenzae Nontypable Strain 3179B Peptide (Agilent_223905)
43696,Seropositivity For Haemophilus Influenzae Peptide (Agilent_228606),Phenotype,Seropositivity For Haemophilus Influenzae Peptide (Agilent_228606)
43697,Seropositivity For Enterobacteria Phage Peptide (Twist_92147),Phenotype,Seropositivity For Enterobacteria Phage Peptide (Twist_92147)
43699,Seropositivity For Enterobacteria Phage Peptide (Twist_65044),Phenotype,Seropositivity For Enterobacteria Phage Peptide (Twist_65044)
43701,Seropositivity For Enterobacteria Phage Phi1 Peptide (Twist_87290),Phenotype,Seropositivity For Enterobacteria Phage Phi1 Peptide (Twist_87290)
43704,Seropositivity For Enterobacteria Phage Phi1 Peptide (Twist_60834),Phenotype,Seropositivity For Enterobacteria Phage Phi1 Peptide (Twist_60834)
43705,Seropositivity For Enterobacteriaceae Peptide (Agilent_241053),Phenotype,Seropositivity For Enterobacteriaceae Peptide (Agilent_241053)
43707,Seropositivity For Enterococcus Faecalis V583 Peptide (Agilent_219731),Phenotype,Seropositivity For Enterococcus Faecalis V583 Peptide (Agilent_219731)
43709,Seropositivity For Enterococcus Faecalis V583 Peptide (Agilent_140151),Phenotype,Seropositivity For Enterococcus Faecalis V583 Peptide (Agilent_140151)
43711,Seropositivity For Enterovirus B Peptide (Twist_28803),Phenotype,Seropositivity For Enterovirus B Peptide (Twist_28803)
43713,Seropositivity For Rhinovirus B Peptide (Twist_28813),Phenotype,Seropositivity For Rhinovirus B Peptide (Twist_28813)
43714,Seropositivity For Enterovirus Peptide (Agilent_4843),Phenotype,Seropositivity For Enterovirus Peptide (Agilent_4843)
43716,Seropositivity For Dorea Formicigenerans (Agilent_160727),Phenotype,Seropositivity For Dorea Formicigenerans (Agilent_160727)
43717,Seropositivity For Escherichia Coli O157:H7 Str. Sakai Peptide (Agilent_90858),Phenotype,Seropositivity For Escherichia Coli O157:H7 Str. Sakai Peptide (Agilent_90858)
43721,Seropositivity For Eubacterium Peptide (Agilent_101119),Phenotype,Seropositivity For Eubacterium Peptide (Agilent_101119)
43723,Seropositivity For Eubacterium Rectale (Agilent_212176),Phenotype,Seropositivity For Eubacterium Rectale (Agilent_212176)
43724,Seropositivity For Eubacterium Rectale (Agilent_108406),Phenotype,Seropositivity For Eubacterium Rectale (Agilent_108406)
43725,Seropositivity For Eubacterium Rectale (Agilent_79020),Phenotype,Seropositivity For Eubacterium Rectale (Agilent_79020)
43727,Seropositivity For Faecalibacterium Prausnitzii A2-165 Peptide (Agilent_199016),Phenotype,Seropositivity For Faecalibacterium Prausnitzii A2-165 Peptide (Agilent_199016)
43730,Seropositivity For Faecalibacterium Prausnitzii A2-165 Peptide (Agilent_194982),Phenotype,Seropositivity For Faecalibacterium Prausnitzii A2-165 Peptide (Agilent_194982)
43733,Alzheimer'S Disease Or Gastroesophageal Reflux Disease And/Or Peptic Ulcer Disease,Phenotype,Alzheimer'S Disease Or Gastroesophageal Reflux Disease And/Or Peptic Ulcer Disease
43736,Neurofilament Light Chain Levels,Phenotype,Neurofilament Light Chain Levels
43741,Thyroid Peroxidase Antibody Positivity In Pregnancy,Phenotype,Thyroid Peroxidase Antibody Positivity In Pregnancy
43756,Cisplatin-Induced Nephrotoxicity (Increased Serum Creatinine Aki-Ctcae),Phenotype,Cisplatin-Induced Nephrotoxicity (Increased Serum Creatinine Aki-Ctcae)
43758,Cisplatin-Induced Nephrotoxicity (Decreased Egfr),Phenotype,Cisplatin-Induced Nephrotoxicity (Decreased Egfr)
43809,Retinal Vascular Fractal Density,Phenotype,Retinal Vascular Fractal Density
43814,Lysophosphatidylcholine(15:0) Levels,Phenotype,Lysophosphatidylcholine(15:0) Levels
43826,5Alpha-Pregnan-3Beta--20Alpha-Diol Monosulfate (1) Levels,Phenotype,5Alpha-Pregnan-3Beta--20Alpha-Diol Monosulfate (1) Levels
43828,Coronary Artery Disease (Mtag),Phenotype,Coronary Artery Disease (Mtag)
43832,Stroke (Mtag),Phenotype,Stroke (Mtag)
43834,Alzheimer'S Disease (Mtag),Phenotype,Alzheimer'S Disease (Mtag)
43835,Carotid Intima-Media Thickness (Mtag),Phenotype,Carotid Intima-Media Thickness (Mtag)
43841,Familial Combined Hyperlipidemia Defined By Brunzell Criteria,Phenotype,Familial Combined Hyperlipidemia Defined By Brunzell Criteria
43854,Acute Encephalopathy With Biphasic Seizures And Late Reduced Diffusion,Phenotype,Acute Encephalopathy With Biphasic Seizures And Late Reduced Diffusion
43856,Hair Colour (Natural-- Before Greying): Blonde (Ukb Data Field 1747_1),Phenotype,Hair Colour (Natural-- Before Greying): Blonde (Ukb Data Field 1747_1)
43878,Hair Colour (Natural-- Before Greying): Red (Ukb Data Field 1747_2),Phenotype,Hair Colour (Natural-- Before Greying): Red (Ukb Data Field 1747_2)
43896,Hair Colour (Natural-- Before Greying): Light Brown (Ukb Data Field 1747_3),Phenotype,Hair Colour (Natural-- Before Greying): Light Brown (Ukb Data Field 1747_3)
43920,Hair Colour (Natural-- Before Greying): Dark Brown (Ukb Data Field 1747_4),Phenotype,Hair Colour (Natural-- Before Greying): Dark Brown (Ukb Data Field 1747_4)
43974,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (1Df),Phenotype,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (1Df)
43976,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (2Df),Phenotype,Cognitive Function (Processing Speed) X Major Depressive Disorder Interaction (2Df)
44007,Long-Chain Dicarboxylacylcarnitines Levels (Dominant Genetic Model),Phenotype,Long-Chain Dicarboxylacylcarnitines Levels (Dominant Genetic Model)
44013,Short-Chain Dicarboxylacylcarnitine Levels (Dominant Genetic Model),Phenotype,Short-Chain Dicarboxylacylcarnitine Levels (Dominant Genetic Model)
44017,Age Related Hearing Loss-Related Regional Glucose Metabolism (Cochlear Nucleus),Phenotype,Age Related Hearing Loss-Related Regional Glucose Metabolism (Cochlear Nucleus)
44022,Thyroid Peroxidase Antibody Levels In Pregnancy,Phenotype,Thyroid Peroxidase Antibody Levels In Pregnancy
44023,Age Related Hearing Loss-Related Regional Glucose Metabolism (Inferior Colliculus),Phenotype,Age Related Hearing Loss-Related Regional Glucose Metabolism (Inferior Colliculus)
44025,Free Thyroxine Levels Within Normal Range In Pregnancy,Phenotype,Free Thyroxine Levels Within Normal Range In Pregnancy
44027,Subclinical Hypothyroidism In Pregnancy,Phenotype,Subclinical Hypothyroidism In Pregnancy
44028,Isolated Hypothyroxinemia  In Pregnancy,Phenotype,Isolated Hypothyroxinemia  In Pregnancy
44030,Subclinical Hyperthyroidism In Pregnancy,Phenotype,Subclinical Hyperthyroidism In Pregnancy
44033,Overt Hyperthyroidism In Pregnancy,Phenotype,Overt Hyperthyroidism In Pregnancy
44039,Thyroid Stimulating Hormone Levels Within Normal Range In Pregnancy,Phenotype,Thyroid Stimulating Hormone Levels Within Normal Range In Pregnancy
44042,Vitamin D Levels,Phenotype,Vitamin D Levels
44055,Steroid Induced Osteonecrosis Of The Femoral Head And Systemic Lupus Erythematosus,Phenotype,Steroid Induced Osteonecrosis Of The Femoral Head And Systemic Lupus Erythematosus
44057,Bone Mineral Density T Score In Postmenopausal Osteoporosis,Phenotype,Bone Mineral Density T Score In Postmenopausal Osteoporosis
44059,Low Hand Grip Strength,Phenotype,Low Hand Grip Strength
44061,Retinal Vascular Fractal Dimension,Phenotype,Retinal Vascular Fractal Dimension
44081,Occupational Attainment,Phenotype,Occupational Attainment
44083,Lifetime Smoking,Phenotype,Lifetime Smoking
44091,Immunoglobulin N-Glycan 10 Levels,Phenotype,Immunoglobulin N-Glycan 10 Levels
44093,Immunoglobulin N-Glycan 19 Levels,Phenotype,Immunoglobulin N-Glycan 19 Levels
44095,Lung Cancer X Sex Interaction,Phenotype,Lung Cancer X Sex Interaction
44097,Lifetime Smoking (Without Educational Attainment),Phenotype,Lifetime Smoking (Without Educational Attainment)
44098,Granulocyte Telomere Length,Phenotype,Granulocyte Telomere Length
44100,Lymphocyte Telomere Length,Phenotype,Lymphocyte Telomere Length
44102,B-Cell Telomere Length,Phenotype,B-Cell Telomere Length
44105,Type Ii Diabetes,Phenotype,Type Ii Diabetes
44118,Response To Gabapentin In Female Chronic Pelvic Pain,Phenotype,Response To Gabapentin In Female Chronic Pelvic Pain
44122,Response To Gabapentin In Female Chronic Pelvic Pain (Side-Effect Burden),Phenotype,Response To Gabapentin In Female Chronic Pelvic Pain (Side-Effect Burden)
44130,Alzheimer'S Disease Or Peptic Ulcer Disease,Phenotype,Alzheimer'S Disease Or Peptic Ulcer Disease
44142,Treatment Or Medication Use - Levothyroxine Sodium (Ukb Data Field 20003_1141191044),Phenotype,Treatment Or Medication Use - Levothyroxine Sodium (Ukb Data Field 20003_1141191044)
44143,Illnesses Of Mother: Alzheimer'S Disease/Dementia (Ukb Data Field 20110_10),Phenotype,Illnesses Of Mother: Alzheimer'S Disease/Dementia (Ukb Data Field 20110_10)
44144,Hearing Difficulty/Problems: No (Ukb Data Field 2247_0),Phenotype,Hearing Difficulty/Problems: No (Ukb Data Field 2247_0)
44146,Hearing Difficulty/Problems: Yes (Ukb Data Field 2247_1),Phenotype,Hearing Difficulty/Problems: Yes (Ukb Data Field 2247_1)
44147,Hair Colour (Natural-- Before Greying): Black (Ukb Data Field 1747_5),Phenotype,Hair Colour (Natural-- Before Greying): Black (Ukb Data Field 1747_5)
44151,Disorders Of Iron Metabolism (Phecode 275.1),Phenotype,Disorders Of Iron Metabolism (Phecode 275.1)
44153,Treatment Or Medication Use - Insulin Product (Ukb Data Field 20003_1140883066),Phenotype,Treatment Or Medication Use - Insulin Product (Ukb Data Field 20003_1140883066)
44156,Treatment Or Medication Use - Sulfasalazine (Ukb Data Field 20003_1140909702),Phenotype,Treatment Or Medication Use - Sulfasalazine (Ukb Data Field 20003_1140909702)
44158,Treatment Or Medication Use - Atorvastatin (Ukb Data Field 20003_1141146234),Phenotype,Treatment Or Medication Use - Atorvastatin (Ukb Data Field 20003_1141146234)
44179,Cognitive Function (Executive Function) X Major Depressive Disorder Interaction (1Df),Phenotype,Cognitive Function (Executive Function) X Major Depressive Disorder Interaction (1Df)
44182,Cognitive Function (Executive Function) X Major Depressive Disorder Interaction (2Df),Phenotype,Cognitive Function (Executive Function) X Major Depressive Disorder Interaction (2Df)
44184,Crohn'S Disease Or Leprosy (Opposite Effect),Phenotype,Crohn'S Disease Or Leprosy (Opposite Effect)
44192,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223208),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223208)
44197,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_227833),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_227833)
44204,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_241214),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_241214)
44207,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243228),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243228)
44208,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_235513),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_235513)
44209,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_236127),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_236127)
44211,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243958),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243958)
44213,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220951),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220951)
44214,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220184),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220184)
44217,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223641),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223641)
44219,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_226792),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_226792)
44220,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_225587),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_225587)
44223,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_231039),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_231039)
44224,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_48171),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_48171)
44226,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220672),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220672)
44232,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220944),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_220944)
44236,Seropositivity For Staphylococcus Aureus Peptide (Twist_34337),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_34337)
44240,Seropositivity For Staphylococcus Aureus Peptide (Twist_39975),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_39975)
44246,Seropositivity For Staphylococcus Aureus Peptide (Agilent_236148),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_236148)
44249,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_204518),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_204518)
44251,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_134645),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_134645)
44254,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_26654),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_26654)
44257,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_205649),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_205649)
44258,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_20117),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_20117)
44260,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_69388),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_69388)
44261,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_236929),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_236929)
44263,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_237201),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_237201)
44266,Seropositivity For Staphylococcus Aureus Subsp. Aureus Strain Newman Peptide (Agilent_239239),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Strain Newman Peptide (Agilent_239239)
44269,Seropositivity For Staphylococcus Peptide (Agilent_237677),Phenotype,Seropositivity For Staphylococcus Peptide (Agilent_237677)
44271,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222726),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222726)
44274,Seropositivity For Staphylococcus Aureus Peptide (Agilent_226247),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_226247)
44275,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_217424),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_217424)
44279,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_105317),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_105317)
44281,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188119),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188119)
44284,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_92408),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_92408)
44285,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_81159),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_81159)
44287,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_204624),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_204624)
44288,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_15915),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_15915)
44298,Seropositivity For Staphylococcus Aureus Peptide (Agilent_241121),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_241121)
44302,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222381),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222381)
44304,Coronary Vascular Stenosis,Phenotype,Coronary Vascular Stenosis
44307,Brain Vascular Stenosis,Phenotype,Brain Vascular Stenosis
44309,Lifetime Major Depressive Disorder (Autocomplete Impute),Phenotype,Lifetime Major Depressive Disorder (Autocomplete Impute)
44312,Total Adipose Tissue,Phenotype,Total Adipose Tissue
44315,Sinus Bradycardia,Phenotype,Sinus Bradycardia
44317,Skeletal Muscle Mass,Phenotype,Skeletal Muscle Mass
44318,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_241884),Phenotype,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_241884)
44319,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_235068),Phenotype,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_235068)
44335,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_221984),Phenotype,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_221984)
44336,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_220658),Phenotype,Seropositivity For Streptococcus Pyogenes Peptide (Agilent_220658)
44360,Seropositivity For Vibrio Cholerae Am-19226 Peptide (Agilent_188248),Phenotype,Seropositivity For Vibrio Cholerae Am-19226 Peptide (Agilent_188248)
44361,Seropositivity For Vibrio Vulnificus Peptide (Agilent_157295),Phenotype,Seropositivity For Vibrio Vulnificus Peptide (Agilent_157295)
44363,Seropositivity For Neisseria Meningitidis Peptide (Agilent_223729),Phenotype,Seropositivity For Neisseria Meningitidis Peptide (Agilent_223729)
44365,Seropositivity For Gallus Gallus Ovomucoid Precursor Gallus Peptide (Twist_28164),Phenotype,Seropositivity For Gallus Gallus Ovomucoid Precursor Gallus Peptide (Twist_28164)
44367,Seropositivity For Gallus Gallus Ovomucoid Precursor Gallus Peptide (Twist_30726),Phenotype,Seropositivity For Gallus Gallus Ovomucoid Precursor Gallus Peptide (Twist_30726)
44375,Seropositivity For Gallus Gallus Ovomucoid Precursor Gallus Peptide (Twist_1603),Phenotype,Seropositivity For Gallus Gallus Ovomucoid Precursor Gallus Peptide (Twist_1603)
44378,Seropositivity For Staphylococcus Aureus Peptide (Twist_2995),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_2995)
44380,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_84757),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_84757)
44390,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_187024),Phenotype,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_187024)
44392,Seropositivity For Lactobacillus Reuteri Peptide (Agilent_204160),Phenotype,Seropositivity For Lactobacillus Reuteri Peptide (Agilent_204160)
44394,Seropositivity For Root Peptide (Agilent_156552),Phenotype,Seropositivity For Root Peptide (Agilent_156552)
44395,Seropositivity For Root Peptide (Agilent_184788),Phenotype,Seropositivity For Root Peptide (Agilent_184788)
44396,Seropositivity For Struthio Camelus (Ostrich) Peptide (Twist_5109),Phenotype,Seropositivity For Struthio Camelus (Ostrich) Peptide (Twist_5109)
44405,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_21920),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_21920)
44408,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_23359),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_23359)
44410,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_39688),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_39688)
44413,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_180726),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_180726)
44414,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_53453),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_53453)
44416,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_80555),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_80555)
44419,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_198635),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_198635)
44420,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_205647),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_205647)
44422,Lifetime Major Depressive Disorder (Mtag),Phenotype,Lifetime Major Depressive Disorder (Mtag)
44423,Lifetime Major Depressive Disorder (Autocomplete Impute And Observed),Phenotype,Lifetime Major Depressive Disorder (Autocomplete Impute And Observed)
44425,Drusen,Phenotype,Drusen
44427,Forced Vital Capacity (Fvc) (%),Phenotype,Forced Vital Capacity (Fvc) (%)
44429,Forced Expiratory Volume In 1 Second (Fev1) (Litres),Phenotype,Forced Expiratory Volume In 1 Second (Fev1) (Litres)
44431,Fev1/Fvc Ratio,Phenotype,Fev1/Fvc Ratio
44434,Urine Ph Measurement,Phenotype,Urine Ph Measurement
44436,Lifetime Major Depressive Disorder (Softimpute),Phenotype,Lifetime Major Depressive Disorder (Softimpute)
44437,Lifetime Major Depressive Disorder (Softimpute And Observed),Phenotype,Lifetime Major Depressive Disorder (Softimpute And Observed)
44438,Seropositivity For Streptococcus Agalactiae Peptide (Agilent_241118),Phenotype,Seropositivity For Streptococcus Agalactiae Peptide (Agilent_241118)
44440,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243291),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243291)
44441,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_241401),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_241401)
44443,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223189),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223189)
44445,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223825),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223825)
44449,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223466),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_223466)
44450,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_221413),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_221413)
44452,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_233612),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_233612)
44457,Seropositivity For Staphylococcus Aureus Peptide (Agilent_221466),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_221466)
44460,Seropositivity For Staphylococcus Aureus Peptide (Agilent_237594),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_237594)
44463,Seropositivity For Staphylococcus Aureus Peptide (Agilent_236695),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_236695)
44464,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222756),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222756)
44466,Seropositivity For Influenza A Virus Peptide (Twist_59245),Phenotype,Seropositivity For Influenza A Virus Peptide (Twist_59245)
44468,Seropositivity For Lachnospiraceae Peptide (Agilent_193943),Phenotype,Seropositivity For Lachnospiraceae Peptide (Agilent_193943)
44469,Seropositivity For Lachnospiraceae Peptide (Agilent_141373),Phenotype,Seropositivity For Lachnospiraceae Peptide (Agilent_141373)
44471,Seropositivity For Lactobacillus Acidophilus Peptide (Agilent_24672),Phenotype,Seropositivity For Lactobacillus Acidophilus Peptide (Agilent_24672)
44472,Seropositivity For Lactobacillus Acidophilus Peptide (Agilent_189058),Phenotype,Seropositivity For Lactobacillus Acidophilus Peptide (Agilent_189058)
44474,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_13363),Phenotype,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_13363)
44475,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_187025),Phenotype,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_187025)
44477,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_193278),Phenotype,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_193278)
44478,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_167634),Phenotype,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_167634)
44479,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_103772),Phenotype,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_103772)
44481,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_78561),Phenotype,Seropositivity For Lactobacillus Plantarum Wcfs1 Peptide (Agilent_78561)
44482,Seropositivity For Staphylococcus Aureus Peptide (Agilent_236333),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_236333)
44484,Seropositivity For Staphylococcus Aureus Peptide (Agilent_227810),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_227810)
44486,Seropositivity For Staphylococcus Aureus Peptide (Agilent_241827),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_241827)
44487,Seropositivity For Staphylococcus Aureus Peptide (Agilent_240086),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_240086)
44489,Seropositivity For Staphylococcus Aureus Peptide (Agilent_233907),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_233907)
44490,Seropositivity For Staphylococcus Aureus Peptide (Agilent_223217),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_223217)
44503,Seropositivity For Staphylococcus Aureus Peptide (Agilent_228814),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_228814)
44504,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222322),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_222322)
44507,Bone Density,Phenotype,Bone Density
44509,Spondylolisthesis,Phenotype,Spondylolisthesis
44512,Seropositivity For Aix Galericulata (Mandarin Duck) Peptide (Twist_23200),Phenotype,Seropositivity For Aix Galericulata (Mandarin Duck) Peptide (Twist_23200)
44516,Seropositivity For Hordeum Vulgare (Barley) Peptide (Twist_15602),Phenotype,Seropositivity For Hordeum Vulgare (Barley) Peptide (Twist_15602)
44520,Seropositivity For Hordeum Vulgare (Barley) Peptide (Twist_7301),Phenotype,Seropositivity For Hordeum Vulgare (Barley) Peptide (Twist_7301)
44521,Seropositivity For Bifidobacterium Longum 35624 Peptide (Agilent_29665),Phenotype,Seropositivity For Bifidobacterium Longum 35624 Peptide (Agilent_29665)
44523,Seropositivity For Blautia Obeum (Agilent_133371),Phenotype,Seropositivity For Blautia Obeum (Agilent_133371)
44525,Seropositivity For Blautia Producta Peptide (Agilent_74695),Phenotype,Seropositivity For Blautia Producta Peptide (Agilent_74695)
44526,Seropositivity For Blautia Producta Peptide (Agilent_122181),Phenotype,Seropositivity For Blautia Producta Peptide (Agilent_122181)
44528,Seropositivity For Blautia Producta Peptide (Agilent_172699),Phenotype,Seropositivity For Blautia Producta Peptide (Agilent_172699)
44530,Seropositivity For Streptococcus Agalactiae Peptide (Agilent_234887),Phenotype,Seropositivity For Streptococcus Agalactiae Peptide (Agilent_234887)
44535,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_6216),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_6216)
44539,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_15509),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_15509)
44541,Seropositivity For Streptococcus Peptide (Agilent_235929),Phenotype,Seropositivity For Streptococcus Peptide (Agilent_235929)
44542,Seropositivity For Streptococcus Peptide (Agilent_223589),Phenotype,Seropositivity For Streptococcus Peptide (Agilent_223589)
44543,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_242450),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_242450)
44545,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_229734),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_229734)
44547,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_221864),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_221864)
44551,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_229757),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_229757)
44555,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_224401),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_224401)
44557,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_231226),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_231226)
44563,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243229),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_243229)
44565,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_226736),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_226736)
44571,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27538),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27538)
44573,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_1075),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_1075)
44575,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_318),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_318)
44576,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_32586),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_32586)
44578,Seropositivity For Bacteria Peptide (Agilent_240518),Phenotype,Seropositivity For Bacteria Peptide (Agilent_240518)
44580,Seropositivity For Bubalus Bubalis (Buffalo) Peptide (Twist_22083),Phenotype,Seropositivity For Bubalus Bubalis (Buffalo) Peptide (Twist_22083)
44582,Seropositivity For Escherichia Virus P1 Peptide (Twist_92719),Phenotype,Seropositivity For Escherichia Virus P1 Peptide (Twist_92719)
44583,Seropositivity For Euarchontoglires Peptide (Agilent_7767),Phenotype,Seropositivity For Euarchontoglires Peptide (Agilent_7767)
44585,Seropositivity For Gallus Peptide (Twist_24274),Phenotype,Seropositivity For Gallus Peptide (Twist_24274)
44586,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_52109),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_52109)
44587,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_9904),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_9904)
44589,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_212),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_212)
44591,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_46426),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_46426)
44593,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27552),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27552)
44594,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_6936),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_6936)
44597,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_8059),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_8059)
44598,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_31240),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_31240)
44599,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_129),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_129)
44601,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_35320),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_35320)
44603,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_7302),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_7302)
44605,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_32108),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_32108)
44607,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_3328),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_3328)
44610,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27540),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27540)
44612,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_321),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_321)
44614,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_34377),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_34377)
44615,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_52019),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_52019)
44617,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_7435),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_7435)
44618,Seropositivity For Shigella Sonnei 53G Peptide (Agilent_75769),Phenotype,Seropositivity For Shigella Sonnei 53G Peptide (Agilent_75769)
44619,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27904),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27904)
44620,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_54751),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_54751)
44622,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_46937),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_46937)
44624,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_43249),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_43249)
44625,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_31993),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_31993)
44626,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_56934),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_56934)
44628,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_6942),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_6942)
44630,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_4834),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_4834)
44632,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_34869),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_34869)
44634,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_52249),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_52249)
44635,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_6000),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_6000)
44636,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_7167),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_7167)
44637,Seropositivity For Shigella Sonnei 53G Peptide (Agilent_197679),Phenotype,Seropositivity For Shigella Sonnei 53G Peptide (Agilent_197679)
44638,Seropositivity For Lactobacillus Phage (Twist_95165),Phenotype,Seropositivity For Lactobacillus Phage (Twist_95165)
44639,Seropositivity For Lactobacillus Phage Lfeinf Peptide (Twist_99693),Phenotype,Seropositivity For Lactobacillus Phage Lfeinf Peptide (Twist_99693)
44640,Seropositivity For Lactobacillus Phage Lfeinf Peptide (Twist_88894),Phenotype,Seropositivity For Lactobacillus Phage Lfeinf Peptide (Twist_88894)
44643,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_235512),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mw2 Peptide (Agilent_235512)
44645,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_39967),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_39967)
44647,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_6963),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Agilent_6963)
44650,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_34196),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_34196)
44652,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_54623),Phenotype,Seropositivity For Streptococcus Pneumoniae Peptide (Twist_54623)
44657,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_142700),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_142700)
44659,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_171284),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_171284)
44662,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_15630),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_15630)
44665,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_16154),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_16154)
44667,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188441),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_188441)
44672,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_79076),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_79076)
44675,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_90420),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_90420)
44678,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_62056),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_62056)
44681,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_96214),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_96214)
44682,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_49012),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_49012)
44683,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_198671),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_198671)
44685,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_217792),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_217792)
44687,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_202443),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_202443)
44688,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_24484),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_24484)
44689,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_174905),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_174905)
44690,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_171144),Phenotype,Seropositivity For Staphylococcus Aureus Subsp. Aureus Mrsa252 Peptide (Agilent_171144)
44696,Seropositivity For Haemophilus Parainfluenzae T3T1 Peptide (Agilent_88528),Phenotype,Seropositivity For Haemophilus Parainfluenzae T3T1 Peptide (Agilent_88528)
44698,Seropositivity For Human Peptide (Twist_18247),Phenotype,Seropositivity For Human Peptide (Twist_18247)
44700,Seropositivity For Human Huntingtin Peptide (Twist_34234),Phenotype,Seropositivity For Human Huntingtin Peptide (Twist_34234)
44701,Seropositivity For Human Twist-Related Protein 1 Peptide (Twist_46270),Phenotype,Seropositivity For Human Twist-Related Protein 1 Peptide (Twist_46270)
44703,Seropositivity For Human Peptide (Twist_55461),Phenotype,Seropositivity For Human Peptide (Twist_55461)
44705,Seropositivity For Ruminococcus Bromii Peptide (Agilent_106172),Phenotype,Seropositivity For Ruminococcus Bromii Peptide (Agilent_106172)
44707,Seropositivity For Ruminococcus Torques (Agilent_153754),Phenotype,Seropositivity For Ruminococcus Torques (Agilent_153754)
44709,Seropositivity For Secale Cereale (Rye) Peptide (Twist_23370),Phenotype,Seropositivity For Secale Cereale (Rye) Peptide (Twist_23370)
44710,Seropositivity For Salmonella Phage Felixo1 Peptide (Twist_85996),Phenotype,Seropositivity For Salmonella Phage Felixo1 Peptide (Twist_85996)
44712,Seropositivity For Shigella Flexneri 2A Str. 301 Peptide (Agilent_182601),Phenotype,Seropositivity For Shigella Flexneri 2A Str. 301 Peptide (Agilent_182601)
44715,Seropositivity (Peptide Co-Occurrence Module 19: Pathobion-- Phages),Phenotype,Seropositivity (Peptide Co-Occurrence Module 19: Pathobion-- Phages)
44718,Seropositivity (Peptide Co-Occurrence Module 21: Plant Thionins),Phenotype,Seropositivity (Peptide Co-Occurrence Module 21: Plant Thionins)
44720,Seropositivity (Peptide Co-Occurrence Module 22: Bacteria-- Phage-- Allergen),Phenotype,Seropositivity (Peptide Co-Occurrence Module 22: Bacteria-- Phage-- Allergen)
44722,Seropositivity For Haemophilus Influenzae Peptide (Agilent_224288),Phenotype,Seropositivity For Haemophilus Influenzae Peptide (Agilent_224288)
44724,Seropositivity For Haemophilus Parainfluenzae T3T1 Peptide (Agilent_32597),Phenotype,Seropositivity For Haemophilus Parainfluenzae T3T1 Peptide (Agilent_32597)
44727,Seropositivity For Root Peptide (Agilent_201897),Phenotype,Seropositivity For Root Peptide (Agilent_201897)
44729,Seropositivity For Triticum Aestivum Wheat Peptide (Twist_41103),Phenotype,Seropositivity For Triticum Aestivum Wheat Peptide (Twist_41103)
44730,Seropositivity For Triticum Aestivum (Common Wheat) Peptide (Twist_14325),Phenotype,Seropositivity For Triticum Aestivum (Common Wheat) Peptide (Twist_14325)
44732,Seropositivity For Triticum Urartu (Wild Einkorn Wheat) Peptide (Twist_11627),Phenotype,Seropositivity For Triticum Urartu (Wild Einkorn Wheat) Peptide (Twist_11627)
44735,Seropositivity For Triticum Monococcum (Einkorn Wheat) Peptide (Twist_2100),Phenotype,Seropositivity For Triticum Monococcum (Einkorn Wheat) Peptide (Twist_2100)
44736,Seropositivity For Triticum Urartu (Wild Einkorn Wheat) Peptide (Twist_12614),Phenotype,Seropositivity For Triticum Urartu (Wild Einkorn Wheat) Peptide (Twist_12614)
44738,Seropositivity (Peptide Co-Occurrence Module 1: Cmv-- (Others)),Phenotype,Seropositivity (Peptide Co-Occurrence Module 1: Cmv-- (Others))
44740,Seropositivity (Peptide Co-Occurrence Module 5: Bacteria-- Phage-- Autoantigens),Phenotype,Seropositivity (Peptide Co-Occurrence Module 5: Bacteria-- Phage-- Autoantigens)
44741,Seropositivity (Peptide Co-Occurrence Module 12: H. Pylori-- For Phages)),Phenotype,Seropositivity (Peptide Co-Occurrence Module 12: H. Pylori-- For Phages))
44743,Seropositivity (Peptide Co-Occurrence Module 13: Abc Transporters -- Atp-Binding Proteins),Phenotype,Seropositivity (Peptide Co-Occurrence Module 13: Abc Transporters -- Atp-Binding Proteins)
44744,Seropositivity (Peptide Co-Occurrence Module 14: Enterovirus),Phenotype,Seropositivity (Peptide Co-Occurrence Module 14: Enterovirus)
44745,Seropositivity For Meleagris Gallopavo (Turkey) Peptide (Twist_3824),Phenotype,Seropositivity For Meleagris Gallopavo (Turkey) Peptide (Twist_3824)
44747,Seropositivity For Oryza Sativa (Rice) Peptide (Twist_19685),Phenotype,Seropositivity For Oryza Sativa (Rice) Peptide (Twist_19685)
44749,Seropositivity For Ovis Aries (Sheep) Peptide (Twist_23154),Phenotype,Seropositivity For Ovis Aries (Sheep) Peptide (Twist_23154)
44751,Seropositivity For Staphylococcus Aureus Peptide (Twist_30077),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_30077)
44752,Seropositivity For Staphylococcus Aureus Peptide (Twist_26858),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_26858)
44753,Seropositivity For Staphylococcus Aureus Peptide (Agilent_7803),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Agilent_7803)
44754,Seropositivity For Staphylococcus Aureus Peptide (Twist_42091),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_42091)
44755,Seropositivity For Staphylococcus Aureus Clumping Factor B Peptide (Agilent_6129),Phenotype,Seropositivity For Staphylococcus Aureus Clumping Factor B Peptide (Agilent_6129)
44756,Seropositivity For Staphylococcaceae Peptide (Agilent_7434),Phenotype,Seropositivity For Staphylococcaceae Peptide (Agilent_7434)
44757,Seropositivity For Staphylococcus Aureus Peptide (Twist_34104),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_34104)
44758,Seropositivity For Staphylococcus Aureus Peptide (Twist_26221),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_26221)
44760,Seropositivity For Japanese Encephalitis Virus Peptide (Agilent_9991),Phenotype,Seropositivity For Japanese Encephalitis Virus Peptide (Agilent_9991)
44761,Seropositivity For Japanese Encephalitis Virus Peptide (Twist_57308),Phenotype,Seropositivity For Japanese Encephalitis Virus Peptide (Twist_57308)
44762,Seropositivity For Klebsiella Phage Peptide (Twist_64561),Phenotype,Seropositivity For Klebsiella Phage Peptide (Twist_64561)
44763,Seropositivity For Meleagris Gallopavo (Turkey) Peptide (Twist_1792),Phenotype,Seropositivity For Meleagris Gallopavo (Turkey) Peptide (Twist_1792)
44768,Seropositivity For Staphylococcus Aureus Peptide (Twist_35030),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_35030)
44770,Seropositivity For Staphylococcus Aureus Peptide (Twist_44831),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_44831)
44771,Seropositivity For Staphylococcus Aureus Peptide (Twist_46764),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_46764)
44774,Seropositivity For Staphylococcus Aureus Peptide (Twist_38332),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_38332)
44775,Seropositivity For Staphylococcus Aureus Peptide (Twist_38683),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_38683)
44779,Seropositivity For Staphylococcus Aureus Peptide (Twist_27464),Phenotype,Seropositivity For Staphylococcus Aureus Peptide (Twist_27464)
44781,Seropositivity For Staphylococcaceae Peptide (Agilent_4825),Phenotype,Seropositivity For Staphylococcaceae Peptide (Agilent_4825)
44782,Seropositivity For Staphylococcaceae Peptide (Agilent_11147),Phenotype,Seropositivity For Staphylococcaceae Peptide (Agilent_11147)
44783,Seropositivity For Staphylococcaceae Peptide (Agilent_1726),Phenotype,Seropositivity For Staphylococcaceae Peptide (Agilent_1726)
44786,Seropositivity For Plasmodium Falciparum Peptide (Twist_49209),Phenotype,Seropositivity For Plasmodium Falciparum Peptide (Twist_49209)
44787,Seropositivity For Human Poliovirus Peptide (Twist_51547),Phenotype,Seropositivity For Human Poliovirus Peptide (Twist_51547)
44789,Seropositivity For Porphyromonas Gingivalis Peptide (Twist_38172),Phenotype,Seropositivity For Porphyromonas Gingivalis Peptide (Twist_38172)
44791,Seropositivity For Human Alphaherpesvirus 2 Peptide (Twist_42886),Phenotype,Seropositivity For Human Alphaherpesvirus 2 Peptide (Twist_42886)
44792,Seropositivity For Human Herpesvirus 1 Peptide (Agilent_3614),Phenotype,Seropositivity For Human Herpesvirus 1 Peptide (Agilent_3614)
44793,Seropositivity For Human Betaherpesvirus 5 (Cytomegalovirus) Peptide (Twist_36146),Phenotype,Seropositivity For Human Betaherpesvirus 5 (Cytomegalovirus) Peptide (Twist_36146)
44796,Seropositivity For Human Betaherpesvirus 5 (Cytomegalovirus) Peptide (Twist_35647),Phenotype,Seropositivity For Human Betaherpesvirus 5 (Cytomegalovirus) Peptide (Twist_35647)
44797,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_26954),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_26954)
44799,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_43798),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_43798)
44800,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_38776),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_38776)
44803,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_58154),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_58154)
44804,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_2111),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Agilent_2111)
44807,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27988),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27988)
44809,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_32572),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_32572)
44810,Seropositivity For Bos Taurus Peptide (Twist_36969),Phenotype,Seropositivity For Bos Taurus Peptide (Twist_36969)
44811,Seropositivity For Bacteria Peptide (Agilent_8927),Phenotype,Seropositivity For Bacteria Peptide (Agilent_8927)
44812,Seropositivity For Bacteria Peptide (Agilent_6224),Phenotype,Seropositivity For Bacteria Peptide (Agilent_6224)
44815,Seropositivity For Lactobacillus Phage Lfeinf Peptide (Twist_64023),Phenotype,Seropositivity For Lactobacillus Phage Lfeinf Peptide (Twist_64023)
44827,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_36361),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_36361)
44830,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_53018),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_53018)
44832,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27542),Phenotype,Seropositivity For Human Gammaherpesvirus 4 (Epstein-Barr Virus) Peptide (Twist_27542)
44836,Seropositivity For Bacteria Peptide (Agilent_9701),Phenotype,Seropositivity For Bacteria Peptide (Agilent_9701)
44837,Seropositivity For Human Mastadenovirus Peptide (Agilent_9680),Phenotype,Seropositivity For Human Mastadenovirus Peptide (Agilent_9680)
44838,Seropositivity For Human Mastadenovirus Peptide (Agilent_329),Phenotype,Seropositivity For Human Mastadenovirus Peptide (Agilent_329)
44841,Seropositivity For Mycobacterium Tuberculosis Peptide (Agilent_2469),Phenotype,Seropositivity For Mycobacterium Tuberculosis Peptide (Agilent_2469)
44842,Seropositivity For Mycobacterium Tuberculosis Peptide (Twist_52112),Phenotype,Seropositivity For Mycobacterium Tuberculosis Peptide (Twist_52112)
44844,Seropositivity For Mycobacterium Tuberculosis Peptide (Agilent_10341),Phenotype,Seropositivity For Mycobacterium Tuberculosis Peptide (Agilent_10341)
44846,Seropositivity For Bos Taurus Peptide (Twist_33039),Phenotype,Seropositivity For Bos Taurus Peptide (Twist_33039)
44848,Seropositivity For Bacteria Peptide (Agilent_240644),Phenotype,Seropositivity For Bacteria Peptide (Agilent_240644)
44849,Seropositivity For Bacteria Peptide (Agilent_225414),Phenotype,Seropositivity For Bacteria Peptide (Agilent_225414)
44850,Seropositivity For Bacteria Peptide (Agilent_220708),Phenotype,Seropositivity For Bacteria Peptide (Agilent_220708)
44852,Seropositivity For Bacteria Peptide (Agilent_241029),Phenotype,Seropositivity For Bacteria Peptide (Agilent_241029)
44853,Seropositivity For Lactobacillus Phage Phig1E Peptide (Twist_69609),Phenotype,Seropositivity For Lactobacillus Phage Phig1E Peptide (Twist_69609)
44855,Seropositivity For Lactococcus Phage Bil285 Peptide (Twist_64633),Phenotype,Seropositivity For Lactococcus Phage Bil285 Peptide (Twist_64633)
44857,Seropositivity For Listeria Monocytogenes Peptide (Agilent_169153),Phenotype,Seropositivity For Listeria Monocytogenes Peptide (Agilent_169153)
44858,Seropositivity For Listeria Monocytogenes Peptide (Twist_41490),Phenotype,Seropositivity For Listeria Monocytogenes Peptide (Twist_41490)
44859,Seropositivity For Listeria Monocytogenes Peptide (Agilent_118201),Phenotype,Seropositivity For Listeria Monocytogenes Peptide (Agilent_118201)
44860,Seropositivity For Listeria Phage 2389 Peptide (Twist_76871),Phenotype,Seropositivity For Listeria Phage 2389 Peptide (Twist_76871)
44862,Glutamic Oxaloacetic Transaminase Levels,Phenotype,Glutamic Oxaloacetic Transaminase Levels
44877,Covid-19 (Covid Pneumonia Vs Population),Phenotype,Covid-19 (Covid Pneumonia Vs Population)
44879,Covid-19 (Covid Vs Negative),Phenotype,Covid-19 (Covid Vs Negative)
44881,Covid-19 (Hospitalized Covid Vs Population),Phenotype,Covid-19 (Hospitalized Covid Vs Population)
44889,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose Iii),Phenotype,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose Iii)
44892,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose Iii) In Non-Secretors,Phenotype,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose Iii) In Non-Secretors
44895,Platelet Count During  First Trimester Of Pregnancy,Phenotype,Platelet Count During  First Trimester Of Pregnancy
44916,Postprandial Total Cholesterol In Hdl2,Phenotype,Postprandial Total Cholesterol In Hdl2
44917,Postprandial Total Cholesterol In Hdl3,Phenotype,Postprandial Total Cholesterol In Hdl3
44918,Postprandial Total Cholesterol In Hdl,Phenotype,Postprandial Total Cholesterol In Hdl
44919,Postprandial Apolipoprotein A-I,Phenotype,Postprandial Apolipoprotein A-I
44920,Postprandial Mean Diameter Of Hdl Particles,Phenotype,Postprandial Mean Diameter Of Hdl Particles
44945,Low Testosterone Levels,Phenotype,Low Testosterone Levels
44947,Mean Platelet Volume During Second Trimester Of Pregnancy,Phenotype,Mean Platelet Volume During Second Trimester Of Pregnancy
44961,Motor Coordination,Phenotype,Motor Coordination
44968,Perceptual And Visual Search Speed (Trail Making Test A),Phenotype,Perceptual And Visual Search Speed (Trail Making Test A)
44971,Disability Level (Impaired Activities Of Daily Living),Phenotype,Disability Level (Impaired Activities Of Daily Living)
44973,Global Cognition (Clinical Dementia Rating Scale Sum Of Boxes),Phenotype,Global Cognition (Clinical Dementia Rating Scale Sum Of Boxes)
44979,Cognitive Impairment Level,Phenotype,Cognitive Impairment Level
44983,Postprandial Serum Total Triglycerides,Phenotype,Postprandial Serum Total Triglycerides
44985,Progression Free Survival In Epithelial Ovarian Cancer,Phenotype,Progression Free Survival In Epithelial Ovarian Cancer
45029,Platelet Count During  Third Trimester Of Pregnancy,Phenotype,Platelet Count During  Third Trimester Of Pregnancy
45032,Platelet Count At Delivery,Phenotype,Platelet Count At Delivery
45033,Platelet Count During  Postpartum Period,Phenotype,Platelet Count During  Postpartum Period
45042,Gestational Thrombocytopenia,Phenotype,Gestational Thrombocytopenia
45062,Response To Buprenorphine In Opioid Use Disorder,Phenotype,Response To Buprenorphine In Opioid Use Disorder
45067,Postprandial Total Cholesterol In Large Vldl,Phenotype,Postprandial Total Cholesterol In Large Vldl
45068,Postprandial Mean Diameter Of Ldl Particles,Phenotype,Postprandial Mean Diameter Of Ldl Particles
45069,Postprandial Total Cholesterol In Large Hdl,Phenotype,Postprandial Total Cholesterol In Large Hdl
45070,Postprandial Cholesterol Esters In Large Hdl,Phenotype,Postprandial Cholesterol Esters In Large Hdl
45071,Postprandial Cholesterol Esters In Medium Hdl,Phenotype,Postprandial Cholesterol Esters In Medium Hdl
45072,Postprandial Free Cholesterol In Medium Hdl,Phenotype,Postprandial Free Cholesterol In Medium Hdl
45073,Postprandial Total Lipids In Medium Hdl,Phenotype,Postprandial Total Lipids In Medium Hdl
45074,Postprandial Medium Hdl Particle Concentration,Phenotype,Postprandial Medium Hdl Particle Concentration
45075,Postprandial Phospholipid Levels In Medium Hdl,Phenotype,Postprandial Phospholipid Levels In Medium Hdl
45076,Postprandial Triglycerides Levels In Medium Hdl,Phenotype,Postprandial Triglycerides Levels In Medium Hdl
45077,Postprandial Free Cholesterol In Large Vldl,Phenotype,Postprandial Free Cholesterol In Large Vldl
45078,Postprandial Total Lipids In Large Vldl,Phenotype,Postprandial Total Lipids In Large Vldl
45079,Postprandial Large Vldl Particle Concentration,Phenotype,Postprandial Large Vldl Particle Concentration
45080,Postprandial Phospholipid Levels In Large Vldl,Phenotype,Postprandial Phospholipid Levels In Large Vldl
45081,Postprandial Total Cholesterol In Medium Hdl,Phenotype,Postprandial Total Cholesterol In Medium Hdl
45082,Postprandial Free Cholesterol In Large Hdl,Phenotype,Postprandial Free Cholesterol In Large Hdl
45083,Postprandial Total Lipids In Large Hdl,Phenotype,Postprandial Total Lipids In Large Hdl
45084,Postprandial Large Hdl Particle Concentration,Phenotype,Postprandial Large Hdl Particle Concentration
45085,Postprandial Phospholipid Levels In Large Hdl,Phenotype,Postprandial Phospholipid Levels In Large Hdl
45086,Postprandial Triglycerides Levels In Large Hdl,Phenotype,Postprandial Triglycerides Levels In Large Hdl
45087,Postprandial Free Cholesterol In Medium Vldl,Phenotype,Postprandial Free Cholesterol In Medium Vldl
45090,Anxious Temperament,Phenotype,Anxious Temperament
45092,Hyperthymic Temperament,Phenotype,Hyperthymic Temperament
45109,Platelet Count During  Second Trimester Of Pregnancy,Phenotype,Platelet Count During  Second Trimester Of Pregnancy
45128,Fasting Total Cholesterol In Small Vldl,Phenotype,Fasting Total Cholesterol In Small Vldl
45129,Fasting Cholesterol Esters In Small Vldl,Phenotype,Fasting Cholesterol Esters In Small Vldl
45130,Fasting Triglycerides Levels In Small Hdl,Phenotype,Fasting Triglycerides Levels In Small Hdl
45136,Conotruncal Heart Defects With Normally Related Great Vessels In 22Q.11.2 Deletion Syndrome,Phenotype,Conotruncal Heart Defects With Normally Related Great Vessels In 22Q.11.2 Deletion Syndrome
45138,Conotruncal Heart Defects With Normally Related Great Vessels (Without 22Q.11.2 Deletion Syndrome),Phenotype,Conotruncal Heart Defects With Normally Related Great Vessels (Without 22Q.11.2 Deletion Syndrome)
45146,Conotruncal Heart Defects With Normally Related Great Vessels,Phenotype,Conotruncal Heart Defects With Normally Related Great Vessels
45171,Liver Volume,Phenotype,Liver Volume
45174,Spleen Volume,Phenotype,Spleen Volume
45206,Postprandial Triglycerides Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Postprandial Triglycerides Levels In Chylomicrons And Extremely Large Vldl
45209,Fasting Apolipoprotein A-I,Phenotype,Fasting Apolipoprotein A-I
45210,Postprandial Total Cholesterol In Chylomicrons And Extremely Large Vldl,Phenotype,Postprandial Total Cholesterol In Chylomicrons And Extremely Large Vldl
45211,Postprandial Free Cholesterol In Chylomicrons And Extremely Large Vldl,Phenotype,Postprandial Free Cholesterol In Chylomicrons And Extremely Large Vldl
45212,Postprandial Total Lipids In Chylomicrons And Extremely Large Vldl,Phenotype,Postprandial Total Lipids In Chylomicrons And Extremely Large Vldl
45213,Postprandial Chylomicrons And Extremely Large Vldl Particle Concentration,Phenotype,Postprandial Chylomicrons And Extremely Large Vldl Particle Concentration
45214,Postprandial Phospholipid Levels In Chylomicrons And Extremely Large Vldl,Phenotype,Postprandial Phospholipid Levels In Chylomicrons And Extremely Large Vldl
45215,Fasting Total Cholesterol In Hdl2,Phenotype,Fasting Total Cholesterol In Hdl2
45216,Fasting Total Cholesterol In Hdl3,Phenotype,Fasting Total Cholesterol In Hdl3
45217,Fasting Total Cholesterol In Hdl,Phenotype,Fasting Total Cholesterol In Hdl
45218,Fasting Mean Diameter Of Hdl Particles,Phenotype,Fasting Mean Diameter Of Hdl Particles
45225,Left Atrial Active Emptying Fraction,Phenotype,Left Atrial Active Emptying Fraction
45230,Psychosis In Alzheimer'S Disease,Phenotype,Psychosis In Alzheimer'S Disease
45245,Cluster Headache,Phenotype,Cluster Headache
45252,Fasting Lactate,Phenotype,Fasting Lactate
45254,Fasting Total Cholesterol In Large Hdl,Phenotype,Fasting Total Cholesterol In Large Hdl
45255,Fasting Cholesterol Esters In Large Hdl,Phenotype,Fasting Cholesterol Esters In Large Hdl
45256,Fasting Free Cholesterol In Large Hdl,Phenotype,Fasting Free Cholesterol In Large Hdl
45257,Fasting Total Lipids In Large Hdl,Phenotype,Fasting Total Lipids In Large Hdl
45258,Fasting Large Hdl Particle Concentration,Phenotype,Fasting Large Hdl Particle Concentration
45268,Relative Brain Age,Phenotype,Relative Brain Age
45293,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose Iii) In Secretors,Phenotype,Human Milk Oligosaccharide Concentration (Lacto-N-Fucopentaose Iii) In Secretors
45304,Fasting Phospholipid Levels In Large Hdl,Phenotype,Fasting Phospholipid Levels In Large Hdl
45305,Fasting Triglycerides Levels In Large Hdl,Phenotype,Fasting Triglycerides Levels In Large Hdl
45306,Fasting Phospholipid Levels In Medium Hdl,Phenotype,Fasting Phospholipid Levels In Medium Hdl
45307,Fasting Triglycerides Levels In Medium Hdl,Phenotype,Fasting Triglycerides Levels In Medium Hdl
45308,Fasting Total Cholesterol In Medium Hdl,Phenotype,Fasting Total Cholesterol In Medium Hdl
45309,Fasting Cholesterol Esters In Medium Hdl,Phenotype,Fasting Cholesterol Esters In Medium Hdl
45310,Fasting Free Cholesterol In Medium Hdl,Phenotype,Fasting Free Cholesterol In Medium Hdl
45311,Fasting Total Lipids In Medium Hdl,Phenotype,Fasting Total Lipids In Medium Hdl
45312,Fasting Medium Hdl Particle Concentration,Phenotype,Fasting Medium Hdl Particle Concentration
45313,Urgency Urinary Incontinence,Phenotype,Urgency Urinary Incontinence
45326,Oral Glucose Tolerance Test-1H,Phenotype,Oral Glucose Tolerance Test-1H
45328,Gestational Diabetes Mellitus,Phenotype,Gestational Diabetes Mellitus
45329,Oral Glucose Tolerance Test-0H,Phenotype,Oral Glucose Tolerance Test-0H
45331,Oral Glucose Tolerance Test-2H,Phenotype,Oral Glucose Tolerance Test-2H
45353,Glycated Hemoglobin Hba1C Levels,Phenotype,Glycated Hemoglobin Hba1C Levels
45370,Hemolysis Of Donated Blood (Osmotic),Phenotype,Hemolysis Of Donated Blood (Osmotic)
45382,Bullous Pemphigoid,Phenotype,Bullous Pemphigoid
45390,Intralaminar Thalamic Nuclei Volume,Phenotype,Intralaminar Thalamic Nuclei Volume
45391,Medial Thalamic Nuclei Volume,Phenotype,Medial Thalamic Nuclei Volume
45393,Posterior Thalamic Nuclei Volume,Phenotype,Posterior Thalamic Nuclei Volume
45394,Lateral Thalamic Nuclei Volume,Phenotype,Lateral Thalamic Nuclei Volume
45420,Hemoglobin Levels In Non-Alcoholic Fatty Liver Disease X Mastiha Supplementation Interaction,Phenotype,Hemoglobin Levels In Non-Alcoholic Fatty Liver Disease X Mastiha Supplementation Interaction
45423,Interleukin-10 Levels In Non-Alcoholic Fatty Liver Disease X Mastiha Supplementation Interaction,Phenotype,Interleukin-10 Levels In Non-Alcoholic Fatty Liver Disease X Mastiha Supplementation Interaction
45432,Heel Bone Mineral Density X Serum Urate Levels Interaction,Phenotype,Heel Bone Mineral Density X Serum Urate Levels Interaction
45437,Major Depressive Disorder (Mtag),Phenotype,Major Depressive Disorder (Mtag)
45455,L1-L4 Bone Mineral Density X Serum Urate Levels Interaction,Phenotype,L1-L4 Bone Mineral Density X Serum Urate Levels Interaction
45476,Body Size (Confirmatory Factor Analysis Factor 21),Phenotype,Body Size (Confirmatory Factor Analysis Factor 21)
45486,Basal Ganglia Structure,Phenotype,Basal Ganglia Structure
45493,Fev1 Or Inflammatory Bowel Disease (Pleiotropy),Phenotype,Fev1 Or Inflammatory Bowel Disease (Pleiotropy)
45496,Fev1 Or Irritable Bowel Syndrome (Pleiotropy),Phenotype,Fev1 Or Irritable Bowel Syndrome (Pleiotropy)
45501,Fvc Or Peptic Ulcer Disease (Pleiotropy),Phenotype,Fvc Or Peptic Ulcer Disease (Pleiotropy)
45503,Fvc Or Inflammatory Bowel Disease (Pleiotropy),Phenotype,Fvc Or Inflammatory Bowel Disease (Pleiotropy)
45505,Fvc Or Irritable Bowel Syndrome (Pleiotropy),Phenotype,Fvc Or Irritable Bowel Syndrome (Pleiotropy)
45507,Fvc Or Gastro-Oesophageal Reflux Disease (Pleiotropy),Phenotype,Fvc Or Gastro-Oesophageal Reflux Disease (Pleiotropy)
45510,Fev1/Fvc Or Irritable Bowel Syndrome (Pleiotropy),Phenotype,Fev1/Fvc Or Irritable Bowel Syndrome (Pleiotropy)
45523,Alkaline Phosphatase Levels,Phenotype,Alkaline Phosphatase Levels
45547,Phosphate Levels,Phenotype,Phosphate Levels
45556,Anxiety Disorder,Phenotype,Anxiety Disorder
45559,Fev1 Or Gastro-Oesophageal Reflux Disease (Pleiotropy),Phenotype,Fev1 Or Gastro-Oesophageal Reflux Disease (Pleiotropy)
45560,Fev1 Or Peptic Ulcer Disease (Pleiotropy),Phenotype,Fev1 Or Peptic Ulcer Disease (Pleiotropy)
45567,Fev1/Fvc Or Peptic Ulcer Disease (Pleiotropy),Phenotype,Fev1/Fvc Or Peptic Ulcer Disease (Pleiotropy)
45570,Fev1/Fvc Or Gastro-Oesophageal Reflux Disease (Pleiotropy),Phenotype,Fev1/Fvc Or Gastro-Oesophageal Reflux Disease (Pleiotropy)
45573,Fev1/Fvc Or Inflammatory Bowel Disease (Pleiotropy),Phenotype,Fev1/Fvc Or Inflammatory Bowel Disease (Pleiotropy)
45584,Erythrocyte Sedimentation Rate,Phenotype,Erythrocyte Sedimentation Rate
45597,Anti-Epstein-Barr Virus Nuclear Antigen 1 (Ebna-1) Igg Levels (Truncated),Phenotype,Anti-Epstein-Barr Virus Nuclear Antigen 1 (Ebna-1) Igg Levels (Truncated)
45598,Anti-Epstein-Barr Virus Nuclear Antigen 1 (Ebna-1) Igg Levels (Peptide),Phenotype,Anti-Epstein-Barr Virus Nuclear Antigen 1 (Ebna-1) Igg Levels (Peptide)
45601,Cerebrospinal Fluid Soluble Trem2 Levels,Phenotype,Cerebrospinal Fluid Soluble Trem2 Levels
45611,Serum Potassium Levels,Phenotype,Serum Potassium Levels
45612,Serum Sodium Levels,Phenotype,Serum Sodium Levels
45614,T4 Levels,Phenotype,T4 Levels
45615,Total Protein Levels,Phenotype,Total Protein Levels
45617,Myocardial Infarction (Phecode 411.2),Phenotype,Myocardial Infarction (Phecode 411.2)
45618,Coronary Atherosclerosis (Phecode 411.4),Phenotype,Coronary Atherosclerosis (Phecode 411.4)
45619,Ulcerative Colitis (Phecode 555.2),Phenotype,Ulcerative Colitis (Phecode 555.2)
45620,Celiac Disease (Phecode 557.1),Phenotype,Celiac Disease (Phecode 557.1)
45623,Platelet Response To Aspirin,Phenotype,Platelet Response To Aspirin
45652,Seropositivity For Bacteroides Peptide (Agilent_153971),Phenotype,Seropositivity For Bacteroides Peptide (Agilent_153971)
45654,Seropositivity For Anser Anser (Greylag Goose) Peptide (Twist_23199),Phenotype,Seropositivity For Anser Anser (Greylag Goose) Peptide (Twist_23199)
45656,Familial Combined Hyperlipidemia Defined By Consensus Criteria,Phenotype,Familial Combined Hyperlipidemia Defined By Consensus Criteria
45658,Seropositivity For Klebsiella Phage Peptide (Twist_73875),Phenotype,Seropositivity For Klebsiella Phage Peptide (Twist_73875)
45660,Familial Combined Hyperlipidemia Defined By Dutch Criteria,Phenotype,Familial Combined Hyperlipidemia Defined By Dutch Criteria
45661,Seropositivity For Bacteroides Peptide (Agilent_161799),Phenotype,Seropositivity For Bacteroides Peptide (Agilent_161799)
45662,Seropositivity For Bacteroides Peptide (Agilent_170659),Phenotype,Seropositivity For Bacteroides Peptide (Agilent_170659)
45665,Seropositivity For Bacilli Peptide (Agilent_5601),Phenotype,Seropositivity For Bacilli Peptide (Agilent_5601)
45666,Seropositivity For Bacilli Peptide (Agilent_236678),Phenotype,Seropositivity For Bacilli Peptide (Agilent_236678)
45668,Seropositivity For Streptococcus Phage Peptide (Twist_76831),Phenotype,Seropositivity For Streptococcus Phage Peptide (Twist_76831)
45670,Seropositivity For Capra Hircus (Goat) Peptide (Twist_20844),Phenotype,Seropositivity For Capra Hircus (Goat) Peptide (Twist_20844)
45671,Seropositivity For Clostridiales Peptide (Agilent_205050),Phenotype,Seropositivity For Clostridiales Peptide (Agilent_205050)
45674,Seropositivity For Clostridium Perfringens (Agilent_61837),Phenotype,Seropositivity For Clostridium Perfringens (Agilent_61837)
45676,Seropositivity For Clostridiales Peptide (Agilent_68956),Phenotype,Seropositivity For Clostridiales Peptide (Agilent_68956)
45680,Seropositivity For Clostridium Perfringens Peptide (Agilent_231580),Phenotype,Seropositivity For Clostridium Perfringens Peptide (Agilent_231580)
45682,Seropositivity For Clostridium Perfringens (Agilent_107181),Phenotype,Seropositivity For Clostridium Perfringens (Agilent_107181)
45683,Seropositivity For Clostridium Perfringens (Agilent_167207),Phenotype,Seropositivity For Clostridium Perfringens (Agilent_167207)
45685,Seropositivity For Coxsackievirus Peptide (Twist_47443),Phenotype,Seropositivity For Coxsackievirus Peptide (Twist_47443)
45687,Seropositivity For Dorea Formicigenerans (Agilent_198014),Phenotype,Seropositivity For Dorea Formicigenerans (Agilent_198014)
45689,Seropositivity For Clostridiales Peptide (Agilent_56881),Phenotype,Seropositivity For Clostridiales Peptide (Agilent_56881)
45691,Gallbladder Cholecystitis,Phenotype,Gallbladder Cholecystitis
45701,Two-Hour Glucose,Phenotype,Two-Hour Glucose
45704,Hypertension (Confirmatory Factor Analysis Factor 12),Phenotype,Hypertension (Confirmatory Factor Analysis Factor 12)
45714,Telangiectasia (>= Grade 1) In Breast Cancer Treated With Radiotherapy,Phenotype,Telangiectasia (>= Grade 1) In Breast Cancer Treated With Radiotherapy
45717,Joint Pain (Confirmatory Factor Analysis Factor 14),Phenotype,Joint Pain (Confirmatory Factor Analysis Factor 14)
45723,Coronary Artery Disease (Confirmatory Factor Analysis Factor 16),Phenotype,Coronary Artery Disease (Confirmatory Factor Analysis Factor 16)
45724,Chronic Pain (Confirmatory Factor Analysis Factor 18),Phenotype,Chronic Pain (Confirmatory Factor Analysis Factor 18)
45725,Bone Density (Confirmatory Factor Analysis Factor 19),Phenotype,Bone Density (Confirmatory Factor Analysis Factor 19)
45738,Fasting Insulin Z-Score (<15Th Percentile),Phenotype,Fasting Insulin Z-Score (<15Th Percentile)
45740,Fasting Insulin Z-Score (<25Th Percentile),Phenotype,Fasting Insulin Z-Score (<25Th Percentile)
45744,Fasting Insulin Z-Score (>50Th Percentile),Phenotype,Fasting Insulin Z-Score (>50Th Percentile)
45746,Fasting Insulin Z-Score (>85Th Percentile),Phenotype,Fasting Insulin Z-Score (>85Th Percentile)
45749,Placental Weight (Fetal Genotype-- Adjusted For Sex And Gestational Age),Phenotype,Placental Weight (Fetal Genotype-- Adjusted For Sex And Gestational Age)
45757,Dementia,Phenotype,Dementia
45763,Handedness (Left-Handed Vs. Right-Handed),Phenotype,Handedness (Left-Handed Vs. Right-Handed)
45783,Placental Weight (Fetal Genotype-- Adjusted For Sex),Phenotype,Placental Weight (Fetal Genotype-- Adjusted For Sex)
45792,Vitamin B12 Levels,Phenotype,Vitamin B12 Levels
45798,Intraocular Pressure (Confirmatory Factor Analysis Factor 26),Phenotype,Intraocular Pressure (Confirmatory Factor Analysis Factor 26)
45799,Age-Related Eyesight Deterioration (Confirmatory Factor Analysis Factor 27),Phenotype,Age-Related Eyesight Deterioration (Confirmatory Factor Analysis Factor 27)
45806,Diabetes (Confirmatory Factor Analysis Factor 28),Phenotype,Diabetes (Confirmatory Factor Analysis Factor 28)
45809,Comfortable Retirement (Confirmatory Factor Analysis Factor 29),Phenotype,Comfortable Retirement (Confirmatory Factor Analysis Factor 29)
45811,Inflammatory Markers And Poor Diet (Confirmatory Factor Analysis Factor 30),Phenotype,Inflammatory Markers And Poor Diet (Confirmatory Factor Analysis Factor 30)
45815,Endometriosis Or Asthma (Pleiotropy),Phenotype,Endometriosis Or Asthma (Pleiotropy)
45820,Gastrointestinal Issues (Confirmatory Factor Analysis Factor 31),Phenotype,Gastrointestinal Issues (Confirmatory Factor Analysis Factor 31)
45823,Neutrophils And Lymphocytes In Blood (Confirmatory Factor Analysis Factor 35),Phenotype,Neutrophils And Lymphocytes In Blood (Confirmatory Factor Analysis Factor 35)
45826,Cognition And Processing Speed (Confirmatory Factor Analysis Factor 34),Phenotype,Cognition And Processing Speed (Confirmatory Factor Analysis Factor 34)
45829,Hearing (Confirmatory Factor Analysis Factor 32),Phenotype,Hearing (Confirmatory Factor Analysis Factor 32)
45841,Vitamin D Insufficiency,Phenotype,Vitamin D Insufficiency
45845,Physical Activity (Confirmatory Factor Analysis Factor 23),Phenotype,Physical Activity (Confirmatory Factor Analysis Factor 23)
45847,Eye Autorefraction And Astigmatism (Confirmatory Factor Analysis Factor 24),Phenotype,Eye Autorefraction And Astigmatism (Confirmatory Factor Analysis Factor 24)
45865,Esophageal Atresia With Or Without Tracheoesophageal Fistula,Phenotype,Esophageal Atresia With Or Without Tracheoesophageal Fistula
45867,Vascular Dementia,Phenotype,Vascular Dementia
45871,Urbanicity (Confirmatory Factor Analysis Factor 4),Phenotype,Urbanicity (Confirmatory Factor Analysis Factor 4)
45873,Occupation And Workplace Environment (Confirmatory Factor Analysis Factor 5),Phenotype,Occupation And Workplace Environment (Confirmatory Factor Analysis Factor 5)
45875,Smoking And Associated Risk Behaviours (Confirmatory Factor Analysis Factor 6),Phenotype,Smoking And Associated Risk Behaviours (Confirmatory Factor Analysis Factor 6)
45878,Bmi And Adiposity (Confirmatory Factor Analysis Factor 7),Phenotype,Bmi And Adiposity (Confirmatory Factor Analysis Factor 7)
45890,Trauma (Confirmatory Factor Analysis Factor 9),Phenotype,Trauma (Confirmatory Factor Analysis Factor 9)
45892,Educational Attainment (Confirmatory Factor Analysis Factor 10),Phenotype,Educational Attainment (Confirmatory Factor Analysis Factor 10)
45895,Respiratory Disease (Confirmatory Factor Analysis Factor 11),Phenotype,Respiratory Disease (Confirmatory Factor Analysis Factor 11)
45917,Amyloid Beta Standardized Uptake Value Ratio (Adjusted For Apoe E4 Count),Phenotype,Amyloid Beta Standardized Uptake Value Ratio (Adjusted For Apoe E4 Count)
45940,Alcohol Consumption X Experiences In Childhood (Felt Loved By Family Member) Interaction,Phenotype,Alcohol Consumption X Experiences In Childhood (Felt Loved By Family Member) Interaction
45942,Alcohol Consumption X Traumatic Event In Childhood (Felt Hated By Family Member) Interaction,Phenotype,Alcohol Consumption X Traumatic Event In Childhood (Felt Hated By Family Member) Interaction
45945,Smoking X Experiences In Childhood (Felt Loved By Family Member) Interaction,Phenotype,Smoking X Experiences In Childhood (Felt Loved By Family Member) Interaction
45947,Smoking X Traumatic Event In Childhood (Felt Hated By Family Member) Interaction,Phenotype,Smoking X Traumatic Event In Childhood (Felt Hated By Family Member) Interaction
45948,Smoking X Traumatic Event In Childhood (Sexually Molested) Interaction,Phenotype,Smoking X Traumatic Event In Childhood (Sexually Molested) Interaction
45962,Reduction In Hba1C Levels In Response To Sulfonylureas Treatment In Type 2 Diabetes,Phenotype,Reduction In Hba1C Levels In Response To Sulfonylureas Treatment In Type 2 Diabetes
45965,Physical Activity (Total Log Acceleration 12Am-2Am),Phenotype,Physical Activity (Total Log Acceleration 12Am-2Am)
45966,Physical Activity (Total Log Acceleration 2Am-4Am),Phenotype,Physical Activity (Total Log Acceleration 2Am-4Am)
45967,Physical Activity (Total Log Acceleration 10Pm-12Am),Phenotype,Physical Activity (Total Log Acceleration 10Pm-12Am)
45968,Major Depressive Disorder Or Stress-Related Disorder,Phenotype,Major Depressive Disorder Or Stress-Related Disorder
46023,Thrombin Generation Parameter (Endogenous Thrombin Potential),Phenotype,Thrombin Generation Parameter (Endogenous Thrombin Potential)
46026,Bevacizumab-Induced Composite Toxicity (Either Hypertension Or Proteinuria),Phenotype,Bevacizumab-Induced Composite Toxicity (Either Hypertension Or Proteinuria)
46041,Sociability Score,Phenotype,Sociability Score
46043,Phospholipids In Idl,Phenotype,Phospholipids In Idl
46046,Bipolar Disorder Or Glomerular Filtration Rate Estimated From Creatine (Mtag),Phenotype,Bipolar Disorder Or Glomerular Filtration Rate Estimated From Creatine (Mtag)
46047,Bipolar Disorder Or Glomerular Filtration Rate Estimated From Cystatin (Mtag),Phenotype,Bipolar Disorder Or Glomerular Filtration Rate Estimated From Cystatin (Mtag)
46050,Bipolar Disorder Or Urinary Albumin-To-Creatinine Ratio (Mtag),Phenotype,Bipolar Disorder Or Urinary Albumin-To-Creatinine Ratio (Mtag)
46052,Major Depressive Disorder Or Blood Urea Nitrogen Levels (Mtag),Phenotype,Major Depressive Disorder Or Blood Urea Nitrogen Levels (Mtag)
46053,Triglyceride Levels In Ldl,Phenotype,Triglyceride Levels In Ldl
46054,Mean Diameter Of Ldl Particles,Phenotype,Mean Diameter Of Ldl Particles
46060,Stable Warfarin Dose,Phenotype,Stable Warfarin Dose
46072,Triglycerides To Total Lipids Ratio In Large Vldl,Phenotype,Triglycerides To Total Lipids Ratio In Large Vldl
46073,Phospholipids In Large Vldl,Phenotype,Phospholipids In Large Vldl
46074,Phospholipids To Total Lipids Ratio In Large Vldl,Phenotype,Phospholipids To Total Lipids Ratio In Large Vldl
46075,Triglycerides In Large Vldl,Phenotype,Triglycerides In Large Vldl
46079,Cholesteryl Esters To Total Lipids Ratio In Medium Ldl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Medium Ldl
46080,Free Cholesterol In Medium Ldl,Phenotype,Free Cholesterol In Medium Ldl
46081,Cholesterol Esters In Medium Ldl,Phenotype,Cholesterol Esters In Medium Ldl
46082,Concentration Of Medium Ldl Particles,Phenotype,Concentration Of Medium Ldl Particles
46090,Stambp Protein Levels,Phenotype,Stambp Protein Levels
46092,Lta Protein Levels,Phenotype,Lta Protein Levels
46095,Mmp10 Protein Levels,Phenotype,Mmp10 Protein Levels
46097,Cxcl8 Protein Levels,Phenotype,Cxcl8 Protein Levels
46099,Sult1A1 Protein Levels,Phenotype,Sult1A1 Protein Levels
46102,Sirt2 Protein Levels,Phenotype,Sirt2 Protein Levels
46103,Vegfa Protein Levels,Phenotype,Vegfa Protein Levels
46105,Bmi X Meat Diet Interaction,Phenotype,Bmi X Meat Diet Interaction
46106,Hdl-C X Sedentary Time Interaction,Phenotype,Hdl-C X Sedentary Time Interaction
46114,Left Atrial Diameter,Phenotype,Left Atrial Diameter
46117,High-Sensitivity Cardiac Troponin T Levels,Phenotype,High-Sensitivity Cardiac Troponin T Levels
46127,High-Density Lipoprotein 3 Cholesterol Levels,Phenotype,High-Density Lipoprotein 3 Cholesterol Levels
46128,Clonal Hematopoiesis (Mutational Barcode Method),Phenotype,Clonal Hematopoiesis (Mutational Barcode Method)
46143,Nt5E Protein Levels,Phenotype,Nt5E Protein Levels
46146,Txlna Protein Levels,Phenotype,Txlna Protein Levels
46147,Msln Protein Levels,Phenotype,Msln Protein Levels
46149,Mica-Micb Heterodimer Protein Levels,Phenotype,Mica-Micb Heterodimer Protein Levels
46157,Rspo3 Protein Levels,Phenotype,Rspo3 Protein Levels
46159,Raynaud'S Syndrome,Phenotype,Raynaud'S Syndrome
46171,Acute Myeloid Leukemia (Normal Cytogenetics),Phenotype,Acute Myeloid Leukemia (Normal Cytogenetics)
46172,Seroconversion Induced By One Dose Of Covid-19 Vaccine,Phenotype,Seroconversion Induced By One Dose Of Covid-19 Vaccine
46174,Seroconversion Induced By Two Doses Of Covid-19 Vaccine,Phenotype,Seroconversion Induced By Two Doses Of Covid-19 Vaccine
46222,Total Lipid Levels In Medium Ldl,Phenotype,Total Lipid Levels In Medium Ldl
46228,Ascvd Risk Score (Systematic Coronary Risk Evaluation 2-Older People-Lipid Scores),Phenotype,Ascvd Risk Score (Systematic Coronary Risk Evaluation 2-Older People-Lipid Scores)
46240,Parkinson'S Disease (Age Of Onset) X Smoking Interaction,Phenotype,Parkinson'S Disease (Age Of Onset) X Smoking Interaction
46245,Phospholipids In Medium Ldl,Phenotype,Phospholipids In Medium Ldl
46256,Glo1 Protein Levels,Phenotype,Glo1 Protein Levels
46263,Havcr1 Protein Levels,Phenotype,Havcr1 Protein Levels
46265,Cblif Protein Levels,Phenotype,Cblif Protein Levels
46267,Ca5A Protein Levels,Phenotype,Ca5A Protein Levels
46269,Thbs2 Protein Levels,Phenotype,Thbs2 Protein Levels
46271,Type 2 Diabetes Mellitus Adjusted For Bmi Or Coronary Artery Disease (Pleiotropy),Phenotype,Type 2 Diabetes Mellitus Adjusted For Bmi Or Coronary Artery Disease (Pleiotropy)
46322,Education Attainment Or Attention Deficit Hyperactivity Disorder,Phenotype,Education Attainment Or Attention Deficit Hyperactivity Disorder
46324,Education Attainment Or Autism Spectrum Disorders,Phenotype,Education Attainment Or Autism Spectrum Disorders
46325,Education Attainment Or Alcohol Use Disorders,Phenotype,Education Attainment Or Alcohol Use Disorders
46326,Education Attainment Or Bipolar Disorder,Phenotype,Education Attainment Or Bipolar Disorder
46327,Education Attainment Or Cannabis Use Disorder,Phenotype,Education Attainment Or Cannabis Use Disorder
46328,Education Attainment Or Tourette’S Syndrome,Phenotype,Education Attainment Or Tourette’S Syndrome
46333,Type 2 Diabetes Mellitus Or Coronary Artery Disease (Pleiotropy),Phenotype,Type 2 Diabetes Mellitus Or Coronary Artery Disease (Pleiotropy)
46348,High-Sensitivity Cardiac Troponin T Levels (Mtag),Phenotype,High-Sensitivity Cardiac Troponin T Levels (Mtag)
46350,High-Sensitivity Cardiac Troponin I Concentration (Mtag),Phenotype,High-Sensitivity Cardiac Troponin I Concentration (Mtag)
46351,Serum Aluminum Levels,Phenotype,Serum Aluminum Levels
46353,Serum Arsenic Levels,Phenotype,Serum Arsenic Levels
46355,Serum Barium Levels,Phenotype,Serum Barium Levels
46360,Serum Calcium Levels,Phenotype,Serum Calcium Levels
46365,Total Cholesterol In Hdl3,Phenotype,Total Cholesterol In Hdl3
46366,Cholesterol Esters In Idl,Phenotype,Cholesterol Esters In Idl
46367,Total Cholesterol To Total Lipids Ratio In Idl,Phenotype,Total Cholesterol To Total Lipids Ratio In Idl
46371,Free Cholesterol In Idl,Phenotype,Free Cholesterol In Idl
46373,Free Cholesterol In Large Hdl,Phenotype,Free Cholesterol In Large Hdl
46378,Phospholipids In Large Ldl,Phenotype,Phospholipids In Large Ldl
46389,Triglycerides In Large Ldl,Phenotype,Triglycerides In Large Ldl
46390,Total Cholesterol In Hdl2,Phenotype,Total Cholesterol In Hdl2
46396,Total Cholesterol In Idl,Phenotype,Total Cholesterol In Idl
46397,Total Cholesterol In Large Hdl,Phenotype,Total Cholesterol In Large Hdl
46402,Triglycerides In Large Hdl,Phenotype,Triglycerides In Large Hdl
46403,Phospholipids In Large Hdl,Phenotype,Phospholipids In Large Hdl
46405,Intestinal Behcet'S Disease,Phenotype,Intestinal Behcet'S Disease
46408,Cholesterol Esters In Large Vldl,Phenotype,Cholesterol Esters In Large Vldl
46409,Total Cholesterol To Total Lipids Ratio In Large Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Large Vldl
46410,Free Cholesterol In Large Vldl,Phenotype,Free Cholesterol In Large Vldl
46415,Triglycerides To Total Lipids Ratio In Medium Hdl,Phenotype,Triglycerides To Total Lipids Ratio In Medium Hdl
46416,Phospholipids To Total Lipids Ratio In Medium Hdl,Phenotype,Phospholipids To Total Lipids Ratio In Medium Hdl
46417,Phospholipids In Medium Hdl,Phenotype,Phospholipids In Medium Hdl
46420,Triglycerides In Medium Hdl,Phenotype,Triglycerides In Medium Hdl
46428,Rectum And Left Colon Stage I/Ii/Iv Colorectal Cancer (Metastasis Vs No Metastasis),Phenotype,Rectum And Left Colon Stage I/Ii/Iv Colorectal Cancer (Metastasis Vs No Metastasis)
46430,Triglycerides In Idl,Phenotype,Triglycerides In Idl
46433,Major Depressive Disorder Or Glomerular Filtration Rate Estimated From Creatine (Mtag),Phenotype,Major Depressive Disorder Or Glomerular Filtration Rate Estimated From Creatine (Mtag)
46438,Major Depressive Disorder Or Glomerular Filtration Rate Estimated From Cystatin (Mtag),Phenotype,Major Depressive Disorder Or Glomerular Filtration Rate Estimated From Cystatin (Mtag)
46458,Total Lipids In Large Vldl,Phenotype,Total Lipids In Large Vldl
46459,Total Cholesterol To Total Lipids Ratio In Medium Ldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Medium Ldl
46460,Total Cholesterol In Medium Ldl,Phenotype,Total Cholesterol In Medium Ldl
46465,Free Cholesterol Levels,Phenotype,Free Cholesterol Levels
46467,Glycoprotein Acetylation,Phenotype,Glycoprotein Acetylation
46477,Total Lipids In Large Hdl,Phenotype,Total Lipids In Large Hdl
46478,Mosaic Loss Of Chromosome X,Phenotype,Mosaic Loss Of Chromosome X
46504,Total Cholesterol In Large Vldl,Phenotype,Total Cholesterol In Large Vldl
46506,Free Cholesterol To Total Lipids Ratio In Medium Hdl,Phenotype,Free Cholesterol To Total Lipids Ratio In Medium Hdl
46507,Total Lipids In Medium Hdl,Phenotype,Total Lipids In Medium Hdl
46508,Free Cholesterol In Medium Hdl,Phenotype,Free Cholesterol In Medium Hdl
46521,Total Lipids In Idl,Phenotype,Total Lipids In Idl
46524,Cholesterol Esters In Large Hdl,Phenotype,Cholesterol Esters In Large Hdl
46525,Total Cholesterol To Total Lipids Ratio In Large Hdl,Phenotype,Total Cholesterol To Total Lipids Ratio In Large Hdl
46542,Cholesterol Esters In Large Ldl,Phenotype,Cholesterol Esters In Large Ldl
46543,Free Cholesterol In Large Ldl,Phenotype,Free Cholesterol In Large Ldl
46544,Total Lipids In Large Ldl,Phenotype,Total Lipids In Large Ldl
46550,Mean Diameter Of Hdl Particles,Phenotype,Mean Diameter Of Hdl Particles
46552,Total Cholesterol Levels In Ldl,Phenotype,Total Cholesterol Levels In Ldl
46553,Ratio Of 18:2 Linoleic Acid To Total Fatty Acids,Phenotype,Ratio Of 18:2 Linoleic Acid To Total Fatty Acids
46555,Linoleic Acid (18:2) Levels,Phenotype,Linoleic Acid (18:2) Levels
46563,Total Cholesterol In Large Ldl,Phenotype,Total Cholesterol In Large Ldl
46564,Total Cholesterol To Total Lipids Ratio In Large Ldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Large Ldl
46575,Total Cholesterol Levels In Medium Hdl,Phenotype,Total Cholesterol Levels In Medium Hdl
46576,Total Cholesterol To Total Lipids Ratio In Medium Hdl,Phenotype,Total Cholesterol To Total Lipids Ratio In Medium Hdl
46579,Cholesterol Esters In Medium Hdl,Phenotype,Cholesterol Esters In Medium Hdl
46580,Cholesteryl Esters To Total Lipids Ratio In Medium Hdl,Phenotype,Cholesteryl Esters To Total Lipids Ratio In Medium Hdl
46582,Plasma Factor V Levels (Parent Of Origin Effect) X Rs75463553 Interaction,Phenotype,Plasma Factor V Levels (Parent Of Origin Effect) X Rs75463553 Interaction
46586,Free Cholesterol To Total Lipids Ratio In Medium Ldl,Phenotype,Free Cholesterol To Total Lipids Ratio In Medium Ldl
46587,Coronary Artery Disease Or Factor Viii Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Factor Viii Levels (Pleiotropy)
46595,Skeletal Age,Phenotype,Skeletal Age
46599,Free Cholesterol In Very Large Hdl,Phenotype,Free Cholesterol In Very Large Hdl
46600,Total Lipids In Very Large Hdl,Phenotype,Total Lipids In Very Large Hdl
46612,Urticaria,Phenotype,Urticaria
46618,Phospholipids In Small Vldl,Phenotype,Phospholipids In Small Vldl
46619,Acute Radiotoxicity In Cancer (Adjusted For Clinical Covariates),Phenotype,Acute Radiotoxicity In Cancer (Adjusted For Clinical Covariates)
46621,Acute Radiotoxicity In Prostate Cancer,Phenotype,Acute Radiotoxicity In Prostate Cancer
46627,Total Lipids In Very Large Vldl,Phenotype,Total Lipids In Very Large Vldl
46629,Coronary Artery Disease Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),Phenotype,Coronary Artery Disease Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy)
46632,Ischemic Stroke Or Factor Vii Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Factor Vii Levels (Pleiotropy)
46633,Ischemic Stroke Or Factor Viii Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Factor Viii Levels (Pleiotropy)
46634,Ischemic Stroke Or Von Willebrand Factor Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Von Willebrand Factor Levels (Pleiotropy)
46636,Free Cholesterol In Small Vldl,Phenotype,Free Cholesterol In Small Vldl
46637,Total Lipids In Small Vldl,Phenotype,Total Lipids In Small Vldl
46638,Melanoma X Citrus Consumption Interaction (2Df),Phenotype,Melanoma X Citrus Consumption Interaction (2Df)
46640,Total Cholesterol Levels In Very Large Hdl,Phenotype,Total Cholesterol Levels In Very Large Hdl
46642,Total Cholesterol To Total Lipids Ratio In Very Large Hdl,Phenotype,Total Cholesterol To Total Lipids Ratio In Very Large Hdl
46643,Cholesterol Esters In Very Large Hdl,Phenotype,Cholesterol Esters In Very Large Hdl
46664,Fibrinogen Levels Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),Phenotype,Fibrinogen Levels Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy)
46667,Fibrinogen Levels Or Factor Vii Levels Or Factor Xi Levels Or Tissue Plasminogen Activator Levels (Pleiotropy),Phenotype,Fibrinogen Levels Or Factor Vii Levels Or Factor Xi Levels Or Tissue Plasminogen Activator Levels (Pleiotropy)
46668,Fibrinogen Levels Or Tissue Plasminogen Activator Levels (Pleiotropy),Phenotype,Fibrinogen Levels Or Tissue Plasminogen Activator Levels (Pleiotropy)
46669,Venous Thromboembolism Or Factor Vii Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Factor Vii Levels (Pleiotropy)
46673,Cholesterol Esters In Small Vldl,Phenotype,Cholesterol Esters In Small Vldl
46674,Age Of Onset Of Type 1 Diabetes,Phenotype,Age Of Onset Of Type 1 Diabetes
46675,Ischemic Stroke Or Factor Xi Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Factor Xi Levels (Pleiotropy)
46676,Ischemic Stroke Or Fibrinogen Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Fibrinogen Levels (Pleiotropy)
46678,Ischemic Stroke Or Tissue Plasminogen Activator Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Tissue Plasminogen Activator Levels (Pleiotropy)
46679,Ischemic Stroke Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),Phenotype,Ischemic Stroke Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy)
46680,Factor Viii Levels Or Von Willebrand Factor Levels (Pleiotropy),Phenotype,Factor Viii Levels Or Von Willebrand Factor Levels (Pleiotropy)
46682,Fibrinogen Levels Or Factor Vii Levels (Pleiotropy),Phenotype,Fibrinogen Levels Or Factor Vii Levels (Pleiotropy)
46692,Acute Radiotoxicity In Cancer,Phenotype,Acute Radiotoxicity In Cancer
46697,Triglycerides In Very Large Hdl,Phenotype,Triglycerides In Very Large Hdl
46718,Total Bone Mineral Density X Gut Microbiota (Genus Dialister) Interaction,Phenotype,Total Bone Mineral Density X Gut Microbiota (Genus Dialister) Interaction
46720,Femur Total Bone Mineral Density X Gut Microbiota (Genus Lactococcus) Interaction,Phenotype,Femur Total Bone Mineral Density X Gut Microbiota (Genus Lactococcus) Interaction
46740,Total Cholesterol To Total Lipids Ratio In Small Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Small Vldl
46745,Total Cholesterol Levels In Vldl,Phenotype,Total Cholesterol Levels In Vldl
46749,Gp41 C34 Peptide-- Hiv Levels,Phenotype,Gp41 C34 Peptide-- Hiv Levels
46752,Granzyme A Levels,Phenotype,Granzyme A Levels
46757,Plasma Titanium Levels,Phenotype,Plasma Titanium Levels
46759,Plasma Vanadium Levels,Phenotype,Plasma Vanadium Levels
46773,Phosphatidylcholine Diacyl C40:6 Levels,Phenotype,Phosphatidylcholine Diacyl C40:6 Levels
46774,Phosphatidylcholine Diacyl C42:5 Levels,Phenotype,Phosphatidylcholine Diacyl C42:5 Levels
46776,Phosphatidylcholine Acyl-Alkyl C34:1 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C34:1 Levels
46777,Phosphatidylcholine Acyl-Alkyl C34:3 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C34:3 Levels
46778,Phosphatidylcholine Diacyl C36:3 Levels,Phenotype,Phosphatidylcholine Diacyl C36:3 Levels
46779,Phosphatidylcholine Diacyl C36:4 Levels,Phenotype,Phosphatidylcholine Diacyl C36:4 Levels
46780,Phosphatidylcholine Acyl-Alkyl C38:5 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C38:5 Levels
46781,Phosphatidylcholine Acyl-Alkyl C38:6 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C38:6 Levels
46782,Phosphatidylcholine Acyl-Alkyl C42:1 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C42:1 Levels
46783,Phosphatidylcholine Diacyl C38:3 Levels,Phenotype,Phosphatidylcholine Diacyl C38:3 Levels
46784,Phosphatidylcholine Diacyl C38:4 Levels,Phenotype,Phosphatidylcholine Diacyl C38:4 Levels
46785,Phosphatidylcholine Diacyl C38:5 Levels,Phenotype,Phosphatidylcholine Diacyl C38:5 Levels
46786,Phosphatidylcholine Diacyl C38:6 Levels,Phenotype,Phosphatidylcholine Diacyl C38:6 Levels
46787,Phosphatidylcholine Acyl-Alkyl C42:3 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C42:3 Levels
46789,Phosphatidylcholine Acyl-Alkyl C42:5 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C42:5 Levels
46798,Phosphatidylcholine Acyl-Alkyl C36:3 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C36:3 Levels
46799,Phosphatidylcholine Acyl-Alkyl C36:4 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C36:4 Levels
46800,Phosphatidylcholine Acyl-Alkyl C36:5 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C36:5 Levels
46801,Phosphatidylcholine Acyl-Alkyl C32:2 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C32:2 Levels
46802,Phosphatidylcholine Diacyl C42:6 Levels,Phenotype,Phosphatidylcholine Diacyl C42:6 Levels
46803,Phosphatidylcholine Acyl-Alkyl C34:2 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C34:2 Levels
46804,Phosphatidylcholine Acyl-Alkyl C32:1 Levels,Phenotype,Phosphatidylcholine Acyl-Alkyl C32:1 Levels
46805,Alkylphosphatidylcholine (O-18:1/18:2) Levels,Phenotype,Alkylphosphatidylcholine (O-18:1/18:2) Levels
46807,Alkenylphosphatidylcholine (P-16:0/20:5) Levels,Phenotype,Alkenylphosphatidylcholine (P-16:0/20:5) Levels
46809,Alkylphosphatidylcholine (O-16:0/22:6) Levels,Phenotype,Alkylphosphatidylcholine (O-16:0/22:6) Levels
46812,Alkenylphosphatidylethanolamine (P-20:1/20:4) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-20:1/20:4) Levels
46814,Phosphatidylglycerol (36:1) Levels,Phenotype,Phosphatidylglycerol (36:1) Levels
46816,Phosphatidylinositol (18:0_20:3) (B) Levels,Phenotype,Phosphatidylinositol (18:0_20:3) (B) Levels
46817,Phosphatidylinositol (18:0_22:4) Levels,Phenotype,Phosphatidylinositol (18:0_22:4) Levels
46818,Alkenylphosphatidylethanolamine (P-19:0/20:4) (A) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-19:0/20:4) (A) Levels
46820,Phosphatidylinositol (18:0_18:1) Levels,Phenotype,Phosphatidylinositol (18:0_18:1) Levels
46825,Alkenylphosphatidylethanolamine (P-18:1/20:5) (B) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-18:1/20:5) (B) Levels
46827,Diacylglycerol (18:1_20:3) Levels,Phenotype,Diacylglycerol (18:1_20:3) Levels
46829,Dehydrocholesteryl Ester (16:0) Levels,Phenotype,Dehydrocholesteryl Ester (16:0) Levels
46831,Dehydrocholesteryl Ester (18:1) Levels,Phenotype,Dehydrocholesteryl Ester (18:1) Levels
46833,C-C Motif Chemokine 19 Levels,Phenotype,C-C Motif Chemokine 19 Levels
46839,Plasma Manganese Levels,Phenotype,Plasma Manganese Levels
46841,Plasma Rubidium Levels,Phenotype,Plasma Rubidium Levels
46843,Plasma Selenium Levels,Phenotype,Plasma Selenium Levels
46845,Plasma Nickel Levels,Phenotype,Plasma Nickel Levels
46847,Plasma Lead Levels,Phenotype,Plasma Lead Levels
46852,Revision Surgery After Total Joint Arthroplasty,Phenotype,Revision Surgery After Total Joint Arthroplasty
46854,Revision Surgery Due To Aseptic Loosening After Total Hip Arthroplasty,Phenotype,Revision Surgery Due To Aseptic Loosening After Total Hip Arthroplasty
46866,Sphingomyeline C18:0 Levels,Phenotype,Sphingomyeline C18:0 Levels
46867,Tetradecadienylcarnitine Levels,Phenotype,Tetradecadienylcarnitine Levels
46868,Tetradecanoylcarnitine Levels,Phenotype,Tetradecanoylcarnitine Levels
46870,Threonine Levels,Phenotype,Threonine Levels
46873,Pimelylcarnitine Levels,Phenotype,Pimelylcarnitine Levels
46876,Sphingomyeline C16:0 Levels,Phenotype,Sphingomyeline C16:0 Levels
46878,Tryptophan Levels,Phenotype,Tryptophan Levels
46880,Number Of Clonal Hematopoiesis Mutations,Phenotype,Number Of Clonal Hematopoiesis Mutations
46882,Phosphatidylinositol (18:0_22:5) (N6) Levels,Phenotype,Phosphatidylinositol (18:0_22:5) (N6) Levels
46883,Phosphatidylinositol (34:1) Levels,Phenotype,Phosphatidylinositol (34:1) Levels
46884,Acylcarnitine (12:0) Levels,Phenotype,Acylcarnitine (12:0) Levels
46891,Acylcarnitine (16:0) Levels,Phenotype,Acylcarnitine (16:0) Levels
46899,Acylcarnitine (16:1) Levels,Phenotype,Acylcarnitine (16:1) Levels
46901,Acylcarnitine (17:0) (A) Levels,Phenotype,Acylcarnitine (17:0) (A) Levels
46902,Acylcarnitine (17:0) (B) Levels,Phenotype,Acylcarnitine (17:0) (B) Levels
46903,Acylcarnitine (18:0) Levels,Phenotype,Acylcarnitine (18:0) Levels
46908,Acylcarnitine (14:0) Levels,Phenotype,Acylcarnitine (14:0) Levels
46910,Acylcarnitine (15:0) (A) Levels,Phenotype,Acylcarnitine (15:0) (A) Levels
46911,Acylcarnitine (15:0) (B) Levels,Phenotype,Acylcarnitine (15:0) (B) Levels
46912,Acylcarnitine (18:1) Levels,Phenotype,Acylcarnitine (18:1) Levels
46915,Acylcarnitine (18:2) Levels,Phenotype,Acylcarnitine (18:2) Levels
46920,Monohexosylceramide (D16:1/20:0) Levels,Phenotype,Monohexosylceramide (D16:1/20:0) Levels
46927,Phosphatidylserine (36:2) Levels,Phenotype,Phosphatidylserine (36:2) Levels
46929,Sphingomyelin (D18:1/20:0) Levels/Sphingomyelin (D16:1/22:0) Levels,Phenotype,Sphingomyelin (D18:1/20:0) Levels/Sphingomyelin (D16:1/22:0) Levels
46945,Serum Copper Levels,Phenotype,Serum Copper Levels
46948,Serum Iron Levels,Phenotype,Serum Iron Levels
46951,Serum Magnesium Levels,Phenotype,Serum Magnesium Levels
46952,Serum Manganese Levels,Phenotype,Serum Manganese Levels
46955,Serum Molybdenum Levels,Phenotype,Serum Molybdenum Levels
46957,Serum Nickel Levels,Phenotype,Serum Nickel Levels
46960,Serum Cobalt Levels,Phenotype,Serum Cobalt Levels
46962,Serum Chromium Levels,Phenotype,Serum Chromium Levels
46965,Cleft Lip (With Or Without Cleft Palate) Or Cleft Palate,Phenotype,Cleft Lip (With Or Without Cleft Palate) Or Cleft Palate
46986,Mediator Of Rna Polymerase Ii Transcription Subunit 1 Levels,Phenotype,Mediator Of Rna Polymerase Ii Transcription Subunit 1 Levels
47001,Carnitine Levels,Phenotype,Carnitine Levels
47003,Arginine Levels,Phenotype,Arginine Levels
47005,Acetylcarnitine Levels,Phenotype,Acetylcarnitine Levels
47006,Venous Thromboembolism In Pregnancy,Phenotype,Venous Thromboembolism In Pregnancy
47008,Alkylphosphatidylcholine (O-16:0/16:0) Levels,Phenotype,Alkylphosphatidylcholine (O-16:0/16:0) Levels
47010,Phosphatidylcholine (40:7) (A) Levels,Phenotype,Phosphatidylcholine (40:7) (A) Levels
47012,Phosphatidylcholine (38:4) (B) Levels,Phenotype,Phosphatidylcholine (38:4) (B) Levels
47013,Phosphatidylcholine (38:5) (A) Levels,Phenotype,Phosphatidylcholine (38:5) (A) Levels
47014,Phosphatidylcholine (38:5) (B) Levels,Phenotype,Phosphatidylcholine (38:5) (B) Levels
47015,Phosphatidylcholine (38:7) (C) Levels,Phenotype,Phosphatidylcholine (38:7) (C) Levels
47016,Phosphatidylcholine (18:1_20:3) Levels,Phenotype,Phosphatidylcholine (18:1_20:3) Levels
47019,Phosphatidylcholine (39:5) (B) Levels,Phenotype,Phosphatidylcholine (39:5) (B) Levels
47020,Alkenylphosphatidylethanolamine (P-18:0/22:6) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-18:0/22:6) Levels
47022,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-16:0/20:3) (A) Levels
47024,Alkenylphosphatidylethanolamine (P-16:0/22:5) (N3) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-16:0/22:5) (N3) Levels
47026,Alkenylphosphatidylethanolamine (P-16:0/22:6) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-16:0/22:6) Levels
47028,Alkenylphosphatidylethanolamine (P-18:0/20:3) (B) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-18:0/20:3) (B) Levels
47029,Diacylglycerol (16:0_22:6) Levels,Phenotype,Diacylglycerol (16:0_22:6) Levels
47032,Dehydrocholesteryl Ester (18:2) Levels,Phenotype,Dehydrocholesteryl Ester (18:2) Levels
47034,Ceramide (D19:1/26:0) Levels,Phenotype,Ceramide (D19:1/26:0) Levels
47036,Ceramide (D19:1/24:0) Levels,Phenotype,Ceramide (D19:1/24:0) Levels
47038,Phosphatidylcholine (16:0_20:3) (A) Levels,Phenotype,Phosphatidylcholine (16:0_20:3) (A) Levels
47041,Phosphatidylcholine (17:0_20:4) Levels,Phenotype,Phosphatidylcholine (17:0_20:4) Levels
47043,Phosphatidylcholine (16:0_18:2) Levels,Phenotype,Phosphatidylcholine (16:0_18:2) Levels
47045,Phosphatidylcholine (15:0_20:4) Levels,Phenotype,Phosphatidylcholine (15:0_20:4) Levels
47046,Phosphatidylcholine (16:0_20:4) Levels,Phenotype,Phosphatidylcholine (16:0_20:4) Levels
47047,Phosphatidylcholine (16:0_22:6) Levels,Phenotype,Phosphatidylcholine (16:0_22:6) Levels
47052,Trefoil Factor 3 Levels,Phenotype,Trefoil Factor 3 Levels
47055,Neutrophil Collagenase Levels,Phenotype,Neutrophil Collagenase Levels
47058,Plasminogen Activator Inhibitor 1 Levels,Phenotype,Plasminogen Activator Inhibitor 1 Levels
47063,Serum Strontium Levels,Phenotype,Serum Strontium Levels
47066,Serum Lead Levels,Phenotype,Serum Lead Levels
47068,Serum Rubidium Levels,Phenotype,Serum Rubidium Levels
47070,Serum Selenium Levels,Phenotype,Serum Selenium Levels
47073,Serum Titanium Levels,Phenotype,Serum Titanium Levels
47076,Serum Vanadium Levels,Phenotype,Serum Vanadium Levels
47081,Cleft Lip With Or Without Cleft Palate,Phenotype,Cleft Lip With Or Without Cleft Palate
47101,Phosphatidylcholine (18:0_20:3) Levels,Phenotype,Phosphatidylcholine (18:0_20:3) Levels
47104,Phosphatidylcholine (18:0_20:4) Levels,Phenotype,Phosphatidylcholine (18:0_20:4) Levels
47105,Phosphatidylcholine (18:0_22:5) (N3) Levels/Phosphatidylcholine (20:1_20:4) Levels,Phenotype,Phosphatidylcholine (18:0_22:5) (N3) Levels/Phosphatidylcholine (20:1_20:4) Levels
47107,Phosphatidylcholine (18:0_22:5) (N6) Levels,Phenotype,Phosphatidylcholine (18:0_22:5) (N6) Levels
47109,Phosphatidylcholine (18:0_22:6) Levels,Phenotype,Phosphatidylcholine (18:0_22:6) Levels
47119,Alkylphosphatidylethanolamine (O-16:0/22:6) Levels,Phenotype,Alkylphosphatidylethanolamine (O-16:0/22:6) Levels
47121,Alkylphosphatidylethanolamine (O-18:0/22:6) Levels,Phenotype,Alkylphosphatidylethanolamine (O-18:0/22:6) Levels
47122,Alkenylphosphatidylethanolamine (P-15:0/22:6) (A) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-15:0/22:6) (A) Levels
47124,Alkenylphosphatidylethanolamine (P-16:0/18:1) Levels,Phenotype,Alkenylphosphatidylethanolamine (P-16:0/18:1) Levels
47126,Phosphatidylethanolamine (18:0_22:5) (N3) Levels,Phenotype,Phosphatidylethanolamine (18:0_22:5) (N3) Levels
47128,Phosphatidylethanolamine (18:0_20:3) (A) Levels,Phenotype,Phosphatidylethanolamine (18:0_20:3) (A) Levels
47134,Ceramide (D18:2/16:0) Levels,Phenotype,Ceramide (D18:2/16:0) Levels
47136,Ceramide (D18:2/22:0) Levels,Phenotype,Ceramide (D18:2/22:0) Levels
47138,Lysophosphatidylinositol (18:1) [Sn1] Levels,Phenotype,Lysophosphatidylinositol (18:1) [Sn1] Levels
47140,Lysophosphatidylcholine (22:5) [Sn2] (N3) Levels,Phenotype,Lysophosphatidylcholine (22:5) [Sn2] (N3) Levels
47142,Lysophosphatidylethanolamine (16:0) [Sn1] Levels,Phenotype,Lysophosphatidylethanolamine (16:0) [Sn1] Levels
47143,Lysophosphatidylethanolamine (16:0) [Sn2] Levels,Phenotype,Lysophosphatidylethanolamine (16:0) [Sn2] Levels
47148,Plasma Copper Levels,Phenotype,Plasma Copper Levels
47151,Plasma Iron Levels,Phenotype,Plasma Iron Levels
47153,Plasma Cadmium Levels,Phenotype,Plasma Cadmium Levels
47155,Plasma Calcium Levels,Phenotype,Plasma Calcium Levels
47159,Revision Surgery After Total Hip Arthroplasty,Phenotype,Revision Surgery After Total Hip Arthroplasty
47160,Revision Surgery After Total Knee Arthroplasty,Phenotype,Revision Surgery After Total Knee Arthroplasty
47163,Kynurenine Levels,Phenotype,Kynurenine Levels
47165,Lysine Levels,Phenotype,Lysine Levels
47168,Ornithine Levels,Phenotype,Ornithine Levels
47169,Phosphatidylcholine Diacyl C32:0 Levels,Phenotype,Phosphatidylcholine Diacyl C32:0 Levels
47170,Lysophosphatidylcholine Acyl C20:3 Levels,Phenotype,Lysophosphatidylcholine Acyl C20:3 Levels
47171,Lysophosphatidylcholine Acyl C20:4 Levels,Phenotype,Lysophosphatidylcholine Acyl C20:4 Levels
47172,Lysophosphatidylcholine Acyl C26:0 Levels,Phenotype,Lysophosphatidylcholine Acyl C26:0 Levels
47173,Hexadecanoylcarnitine Levels,Phenotype,Hexadecanoylcarnitine Levels
47174,Hexadecenoylcarnitine Levels,Phenotype,Hexadecenoylcarnitine Levels
47175,Methylglutarylcarnitine Levels,Phenotype,Methylglutarylcarnitine Levels
47176,Octadecandienylcarnitine Levels,Phenotype,Octadecandienylcarnitine Levels
47177,Octadecanoylcarnitine Levels,Phenotype,Octadecanoylcarnitine Levels
47178,Octadecenoylcarnitine Levels,Phenotype,Octadecenoylcarnitine Levels
47182,Cholesteryl Ester (16:0) Levels,Phenotype,Cholesteryl Ester (16:0) Levels
47183,Cholesteryl Ester (16:2) Levels,Phenotype,Cholesteryl Ester (16:2) Levels
47185,Cholesteryl Ester (18:0) Levels,Phenotype,Cholesteryl Ester (18:0) Levels
47186,Cholesteryl Ester (18:3) Levels,Phenotype,Cholesteryl Ester (18:3) Levels
47187,Cholesteryl Ester (20:3) Levels,Phenotype,Cholesteryl Ester (20:3) Levels
47189,Cholesteryl Ester (20:5) Levels,Phenotype,Cholesteryl Ester (20:5) Levels
47191,Cholesteryl Ester (24:5) Levels,Phenotype,Cholesteryl Ester (24:5) Levels
47198,Cholesteryl Ester (24:6) Levels,Phenotype,Cholesteryl Ester (24:6) Levels
47199,Lysophosphatidylcholine (15-Mhda) [Sn1] Levels /Lysophosphatidylcholine (17:0) [Sn2] Levels,Phenotype,Lysophosphatidylcholine (15-Mhda) [Sn1] Levels /Lysophosphatidylcholine (17:0) [Sn2] Levels
47201,Lysophosphatidylcholine (15-Mhda) [Sn2] Levels,Phenotype,Lysophosphatidylcholine (15-Mhda) [Sn2] Levels
47203,Lysophosphatidylcholine (18:2) [Sn2] Levels,Phenotype,Lysophosphatidylcholine (18:2) [Sn2] Levels
47205,Lysophosphatidylcholine (20:1) [Sn1] Levels,Phenotype,Lysophosphatidylcholine (20:1) [Sn1] Levels
47207,Lysophosphatidylcholine (20:2) [Sn1] Levels,Phenotype,Lysophosphatidylcholine (20:2) [Sn1] Levels
47208,Lysophosphatidylcholine (22:5) [Sn1] (N3) Levels/Lysophosphatidylcholine (22:5) [Sn2] (N6) Levels,Phenotype,Lysophosphatidylcholine (22:5) [Sn1] (N3) Levels/Lysophosphatidylcholine (22:5) [Sn2] (N6) Levels
47210,Lysophosphatidylcholine (22:5) [Sn1] (N6) Levels,Phenotype,Lysophosphatidylcholine (22:5) [Sn1] (N6) Levels
47212,Lysophosphatidylcholine (20:3) [Sn1] Levels,Phenotype,Lysophosphatidylcholine (20:3) [Sn1] Levels
47215,Lysophosphatidylcholine (20:3) [Sn2] Levels,Phenotype,Lysophosphatidylcholine (20:3) [Sn2] Levels
47218,Lysophosphatidylcholine (15:0) [Sn1] Levels,Phenotype,Lysophosphatidylcholine (15:0) [Sn1] Levels
47220,Lysophosphatidylcholine (15:0) [Sn2] Levels,Phenotype,Lysophosphatidylcholine (15:0) [Sn2] Levels
47221,Lysophosphatidylcholine (15-Mhda) [Sn1]  [104_Sn1] Levels,Phenotype,Lysophosphatidylcholine (15-Mhda) [Sn1]  [104_Sn1] Levels
47222,Monohexosylceramide (D18:1/24:1) Levels,Phenotype,Monohexosylceramide (D18:1/24:1) Levels
47224,Monohexosylceramide (D18:1/22:0) Levels,Phenotype,Monohexosylceramide (D18:1/22:0) Levels
47226,Triacylglycerol (50:2) [Nl-18:2] Levels,Phenotype,Triacylglycerol (50:2) [Nl-18:2] Levels
47229,Triacylglycerol (51:1) [Nl-18:1] Levels,Phenotype,Triacylglycerol (51:1) [Nl-18:1] Levels
47231,Triacylglycerol (54:1) [Nl-18:1] Levels,Phenotype,Triacylglycerol (54:1) [Nl-18:1] Levels
47232,Triacylglycerol (50:0) [Nl-18:0] Levels,Phenotype,Triacylglycerol (50:0) [Nl-18:0] Levels
47233,Triacylglycerol (50:1) [Nl-18:1] Levels,Phenotype,Triacylglycerol (50:1) [Nl-18:1] Levels
47235,Total Cholesterol To Total Lipids Ratio In Medium Vldl,Phenotype,Total Cholesterol To Total Lipids Ratio In Medium Vldl
47236,Total Cholesterol In Medium Vldl,Phenotype,Total Cholesterol In Medium Vldl
47245,Concentration Of Medium Vldl Particles,Phenotype,Concentration Of Medium Vldl Particles
47246,Total Lipids In Medium Vldl,Phenotype,Total Lipids In Medium Vldl
47255,Triglycerides In Small Hdl,Phenotype,Triglycerides In Small Hdl
47256,Phospholipids In Small Hdl,Phenotype,Phospholipids In Small Hdl
47257,Sphingomyelins Levels,Phenotype,Sphingomyelins Levels
47270,Ratio Of 22:6 Docosahexaenoic Acid To Total Fatty Acids,Phenotype,Ratio Of 22:6 Docosahexaenoic Acid To Total Fatty Acids
47271,Diacylglycerol Levels,Phenotype,Diacylglycerol Levels
47272,Ratio Of Diacylglycerol To Triglycerides,Phenotype,Ratio Of Diacylglycerol To Triglycerides
47273,Docosahexaenoic Acid (22:6) Levels,Phenotype,Docosahexaenoic Acid (22:6) Levels
47280,Pulse Pressure (Bmi Unadjusted),Phenotype,Pulse Pressure (Bmi Unadjusted)
47284,Pulse Pressure (Bmi Adjusted),Phenotype,Pulse Pressure (Bmi Adjusted)
47286,Esterified Cholesterol Levels,Phenotype,Esterified Cholesterol Levels
47288,Estimated Description Of Fatty Acid Chain Length Not Actual Carbon Number,Phenotype,Estimated Description Of Fatty Acid Chain Length Not Actual Carbon Number
47289,Mean Arterial Pressure (Bmi Unadjusted),Phenotype,Mean Arterial Pressure (Bmi Unadjusted)
47290,Total Phosphatidylserine Levels,Phenotype,Total Phosphatidylserine Levels
47292,Total Alkyldiacylglycerol Levels,Phenotype,Total Alkyldiacylglycerol Levels
47294,Alkylphosphatidylcholine (O-34:1) Levels,Phenotype,Alkylphosphatidylcholine (O-34:1) Levels
47295,Alkenylphosphatidylcholine (P-16:0/22:6) Levels,Phenotype,Alkenylphosphatidylcholine (P-16:0/22:6) Levels
47301,Glycated Haemoglobin Hba1C Levels Adjusted For Bmi,Phenotype,Glycated Haemoglobin Hba1C Levels Adjusted For Bmi
47343,White Matter Fractional Anisotropy X Age Interaction (2Df),Phenotype,White Matter Fractional Anisotropy X Age Interaction (2Df)
47349,Enorma Massiliensis Abundance In Stool,Phenotype,Enorma Massiliensis Abundance In Stool
47351,Eubacterium I Ramulus A Abundance In Stool,Phenotype,Eubacterium I Ramulus A Abundance In Stool
47353,Ezakiellaceae Abundance In Stool,Phenotype,Ezakiellaceae Abundance In Stool
47355,Faecalicatena Glycyrrhizinilyticum Abundance In Stool,Phenotype,Faecalicatena Glycyrrhizinilyticum Abundance In Stool
47357,Pediatric Asthma,Phenotype,Pediatric Asthma
47359,Enteroscipio Abundance In Stool,Phenotype,Enteroscipio Abundance In Stool
47363,Geobacteraceae Abundance In Stool,Phenotype,Geobacteraceae Abundance In Stool
47365,Holdemania Sp900120005 Abundance In Stool,Phenotype,Holdemania Sp900120005 Abundance In Stool
47367,Firmicutes E Abundance In Stool,Phenotype,Firmicutes E Abundance In Stool
47373,Klebsiella A Abundance In Stool,Phenotype,Klebsiella A Abundance In Stool
47375,Klebsiella Pneumoniae Abundance In Stool,Phenotype,Klebsiella Pneumoniae Abundance In Stool
47377,Klebsiella Abundance In Stool,Phenotype,Klebsiella Abundance In Stool
47379,Paraglaciecola Abundance In Stool,Phenotype,Paraglaciecola Abundance In Stool
47381,Megamonas Funiformis Abundance In Stool,Phenotype,Megamonas Funiformis Abundance In Stool
47383,Methanobacterium B Abundance In Stool,Phenotype,Methanobacterium B Abundance In Stool
47389,Negativibacillus Massiliensis Abundance In Stool,Phenotype,Negativibacillus Massiliensis Abundance In Stool
47391,Sleep Apnea Syndrome,Phenotype,Sleep Apnea Syndrome
47398,Skin Cancer,Phenotype,Skin Cancer
47402,Spinal Canal Stenosis,Phenotype,Spinal Canal Stenosis
47404,Venous Thromboembolism Or Factor Viii Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Factor Viii Levels (Pleiotropy)
47405,Venous Thromboembolism Or Von Willebrand Factor Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Von Willebrand Factor Levels (Pleiotropy)
47408,Venous Thromboembolism Or Factor Xi Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Factor Xi Levels (Pleiotropy)
47409,Venous Thromboembolism Or Fibrinogen Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Fibrinogen Levels (Pleiotropy)
47410,Venous Thromboembolism Or Tissue Plasminogen Activator Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Tissue Plasminogen Activator Levels (Pleiotropy)
47411,Venous Thromboembolism Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy),Phenotype,Venous Thromboembolism Or Plasminogen Activator Inhibitor 1 Levels (Pleiotropy)
47432,Triacylglycerol (54:4) [Nl-18:0] Levels,Phenotype,Triacylglycerol (54:4) [Nl-18:0] Levels
47434,Triacylglycerol (54:5) [Nl-18:1] Levels,Phenotype,Triacylglycerol (54:5) [Nl-18:1] Levels
47435,Triacylglycerol (56:6) [Nl-20:4] Levels,Phenotype,Triacylglycerol (56:6) [Nl-20:4] Levels
47437,Total Phosphatidylcholine Levels,Phenotype,Total Phosphatidylcholine Levels
47439,Alkylphosphatidylcholine (O-32:1) Levels,Phenotype,Alkylphosphatidylcholine (O-32:1) Levels
47440,Total Phosphatidylinositol Levels,Phenotype,Total Phosphatidylinositol Levels
47442,Sphingomyelin (D19:1/24:1) Levels,Phenotype,Sphingomyelin (D19:1/24:1) Levels
47444,Sulfatide (D18:1/16:0) Levels,Phenotype,Sulfatide (D18:1/16:0) Levels
47446,Total Triacylglycerol Levels,Phenotype,Total Triacylglycerol Levels
47448,Alkyldiacylglycerol (O-50:1) [Nl-16:0] Levels,Phenotype,Alkyldiacylglycerol (O-50:1) [Nl-16:0] Levels
47449,Alkyldiacylglycerol (O-52:0) [Nl-16:0] Levels,Phenotype,Alkyldiacylglycerol (O-52:0) [Nl-16:0] Levels
47450,Alkyldiacylglycerol (O-52:2) [Nl-16:0] Levels,Phenotype,Alkyldiacylglycerol (O-52:2) [Nl-16:0] Levels
47451,Total Acylcarnitine Levels,Phenotype,Total Acylcarnitine Levels
47452,Total Cholesteryl Ester Levels,Phenotype,Total Cholesteryl Ester Levels
47454,Total Dehydrocholesteryl Ester Levels,Phenotype,Total Dehydrocholesteryl Ester Levels
47457,Alkenylphosphatidylcholine (P-16:0/16:0) Levels,Phenotype,Alkenylphosphatidylcholine (P-16:0/16:0) Levels
47460,Asthma-Copd Overlap Syndrome,Phenotype,Asthma-Copd Overlap Syndrome
47475,Vascular Endothelial Growth Factor A Level In Chronic Kidney Disease With Hypertension And No Diabetes (2597_8),Phenotype,Vascular Endothelial Growth Factor A Level In Chronic Kidney Disease With Hypertension And No Diabetes (2597_8)
47477,Adhesion G Protein-Coupled Receptor F5 Level In Chronic Kidney Disease With Hypertension And No Diabetes (6409_57),Phenotype,Adhesion G Protein-Coupled Receptor F5 Level In Chronic Kidney Disease With Hypertension And No Diabetes (6409_57)
47479,Tenascin-X Level In Chronic Kidney Disease With Hypertension And No Diabetes (5698_60),Phenotype,Tenascin-X Level In Chronic Kidney Disease With Hypertension And No Diabetes (5698_60)
47481,Retinoic Acid Early Transcript 1L Protein Level In Chronic Kidney Disease With Hypertension And No Diabetes (20526_3),Phenotype,Retinoic Acid Early Transcript 1L Protein Level In Chronic Kidney Disease With Hypertension And No Diabetes (20526_3)
47483,Izumo Sperm-Egg Fusion Protein 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (20549_1),Phenotype,Izumo Sperm-Egg Fusion Protein 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (20549_1)
47484,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (5992_50),Phenotype,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (5992_50)
47486,Protein Mdm4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (13229_20),Phenotype,Protein Mdm4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (13229_20)
47490,Interleukin-36 Alpha Level In Chronic Kidney Disease With Hypertension And No Diabetes (14150_7),Phenotype,Interleukin-36 Alpha Level In Chronic Kidney Disease With Hypertension And No Diabetes (14150_7)
47492,Prolyl Endopeptidase Level In Chronic Kidney Disease With Hypertension And No Diabetes (14273_19),Phenotype,Prolyl Endopeptidase Level In Chronic Kidney Disease With Hypertension And No Diabetes (14273_19)
47493,Butyrophilin Subfamily 3 Member A2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (21433_3),Phenotype,Butyrophilin Subfamily 3 Member A2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (21433_3)
47495,Mtss1-Like Protein Level In Chronic Kidney Disease With Hypertension And No Diabetes (25252_29),Phenotype,Mtss1-Like Protein Level In Chronic Kidney Disease With Hypertension And No Diabetes (25252_29)
47497,Interleukin-21 Level In Chronic Kidney Disease With Hypertension And No Diabetes (7124_18),Phenotype,Interleukin-21 Level In Chronic Kidney Disease With Hypertension And No Diabetes (7124_18)
47499,Uncharacterized Metallophosphoesterase Cstp1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (21108_5),Phenotype,Uncharacterized Metallophosphoesterase Cstp1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (21108_5)
47501,Mhc Class I Polypeptide-Related Sequence A Level In Chronic Kidney Disease With Hypertension And No Diabetes (2730_58),Phenotype,Mhc Class I Polypeptide-Related Sequence A Level In Chronic Kidney Disease With Hypertension And No Diabetes (2730_58)
47503,Vascular Endothelial Growth Factor A-- Isoform 121 Level In Chronic Kidney Disease With Hypertension And No Diabetes (14032_2),Phenotype,Vascular Endothelial Growth Factor A-- Isoform 121 Level In Chronic Kidney Disease With Hypertension And No Diabetes (14032_2)
47504,Alpha-L-Fucoside Fucohydrolase Level In Chronic Kidney Disease With Hypertension And No Diabetes (21384_2),Phenotype,Alpha-L-Fucoside Fucohydrolase Level In Chronic Kidney Disease With Hypertension And No Diabetes (21384_2)
47505,Neutrophil Collagenase Level In Chronic Kidney Disease With Hypertension And No Diabetes (2954_56),Phenotype,Neutrophil Collagenase Level In Chronic Kidney Disease With Hypertension And No Diabetes (2954_56)
47506,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 5 Level In Chronic Kidney Disease With Hypertension And No Diabetes (6556_5),Phenotype,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 5 Level In Chronic Kidney Disease With Hypertension And No Diabetes (6556_5)
47507,Low-Density Lipoprotein Receptor-Related Protein 11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (6713_4),Phenotype,Low-Density Lipoprotein Receptor-Related Protein 11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (6713_4)
47509,Hemoglobin Subunit Zeta Level In Chronic Kidney Disease With Hypertension And No Diabetes (6919_3),Phenotype,Hemoglobin Subunit Zeta Level In Chronic Kidney Disease With Hypertension And No Diabetes (6919_3)
47511,Haptoglobin Level In Chronic Kidney Disease With Hypertension And No Diabetes (3054_3),Phenotype,Haptoglobin Level In Chronic Kidney Disease With Hypertension And No Diabetes (3054_3)
47512,Sialidase-1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15426_5),Phenotype,Sialidase-1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15426_5)
47514,N-Sulphoglucosamine Sulphohydrolase Level In Chronic Kidney Disease With Hypertension And No Diabetes (21766_50),Phenotype,N-Sulphoglucosamine Sulphohydrolase Level In Chronic Kidney Disease With Hypertension And No Diabetes (21766_50)
47516,Hla-C Level In Chronic Kidney Disease With Hypertension And No Diabetes (21797_4),Phenotype,Hla-C Level In Chronic Kidney Disease With Hypertension And No Diabetes (21797_4)
47517,Neuregulin-1-- Sensory And Motor Neuron-Derived Factor Isoform Level In Chronic Kidney Disease With Hypertension And No Diabetes (15446_25),Phenotype,Neuregulin-1-- Sensory And Motor Neuron-Derived Factor Isoform Level In Chronic Kidney Disease With Hypertension And No Diabetes (15446_25)
47518,5'-Nucleotidase Level In Chronic Kidney Disease With Hypertension And No Diabetes (15452_5),Phenotype,5'-Nucleotidase Level In Chronic Kidney Disease With Hypertension And No Diabetes (15452_5)
47520,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (15462_28),Phenotype,T-Cell Surface Glycoprotein Cd8 Alpha Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (15462_28)
47522,Low-Density Lipoprotein Receptor-Related Protein 11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15472_16),Phenotype,Low-Density Lipoprotein Receptor-Related Protein 11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15472_16)
47524,Vascular Non-Inflammatory Molecule 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15480_2),Phenotype,Vascular Non-Inflammatory Molecule 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15480_2)
47526,Glutamate Receptor 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (10760_107),Phenotype,Glutamate Receptor 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (10760_107)
47528,Cerebellin-2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (21887_2),Phenotype,Cerebellin-2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (21887_2)
47530,Apolipoprotein M Level In Chronic Kidney Disease With Hypertension And No Diabetes (10445_20),Phenotype,Apolipoprotein M Level In Chronic Kidney Disease With Hypertension And No Diabetes (10445_20)
47532,Tryptase Beta-2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (14696_45),Phenotype,Tryptase Beta-2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (14696_45)
47534,Coiled-Coil Domain-Containing Protein 134 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15300_66),Phenotype,Coiled-Coil Domain-Containing Protein 134 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15300_66)
47535,Thioredoxin-Like Protein 4B Level In Chronic Kidney Disease With Hypertension And No Diabetes (15316_262),Phenotype,Thioredoxin-Like Protein 4B Level In Chronic Kidney Disease With Hypertension And No Diabetes (15316_262)
47537,Stromal Cell-Derived Factor 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15333_11),Phenotype,Stromal Cell-Derived Factor 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (15333_11)
47539,Alpha-2-Macroglobulin Receptor-Associated Protein Level In Chronic Kidney Disease With Hypertension And No Diabetes (3640_14),Phenotype,Alpha-2-Macroglobulin Receptor-Associated Protein Level In Chronic Kidney Disease With Hypertension And No Diabetes (3640_14)
47540,Cation-Independent Mannose-6-Phosphate Receptor Level In Chronic Kidney Disease With Hypertension And No Diabetes (3676_15),Phenotype,Cation-Independent Mannose-6-Phosphate Receptor Level In Chronic Kidney Disease With Hypertension And No Diabetes (3676_15)
47541,Spermatogenesis-Associated Protein 20 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11117_2),Phenotype,Spermatogenesis-Associated Protein 20 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11117_2)
47544,Cd109 Antigen Level In Chronic Kidney Disease With Hypertension And No Diabetes (3290_50),Phenotype,Cd109 Antigen Level In Chronic Kidney Disease With Hypertension And No Diabetes (3290_50)
47546,Heparin Cofactor 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (3316_58),Phenotype,Heparin Cofactor 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (3316_58)
47547,Complement C4B Level In Chronic Kidney Disease With Hypertension And No Diabetes (2182_54),Phenotype,Complement C4B Level In Chronic Kidney Disease With Hypertension And No Diabetes (2182_54)
47548,Tryptase Beta-2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (3403_1),Phenotype,Tryptase Beta-2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (3403_1)
47550,Calsequestrin-1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11263_57),Phenotype,Calsequestrin-1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11263_57)
47551,Cyclic Amp-Responsive Element-Binding Protein 3-Like Protein 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11308_8),Phenotype,Cyclic Amp-Responsive Element-Binding Protein 3-Like Protein 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11308_8)
47552,Mam Domain-Containing Glycosylphosphatidylinositol Anchor Protein 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (16900_29),Phenotype,Mam Domain-Containing Glycosylphosphatidylinositol Anchor Protein 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (16900_29)
47554,Alanine--Trna Ligase-- Cytoplasmic Level In Chronic Kidney Disease With Hypertension And No Diabetes (12340_17),Phenotype,Alanine--Trna Ligase-- Cytoplasmic Level In Chronic Kidney Disease With Hypertension And No Diabetes (12340_17)
47556,Aspartate Aminotransferase-- Mitochondrial Level In Chronic Kidney Disease With Hypertension And No Diabetes (18233_10),Phenotype,Aspartate Aminotransferase-- Mitochondrial Level In Chronic Kidney Disease With Hypertension And No Diabetes (18233_10)
47558,Ermin Level In Chronic Kidney Disease With Hypertension And No Diabetes (23425_19),Phenotype,Ermin Level In Chronic Kidney Disease With Hypertension And No Diabetes (23425_19)
47559,Methyltransferase-Like Protein 2B Level In Chronic Kidney Disease With Hypertension And No Diabetes (23558_33),Phenotype,Methyltransferase-Like Protein 2B Level In Chronic Kidney Disease With Hypertension And No Diabetes (23558_33)
47560,Coiled-Coil Domain-Containing Protein 94 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23571_93),Phenotype,Coiled-Coil Domain-Containing Protein 94 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23571_93)
47561,Gata Zinc Finger Domain-Containing Protein 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (22154_37),Phenotype,Gata Zinc Finger Domain-Containing Protein 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (22154_37)
47562,Complement Factor B Level In Chronic Kidney Disease With Hypertension And No Diabetes (4129_72),Phenotype,Complement Factor B Level In Chronic Kidney Disease With Hypertension And No Diabetes (4129_72)
47564,Butyrophilin Subfamily 2 Member A2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (22586_24),Phenotype,Butyrophilin Subfamily 2 Member A2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (22586_24)
47565,Collagen Alpha-1(X) Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (15653_9),Phenotype,Collagen Alpha-1(X) Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (15653_9)
47567,Cation-Independent Mannose-6-Phosphate Receptor Level In Chronic Kidney Disease With Hypertension And No Diabetes (16057_6),Phenotype,Cation-Independent Mannose-6-Phosphate Receptor Level In Chronic Kidney Disease With Hypertension And No Diabetes (16057_6)
47568,Triggering Receptor Expressed On Myeloid Cells 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (16300_4),Phenotype,Triggering Receptor Expressed On Myeloid Cells 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (16300_4)
47570,Vascular Endothelial Growth Factor A-- Isoform 121 Level In Chronic Kidney Disease With Hypertension And No Diabetes (4867_15),Phenotype,Vascular Endothelial Growth Factor A-- Isoform 121 Level In Chronic Kidney Disease With Hypertension And No Diabetes (4867_15)
47571,Apolipoprotein L1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11510_31),Phenotype,Apolipoprotein L1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (11510_31)
47573,Folate Receptor Alpha Level In Chronic Kidney Disease With Hypertension And No Diabetes (17455_42),Phenotype,Folate Receptor Alpha Level In Chronic Kidney Disease With Hypertension And No Diabetes (17455_42)
47574,Butyrophilin Subfamily 3 Member A3 Level In Chronic Kidney Disease With Hypertension And No Diabetes (17692_2),Phenotype,Butyrophilin Subfamily 3 Member A3 Level In Chronic Kidney Disease With Hypertension And No Diabetes (17692_2)
47575,Butyrophilin Subfamily 3 Member A3 Level In Chronic Kidney Disease With Hypertension And No Diabetes (22950_6),Phenotype,Butyrophilin Subfamily 3 Member A3 Level In Chronic Kidney Disease With Hypertension And No Diabetes (22950_6)
47577,Endophilin-A3 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23029_3),Phenotype,Endophilin-A3 Level In Chronic Kidney Disease With Hypertension And No Diabetes (23029_3)
47578,Tapasin Level In Chronic Kidney Disease With Hypertension And No Diabetes (12378_71),Phenotype,Tapasin Level In Chronic Kidney Disease With Hypertension And No Diabetes (12378_71)
47580,Dipeptidase 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8794_13),Phenotype,Dipeptidase 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8794_13)
47582,Dipeptidase 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8327_26),Phenotype,Dipeptidase 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8327_26)
47584,Low-Density Lipoprotein Receptor-Related Protein 11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8330_1),Phenotype,Low-Density Lipoprotein Receptor-Related Protein 11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8330_1)
47586,Zymogen Granule Membrane Protein 16 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8219_14),Phenotype,Zymogen Granule Membrane Protein 16 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8219_14)
47590,Triggering Receptor Expressed On Myeloid Cells 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9266_1),Phenotype,Triggering Receptor Expressed On Myeloid Cells 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9266_1)
47592,Cysteine-Rich Secretory Protein 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9282_12),Phenotype,Cysteine-Rich Secretory Protein 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9282_12)
47594,Cerebellin-1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9313_27),Phenotype,Cerebellin-1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9313_27)
47595,Wap Four-Disulfide Core Domain Protein 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9316_67),Phenotype,Wap Four-Disulfide Core Domain Protein 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9316_67)
47596,Trimeric Intracellular Cation Channel Type B Level In Chronic Kidney Disease With Hypertension And No Diabetes (9509_4),Phenotype,Trimeric Intracellular Cation Channel Type B Level In Chronic Kidney Disease With Hypertension And No Diabetes (9509_4)
47597,Hla Class Ii Histocompatibility Antigen-- Dq Alpha 2 Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (7757_5),Phenotype,Hla Class Ii Histocompatibility Antigen-- Dq Alpha 2 Chain Level In Chronic Kidney Disease With Hypertension And No Diabetes (7757_5)
47598,Haptoglobin Isoform 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (7905_30),Phenotype,Haptoglobin Isoform 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (7905_30)
47599,Glycoprotein Endo-Alpha-1--2-Mannosidase Level In Chronic Kidney Disease With Hypertension And No Diabetes (8014_359),Phenotype,Glycoprotein Endo-Alpha-1--2-Mannosidase Level In Chronic Kidney Disease With Hypertension And No Diabetes (8014_359)
47601,Dnaj Homolog Subfamily C Member 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8016_19),Phenotype,Dnaj Homolog Subfamily C Member 4 Level In Chronic Kidney Disease With Hypertension And No Diabetes (8016_19)
47602,Ferritin-- Mitochondrial Level In Chronic Kidney Disease With Hypertension And No Diabetes (8048_9),Phenotype,Ferritin-- Mitochondrial Level In Chronic Kidney Disease With Hypertension And No Diabetes (8048_9)
47603,Cadherin-11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9604_14),Phenotype,Cadherin-11 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9604_14)
47605,T-Cell Surface Protein Tactile Level In Chronic Kidney Disease With Hypertension And No Diabetes (9735_44),Phenotype,T-Cell Surface Protein Tactile Level In Chronic Kidney Disease With Hypertension And No Diabetes (9735_44)
47606,Nad(P)H Dehydrogenase [Quinone] 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9837_60),Phenotype,Nad(P)H Dehydrogenase [Quinone] 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (9837_60)
47620,Suicide Attempts,Phenotype,Suicide Attempts
47622,Circulating Levels Of Total-Tau,Phenotype,Circulating Levels Of Total-Tau
47628,Overall Survival In Advanced Colorectal Cancer,Phenotype,Overall Survival In Advanced Colorectal Cancer
47641,Fasting Insulin Adjusted For Bmi,Phenotype,Fasting Insulin Adjusted For Bmi
47652,Acute Graft-Versus-Host Disease (Stage 2 To 4) (Donor Effect),Phenotype,Acute Graft-Versus-Host Disease (Stage 2 To 4) (Donor Effect)
47654,Acute Graft-Versus-Host Disease (Stage 2B To 4) (Donor Effect),Phenotype,Acute Graft-Versus-Host Disease (Stage 2B To 4) (Donor Effect)
47656,Acute Graft-Versus-Host Disease (Gut) (Donor Effect),Phenotype,Acute Graft-Versus-Host Disease (Gut) (Donor Effect)
47658,Chronic Graft-Versus-Host Disease (Recipient Effect),Phenotype,Chronic Graft-Versus-Host Disease (Recipient Effect)
47684,Guanylate-Binding Protein 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (18891_98),Phenotype,Guanylate-Binding Protein 2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (18891_98)
47685,Katanin P60 Atpase-Containing Subunit A-Like 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (24494_67),Phenotype,Katanin P60 Atpase-Containing Subunit A-Like 1 Level In Chronic Kidney Disease With Hypertension And No Diabetes (24494_67)
47687,Mhc Class I Polypeptide-Related Sequence B Level In Chronic Kidney Disease With Hypertension And No Diabetes (5102_55),Phenotype,Mhc Class I Polypeptide-Related Sequence B Level In Chronic Kidney Disease With Hypertension And No Diabetes (5102_55)
47688,Camp-Specific 3'--5'-Cyclic Phosphodiesterase 4D Level In Chronic Kidney Disease With Hypertension And No Diabetes (5255_22),Phenotype,Camp-Specific 3'--5'-Cyclic Phosphodiesterase 4D Level In Chronic Kidney Disease With Hypertension And No Diabetes (5255_22)
47689,Histone Deacetylase Complex Subunit Sap30 Level In Chronic Kidney Disease With Hypertension And No Diabetes (12888_18),Phenotype,Histone Deacetylase Complex Subunit Sap30 Level In Chronic Kidney Disease With Hypertension And No Diabetes (12888_18)
47690,Isoform L-Vegf165 Level In Chronic Kidney Disease With Hypertension And No Diabetes (19437_61),Phenotype,Isoform L-Vegf165 Level In Chronic Kidney Disease With Hypertension And No Diabetes (19437_61)
47692,Chymotrypsinogen B2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (5648_28),Phenotype,Chymotrypsinogen B2 Level In Chronic Kidney Disease With Hypertension And No Diabetes (5648_28)
47710,Glaucoma (Low Intraocular Pressure),Phenotype,Glaucoma (Low Intraocular Pressure)
47714,Cd127 On Cd28+ Cd45Ra+ Cd8+ T Cell,Phenotype,Cd127 On Cd28+ Cd45Ra+ Cd8+ T Cell
47716,Cd127 On Cd28- Cd8+ T Cell,Phenotype,Cd127 On Cd28- Cd8+ T Cell
47718,Cd127 On Cd4+ T Cell,Phenotype,Cd127 On Cd4+ T Cell
47720,Cd45 On Cd4+ T Cell,Phenotype,Cd45 On Cd4+ T Cell
47722,Cd127 On Cd45Ra+ Cd4+ T Cell,Phenotype,Cd127 On Cd45Ra+ Cd4+ T Cell
47724,Cd45 On Hla Dr+ T Cell,Phenotype,Cd45 On Hla Dr+ T Cell
47726,Ccr7 On Naive Cd8+ T Cell,Phenotype,Ccr7 On Naive Cd8+ T Cell
47729,Cd45 On Hla Dr+ Cd4+ T Cell,Phenotype,Cd45 On Hla Dr+ Cd4+ T Cell
47731,Cd127 On Cd28+ Cd4+ T Cell,Phenotype,Cd127 On Cd28+ Cd4+ T Cell
47732,Cd127 On Cd28+ Cd4-Cd8- T Cell,Phenotype,Cd127 On Cd28+ Cd4-Cd8- T Cell
47734,Cd4 On Monocyte,Phenotype,Cd4 On Monocyte
47735,Cd4 On Hla Dr+ Cd4+ T Cell,Phenotype,Cd4 On Hla Dr+ Cd4+ T Cell
47737,Hippsubfield Lh Volume Subiculum-Head,Phenotype,Hippsubfield Lh Volume Subiculum-Head
47739,Cd16-Cd56 On Natural Killer T,Phenotype,Cd16-Cd56 On Natural Killer T
47740,Cd28 On Cd45Ra+ Cd4+ T Cell,Phenotype,Cd28 On Cd45Ra+ Cd4+ T Cell
47741,Cd34 On Hematopoietic Stem Cell,Phenotype,Cd34 On Hematopoietic Stem Cell
47743,Hvem On Naive Cd8+ T Cell,Phenotype,Hvem On Naive Cd8+ T Cell
47745,Cd28 On Cd28+ Cd4+ T Cell,Phenotype,Cd28 On Cd28+ Cd4+ T Cell
47746,Cd28 On Cd28+ Cd4-Cd8- T Cell,Phenotype,Cd28 On Cd28+ Cd4-Cd8- T Cell
47747,Cd28 On Cd28+ Cd45Ra+ Cd8+ T Cell,Phenotype,Cd28 On Cd28+ Cd45Ra+ Cd8+ T Cell
47749,Cd28 On Cd4+ T Cell,Phenotype,Cd28 On Cd4+ T Cell
47750,Cd28 On Resting Cd4 Regulatory T Cell,Phenotype,Cd28 On Resting Cd4 Regulatory T Cell
47751,Aseg Rh Volume Choroid-Plexus,Phenotype,Aseg Rh Volume Choroid-Plexus
47752,Aseg Rh Volume Lateral-Ventricle,Phenotype,Aseg Rh Volume Lateral-Ventricle
47753,Ccr7 On Naive Cd4+ T Cell,Phenotype,Ccr7 On Naive Cd4+ T Cell
47754,Hla Dr On Cd14- Cd16+ Monocyte,Phenotype,Hla Dr On Cd14- Cd16+ Monocyte
47756,Hla Dr On Plasmacytoid Dendritic Cell,Phenotype,Hla Dr On Plasmacytoid Dendritic Cell
47757,Hla Dr On Dendritic Cell,Phenotype,Hla Dr On Dendritic Cell
47760,Hla Dr On Hematopoietic Stem Cell,Phenotype,Hla Dr On Hematopoietic Stem Cell
47762,Hla Dr On Cd33+ Hla Dr+ Cd14-,Phenotype,Hla Dr On Cd33+ Hla Dr+ Cd14-
47765,Hla Dr On Cd33+ Hla Dr+ Cd14Dim,Phenotype,Hla Dr On Cd33+ Hla Dr+ Cd14Dim
47766,Hla Dr On Cd33Dim Hla Dr+ Cd11B+,Phenotype,Hla Dr On Cd33Dim Hla Dr+ Cd11B+
47770,Hla Dr On Cd33Dim Hla Dr+ Cd11B-,Phenotype,Hla Dr On Cd33Dim Hla Dr+ Cd11B-
47772,Hla Dr On Cd33- Hla Dr+,Phenotype,Hla Dr On Cd33- Hla Dr+
47773,Cd11C On Myeloid Dendritic Cell,Phenotype,Cd11C On Myeloid Dendritic Cell
47777,Cd11C On Cd62L+ Myeloid Dendritic Cell,Phenotype,Cd11C On Cd62L+ Myeloid Dendritic Cell
47779,Cd11C On Monocyte,Phenotype,Cd11C On Monocyte
47781,Cd11C On Granulocyte,Phenotype,Cd11C On Granulocyte
47783,Hla Dr On Hla Dr+ T Cell,Phenotype,Hla Dr On Hla Dr+ T Cell
47785,Hla Dr On Hla Dr+ Cd4+ T Cell,Phenotype,Hla Dr On Hla Dr+ Cd4+ T Cell
47786,Hla Dr On B Cell,Phenotype,Hla Dr On B Cell
47789,Hla Dr On Hla Dr+ Natural Killer,Phenotype,Hla Dr On Hla Dr+ Natural Killer
47792,Cd8 On Cd28+ Cd45Ra- Cd8+ T Cell,Phenotype,Cd8 On Cd28+ Cd45Ra- Cd8+ T Cell
47794,Cd8 On Cd28+ Cd45Ra+ Cd8+ T Cell,Phenotype,Cd8 On Cd28+ Cd45Ra+ Cd8+ T Cell
47796,Cd8 On Cd28- Cd8+ T Cell,Phenotype,Cd8 On Cd28- Cd8+ T Cell
47797,Cd8 On Cd39+ Cd8+ T Cell,Phenotype,Cd8 On Cd39+ Cd8+ T Cell
47799,Idp Swi T2Star Left Putamen,Phenotype,Idp Swi T2Star Left Putamen
47800,Idp Swi T2Star Right Putamen,Phenotype,Idp Swi T2Star Right Putamen
47802,Hla Dr On Myeloid Dendritic Cell,Phenotype,Hla Dr On Myeloid Dendritic Cell
47811,Idp Dmri Probtrackx L2 Unc R,Phenotype,Idp Dmri Probtrackx L2 Unc R
47812,Idp Dmri Probtrackx L1 Unc R,Phenotype,Idp Dmri Probtrackx L1 Unc R
47813,Idp Dmri Probtrackx L2 Ifo L,Phenotype,Idp Dmri Probtrackx L2 Ifo L
47814,Idp Dmri Probtrackx L1 Unc L,Phenotype,Idp Dmri Probtrackx L1 Unc L
47816,Aparc-Pial Rh Area Totalsurface,Phenotype,Aparc-Pial Rh Area Totalsurface
47817,Aparc-Pial Rh Area Caudalmiddlefrontal,Phenotype,Aparc-Pial Rh Area Caudalmiddlefrontal
47818,Aparc-Pial Rh Area Cuneus,Phenotype,Aparc-Pial Rh Area Cuneus
47819,Aparc-Pial Rh Area Lateraloccipital,Phenotype,Aparc-Pial Rh Area Lateraloccipital
47820,Aparc-Pial Rh Area Lateralorbitofrontal,Phenotype,Aparc-Pial Rh Area Lateralorbitofrontal
47822,Aparc-Pial Lh Area Caudalmiddlefrontal,Phenotype,Aparc-Pial Lh Area Caudalmiddlefrontal
47823,Aparc-Pial Lh Area Lateralorbitofrontal,Phenotype,Aparc-Pial Lh Area Lateralorbitofrontal
47824,Aparc-Pial Lh Area Pericalcarine,Phenotype,Aparc-Pial Lh Area Pericalcarine
47826,Aparc-A2009S Rh Area Pole-Occipital,Phenotype,Aparc-A2009S Rh Area Pole-Occipital
47828,Aparc-A2009S Rh Area G-Cuneus,Phenotype,Aparc-A2009S Rh Area G-Cuneus
47829,Idp Dmri Tbss Isovf Posterior Corona Radiata L,Phenotype,Idp Dmri Tbss Isovf Posterior Corona Radiata L
47830,Idp Dmri Tbss Isovf Posterior Thalamic Radiation L,Phenotype,Idp Dmri Tbss Isovf Posterior Thalamic Radiation L
47831,Idp Dmri Tbss Isovf Sagittal Stratum R,Phenotype,Idp Dmri Tbss Isovf Sagittal Stratum R
47832,Idp Dmri Tbss Isovf Sagittal Stratum L,Phenotype,Idp Dmri Tbss Isovf Sagittal Stratum L
47833,Idp Dmri Tbss Isovf External Capsule R,Phenotype,Idp Dmri Tbss Isovf External Capsule R
47835,Idp Dmri Tbss Isovf External Capsule L,Phenotype,Idp Dmri Tbss Isovf External Capsule L
47836,Idp Dmri Tbss Isovf Cingulum Cingulate Gyrus R,Phenotype,Idp Dmri Tbss Isovf Cingulum Cingulate Gyrus R
47837,Idp Dmri Tbss Isovf Superior Longitudinal Fasciculus R,Phenotype,Idp Dmri Tbss Isovf Superior Longitudinal Fasciculus R
47838,Idp Dmri Tbss Isovf Superior Longitudinal Fasciculus L,Phenotype,Idp Dmri Tbss Isovf Superior Longitudinal Fasciculus L
47839,Idp Dmri Probtrackx Isovf Ar R,Phenotype,Idp Dmri Probtrackx Isovf Ar R
47840,Idp T1 Fast Rois R Mid Front Gyrus,Phenotype,Idp T1 Fast Rois R Mid Front Gyrus
47841,Idp Dmri Probtrackx Isovf Slf L,Phenotype,Idp Dmri Probtrackx Isovf Slf L
47842,Idp Dmri Probtrackx Isovf Slf R,Phenotype,Idp Dmri Probtrackx Isovf Slf R
47844,Idp Dmri Probtrackx Isovf Str L,Phenotype,Idp Dmri Probtrackx Isovf Str L
47845,Idp Dmri Probtrackx Isovf Str R,Phenotype,Idp Dmri Probtrackx Isovf Str R
47846,Idp Dmri Probtrackx Isovf Unc L,Phenotype,Idp Dmri Probtrackx Isovf Unc L
47847,Idp Dmri Probtrackx Isovf Unc R,Phenotype,Idp Dmri Probtrackx Isovf Unc R
47848,Idp Dmri Probtrackx Isovf Cgc L,Phenotype,Idp Dmri Probtrackx Isovf Cgc L
47849,Idp Dmri Probtrackx Isovf Cgc R,Phenotype,Idp Dmri Probtrackx Isovf Cgc R
47850,Idp Dmri Probtrackx Isovf Fmi,Phenotype,Idp Dmri Probtrackx Isovf Fmi
47852,Idp Dmri Probtrackx Isovf Ifo L,Phenotype,Idp Dmri Probtrackx Isovf Ifo L
47853,Idp Dmri Probtrackx Isovf Ifo R,Phenotype,Idp Dmri Probtrackx Isovf Ifo R
47854,Idp Dmri Probtrackx Isovf Ilf L,Phenotype,Idp Dmri Probtrackx Isovf Ilf L
47855,Idp Dmri Probtrackx Isovf Ilf R,Phenotype,Idp Dmri Probtrackx Isovf Ilf R
47856,Idp T1 Sienax Csf Normalised Volume,Phenotype,Idp T1 Sienax Csf Normalised Volume
47857,Idp T1 Sienax Csf Unnormalised Volume,Phenotype,Idp T1 Sienax Csf Unnormalised Volume
47858,Aseg Lh Intensity Cerebellum-Cortex,Phenotype,Aseg Lh Intensity Cerebellum-Cortex
47859,Aseg Lh Intensity Thalamus-Proper,Phenotype,Aseg Lh Intensity Thalamus-Proper
47861,Aseg Lh Intensity Putamen,Phenotype,Aseg Lh Intensity Putamen
47863,Wg Lh Intensity-Contrast Lateraloccipital,Phenotype,Wg Lh Intensity-Contrast Lateraloccipital
47865,Wg Lh Intensity-Contrast Lateralorbitofrontal,Phenotype,Wg Lh Intensity-Contrast Lateralorbitofrontal
47867,Wg Lh Intensity-Contrast Medialorbitofrontal,Phenotype,Wg Lh Intensity-Contrast Medialorbitofrontal
47869,Aseg Rh Intensity Cerebellum-Cortex,Phenotype,Aseg Rh Intensity Cerebellum-Cortex
47870,Aseg Rh Intensity Thalamus-Proper,Phenotype,Aseg Rh Intensity Thalamus-Proper
47871,Aseg Rh Intensity Putamen,Phenotype,Aseg Rh Intensity Putamen
47872,Wg Lh Intensity-Contrast Fusiform,Phenotype,Wg Lh Intensity-Contrast Fusiform
47874,Wg Lh Intensity-Contrast Inferiorparietal,Phenotype,Wg Lh Intensity-Contrast Inferiorparietal
47875,Wg Lh Intensity-Contrast Inferiortemporal,Phenotype,Wg Lh Intensity-Contrast Inferiortemporal
47876,Wg Lh Intensity-Contrast Isthmuscingulate,Phenotype,Wg Lh Intensity-Contrast Isthmuscingulate
47877,Wg Lh Intensity-Contrast Bankssts,Phenotype,Wg Lh Intensity-Contrast Bankssts
47879,Highest Math Class Taken (Mtag),Phenotype,Highest Math Class Taken (Mtag)
47882,Rotator Cuff Injury,Phenotype,Rotator Cuff Injury
47884,Body Fat Percentage And Type 2 Diabetes (Pairwise),Phenotype,Body Fat Percentage And Type 2 Diabetes (Pairwise)
47886,Body Mass Index And Hdl-C (Pairwise),Phenotype,Body Mass Index And Hdl-C (Pairwise)
47887,Body Mass Index And Ldl-C (Pairwise),Phenotype,Body Mass Index And Ldl-C (Pairwise)
47889,Body Mass Index And Triglycerides (Pairwise),Phenotype,Body Mass Index And Triglycerides (Pairwise)
47890,Adipsin Levels,Phenotype,Adipsin Levels
47892,Adipsin Levels In Overweight Individuals,Phenotype,Adipsin Levels In Overweight Individuals
47893,Adipsin Levels In Type 2 Diabetes,Phenotype,Adipsin Levels In Type 2 Diabetes
47897,Ghrelin Levels In Lean Individuals,Phenotype,Ghrelin Levels In Lean Individuals
47899,Ghrelin Levels In Overweight Individuals,Phenotype,Ghrelin Levels In Overweight Individuals
47901,Chronic Lymphocytic Leukemia (Time To First Treatment),Phenotype,Chronic Lymphocytic Leukemia (Time To First Treatment)
47902,Gastrointestinal Event In Colchicine-Treated Recent Myocardial Infarction (Time To Event),Phenotype,Gastrointestinal Event In Colchicine-Treated Recent Myocardial Infarction (Time To Event)
47904,Podoconiosis,Phenotype,Podoconiosis
47912,Hla Dr++ Monocyte %Monocyte,Phenotype,Hla Dr++ Monocyte %Monocyte
47914,Hla Dr++ Monocyte %Leukocyte,Phenotype,Hla Dr++ Monocyte %Leukocyte
47915,Hla Dr++ Monocyte Absolute Count,Phenotype,Hla Dr++ Monocyte Absolute Count
47917,Cd4+/Cd8+ T Cell,Phenotype,Cd4+/Cd8+ T Cell
47919,Cd4+ T Cell %T Cell,Phenotype,Cd4+ T Cell %T Cell
47920,Cd8+ T Cell Absolute Count,Phenotype,Cd8+ T Cell Absolute Count
47922,Cd8+ T Cell %T Cell,Phenotype,Cd8+ T Cell %T Cell
47923,Cd8Dim T Cell Absolute Count,Phenotype,Cd8Dim T Cell Absolute Count
47924,Cd8Dim T Cell %T Cell,Phenotype,Cd8Dim T Cell %T Cell
47925,Cd4-Cd8- T Cell Absolute Count,Phenotype,Cd4-Cd8- T Cell Absolute Count
47926,Cd4-Cd8- T Cell %T Cell,Phenotype,Cd4-Cd8- T Cell %T Cell
47927,Lymphocyte Absolute Count,Phenotype,Lymphocyte Absolute Count
47929,T Cell Absolute Count,Phenotype,T Cell Absolute Count
47930,Cd4+ T Cell %Leukocyte,Phenotype,Cd4+ T Cell %Leukocyte
47931,Cd8+ T Cell %Leukocyte,Phenotype,Cd8+ T Cell %Leukocyte
47932,Cd4+ Cd8Dim T Cell Absolute Count,Phenotype,Cd4+ Cd8Dim T Cell Absolute Count
47934,Cd4+ Cd8Dim T Cell %Lymphocyte,Phenotype,Cd4+ Cd8Dim T Cell %Lymphocyte
47936,Cd4+ Cd8Dim T Cell %Leukocyte,Phenotype,Cd4+ Cd8Dim T Cell %Leukocyte
47937,Cd8Dim T Cell %Leukocyte,Phenotype,Cd8Dim T Cell %Leukocyte
47938,Cd4-Cd8- T Cell %Leukocyte,Phenotype,Cd4-Cd8- T Cell %Leukocyte
47939,Cd8+ And Cd8Dim T Cell %Leukocyte,Phenotype,Cd8+ And Cd8Dim T Cell %Leukocyte
47940,Tcrgd T Cell Absolute Count,Phenotype,Tcrgd T Cell Absolute Count
47942,Tcrgd T Cell %Lymphocyte,Phenotype,Tcrgd T Cell %Lymphocyte
47944,Hla Dr+ T Cell Absolute Count,Phenotype,Hla Dr+ T Cell Absolute Count
47947,Hla Dr+ T Cell%T Cell,Phenotype,Hla Dr+ T Cell%T Cell
47948,Hla Dr+ T Cell%Lymphocyte,Phenotype,Hla Dr+ T Cell%Lymphocyte
47950,Natural Killer T Absolute Count,Phenotype,Natural Killer T Absolute Count
47951,Natural Killer T %T Cell,Phenotype,Natural Killer T %T Cell
47952,Natural Killer T %Lymphocyte,Phenotype,Natural Killer T %Lymphocyte
47953,Hla Dr+ Cd4+ T Cell Absolute Count,Phenotype,Hla Dr+ Cd4+ T Cell Absolute Count
47954,Hla Dr+ Cd4+ T Cell %T Cell,Phenotype,Hla Dr+ Cd4+ T Cell %T Cell
47956,Hla Dr+ Cd4+ T Cell %Lymphocyte,Phenotype,Hla Dr+ Cd4+ T Cell %Lymphocyte
47957,Hla Dr+ Cd8+ T Cell Absolute Count,Phenotype,Hla Dr+ Cd8+ T Cell Absolute Count
47958,Hla Dr+ Cd8+ T Cell %T Cell,Phenotype,Hla Dr+ Cd8+ T Cell %T Cell
47959,Hla Dr+ Cd8+ T Cell %Lymphocyte,Phenotype,Hla Dr+ Cd8+ T Cell %Lymphocyte
47960,Cd8+ Natural Killer T Absolute Count,Phenotype,Cd8+ Natural Killer T Absolute Count
47962,Cd8Dim Natural Killer T Absolute Count,Phenotype,Cd8Dim Natural Killer T Absolute Count
47963,Cd25 On Cd28+ Cd4+ T Cell,Phenotype,Cd25 On Cd28+ Cd4+ T Cell
47965,Fsc-A On Plasmacytoid Dendritic Cell,Phenotype,Fsc-A On Plasmacytoid Dendritic Cell
47966,Fsc-A On Cd4+ T Cell,Phenotype,Fsc-A On Cd4+ T Cell
47968,Idp Dmri Probtrackx Fa Str L,Phenotype,Idp Dmri Probtrackx Fa Str L
47970,Brainstem Global Volume Whole-Brainstem,Phenotype,Brainstem Global Volume Whole-Brainstem
47972,Aparc-Desikan Lh Volume Caudalmiddlefrontal,Phenotype,Aparc-Desikan Lh Volume Caudalmiddlefrontal
47973,Aparc-Desikan Lh Volume Pericalcarine,Phenotype,Aparc-Desikan Lh Volume Pericalcarine
47974,Brainstem Global Volume Pons,Phenotype,Brainstem Global Volume Pons
47976,Brainstem Global Volume Medulla,Phenotype,Brainstem Global Volume Medulla
47978,Idp Dmri Probtrackx Md Unc R,Phenotype,Idp Dmri Probtrackx Md Unc R
47979,Aparc-Desikan Rh Area Caudalmiddlefrontal,Phenotype,Aparc-Desikan Rh Area Caudalmiddlefrontal
47980,Aparc-Desikan Rh Area Cuneus,Phenotype,Aparc-Desikan Rh Area Cuneus
47981,Idp Dmri Probtrackx Icvf Ar L,Phenotype,Idp Dmri Probtrackx Icvf Ar L
47982,Idp Dmri Probtrackx Icvf Ar R,Phenotype,Idp Dmri Probtrackx Icvf Ar R
47983,Idp Dmri Probtrackx Icvf Ifo R,Phenotype,Idp Dmri Probtrackx Icvf Ifo R
47984,Idp Dmri Probtrackx Icvf Cst R,Phenotype,Idp Dmri Probtrackx Icvf Cst R
47986,Idp Dmri Probtrackx Icvf Ilf R,Phenotype,Idp Dmri Probtrackx Icvf Ilf R
47987,Idp Dmri Probtrackx Icvf Ptr L,Phenotype,Idp Dmri Probtrackx Icvf Ptr L
47988,Idp Dmri Probtrackx Icvf Ptr R,Phenotype,Idp Dmri Probtrackx Icvf Ptr R
47989,Idp Dmri Probtrackx Icvf Slf L,Phenotype,Idp Dmri Probtrackx Icvf Slf L
47990,Keratoconus,Phenotype,Keratoconus
47991,Age-Related Hearing Impairment (Mtag),Phenotype,Age-Related Hearing Impairment (Mtag)
47994,Myeloperoxidase-Dna Complexes,Phenotype,Myeloperoxidase-Dna Complexes
47996,Odorant Perception,Phenotype,Odorant Perception
47998,Low Hand Grip Strength (60 Years And Older) (Ewgsop),Phenotype,Low Hand Grip Strength (60 Years And Older) (Ewgsop)
48011,Low Hand Grip Strength (60 Years And Older) (Fnih),Phenotype,Low Hand Grip Strength (60 Years And Older) (Fnih)
48013,Highest Math Class Taken,Phenotype,Highest Math Class Taken
48021,Cd33Dim Hla Dr+ Cd11B- Absolute Count,Phenotype,Cd33Dim Hla Dr+ Cd11B- Absolute Count
48023,Monocytic Myeloid-Derived Suppressor Cells Absolute Count,Phenotype,Monocytic Myeloid-Derived Suppressor Cells Absolute Count
48024,Cd28- Cd4-Cd8- T Cell %T Cell,Phenotype,Cd28- Cd4-Cd8- T Cell %T Cell
48025,Cd20 On Igd- Cd38Dim B Cell,Phenotype,Cd20 On Igd- Cd38Dim B Cell
48027,Cd20 On Memory B Cell,Phenotype,Cd20 On Memory B Cell
48030,Cd20 On Naive-Mature B Cell,Phenotype,Cd20 On Naive-Mature B Cell
48033,Cd20 On Unswitched Memory B Cell,Phenotype,Cd20 On Unswitched Memory B Cell
48036,Cd20 On Switched Memory B Cell,Phenotype,Cd20 On Switched Memory B Cell
48038,Cd20 On Igd+ B Cell,Phenotype,Cd20 On Igd+ B Cell
48039,Cd20 On Igd+ Cd38+ B Cell,Phenotype,Cd20 On Igd+ Cd38+ B Cell
48042,Cd20 On Igd+ Cd38Dim B Cell,Phenotype,Cd20 On Igd+ Cd38Dim B Cell
48044,Cd20 On Igd- Cd24- B Cell,Phenotype,Cd20 On Igd- Cd24- B Cell
48046,Cd20 On Igd- Cd27- B Cell,Phenotype,Cd20 On Igd- Cd27- B Cell
48048,Cd20 On Igd- Cd38- B Cell,Phenotype,Cd20 On Igd- Cd38- B Cell
48050,Cd19 On Switched Memory B Cell,Phenotype,Cd19 On Switched Memory B Cell
48051,Cd19 On Transitional B Cell,Phenotype,Cd19 On Transitional B Cell
48053,Cd20 On B Cell,Phenotype,Cd20 On B Cell
48055,Cd20 On Cd24+ Cd27+ B Cell,Phenotype,Cd20 On Cd24+ Cd27+ B Cell
48056,Cd20 On Igd+ Cd24+ B Cell,Phenotype,Cd20 On Igd+ Cd24+ B Cell
48057,Cd20 On Igd+ Cd24- B Cell,Phenotype,Cd20 On Igd+ Cd24- B Cell
48058,Cd20 On Igd+ Cd38- B Cell,Phenotype,Cd20 On Igd+ Cd38- B Cell
48059,Cd19 On Igd+ Cd24+ B Cell,Phenotype,Cd19 On Igd+ Cd24+ B Cell
48061,Cd19 On Igd+ Cd24- B Cell,Phenotype,Cd19 On Igd+ Cd24- B Cell
48063,Cd19 On Igd+ Cd38+ B Cell,Phenotype,Cd19 On Igd+ Cd38+ B Cell
48064,Cd19 On Igd+ Cd38Dim B Cell,Phenotype,Cd19 On Igd+ Cd38Dim B Cell
48065,Cd19 On Igd- Cd27- B Cell,Phenotype,Cd19 On Igd- Cd27- B Cell
48066,Cd19 On Igd- Cd38- B Cell,Phenotype,Cd19 On Igd- Cd38- B Cell
48067,Cd19 On Igd- Cd38Dim B Cell,Phenotype,Cd19 On Igd- Cd38Dim B Cell
48068,Cd19 On Unswitched Memory B Cell,Phenotype,Cd19 On Unswitched Memory B Cell
48069,Cd64 On Cd14+ Cd16- Monocyte,Phenotype,Cd64 On Cd14+ Cd16- Monocyte
48071,Hla Dr On Cd14+ Cd16- Monocyte,Phenotype,Hla Dr On Cd14+ Cd16- Monocyte
48073,Cd40 On Cd14- Cd16+ Monocyte,Phenotype,Cd40 On Cd14- Cd16+ Monocyte
48075,Hla Dr On Cd14+ Monocyte,Phenotype,Hla Dr On Cd14+ Monocyte
48076,Ccr2 On Cd14+ Cd16+ Monocyte,Phenotype,Ccr2 On Cd14+ Cd16+ Monocyte
48078,Hla Dr On Cd14- Cd16-,Phenotype,Hla Dr On Cd14- Cd16-
48080,Hla Dr On Monocyte,Phenotype,Hla Dr On Monocyte
48081,Cd64 On Cd14+ Cd16+ Monocyte,Phenotype,Cd64 On Cd14+ Cd16+ Monocyte
48082,Cd4 On Cd4+ T Cell,Phenotype,Cd4 On Cd4+ T Cell
48084,Cd4 On Central Memory Cd4+ T Cell,Phenotype,Cd4 On Central Memory Cd4+ T Cell
48085,Cd4 On Naive Cd4+ T Cell,Phenotype,Cd4 On Naive Cd4+ T Cell
48087,Cd4 On Effector Memory Cd4+ T Cell,Phenotype,Cd4 On Effector Memory Cd4+ T Cell
48089,Cd4 On Cd45Ra+ Cd4+ T Cell,Phenotype,Cd4 On Cd45Ra+ Cd4+ T Cell
48090,Cd19 On B Cell,Phenotype,Cd19 On B Cell
48091,Cd64 On Cd14- Cd16-,Phenotype,Cd64 On Cd14- Cd16-
48093,Cd64 On Monocyte,Phenotype,Cd64 On Monocyte
48094,Hla Dr On Cd14+ Cd16+ Monocyte,Phenotype,Hla Dr On Cd14+ Cd16+ Monocyte
48095,Thalamnuclei Lh Volume L-Sg,Phenotype,Thalamnuclei Lh Volume L-Sg
48097,Wg Rh Intensity-Contrast Precuneus,Phenotype,Wg Rh Intensity-Contrast Precuneus
48098,Wg Rh Intensity-Contrast Rostralanteriorcingulate,Phenotype,Wg Rh Intensity-Contrast Rostralanteriorcingulate
48100,Wg Rh Intensity-Contrast Rostralmiddlefrontal,Phenotype,Wg Rh Intensity-Contrast Rostralmiddlefrontal
48101,Wg Rh Intensity-Contrast Superiorfrontal,Phenotype,Wg Rh Intensity-Contrast Superiorfrontal
48103,Idp Dmri Tbss Md Sagittal Stratum R,Phenotype,Idp Dmri Tbss Md Sagittal Stratum R
48104,Idp Dmri Tbss Md Sagittal Stratum L,Phenotype,Idp Dmri Tbss Md Sagittal Stratum L
48105,Aparc-Dktatlas Rh Volume Lingual,Phenotype,Aparc-Dktatlas Rh Volume Lingual
48106,Idp Dmri Tbss Md Corticospinal Tract R,Phenotype,Idp Dmri Tbss Md Corticospinal Tract R
48108,Aparc-Dktatlas Rh Volume Pericalcarine,Phenotype,Aparc-Dktatlas Rh Volume Pericalcarine
48109,Idp Dmri Tbss Md Posterior Thalamic Radiation R,Phenotype,Idp Dmri Tbss Md Posterior Thalamic Radiation R
48110,Idp Dmri Tbss Icvf Retrolenticular Part Of Internal Capsule R,Phenotype,Idp Dmri Tbss Icvf Retrolenticular Part Of Internal Capsule R
48111,Aparc-Dktatlas Rh Area Caudalmiddlefrontal,Phenotype,Aparc-Dktatlas Rh Area Caudalmiddlefrontal
48112,Aparc-Dktatlas Rh Area Cuneus,Phenotype,Aparc-Dktatlas Rh Area Cuneus
48113,Aparc-Dktatlas Lh Area Pericalcarine,Phenotype,Aparc-Dktatlas Lh Area Pericalcarine
48114,Idp Dmri Tbss Icvf Posterior Thalamic Radiation R,Phenotype,Idp Dmri Tbss Icvf Posterior Thalamic Radiation R
48115,Idp Dmri Tbss Icvf Posterior Thalamic Radiation L,Phenotype,Idp Dmri Tbss Icvf Posterior Thalamic Radiation L
48116,Idp Dmri Tbss Icvf Sagittal Stratum R,Phenotype,Idp Dmri Tbss Icvf Sagittal Stratum R
48117,Ba-Exvivo Lh Area Ba6,Phenotype,Ba-Exvivo Lh Area Ba6
48118,Ba-Exvivo Lh Area V1,Phenotype,Ba-Exvivo Lh Area V1
48119,Ba-Exvivo Lh Area V2,Phenotype,Ba-Exvivo Lh Area V2
48120,Ba-Exvivo Rh Area V1,Phenotype,Ba-Exvivo Rh Area V1
48121,Ba-Exvivo Rh Area Perirhinal,Phenotype,Ba-Exvivo Rh Area Perirhinal
48123,Ba-Exvivo Rh Area Entorhinal,Phenotype,Ba-Exvivo Rh Area Entorhinal
48124,Aparc-Dktatlas Lh Area Caudalmiddlefrontal,Phenotype,Aparc-Dktatlas Lh Area Caudalmiddlefrontal
48125,Idp Dmri Tbss Icvf Superior Corona Radiata R,Phenotype,Idp Dmri Tbss Icvf Superior Corona Radiata R
48126,Idp Dmri Tbss Icvf Posterior Corona Radiata L,Phenotype,Idp Dmri Tbss Icvf Posterior Corona Radiata L
48127,Wg Rh Intensity-Contrast Parsopercularis,Phenotype,Wg Rh Intensity-Contrast Parsopercularis
48128,Wg Rh Intensity-Contrast Parsorbitalis,Phenotype,Wg Rh Intensity-Contrast Parsorbitalis
48129,Wg Rh Intensity-Contrast Parstriangularis,Phenotype,Wg Rh Intensity-Contrast Parstriangularis
48130,Idp T1 Fast Rois L Intracalc Cortex,Phenotype,Idp T1 Fast Rois L Intracalc Cortex
48131,Wg Rh Intensity-Contrast Medialorbitofrontal,Phenotype,Wg Rh Intensity-Contrast Medialorbitofrontal
48133,Wg Rh Intensity-Contrast Middletemporal,Phenotype,Wg Rh Intensity-Contrast Middletemporal
48134,Wg Rh Intensity-Contrast Inferiortemporal,Phenotype,Wg Rh Intensity-Contrast Inferiortemporal
48135,Wg Rh Intensity-Contrast Lateraloccipital,Phenotype,Wg Rh Intensity-Contrast Lateraloccipital
48136,Wg Rh Intensity-Contrast Lateralorbitofrontal,Phenotype,Wg Rh Intensity-Contrast Lateralorbitofrontal
48138,Idp T1 Fast Rois R Intracalc Cortex,Phenotype,Idp T1 Fast Rois R Intracalc Cortex
48139,Idp T1 Fast Rois R Planum Temporale,Phenotype,Idp T1 Fast Rois R Planum Temporale
48140,Idp T1 Fast Rois L Occ Pole,Phenotype,Idp T1 Fast Rois L Occ Pole
48142,Idp T1 Fast Rois R Cerebellum Crus I,Phenotype,Idp T1 Fast Rois R Cerebellum Crus I
48144,Idp T1 Fast Rois R Occ Pole,Phenotype,Idp T1 Fast Rois R Occ Pole
48145,Idp T1 Fast Rois L Caudate,Phenotype,Idp T1 Fast Rois L Caudate
48146,Idp T1 Fast Rois L Putamen,Phenotype,Idp T1 Fast Rois L Putamen
48147,Idp T1 Fast Rois R Putamen,Phenotype,Idp T1 Fast Rois R Putamen
48151,Left–Right Brain Asymmetry,Phenotype,Left–Right Brain Asymmetry
48157,Chronic Pain,Phenotype,Chronic Pain
48159,Dilated Cardiomyopathy,Phenotype,Dilated Cardiomyopathy
48161,Childhood Asthma Exacerbations In Long-Acting Beta2-Agonist Treatment,Phenotype,Childhood Asthma Exacerbations In Long-Acting Beta2-Agonist Treatment
48187,Aparc-A2009S Rh Volume Pole-Occipital,Phenotype,Aparc-A2009S Rh Volume Pole-Occipital
48188,Aparc-Desikan Lh Area Caudalmiddlefrontal,Phenotype,Aparc-Desikan Lh Area Caudalmiddlefrontal
48189,Aparc-Desikan Lh Area Pericalcarine,Phenotype,Aparc-Desikan Lh Area Pericalcarine
48190,Idp Dmri Tbss L3 Posterior Thalamic Radiation L,Phenotype,Idp Dmri Tbss L3 Posterior Thalamic Radiation L
48192,Idp Dmri Tbss L3 Sagittal Stratum R,Phenotype,Idp Dmri Tbss L3 Sagittal Stratum R
48199,Idp Dmri Tbss Icvf Superior Longitudinal Fasciculus R,Phenotype,Idp Dmri Tbss Icvf Superior Longitudinal Fasciculus R
48200,Idp Dmri Tbss Icvf Superior Longitudinal Fasciculus L,Phenotype,Idp Dmri Tbss Icvf Superior Longitudinal Fasciculus L
48202,Idp Dmri Tbss Icvf Sagittal Stratum L,Phenotype,Idp Dmri Tbss Icvf Sagittal Stratum L
48212,Pancreatic Ductal Adenocarcinoma X Smoking Interaction,Phenotype,Pancreatic Ductal Adenocarcinoma X Smoking Interaction
48214,Sick Sinus Syndrome,Phenotype,Sick Sinus Syndrome
48215,Plasma Blast-Plasma Cell %Lymphocyte,Phenotype,Plasma Blast-Plasma Cell %Lymphocyte
48217,Cd8Dim Natural Killer T %T Cell,Phenotype,Cd8Dim Natural Killer T %T Cell
48218,Cd8Dim Natural Killer T %Lymphocyte,Phenotype,Cd8Dim Natural Killer T %Lymphocyte
48219,Cd4-Cd8- Natural Killer T Absolute Count,Phenotype,Cd4-Cd8- Natural Killer T Absolute Count
48220,Cd4-Cd8- Natural Killer T %T Cell,Phenotype,Cd4-Cd8- Natural Killer T %T Cell
48221,Cd4-Cd8- Natural Killer T %Lymphocyte,Phenotype,Cd4-Cd8- Natural Killer T %Lymphocyte
48222,Igd+ Cd38- B Cell %B Cell,Phenotype,Igd+ Cd38- B Cell %B Cell
48224,Igd On Unswitched Memory B Cell,Phenotype,Igd On Unswitched Memory B Cell
48227,Igd On Transitional B Cell,Phenotype,Igd On Transitional B Cell
48229,Cd3 On Naive Cd8+ T Cell,Phenotype,Cd3 On Naive Cd8+ T Cell
48231,Igd On Igd+ Cd24+ B Cell,Phenotype,Igd On Igd+ Cd24+ B Cell
48233,Igd On Igd+ Cd38+ B Cell,Phenotype,Igd On Igd+ Cd38+ B Cell
48235,Cd25 On Igd- Cd24- B Cell,Phenotype,Cd25 On Igd- Cd24- B Cell
48236,Cd20 On Transitional B Cell,Phenotype,Cd20 On Transitional B Cell
48238,Cd24 On Cd24+ Cd27+ B Cell,Phenotype,Cd24 On Cd24+ Cd27+ B Cell
48241,Cd24 On Igd+ Cd24+ B Cell,Phenotype,Cd24 On Igd+ Cd24+ B Cell
48245,Cd24 On Igd+ Cd38- B Cell,Phenotype,Cd24 On Igd+ Cd38- B Cell
48246,Cd24 On Igd+ Cd38+ B Cell,Phenotype,Cd24 On Igd+ Cd38+ B Cell
48248,Cd24 On Igd- Cd38- B Cell,Phenotype,Cd24 On Igd- Cd38- B Cell
48249,Cd24 On Igd- Cd38Dim B Cell,Phenotype,Cd24 On Igd- Cd38Dim B Cell
48250,Cd24 On Memory B Cell,Phenotype,Cd24 On Memory B Cell
48251,Cd24 On Unswitched Memory B Cell,Phenotype,Cd24 On Unswitched Memory B Cell
48252,Cd24 On Switched Memory B Cell,Phenotype,Cd24 On Switched Memory B Cell
48253,Cd24 On Transitional B Cell,Phenotype,Cd24 On Transitional B Cell
48255,Cd3 On Hla Dr+ T Cell,Phenotype,Cd3 On Hla Dr+ T Cell
48257,Cd3 On Natural Killer T,Phenotype,Cd3 On Natural Killer T
48258,Cd3 On Naive Cd4+ T Cell,Phenotype,Cd3 On Naive Cd4+ T Cell
48260,Cd3 On Cd45Ra+ Cd4+ T Cell,Phenotype,Cd3 On Cd45Ra+ Cd4+ T Cell
48261,Idp Dmri Tbss Mo Retrolenticular Part Of Internal Capsule R,Phenotype,Idp Dmri Tbss Mo Retrolenticular Part Of Internal Capsule R
48262,Idp Dmri Tbss Mo Superior Corona Radiata R,Phenotype,Idp Dmri Tbss Mo Superior Corona Radiata R
48264,Idp Dmri Tbss Mo Superior Corona Radiata L,Phenotype,Idp Dmri Tbss Mo Superior Corona Radiata L
48266,Idp Dmri Tbss Mo Posterior Corona Radiata R,Phenotype,Idp Dmri Tbss Mo Posterior Corona Radiata R
48267,Idp Dmri Probtrackx Mo Str L,Phenotype,Idp Dmri Probtrackx Mo Str L
48269,Idp Dmri Probtrackx Mo Str R,Phenotype,Idp Dmri Probtrackx Mo Str R
48271,Idp Dmri Tbss Mo Body Of Corpus Callosum,Phenotype,Idp Dmri Tbss Mo Body Of Corpus Callosum
48272,Idp Dmri Tbss Mo Fornix,Phenotype,Idp Dmri Tbss Mo Fornix
48273,Aparc-Desikan Rh Volume Lingual,Phenotype,Aparc-Desikan Rh Volume Lingual
48274,Aparc-Dktatlas Lh Volume Pericalcarine,Phenotype,Aparc-Dktatlas Lh Volume Pericalcarine
48275,Ba-Exvivo Rh Volume V1,Phenotype,Ba-Exvivo Rh Volume V1
48276,Ba-Exvivo Rh Volume V2,Phenotype,Ba-Exvivo Rh Volume V2
48277,Aparc-Dktatlas Lh Volume Caudalanteriorcingulate,Phenotype,Aparc-Dktatlas Lh Volume Caudalanteriorcingulate
48278,Aparc-Dktatlas Lh Volume Caudalmiddlefrontal,Phenotype,Aparc-Dktatlas Lh Volume Caudalmiddlefrontal
48279,Aparc-Desikan Rh Volume Pericalcarine,Phenotype,Aparc-Desikan Rh Volume Pericalcarine
48280,Ba-Exvivo Lh Volume V2,Phenotype,Ba-Exvivo Lh Volume V2
48281,Idp Dmri Tbss Icvf Retrolenticular Part Of Internal Capsule L,Phenotype,Idp Dmri Tbss Icvf Retrolenticular Part Of Internal Capsule L
48283,Aparc-Pial Rh Area Pericalcarine,Phenotype,Aparc-Pial Rh Area Pericalcarine
48284,Idp Dmri Probtrackx L3 Unc R,Phenotype,Idp Dmri Probtrackx L3 Unc R
48285,Idp Dmri Tbss Icvf Fornix,Phenotype,Idp Dmri Tbss Icvf Fornix
48286,Idp Dmri Tbss Icvf Cerebral Peduncle R,Phenotype,Idp Dmri Tbss Icvf Cerebral Peduncle R
48287,Idp Dmri Tbss Icvf Cerebral Peduncle L,Phenotype,Idp Dmri Tbss Icvf Cerebral Peduncle L
48288,Wg Lh Intensity-Contrast Posteriorcingulate,Phenotype,Wg Lh Intensity-Contrast Posteriorcingulate
48290,Wg Lh Intensity-Contrast Rostralanteriorcingulate,Phenotype,Wg Lh Intensity-Contrast Rostralanteriorcingulate
48291,Wg Lh Intensity-Contrast Rostralmiddlefrontal,Phenotype,Wg Lh Intensity-Contrast Rostralmiddlefrontal
48292,Wg Lh Intensity-Contrast Superiorfrontal,Phenotype,Wg Lh Intensity-Contrast Superiorfrontal
48293,Wg Rh Intensity-Contrast Fusiform,Phenotype,Wg Rh Intensity-Contrast Fusiform
48294,Wg Rh Intensity-Contrast Inferiorparietal,Phenotype,Wg Rh Intensity-Contrast Inferiorparietal
48295,Wg Lh Intensity-Contrast Frontalpole,Phenotype,Wg Lh Intensity-Contrast Frontalpole
48296,Wg Lh Intensity-Contrast Temporalpole,Phenotype,Wg Lh Intensity-Contrast Temporalpole
48299,Wg Lh Intensity-Contrast Superiorparietal,Phenotype,Wg Lh Intensity-Contrast Superiorparietal
48300,Wg Lh Intensity-Contrast Superiortemporal,Phenotype,Wg Lh Intensity-Contrast Superiortemporal
48301,Wg Lh Intensity-Contrast Supramarginal,Phenotype,Wg Lh Intensity-Contrast Supramarginal
48302,Wg Lh Intensity-Contrast Middletemporal,Phenotype,Wg Lh Intensity-Contrast Middletemporal
48304,Wg Lh Intensity-Contrast Parsopercularis,Phenotype,Wg Lh Intensity-Contrast Parsopercularis
48305,Wg Lh Intensity-Contrast Parsorbitalis,Phenotype,Wg Lh Intensity-Contrast Parsorbitalis
48307,Wg Lh Intensity-Contrast Parstriangularis,Phenotype,Wg Lh Intensity-Contrast Parstriangularis
48309,Rapid Response To Perioperative Phenylephrine (Change In Diastolic Blood Pressure),Phenotype,Rapid Response To Perioperative Phenylephrine (Change In Diastolic Blood Pressure)
48311,Liver Fibrogenesis (Alpha Smooth Muscle Actin Levels),Phenotype,Liver Fibrogenesis (Alpha Smooth Muscle Actin Levels)
48313,Liver Fibrosis (Total Hepatic Collagen Content),Phenotype,Liver Fibrosis (Total Hepatic Collagen Content)
48314,Body Fat Percentage And Hdl-C (Pairwise),Phenotype,Body Fat Percentage And Hdl-C (Pairwise)
48315,Body Fat Percentage And Ldl-C (Pairwise),Phenotype,Body Fat Percentage And Ldl-C (Pairwise)
48316,Body Fat Percentage And Triglycerides (Pairwise),Phenotype,Body Fat Percentage And Triglycerides (Pairwise)
48322,Interleukin-6 Levels In Overweight Individuals,Phenotype,Interleukin-6 Levels In Overweight Individuals
48324,Insulin Levels In Lean Individuals,Phenotype,Insulin Levels In Lean Individuals
48328,Glucagon Levels,Phenotype,Glucagon Levels
48330,Glucagon Levels In Overweight Individuals,Phenotype,Glucagon Levels In Overweight Individuals
48337,Cd28- Cd25++ Cd8+ T Cell Absolute Count,Phenotype,Cd28- Cd25++ Cd8+ T Cell Absolute Count
48338,Cd127- Cd8+ T Cell Absolute Count,Phenotype,Cd127- Cd8+ T Cell Absolute Count
48339,Cd28- Cd8+ T Cell %T Cell,Phenotype,Cd28- Cd8+ T Cell %T Cell
48341,Cd28- Cd8+ T Cell %Cd8+ T Cell,Phenotype,Cd28- Cd8+ T Cell %Cd8+ T Cell
48343,Cd28- Cd8+ T Cell Absolute Count,Phenotype,Cd28- Cd8+ T Cell Absolute Count
48344,Cd28+ Cd45Ra+ Cd8+ T Cell %T Cell,Phenotype,Cd28+ Cd45Ra+ Cd8+ T Cell %T Cell
48346,Cd28+ Cd45Ra+ Cd8+ T Cell Absolute Count,Phenotype,Cd28+ Cd45Ra+ Cd8+ T Cell Absolute Count
48348,Cd28+ Cd45Ra- Cd8+ T Cell %Cd8+ T Cell,Phenotype,Cd28+ Cd45Ra- Cd8+ T Cell %Cd8+ T Cell
48350,Naive Cd4+ T Cell Absolute Count,Phenotype,Naive Cd4+ T Cell Absolute Count
48351,Naive Cd4+ T Cell %Cd4+ T Cell,Phenotype,Naive Cd4+ T Cell %Cd4+ T Cell
48352,Effector Memory Cd4+ T Cell %Cd4+ T Cell,Phenotype,Effector Memory Cd4+ T Cell %Cd4+ T Cell
48354,Effector Memory Cd4+ T Cell %T Cell,Phenotype,Effector Memory Cd4+ T Cell %T Cell
48355,Terminally Differentiated Cd4+ T Cell Absolute Count,Phenotype,Terminally Differentiated Cd4+ T Cell Absolute Count
48357,Terminally Differentiated Cd4+ T Cell %Cd4+ T Cell,Phenotype,Terminally Differentiated Cd4+ T Cell %Cd4+ T Cell
48358,Terminally Differentiated Cd4+ T Cell %T Cell,Phenotype,Terminally Differentiated Cd4+ T Cell %T Cell
48359,Naive Cd8+ T Cell Absolute Count,Phenotype,Naive Cd8+ T Cell Absolute Count
48361,Naive Cd8+ T Cell %T Cell,Phenotype,Naive Cd8+ T Cell %T Cell
48362,Effector Memory Cd8+ T Cell Absolute Count,Phenotype,Effector Memory Cd8+ T Cell Absolute Count
48363,Terminally Differentiated Cd4-Cd8- T Cell %T Cell,Phenotype,Terminally Differentiated Cd4-Cd8- T Cell %T Cell
48365,Cd28- Cd4-Cd8- T Cell Absolute Count,Phenotype,Cd28- Cd4-Cd8- T Cell Absolute Count
48367,Cd28- Cd8Dim T Cell %T Cell,Phenotype,Cd28- Cd8Dim T Cell %T Cell
48368,Cd45Ra+ Cd8+ T Cell Absolute Count,Phenotype,Cd45Ra+ Cd8+ T Cell Absolute Count
48369,Cd45Ra+ Cd8+ T Cell %T Cell,Phenotype,Cd45Ra+ Cd8+ T Cell %T Cell
48371,Naive Cd4-Cd8- T Cell %T Cell,Phenotype,Naive Cd4-Cd8- T Cell %T Cell
48372,Effector Memory Cd4-Cd8- T Cell Absolute Count,Phenotype,Effector Memory Cd4-Cd8- T Cell Absolute Count
48373,Effector Memory Cd4-Cd8- T Cell %T Cell,Phenotype,Effector Memory Cd4-Cd8- T Cell %T Cell
48374,Terminally Differentiated Cd4-Cd8- T Cell Absolute Count,Phenotype,Terminally Differentiated Cd4-Cd8- T Cell Absolute Count
48376,Cd28- Cd8Dim T Cell Absolute Count,Phenotype,Cd28- Cd8Dim T Cell Absolute Count
48377,Cd28+ Cd45Ra+ Cd8Dim T Cell %T Cell,Phenotype,Cd28+ Cd45Ra+ Cd8Dim T Cell %T Cell
48379,Cd28+ Cd45Ra+ Cd8Dim T Cell %Cd8Dim T Cell,Phenotype,Cd28+ Cd45Ra+ Cd8Dim T Cell %Cd8Dim T Cell
48380,Cd28- Cd127- Cd25++ Cd8+ T Cell Absolute Count,Phenotype,Cd28- Cd127- Cd25++ Cd8+ T Cell Absolute Count
48382,Cd25++ Cd4+ T Cell %T Cell,Phenotype,Cd25++ Cd4+ T Cell %T Cell
48383,Cd25++ Cd45Ra- Cd4 Not Regulatory T Cell Absolute Count,Phenotype,Cd25++ Cd45Ra- Cd4 Not Regulatory T Cell Absolute Count
48384,Cd25++ Cd45Ra- Cd4 Not Regulatory T Cell %T Cell,Phenotype,Cd25++ Cd45Ra- Cd4 Not Regulatory T Cell %T Cell
48385,Cd45Ra- Cd4+ T Cell %T Cell,Phenotype,Cd45Ra- Cd4+ T Cell %T Cell
48386,Wg Rh Intensity-Contrast Temporalpole,Phenotype,Wg Rh Intensity-Contrast Temporalpole
48389,Idp T2 Flair Bianca Wmh Volume,Phenotype,Idp T2 Flair Bianca Wmh Volume
48390,Idp Swi T2Star Left Thalamus,Phenotype,Idp Swi T2Star Left Thalamus
48391,Cd4 On Activated Cd4 Regulatory T Cell,Phenotype,Cd4 On Activated Cd4 Regulatory T Cell
48393,Cd4 On Cd39+ Secreting Cd4 Regulatory T Cell,Phenotype,Cd4 On Cd39+ Secreting Cd4 Regulatory T Cell
48394,Cd45 On Cd33- Hla Dr+,Phenotype,Cd45 On Cd33- Hla Dr+
48396,Cd8 On Central Memory Cd8+ T Cell,Phenotype,Cd8 On Central Memory Cd8+ T Cell
48400,Cd8 On Naive Cd8+ T Cell,Phenotype,Cd8 On Naive Cd8+ T Cell
48401,Cd8 On Effector Memory Cd8+ T Cell,Phenotype,Cd8 On Effector Memory Cd8+ T Cell
48403,Cd8 On Cd8+ T Cell,Phenotype,Cd8 On Cd8+ T Cell
48404,Ssc-A On Cd4+ T Cell,Phenotype,Ssc-A On Cd4+ T Cell
48405,Ssc-A On Hla Dr+ T Cell,Phenotype,Ssc-A On Hla Dr+ T Cell
48406,Cd80 On Myeloid Dendritic Cell,Phenotype,Cd80 On Myeloid Dendritic Cell
48408,Cd80 On Cd62L+ Myeloid Dendritic Cell,Phenotype,Cd80 On Cd62L+ Myeloid Dendritic Cell
48410,Cd8 On Natural Killer T,Phenotype,Cd8 On Natural Killer T
48411,Cd4 On Cd28+ Cd4+ T Cell,Phenotype,Cd4 On Cd28+ Cd4+ T Cell
48412,Cd4 On Cd39+ Activated Cd4 Regulatory T Cell,Phenotype,Cd4 On Cd39+ Activated Cd4 Regulatory T Cell
48413,Wg Rh Intensity-Contrast Superiorparietal,Phenotype,Wg Rh Intensity-Contrast Superiorparietal
48414,Wg Rh Intensity-Contrast Supramarginal,Phenotype,Wg Rh Intensity-Contrast Supramarginal
48415,Wg Rh Intensity-Contrast Frontalpole,Phenotype,Wg Rh Intensity-Contrast Frontalpole
48416,Idp Swi T2Star Left Caudate,Phenotype,Idp Swi T2Star Left Caudate
48417,Idp Swi T2Star Right Caudate,Phenotype,Idp Swi T2Star Right Caudate
48418,Ssc-A On Myeloid Dendritic Cell,Phenotype,Ssc-A On Myeloid Dendritic Cell
48420,Idp Dmri Tbss L1 Superior Longitudinal Fasciculus L,Phenotype,Idp Dmri Tbss L1 Superior Longitudinal Fasciculus L
48421,Idp Dmri Tbss L2 Corticospinal Tract R,Phenotype,Idp Dmri Tbss L2 Corticospinal Tract R
48423,Idp Dmri Tbss L1 Corticospinal Tract R,Phenotype,Idp Dmri Tbss L1 Corticospinal Tract R
48424,Idp Dmri Tbss L1 Superior Corona Radiata L,Phenotype,Idp Dmri Tbss L1 Superior Corona Radiata L
48426,Idp Dmri Tbss L1 Sagittal Stratum R,Phenotype,Idp Dmri Tbss L1 Sagittal Stratum R
48427,Aparc-A2009S Lh Area S-Orbital-Med-Olfact,Phenotype,Aparc-A2009S Lh Area S-Orbital-Med-Olfact
48428,Idp Dmri Tbss Od Body Of Corpus Callosum,Phenotype,Idp Dmri Tbss Od Body Of Corpus Callosum
48429,Idp Dmri Tbss Od Superior Corona Radiata L,Phenotype,Idp Dmri Tbss Od Superior Corona Radiata L
48430,Idp Dmri Tbss Od Posterior Corona Radiata R,Phenotype,Idp Dmri Tbss Od Posterior Corona Radiata R
48431,Aparc-Dktatlas Rh Area Insula,Phenotype,Aparc-Dktatlas Rh Area Insula
48433,Aparc-A2009S Lh Area G-Cuneus,Phenotype,Aparc-A2009S Lh Area G-Cuneus
48434,Aparc-A2009S Lh Area S-Calcarine,Phenotype,Aparc-A2009S Lh Area S-Calcarine
48435,Idp Dmri Probtrackx Od Str L,Phenotype,Idp Dmri Probtrackx Od Str L
48436,Idp Dmri Probtrackx Od Str R,Phenotype,Idp Dmri Probtrackx Od Str R
48437,Idp Dmri Tbss Isovf Corticospinal Tract R,Phenotype,Idp Dmri Tbss Isovf Corticospinal Tract R
48438,Idp Dmri Tbss Isovf Anterior Corona Radiata R,Phenotype,Idp Dmri Tbss Isovf Anterior Corona Radiata R
48440,Idp Dmri Tbss Isovf Anterior Corona Radiata L,Phenotype,Idp Dmri Tbss Isovf Anterior Corona Radiata L
48441,Idp Dmri Tbss Isovf Posterior Corona Radiata R,Phenotype,Idp Dmri Tbss Isovf Posterior Corona Radiata R
48443,Qc T2 Flair-To-T1 Linear Alignment Discrepancy,Phenotype,Qc T2 Flair-To-T1 Linear Alignment Discrepancy
48444,Aseg Lh Volume Ventraldc,Phenotype,Aseg Lh Volume Ventraldc
48445,Aseg Lh Volume Choroid-Plexus,Phenotype,Aseg Lh Volume Choroid-Plexus
48446,Aseg Lh Volume Cerebralwhitematter,Phenotype,Aseg Lh Volume Cerebralwhitematter
48447,Aseg Global Volume Ventriclechoroid,Phenotype,Aseg Global Volume Ventriclechoroid
48449,Aseg Global Volume 4Th-Ventricle,Phenotype,Aseg Global Volume 4Th-Ventricle
48450,Aseg Global Volume Wm-Hypointensities,Phenotype,Aseg Global Volume Wm-Hypointensities
48451,Idp T1 Fast Rois L Cerebellum Viiia,Phenotype,Idp T1 Fast Rois L Cerebellum Viiia
48453,Idp T1 Fast Rois V Cerebellum Viiia,Phenotype,Idp T1 Fast Rois V Cerebellum Viiia
48454,Idp T1 Fast Rois L Cerebellum Viiib,Phenotype,Idp T1 Fast Rois L Cerebellum Viiib
48455,Idp T1 Fast Rois V Cerebellum Viiib,Phenotype,Idp T1 Fast Rois V Cerebellum Viiib
48457,Idp T1 Fast Rois V Cerebellum Ix,Phenotype,Idp T1 Fast Rois V Cerebellum Ix
48458,Body Mass Index And Fasting Glucose (Pairwise),Phenotype,Body Mass Index And Fasting Glucose (Pairwise)
48459,Body Mass Index And Systole Blood Pressure (Pairwise),Phenotype,Body Mass Index And Systole Blood Pressure (Pairwise)
48460,Body Mass Index And Coronary Artery Disease (Pairwise),Phenotype,Body Mass Index And Coronary Artery Disease (Pairwise)
48461,Waist-Hip Ratio And Hdl-C (Pairwise),Phenotype,Waist-Hip Ratio And Hdl-C (Pairwise)
48462,Waist-Hip Ratio And Systolic Blood Pressure (Pairwise),Phenotype,Waist-Hip Ratio And Systolic Blood Pressure (Pairwise)
48463,Visfatin Levels In Type 2 Diabetes,Phenotype,Visfatin Levels In Type 2 Diabetes
48465,Glucose-Dependent Insulinotropic Peptide Levels,Phenotype,Glucose-Dependent Insulinotropic Peptide Levels
48467,Glucagon-Like Peptide-1 Levels In Overweight Individuals,Phenotype,Glucagon-Like Peptide-1 Levels In Overweight Individuals
48469,Ghrelin Levels,Phenotype,Ghrelin Levels
48472,Glucose-Dependent Insulinotropic Peptide Levels In Lean Individuals,Phenotype,Glucose-Dependent Insulinotropic Peptide Levels In Lean Individuals
48474,Fibrosis-4 Index In High Alcohol Intake,Phenotype,Fibrosis-4 Index In High Alcohol Intake
48477,Aspartate Transaminase Levels In High Alcohol Intake,Phenotype,Aspartate Transaminase Levels In High Alcohol Intake
48478,Forns Index In High Alcohol Intake,Phenotype,Forns Index In High Alcohol Intake
48484,Hair Morphology Traits,Phenotype,Hair Morphology Traits
48488,Depression (Broad),Phenotype,Depression (Broad)
48535,Nicotine Dependence And Major Depression (Severity Of Comorbidity),Phenotype,Nicotine Dependence And Major Depression (Severity Of Comorbidity)
48544,Lateral Ventricular Volume In Normal Aging,Phenotype,Lateral Ventricular Volume In Normal Aging
48555,Offspring Birth Weight,Phenotype,Offspring Birth Weight
48561,Cholesteryl Ester Transfer Protein Levels,Phenotype,Cholesteryl Ester Transfer Protein Levels
48599,Response To Opioid Analgesics In Cancer (Pain Decrease),Phenotype,Response To Opioid Analgesics In Cancer (Pain Decrease)
48631,Anti-Rubella Virus Igg Levels,Phenotype,Anti-Rubella Virus Igg Levels
48633,Subiculum Volume (Corrected For Total Hippocampal Volume),Phenotype,Subiculum Volume (Corrected For Total Hippocampal Volume)
48640,Ewing Sarcoma,Phenotype,Ewing Sarcoma
48643,Hip Bone Mineral Density And Total Body Fat Mass (Bivariate Analysis),Phenotype,Hip Bone Mineral Density And Total Body Fat Mass (Bivariate Analysis)
48646,Falling Risk,Phenotype,Falling Risk
48649,Eye Color Traits,Phenotype,Eye Color Traits
48650,Anthropometric Traits (Multi-Trait Analysis),Phenotype,Anthropometric Traits (Multi-Trait Analysis)
48654,Skin Pigmentation Traits,Phenotype,Skin Pigmentation Traits
48657,Endometrial Cancer (Non-Endometrioid Histology),Phenotype,Endometrial Cancer (Non-Endometrioid Histology)
48661,Endometrial Cancer (Endometrioid Histology),Phenotype,Endometrial Cancer (Endometrioid Histology)
48664,Extremely High Intelligence,Phenotype,Extremely High Intelligence
48689,Anorexia Nervosa Or Obsessive-Compulsive Disorder,Phenotype,Anorexia Nervosa Or Obsessive-Compulsive Disorder
48697,Postburn Scar Pliability,Phenotype,Postburn Scar Pliability
48703,Response To Tnf Inhibitor In Rheumatoid Arthritis (Change In Swollen 28-Joint Count),Phenotype,Response To Tnf Inhibitor In Rheumatoid Arthritis (Change In Swollen 28-Joint Count)
48707,Eudaimonic Well-Being,Phenotype,Eudaimonic Well-Being
48753,Lung Cancer (Snp X Snp Interaction),Phenotype,Lung Cancer (Snp X Snp Interaction)
48763,Relative Amplitude Of Rest-Activity Cycles,Phenotype,Relative Amplitude Of Rest-Activity Cycles
48766,Disrupted Circadian Rhythm (Low Relative Amplitude Of Rest-Activity Cycles),Phenotype,Disrupted Circadian Rhythm (Low Relative Amplitude Of Rest-Activity Cycles)
48803,Adrenomedullin Levels,Phenotype,Adrenomedullin Levels
48805,Growth Differentiation Factor-15 Levels,Phenotype,Growth Differentiation Factor-15 Levels
48807,C-C Motif Chemokine 20 Levels,Phenotype,C-C Motif Chemokine 20 Levels
48808,Ovarian Cancer-Related Tumor Marker Ca 125 Levels,Phenotype,Ovarian Cancer-Related Tumor Marker Ca 125 Levels
48811,Cathepsin L1 Levels,Phenotype,Cathepsin L1 Levels
48815,Cx3Cl1 Levels,Phenotype,Cx3Cl1 Levels
48818,Estimated Glomerular Filtration Rate (Creatinine-- Rapid3),Phenotype,Estimated Glomerular Filtration Rate (Creatinine-- Rapid3)
48819,Estimated Glomerular Filtration Rate (Creatinine-- Ckdi25),Phenotype,Estimated Glomerular Filtration Rate (Creatinine-- Ckdi25)
48820,Stool Frequency,Phenotype,Stool Frequency
48822,Body Composition Traits,Phenotype,Body Composition Traits
48828,Gut Microbiota Alpha Diversity (Simpson Index),Phenotype,Gut Microbiota Alpha Diversity (Simpson Index)
48830,Gut Microbiota Alpha Diversity (Inverse Simpson Index),Phenotype,Gut Microbiota Alpha Diversity (Inverse Simpson Index)
48836,Verbal-Numerical Reasoning,Phenotype,Verbal-Numerical Reasoning
48838,Low Myopia Vs Hyperopia,Phenotype,Low Myopia Vs Hyperopia
48853,Cd99L2/Rarres2 Protein Level Ratio,Phenotype,Cd99L2/Rarres2 Protein Level Ratio
48854,Cd84/Sdc4 Protein Level Ratio,Phenotype,Cd84/Sdc4 Protein Level Ratio
48856,Cd84/Treml2 Protein Level Ratio,Phenotype,Cd84/Treml2 Protein Level Ratio
48857,Cd93/Clec14A Protein Level Ratio,Phenotype,Cd93/Clec14A Protein Level Ratio
48858,Gp1Ba/Sdc4 Protein Level Ratio,Phenotype,Gp1Ba/Sdc4 Protein Level Ratio
48860,Cd79B/Tnfrsf13B Protein Level Ratio,Phenotype,Cd79B/Tnfrsf13B Protein Level Ratio
48862,Cd79B/Tnfrsf4 Protein Level Ratio,Phenotype,Cd79B/Tnfrsf4 Protein Level Ratio
48864,Cd83/Havcr2 Protein Level Ratio,Phenotype,Cd83/Havcr2 Protein Level Ratio
48866,Cd83/Il12A_Il12B Protein Level Ratio,Phenotype,Cd83/Il12A_Il12B Protein Level Ratio
48868,Cd83/Lamp3 Protein Level Ratio,Phenotype,Cd83/Lamp3 Protein Level Ratio
48870,Cd83/Tnfrsf4 Protein Level Ratio,Phenotype,Cd83/Tnfrsf4 Protein Level Ratio
48872,Cd83/Trem2 Protein Level Ratio,Phenotype,Cd83/Trem2 Protein Level Ratio
48873,Cd74/Jam2 Protein Level Ratio,Phenotype,Cd74/Jam2 Protein Level Ratio
48875,Cd74/Lilrb4 Protein Level Ratio,Phenotype,Cd74/Lilrb4 Protein Level Ratio
48876,Cd74/Npdc1 Protein Level Ratio,Phenotype,Cd74/Npdc1 Protein Level Ratio
48878,Cd74/Timd4 Protein Level Ratio,Phenotype,Cd74/Timd4 Protein Level Ratio
48879,Cd74/Tnfrsf21 Protein Level Ratio,Phenotype,Cd74/Tnfrsf21 Protein Level Ratio
48881,Cd79B/Fcrl1 Protein Level Ratio,Phenotype,Cd79B/Fcrl1 Protein Level Ratio
48883,Cd79B/Fcrl2 Protein Level Ratio,Phenotype,Cd79B/Fcrl2 Protein Level Ratio
48886,Cd79B/Icam3 Protein Level Ratio,Phenotype,Cd79B/Icam3 Protein Level Ratio
48887,Cd84/Cdkn1A Protein Level Ratio,Phenotype,Cd84/Cdkn1A Protein Level Ratio
48888,Cdc37/Snx9 Protein Level Ratio,Phenotype,Cdc37/Snx9 Protein Level Ratio
48889,Cdcp1/Il18Bp Protein Level Ratio,Phenotype,Cdcp1/Il18Bp Protein Level Ratio
48891,Cdcp1/Msr1 Protein Level Ratio,Phenotype,Cdcp1/Msr1 Protein Level Ratio
48892,Cdh17/Galnt3 Protein Level Ratio,Phenotype,Cdh17/Galnt3 Protein Level Ratio
48893,Gopc/Plxna4 Protein Level Ratio,Phenotype,Gopc/Plxna4 Protein Level Ratio
48894,Gp1Ba/Hbegf Protein Level Ratio,Phenotype,Gp1Ba/Hbegf Protein Level Ratio
48895,Cd69/Txndc5 Protein Level Ratio,Phenotype,Cd69/Txndc5 Protein Level Ratio
48896,Cd74/Dll1 Protein Level Ratio,Phenotype,Cd74/Dll1 Protein Level Ratio
48898,Cd74/Il18Bp Protein Level Ratio,Phenotype,Cd74/Il18Bp Protein Level Ratio
48900,Hspa1A/Mitd1 Protein Level Ratio,Phenotype,Hspa1A/Mitd1 Protein Level Ratio
48902,Hspa1A/Stip1 Protein Level Ratio,Phenotype,Hspa1A/Stip1 Protein Level Ratio
48905,Hspa1A/Wwp2 Protein Level Ratio,Phenotype,Hspa1A/Wwp2 Protein Level Ratio
48908,Hspb1/Kyat1 Protein Level Ratio,Phenotype,Hspb1/Kyat1 Protein Level Ratio
48909,Hspb1/Plin3 Protein Level Ratio,Phenotype,Hspb1/Plin3 Protein Level Ratio
48910,Hspb1/Qdpr Protein Level Ratio,Phenotype,Hspb1/Qdpr Protein Level Ratio
48911,Hspg2/Smoc2 Protein Level Ratio,Phenotype,Hspg2/Smoc2 Protein Level Ratio
48912,Hspg2/Vasn Protein Level Ratio,Phenotype,Hspg2/Vasn Protein Level Ratio
48913,Hyou1/Ptprf Protein Level Ratio,Phenotype,Hyou1/Ptprf Protein Level Ratio
48914,Icam2/Il7R Protein Level Ratio,Phenotype,Icam2/Il7R Protein Level Ratio
48916,Icam3/Ly9 Protein Level Ratio,Phenotype,Icam3/Ly9 Protein Level Ratio
48919,Icam3/Notch1 Protein Level Ratio,Phenotype,Icam3/Notch1 Protein Level Ratio
48920,Ids/Smpdl3A Protein Level Ratio,Phenotype,Ids/Smpdl3A Protein Level Ratio
48921,Ifngr1/Ltbr Protein Level Ratio,Phenotype,Ifngr1/Ltbr Protein Level Ratio
48923,Igf2R/Lgmn Protein Level Ratio,Phenotype,Igf2R/Lgmn Protein Level Ratio
48925,Igfbp6/Smoc2 Protein Level Ratio,Phenotype,Igfbp6/Smoc2 Protein Level Ratio
48926,Igsf8/Nectin2 Protein Level Ratio,Phenotype,Igsf8/Nectin2 Protein Level Ratio
48927,Il18Bp/Thbd Protein Level Ratio,Phenotype,Il18Bp/Thbd Protein Level Ratio
48928,Il1R2/Megf9 Protein Level Ratio,Phenotype,Il1R2/Megf9 Protein Level Ratio
48930,Ikbkg/Tjap1 Protein Level Ratio,Phenotype,Ikbkg/Tjap1 Protein Level Ratio
48932,Il12A_Il12B/Lag3 Protein Level Ratio,Phenotype,Il12A_Il12B/Lag3 Protein Level Ratio
48934,Hyou1/Thbd Protein Level Ratio,Phenotype,Hyou1/Thbd Protein Level Ratio
48936,Hpcal1/Pla2G4A Protein Level Ratio,Phenotype,Hpcal1/Pla2G4A Protein Level Ratio
48937,Hspa1A/Mgll Protein Level Ratio,Phenotype,Hspa1A/Mgll Protein Level Ratio
48940,Ceacam8/Pglyrp1 Protein Level Ratio,Phenotype,Ceacam8/Pglyrp1 Protein Level Ratio
48942,Cela3A/Cpa1 Protein Level Ratio,Phenotype,Cela3A/Cpa1 Protein Level Ratio
48944,Cela3A/Cpb1 Protein Level Ratio,Phenotype,Cela3A/Cpb1 Protein Level Ratio
48946,Cela3A/Ctrb1 Protein Level Ratio,Phenotype,Cela3A/Ctrb1 Protein Level Ratio
48948,Cela3A/Ctrc Protein Level Ratio,Phenotype,Cela3A/Ctrc Protein Level Ratio
48949,Cela3A/Kirrel2 Protein Level Ratio,Phenotype,Cela3A/Kirrel2 Protein Level Ratio
48951,Cela3A/Pla2G1B Protein Level Ratio,Phenotype,Cela3A/Pla2G1B Protein Level Ratio
48952,Cep20/Lbr Protein Level Ratio,Phenotype,Cep20/Lbr Protein Level Ratio
48954,Cep20/Med18 Protein Level Ratio,Phenotype,Cep20/Med18 Protein Level Ratio
48955,Cep20/Prkra Protein Level Ratio,Phenotype,Cep20/Prkra Protein Level Ratio
48957,Cdkn2D/Tbl1X Protein Level Ratio,Phenotype,Cdkn2D/Tbl1X Protein Level Ratio
48958,Cdsn/Klk8 Protein Level Ratio,Phenotype,Cdsn/Klk8 Protein Level Ratio
48959,Cdsn/Ly6D Protein Level Ratio,Phenotype,Cdsn/Ly6D Protein Level Ratio
48960,Cdsn/Nectin4 Protein Level Ratio,Phenotype,Cdsn/Nectin4 Protein Level Ratio
48961,Ceacam8/Mmp9 Protein Level Ratio,Phenotype,Ceacam8/Mmp9 Protein Level Ratio
48962,Cep43/Mphosph8 Protein Level Ratio,Phenotype,Cep43/Mphosph8 Protein Level Ratio
48963,Cep43/Plxnb3 Protein Level Ratio,Phenotype,Cep43/Plxnb3 Protein Level Ratio
48964,Ipcef1/Txlna Protein Level Ratio,Phenotype,Ipcef1/Txlna Protein Level Ratio
48966,Irag2/Wasf1 Protein Level Ratio,Phenotype,Irag2/Wasf1 Protein Level Ratio
48987,Type 1 Diabetes (Age At Diagnosis),Phenotype,Type 1 Diabetes (Age At Diagnosis)
49016,Gut Microbiota Presence (Family Pseudomonadaceae Id.3718),Phenotype,Gut Microbiota Presence (Family Pseudomonadaceae Id.3718)
49018,Gut Microbiota Abundance (Order Gastranaerophilales Id.1591),Phenotype,Gut Microbiota Abundance (Order Gastranaerophilales Id.1591)
49020,Gut Microbiota Abundance (Unknown Family Id.1000001214),Phenotype,Gut Microbiota Abundance (Unknown Family Id.1000001214)
49021,Episodic Memory (Pairs-Matching),Phenotype,Episodic Memory (Pairs-Matching)
49024,Theta Electroencephalogram Power,Phenotype,Theta Electroencephalogram Power
49028,Ischemic Stroke In Hypertension,Phenotype,Ischemic Stroke In Hypertension
49030,Cardio-Cerebrovascular Disease In Diabetes Mellitus,Phenotype,Cardio-Cerebrovascular Disease In Diabetes Mellitus
49032,Coronary Artery Disease In Hypertension,Phenotype,Coronary Artery Disease In Hypertension
49034,Cardio-Cerebrovascular Disease In Dyslipidemia,Phenotype,Cardio-Cerebrovascular Disease In Dyslipidemia
49037,Ischemic Stroke In Diabetes Mellitus,Phenotype,Ischemic Stroke In Diabetes Mellitus
49043,Cd63/Edar Protein Level Ratio,Phenotype,Cd63/Edar Protein Level Ratio
49045,Cd69/Chmp1A Protein Level Ratio,Phenotype,Cd69/Chmp1A Protein Level Ratio
49046,Cd69/Edar Protein Level Ratio,Phenotype,Cd69/Edar Protein Level Ratio
49047,Cd69/Plxna4 Protein Level Ratio,Phenotype,Cd69/Plxna4 Protein Level Ratio
49049,Homa-B (Corrected For Homa-Ir),Phenotype,Homa-B (Corrected For Homa-Ir)
49052,Gzmh/Klrd1 Protein Level Ratio,Phenotype,Gzmh/Klrd1 Protein Level Ratio
49054,Hagh/Hbq1 Protein Level Ratio,Phenotype,Hagh/Hbq1 Protein Level Ratio
49057,Hagh/Hmbs Protein Level Ratio,Phenotype,Hagh/Hmbs Protein Level Ratio
49059,Hagh/Pklr Protein Level Ratio,Phenotype,Hagh/Pklr Protein Level Ratio
49060,Hagh/Psmd9 Protein Level Ratio,Phenotype,Hagh/Psmd9 Protein Level Ratio
49061,Hagh/Ubac1 Protein Level Ratio,Phenotype,Hagh/Ubac1 Protein Level Ratio
49062,Hars1/Rwdd1 Protein Level Ratio,Phenotype,Hars1/Rwdd1 Protein Level Ratio
49064,Hars1/Serpinb1 Protein Level Ratio,Phenotype,Hars1/Serpinb1 Protein Level Ratio
49066,Havcr2/Lrrc25 Protein Level Ratio,Phenotype,Havcr2/Lrrc25 Protein Level Ratio
49067,Havcr2/Pilra Protein Level Ratio,Phenotype,Havcr2/Pilra Protein Level Ratio
49068,Havcr2/Tnfrsf1B Protein Level Ratio,Phenotype,Havcr2/Tnfrsf1B Protein Level Ratio
49070,Hbegf/Lat2 Protein Level Ratio,Phenotype,Hbegf/Lat2 Protein Level Ratio
49071,Stambp/Wwp2 Protein Level Ratio,Phenotype,Stambp/Wwp2 Protein Level Ratio
49073,Gys1/Usp8 Protein Level Ratio,Phenotype,Gys1/Usp8 Protein Level Ratio
49075,Gys1/Wasf1 Protein Level Ratio,Phenotype,Gys1/Wasf1 Protein Level Ratio
49076,Gzma/Gzmb Protein Level Ratio,Phenotype,Gzma/Gzmb Protein Level Ratio
49077,Gzma/Il12A_Il12B Protein Level Ratio,Phenotype,Gzma/Il12A_Il12B Protein Level Ratio
49078,Gzma/Itgb7 Protein Level Ratio,Phenotype,Gzma/Itgb7 Protein Level Ratio
49079,Gzma/Kir2Dl3 Protein Level Ratio,Phenotype,Gzma/Kir2Dl3 Protein Level Ratio
49081,Gzma/Lta Protein Level Ratio,Phenotype,Gzma/Lta Protein Level Ratio
49082,Gzma/Tnfrsf4 Protein Level Ratio,Phenotype,Gzma/Tnfrsf4 Protein Level Ratio
49084,Gzma/Tnfrsf8 Protein Level Ratio,Phenotype,Gzma/Tnfrsf8 Protein Level Ratio
49085,Gzmb/Il15 Protein Level Ratio,Phenotype,Gzmb/Il15 Protein Level Ratio
49086,Gp6/Manf Protein Level Ratio,Phenotype,Gp6/Manf Protein Level Ratio
49087,Gp6/Serpinb1 Protein Level Ratio,Phenotype,Gp6/Serpinb1 Protein Level Ratio
49088,Gsta1/Pbld Protein Level Ratio,Phenotype,Gsta1/Pbld Protein Level Ratio
49090,Gsta1/Rbp5 Protein Level Ratio,Phenotype,Gsta1/Rbp5 Protein Level Ratio
49091,Gsta1/Sult2A1 Protein Level Ratio,Phenotype,Gsta1/Sult2A1 Protein Level Ratio
49092,Gsta3/Krt18 Protein Level Ratio,Phenotype,Gsta3/Krt18 Protein Level Ratio
49093,Gys1/Itgb1Bp2 Protein Level Ratio,Phenotype,Gys1/Itgb1Bp2 Protein Level Ratio
49094,Gys1/Ppp1R2 Protein Level Ratio,Phenotype,Gys1/Ppp1R2 Protein Level Ratio
49095,Gys1/Stk11 Protein Level Ratio,Phenotype,Gys1/Stk11 Protein Level Ratio
49096,Gys1/Susd1 Protein Level Ratio,Phenotype,Gys1/Susd1 Protein Level Ratio
49098,Gsta1/Krt18 Protein Level Ratio,Phenotype,Gsta1/Krt18 Protein Level Ratio
49099,Ambp/Efemp1 Protein Level Ratio,Phenotype,Ambp/Efemp1 Protein Level Ratio
49101,Ambp/Hyou1 Protein Level Ratio,Phenotype,Ambp/Hyou1 Protein Level Ratio
49102,Alcam/Cdh5 Protein Level Ratio,Phenotype,Alcam/Cdh5 Protein Level Ratio
49105,Alcam/Cntn1 Protein Level Ratio,Phenotype,Alcam/Cntn1 Protein Level Ratio
49106,Alcam/Icam3 Protein Level Ratio,Phenotype,Alcam/Icam3 Protein Level Ratio
49107,Alcam/Lrrc25 Protein Level Ratio,Phenotype,Alcam/Lrrc25 Protein Level Ratio
49109,Alcam/Notch1 Protein Level Ratio,Phenotype,Alcam/Notch1 Protein Level Ratio
49111,Alcam/Spint1 Protein Level Ratio,Phenotype,Alcam/Spint1 Protein Level Ratio
49112,Aldh1A1/Ca2 Protein Level Ratio,Phenotype,Aldh1A1/Ca2 Protein Level Ratio
49113,Aldh1A1/Pts Protein Level Ratio,Phenotype,Aldh1A1/Pts Protein Level Ratio
49114,Anpep/Nt5E Protein Level Ratio,Phenotype,Anpep/Nt5E Protein Level Ratio
49116,Anxa11/Nt5C3A Protein Level Ratio,Phenotype,Anxa11/Nt5C3A Protein Level Ratio
49118,Impa1/Tbcc Protein Level Ratio,Phenotype,Impa1/Tbcc Protein Level Ratio
49120,Angpt1/Ccn2 Protein Level Ratio,Phenotype,Angpt1/Ccn2 Protein Level Ratio
49122,Angpt1/Cpxm1 Protein Level Ratio,Phenotype,Angpt1/Cpxm1 Protein Level Ratio
49124,Inpp1/Tbcc Protein Level Ratio,Phenotype,Inpp1/Tbcc Protein Level Ratio
49125,Ipcef1/Smad1 Protein Level Ratio,Phenotype,Ipcef1/Smad1 Protein Level Ratio
49126,Angpt1/Pdgfb Protein Level Ratio,Phenotype,Angpt1/Pdgfb Protein Level Ratio
49127,Ipcef1/Sparc Protein Level Ratio,Phenotype,Ipcef1/Sparc Protein Level Ratio
49129,Ipcef1/Tbcb Protein Level Ratio,Phenotype,Ipcef1/Tbcb Protein Level Ratio
49130,Ipcef1/Tbcc Protein Level Ratio,Phenotype,Ipcef1/Tbcc Protein Level Ratio
49132,Itga5/Vcam1 Protein Level Ratio,Phenotype,Itga5/Vcam1 Protein Level Ratio
49133,Itga6/Thpo Protein Level Ratio,Phenotype,Itga6/Thpo Protein Level Ratio
49134,Itgam/Itgav Protein Level Ratio,Phenotype,Itgam/Itgav Protein Level Ratio
49136,Itgb1Bp2/Lat2 Protein Level Ratio,Phenotype,Itgb1Bp2/Lat2 Protein Level Ratio
49137,Itga5/Itgb7 Protein Level Ratio,Phenotype,Itga5/Itgb7 Protein Level Ratio
49138,Itgb1Bp2/Usp8 Protein Level Ratio,Phenotype,Itgb1Bp2/Usp8 Protein Level Ratio
49139,Itgb1Bp2/Wasf1 Protein Level Ratio,Phenotype,Itgb1Bp2/Wasf1 Protein Level Ratio
49140,Itgb1/Itgb2 Protein Level Ratio,Phenotype,Itgb1/Itgb2 Protein Level Ratio
49142,Itgb1/Mcam Protein Level Ratio,Phenotype,Itgb1/Mcam Protein Level Ratio
49144,Itgb1/Vasn Protein Level Ratio,Phenotype,Itgb1/Vasn Protein Level Ratio
49146,Itgb1Bp2/Med18 Protein Level Ratio,Phenotype,Itgb1Bp2/Med18 Protein Level Ratio
49147,Itgb1Bp2/Mitd1 Protein Level Ratio,Phenotype,Itgb1Bp2/Mitd1 Protein Level Ratio
49148,Itgb1Bp2/Pdlim7 Protein Level Ratio,Phenotype,Itgb1Bp2/Pdlim7 Protein Level Ratio
49149,Itgb1Bp2/Plxna4 Protein Level Ratio,Phenotype,Itgb1Bp2/Plxna4 Protein Level Ratio
49150,Itgb1Bp2/Tia1 Protein Level Ratio,Phenotype,Itgb1Bp2/Tia1 Protein Level Ratio
49151,Itgb1Bp2/Skap2 Protein Level Ratio,Phenotype,Itgb1Bp2/Skap2 Protein Level Ratio
49152,Itgb1Bp2/Stat5B Protein Level Ratio,Phenotype,Itgb1Bp2/Stat5B Protein Level Ratio
49153,Itgb1Bp2/Stk11 Protein Level Ratio,Phenotype,Itgb1Bp2/Stk11 Protein Level Ratio
49154,Itgb1Bp2/Ppp1R12A Protein Level Ratio,Phenotype,Itgb1Bp2/Ppp1R12A Protein Level Ratio
49155,Itgb1Bp2/Ptpn6 Protein Level Ratio,Phenotype,Itgb1Bp2/Ptpn6 Protein Level Ratio
49156,Cd40 Ligand Levels,Phenotype,Cd40 Ligand Levels
49159,Proheparin-Binding Egf-Like Growth Factor Levels,Phenotype,Proheparin-Binding Egf-Like Growth Factor Levels
49160,C-C Motif Chemokine 3 Levels,Phenotype,C-C Motif Chemokine 3 Levels
49162,C-X-C Motif Chemokine 16 Levels,Phenotype,C-X-C Motif Chemokine 16 Levels
49164,Receptor For Advanced Glycosylation End Products Levels,Phenotype,Receptor For Advanced Glycosylation End Products Levels
49168,Matrix Metalloproteinase-10 Levels,Phenotype,Matrix Metalloproteinase-10 Levels
49170,Kidney Injury Molecule 1 Levels,Phenotype,Kidney Injury Molecule 1 Levels
49171,Dickkopf-Related Protein 1 Levels,Phenotype,Dickkopf-Related Protein 1 Levels
49172,Galanin Peptide Levels,Phenotype,Galanin Peptide Levels
49179,Gut Microbiota Abundance (Unknown Genus Id.1000001215),Phenotype,Gut Microbiota Abundance (Unknown Genus Id.1000001215)
49180,Gut Microbiota Abundance (Family Oxalobacteraceae Id.2966),Phenotype,Gut Microbiota Abundance (Family Oxalobacteraceae Id.2966)
49182,Gut Microbiota Abundance (Class Actinobacteria Id.419),Phenotype,Gut Microbiota Abundance (Class Actinobacteria Id.419)
49184,Cognitive Traits (Mtag),Phenotype,Cognitive Traits (Mtag)
49187,Tuberculosis Susceptibility In Hiv Infection,Phenotype,Tuberculosis Susceptibility In Hiv Infection
49198,Coronary Artery Disease In Dyslipidemia,Phenotype,Coronary Artery Disease In Dyslipidemia
49202,Ischemic Stroke In Dyslipidemia,Phenotype,Ischemic Stroke In Dyslipidemia
49207,Lacunar Stroke,Phenotype,Lacunar Stroke
49218,Cdkn2D/Manf Protein Level Ratio,Phenotype,Cdkn2D/Manf Protein Level Ratio
49220,Cdkn2D/Itgb1Bp2 Protein Level Ratio,Phenotype,Cdkn2D/Itgb1Bp2 Protein Level Ratio
49221,Cdkn2D/Chmp1A Protein Level Ratio,Phenotype,Cdkn2D/Chmp1A Protein Level Ratio
49222,Cdkn2D/Cnpy4 Protein Level Ratio,Phenotype,Cdkn2D/Cnpy4 Protein Level Ratio
49225,Cdkn2D/Tacc3 Protein Level Ratio,Phenotype,Cdkn2D/Tacc3 Protein Level Ratio
49226,Cdkn1A/Tbl1X Protein Level Ratio,Phenotype,Cdkn1A/Tbl1X Protein Level Ratio
49227,Cdkn1A/Tmsb10 Protein Level Ratio,Phenotype,Cdkn1A/Tmsb10 Protein Level Ratio
49228,Cdkn1A/Txlna Protein Level Ratio,Phenotype,Cdkn1A/Txlna Protein Level Ratio
49229,Cdkn1A/Yes1 Protein Level Ratio,Phenotype,Cdkn1A/Yes1 Protein Level Ratio
49230,Tumor Necrosis Factor Receptor 2 Levels,Phenotype,Tumor Necrosis Factor Receptor 2 Levels
49231,Resistin Levels,Phenotype,Resistin Levels
49234,Tumor Necrosis Factor Receptor Superfamily Member 6 Levels,Phenotype,Tumor Necrosis Factor Receptor Superfamily Member 6 Levels
49235,Angiopoietin-1 Receptor Levels,Phenotype,Angiopoietin-1 Receptor Levels
49238,Heat Shock 27 Kda Protein Levels,Phenotype,Heat Shock 27 Kda Protein Levels
49240,Myeloperoxidase Levels,Phenotype,Myeloperoxidase Levels
49241,Lectin-Like Oxidized Ldl Receptor 1 Levels,Phenotype,Lectin-Like Oxidized Ldl Receptor 1 Levels
49244,Tissue Factor Levels,Phenotype,Tissue Factor Levels
49251,Type 2 Diabetes Or Prostate Cancer (Pleiotropy),Phenotype,Type 2 Diabetes Or Prostate Cancer (Pleiotropy)
49267,Tnf/Tnfrsf1B Protein Level Ratio,Phenotype,Tnf/Tnfrsf1B Protein Level Ratio
49268,Traf2/Wwp2 Protein Level Ratio,Phenotype,Traf2/Wwp2 Protein Level Ratio
49269,Usp8/Wasf1 Protein Level Ratio,Phenotype,Usp8/Wasf1 Protein Level Ratio
49270,Hbegf/Pdgfa Protein Level Ratio,Phenotype,Hbegf/Pdgfa Protein Level Ratio
49271,Tnfrsf1A/Tnfrsf1B Protein Level Ratio,Phenotype,Tnfrsf1A/Tnfrsf1B Protein Level Ratio
49272,Tnfrsf4/Tnfrsf9 Protein Level Ratio,Phenotype,Tnfrsf4/Tnfrsf9 Protein Level Ratio
49273,Tbcc/Txlna Protein Level Ratio,Phenotype,Tbcc/Txlna Protein Level Ratio
49274,Tbcc/Wwp2 Protein Level Ratio,Phenotype,Tbcc/Wwp2 Protein Level Ratio
49275,Tcl1A/Tnfrsf13C Protein Level Ratio,Phenotype,Tcl1A/Tnfrsf13C Protein Level Ratio
49276,Tgfbi/Vasn Protein Level Ratio,Phenotype,Tgfbi/Vasn Protein Level Ratio
49277,Tgfbr2/Thbd Protein Level Ratio,Phenotype,Tgfbr2/Thbd Protein Level Ratio
49279,Stat5B/Wasf1 Protein Level Ratio,Phenotype,Stat5B/Wasf1 Protein Level Ratio
49280,Stk4/Vta1 Protein Level Ratio,Phenotype,Stk4/Vta1 Protein Level Ratio
49281,Sugt1/Tbl1X Protein Level Ratio,Phenotype,Sugt1/Tbl1X Protein Level Ratio
49282,Sult1A1/Vta1 Protein Level Ratio,Phenotype,Sult1A1/Vta1 Protein Level Ratio
49283,Susd1/Thpo Protein Level Ratio,Phenotype,Susd1/Thpo Protein Level Ratio
49284,Tnfrsf13B/Tnfrsf9 Protein Level Ratio,Phenotype,Tnfrsf13B/Tnfrsf9 Protein Level Ratio
49285,Tacc3/Tbc1D23 Protein Level Ratio,Phenotype,Tacc3/Tbc1D23 Protein Level Ratio
49286,Tacc3/Triap1 Protein Level Ratio,Phenotype,Tacc3/Triap1 Protein Level Ratio
49287,Tbcb/Tbcc Protein Level Ratio,Phenotype,Tbcb/Tbcc Protein Level Ratio
49288,Cdh5/Ptprm Protein Level Ratio,Phenotype,Cdh5/Ptprm Protein Level Ratio
49289,Cdh5/Tek Protein Level Ratio,Phenotype,Cdh5/Tek Protein Level Ratio
49291,Cdkn1A/Cdkn2D Protein Level Ratio,Phenotype,Cdkn1A/Cdkn2D Protein Level Ratio
49292,Cdkn1A/Dab2 Protein Level Ratio,Phenotype,Cdkn1A/Dab2 Protein Level Ratio
49293,Cdh17/Spint1 Protein Level Ratio,Phenotype,Cdh17/Spint1 Protein Level Ratio
49294,Cdh3/Nectin4 Protein Level Ratio,Phenotype,Cdh3/Nectin4 Protein Level Ratio
49295,Cdh3/Tnfrsf21 Protein Level Ratio,Phenotype,Cdh3/Tnfrsf21 Protein Level Ratio
49296,Cdh5/Eng Protein Level Ratio,Phenotype,Cdh5/Eng Protein Level Ratio
49297,Cdh5/Notch1 Protein Level Ratio,Phenotype,Cdh5/Notch1 Protein Level Ratio
49298,Anxa3/Edar Protein Level Ratio,Phenotype,Anxa3/Edar Protein Level Ratio
49299,Anxa3/Rwdd1 Protein Level Ratio,Phenotype,Anxa3/Rwdd1 Protein Level Ratio
49300,Anxa3/Serpinb1 Protein Level Ratio,Phenotype,Anxa3/Serpinb1 Protein Level Ratio
49301,Anxa4/Hspb1 Protein Level Ratio,Phenotype,Anxa4/Hspb1 Protein Level Ratio
49302,Cdkn1A/Tacc3 Protein Level Ratio,Phenotype,Cdkn1A/Tacc3 Protein Level Ratio
49303,Cdkn1A/Tbc1D23 Protein Level Ratio,Phenotype,Cdkn1A/Tbc1D23 Protein Level Ratio
49304,Cdkn1A/Fxn Protein Level Ratio,Phenotype,Cdkn1A/Fxn Protein Level Ratio
49305,Cdkn1A/Hbegf Protein Level Ratio,Phenotype,Cdkn1A/Hbegf Protein Level Ratio
49306,Cdkn1A/Nck2 Protein Level Ratio,Phenotype,Cdkn1A/Nck2 Protein Level Ratio
49307,Cdkn1A/Pla2G4A Protein Level Ratio,Phenotype,Cdkn1A/Pla2G4A Protein Level Ratio
49308,Cdkn1A/Dnajb1 Protein Level Ratio,Phenotype,Cdkn1A/Dnajb1 Protein Level Ratio
49309,Cdkn1A/Eno2 Protein Level Ratio,Phenotype,Cdkn1A/Eno2 Protein Level Ratio
49310,Cdkn1A/Foxo1 Protein Level Ratio,Phenotype,Cdkn1A/Foxo1 Protein Level Ratio
49311,Aspartate Aminotransferase Platelet Ratio Index In High Alcohol Intake,Phenotype,Aspartate Aminotransferase Platelet Ratio Index In High Alcohol Intake
49314,Ondansetron-Induced Qt Prolongation,Phenotype,Ondansetron-Induced Qt Prolongation
49315,Carotid Artery Stenosis,Phenotype,Carotid Artery Stenosis
49317,Gut Microbiota Presence (Family Bacteroidales S24 7Group Id.11173),Phenotype,Gut Microbiota Presence (Family Bacteroidales S24 7Group Id.11173)
49318,Gut Microbiota Presence (Genus Lachnospiraceae Ucg 010 Id.11330),Phenotype,Gut Microbiota Presence (Genus Lachnospiraceae Ucg 010 Id.11330)
49320,Gut Microbiota Presence (Genus Anaerostipes Id.1991),Phenotype,Gut Microbiota Presence (Genus Anaerostipes Id.1991)
49329,Alzheimer'S Disease Or Ldl Levels (Pleiotropy),Phenotype,Alzheimer'S Disease Or Ldl Levels (Pleiotropy)
49333,Tinnitus,Phenotype,Tinnitus
49336,Low Myopia,Phenotype,Low Myopia
49343,Mitochondrial Heteroplasmy Measurement,Phenotype,Mitochondrial Heteroplasmy Measurement
49347,Ldl Levels X Ssri Levels (Escitalopram Or Citalopram) Interaction In Schizophrenia Or Bipolar Disorder,Phenotype,Ldl Levels X Ssri Levels (Escitalopram Or Citalopram) Interaction In Schizophrenia Or Bipolar Disorder
49353,Total Cholesterol Levels X Ssri Levels (Escitalopram Or Citalopram) Interaction In Schizophrenia Or Bipolar Disorder,Phenotype,Total Cholesterol Levels X Ssri Levels (Escitalopram Or Citalopram) Interaction In Schizophrenia Or Bipolar Disorder
49354,Triglyceride Levels X Ssri Levels (Escitalopram Or Citalopram) Interaction In Schizophrenia Or Bipolar Disorder,Phenotype,Triglyceride Levels X Ssri Levels (Escitalopram Or Citalopram) Interaction In Schizophrenia Or Bipolar Disorder
49358,Ldl Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder,Phenotype,Ldl Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder
49359,Hdl Levels X Fish Oil Supplementation Interaction (2Df),Phenotype,Hdl Levels X Fish Oil Supplementation Interaction (2Df)
49361,Hdl Levels X Fish Oil Supplementation Interaction (1Df),Phenotype,Hdl Levels X Fish Oil Supplementation Interaction (1Df)
49362,Triglyceride Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder,Phenotype,Triglyceride Levels X Ssri Defined Daily Dose Interaction In Schizophrenia Or Bipolar Disorder
49364,Hlae/Lilrb1 Protein Level Ratio,Phenotype,Hlae/Lilrb1 Protein Level Ratio
49366,Hmbs/Pklr Protein Level Ratio,Phenotype,Hmbs/Pklr Protein Level Ratio
49367,Hmbs/Psmg3 Protein Level Ratio,Phenotype,Hmbs/Psmg3 Protein Level Ratio
49369,Hmbs/Tgm2 Protein Level Ratio,Phenotype,Hmbs/Tgm2 Protein Level Ratio
49370,Hbegf/Pfkfb2 Protein Level Ratio,Phenotype,Hbegf/Pfkfb2 Protein Level Ratio
49371,Hbegf/Plxna4 Protein Level Ratio,Phenotype,Hbegf/Plxna4 Protein Level Ratio
49372,Hbegf/Sdc4 Protein Level Ratio,Phenotype,Hbegf/Sdc4 Protein Level Ratio
49373,Hbegf/Wwp2 Protein Level Ratio,Phenotype,Hbegf/Wwp2 Protein Level Ratio
49374,Hbegf/Yes1 Protein Level Ratio,Phenotype,Hbegf/Yes1 Protein Level Ratio
49375,Hbq1/Hmbs Protein Level Ratio,Phenotype,Hbq1/Hmbs Protein Level Ratio
49378,Hbegf/Pdgfb Protein Level Ratio,Phenotype,Hbegf/Pdgfb Protein Level Ratio
49379,Hexim1/Ikbkg Protein Level Ratio,Phenotype,Hexim1/Ikbkg Protein Level Ratio
49380,Hexim1/Stk11 Protein Level Ratio,Phenotype,Hexim1/Stk11 Protein Level Ratio
49381,Hexim1/Ipcef1 Protein Level Ratio,Phenotype,Hexim1/Ipcef1 Protein Level Ratio
49382,Hexim1/Srpk2 Protein Level Ratio,Phenotype,Hexim1/Srpk2 Protein Level Ratio
49383,Jam2/Tgfbr2 Protein Level Ratio,Phenotype,Jam2/Tgfbr2 Protein Level Ratio
49385,Jam2/Tnfrsf21 Protein Level Ratio,Phenotype,Jam2/Tnfrsf21 Protein Level Ratio
49387,Kirrel2/Pla2G1B Protein Level Ratio,Phenotype,Kirrel2/Pla2G1B Protein Level Ratio
49389,Klk6/Mog Protein Level Ratio,Phenotype,Klk6/Mog Protein Level Ratio
49390,Klrb1/Klrd1 Protein Level Ratio,Phenotype,Klrb1/Klrd1 Protein Level Ratio
49392,Chmp1A/Vash1 Protein Level Ratio,Phenotype,Chmp1A/Vash1 Protein Level Ratio
49393,Chrdl1/Smoc2 Protein Level Ratio,Phenotype,Chrdl1/Smoc2 Protein Level Ratio
49394,Ciapin1/Msra Protein Level Ratio,Phenotype,Ciapin1/Msra Protein Level Ratio
49396,Ciapin1/Park7 Protein Level Ratio,Phenotype,Ciapin1/Park7 Protein Level Ratio
49398,Ciapin1/Pla2G4A Protein Level Ratio,Phenotype,Ciapin1/Pla2G4A Protein Level Ratio
49399,Ciapin1/Plpbp Protein Level Ratio,Phenotype,Ciapin1/Plpbp Protein Level Ratio
49401,Ciapin1/Snx9 Protein Level Ratio,Phenotype,Ciapin1/Snx9 Protein Level Ratio
49402,Kifbp/Tacc3 Protein Level Ratio,Phenotype,Kifbp/Tacc3 Protein Level Ratio
49403,Chac2/Gmpr Protein Level Ratio,Phenotype,Chac2/Gmpr Protein Level Ratio
49413,Monoclonal Gammopathy Of Undetermined Significance,Phenotype,Monoclonal Gammopathy Of Undetermined Significance
49438,Energy Expenditure,Phenotype,Energy Expenditure
49449,Skin Reflectance (Melanin Index),Phenotype,Skin Reflectance (Melanin Index)
49454,Pemphigus Foliaceus,Phenotype,Pemphigus Foliaceus
49464,Iris Color (B* Coordinate),Phenotype,Iris Color (B* Coordinate)
49466,Anxiety/Tension (Special Factor Of Neuroticism),Phenotype,Anxiety/Tension (Special Factor Of Neuroticism)
49467,3-Month Functional Outcome In Ischaemic Stroke (Modified Rankin Score),Phenotype,3-Month Functional Outcome In Ischaemic Stroke (Modified Rankin Score)
49471,3-Month Functional Outcome In Non-Lacunar Ischaemic Stroke (Modified Rankin Score),Phenotype,3-Month Functional Outcome In Non-Lacunar Ischaemic Stroke (Modified Rankin Score)
49489,General Factor Of Neuroticism,Phenotype,General Factor Of Neuroticism
49509,Post Bronchodilator Fev1/Fvc Ratio In Smoking,Phenotype,Post Bronchodilator Fev1/Fvc Ratio In Smoking
49538,Obesity Without Metabolic Disease,Phenotype,Obesity Without Metabolic Disease
49544,Bronchopulmonary Dysplasia In Preterm Infants,Phenotype,Bronchopulmonary Dysplasia In Preterm Infants
49547,Plasma Parathyroid Hormone Levels,Phenotype,Plasma Parathyroid Hormone Levels
49551,Cannabis Use,Phenotype,Cannabis Use
49553,Abdominal Aortic Aneurysm,Phenotype,Abdominal Aortic Aneurysm
49555,Response To Antidepressants (Symptom Improvement),Phenotype,Response To Antidepressants (Symptom Improvement)
49558,Remission After Antidepressant Treatment In Major Depression,Phenotype,Remission After Antidepressant Treatment In Major Depression
49559,Alpha Synuclein Levels (Mtag),Phenotype,Alpha Synuclein Levels (Mtag)
49574,Response To Lurasidone In Schizophrenia,Phenotype,Response To Lurasidone In Schizophrenia
49578,Waldenström Macroglobulinemia / Lymphoplasmacytic Lymphoma,Phenotype,Waldenström Macroglobulinemia / Lymphoplasmacytic Lymphoma
49593,High Il-1Beta Levels In Gingival Crevicular Fluid,Phenotype,High Il-1Beta Levels In Gingival Crevicular Fluid
49596,Uterine Fibroid Number (Single Vs Multiple),Phenotype,Uterine Fibroid Number (Single Vs Multiple)
49598,Uterine Fibroid Size (Maximum Dimension),Phenotype,Uterine Fibroid Size (Maximum Dimension)
49600,Uterine Fibroid Size (Maximum Volume),Phenotype,Uterine Fibroid Size (Maximum Volume)
49640,Iris Heterochromicity,Phenotype,Iris Heterochromicity
49652,Gemcitabine-Induced Early High-Grade Neutropenia In Pancreatic Cancer,Phenotype,Gemcitabine-Induced Early High-Grade Neutropenia In Pancreatic Cancer
49681,Med18/Zbtb16 Protein Level Ratio,Phenotype,Med18/Zbtb16 Protein Level Ratio
49682,Col6A3/Smoc2 Protein Level Ratio,Phenotype,Col6A3/Smoc2 Protein Level Ratio
49683,Colec12/Lair1 Protein Level Ratio,Phenotype,Colec12/Lair1 Protein Level Ratio
49684,Manf/Nck2 Protein Level Ratio,Phenotype,Manf/Nck2 Protein Level Ratio
49686,Manf/Pdgfb Protein Level Ratio,Phenotype,Manf/Pdgfb Protein Level Ratio
49688,Manf/Pla2G4A Protein Level Ratio,Phenotype,Manf/Pla2G4A Protein Level Ratio
49689,Manf/Pmvk Protein Level Ratio,Phenotype,Manf/Pmvk Protein Level Ratio
49690,Mcam/Ncam1 Protein Level Ratio,Phenotype,Mcam/Ncam1 Protein Level Ratio
49691,Mcam/Ntrk3 Protein Level Ratio,Phenotype,Mcam/Ntrk3 Protein Level Ratio
49692,Mcfd2/Txndc5 Protein Level Ratio,Phenotype,Mcfd2/Txndc5 Protein Level Ratio
49693,Med18/Sh2B3 Protein Level Ratio,Phenotype,Med18/Sh2B3 Protein Level Ratio
49695,Med18/Tacc3 Protein Level Ratio,Phenotype,Med18/Tacc3 Protein Level Ratio
49696,Med18/Tbl1X Protein Level Ratio,Phenotype,Med18/Tbl1X Protein Level Ratio
49697,Map3K5/Zbtb16 Protein Level Ratio,Phenotype,Map3K5/Zbtb16 Protein Level Ratio
49699,Map4K5/Tbcc Protein Level Ratio,Phenotype,Map4K5/Tbcc Protein Level Ratio
49700,Manf/Ptpn6 Protein Level Ratio,Phenotype,Manf/Ptpn6 Protein Level Ratio
49701,Manf/Txndc5 Protein Level Ratio,Phenotype,Manf/Txndc5 Protein Level Ratio
49703,Map3K5/Mavs Protein Level Ratio,Phenotype,Map3K5/Mavs Protein Level Ratio
49704,Brain Shape (Segment 117),Phenotype,Brain Shape (Segment 117)
49706,Brain Shape (Segment 140),Phenotype,Brain Shape (Segment 140)
49707,Brain Shape (Segment 199),Phenotype,Brain Shape (Segment 199)
49709,Brain Shape (Segment 204),Phenotype,Brain Shape (Segment 204)
49711,Brain Shape (Segment 116),Phenotype,Brain Shape (Segment 116)
49713,Ctso/Igf2R Protein Level Ratio,Phenotype,Ctso/Igf2R Protein Level Ratio
49714,Ctsz/Smpdl3A Protein Level Ratio,Phenotype,Ctsz/Smpdl3A Protein Level Ratio
49715,Cx3Cl1/Ephb6 Protein Level Ratio,Phenotype,Cx3Cl1/Ephb6 Protein Level Ratio
49717,Cx3Cl1/Layn Protein Level Ratio,Phenotype,Cx3Cl1/Layn Protein Level Ratio
49718,Cx3Cl1/Rgmb Protein Level Ratio,Phenotype,Cx3Cl1/Rgmb Protein Level Ratio
49720,Csf1/Sema3F Protein Level Ratio,Phenotype,Csf1/Sema3F Protein Level Ratio
49721,Cst3/Defa1_Defa1B Protein Level Ratio,Phenotype,Cst3/Defa1_Defa1B Protein Level Ratio
49723,Cst3/Rarres2 Protein Level Ratio,Phenotype,Cst3/Rarres2 Protein Level Ratio
49724,Cst3/Retn Protein Level Ratio,Phenotype,Cst3/Retn Protein Level Ratio
49725,Cst3/Tff3 Protein Level Ratio,Phenotype,Cst3/Tff3 Protein Level Ratio
49726,Ctf1/Itgb1Bp2 Protein Level Ratio,Phenotype,Ctf1/Itgb1Bp2 Protein Level Ratio
49727,Ctrb1/Kirrel2 Protein Level Ratio,Phenotype,Ctrb1/Kirrel2 Protein Level Ratio
49729,Ctrb1/Pla2G1B Protein Level Ratio,Phenotype,Ctrb1/Pla2G1B Protein Level Ratio
49730,Ctrb1/Prss2 Protein Level Ratio,Phenotype,Ctrb1/Prss2 Protein Level Ratio
49731,Ctrc/Kirrel2 Protein Level Ratio,Phenotype,Ctrc/Kirrel2 Protein Level Ratio
49732,Ctrc/Pla2G1B Protein Level Ratio,Phenotype,Ctrc/Pla2G1B Protein Level Ratio
49733,Ctsf/Smpdl3A Protein Level Ratio,Phenotype,Ctsf/Smpdl3A Protein Level Ratio
49734,Crtam/Pdcd1 Protein Level Ratio,Phenotype,Crtam/Pdcd1 Protein Level Ratio
49736,Crtam/Tnfrsf9 Protein Level Ratio,Phenotype,Crtam/Tnfrsf9 Protein Level Ratio
49737,Crtam/Vcam1 Protein Level Ratio,Phenotype,Crtam/Vcam1 Protein Level Ratio
49738,Dag1/F2R Protein Level Ratio,Phenotype,Dag1/F2R Protein Level Ratio
49740,Dag1/Hbegf Protein Level Ratio,Phenotype,Dag1/Hbegf Protein Level Ratio
49741,Dag1/Mgll Protein Level Ratio,Phenotype,Dag1/Mgll Protein Level Ratio
49744,Thymus And Reactivation Regulated Chemokine Levels,Phenotype,Thymus And Reactivation Regulated Chemokine Levels
49746,Vascular Endothelial Growth Factor A Levels,Phenotype,Vascular Endothelial Growth Factor A Levels
49748,Pdcd1/Tnfrsf4 Protein Level Ratio,Phenotype,Pdcd1/Tnfrsf4 Protein Level Ratio
49750,Pdcd1/Tnfrsf8 Protein Level Ratio,Phenotype,Pdcd1/Tnfrsf8 Protein Level Ratio
49752,Pdcd1/Tnfrsf9 Protein Level Ratio,Phenotype,Pdcd1/Tnfrsf9 Protein Level Ratio
49754,Pdgfb/Snap29 Protein Level Ratio,Phenotype,Pdgfb/Snap29 Protein Level Ratio
49758,Defa1_Defa1B/Lcn2 Protein Level Ratio,Phenotype,Defa1_Defa1B/Lcn2 Protein Level Ratio
49761,Dffa/Sirt2 Protein Level Ratio,Phenotype,Dffa/Sirt2 Protein Level Ratio
49763,Dkk1/Vegfc Protein Level Ratio,Phenotype,Dkk1/Vegfc Protein Level Ratio
49764,Pklr/Tgm2 Protein Level Ratio,Phenotype,Pklr/Tgm2 Protein Level Ratio
49765,Pklr/Ubac1 Protein Level Ratio,Phenotype,Pklr/Ubac1 Protein Level Ratio
49766,Pla2G15/Prcp Protein Level Ratio,Phenotype,Pla2G15/Prcp Protein Level Ratio
49767,Dkk1/Ipcef1 Protein Level Ratio,Phenotype,Dkk1/Ipcef1 Protein Level Ratio
49768,Dkk1/Sdc4 Protein Level Ratio,Phenotype,Dkk1/Sdc4 Protein Level Ratio
49770,Dkk1/Vegfa Protein Level Ratio,Phenotype,Dkk1/Vegfa Protein Level Ratio
49771,Dsg3/Dsg4 Protein Level Ratio,Phenotype,Dsg3/Dsg4 Protein Level Ratio
49773,Dnmbp/Stx4 Protein Level Ratio,Phenotype,Dnmbp/Stx4 Protein Level Ratio
49775,Dnmbp/Tbc1D5 Protein Level Ratio,Phenotype,Dnmbp/Tbc1D5 Protein Level Ratio
49776,Dnmbp/Tbcc Protein Level Ratio,Phenotype,Dnmbp/Tbcc Protein Level Ratio
49777,Dnmbp/Tjap1 Protein Level Ratio,Phenotype,Dnmbp/Tjap1 Protein Level Ratio
49778,Dnmbp/Wwp2 Protein Level Ratio,Phenotype,Dnmbp/Wwp2 Protein Level Ratio
49779,Dnph1/Eif4Ebp1 Protein Level Ratio,Phenotype,Dnph1/Eif4Ebp1 Protein Level Ratio
49781,Dnph1/Glod4 Protein Level Ratio,Phenotype,Dnph1/Glod4 Protein Level Ratio
49782,Dnph1/Lhpp Protein Level Ratio,Phenotype,Dnph1/Lhpp Protein Level Ratio
49784,Dnph1/Nsfl1C Protein Level Ratio,Phenotype,Dnph1/Nsfl1C Protein Level Ratio
49785,Dll1/Efemp1 Protein Level Ratio,Phenotype,Dll1/Efemp1 Protein Level Ratio
49787,Dll1/Il18Bp Protein Level Ratio,Phenotype,Dll1/Il18Bp Protein Level Ratio
49789,Dll1/Nbl1 Protein Level Ratio,Phenotype,Dll1/Nbl1 Protein Level Ratio
49791,Dll1/Nectin4 Protein Level Ratio,Phenotype,Dll1/Nectin4 Protein Level Ratio
49792,Dll1/Notch1 Protein Level Ratio,Phenotype,Dll1/Notch1 Protein Level Ratio
49793,Dll1/Tgfbr2 Protein Level Ratio,Phenotype,Dll1/Tgfbr2 Protein Level Ratio
49795,Dnaja2/Fis1 Protein Level Ratio,Phenotype,Dnaja2/Fis1 Protein Level Ratio
49796,Dnph1/Pklr Protein Level Ratio,Phenotype,Dnph1/Pklr Protein Level Ratio
49797,Dnph1/Psmg3 Protein Level Ratio,Phenotype,Dnph1/Psmg3 Protein Level Ratio
49799,Drg2/Inpp1 Protein Level Ratio,Phenotype,Drg2/Inpp1 Protein Level Ratio
49800,Drg2/Sema4D Protein Level Ratio,Phenotype,Drg2/Sema4D Protein Level Ratio
49801,Dnajb1/Sirt2 Protein Level Ratio,Phenotype,Dnajb1/Sirt2 Protein Level Ratio
49802,Dnmbp/Fkbp5 Protein Level Ratio,Phenotype,Dnmbp/Fkbp5 Protein Level Ratio
49804,Dnmbp/Ptpn1 Protein Level Ratio,Phenotype,Dnmbp/Ptpn1 Protein Level Ratio
49805,Dpp6/Sez6L Protein Level Ratio,Phenotype,Dpp6/Sez6L Protein Level Ratio
49806,Eif4G1/Hexim1 Protein Level Ratio,Phenotype,Eif4G1/Hexim1 Protein Level Ratio
49807,Efna1/Tnfrsf1A Protein Level Ratio,Phenotype,Efna1/Tnfrsf1A Protein Level Ratio
49809,Efna4/Layn Protein Level Ratio,Phenotype,Efna4/Layn Protein Level Ratio
49810,Eif4B/Rwdd1 Protein Level Ratio,Phenotype,Eif4B/Rwdd1 Protein Level Ratio
49811,Eif4B/Tbcc Protein Level Ratio,Phenotype,Eif4B/Tbcc Protein Level Ratio
49812,Eif4Ebp1/Glrx Protein Level Ratio,Phenotype,Eif4Ebp1/Glrx Protein Level Ratio
49813,Eif4Ebp1/Psmg3 Protein Level Ratio,Phenotype,Eif4Ebp1/Psmg3 Protein Level Ratio
49814,Eif4G1/Fkbp5 Protein Level Ratio,Phenotype,Eif4G1/Fkbp5 Protein Level Ratio
49815,Sdc4/Selp Protein Level Ratio,Phenotype,Sdc4/Selp Protein Level Ratio
49816,Efna4/Scarb2 Protein Level Ratio,Phenotype,Efna4/Scarb2 Protein Level Ratio
49817,Efna4/Tnfrsf10A Protein Level Ratio,Phenotype,Efna4/Tnfrsf10A Protein Level Ratio
49819,Efna4/Tnfrsf10B Protein Level Ratio,Phenotype,Efna4/Tnfrsf10B Protein Level Ratio
49820,Efna4/Tnfrsf9 Protein Level Ratio,Phenotype,Efna4/Tnfrsf9 Protein Level Ratio
49821,Egf/Manf Protein Level Ratio,Phenotype,Egf/Manf Protein Level Ratio
49822,Eif4B/Ipcef1 Protein Level Ratio,Phenotype,Eif4B/Ipcef1 Protein Level Ratio
49823,Eif4B/Metap2 Protein Level Ratio,Phenotype,Eif4B/Metap2 Protein Level Ratio
49824,Egf/Mgll Protein Level Ratio,Phenotype,Egf/Mgll Protein Level Ratio
49826,Egf/Ppib Protein Level Ratio,Phenotype,Egf/Ppib Protein Level Ratio
49827,Cc2D1A/Cdkn1A Protein Level Ratio,Phenotype,Cc2D1A/Cdkn1A Protein Level Ratio
49828,Cc2D1A/Tbcc Protein Level Ratio,Phenotype,Cc2D1A/Tbcc Protein Level Ratio
49829,Cc2D1A/Wwp2 Protein Level Ratio,Phenotype,Cc2D1A/Wwp2 Protein Level Ratio
49831,Ccl13/Ccl17 Protein Level Ratio,Phenotype,Ccl13/Ccl17 Protein Level Ratio
49833,Ccl17/Ccl22 Protein Level Ratio,Phenotype,Ccl17/Ccl22 Protein Level Ratio
49835,Ccl5/Cxcl3 Protein Level Ratio,Phenotype,Ccl5/Cxcl3 Protein Level Ratio
49837,Ccl5/Cxcl5 Protein Level Ratio,Phenotype,Ccl5/Cxcl5 Protein Level Ratio
49838,F2R/Itgb1Bp2 Protein Level Ratio,Phenotype,F2R/Itgb1Bp2 Protein Level Ratio
49839,Casp8/Serpinb1 Protein Level Ratio,Phenotype,Casp8/Serpinb1 Protein Level Ratio
49840,Cc2D1A/Cd2Ap Protein Level Ratio,Phenotype,Cc2D1A/Cd2Ap Protein Level Ratio
49842,Casp3/Sult1A1 Protein Level Ratio,Phenotype,Casp3/Sult1A1 Protein Level Ratio
49843,Casp8/Ciapin1 Protein Level Ratio,Phenotype,Casp8/Ciapin1 Protein Level Ratio
49844,Ccl17/Pdgfb Protein Level Ratio,Phenotype,Ccl17/Pdgfb Protein Level Ratio
49846,Ccl17/Thpo Protein Level Ratio,Phenotype,Ccl17/Thpo Protein Level Ratio
49847,Ccl17/Ccl5 Protein Level Ratio,Phenotype,Ccl17/Ccl5 Protein Level Ratio
49849,Ccl17/Cd69 Protein Level Ratio,Phenotype,Ccl17/Cd69 Protein Level Ratio
49851,Ccl17/Cxcl3 Protein Level Ratio,Phenotype,Ccl17/Cxcl3 Protein Level Ratio
49852,Ccl17/F2R Protein Level Ratio,Phenotype,Ccl17/F2R Protein Level Ratio
49853,Cd46/Timp1 Protein Level Ratio,Phenotype,Cd46/Timp1 Protein Level Ratio
49855,Cd48/Crtam Protein Level Ratio,Phenotype,Cd48/Crtam Protein Level Ratio
49856,Cd48/Fcrl6 Protein Level Ratio,Phenotype,Cd48/Fcrl6 Protein Level Ratio
49858,Cd48/Itgb7 Protein Level Ratio,Phenotype,Cd48/Itgb7 Protein Level Ratio
49859,Cd4/Lilrb4 Protein Level Ratio,Phenotype,Cd4/Lilrb4 Protein Level Ratio
49860,Cd58/Ifngr1 Protein Level Ratio,Phenotype,Cd58/Ifngr1 Protein Level Ratio
49862,Cd58/Mcam Protein Level Ratio,Phenotype,Cd58/Mcam Protein Level Ratio
49863,Cd5/Il16 Protein Level Ratio,Phenotype,Cd5/Il16 Protein Level Ratio
49864,Cd5/Tnfrsf9 Protein Level Ratio,Phenotype,Cd5/Tnfrsf9 Protein Level Ratio
49865,Cd38/Il12A_Il12B Protein Level Ratio,Phenotype,Cd38/Il12A_Il12B Protein Level Ratio
49866,Cd40/Fis1 Protein Level Ratio,Phenotype,Cd40/Fis1 Protein Level Ratio
49867,Cd40/Vsir Protein Level Ratio,Phenotype,Cd40/Vsir Protein Level Ratio
49901,Retinal Nerve Fibre Layer (Rnfl) Thickness,Phenotype,Retinal Nerve Fibre Layer (Rnfl) Thickness
49904,Abdominal Fat Cell Number,Phenotype,Abdominal Fat Cell Number
49908,Ganglion Cell Inner Plexiform Layer (Gcipl) Thickness,Phenotype,Ganglion Cell Inner Plexiform Layer (Gcipl) Thickness
49916,Retinal Nerve Fibre Layer Thickness Or Ganglion Cell Inner Plexiform Layer Thickness (Mtag),Phenotype,Retinal Nerve Fibre Layer Thickness Or Ganglion Cell Inner Plexiform Layer Thickness (Mtag)
49917,Qt Dynamics During Exercise,Phenotype,Qt Dynamics During Exercise
49919,Endometriosis Or Depression (Pleiotropy),Phenotype,Endometriosis Or Depression (Pleiotropy)
49936,Ssri Response To Core Syndromal Factor Measured By Ham-D-21 In Major Depressive Disorder,Phenotype,Ssri Response To Core Syndromal Factor Measured By Ham-D-21 In Major Depressive Disorder
49937,Ssri Response To Anorexia Syndromal Factor Measured By Ham-D-21 In Major Depressive Disorder,Phenotype,Ssri Response To Anorexia Syndromal Factor Measured By Ham-D-21 In Major Depressive Disorder
49939,Ssri Response To Total Ham-D-21 Score In Major Depressive Disorder,Phenotype,Ssri Response To Total Ham-D-21 Score In Major Depressive Disorder
49940,Cardiometabolic Multimorbidity,Phenotype,Cardiometabolic Multimorbidity
49941,Multisite Chronic Pain,Phenotype,Multisite Chronic Pain
49943,Haemorrhoidal Disease,Phenotype,Haemorrhoidal Disease
49946,Hair Curvature (Quantitative),Phenotype,Hair Curvature (Quantitative)
49948,Hair Curvature (Observational),Phenotype,Hair Curvature (Observational)
49970,Opioid Use Disorder Vs Exposed Controls,Phenotype,Opioid Use Disorder Vs Exposed Controls
49972,Age At Natural Menopause,Phenotype,Age At Natural Menopause
50022,Metastatic Colorectal Cancer Survival In Treatment With Chemotherapy Plus Biologics,Phenotype,Metastatic Colorectal Cancer Survival In Treatment With Chemotherapy Plus Biologics
50024,Biological Sex,Phenotype,Biological Sex
50028,Congenital Heart Disease (Anomalies Of Thoracic Arteries And Veins),Phenotype,Congenital Heart Disease (Anomalies Of Thoracic Arteries And Veins)
50035,Vitamin C Levels,Phenotype,Vitamin C Levels
50040,Phoneme Awareness,Phenotype,Phoneme Awareness
50045,Word Spelling,Phenotype,Word Spelling
50050,Reading Ability (Multivariate),Phenotype,Reading Ability (Multivariate)
50056,Rapid Automised Naming Of Letters,Phenotype,Rapid Automised Naming Of Letters
50060,Non-Word Reading,Phenotype,Non-Word Reading
50073,Smoking Status,Phenotype,Smoking Status
50078,Adverse Response To Chemotherapy (Amenorrhea) In Breast Cancer,Phenotype,Adverse Response To Chemotherapy (Amenorrhea) In Breast Cancer
50080,Alcohol Consumption,Phenotype,Alcohol Consumption
50092,Participation In An Health Questionnaire (Not Invited Vs Invited),Phenotype,Participation In An Health Questionnaire (Not Invited Vs Invited)
50096,Glucosuria (Moderate To Severe),Phenotype,Glucosuria (Moderate To Severe)
50099,Glucosuria (Mild),Phenotype,Glucosuria (Mild)
50101,Glucosuria,Phenotype,Glucosuria
50141,Liver Fibrosis In Non-Alcoholic Fatty Liver Disease,Phenotype,Liver Fibrosis In Non-Alcoholic Fatty Liver Disease
50143,Non-Alcoholic Fatty Liver Disease Activity Score In Non-Alcoholic Fatty Liver Disease,Phenotype,Non-Alcoholic Fatty Liver Disease Activity Score In Non-Alcoholic Fatty Liver Disease
50147,Neurological Blood Protein Biomarker Levels,Phenotype,Neurological Blood Protein Biomarker Levels
50181,Annualised Percent Change Of Cerebrospinal Fluid Ab1-42 Levels,Phenotype,Annualised Percent Change Of Cerebrospinal Fluid Ab1-42 Levels
50183,Cognitive Ability-- Years Of Educational Attainment Or Schizophrenia (Pleiotropy),Phenotype,Cognitive Ability-- Years Of Educational Attainment Or Schizophrenia (Pleiotropy)
50191,Anti-Anoctamin 2 Antibody Levels,Phenotype,Anti-Anoctamin 2 Antibody Levels
50201,Airway Obstruction (Fev1/Fvc<70%) In Never Smokers,Phenotype,Airway Obstruction (Fev1/Fvc<70%) In Never Smokers
50203,Airway Obstruction (Fev1/Fvc<Lower Limit Of Normal) In Never Smokers,Phenotype,Airway Obstruction (Fev1/Fvc<Lower Limit Of Normal) In Never Smokers
50227,Glomerular Filtration Rate In Type 2 Diabetes,Phenotype,Glomerular Filtration Rate In Type 2 Diabetes
50228,Glomerular Filtration Rate In Diabetes,Phenotype,Glomerular Filtration Rate In Diabetes
50229,Diabetic Kidney Disease In Type 2 Diabetes (Esrd Vs. No Esrd),Phenotype,Diabetic Kidney Disease In Type 2 Diabetes (Esrd Vs. No Esrd)
50232,Early Diabetic Kidney Disease In Type 2 Diabetes,Phenotype,Early Diabetic Kidney Disease In Type 2 Diabetes
50234,Diabetic Kidney Disease In Type 2 Diabetes,Phenotype,Diabetic Kidney Disease In Type 2 Diabetes
50236,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio,Phenotype,Central Cerebrospinal Fluid Amyloid Beta 42 To 40 Ratio
50238,Contamination Dimension In Obsessive Compulsive Disorder,Phenotype,Contamination Dimension In Obsessive Compulsive Disorder
50250,Type 2 Diabetes Nephropathy Including Microalbuminuria,Phenotype,Type 2 Diabetes Nephropathy Including Microalbuminuria
50308,Facial Morphology (Forehead Protrusion 1),Phenotype,Facial Morphology (Forehead Protrusion 1)
50310,Facial Morphology (Brow Ridge Protrusion 1),Phenotype,Facial Morphology (Brow Ridge Protrusion 1)
50312,Facial Morphology (Lower Lip Protrusion),Phenotype,Facial Morphology (Lower Lip Protrusion)
50314,Facial Morphology (Lip Protrusion),Phenotype,Facial Morphology (Lip Protrusion)
50315,Facial Morphology (Brow Ridge Protrusion 2),Phenotype,Facial Morphology (Brow Ridge Protrusion 2)
50316,Facial Morphology (Upper Face Flatness),Phenotype,Facial Morphology (Upper Face Flatness)
50317,Tuberculosis (Snp X Snp Interaction),Phenotype,Tuberculosis (Snp X Snp Interaction)
50322,Psychological Distress,Phenotype,Psychological Distress
50334,Fish Intake Frequency,Phenotype,Fish Intake Frequency
50340,Lag3/Vcam1 Protein Level Ratio,Phenotype,Lag3/Vcam1 Protein Level Ratio
50342,Layn/Ulbp2 Protein Level Ratio,Phenotype,Layn/Ulbp2 Protein Level Ratio
50344,Lbr/Rwdd1 Protein Level Ratio,Phenotype,Lbr/Rwdd1 Protein Level Ratio
50345,Lbr/Serpinb1 Protein Level Ratio,Phenotype,Lbr/Serpinb1 Protein Level Ratio
50346,Klrd1/Ly9 Protein Level Ratio,Phenotype,Klrd1/Ly9 Protein Level Ratio
50347,Cep43/Usp8 Protein Level Ratio,Phenotype,Cep43/Usp8 Protein Level Ratio
50348,Cep43/Wasf1 Protein Level Ratio,Phenotype,Cep43/Wasf1 Protein Level Ratio
50349,Lama4/Nid1 Protein Level Ratio,Phenotype,Lama4/Nid1 Protein Level Ratio
50351,Lamp3/Msln Protein Level Ratio,Phenotype,Lamp3/Msln Protein Level Ratio
50353,Lat2/Manf Protein Level Ratio,Phenotype,Lat2/Manf Protein Level Ratio
50354,Lat2/Serpinb1 Protein Level Ratio,Phenotype,Lat2/Serpinb1 Protein Level Ratio
50355,Lat2/Yes1 Protein Level Ratio,Phenotype,Lat2/Yes1 Protein Level Ratio
50356,Chac2/Tpmt Protein Level Ratio,Phenotype,Chac2/Tpmt Protein Level Ratio
50358,Chgb/Mog Protein Level Ratio,Phenotype,Chgb/Mog Protein Level Ratio
50360,Chgb/Ptprn2 Protein Level Ratio,Phenotype,Chgb/Ptprn2 Protein Level Ratio
50361,Chmp1A/Cradd Protein Level Ratio,Phenotype,Chmp1A/Cradd Protein Level Ratio
50362,Chmp1A/Dctn1 Protein Level Ratio,Phenotype,Chmp1A/Dctn1 Protein Level Ratio
50363,Chmp1A/Eif4B Protein Level Ratio,Phenotype,Chmp1A/Eif4B Protein Level Ratio
50364,Chmp1A/Ereg Protein Level Ratio,Phenotype,Chmp1A/Ereg Protein Level Ratio
50365,Chmp1A/Hpcal1 Protein Level Ratio,Phenotype,Chmp1A/Hpcal1 Protein Level Ratio
50366,Chmp1A/Mitd1 Protein Level Ratio,Phenotype,Chmp1A/Mitd1 Protein Level Ratio
50367,Chmp1A/Pla2G4A Protein Level Ratio,Phenotype,Chmp1A/Pla2G4A Protein Level Ratio
50368,Chmp1A/Ptpn6 Protein Level Ratio,Phenotype,Chmp1A/Ptpn6 Protein Level Ratio
50369,Chmp1A/Rhoc Protein Level Ratio,Phenotype,Chmp1A/Rhoc Protein Level Ratio
50370,Chmp1A/Snap23 Protein Level Ratio,Phenotype,Chmp1A/Snap23 Protein Level Ratio
50371,Chmp1A/Snap29 Protein Level Ratio,Phenotype,Chmp1A/Snap29 Protein Level Ratio
50372,Chmp1A/Stambp Protein Level Ratio,Phenotype,Chmp1A/Stambp Protein Level Ratio
50373,Chmp1A/Stk11 Protein Level Ratio,Phenotype,Chmp1A/Stk11 Protein Level Ratio
50374,Chmp1A/Sugt1 Protein Level Ratio,Phenotype,Chmp1A/Sugt1 Protein Level Ratio
50375,Chmp1A/Tbcb Protein Level Ratio,Phenotype,Chmp1A/Tbcb Protein Level Ratio
50376,Chmp1A/Usp8 Protein Level Ratio,Phenotype,Chmp1A/Usp8 Protein Level Ratio
50377,Clec1B/Egf Protein Level Ratio,Phenotype,Clec1B/Egf Protein Level Ratio
50378,Clec1B/Hbegf Protein Level Ratio,Phenotype,Clec1B/Hbegf Protein Level Ratio
50379,Clec1B/Hexim1 Protein Level Ratio,Phenotype,Clec1B/Hexim1 Protein Level Ratio
50380,Mpi/Sirt2 Protein Level Ratio,Phenotype,Mpi/Sirt2 Protein Level Ratio
50381,Mpi/Tacc3 Protein Level Ratio,Phenotype,Mpi/Tacc3 Protein Level Ratio
50382,Mpo/Prtn3 Protein Level Ratio,Phenotype,Mpo/Prtn3 Protein Level Ratio
50383,Mog/Ptprn2 Protein Level Ratio,Phenotype,Mog/Ptprn2 Protein Level Ratio
50384,Mog/Rtbdn Protein Level Ratio,Phenotype,Mog/Rtbdn Protein Level Ratio
50385,Mog/Sez6L Protein Level Ratio,Phenotype,Mog/Sez6L Protein Level Ratio
50386,Creld2/Sumf2 Protein Level Ratio,Phenotype,Creld2/Sumf2 Protein Level Ratio
50388,Creld2/Txndc5 Protein Level Ratio,Phenotype,Creld2/Txndc5 Protein Level Ratio
50389,Crim1/Nrp2 Protein Level Ratio,Phenotype,Crim1/Nrp2 Protein Level Ratio
50391,Crkl/Serpinb1 Protein Level Ratio,Phenotype,Crkl/Serpinb1 Protein Level Ratio
50392,Crtam/Fcrl6 Protein Level Ratio,Phenotype,Crtam/Fcrl6 Protein Level Ratio
50394,Crtam/Gzma Protein Level Ratio,Phenotype,Crtam/Gzma Protein Level Ratio
50395,Crtam/Icam3 Protein Level Ratio,Phenotype,Crtam/Icam3 Protein Level Ratio
50396,Crtam/Klrd1 Protein Level Ratio,Phenotype,Crtam/Klrd1 Protein Level Ratio
50398,Crkl/Manf Protein Level Ratio,Phenotype,Crkl/Manf Protein Level Ratio
50399,Crkl/Mgll Protein Level Ratio,Phenotype,Crkl/Mgll Protein Level Ratio
50400,Mphosph8/Wasf1 Protein Level Ratio,Phenotype,Mphosph8/Wasf1 Protein Level Ratio
50401,Mpig6B/Plxna4 Protein Level Ratio,Phenotype,Mpig6B/Plxna4 Protein Level Ratio
50403,Msra/Serpinb1 Protein Level Ratio,Phenotype,Msra/Serpinb1 Protein Level Ratio
50404,Obstructive Sleep Apnea,Phenotype,Obstructive Sleep Apnea
50405,Brain Shape (Segment 1),Phenotype,Brain Shape (Segment 1)
50408,Nid1/Sort1 Protein Level Ratio,Phenotype,Nid1/Sort1 Protein Level Ratio
50410,Notch1/Tie1 Protein Level Ratio,Phenotype,Notch1/Tie1 Protein Level Ratio
50412,Msra/Snx9 Protein Level Ratio,Phenotype,Msra/Snx9 Protein Level Ratio
50413,Msra/Tjap1 Protein Level Ratio,Phenotype,Msra/Tjap1 Protein Level Ratio
50414,Mvk/Shmt1 Protein Level Ratio,Phenotype,Mvk/Shmt1 Protein Level Ratio
50416,Nfatc1/Tjap1 Protein Level Ratio,Phenotype,Nfatc1/Tjap1 Protein Level Ratio
50417,Nsfl1C/Psmg3 Protein Level Ratio,Phenotype,Nsfl1C/Psmg3 Protein Level Ratio
50418,Nsfl1C/Rwdd1 Protein Level Ratio,Phenotype,Nsfl1C/Rwdd1 Protein Level Ratio
50419,Nucb2/Txndc5 Protein Level Ratio,Phenotype,Nucb2/Txndc5 Protein Level Ratio
50420,Nudt5/Rwdd1 Protein Level Ratio,Phenotype,Nudt5/Rwdd1 Protein Level Ratio
50421,Nudt5/Serpinb1 Protein Level Ratio,Phenotype,Nudt5/Serpinb1 Protein Level Ratio
50422,Olr1/Osm Protein Level Ratio,Phenotype,Olr1/Osm Protein Level Ratio
50424,Dapp1/Itgb1Bp2 Protein Level Ratio,Phenotype,Dapp1/Itgb1Bp2 Protein Level Ratio
50425,Pik3Ip1/Tnfrsf1A Protein Level Ratio,Phenotype,Pik3Ip1/Tnfrsf1A Protein Level Ratio
50426,Pik3Ip1/Tnfrsf1B Protein Level Ratio,Phenotype,Pik3Ip1/Tnfrsf1B Protein Level Ratio
50428,App/Hbegf Protein Level Ratio,Phenotype,App/Hbegf Protein Level Ratio
50430,Pear1/Treml2 Protein Level Ratio,Phenotype,Pear1/Treml2 Protein Level Ratio
50431,Pfkfb2/Serpinb1 Protein Level Ratio,Phenotype,Pfkfb2/Serpinb1 Protein Level Ratio
50432,Pik3Ap1/Psmg3 Protein Level Ratio,Phenotype,Pik3Ap1/Psmg3 Protein Level Ratio
50433,Urine 6-Hydroxymelatonin Sulfate-To-Creatinine Ratio,Phenotype,Urine 6-Hydroxymelatonin Sulfate-To-Creatinine Ratio
50435,Ppp1R2/Tbl1X Protein Level Ratio,Phenotype,Ppp1R2/Tbl1X Protein Level Ratio
50436,Axin1/Calcoco1 Protein Level Ratio,Phenotype,Axin1/Calcoco1 Protein Level Ratio
50438,Axin1/Cdkn1A Protein Level Ratio,Phenotype,Axin1/Cdkn1A Protein Level Ratio
50439,Axin1/Clip2 Protein Level Ratio,Phenotype,Axin1/Clip2 Protein Level Ratio
50440,Axin1/Dapp1 Protein Level Ratio,Phenotype,Axin1/Dapp1 Protein Level Ratio
50441,Ppp1R2/Tacc3 Protein Level Ratio,Phenotype,Ppp1R2/Tacc3 Protein Level Ratio
50442,Prkar1A/Snap23 Protein Level Ratio,Phenotype,Prkar1A/Snap23 Protein Level Ratio
50443,Axin1/Bach1 Protein Level Ratio,Phenotype,Axin1/Bach1 Protein Level Ratio
50444,Axin1/Bank1 Protein Level Ratio,Phenotype,Axin1/Bank1 Protein Level Ratio
50445,Axin1/Dok2 Protein Level Ratio,Phenotype,Axin1/Dok2 Protein Level Ratio
50446,Axin1/Gopc Protein Level Ratio,Phenotype,Axin1/Gopc Protein Level Ratio
50447,Axin1/Hexim1 Protein Level Ratio,Phenotype,Axin1/Hexim1 Protein Level Ratio
50448,Robo2/Scarf2 Protein Level Ratio,Phenotype,Robo2/Scarf2 Protein Level Ratio
50449,Robo2/Sftpd Protein Level Ratio,Phenotype,Robo2/Sftpd Protein Level Ratio
50451,Rwdd1/Serpinb6 Protein Level Ratio,Phenotype,Rwdd1/Serpinb6 Protein Level Ratio
50454,Rwdd1/Stambp Protein Level Ratio,Phenotype,Rwdd1/Stambp Protein Level Ratio
50455,Rwdd1/Sult1A1 Protein Level Ratio,Phenotype,Rwdd1/Sult1A1 Protein Level Ratio
50456,Blvrb/Hagh Protein Level Ratio,Phenotype,Blvrb/Hagh Protein Level Ratio
50457,Blvrb/Hbq1 Protein Level Ratio,Phenotype,Blvrb/Hbq1 Protein Level Ratio
50458,Blvrb/Hmbs Protein Level Ratio,Phenotype,Blvrb/Hmbs Protein Level Ratio
50459,Bcan/Mog Protein Level Ratio,Phenotype,Bcan/Mog Protein Level Ratio
50461,Rwdd1/Txndc5 Protein Level Ratio,Phenotype,Rwdd1/Txndc5 Protein Level Ratio
50462,Rwdd1/Vta1 Protein Level Ratio,Phenotype,Rwdd1/Vta1 Protein Level Ratio
50464,S100A4/Snx9 Protein Level Ratio,Phenotype,S100A4/Snx9 Protein Level Ratio
50465,Bcr/Itgb1Bp2 Protein Level Ratio,Phenotype,Bcr/Itgb1Bp2 Protein Level Ratio
50466,Bcr/Plxna4 Protein Level Ratio,Phenotype,Bcr/Plxna4 Protein Level Ratio
50467,Bin2/Tjap1 Protein Level Ratio,Phenotype,Bin2/Tjap1 Protein Level Ratio
50468,Blvrb/Ca2 Protein Level Ratio,Phenotype,Blvrb/Ca2 Protein Level Ratio
50469,Bin2/Coro1A Protein Level Ratio,Phenotype,Bin2/Coro1A Protein Level Ratio
50470,Cant1/Gsta1 Protein Level Ratio,Phenotype,Cant1/Gsta1 Protein Level Ratio
50471,Carhsp1/Hmbs Protein Level Ratio,Phenotype,Carhsp1/Hmbs Protein Level Ratio
50473,Carhsp1/Tbc1D17 Protein Level Ratio,Phenotype,Carhsp1/Tbc1D17 Protein Level Ratio
50474,Eng/Ncam2 Protein Level Ratio,Phenotype,Eng/Ncam2 Protein Level Ratio
50475,Ca3/Hmbs Protein Level Ratio,Phenotype,Ca3/Hmbs Protein Level Ratio
50476,Ca5A/Grpel1 Protein Level Ratio,Phenotype,Ca5A/Grpel1 Protein Level Ratio
50478,Ca5A/Gsta1 Protein Level Ratio,Phenotype,Ca5A/Gsta1 Protein Level Ratio
50479,Ca5A/Krt18 Protein Level Ratio,Phenotype,Ca5A/Krt18 Protein Level Ratio
50480,Ca5A/Sult2A1 Protein Level Ratio,Phenotype,Ca5A/Sult2A1 Protein Level Ratio
50481,Ca9/Cblif Protein Level Ratio,Phenotype,Ca9/Cblif Protein Level Ratio
50483,Eno1/Fis1 Protein Level Ratio,Phenotype,Eno1/Fis1 Protein Level Ratio
50484,Eno1/Rwdd1 Protein Level Ratio,Phenotype,Eno1/Rwdd1 Protein Level Ratio
50485,Eno1/Serpinb6 Protein Level Ratio,Phenotype,Eno1/Serpinb6 Protein Level Ratio
50486,Eno1/Sult1A1 Protein Level Ratio,Phenotype,Eno1/Sult1A1 Protein Level Ratio
50487,Eno1/Vta1 Protein Level Ratio,Phenotype,Eno1/Vta1 Protein Level Ratio
50488,Ca1/Ca2 Protein Level Ratio,Phenotype,Ca1/Ca2 Protein Level Ratio
50489,Ca1/Hmbs Protein Level Ratio,Phenotype,Ca1/Hmbs Protein Level Ratio
50490,Ca1/Tgm2 Protein Level Ratio,Phenotype,Ca1/Tgm2 Protein Level Ratio
50491,Ca2/Ca3 Protein Level Ratio,Phenotype,Ca2/Ca3 Protein Level Ratio
50492,Ca2/Dnph1 Protein Level Ratio,Phenotype,Ca2/Dnph1 Protein Level Ratio
50493,Ca2/Hagh Protein Level Ratio,Phenotype,Ca2/Hagh Protein Level Ratio
50494,Ca2/Hmbs Protein Level Ratio,Phenotype,Ca2/Hmbs Protein Level Ratio
50495,Ca2/Psmg3 Protein Level Ratio,Phenotype,Ca2/Psmg3 Protein Level Ratio
50496,Calcoco1/Map3K5 Protein Level Ratio,Phenotype,Calcoco1/Map3K5 Protein Level Ratio
50497,Calcoco1/Tjap1 Protein Level Ratio,Phenotype,Calcoco1/Tjap1 Protein Level Ratio
50498,Cd209/Gp2 Protein Level Ratio,Phenotype,Cd209/Gp2 Protein Level Ratio
50499,Cd22/Cd79B Protein Level Ratio,Phenotype,Cd22/Cd79B Protein Level Ratio
50501,Cd22/Fcer2 Protein Level Ratio,Phenotype,Cd22/Fcer2 Protein Level Ratio
50503,Cd22/Fcrl1 Protein Level Ratio,Phenotype,Cd22/Fcrl1 Protein Level Ratio
50504,Cd22/Folr2 Protein Level Ratio,Phenotype,Cd22/Folr2 Protein Level Ratio
50505,Cd22/Sema7A Protein Level Ratio,Phenotype,Cd22/Sema7A Protein Level Ratio
50506,Fcrl5/Mzb1 Protein Level Ratio,Phenotype,Fcrl5/Mzb1 Protein Level Ratio
50507,Fcrl6/Gzma Protein Level Ratio,Phenotype,Fcrl6/Gzma Protein Level Ratio
50509,Fcrl6/Klrd1 Protein Level Ratio,Phenotype,Fcrl6/Klrd1 Protein Level Ratio
50511,Cd22/Tnfrsf13C Protein Level Ratio,Phenotype,Cd22/Tnfrsf13C Protein Level Ratio
50512,Cd244/Crtam Protein Level Ratio,Phenotype,Cd244/Crtam Protein Level Ratio
50514,Cd244/Treml2 Protein Level Ratio,Phenotype,Cd244/Treml2 Protein Level Ratio
50516,Cd109/Cntn4 Protein Level Ratio,Phenotype,Cd109/Cntn4 Protein Level Ratio
50518,Cd160/Il15 Protein Level Ratio,Phenotype,Cd160/Il15 Protein Level Ratio
50519,Cd160/Kir2Dl3 Protein Level Ratio,Phenotype,Cd160/Kir2Dl3 Protein Level Ratio
50520,Cd160/Klrb1 Protein Level Ratio,Phenotype,Cd160/Klrb1 Protein Level Ratio
50521,Cd160/Ncr1 Protein Level Ratio,Phenotype,Cd160/Ncr1 Protein Level Ratio
50523,Fis1/Hspa1A Protein Level Ratio,Phenotype,Fis1/Hspa1A Protein Level Ratio
50524,Fis1/Htra2 Protein Level Ratio,Phenotype,Fis1/Htra2 Protein Level Ratio
50525,Cd163/Msr1 Protein Level Ratio,Phenotype,Cd163/Msr1 Protein Level Ratio
50526,Cd163/Siglec1 Protein Level Ratio,Phenotype,Cd163/Siglec1 Protein Level Ratio
50527,Cd164/Cd99 Protein Level Ratio,Phenotype,Cd164/Cd99 Protein Level Ratio
50529,Cd1C/Cd207 Protein Level Ratio,Phenotype,Cd1C/Cd207 Protein Level Ratio
50530,Cd27/Icam3 Protein Level Ratio,Phenotype,Cd27/Icam3 Protein Level Ratio
50531,Cd27/Tnfrsf13B Protein Level Ratio,Phenotype,Cd27/Tnfrsf13B Protein Level Ratio
50533,Cd2Ap/Cd40 Protein Level Ratio,Phenotype,Cd2Ap/Cd40 Protein Level Ratio
50534,Cd2Ap/Eif4Ebp1 Protein Level Ratio,Phenotype,Cd2Ap/Eif4Ebp1 Protein Level Ratio
50535,Cd2Ap/Plpbp Protein Level Ratio,Phenotype,Cd2Ap/Plpbp Protein Level Ratio
50536,Cd2Ap/Snx9 Protein Level Ratio,Phenotype,Cd2Ap/Snx9 Protein Level Ratio
50538,Cd2Ap/Traf2 Protein Level Ratio,Phenotype,Cd2Ap/Traf2 Protein Level Ratio
50539,Cd2Ap/Vsir Protein Level Ratio,Phenotype,Cd2Ap/Vsir Protein Level Ratio
50540,Fcrl2/Ly9 Protein Level Ratio,Phenotype,Fcrl2/Ly9 Protein Level Ratio
50543,Fcrl2/Sema7A Protein Level Ratio,Phenotype,Fcrl2/Sema7A Protein Level Ratio
50544,Fcrl2/Tnfrsf13B Protein Level Ratio,Phenotype,Fcrl2/Tnfrsf13B Protein Level Ratio
50555,Ahsp/Hmbs Protein Level Ratio,Phenotype,Ahsp/Hmbs Protein Level Ratio
50558,Aif1/Tpmt Protein Level Ratio,Phenotype,Aif1/Tpmt Protein Level Ratio
50560,Ak1/Dnph1 Protein Level Ratio,Phenotype,Ak1/Dnph1 Protein Level Ratio
50561,Agxt/Ca5A Protein Level Ratio,Phenotype,Agxt/Ca5A Protein Level Ratio
50562,Agxt/Gsta1 Protein Level Ratio,Phenotype,Agxt/Gsta1 Protein Level Ratio
50563,Ahcy/Hspa1A Protein Level Ratio,Phenotype,Ahcy/Hspa1A Protein Level Ratio
50564,Ahsp/Blvrb Protein Level Ratio,Phenotype,Ahsp/Blvrb Protein Level Ratio
50566,Ahsp/Ca2 Protein Level Ratio,Phenotype,Ahsp/Ca2 Protein Level Ratio
50568,Ahsp/Hbq1 Protein Level Ratio,Phenotype,Ahsp/Hbq1 Protein Level Ratio
50570,Aarsd1/Pik3Ap1 Protein Level Ratio,Phenotype,Aarsd1/Pik3Ap1 Protein Level Ratio
50571,Aarsd1/Psmg3 Protein Level Ratio,Phenotype,Aarsd1/Psmg3 Protein Level Ratio
50572,Aarsd1/Rwdd1 Protein Level Ratio,Phenotype,Aarsd1/Rwdd1 Protein Level Ratio
50573,Abhd14B/Aprt Protein Level Ratio,Phenotype,Abhd14B/Aprt Protein Level Ratio
50575,Abhd14B/Ccs Protein Level Ratio,Phenotype,Abhd14B/Ccs Protein Level Ratio
50576,Adh4/Ca5A Protein Level Ratio,Phenotype,Adh4/Ca5A Protein Level Ratio
50577,Adh4/Gsta1 Protein Level Ratio,Phenotype,Adh4/Gsta1 Protein Level Ratio
50578,Adh4/Krt18 Protein Level Ratio,Phenotype,Adh4/Krt18 Protein Level Ratio
50580,Agrn/Btn2A1 Protein Level Ratio,Phenotype,Agrn/Btn2A1 Protein Level Ratio
50582,Longevity (100 Years And Older),Phenotype,Longevity (100 Years And Older)
50584,Facial Wrinkles (Frown Lines),Phenotype,Facial Wrinkles (Frown Lines)
50589,Lbr/Txndc5 Protein Level Ratio,Phenotype,Lbr/Txndc5 Protein Level Ratio
50590,Lcn2/Pglyrp1 Protein Level Ratio,Phenotype,Lcn2/Pglyrp1 Protein Level Ratio
50591,Lcn2/Retn Protein Level Ratio,Phenotype,Lcn2/Retn Protein Level Ratio
50592,Ldlr/Megf9 Protein Level Ratio,Phenotype,Ldlr/Megf9 Protein Level Ratio
50593,Manf/Mesd Protein Level Ratio,Phenotype,Manf/Mesd Protein Level Ratio
50594,Manf/Mpig6B Protein Level Ratio,Phenotype,Manf/Mpig6B Protein Level Ratio
50595,Lyn/Tacc3 Protein Level Ratio,Phenotype,Lyn/Tacc3 Protein Level Ratio
50596,Col18A1/Retn Protein Level Ratio,Phenotype,Col18A1/Retn Protein Level Ratio
50597,Cnpy4/Sirt2 Protein Level Ratio,Phenotype,Cnpy4/Sirt2 Protein Level Ratio
50600,Cnpy4/Tbc1D23 Protein Level Ratio,Phenotype,Cnpy4/Tbc1D23 Protein Level Ratio
50602,Cnst/Itgb1Bp2 Protein Level Ratio,Phenotype,Cnst/Itgb1Bp2 Protein Level Ratio
50603,Cntn1/Egfr Protein Level Ratio,Phenotype,Cntn1/Egfr Protein Level Ratio
50604,Cnpy4/Inpp1 Protein Level Ratio,Phenotype,Cnpy4/Inpp1 Protein Level Ratio
50605,Cnpy4/Kifbp Protein Level Ratio,Phenotype,Cnpy4/Kifbp Protein Level Ratio
50606,Cnpy4/Manf Protein Level Ratio,Phenotype,Cnpy4/Manf Protein Level Ratio
50607,Cnpy4/Mesd Protein Level Ratio,Phenotype,Cnpy4/Mesd Protein Level Ratio
50609,Cnpy4/Mpi Protein Level Ratio,Phenotype,Cnpy4/Mpi Protein Level Ratio
50612,Clps/Ctrb1 Protein Level Ratio,Phenotype,Clps/Ctrb1 Protein Level Ratio
50614,Clps/Pla2G1B Protein Level Ratio,Phenotype,Clps/Pla2G1B Protein Level Ratio
50615,Clps/Prss2 Protein Level Ratio,Phenotype,Clps/Prss2 Protein Level Ratio
50616,Cnpy4/Erbin Protein Level Ratio,Phenotype,Cnpy4/Erbin Protein Level Ratio
50618,Clip2/Pdlim7 Protein Level Ratio,Phenotype,Clip2/Pdlim7 Protein Level Ratio
50619,Cpb1/Prss2 Protein Level Ratio,Phenotype,Cpb1/Prss2 Protein Level Ratio
50620,Cpb1/Reg1A Protein Level Ratio,Phenotype,Cpb1/Reg1A Protein Level Ratio
50621,Cpped1/Ppcdc Protein Level Ratio,Phenotype,Cpped1/Ppcdc Protein Level Ratio
50623,Cpxm1/Dkk1 Protein Level Ratio,Phenotype,Cpxm1/Dkk1 Protein Level Ratio
50624,Cpxm1/Hbegf Protein Level Ratio,Phenotype,Cpxm1/Hbegf Protein Level Ratio
50626,Colec12/Tgfbr2 Protein Level Ratio,Phenotype,Colec12/Tgfbr2 Protein Level Ratio
50627,Cradd/Stambp Protein Level Ratio,Phenotype,Cradd/Stambp Protein Level Ratio
50628,Cradd/Tbcc Protein Level Ratio,Phenotype,Cradd/Tbcc Protein Level Ratio
50629,Creg1/Gusb Protein Level Ratio,Phenotype,Creg1/Gusb Protein Level Ratio
50630,Cpb1/Ctrb1 Protein Level Ratio,Phenotype,Cpb1/Ctrb1 Protein Level Ratio
50631,Cpb1/Ctrc Protein Level Ratio,Phenotype,Cpb1/Ctrc Protein Level Ratio
50632,Cpb1/Kirrel2 Protein Level Ratio,Phenotype,Cpb1/Kirrel2 Protein Level Ratio
50633,Cradd/Edar Protein Level Ratio,Phenotype,Cradd/Edar Protein Level Ratio
50634,Cradd/Fadd Protein Level Ratio,Phenotype,Cradd/Fadd Protein Level Ratio
50635,Cradd/Hspa1A Protein Level Ratio,Phenotype,Cradd/Hspa1A Protein Level Ratio
50636,Cradd/Sirt2 Protein Level Ratio,Phenotype,Cradd/Sirt2 Protein Level Ratio
50637,Comt/Itgb1Bp2 Protein Level Ratio,Phenotype,Comt/Itgb1Bp2 Protein Level Ratio
50638,Coro1A/Snx9 Protein Level Ratio,Phenotype,Coro1A/Snx9 Protein Level Ratio
50639,Coro1A/Tbc1D5 Protein Level Ratio,Phenotype,Coro1A/Tbc1D5 Protein Level Ratio
50641,Cpxm1/Lgmn Protein Level Ratio,Phenotype,Cpxm1/Lgmn Protein Level Ratio
50642,Cpxm1/Mdk Protein Level Ratio,Phenotype,Cpxm1/Mdk Protein Level Ratio
50643,Cpxm1/Sparc Protein Level Ratio,Phenotype,Cpxm1/Sparc Protein Level Ratio
50644,Cpxm1/Vegfc Protein Level Ratio,Phenotype,Cpxm1/Vegfc Protein Level Ratio
50645,Cr2/Tnfrsf13B Protein Level Ratio,Phenotype,Cr2/Tnfrsf13B Protein Level Ratio
50646,Cracr2A/Dnmbp Protein Level Ratio,Phenotype,Cracr2A/Dnmbp Protein Level Ratio
50648,Cpa1/Ctrb1 Protein Level Ratio,Phenotype,Cpa1/Ctrb1 Protein Level Ratio
50649,Cpa1/Ctrc Protein Level Ratio,Phenotype,Cpa1/Ctrc Protein Level Ratio
50650,Cracr2A/Map3K5 Protein Level Ratio,Phenotype,Cracr2A/Map3K5 Protein Level Ratio
50651,Cradd/Dars1 Protein Level Ratio,Phenotype,Cradd/Dars1 Protein Level Ratio
50652,Brain Shape (Segment 3),Phenotype,Brain Shape (Segment 3)
50653,Brain Shape (Segment 5),Phenotype,Brain Shape (Segment 5)
50655,Brain Shape (Segment 2),Phenotype,Brain Shape (Segment 2)
50658,Apom/Erbb3 Protein Level Ratio,Phenotype,Apom/Erbb3 Protein Level Ratio
50660,Nsfl1C/Serpinb1 Protein Level Ratio,Phenotype,Nsfl1C/Serpinb1 Protein Level Ratio
50661,Nsfl1C/Stip1 Protein Level Ratio,Phenotype,Nsfl1C/Stip1 Protein Level Ratio
50662,Nsfl1C/Txndc5 Protein Level Ratio,Phenotype,Nsfl1C/Txndc5 Protein Level Ratio
50663,Nt5C3A/Rwdd1 Protein Level Ratio,Phenotype,Nt5C3A/Rwdd1 Protein Level Ratio
50666,Oscar/Tnfrsf14 Protein Level Ratio,Phenotype,Oscar/Tnfrsf14 Protein Level Ratio
50667,Park7/S100A4 Protein Level Ratio,Phenotype,Park7/S100A4 Protein Level Ratio
50669,Park7/Stip1 Protein Level Ratio,Phenotype,Park7/Stip1 Protein Level Ratio
50670,Park7/Txndc5 Protein Level Ratio,Phenotype,Park7/Txndc5 Protein Level Ratio
50671,Pcdh17/Thbd Protein Level Ratio,Phenotype,Pcdh17/Thbd Protein Level Ratio
50672,Adiponectin Levels (Bmi-Adjusted),Phenotype,Adiponectin Levels (Bmi-Adjusted)
50678,Arg1/Hmbs Protein Level Ratio,Phenotype,Arg1/Hmbs Protein Level Ratio
50679,Arg1/Pklr Protein Level Ratio,Phenotype,Arg1/Pklr Protein Level Ratio
50681,Arhgap1/Rad23B Protein Level Ratio,Phenotype,Arhgap1/Rad23B Protein Level Ratio
50682,Arhgef12/Axin1 Protein Level Ratio,Phenotype,Arhgef12/Axin1 Protein Level Ratio
50683,Arhgef12/Bank1 Protein Level Ratio,Phenotype,Arhgef12/Bank1 Protein Level Ratio
50684,Art3/Rgma Protein Level Ratio,Phenotype,Art3/Rgma Protein Level Ratio
50685,Art3/Rgmb Protein Level Ratio,Phenotype,Art3/Rgmb Protein Level Ratio
50686,Arg1/Hagh Protein Level Ratio,Phenotype,Arg1/Hagh Protein Level Ratio
50687,Plaur/Prss8 Protein Level Ratio,Phenotype,Plaur/Prss8 Protein Level Ratio
50689,Plaur/Trem2 Protein Level Ratio,Phenotype,Plaur/Trem2 Protein Level Ratio
50690,Plpbp/Rwdd1 Protein Level Ratio,Phenotype,Plpbp/Rwdd1 Protein Level Ratio
50691,Plpbp/Serpinb1 Protein Level Ratio,Phenotype,Plpbp/Serpinb1 Protein Level Ratio
50692,Plpbp/Snx9 Protein Level Ratio,Phenotype,Plpbp/Snx9 Protein Level Ratio
50693,Pmvk/Rhoc Protein Level Ratio,Phenotype,Pmvk/Rhoc Protein Level Ratio
50695,Ppcdc/Rwdd1 Protein Level Ratio,Phenotype,Ppcdc/Rwdd1 Protein Level Ratio
50696,Pla2G15/Smpd1 Protein Level Ratio,Phenotype,Pla2G15/Smpd1 Protein Level Ratio
50698,Pla2G15/Smpdl3A Protein Level Ratio,Phenotype,Pla2G15/Smpdl3A Protein Level Ratio
50699,Plxna4/Vash1 Protein Level Ratio,Phenotype,Plxna4/Vash1 Protein Level Ratio
50700,Pla2G4A/Snx9 Protein Level Ratio,Phenotype,Pla2G4A/Snx9 Protein Level Ratio
50701,Pla2G4A/Tbl1X Protein Level Ratio,Phenotype,Pla2G4A/Tbl1X Protein Level Ratio
50702,Plxna4/Snap29 Protein Level Ratio,Phenotype,Plxna4/Snap29 Protein Level Ratio
50704,Plxna4/Srpk2 Protein Level Ratio,Phenotype,Plxna4/Srpk2 Protein Level Ratio
50706,Plxna4/Usp8 Protein Level Ratio,Phenotype,Plxna4/Usp8 Protein Level Ratio
50707,Ppp1R12A/Txndc5 Protein Level Ratio,Phenotype,Ppp1R12A/Txndc5 Protein Level Ratio
50709,Qpct/Rnaset2 Protein Level Ratio,Phenotype,Qpct/Rnaset2 Protein Level Ratio
50710,Rarres2/Tfpi Protein Level Ratio,Phenotype,Rarres2/Tfpi Protein Level Ratio
50712,Rhoc/Tia1 Protein Level Ratio,Phenotype,Rhoc/Tia1 Protein Level Ratio
50713,Rilp/Rwdd1 Protein Level Ratio,Phenotype,Rilp/Rwdd1 Protein Level Ratio
50714,Rnf41/Wwp2 Protein Level Ratio,Phenotype,Rnf41/Wwp2 Protein Level Ratio
50715,Rgmb/Smoc2 Protein Level Ratio,Phenotype,Rgmb/Smoc2 Protein Level Ratio
50716,Rgmb/Tnfrsf21 Protein Level Ratio,Phenotype,Rgmb/Tnfrsf21 Protein Level Ratio
50717,Rhoc/Tbcb Protein Level Ratio,Phenotype,Rhoc/Tbcb Protein Level Ratio
50718,Rhoc/Tbcc Protein Level Ratio,Phenotype,Rhoc/Tbcc Protein Level Ratio
50719,Reg1A/Tff3 Protein Level Ratio,Phenotype,Reg1A/Tff3 Protein Level Ratio
50720,Retn/Rnaset2 Protein Level Ratio,Phenotype,Retn/Rnaset2 Protein Level Ratio
50721,Ebag9/Fkbp5 Protein Level Ratio,Phenotype,Ebag9/Fkbp5 Protein Level Ratio
50722,Psmd9/Ubac1 Protein Level Ratio,Phenotype,Psmd9/Ubac1 Protein Level Ratio
50723,Psme2/Psmg3 Protein Level Ratio,Phenotype,Psme2/Psmg3 Protein Level Ratio
50724,Psme2/Rbks Protein Level Ratio,Phenotype,Psme2/Rbks Protein Level Ratio
50725,Ptpn1/Wwp2 Protein Level Ratio,Phenotype,Ptpn1/Wwp2 Protein Level Ratio
50726,Ptpn6/Sult1A1 Protein Level Ratio,Phenotype,Ptpn6/Sult1A1 Protein Level Ratio
50727,Ptpn6/Txndc5 Protein Level Ratio,Phenotype,Ptpn6/Txndc5 Protein Level Ratio
50728,Ephb6/Tnfrsf9 Protein Level Ratio,Phenotype,Ephb6/Tnfrsf9 Protein Level Ratio
50729,Epo/Tfrc Protein Level Ratio,Phenotype,Epo/Tfrc Protein Level Ratio
50730,Esam/Lama4 Protein Level Ratio,Phenotype,Esam/Lama4 Protein Level Ratio
50732,Esam/Thpo Protein Level Ratio,Phenotype,Esam/Thpo Protein Level Ratio
50733,Eno2/Rwdd1 Protein Level Ratio,Phenotype,Eno2/Rwdd1 Protein Level Ratio
50734,Eno2/Sult1A1 Protein Level Ratio,Phenotype,Eno2/Sult1A1 Protein Level Ratio
50735,Eno2/Txndc5 Protein Level Ratio,Phenotype,Eno2/Txndc5 Protein Level Ratio
50736,Erbb2/Ptprf Protein Level Ratio,Phenotype,Erbb2/Ptprf Protein Level Ratio
50737,Erbb3/Il1R2 Protein Level Ratio,Phenotype,Erbb3/Il1R2 Protein Level Ratio
50738,Erbb4/Umod Protein Level Ratio,Phenotype,Erbb4/Umod Protein Level Ratio
50739,Erbin/Lat2 Protein Level Ratio,Phenotype,Erbin/Lat2 Protein Level Ratio
50740,Ereg/Hbegf Protein Level Ratio,Phenotype,Ereg/Hbegf Protein Level Ratio
50742,Ereg/Itgb1Bp2 Protein Level Ratio,Phenotype,Ereg/Itgb1Bp2 Protein Level Ratio
50743,Erp44/Sumf2 Protein Level Ratio,Phenotype,Erp44/Sumf2 Protein Level Ratio
50744,Eno2/Itgb1Bp2 Protein Level Ratio,Phenotype,Eno2/Itgb1Bp2 Protein Level Ratio
50745,Eno2/Mgll Protein Level Ratio,Phenotype,Eno2/Mgll Protein Level Ratio
50746,Casp3/Serpinb1 Protein Level Ratio,Phenotype,Casp3/Serpinb1 Protein Level Ratio
50747,Neck Circumference,Phenotype,Neck Circumference
50748,Fkbp4/Rwdd1 Protein Level Ratio,Phenotype,Fkbp4/Rwdd1 Protein Level Ratio
50749,Fkbp4/Wwp2 Protein Level Ratio,Phenotype,Fkbp4/Wwp2 Protein Level Ratio
50750,Fkbp5/Map4K5 Protein Level Ratio,Phenotype,Fkbp5/Map4K5 Protein Level Ratio
50751,Fkbp5/Mitd1 Protein Level Ratio,Phenotype,Fkbp5/Mitd1 Protein Level Ratio
50752,Fkbp5/Mpig6B Protein Level Ratio,Phenotype,Fkbp5/Mpig6B Protein Level Ratio
50753,Fkbp5/Ptpn1 Protein Level Ratio,Phenotype,Fkbp5/Ptpn1 Protein Level Ratio
50754,Folr1/Msln Protein Level Ratio,Phenotype,Folr1/Msln Protein Level Ratio
50755,Folr2/Havcr2 Protein Level Ratio,Phenotype,Folr2/Havcr2 Protein Level Ratio
50756,Folr2/Msr1 Protein Level Ratio,Phenotype,Folr2/Msr1 Protein Level Ratio
50757,Folr2/Thy1 Protein Level Ratio,Phenotype,Folr2/Thy1 Protein Level Ratio
50759,Cd300E/Cxcl10 Protein Level Ratio,Phenotype,Cd300E/Cxcl10 Protein Level Ratio
50761,Cd300E/Lilra5 Protein Level Ratio,Phenotype,Cd300E/Lilra5 Protein Level Ratio
50763,Fli1/Tbl1X Protein Level Ratio,Phenotype,Fli1/Tbl1X Protein Level Ratio
50764,Flt1/Vegfa Protein Level Ratio,Phenotype,Flt1/Vegfa Protein Level Ratio
50765,Flt4/Icam2 Protein Level Ratio,Phenotype,Flt4/Icam2 Protein Level Ratio
50767,Cd300C/Clec14A Protein Level Ratio,Phenotype,Cd300C/Clec14A Protein Level Ratio
50768,Cd300C/Golm2 Protein Level Ratio,Phenotype,Cd300C/Golm2 Protein Level Ratio
50769,Cd300C/Havcr2 Protein Level Ratio,Phenotype,Cd300C/Havcr2 Protein Level Ratio
50770,Fis1/Mgll Protein Level Ratio,Phenotype,Fis1/Mgll Protein Level Ratio
50771,Fis1/Mpig6B Protein Level Ratio,Phenotype,Fis1/Mpig6B Protein Level Ratio
50772,Fis1/Skap2 Protein Level Ratio,Phenotype,Fis1/Skap2 Protein Level Ratio
50773,Fkbp4/Fkbp5 Protein Level Ratio,Phenotype,Fkbp4/Fkbp5 Protein Level Ratio
50774,Foxo1/Map3K5 Protein Level Ratio,Phenotype,Foxo1/Map3K5 Protein Level Ratio
50775,Fkbp5/Rhoc Protein Level Ratio,Phenotype,Fkbp5/Rhoc Protein Level Ratio
50776,Fkbp5/Tbcb Protein Level Ratio,Phenotype,Fkbp5/Tbcb Protein Level Ratio
50777,Fkbp5/Tbcc Protein Level Ratio,Phenotype,Fkbp5/Tbcc Protein Level Ratio
50778,Fkbp5/Zbtb16 Protein Level Ratio,Phenotype,Fkbp5/Zbtb16 Protein Level Ratio
50779,Fli1/Ipcef1 Protein Level Ratio,Phenotype,Fli1/Ipcef1 Protein Level Ratio
50786,Ace2/Ggt1 Protein Level Ratio,Phenotype,Ace2/Ggt1 Protein Level Ratio
50787,Acvrl1/Efna4 Protein Level Ratio,Phenotype,Acvrl1/Efna4 Protein Level Ratio
50789,Acvrl1/Tnfrsf9 Protein Level Ratio,Phenotype,Acvrl1/Tnfrsf9 Protein Level Ratio
50790,Acy1/Gsta1 Protein Level Ratio,Phenotype,Acy1/Gsta1 Protein Level Ratio
50791,Lta/Ltbr Protein Level Ratio,Phenotype,Lta/Ltbr Protein Level Ratio
50792,Ltbp2/Pdgfra Protein Level Ratio,Phenotype,Ltbp2/Pdgfra Protein Level Ratio
50794,Lgmn/Spint2 Protein Level Ratio,Phenotype,Lgmn/Spint2 Protein Level Ratio
50795,Lhpp/Pklr Protein Level Ratio,Phenotype,Lhpp/Pklr Protein Level Ratio
50796,Lrp11/Nectin2 Protein Level Ratio,Phenotype,Lrp11/Nectin2 Protein Level Ratio
50798,Lrp11/Ror1 Protein Level Ratio,Phenotype,Lrp11/Ror1 Protein Level Ratio
50799,Ckap4/Il4R Protein Level Ratio,Phenotype,Ckap4/Il4R Protein Level Ratio
50801,Ckap4/Tnfrsf4 Protein Level Ratio,Phenotype,Ckap4/Tnfrsf4 Protein Level Ratio
50802,Clec14A/Ephb4 Protein Level Ratio,Phenotype,Clec14A/Ephb4 Protein Level Ratio
50803,Clec14A/Pik3Ip1 Protein Level Ratio,Phenotype,Clec14A/Pik3Ip1 Protein Level Ratio
50805,Clec14A/Tnfrsf21 Protein Level Ratio,Phenotype,Clec14A/Tnfrsf21 Protein Level Ratio
50806,Clec4D/Mmp9 Protein Level Ratio,Phenotype,Clec4D/Mmp9 Protein Level Ratio
50807,Clec4D/Osm Protein Level Ratio,Phenotype,Clec4D/Osm Protein Level Ratio
50808,Clec4D/Tgfa Protein Level Ratio,Phenotype,Clec4D/Tgfa Protein Level Ratio
50809,Ldlr/Pcsk9 Protein Level Ratio,Phenotype,Ldlr/Pcsk9 Protein Level Ratio
50810,Lgals8/Rwdd1 Protein Level Ratio,Phenotype,Lgals8/Rwdd1 Protein Level Ratio
50811,Lgals8/Serpinb6 Protein Level Ratio,Phenotype,Lgals8/Serpinb6 Protein Level Ratio
50812,Lgals8/Txndc5 Protein Level Ratio,Phenotype,Lgals8/Txndc5 Protein Level Ratio
50813,Clec1B/Txndc5 Protein Level Ratio,Phenotype,Clec1B/Txndc5 Protein Level Ratio
50814,Clec4G/Mertk Protein Level Ratio,Phenotype,Clec4G/Mertk Protein Level Ratio
50816,Clostridioides Difficle Infection In Antibiotics-Users,Phenotype,Clostridioides Difficle Infection In Antibiotics-Users
50825,Mitd1/Tbcc Protein Level Ratio,Phenotype,Mitd1/Tbcc Protein Level Ratio
50826,Mln/Tnfrsf12A Protein Level Ratio,Phenotype,Mln/Tnfrsf12A Protein Level Ratio
50828,Mmp8/Mmp9 Protein Level Ratio,Phenotype,Mmp8/Mmp9 Protein Level Ratio
50829,Mmp8/Pglyrp1 Protein Level Ratio,Phenotype,Mmp8/Pglyrp1 Protein Level Ratio
50831,Mmp9/Olr1 Protein Level Ratio,Phenotype,Mmp9/Olr1 Protein Level Ratio
50833,Mmp9/Pglyrp1 Protein Level Ratio,Phenotype,Mmp9/Pglyrp1 Protein Level Ratio
50835,Mgll/Ptpn6 Protein Level Ratio,Phenotype,Mgll/Ptpn6 Protein Level Ratio
50836,Mgll/Shmt1 Protein Level Ratio,Phenotype,Mgll/Shmt1 Protein Level Ratio
50837,Mgll/Stk4 Protein Level Ratio,Phenotype,Mgll/Stk4 Protein Level Ratio
50838,Mgll/Vta1 Protein Level Ratio,Phenotype,Mgll/Vta1 Protein Level Ratio
50839,Micb_Mica/Tek Protein Level Ratio,Phenotype,Micb_Mica/Tek Protein Level Ratio
50841,Mif/Serpinb1 Protein Level Ratio,Phenotype,Mif/Serpinb1 Protein Level Ratio
50842,Mitd1/Snx9 Protein Level Ratio,Phenotype,Mitd1/Snx9 Protein Level Ratio
50843,Mgll/Mitd1 Protein Level Ratio,Phenotype,Mgll/Mitd1 Protein Level Ratio
50844,Mgll/Mpig6B Protein Level Ratio,Phenotype,Mgll/Mpig6B Protein Level Ratio
50845,Mgll/Pla2G4A Protein Level Ratio,Phenotype,Mgll/Pla2G4A Protein Level Ratio
50846,Metap2/Plpbp Protein Level Ratio,Phenotype,Metap2/Plpbp Protein Level Ratio
50847,Creg1/Pla2G15 Protein Level Ratio,Phenotype,Creg1/Pla2G15 Protein Level Ratio
50848,Creg1/Smpdl3A Protein Level Ratio,Phenotype,Creg1/Smpdl3A Protein Level Ratio
50849,Mesd/Serpinb1 Protein Level Ratio,Phenotype,Mesd/Serpinb1 Protein Level Ratio
50850,Brain Shape (Segment 62),Phenotype,Brain Shape (Segment 62)
50852,Brain Shape (Segment 81),Phenotype,Brain Shape (Segment 81)
50854,Brain Shape (Segment 86),Phenotype,Brain Shape (Segment 86)
50856,Brain Shape (Segment 31),Phenotype,Brain Shape (Segment 31)
50858,Brain Shape (Segment 20),Phenotype,Brain Shape (Segment 20)
50859,Brain Shape (Segment 21),Phenotype,Brain Shape (Segment 21)
50860,Brain Shape (Segment 7),Phenotype,Brain Shape (Segment 7)
50862,Cxcl3/Cxcl5 Protein Level Ratio,Phenotype,Cxcl3/Cxcl5 Protein Level Ratio
50863,Cxcl3/Mgll Protein Level Ratio,Phenotype,Cxcl3/Mgll Protein Level Ratio
50864,Cxcl3/Ptpn6 Protein Level Ratio,Phenotype,Cxcl3/Ptpn6 Protein Level Ratio
50865,App/Dkk1 Protein Level Ratio,Phenotype,App/Dkk1 Protein Level Ratio
50866,Cxcl10/Cxcl9 Protein Level Ratio,Phenotype,Cxcl10/Cxcl9 Protein Level Ratio
50867,Cxcl10/Wars Protein Level Ratio,Phenotype,Cxcl10/Wars Protein Level Ratio
50868,Cxcl11/Cxcl13 Protein Level Ratio,Phenotype,Cxcl11/Cxcl13 Protein Level Ratio
50869,Cxcl11/Itgb1Bp2 Protein Level Ratio,Phenotype,Cxcl11/Itgb1Bp2 Protein Level Ratio
50870,Cxcl11/Sdc4 Protein Level Ratio,Phenotype,Cxcl11/Sdc4 Protein Level Ratio
50871,Cxcl5/Cxcl6 Protein Level Ratio,Phenotype,Cxcl5/Cxcl6 Protein Level Ratio
50872,Cxcl5/Edar Protein Level Ratio,Phenotype,Cxcl5/Edar Protein Level Ratio
50873,Cxcl5/Mesd Protein Level Ratio,Phenotype,Cxcl5/Mesd Protein Level Ratio
50876,Brain Shape (Segment 276),Phenotype,Brain Shape (Segment 276)
50878,Brain Shape (Segment 285),Phenotype,Brain Shape (Segment 285)
50879,Cxcl5/Serpine1 Protein Level Ratio,Phenotype,Cxcl5/Serpine1 Protein Level Ratio
50880,Dab2/Nck2 Protein Level Ratio,Phenotype,Dab2/Nck2 Protein Level Ratio
50881,Dab2/Fkbp5 Protein Level Ratio,Phenotype,Dab2/Fkbp5 Protein Level Ratio
50882,Dab2/Grap2 Protein Level Ratio,Phenotype,Dab2/Grap2 Protein Level Ratio
50883,Cxcl5/Plxna4 Protein Level Ratio,Phenotype,Cxcl5/Plxna4 Protein Level Ratio
50884,Cxcl5/Ppib Protein Level Ratio,Phenotype,Cxcl5/Ppib Protein Level Ratio
50885,Brain Shape (Segment 51),Phenotype,Brain Shape (Segment 51)
50887,Brain Shape (Segment 60),Phenotype,Brain Shape (Segment 60)
50889,Atg4A/Tpmt Protein Level Ratio,Phenotype,Atg4A/Tpmt Protein Level Ratio
50890,Atox1/Gys1 Protein Level Ratio,Phenotype,Atox1/Gys1 Protein Level Ratio
50891,Dctn1/Rwdd1 Protein Level Ratio,Phenotype,Dctn1/Rwdd1 Protein Level Ratio
50892,Dcxr/Gsta1 Protein Level Ratio,Phenotype,Dcxr/Gsta1 Protein Level Ratio
50893,Dbnl/Edar Protein Level Ratio,Phenotype,Dbnl/Edar Protein Level Ratio
50894,Dbnl/Hexim1 Protein Level Ratio,Phenotype,Dbnl/Hexim1 Protein Level Ratio
50895,Dbnl/Hspa1A Protein Level Ratio,Phenotype,Dbnl/Hspa1A Protein Level Ratio
50896,Dbnl/Rwdd1 Protein Level Ratio,Phenotype,Dbnl/Rwdd1 Protein Level Ratio
50897,Dbi/Stip1 Protein Level Ratio,Phenotype,Dbi/Stip1 Protein Level Ratio
50898,Ddr1/Sftpd Protein Level Ratio,Phenotype,Ddr1/Sftpd Protein Level Ratio
50899,Atp5If1/Hspa1A Protein Level Ratio,Phenotype,Atp5If1/Hspa1A Protein Level Ratio
50900,Axl/Msr1 Protein Level Ratio,Phenotype,Axl/Msr1 Protein Level Ratio
50901,Bcam/Cdh5 Protein Level Ratio,Phenotype,Bcam/Cdh5 Protein Level Ratio
50902,Bcam/Epo Protein Level Ratio,Phenotype,Bcam/Epo Protein Level Ratio
50903,Bag6/Wasf1 Protein Level Ratio,Phenotype,Bag6/Wasf1 Protein Level Ratio
50904,Bank1/Hexim1 Protein Level Ratio,Phenotype,Bank1/Hexim1 Protein Level Ratio
50905,B4Galt1/Lrp11 Protein Level Ratio,Phenotype,B4Galt1/Lrp11 Protein Level Ratio
50906,B4Galt1/Smoc2 Protein Level Ratio,Phenotype,B4Galt1/Smoc2 Protein Level Ratio
50907,Bach1/Cd2Ap Protein Level Ratio,Phenotype,Bach1/Cd2Ap Protein Level Ratio
50908,Axin1/Nfatc1 Protein Level Ratio,Phenotype,Axin1/Nfatc1 Protein Level Ratio
50909,Axin1/Plxna4 Protein Level Ratio,Phenotype,Axin1/Plxna4 Protein Level Ratio
50910,Axin1/Srpk2 Protein Level Ratio,Phenotype,Axin1/Srpk2 Protein Level Ratio
50911,Axl/Il18Bp Protein Level Ratio,Phenotype,Axl/Il18Bp Protein Level Ratio
50913,Axl/Mcam Protein Level Ratio,Phenotype,Axl/Mcam Protein Level Ratio
50914,Axin1/Itgb1Bp2 Protein Level Ratio,Phenotype,Axin1/Itgb1Bp2 Protein Level Ratio
50915,Axin1/Map2K6 Protein Level Ratio,Phenotype,Axin1/Map2K6 Protein Level Ratio
50916,Axin1/Mavs Protein Level Ratio,Phenotype,Axin1/Mavs Protein Level Ratio
50917,Axin1/Ikbkg Protein Level Ratio,Phenotype,Axin1/Ikbkg Protein Level Ratio
50918,Axin1/Inppl1 Protein Level Ratio,Phenotype,Axin1/Inppl1 Protein Level Ratio
50919,Axin1/Irak4 Protein Level Ratio,Phenotype,Axin1/Irak4 Protein Level Ratio
50920,Bach1/Snx9 Protein Level Ratio,Phenotype,Bach1/Snx9 Protein Level Ratio
50921,Bmp6/Spint2 Protein Level Ratio,Phenotype,Bmp6/Spint2 Protein Level Ratio
50923,Bpifb1/Glrx Protein Level Ratio,Phenotype,Bpifb1/Glrx Protein Level Ratio
50924,Btn2A1/Btn3A2 Protein Level Ratio,Phenotype,Btn2A1/Btn3A2 Protein Level Ratio
50926,Btn2A1/Csf1 Protein Level Ratio,Phenotype,Btn2A1/Csf1 Protein Level Ratio
50929,Btn2A1/Epha1 Protein Level Ratio,Phenotype,Btn2A1/Epha1 Protein Level Ratio
50931,Btn2A1/Ifngr1 Protein Level Ratio,Phenotype,Btn2A1/Ifngr1 Protein Level Ratio
50933,Btn2A1/Il10Rb Protein Level Ratio,Phenotype,Btn2A1/Il10Rb Protein Level Ratio
50934,Btn2A1/Il18Bp Protein Level Ratio,Phenotype,Btn2A1/Il18Bp Protein Level Ratio
50935,Btn2A1/Lilrb4 Protein Level Ratio,Phenotype,Btn2A1/Lilrb4 Protein Level Ratio
50936,Btn2A1/Pik3Ip1 Protein Level Ratio,Phenotype,Btn2A1/Pik3Ip1 Protein Level Ratio
50937,Btn2A1/Smoc2 Protein Level Ratio,Phenotype,Btn2A1/Smoc2 Protein Level Ratio
50938,C2/Lilrb4 Protein Level Ratio,Phenotype,C2/Lilrb4 Protein Level Ratio
50939,C2/Ssc5D Protein Level Ratio,Phenotype,C2/Ssc5D Protein Level Ratio
50940,Ebag9/Hbegf Protein Level Ratio,Phenotype,Ebag9/Hbegf Protein Level Ratio
50941,Ebag9/Tbcc Protein Level Ratio,Phenotype,Ebag9/Tbcc Protein Level Ratio
50942,Edar/Serpinb1 Protein Level Ratio,Phenotype,Edar/Serpinb1 Protein Level Ratio
50943,Edar/Snap23 Protein Level Ratio,Phenotype,Edar/Snap23 Protein Level Ratio
50944,Edar/Tmsb10 Protein Level Ratio,Phenotype,Edar/Tmsb10 Protein Level Ratio
50945,Edar/Txndc5 Protein Level Ratio,Phenotype,Edar/Txndc5 Protein Level Ratio
50946,Edar/Eno2 Protein Level Ratio,Phenotype,Edar/Eno2 Protein Level Ratio
50947,Edar/F2R Protein Level Ratio,Phenotype,Edar/F2R Protein Level Ratio
50948,Edar/Prdx5 Protein Level Ratio,Phenotype,Edar/Prdx5 Protein Level Ratio
50949,Edar/Sdc4 Protein Level Ratio,Phenotype,Edar/Sdc4 Protein Level Ratio
50950,Edar/Irak4 Protein Level Ratio,Phenotype,Edar/Irak4 Protein Level Ratio
50951,Edar/Itgb1Bp2 Protein Level Ratio,Phenotype,Edar/Itgb1Bp2 Protein Level Ratio
50952,Src/Sult1A1 Protein Level Ratio,Phenotype,Src/Sult1A1 Protein Level Ratio
50953,C4Bpb/Entpd5 Protein Level Ratio,Phenotype,C4Bpb/Entpd5 Protein Level Ratio
50954,Snx9/Vta1 Protein Level Ratio,Phenotype,Snx9/Vta1 Protein Level Ratio
50955,Snx9/Wwp2 Protein Level Ratio,Phenotype,Snx9/Wwp2 Protein Level Ratio
50956,Sort1/Vsir Protein Level Ratio,Phenotype,Sort1/Vsir Protein Level Ratio
50957,Slamf7/Txndc15 Protein Level Ratio,Phenotype,Slamf7/Txndc15 Protein Level Ratio
50958,Smad1/Zbtb16 Protein Level Ratio,Phenotype,Smad1/Zbtb16 Protein Level Ratio
50959,Sez6L/Sez6L2 Protein Level Ratio,Phenotype,Sez6L/Sez6L2 Protein Level Ratio
50960,Sh2B3/Tbl1X Protein Level Ratio,Phenotype,Sh2B3/Tbl1X Protein Level Ratio
50961,Sema4D/Treml2 Protein Level Ratio,Phenotype,Sema4D/Treml2 Protein Level Ratio
50962,Sema4D/Txndc5 Protein Level Ratio,Phenotype,Sema4D/Txndc5 Protein Level Ratio
50963,Serpinb1/Serpinb6 Protein Level Ratio,Phenotype,Serpinb1/Serpinb6 Protein Level Ratio
50964,Serpinb1/Serpinb9 Protein Level Ratio,Phenotype,Serpinb1/Serpinb9 Protein Level Ratio
50965,Serpinb1/Stat5B Protein Level Ratio,Phenotype,Serpinb1/Stat5B Protein Level Ratio
50966,Serpinb1/Stip1 Protein Level Ratio,Phenotype,Serpinb1/Stip1 Protein Level Ratio
50967,Serpinb1/Tmsb10 Protein Level Ratio,Phenotype,Serpinb1/Tmsb10 Protein Level Ratio
50968,Serpinb6/Sod1 Protein Level Ratio,Phenotype,Serpinb6/Sod1 Protein Level Ratio
50969,Serpinb6/Txndc5 Protein Level Ratio,Phenotype,Serpinb6/Txndc5 Protein Level Ratio
50970,Smpd1/Smpdl3A Protein Level Ratio,Phenotype,Smpd1/Smpdl3A Protein Level Ratio
50971,Snap23/Tbl1X Protein Level Ratio,Phenotype,Snap23/Tbl1X Protein Level Ratio
50972,Snap23/Zbtb16 Protein Level Ratio,Phenotype,Snap23/Zbtb16 Protein Level Ratio
50973,Snap29/Snx9 Protein Level Ratio,Phenotype,Snap29/Snx9 Protein Level Ratio
50974,Snap29/Tjap1 Protein Level Ratio,Phenotype,Snap29/Tjap1 Protein Level Ratio
50975,Snx9/Stambp Protein Level Ratio,Phenotype,Snx9/Stambp Protein Level Ratio
50976,Snx9/Stip1 Protein Level Ratio,Phenotype,Snx9/Stip1 Protein Level Ratio
50977,Snx9/Stk4 Protein Level Ratio,Phenotype,Snx9/Stk4 Protein Level Ratio
50978,Snx9/Vash1 Protein Level Ratio,Phenotype,Snx9/Vash1 Protein Level Ratio
50980,Early-Onset Schizophrenia,Phenotype,Early-Onset Schizophrenia
50982,Fbp1/Gsta1 Protein Level Ratio,Phenotype,Fbp1/Gsta1 Protein Level Ratio
50983,Fcer2/Fcrl1 Protein Level Ratio,Phenotype,Fcer2/Fcrl1 Protein Level Ratio
50986,Fcer2/Tcl1A Protein Level Ratio,Phenotype,Fcer2/Tcl1A Protein Level Ratio
50987,Fcer2/Tnfrsf9 Protein Level Ratio,Phenotype,Fcer2/Tnfrsf9 Protein Level Ratio
50990,Fam3B/Guca2A Protein Level Ratio,Phenotype,Fam3B/Guca2A Protein Level Ratio
50991,Ccn2/Hbegf Protein Level Ratio,Phenotype,Ccn2/Hbegf Protein Level Ratio
50992,Fcrl1/Tnfrsf13C Protein Level Ratio,Phenotype,Fcrl1/Tnfrsf13C Protein Level Ratio
50995,Fcrl1/Treml2 Protein Level Ratio,Phenotype,Fcrl1/Treml2 Protein Level Ratio
50996,Ccn2/Dkk1 Protein Level Ratio,Phenotype,Ccn2/Dkk1 Protein Level Ratio
50999,Ccn2/Spint2 Protein Level Ratio,Phenotype,Ccn2/Spint2 Protein Level Ratio
51000,Ccn2/Tpp1 Protein Level Ratio,Phenotype,Ccn2/Tpp1 Protein Level Ratio
51001,Ccn2/Vegfc Protein Level Ratio,Phenotype,Ccn2/Vegfc Protein Level Ratio
51003,Ccn3/Fap Protein Level Ratio,Phenotype,Ccn3/Fap Protein Level Ratio
51005,Fadd/Mgll Protein Level Ratio,Phenotype,Fadd/Mgll Protein Level Ratio
51006,F2R/Snx9 Protein Level Ratio,Phenotype,F2R/Snx9 Protein Level Ratio
51007,Gfer/Rrm2B Protein Level Ratio,Phenotype,Gfer/Rrm2B Protein Level Ratio
51009,Gfer/Triap1 Protein Level Ratio,Phenotype,Gfer/Triap1 Protein Level Ratio
51011,Gfra1/Tnfrsf1A Protein Level Ratio,Phenotype,Gfra1/Tnfrsf1A Protein Level Ratio
51012,Gfra3/Layn Protein Level Ratio,Phenotype,Gfra3/Layn Protein Level Ratio
51013,Glrx/Qdpr Protein Level Ratio,Phenotype,Glrx/Qdpr Protein Level Ratio
51014,Gmpr/Nsfl1C Protein Level Ratio,Phenotype,Gmpr/Nsfl1C Protein Level Ratio
51015,Gmpr/Psmg3 Protein Level Ratio,Phenotype,Gmpr/Psmg3 Protein Level Ratio
51016,Gnly/Gzma Protein Level Ratio,Phenotype,Gnly/Gzma Protein Level Ratio
51018,Gnly/Kir2Dl3 Protein Level Ratio,Phenotype,Gnly/Kir2Dl3 Protein Level Ratio
51019,Golm2/Itga5 Protein Level Ratio,Phenotype,Golm2/Itga5 Protein Level Ratio
51020,Ada2/Comp Protein Level Ratio,Phenotype,Ada2/Comp Protein Level Ratio
51021,Ada2/Vcam1 Protein Level Ratio,Phenotype,Ada2/Vcam1 Protein Level Ratio
51022,Glo1/Glod4 Protein Level Ratio,Phenotype,Glo1/Glod4 Protein Level Ratio
51023,Glo1/S100A4 Protein Level Ratio,Phenotype,Glo1/S100A4 Protein Level Ratio
51024,Glod4/Gmpr Protein Level Ratio,Phenotype,Glod4/Gmpr Protein Level Ratio
51025,Glod4/Hspa1A Protein Level Ratio,Phenotype,Glod4/Hspa1A Protein Level Ratio
51026,Adgre5/Itgb2 Protein Level Ratio,Phenotype,Adgre5/Itgb2 Protein Level Ratio
51027,Adgre5/Vcam1 Protein Level Ratio,Phenotype,Adgre5/Vcam1 Protein Level Ratio
51028,Adam23/Bsg Protein Level Ratio,Phenotype,Adam23/Bsg Protein Level Ratio
51029,Adamts15/Clmp Protein Level Ratio,Phenotype,Adamts15/Clmp Protein Level Ratio
51030,Adgre2/B4Galt1 Protein Level Ratio,Phenotype,Adgre2/B4Galt1 Protein Level Ratio
51032,Adgre2/Crim1 Protein Level Ratio,Phenotype,Adgre2/Crim1 Protein Level Ratio
51033,Adgre2/Ifngr1 Protein Level Ratio,Phenotype,Adgre2/Ifngr1 Protein Level Ratio
51034,Adgre2/Siglec1 Protein Level Ratio,Phenotype,Adgre2/Siglec1 Protein Level Ratio
51035,Parkinson'S Disease Progression (Cognitive),Phenotype,Parkinson'S Disease Progression (Cognitive)
51038,Serum Levels Of Protein Apoa1,Phenotype,Serum Levels Of Protein Apoa1
51039,Serum Levels Of Protein Adgre5,Phenotype,Serum Levels Of Protein Adgre5
51040,Serum Levels Of Protein Adgrf5,Phenotype,Serum Levels Of Protein Adgrf5
51043,Serum Levels Of Protein Apoa5,Phenotype,Serum Levels Of Protein Apoa5
51044,Serum Levels Of Protein Ager,Phenotype,Serum Levels Of Protein Ager
51045,Serum Levels Of Protein Agrp,Phenotype,Serum Levels Of Protein Agrp
51048,Serum Levels Of Protein Ahsa1,Phenotype,Serum Levels Of Protein Ahsa1
51049,Serum Levels Of Protein Rab17,Phenotype,Serum Levels Of Protein Rab17
51050,Serum Levels Of Protein Ptpn1,Phenotype,Serum Levels Of Protein Ptpn1
51051,Serum Levels Of Protein Rab5C,Phenotype,Serum Levels Of Protein Rab5C
51052,Serum Levels Of Protein Racgap1,Phenotype,Serum Levels Of Protein Racgap1
51055,Serum Levels Of Protein Rad51,Phenotype,Serum Levels Of Protein Rad51
51056,Serum Levels Of Protein Naalad2,Phenotype,Serum Levels Of Protein Naalad2
51057,Serum Levels Of Protein Ncr3,Phenotype,Serum Levels Of Protein Ncr3
51059,Serum Levels Of Protein Ndufb4,Phenotype,Serum Levels Of Protein Ndufb4
51060,Serum Levels Of Protein Epo,Phenotype,Serum Levels Of Protein Epo
51061,Serum Levels Of Protein Erp29,Phenotype,Serum Levels Of Protein Erp29
51063,Serum Levels Of Protein Enpp5,Phenotype,Serum Levels Of Protein Enpp5
51064,Serum Levels Of Protein Entpd3,Phenotype,Serum Levels Of Protein Entpd3
51066,Serum Levels Of Protein Nagpa,Phenotype,Serum Levels Of Protein Nagpa
51068,Serum Levels Of Protein Nbl1,Phenotype,Serum Levels Of Protein Nbl1
51069,Serum Levels Of Protein Ncam2,Phenotype,Serum Levels Of Protein Ncam2
51071,Serum Levels Of Protein Ptn,Phenotype,Serum Levels Of Protein Ptn
51073,Bilateral Cleft Lip,Phenotype,Bilateral Cleft Lip
51076,Serum Levels Of Protein Fas,Phenotype,Serum Levels Of Protein Fas
51077,Serum Levels Of Protein Fcer1A,Phenotype,Serum Levels Of Protein Fcer1A
51078,Serum Levels Of Protein Pcdha4,Phenotype,Serum Levels Of Protein Pcdha4
51080,Serum Levels Of Protein Pcdhb14,Phenotype,Serum Levels Of Protein Pcdhb14
51081,Serum Levels Of Protein Pcdhb4,Phenotype,Serum Levels Of Protein Pcdhb4
51082,Serum Levels Of Protein Pcdhga11,Phenotype,Serum Levels Of Protein Pcdhga11
51084,Serum Levels Of Protein Pcdhgb4,Phenotype,Serum Levels Of Protein Pcdhgb4
51085,Serum Levels Of Protein Nrxn3,Phenotype,Serum Levels Of Protein Nrxn3
51086,Serum Levels Of Protein Nptx1,Phenotype,Serum Levels Of Protein Nptx1
51087,Serum Levels Of Protein Npw,Phenotype,Serum Levels Of Protein Npw
51089,Serum Levels Of Protein Nqo1,Phenotype,Serum Levels Of Protein Nqo1
51090,Serum Levels Of Protein Nqo2,Phenotype,Serum Levels Of Protein Nqo2
51094,Bilateral Cleft Lip And Palate,Phenotype,Bilateral Cleft Lip And Palate
51097,Unilateral Cleft Lip,Phenotype,Unilateral Cleft Lip
51099,Serum Levels Of Protein Atf6,Phenotype,Serum Levels Of Protein Atf6
51101,Serum Levels Of Protein Atf6B,Phenotype,Serum Levels Of Protein Atf6B
51102,Serum Levels Of Protein Ifnar1,Phenotype,Serum Levels Of Protein Ifnar1
51103,Serum Levels Of Protein Piga,Phenotype,Serum Levels Of Protein Piga
51104,Serum Levels Of Protein Pik3Cg,Phenotype,Serum Levels Of Protein Pik3Cg
51105,Serum Levels Of Protein Pilra,Phenotype,Serum Levels Of Protein Pilra
51106,Serum Levels Of Protein C2,Phenotype,Serum Levels Of Protein C2
51108,Serum Levels Of Protein C2Orf40,Phenotype,Serum Levels Of Protein C2Orf40
51109,Serum Levels Of Protein C4A;C4B,Phenotype,Serum Levels Of Protein C4A;C4B
51115,Serum Levels Of Protein Cbln1,Phenotype,Serum Levels Of Protein Cbln1
51117,Serum Levels Of Protein C6Orf25,Phenotype,Serum Levels Of Protein C6Orf25
51119,Serum Levels Of Protein Ca4,Phenotype,Serum Levels Of Protein Ca4
51122,Serum Levels Of Protein Il15,Phenotype,Serum Levels Of Protein Il15
51124,Serum Levels Of Protein Il21,Phenotype,Serum Levels Of Protein Il21
51125,Serum Levels Of Protein Il34,Phenotype,Serum Levels Of Protein Il34
51127,Serum Levels Of Protein Il36A,Phenotype,Serum Levels Of Protein Il36A
51129,Serum Levels Of Protein Il18R1,Phenotype,Serum Levels Of Protein Il18R1
51130,Serum Levels Of Protein Il18Rap,Phenotype,Serum Levels Of Protein Il18Rap
51132,Serum Levels Of Protein Clps,Phenotype,Serum Levels Of Protein Clps
51137,Serum Levels Of Protein Cmpk1,Phenotype,Serum Levels Of Protein Cmpk1
51138,Noncognitive Aspects Of Educational Attainment,Phenotype,Noncognitive Aspects Of Educational Attainment
51140,Serum Levels Of Protein Clic5,Phenotype,Serum Levels Of Protein Clic5
51141,Serum Levels Of Protein Kir2Ds2,Phenotype,Serum Levels Of Protein Kir2Ds2
51142,Serum Levels Of Protein Klk12,Phenotype,Serum Levels Of Protein Klk12
51143,Serum Levels Of Protein Clec12B,Phenotype,Serum Levels Of Protein Clec12B
51144,Serum Levels Of Protein Kcne2,Phenotype,Serum Levels Of Protein Kcne2
51146,Serum Levels Of Protein Layn,Phenotype,Serum Levels Of Protein Layn
51147,Serum Levels Of Protein Klk6,Phenotype,Serum Levels Of Protein Klk6
51148,Serum Levels Of Protein Klrc3,Phenotype,Serum Levels Of Protein Klrc3
51149,Serum Levels Of Protein Ldlrad4,Phenotype,Serum Levels Of Protein Ldlrad4
51150,Serum Levels Of Protein Cpb1,Phenotype,Serum Levels Of Protein Cpb1
51151,Serum Levels Of Protein Cpxm1,Phenotype,Serum Levels Of Protein Cpxm1
51153,Serum Levels Of Protein Crabp1,Phenotype,Serum Levels Of Protein Crabp1
51154,Serum Levels Of Protein Creb3L4,Phenotype,Serum Levels Of Protein Creb3L4
51155,Serum Levels Of Protein Col11A2,Phenotype,Serum Levels Of Protein Col11A2
51159,Serum Levels Of Protein Crisp2,Phenotype,Serum Levels Of Protein Crisp2
51164,Serum Levels Of Protein Crispld2,Phenotype,Serum Levels Of Protein Crispld2
51167,Serum Levels Of Protein Cntn1,Phenotype,Serum Levels Of Protein Cntn1
51168,Serum Levels Of Protein Mica,Phenotype,Serum Levels Of Protein Mica
51171,Serum Levels Of Protein Micb,Phenotype,Serum Levels Of Protein Micb
51175,Serum Levels Of Protein Ppil1,Phenotype,Serum Levels Of Protein Ppil1
51177,Serum Levels Of Protein Mettl24,Phenotype,Serum Levels Of Protein Mettl24
51180,Serum Levels Of Protein Plxdc2,Phenotype,Serum Levels Of Protein Plxdc2
51181,Serum Levels Of Protein Pnliprp1,Phenotype,Serum Levels Of Protein Pnliprp1
51182,Serum Levels Of Protein Gpc3,Phenotype,Serum Levels Of Protein Gpc3
51184,Serum Levels Of Protein Gramd1C,Phenotype,Serum Levels Of Protein Gramd1C
51187,Serum Levels Of Protein Mln,Phenotype,Serum Levels Of Protein Mln
51189,Serum Levels Of Protein Polr1C,Phenotype,Serum Levels Of Protein Polr1C
51190,Serum Levels Of Protein Pomc,Phenotype,Serum Levels Of Protein Pomc
51191,Serum Levels Of Protein Eef2K,Phenotype,Serum Levels Of Protein Eef2K
51192,Serum Levels Of Protein Mocs3,Phenotype,Serum Levels Of Protein Mocs3
51193,Serum Levels Of Protein Mpg,Phenotype,Serum Levels Of Protein Mpg
51195,Serum Levels Of Protein Prss2,Phenotype,Serum Levels Of Protein Prss2
51196,Serum Levels Of Protein Prss22,Phenotype,Serum Levels Of Protein Prss22
51198,Serum Levels Of Protein Prss57,Phenotype,Serum Levels Of Protein Prss57
51200,Serum Levels Of Protein Psmb1,Phenotype,Serum Levels Of Protein Psmb1
51202,Serum Levels Of Protein Mmp7,Phenotype,Serum Levels Of Protein Mmp7
51203,Serum Levels Of Protein Mrpl55,Phenotype,Serum Levels Of Protein Mrpl55
51204,Serum Levels Of Protein Mst1R,Phenotype,Serum Levels Of Protein Mst1R
51205,Serum Levels Of Protein Prss8,Phenotype,Serum Levels Of Protein Prss8
51207,Serum Levels Of Protein Prtn3,Phenotype,Serum Levels Of Protein Prtn3
51208,Serum Levels Of Protein Psmd11,Phenotype,Serum Levels Of Protein Psmd11
51209,Serum Levels Of Protein Hpse,Phenotype,Serum Levels Of Protein Hpse
51211,Serum Levels Of Protein Hspa1A,Phenotype,Serum Levels Of Protein Hspa1A
51212,Serum Levels Of Protein Antxr1,Phenotype,Serum Levels Of Protein Antxr1
51213,Serum Levels Of Protein Anxa10,Phenotype,Serum Levels Of Protein Anxa10
51214,Serum Levels Of Protein Hnf4A,Phenotype,Serum Levels Of Protein Hnf4A
51215,Serum Levels Of Protein Hp,Phenotype,Serum Levels Of Protein Hp
51217,Serum Levels Of Protein Aif1,Phenotype,Serum Levels Of Protein Aif1
51219,Serum Levels Of Protein Akt3,Phenotype,Serum Levels Of Protein Akt3
51220,Serum Levels Of Protein Alb,Phenotype,Serum Levels Of Protein Alb
51222,Serum Levels Of Protein Rgs8,Phenotype,Serum Levels Of Protein Rgs8
51223,Serum Levels Of Protein Rbm19,Phenotype,Serum Levels Of Protein Rbm19
51224,Serum Levels Of Protein Osm,Phenotype,Serum Levels Of Protein Osm
51225,Serum Levels Of Protein P4Hb,Phenotype,Serum Levels Of Protein P4Hb
51227,Serum Levels Of Protein F13B,Phenotype,Serum Levels Of Protein F13B
51233,Serum Levels Of Protein Pcsk7,Phenotype,Serum Levels Of Protein Pcsk7
51235,Serum Levels Of Protein Rspo3,Phenotype,Serum Levels Of Protein Rspo3
51238,Serum Levels Of Protein Rnf43,Phenotype,Serum Levels Of Protein Rnf43
51239,Serum Levels Of Protein Rpl30,Phenotype,Serum Levels Of Protein Rpl30
51240,Serum Levels Of Protein Rps10,Phenotype,Serum Levels Of Protein Rps10
51241,Serum Levels Of Protein Pdia3,Phenotype,Serum Levels Of Protein Pdia3
51243,Serum Levels Of Protein Pdia5,Phenotype,Serum Levels Of Protein Pdia5
51245,Serum Levels Of Protein Pdilt,Phenotype,Serum Levels Of Protein Pdilt
51247,Serum Levels Of Protein Apol1,Phenotype,Serum Levels Of Protein Apol1
51248,Serum Levels Of Protein Apom,Phenotype,Serum Levels Of Protein Apom
51251,Unilateral Cleft Lip And Palate,Phenotype,Unilateral Cleft Lip And Palate
51255,Serum Levels Of Protein Bglap,Phenotype,Serum Levels Of Protein Bglap
51256,Serum Levels Of Protein Bgn,Phenotype,Serum Levels Of Protein Bgn
51259,Serum Levels Of Protein Bmp7,Phenotype,Serum Levels Of Protein Bmp7
51261,Serum Levels Of Protein Il10Ra,Phenotype,Serum Levels Of Protein Il10Ra
51262,Serum Levels Of Protein Bage3,Phenotype,Serum Levels Of Protein Bage3
51263,Serum Levels Of Protein Bcl2L1,Phenotype,Serum Levels Of Protein Bcl2L1
51264,Serum Levels Of Protein Bcl2L10,Phenotype,Serum Levels Of Protein Bcl2L10
51265,Serum Levels Of Protein Azgp1,Phenotype,Serum Levels Of Protein Azgp1
51266,Serum Levels Of Protein B2M,Phenotype,Serum Levels Of Protein B2M
51268,Serum Levels Of Protein Igf2R,Phenotype,Serum Levels Of Protein Igf2R
51272,Serum Levels Of Protein Igfbp6,Phenotype,Serum Levels Of Protein Igfbp6
51273,Serum Levels Of Protein Igfbpl1,Phenotype,Serum Levels Of Protein Igfbpl1
51275,Serum Levels Of Protein Igfl3,Phenotype,Serum Levels Of Protein Igfl3
51276,Serum Levels Of Protein C11Orf87,Phenotype,Serum Levels Of Protein C11Orf87
51278,Serum Levels Of Protein Fn1,Phenotype,Serum Levels Of Protein Fn1
51279,Serum Levels Of Protein Ccl17,Phenotype,Serum Levels Of Protein Ccl17
51281,Serum Levels Of Protein Ccl19,Phenotype,Serum Levels Of Protein Ccl19
51283,Serum Levels Of Protein Ccl22,Phenotype,Serum Levels Of Protein Ccl22
51285,Cervical Intraepithelial Neoplasia Grade 3,Phenotype,Cervical Intraepithelial Neoplasia Grade 3
51287,Cervical Intraepithelial Neoplasia Grade 3 And Invasive Cervical Cancer,Phenotype,Cervical Intraepithelial Neoplasia Grade 3 And Invasive Cervical Cancer
51290,Serum Levels Of Protein Ccl1,Phenotype,Serum Levels Of Protein Ccl1
51291,Serum Levels Of Protein Cd109,Phenotype,Serum Levels Of Protein Cd109
51295,Serum Levels Of Protein Cd8A,Phenotype,Serum Levels Of Protein Cd8A
51296,Serum Levels Of Protein Cfb,Phenotype,Serum Levels Of Protein Cfb
51298,Serum Levels Of Protein Isg15,Phenotype,Serum Levels Of Protein Isg15
51300,Serum Levels Of Protein Cdh7,Phenotype,Serum Levels Of Protein Cdh7
51301,Serum Levels Of Protein Cdk5;Cdk5R1,Phenotype,Serum Levels Of Protein Cdk5;Cdk5R1
51302,Serum Levels Of Protein Cfp,Phenotype,Serum Levels Of Protein Cfp
51303,Serum Levels Of Protein Cftr,Phenotype,Serum Levels Of Protein Cftr
51304,Serum Levels Of Protein Cga;Tshb,Phenotype,Serum Levels Of Protein Cga;Tshb
51306,Serum Levels Of Protein Cdh11,Phenotype,Serum Levels Of Protein Cdh11
51309,Serum Levels Of Protein Lilrb1,Phenotype,Serum Levels Of Protein Lilrb1
51311,Serum Levels Of Protein Frs2,Phenotype,Serum Levels Of Protein Frs2
51313,Serum Levels Of Protein Lipa,Phenotype,Serum Levels Of Protein Lipa
51314,Serum Levels Of Protein Lpo,Phenotype,Serum Levels Of Protein Lpo
51316,Serum Levels Of Protein Lrp11,Phenotype,Serum Levels Of Protein Lrp11
51319,Serum Levels Of Protein Lrpap1,Phenotype,Serum Levels Of Protein Lrpap1
51324,Serum Levels Of Protein Frzb,Phenotype,Serum Levels Of Protein Frzb
51325,Serum Levels Of Protein Ctgf,Phenotype,Serum Levels Of Protein Ctgf
51328,Serum Levels Of Protein Ctrb2,Phenotype,Serum Levels Of Protein Ctrb2
51330,Serum Levels Of Protein Gfral,Phenotype,Serum Levels Of Protein Gfral
51333,Serum Levels Of Protein Gip,Phenotype,Serum Levels Of Protein Gip
51335,Serum Levels Of Protein Fth1;Ftl,Phenotype,Serum Levels Of Protein Fth1;Ftl
51336,Serum Levels Of Protein Ftmt,Phenotype,Serum Levels Of Protein Ftmt
51337,Serum Levels Of Protein Cx3Cl1,Phenotype,Serum Levels Of Protein Cx3Cl1
51339,Serum Levels Of Protein Cxcl2;Cxcl3,Phenotype,Serum Levels Of Protein Cxcl2;Cxcl3
51345,Serum Levels Of Protein Gabarapl2,Phenotype,Serum Levels Of Protein Gabarapl2
51353,Serum Levels Of Protein Gbp6,Phenotype,Serum Levels Of Protein Gbp6
51354,Serum Levels Of Protein Gcnt4,Phenotype,Serum Levels Of Protein Gcnt4
51355,Serum Levels Of Protein Des,Phenotype,Serum Levels Of Protein Des
51356,Serum Levels Of Protein Defb119,Phenotype,Serum Levels Of Protein Defb119
51358,Serum Levels Of Protein Mapk13,Phenotype,Serum Levels Of Protein Mapk13
51360,Serum Levels Of Protein Dcun1D5,Phenotype,Serum Levels Of Protein Dcun1D5
51361,Serum Levels Of Protein Ddr1,Phenotype,Serum Levels Of Protein Ddr1
51363,Serum Levels Of Protein Gnly,Phenotype,Serum Levels Of Protein Gnly
51365,Serum Levels Of Protein Gnmt,Phenotype,Serum Levels Of Protein Gnmt
51367,Serum Levels Of Protein Gnptg,Phenotype,Serum Levels Of Protein Gnptg
51369,Serum Levels Of Protein Manea,Phenotype,Serum Levels Of Protein Manea
51371,Serum Levels Of Protein Plg,Phenotype,Serum Levels Of Protein Plg
51376,Serum Levels Of Protein Glo1,Phenotype,Serum Levels Of Protein Glo1
51379,Cognitive Aspects Of Educational Attainment,Phenotype,Cognitive Aspects Of Educational Attainment
51382,Serum Levels Of Protein Dlk2,Phenotype,Serum Levels Of Protein Dlk2
51384,Serum Levels Of Protein Dnajb11,Phenotype,Serum Levels Of Protein Dnajb11
51386,Serum Levels Of Protein Prep,Phenotype,Serum Levels Of Protein Prep
51388,Serum Levels Of Protein Hbz,Phenotype,Serum Levels Of Protein Hbz
51390,Serum Levels Of Protein Gzma,Phenotype,Serum Levels Of Protein Gzma
51392,Serum Levels Of Protein Gzmb,Phenotype,Serum Levels Of Protein Gzmb
51394,Serum Levels Of Protein H6Pd,Phenotype,Serum Levels Of Protein H6Pd
51395,Serum Levels Of Protein Havcr2,Phenotype,Serum Levels Of Protein Havcr2
51399,Serum Levels Of Protein Dnajc10,Phenotype,Serum Levels Of Protein Dnajc10
51401,Serum Levels Of Protein Dpep1,Phenotype,Serum Levels Of Protein Dpep1
51403,Serum Levels Of Protein Dsg1,Phenotype,Serum Levels Of Protein Dsg1
51404,Serum Levels Of Protein Serpind1,Phenotype,Serum Levels Of Protein Serpind1
51407,Serum Levels Of Protein Serpinf2,Phenotype,Serum Levels Of Protein Serpinf2
51408,Serum Levels Of Protein Sema6C,Phenotype,Serum Levels Of Protein Sema6C
51409,Serum Levels Of Protein Siglec8,Phenotype,Serum Levels Of Protein Siglec8
51410,Serum Levels Of Protein Smpdl3A,Phenotype,Serum Levels Of Protein Smpdl3A
51420,Primary Central Nervous System Lymphoma,Phenotype,Primary Central Nervous System Lymphoma
51433,Gallstone Disease,Phenotype,Gallstone Disease
51435,Arterial Stiffness Index,Phenotype,Arterial Stiffness Index
51437,Strabismus,Phenotype,Strabismus
51452,Invasive Breast Cancer,Phenotype,Invasive Breast Cancer
51453,Serum Levels Of Protein Tdo2,Phenotype,Serum Levels Of Protein Tdo2
51454,Serum Levels Of Protein Tek,Phenotype,Serum Levels Of Protein Tek
51455,Serum Levels Of Protein Syt11,Phenotype,Serum Levels Of Protein Syt11
51456,Serum Levels Of Protein Tapbp,Phenotype,Serum Levels Of Protein Tapbp
51458,Serum Levels Of Protein Tapbpl,Phenotype,Serum Levels Of Protein Tapbpl
51460,Serum Levels Of Protein Sparcl1,Phenotype,Serum Levels Of Protein Sparcl1
51461,Serum Levels Of Protein Spag11B,Phenotype,Serum Levels Of Protein Spag11B
51463,Serum Levels Of Protein Sult4A1,Phenotype,Serum Levels Of Protein Sult4A1
51464,Serum Levels Of Protein Surf1,Phenotype,Serum Levels Of Protein Surf1
51465,Serum Levels Of Protein Syncrip,Phenotype,Serum Levels Of Protein Syncrip
51466,Serum Levels Of Protein Srl,Phenotype,Serum Levels Of Protein Srl
51468,Breast Cancer (Triple Negative Or Brca1-Positive),Phenotype,Breast Cancer (Triple Negative Or Brca1-Positive)
51470,Serum Levels Of Protein Tmx3,Phenotype,Serum Levels Of Protein Tmx3
51472,Serum Levels Of Protein Tf,Phenotype,Serum Levels Of Protein Tf
51473,Serum Levels Of Protein Tff3,Phenotype,Serum Levels Of Protein Tff3
51474,Serum Levels Of Protein Tgm3,Phenotype,Serum Levels Of Protein Tgm3
51475,Serum Levels Of Protein Thbs2,Phenotype,Serum Levels Of Protein Thbs2
51476,Serum Levels Of Protein Tmcc3,Phenotype,Serum Levels Of Protein Tmcc3
51477,Serum Levels Of Protein Tmem52B,Phenotype,Serum Levels Of Protein Tmem52B
51480,Serum Levels Of Protein Trem2,Phenotype,Serum Levels Of Protein Trem2
51482,Serum Levels Of Protein Treml1,Phenotype,Serum Levels Of Protein Treml1
51484,Serum Levels Of Protein Tril,Phenotype,Serum Levels Of Protein Tril
51485,Serum Levels Of Protein Txndc15,Phenotype,Serum Levels Of Protein Txndc15
51486,Serum Levels Of Protein Usp25,Phenotype,Serum Levels Of Protein Usp25
51487,Serum Levels Of Protein Ust,Phenotype,Serum Levels Of Protein Ust
51488,Serum Levels Of Protein Uts2,Phenotype,Serum Levels Of Protein Uts2
51489,Serum Levels Of Protein Uxs1,Phenotype,Serum Levels Of Protein Uxs1
51491,Serum Levels Of Protein Vegfa,Phenotype,Serum Levels Of Protein Vegfa
51492,Serum Levels Of Protein Vegfb,Phenotype,Serum Levels Of Protein Vegfb
51493,Serum Levels Of Protein Txndc5,Phenotype,Serum Levels Of Protein Txndc5
51495,Serum Levels Of Protein Tyk2,Phenotype,Serum Levels Of Protein Tyk2
51496,Serum Levels Of Protein Ubc,Phenotype,Serum Levels Of Protein Ubc
51497,Serum Levels Of Protein Tpm2,Phenotype,Serum Levels Of Protein Tpm2
51498,Serum Levels Of Protein Tppp2,Phenotype,Serum Levels Of Protein Tppp2
51500,Serum Levels Of Protein Tpsb2,Phenotype,Serum Levels Of Protein Tpsb2
51503,Serum Levels Of Protein Tnxb,Phenotype,Serum Levels Of Protein Tnxb
51504,Serum Levels Of Protein Tpsb2;Tpsab1,Phenotype,Serum Levels Of Protein Tpsb2;Tpsab1
51510,Serum Levels Of Protein Trem1,Phenotype,Serum Levels Of Protein Trem1
51515,Serum Levels Of Protein Vopp1,Phenotype,Serum Levels Of Protein Vopp1
51516,Serum Levels Of Protein Zap70,Phenotype,Serum Levels Of Protein Zap70
51517,Serum Levels Of Protein Zg16B,Phenotype,Serum Levels Of Protein Zg16B
51518,Serum Levels Of Protein Wfdc1,Phenotype,Serum Levels Of Protein Wfdc1
51519,Serum Levels Of Protein Wfikkn1,Phenotype,Serum Levels Of Protein Wfikkn1
51522,Serum Levels Of Protein Wif1,Phenotype,Serum Levels Of Protein Wif1
51524,Serum Levels Of Protein Znf276,Phenotype,Serum Levels Of Protein Znf276
51525,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (2Df),Phenotype,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (2Df)
51528,Skin And Soft Tissue Infections,Phenotype,Skin And Soft Tissue Infections
51530,Chronic Obstructive Pulmonary Disease In Ever Smokers,Phenotype,Chronic Obstructive Pulmonary Disease In Ever Smokers
51531,Chronic Obstructive Pulmonary Disease In Never Smokers,Phenotype,Chronic Obstructive Pulmonary Disease In Never Smokers
51532,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (Main Effect),Phenotype,Chronic Obstructive Pulmonary Disease X Ever Smoker Interaction (Main Effect)
51533,Chronic Obstructive Pulmonary Disease X Current Smoker Interaction (2Df),Phenotype,Chronic Obstructive Pulmonary Disease X Current Smoker Interaction (2Df)
51534,Chronic Obstructive Pulmonary Disease X Current Smoker Interaction (Main Effect),Phenotype,Chronic Obstructive Pulmonary Disease X Current Smoker Interaction (Main Effect)
51544,Bioavailable Testosterone Levels,Phenotype,Bioavailable Testosterone Levels
51567,Spondylosis,Phenotype,Spondylosis
51578,Body Size At Age 10,Phenotype,Body Size At Age 10
51588,Coronary Artery Disease In Individuals Without Type 2 Diabetes,Phenotype,Coronary Artery Disease In Individuals Without Type 2 Diabetes
51589,Childhood Asthma With Severe Exacerbations,Phenotype,Childhood Asthma With Severe Exacerbations
51636,Neuropsychiatric Disorders,Phenotype,Neuropsychiatric Disorders
51646,Esophageal Or Stomach Cancer,Phenotype,Esophageal Or Stomach Cancer
51655,Thyroid Cancer,Phenotype,Thyroid Cancer
51657,Lymphocytic Leukemia,Phenotype,Lymphocytic Leukemia
51666,Walking Pace,Phenotype,Walking Pace
51676,Cancer (Pleiotropy)(Bidirectional),Phenotype,Cancer (Pleiotropy)(Bidirectional)
51682,Interferon-Related Traits,Phenotype,Interferon-Related Traits
51732,Non-Tuberculous Mycobacterial Pulmonary Disease,Phenotype,Non-Tuberculous Mycobacterial Pulmonary Disease
51740,Estimated Glomerular Filtration Rate After 5 Years In Renal Transplantation (Donor Effect),Phenotype,Estimated Glomerular Filtration Rate After 5 Years In Renal Transplantation (Donor Effect)
51748,Type 2 Diabetes (Snp X Snp Interaction-- 2Df),Phenotype,Type 2 Diabetes (Snp X Snp Interaction-- 2Df)
51750,Type 2 Diabetes (Snp X Snp Interaction-- 1Df),Phenotype,Type 2 Diabetes (Snp X Snp Interaction-- 1Df)
51758,Fasting Blood Glucose Adjusted For Bmi,Phenotype,Fasting Blood Glucose Adjusted For Bmi
51768,Benign Prostatic Hyperplasia,Phenotype,Benign Prostatic Hyperplasia
51797,Hyperuricemia,Phenotype,Hyperuricemia
51800,Resting-State Electroencephalogram Vigilance,Phenotype,Resting-State Electroencephalogram Vigilance
51813,Remission After Ssri Treatment In Mdd Or Openness,Phenotype,Remission After Ssri Treatment In Mdd Or Openness
51815,Response To Ssri In Mdd Or Openness,Phenotype,Response To Ssri In Mdd Or Openness
51847,Non-Hodgkin'S Lymphoma,Phenotype,Non-Hodgkin'S Lymphoma
51852,Thyrotoxic Periodic Paralysis,Phenotype,Thyrotoxic Periodic Paralysis
51888,Inflammatory Biomarkers (Multivariate Analysis),Phenotype,Inflammatory Biomarkers (Multivariate Analysis)
51895,Cryptococcosis In Hiv Infection,Phenotype,Cryptococcosis In Hiv Infection
51898,Hypertension In Type 2 Diabetes,Phenotype,Hypertension In Type 2 Diabetes
51900,Barrett'S Esophagus Or Esophageal Adenocarcinoma X Sex Interaction (2Df Test),Phenotype,Barrett'S Esophagus Or Esophageal Adenocarcinoma X Sex Interaction (2Df Test)
51971,Attention Deficit Hyperactivity Disorder Symptom Score,Phenotype,Attention Deficit Hyperactivity Disorder Symptom Score
51973,Tricyclic Pyrone Compound Response (Ic50),Phenotype,Tricyclic Pyrone Compound Response (Ic50)
51975,Shoulder Impingement,Phenotype,Shoulder Impingement
51977,Plasma Factor Vii Activating Protease Levels,Phenotype,Plasma Factor Vii Activating Protease Levels
51995,Cigarettes Smoked Per Day (Mtag),Phenotype,Cigarettes Smoked Per Day (Mtag)
52019,Asthma Onset (Childhood Vs Adult),Phenotype,Asthma Onset (Childhood Vs Adult)
52047,Handedness (Right-Handed Vs. Non-Right-Handed),Phenotype,Handedness (Right-Handed Vs. Non-Right-Handed)
52049,Breast Cancer Specific Mortality In Breast Cancer,Phenotype,Breast Cancer Specific Mortality In Breast Cancer
52055,Breast Cancer Specific Mortality In Estrogen Receptor Negative Breast Cancer,Phenotype,Breast Cancer Specific Mortality In Estrogen Receptor Negative Breast Cancer
52057,Smoking Cessation (Mtag),Phenotype,Smoking Cessation (Mtag)
52061,Breast Cancer Specific Mortality In Estrogen Receptor Positive Breast Cancer,Phenotype,Breast Cancer Specific Mortality In Estrogen Receptor Positive Breast Cancer
52065,Cortical Brain Region Measurements (Area-- Volume And Thickness),Phenotype,Cortical Brain Region Measurements (Area-- Volume And Thickness)
52067,Chronic Obstructive Pulmonary Disease Or High Blood Pressure (Pleiotropy),Phenotype,Chronic Obstructive Pulmonary Disease Or High Blood Pressure (Pleiotropy)
52070,Chronic Obstructive Pulmonary Disease Or Coronary Artery Disease (Pleiotropy),Phenotype,Chronic Obstructive Pulmonary Disease Or Coronary Artery Disease (Pleiotropy)
52074,Spine Bone Size,Phenotype,Spine Bone Size
52090,Thyrotoxic Hypokalemic Periodic Paralysis And Graves Disease,Phenotype,Thyrotoxic Hypokalemic Periodic Paralysis And Graves Disease
52095,Supraventricular Ectopy,Phenotype,Supraventricular Ectopy
52111,Early Chronic Obstructive Pulmonary Disease In Never Smokers,Phenotype,Early Chronic Obstructive Pulmonary Disease In Never Smokers
52114,Early Chronic Obstructive Pulmonary Disease,Phenotype,Early Chronic Obstructive Pulmonary Disease
52145,Nocturnal Enuresis,Phenotype,Nocturnal Enuresis
52153,Idiopathic Intracranial Hypertension,Phenotype,Idiopathic Intracranial Hypertension
52156,Global Electrical Heterogeneity Phenotypes,Phenotype,Global Electrical Heterogeneity Phenotypes
52158,Clostridium Difficile Infection In Multiple Myeloma,Phenotype,Clostridium Difficile Infection In Multiple Myeloma
52163,Lipid Traits (Pleiotropy) (Hipo Component 2),Phenotype,Lipid Traits (Pleiotropy) (Hipo Component 2)
52165,Social Science Traits (Pleiotropy) (Hipo Component 1),Phenotype,Social Science Traits (Pleiotropy) (Hipo Component 1)
52168,Endometriosis Or Endometrial Cancer (Pleiotropy),Phenotype,Endometriosis Or Endometrial Cancer (Pleiotropy)
52170,Warfarin-Associated Bleeding,Phenotype,Warfarin-Associated Bleeding
52190,Antidepressant Treatment Resistance (> 2 Drugs Prescribed),Phenotype,Antidepressant Treatment Resistance (> 2 Drugs Prescribed)
52201,Dna Methylation Variation (Age Effect),Phenotype,Dna Methylation Variation (Age Effect)
52214,Diffusing Capacity Of Carbon Monoxide,Phenotype,Diffusing Capacity Of Carbon Monoxide
52221,Cortical Amyloid Beta Load,Phenotype,Cortical Amyloid Beta Load
52223,Alzheimer'S Disease Progression Score,Phenotype,Alzheimer'S Disease Progression Score
52226,Body Mass Index And Waist-Hip Ratio (Pleiotropy),Phenotype,Body Mass Index And Waist-Hip Ratio (Pleiotropy)
52269,Cholesterol Efflux Capacity,Phenotype,Cholesterol Efflux Capacity
52270,Cholesterol Efflux Capacity (Camp Stimulated Assay),Phenotype,Cholesterol Efflux Capacity (Camp Stimulated Assay)
52274,Atypical Femoral Fracture In Phosphonate Treatment,Phenotype,Atypical Femoral Fracture In Phosphonate Treatment
52276,Bisphosphonate-Associated Atypical Femoral Fracture,Phenotype,Bisphosphonate-Associated Atypical Femoral Fracture
52319,Asthma (Age Of Onset),Phenotype,Asthma (Age Of Onset)
52326,Infliximab-Induced Mucosal Healing In Crohn'S Disease,Phenotype,Infliximab-Induced Mucosal Healing In Crohn'S Disease
52329,Low Susceptibility To Hepatitis C Infection,Phenotype,Low Susceptibility To Hepatitis C Infection
52331,Cocaine Dependence,Phenotype,Cocaine Dependence
52335,Severity Of Nausea And Vomiting Of Pregnancy,Phenotype,Severity Of Nausea And Vomiting Of Pregnancy
52375,Verbal Learning,Phenotype,Verbal Learning
52377,Metabolite Peak Levels (Qi15571),Phenotype,Metabolite Peak Levels (Qi15571)
52379,Metabolite Peak Levels (Qi9645),Phenotype,Metabolite Peak Levels (Qi9645)
52381,Metabolite Peak Levels (Qi7379),Phenotype,Metabolite Peak Levels (Qi7379)
52382,Metabolite Peak Levels (Qi7380),Phenotype,Metabolite Peak Levels (Qi7380)
52383,Metabolite Peak Levels (Qi7389),Phenotype,Metabolite Peak Levels (Qi7389)
52385,Metabolite Peak Levels (Qi7549),Phenotype,Metabolite Peak Levels (Qi7549)
52387,Metabolite Peak Levels (Qi8421),Phenotype,Metabolite Peak Levels (Qi8421)
52390,Metabolite Peak Levels (Qi8422),Phenotype,Metabolite Peak Levels (Qi8422)
52392,Metabolite Peak Levels (Qi843),Phenotype,Metabolite Peak Levels (Qi843)
52393,Metabolite Peak Levels (Qi8774),Phenotype,Metabolite Peak Levels (Qi8774)
52394,Metabolite Peak Levels (Qi8814),Phenotype,Metabolite Peak Levels (Qi8814)
52395,Metabolite Peak Levels (Qi7090),Phenotype,Metabolite Peak Levels (Qi7090)
52396,Metabolite Peak Levels (Qi14245),Phenotype,Metabolite Peak Levels (Qi14245)
52400,Peptidoglycan Recognition Protein 1 Levels,Phenotype,Peptidoglycan Recognition Protein 1 Levels
52409,Cerebrospinal Fluid P-Tau Levels,Phenotype,Cerebrospinal Fluid P-Tau Levels
52424,Sterol Ester (27:1/20:3) Levels,Phenotype,Sterol Ester (27:1/20:3) Levels
52425,Phosphatidylcholine (15:0_18:2) Levels,Phenotype,Phosphatidylcholine (15:0_18:2) Levels
52426,Phosphatidylcholine (16:0_16:0) Levels,Phenotype,Phosphatidylcholine (16:0_16:0) Levels
52427,Phosphatidylcholine (16:0_18:3) Levels,Phenotype,Phosphatidylcholine (16:0_18:3) Levels
52428,Sterol Ester (27:1/20:4) Levels,Phenotype,Sterol Ester (27:1/20:4) Levels
52430,Sterol Ester (27:1/16:0) Levels,Phenotype,Sterol Ester (27:1/16:0) Levels
52431,Sterol Ester (27:1/18:0) Levels,Phenotype,Sterol Ester (27:1/18:0) Levels
52432,Sedentary Behavior At Work,Phenotype,Sedentary Behavior At Work
52434,Leisure Screen Time (Mtag),Phenotype,Leisure Screen Time (Mtag)
52435,Moderate-To-Vigorous Intensity Physical Activity During Leisure Time (Mtag),Phenotype,Moderate-To-Vigorous Intensity Physical Activity During Leisure Time (Mtag)
52436,Phosphatidylinositol (18:0_20:3) Levels,Phenotype,Phosphatidylinositol (18:0_20:3) Levels
52438,Phosphatidylcholine (18:1_18:1) Levels,Phenotype,Phosphatidylcholine (18:1_18:1) Levels
52439,Phosphatidylcholine (18:1_18:2) Levels,Phenotype,Phosphatidylcholine (18:1_18:2) Levels
52440,Phosphatidylinositol (18:1_20:4) Levels,Phenotype,Phosphatidylinositol (18:1_20:4) Levels
52445,Apolipoprotein L1 Levels,Phenotype,Apolipoprotein L1 Levels
52447,Heat Shock Protein Beta-1 Levels,Phenotype,Heat Shock Protein Beta-1 Levels
52449,Triacylglycerol (50:1) Levels,Phenotype,Triacylglycerol (50:1) Levels
52457,R-Spondin-3 Levels,Phenotype,R-Spondin-3 Levels
52460,Apolipoprotein M Levels,Phenotype,Apolipoprotein M Levels
52532,Complement Component 1 Q Subcomponent-Binding Protein-- Mitochondrial Levels,Phenotype,Complement Component 1 Q Subcomponent-Binding Protein-- Mitochondrial Levels
52533,Endoplasmic Reticulum Resident Protein 29 Levels,Phenotype,Endoplasmic Reticulum Resident Protein 29 Levels
52563,Gremlin-1 Levels,Phenotype,Gremlin-1 Levels
52565,Interleukin-22 Receptor Subunit Alpha-2 Levels,Phenotype,Interleukin-22 Receptor Subunit Alpha-2 Levels
52567,Contactin-1 Levels,Phenotype,Contactin-1 Levels
52570,Verbal Short Term Memory,Phenotype,Verbal Short Term Memory
52579,Descending Aorta Maximum Area,Phenotype,Descending Aorta Maximum Area
52580,Ascending Aorta Distensibility,Phenotype,Ascending Aorta Distensibility
52584,Ascending Aorta Distensibility (Mtag),Phenotype,Ascending Aorta Distensibility (Mtag)
52586,Descending Aorta Distensibility (Mtag),Phenotype,Descending Aorta Distensibility (Mtag)
52589,Ascending Aorta Maximum Area (Mtag),Phenotype,Ascending Aorta Maximum Area (Mtag)
52591,Facial Phenotypes (Interpalpebral Inferius Length),Phenotype,Facial Phenotypes (Interpalpebral Inferius Length)
52593,Facial Phenotypes (Nasion To Pogonion),Phenotype,Facial Phenotypes (Nasion To Pogonion)
52596,Facial Phenotypes (Left Palpebral Fissure Length),Phenotype,Facial Phenotypes (Left Palpebral Fissure Length)
52598,Facial Phenotypes (Outercanthal Width),Phenotype,Facial Phenotypes (Outercanthal Width)
52600,Facial Phenotypes (Midendocanthion To Pogonion),Phenotype,Facial Phenotypes (Midendocanthion To Pogonion)
52603,Descending Aorta Maximum Area (Mtag),Phenotype,Descending Aorta Maximum Area (Mtag)
52604,Facial Phenotypes (Right Palpebrale Fissure Height),Phenotype,Facial Phenotypes (Right Palpebrale Fissure Height)
52606,Facial Phenotypes (Midendocanthion To Subnasale),Phenotype,Facial Phenotypes (Midendocanthion To Subnasale)
52617,Descending Aorta Minimum Area,Phenotype,Descending Aorta Minimum Area
52625,N4-Acetylcytidine Levels,Phenotype,N4-Acetylcytidine Levels
52627,Metabolite Peak Levels (Qi11461),Phenotype,Metabolite Peak Levels (Qi11461)
52642,Metabolite Peak Levels (Qi12750),Phenotype,Metabolite Peak Levels (Qi12750)
52643,Metabolite Peak Levels (Qi13644),Phenotype,Metabolite Peak Levels (Qi13644)
52644,Xanthosine Levels,Phenotype,Xanthosine Levels
52645,Metabolite Peak Levels (Qi4584),Phenotype,Metabolite Peak Levels (Qi4584)
52646,Metabolite Peak Levels (Qi2718),Phenotype,Metabolite Peak Levels (Qi2718)
52648,Metabolite Peak Levels (Qi3783),Phenotype,Metabolite Peak Levels (Qi3783)
52670,Metabolite Peak Levels (Qi12380),Phenotype,Metabolite Peak Levels (Qi12380)
52672,Protein Wnt-7A Levels,Phenotype,Protein Wnt-7A Levels
52674,C34 Gp41 Hiv Fragment Levels,Phenotype,C34 Gp41 Hiv Fragment Levels
52675,Dctp Pyrophosphatase 1 Levels,Phenotype,Dctp Pyrophosphatase 1 Levels
52708,Leisure Screen Time,Phenotype,Leisure Screen Time
52711,Moderate-To-Vigorous Intensity Physical Activity During Leisure Time,Phenotype,Moderate-To-Vigorous Intensity Physical Activity During Leisure Time
52717,Phosphatidylcholine (18:0_18:2) Levels,Phenotype,Phosphatidylcholine (18:0_18:2) Levels
52719,Phosphatidylcholine (O-18:2_18:2) Levels,Phenotype,Phosphatidylcholine (O-18:2_18:2) Levels
52720,Phosphatidylethanolamine (18:0_18:2) Levels,Phenotype,Phosphatidylethanolamine (18:0_18:2) Levels
52721,Phosphatidylcholine (O-16:0_16:1) Levels,Phenotype,Phosphatidylcholine (O-16:0_16:1) Levels
52722,Phosphatidylcholine (O-16:0_18:1) Levels,Phenotype,Phosphatidylcholine (O-16:0_18:1) Levels
52723,Phosphatidylcholine (O-16:0_18:2) Levels,Phenotype,Phosphatidylcholine (O-16:0_18:2) Levels
52724,Phosphatidylcholine (O-16:0_20:3) Levels,Phenotype,Phosphatidylcholine (O-16:0_20:3) Levels
52725,Phosphatidylcholine (O-16:1_18:2) Levels,Phenotype,Phosphatidylcholine (O-16:1_18:2) Levels
52726,Phosphatidylcholine (O-16:1_20:3) Levels,Phenotype,Phosphatidylcholine (O-16:1_20:3) Levels
52727,Phosphatidylcholine (O-17:0_17:1) Levels,Phenotype,Phosphatidylcholine (O-17:0_17:1) Levels
52728,Phosphatidylcholine (O-18:1_16:0) Levels,Phenotype,Phosphatidylcholine (O-18:1_16:0) Levels
52729,Phosphatidylcholine (O-18:1_20:3) Levels,Phenotype,Phosphatidylcholine (O-18:1_20:3) Levels
52730,Phosphatidylcholine (O-18:1_20:4) Levels,Phenotype,Phosphatidylcholine (O-18:1_20:4) Levels
52731,Phosphatidylcholine (O-18:2_16:0) Levels,Phenotype,Phosphatidylcholine (O-18:2_16:0) Levels
52732,Phosphatidylcholine (16:0_20:3) Levels,Phenotype,Phosphatidylcholine (16:0_20:3) Levels
52733,Phosphatidylcholine (16:1_18:2) Levels,Phenotype,Phosphatidylcholine (16:1_18:2) Levels
52734,Interleukin-17F Levels,Phenotype,Interleukin-17F Levels
52737,Mitogen-Activated Protein Kinase 3 Levels,Phenotype,Mitogen-Activated Protein Kinase 3 Levels
52740,Fractalkine Levels,Phenotype,Fractalkine Levels
52741,Tumor Necrosis Factor Receptor Superfamily Member Edar Levels,Phenotype,Tumor Necrosis Factor Receptor Superfamily Member Edar Levels
52744,Platelet-Activating Factor Levels,Phenotype,Platelet-Activating Factor Levels
52747,Stem Cell Growth Factor-Beta Levels,Phenotype,Stem Cell Growth Factor-Beta Levels
52752,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1 Levels,Phenotype,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1 Levels
52767,Non-Receptor Tyrosine-Protein Kinase Tyk2 Levels,Phenotype,Non-Receptor Tyrosine-Protein Kinase Tyk2 Levels
52835,Total Omega-3 Fatty Acid Levels,Phenotype,Total Omega-3 Fatty Acid Levels
52839,Total Omega-6 Fatty Acid Levels,Phenotype,Total Omega-6 Fatty Acid Levels
52842,Perinatal Depression,Phenotype,Perinatal Depression
52845,Metabolonic Lactone Sulfate Levels,Phenotype,Metabolonic Lactone Sulfate Levels
52862,Age Of Onset Of Depression X Felt Loved As A Child Interaction,Phenotype,Age Of Onset Of Depression X Felt Loved As A Child Interaction
52868,Von Willebrand Factor Levels,Phenotype,Von Willebrand Factor Levels
52877,Large Artery Stroke (Mtag),Phenotype,Large Artery Stroke (Mtag)
52878,Small Vessel Stroke (Mtag),Phenotype,Small Vessel Stroke (Mtag)
52915,Egfr Decline After Treatment With Platinum Based Chemotherapy,Phenotype,Egfr Decline After Treatment With Platinum Based Chemotherapy
52939,Survival In Coronary Artery Disease,Phenotype,Survival In Coronary Artery Disease
52942,Circulating Docosahexaenoic Acid Levels,Phenotype,Circulating Docosahexaenoic Acid Levels
52970,Chronic Spontaneous Urticaria,Phenotype,Chronic Spontaneous Urticaria
52991,Covid-19 (Hospitalized Vs Tested-- Not Hospitalized),Phenotype,Covid-19 (Hospitalized Vs Tested-- Not Hospitalized)
52993,Covid-19 (Hospitalized Vs Not Hospitalized),Phenotype,Covid-19 (Hospitalized Vs Not Hospitalized)
53015,Facial Morphology (Multitrait Analysis),Phenotype,Facial Morphology (Multitrait Analysis)
53018,C-Reactive Protein Levels (Mtag),Phenotype,C-Reactive Protein Levels (Mtag)
53020,Drinks Per Week,Phenotype,Drinks Per Week
53031,Covid-19 Death (Death Vs Tested And Survived),Phenotype,Covid-19 Death (Death Vs Tested And Survived)
53033,Covid-19 Death (Death Vs Population),Phenotype,Covid-19 Death (Death Vs Population)
53049,Covid-19 (Severe Vs Tested-- Not Severe),Phenotype,Covid-19 (Severe Vs Tested-- Not Severe)
53053,Covid-19 (Severe Vs Population),Phenotype,Covid-19 (Severe Vs Population)
53072,Acute Tubulointerstitial Nephritis,Phenotype,Acute Tubulointerstitial Nephritis
53080,Episodic Memory,Phenotype,Episodic Memory
53082,Language Performance,Phenotype,Language Performance
53091,Visuospatial Ability,Phenotype,Visuospatial Ability
53097,sarcopenia,Phenotype,sarcopenia
53099,Covid-19 (Severe Vs Non-Severe With Positive Test),Phenotype,Covid-19 (Severe Vs Non-Severe With Positive Test)
53112,School Performance E-Factor 1 (Overall Performance),Phenotype,School Performance E-Factor 1 (Overall Performance)
53113,School Performance E-Factor 2 (Language Performance Relative To Maths),Phenotype,School Performance E-Factor 2 (Language Performance Relative To Maths)
53114,School Performance E-Factor 3 (Oral Performance Relative To Written),Phenotype,School Performance E-Factor 3 (Oral Performance Relative To Written)
53156,Pulmonary Embolism,Phenotype,Pulmonary Embolism
53181,Frequency Of Common Cold Infection,Phenotype,Frequency Of Common Cold Infection
53183,Systemic Infections,Phenotype,Systemic Infections
53200,Covid-19 Hospitalization Or Rheumatoid Arthritis (Mtag),Phenotype,Covid-19 Hospitalization Or Rheumatoid Arthritis (Mtag)
53203,Severe Covid-19 Or Rheumatoid Arthritis (Mtag),Phenotype,Severe Covid-19 Or Rheumatoid Arthritis (Mtag)
53234,Antipsychotic-Induced Metabolic Syndrome In Schizophrenia,Phenotype,Antipsychotic-Induced Metabolic Syndrome In Schizophrenia
53236,Chronic Chagas Cardiomyopathy In Chagas Disease,Phenotype,Chronic Chagas Cardiomyopathy In Chagas Disease
53240,Free Testosterone Levels,Phenotype,Free Testosterone Levels
53257,Nonsyndromic Orofacial Cleft X Sex Interaction,Phenotype,Nonsyndromic Orofacial Cleft X Sex Interaction
53277,Severe Covid-19 Or Systemic Lupus Erythematosus (Inverse Variance),Phenotype,Severe Covid-19 Or Systemic Lupus Erythematosus (Inverse Variance)
53278,Premature Atrial Contraction Frequency,Phenotype,Premature Atrial Contraction Frequency
53292,Albumin Levels,Phenotype,Albumin Levels
53312,Risk-Taking Behavior (Multivariate Analysis),Phenotype,Risk-Taking Behavior (Multivariate Analysis)
53327,Very Low Density Lipoprotein Cholesterol Levels,Phenotype,Very Low Density Lipoprotein Cholesterol Levels
53330,Smoking Initiation (Ever Vs Never),Phenotype,Smoking Initiation (Ever Vs Never)
53332,Smoking Cessation (Current Vs Former),Phenotype,Smoking Cessation (Current Vs Former)
53334,Nonsyndromic Orofacial Cleft X Sex Interaction (2Df),Phenotype,Nonsyndromic Orofacial Cleft X Sex Interaction (2Df)
53337,Serum Glutamic-Oxaloacetic Transaminase Levels,Phenotype,Serum Glutamic-Oxaloacetic Transaminase Levels
53338,Urinary Microalbumin Levels,Phenotype,Urinary Microalbumin Levels
53342,Univariate Microbial Feature (Genus: Staphylococcus) At The Forehead (Sebaceous Skin),Phenotype,Univariate Microbial Feature (Genus: Staphylococcus) At The Forehead (Sebaceous Skin)
53344,Univariate Microbial Feature (Asv: Asv004) At The Forehead (Sebaceous Skin),Phenotype,Univariate Microbial Feature (Asv: Asv004) At The Forehead (Sebaceous Skin)
53346,Univariate Microbial Feature (Genus: Anaerococcus) At The Dorsal Forearm (Dry Skin),Phenotype,Univariate Microbial Feature (Genus: Anaerococcus) At The Dorsal Forearm (Dry Skin)
53348,Univariate Microbial Feature (Family: Clostridiales) At The Incertae (Moist Skin),Phenotype,Univariate Microbial Feature (Family: Clostridiales) At The Incertae (Moist Skin)
53352,Blood Pressure (Pleiotropy Model 1 Dbp Adjusted For Estimated Causal Effects X Sbp),Phenotype,Blood Pressure (Pleiotropy Model 1 Dbp Adjusted For Estimated Causal Effects X Sbp)
53359,Change In Processing Speed In Pediatric Cns Tumors Treated With Craniospinal Irradiation,Phenotype,Change In Processing Speed In Pediatric Cns Tumors Treated With Craniospinal Irradiation
53362,3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoate (Cmpf) Levels,Phenotype,3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoate (Cmpf) Levels
53363,21-Hydroxypregnenolone Disulfate Levels,Phenotype,21-Hydroxypregnenolone Disulfate Levels
53364,3-Methoxytyrosine Levels,Phenotype,3-Methoxytyrosine Levels
53365,3-Phenylpropionate (Hydrocinnamate) Levels,Phenotype,3-Phenylpropionate (Hydrocinnamate) Levels
53367,4-Allylphenol Sulfate Levels,Phenotype,4-Allylphenol Sulfate Levels
53371,1-Stearoyl-2-Dihomo-Linolenoyl-Gpi (18:0/20:3N3 Or 6) Levels,Phenotype,1-Stearoyl-2-Dihomo-Linolenoyl-Gpi (18:0/20:3N3 Or 6) Levels
53372,1-Stearoyl-2-Docosapentaenoyl-Gpc (18:0/22:5N3) Levels,Phenotype,1-Stearoyl-2-Docosapentaenoyl-Gpc (18:0/22:5N3) Levels
53374,4-Androsten-3Beta--17Beta-Diol Disulfate (2) Levels,Phenotype,4-Androsten-3Beta--17Beta-Diol Disulfate (2) Levels
53376,4-Androsten-3Beta--17Beta-Diol Monosulfate (2) Levels,Phenotype,4-Androsten-3Beta--17Beta-Diol Monosulfate (2) Levels
53378,4-Ethylphenylsulfate Levels,Phenotype,4-Ethylphenylsulfate Levels
53379,5Alpha-Androstan-3Alpha--17Beta-Diol Monosulfate (1) Levels,Phenotype,5Alpha-Androstan-3Alpha--17Beta-Diol Monosulfate (1) Levels
53380,5Alpha-Androstan-3Beta--17Beta-Diol Monosulfate (2) Levels,Phenotype,5Alpha-Androstan-3Beta--17Beta-Diol Monosulfate (2) Levels
53381,5-Bromotryptophan Levels,Phenotype,5-Bromotryptophan Levels
53384,Dihomo-Linolenate (20:3N3 Or N6) Levels,Phenotype,Dihomo-Linolenate (20:3N3 Or N6) Levels
53385,Dodecadienoate (12:2) (X-21343) Levels,Phenotype,Dodecadienoate (12:2) (X-21343) Levels
53387,Ethylmalonate Levels,Phenotype,Ethylmalonate Levels
53388,Gamma-Glutamyl-Alpha-Lysine Levels,Phenotype,Gamma-Glutamyl-Alpha-Lysine Levels
53390,Gamma-Glutamyltyrosine Levels,Phenotype,Gamma-Glutamyltyrosine Levels
53394,Epiandrosterone Sulfate Levels,Phenotype,Epiandrosterone Sulfate Levels
53395,Ergothioneine Levels,Phenotype,Ergothioneine Levels
53397,Hydroxy-Cmpf (X-02269) Levels,Phenotype,Hydroxy-Cmpf (X-02269) Levels
53398,Imidazole Lactate Levels,Phenotype,Imidazole Lactate Levels
53401,1-Oleoyl-2-Docosahexaenoyl-Gpc (18:1/22:6) Levels,Phenotype,1-Oleoyl-2-Docosahexaenoyl-Gpc (18:1/22:6) Levels
53403,1-Palmitoyl-2-Docosahexaenoyl-Gpc (16:0/22:6) Levels,Phenotype,1-Palmitoyl-2-Docosahexaenoyl-Gpc (16:0/22:6) Levels
53404,1-(1-Enyl-Palmitoyl)-2-Linoleoyl-Gpc (P-16:0/18:2) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Linoleoyl-Gpc (P-16:0/18:2) Levels
53405,1-(1-Enyl-Palmitoyl)-2-Oleoyl-Gpc (P-16:0/18:1) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Oleoyl-Gpc (P-16:0/18:1) Levels
53406,1-(1-Enyl-Palmitoyl)-2-Palmitoleoyl-Gpc (P-16:0/16:1) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Palmitoleoyl-Gpc (P-16:0/16:1) Levels
53407,1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0) Levels
53408,1-(1-Enyl-Stearoyl)-2-Linoleoyl-Gpc (P-18:0/18:2) Levels,Phenotype,1-(1-Enyl-Stearoyl)-2-Linoleoyl-Gpc (P-18:0/18:2) Levels
53409,1-Dihomo-Linolenoyl-Gpc (20:3N3 Or 6) Levels,Phenotype,1-Dihomo-Linolenoyl-Gpc (20:3N3 Or 6) Levels
53410,1-Docosahexaenoyl-Gpc (22:6) Levels,Phenotype,1-Docosahexaenoyl-Gpc (22:6) Levels
53412,1-Docosahexaenoyl-Gpe (22:6) Levels,Phenotype,1-Docosahexaenoyl-Gpe (22:6) Levels
53414,1-(1-Enyl-Stearoyl)-2-Oleoyl-Gpc (P-18:0/18:1) Levels,Phenotype,1-(1-Enyl-Stearoyl)-2-Oleoyl-Gpc (P-18:0/18:1) Levels
53415,1--2-Dipalmitoyl-Gpc (16:0/16:0) Levels,Phenotype,1--2-Dipalmitoyl-Gpc (16:0/16:0) Levels
53416,1--3--7-Trimethylurate Levels,Phenotype,1--3--7-Trimethylurate Levels
53418,Xanthurenate Levels,Phenotype,Xanthurenate Levels
53419,1-(1-Enyl-Palmitoyl)-2-Arachidonoyl-Gpc (P-16:0/20:4) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Arachidonoyl-Gpc (P-16:0/20:4) Levels
53420,X-23749 Levels,Phenotype,X-23749 Levels
53424,Waist Circumference (Aged 40-50 Years),Phenotype,Waist Circumference (Aged 40-50 Years)
53425,Migraine Or Type 2 Diabetes,Phenotype,Migraine Or Type 2 Diabetes
53428,Remission After Antidepressant Treatment In Major Depressive Disorder,Phenotype,Remission After Antidepressant Treatment In Major Depressive Disorder
53429,Response To Antidepressants (Symptom Improvement) In Major Depressive Disorder,Phenotype,Response To Antidepressants (Symptom Improvement) In Major Depressive Disorder
53432,1-Palmityl-2-Oleoyl-Gpc (O-16:0/18:1) Levels,Phenotype,1-Palmityl-2-Oleoyl-Gpc (O-16:0/18:1) Levels
53433,1-Palmityl-2-Palmitoyl-Gpc (O-16:0/16:0) Levels,Phenotype,1-Palmityl-2-Palmitoyl-Gpc (O-16:0/16:0) Levels
53434,1-Palmityl-2-Stearoyl-Gpc (O-16:0/18:0) Levels,Phenotype,1-Palmityl-2-Stearoyl-Gpc (O-16:0/18:0) Levels
53435,1-Pentadecanoyl-2-Docosahexaenoyl-Gpc (15:0/22:6) Levels,Phenotype,1-Pentadecanoyl-2-Docosahexaenoyl-Gpc (15:0/22:6) Levels
53443,1-Palmitoyl-2-Linoleoyl-Gpc (16:0/18:2) Levels,Phenotype,1-Palmitoyl-2-Linoleoyl-Gpc (16:0/18:2) Levels
53444,1-Stearoyl-2-Dihomo-Linolenoyl-Gpc (18:0/20:3N3 Or 6) Levels,Phenotype,1-Stearoyl-2-Dihomo-Linolenoyl-Gpc (18:0/20:3N3 Or 6) Levels
53447,Estimated Glomerular Filtration Rate In Type 2 Diabetes,Phenotype,Estimated Glomerular Filtration Rate In Type 2 Diabetes
53449,Ascorbic Acid 3-Sulfate (X-12206) Levels,Phenotype,Ascorbic Acid 3-Sulfate (X-12206) Levels
53452,Beta-Hydroxyisovalerate Levels,Phenotype,Beta-Hydroxyisovalerate Levels
53455,Betaine Levels,Phenotype,Betaine Levels
53456,Cis-4-Decenoyl Carnitine Levels,Phenotype,Cis-4-Decenoyl Carnitine Levels
53458,Androsterone Sulfate Levels,Phenotype,Androsterone Sulfate Levels
53459,Cys-Gly-- Oxidized Levels,Phenotype,Cys-Gly-- Oxidized Levels
53462,Cysteine S-Sulfate Levels,Phenotype,Cysteine S-Sulfate Levels
53464,Cysteinylglycine Levels,Phenotype,Cysteinylglycine Levels
53467,Cystine Levels,Phenotype,Cystine Levels
53468,Cytidine Levels,Phenotype,Cytidine Levels
53469,Decadienedioic Acid (C10:2-Dc) (X-21792) Levels,Phenotype,Decadienedioic Acid (C10:2-Dc) (X-21792) Levels
53472,Indolepropionate Levels,Phenotype,Indolepropionate Levels
53474,Isobutyrylcarnitine Levels,Phenotype,Isobutyrylcarnitine Levels
53475,Isoleucylleucine/Leucylisoleucine Levels,Phenotype,Isoleucylleucine/Leucylisoleucine Levels
53478,Laurylcarnitine Levels,Phenotype,Laurylcarnitine Levels
53480,Methionine Sulfone Levels,Phenotype,Methionine Sulfone Levels
53481,Myristoylcarnitine Levels,Phenotype,Myristoylcarnitine Levels
53482,N1-Methyladenosine Levels,Phenotype,N1-Methyladenosine Levels
53484,N6--N6--N6-Trimethyllysine Levels,Phenotype,N6--N6--N6-Trimethyllysine Levels
53495,N-Acetylcarnosine Levels,Phenotype,N-Acetylcarnosine Levels
53496,N-Acetylphenylalanine Levels,Phenotype,N-Acetylphenylalanine Levels
53497,Linoleoylcarnitine Levels,Phenotype,Linoleoylcarnitine Levels
53499,N-Acetylglucosamine/N-Acetylgalactosamine Levels,Phenotype,N-Acetylglucosamine/N-Acetylgalactosamine Levels
53501,N-Acetylhistidine Levels,Phenotype,N-Acetylhistidine Levels
53502,N-Acetyl-Isoputreanine (X-12688) Levels,Phenotype,N-Acetyl-Isoputreanine (X-12688) Levels
53505,Palmitoylcarnitine Levels,Phenotype,Palmitoylcarnitine Levels
53506,P-Cresol-Glucuronide Levels,Phenotype,P-Cresol-Glucuronide Levels
53508,Phenyllactate (Pla) Levels,Phenotype,Phenyllactate (Pla) Levels
53513,Orotate Levels,Phenotype,Orotate Levels
53514,Palmitoleoylcarnitine Levels,Phenotype,Palmitoleoylcarnitine Levels
53515,Oleoylcarnitine Levels,Phenotype,Oleoylcarnitine Levels
53516,Stearoylcarnitine Levels,Phenotype,Stearoylcarnitine Levels
53517,Succinylcarnitine Levels,Phenotype,Succinylcarnitine Levels
53520,Blood Pressure (Pleiotropy Model 2 Sbp Adjusted For Estimated Causal Effects X Dbp),Phenotype,Blood Pressure (Pleiotropy Model 2 Sbp Adjusted For Estimated Causal Effects X Dbp)
53526,X-11470 Levels,Phenotype,X-11470 Levels
53531,X-11478 Levels,Phenotype,X-11478 Levels
53533,X-12100 Levels,Phenotype,X-12100 Levels
53534,X-19141 Levels,Phenotype,X-19141 Levels
53536,X-21319 Levels,Phenotype,X-21319 Levels
53539,X-21364 Levels,Phenotype,X-21364 Levels
53540,X-21410 Levels,Phenotype,X-21410 Levels
53542,X-12847 Levels,Phenotype,X-12847 Levels
53544,X-13684 Levels,Phenotype,X-13684 Levels
53547,X-13866 Levels,Phenotype,X-13866 Levels
53550,X-15469 Levels,Phenotype,X-15469 Levels
53552,X-15486 Levels,Phenotype,X-15486 Levels
53553,X-11261 Levels,Phenotype,X-11261 Levels
53555,X-11381 Levels,Phenotype,X-11381 Levels
53557,X-17676 Levels,Phenotype,X-17676 Levels
53560,X-17690 Levels,Phenotype,X-17690 Levels
53562,X-18921 Levels,Phenotype,X-18921 Levels
53590,Posterior Urethral Valves,Phenotype,Posterior Urethral Valves
53630,Bone Stiffness Index,Phenotype,Bone Stiffness Index
53638,Hip Fracture,Phenotype,Hip Fracture
53645,Skin Autofluorescence,Phenotype,Skin Autofluorescence
53646,Skin Reflectance,Phenotype,Skin Reflectance
53653,Suicide Behavior,Phenotype,Suicide Behavior
53656,4-Acetaminophen Sulfate Levels,Phenotype,4-Acetaminophen Sulfate Levels
53658,4-Acetylphenol Sulfate Levels,Phenotype,4-Acetylphenol Sulfate Levels
53660,4-Androsten-3Alpha--17Alpha-Diol Monosulfate (2) Levels,Phenotype,4-Androsten-3Alpha--17Alpha-Diol Monosulfate (2) Levels
53663,4-Androsten-3Beta--17Beta-Diol Disulfate (1) Levels,Phenotype,4-Androsten-3Beta--17Beta-Diol Disulfate (1) Levels
53666,4-Androsten-3Beta--17Beta-Diol Monosulfate (1) Levels,Phenotype,4-Androsten-3Beta--17Beta-Diol Monosulfate (1) Levels
53668,Triglyceride Levels In Type 2 Diabetes,Phenotype,Triglyceride Levels In Type 2 Diabetes
53669,Triglyceride Levels In Non-Type 2 Diabetes,Phenotype,Triglyceride Levels In Non-Type 2 Diabetes
53671,4-Guanidinobutanoate Levels,Phenotype,4-Guanidinobutanoate Levels
53672,4-Hydroxycoumarin Levels,Phenotype,4-Hydroxycoumarin Levels
53674,4-Methylcatechol Sulfate Levels,Phenotype,4-Methylcatechol Sulfate Levels
53676,4-Vinylguaiacol Sulfate Levels,Phenotype,4-Vinylguaiacol Sulfate Levels
53678,5Alpha-Androstan-3Alpha--17Beta-Diol Monosulfate (2) Levels,Phenotype,5Alpha-Androstan-3Alpha--17Beta-Diol Monosulfate (2) Levels
53680,5Alpha-Androstan-3Beta--17Alpha-Diol Disulfate Levels,Phenotype,5Alpha-Androstan-3Beta--17Alpha-Diol Disulfate Levels
53682,5Alpha-Androstan-3Beta--17Beta-Diol Disulfate Levels,Phenotype,5Alpha-Androstan-3Beta--17Beta-Diol Disulfate Levels
53683,5Alpha-Pregnan-3Beta--20Beta-Diol Monosulfate (1) Levels,Phenotype,5Alpha-Pregnan-3Beta--20Beta-Diol Monosulfate (1) Levels
53685,4-Vinylphenol Sulfate Levels,Phenotype,4-Vinylphenol Sulfate Levels
53686,5Alpha-Androstan-3Alpha--17Beta-Diol Disulfate Levels,Phenotype,5Alpha-Androstan-3Alpha--17Beta-Diol Disulfate Levels
53689,5-Methyluridine (Ribothymidine) Levels,Phenotype,5-Methyluridine (Ribothymidine) Levels
53692,6-Hydroxyindole Sulfate Levels,Phenotype,6-Hydroxyindole Sulfate Levels
53694,Asparagine Levels,Phenotype,Asparagine Levels
53698,Bilirubin (Z--Z) Levels,Phenotype,Bilirubin (Z--Z) Levels
53700,Cholate Levels,Phenotype,Cholate Levels
53702,Alpha-Hydroxyisovalerate Levels,Phenotype,Alpha-Hydroxyisovalerate Levels
53704,Andro Steroid Monosulfate (1) Levels,Phenotype,Andro Steroid Monosulfate (1) Levels
53705,Acisoga Levels,Phenotype,Acisoga Levels
53707,Adenine Levels,Phenotype,Adenine Levels
53709,Adipoylcarnitine Levels,Phenotype,Adipoylcarnitine Levels
53710,Docosahexaenoate (Dha; 22:6N3) Levels,Phenotype,Docosahexaenoate (Dha; 22:6N3) Levels
53712,Dodecanedioate Levels,Phenotype,Dodecanedioate Levels
53715,Dihydroferulic Acid Levels,Phenotype,Dihydroferulic Acid Levels
53717,Cysteine-Glutathione Disulfide Levels,Phenotype,Cysteine-Glutathione Disulfide Levels
53718,Dehydroisoandrosterone Sulfate (Dhea-S) Levels,Phenotype,Dehydroisoandrosterone Sulfate (Dhea-S) Levels
53725,Etiocholanolone Glucuronide Levels,Phenotype,Etiocholanolone Glucuronide Levels
53726,Ferulic Acid 4-Sulfate Levels,Phenotype,Ferulic Acid 4-Sulfate Levels
53727,Gamma-Cehc Levels,Phenotype,Gamma-Cehc Levels
53728,Gamma-Glutamylleucine Levels,Phenotype,Gamma-Glutamylleucine Levels
53730,Gamma-Glutamylmethionine Levels,Phenotype,Gamma-Glutamylmethionine Levels
53731,Gamma-Glutamylphenylalanine Levels,Phenotype,Gamma-Glutamylphenylalanine Levels
53734,Glutarylcarnitine (C5) Levels,Phenotype,Glutarylcarnitine (C5) Levels
53737,Hexanoylcarnitine Levels,Phenotype,Hexanoylcarnitine Levels
53738,Glycodeoxycholate Sulfate Levels,Phenotype,Glycodeoxycholate Sulfate Levels
53740,Glycolithocholate Sulfate Levels,Phenotype,Glycolithocholate Sulfate Levels
53742,Gamma-Glutamyl-2-Aminobutyrate Levels,Phenotype,Gamma-Glutamyl-2-Aminobutyrate Levels
53743,Gamma-Glutamyl-Epsilon-Lysine Levels,Phenotype,Gamma-Glutamyl-Epsilon-Lysine Levels
53745,Gamma-Glutamylglutamate Levels,Phenotype,Gamma-Glutamylglutamate Levels
53746,Gamma-Glutamylglutamine Levels,Phenotype,Gamma-Glutamylglutamine Levels
53747,Gamma-Glutamylhistidine Levels,Phenotype,Gamma-Glutamylhistidine Levels
53751,Glycocholenate Sulfate Levels,Phenotype,Glycocholenate Sulfate Levels
53753,Gluconic Acid Levels,Phenotype,Gluconic Acid Levels
53755,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels,Phenotype,1-Palmitoyl-2-Oleoyl-Gpc (16:0/18:1) Levels
53757,1-Palmitoyl-2-Palmitoleoyl-Gpc (16:0/16:1) Levels,Phenotype,1-Palmitoyl-2-Palmitoleoyl-Gpc (16:0/16:1) Levels
53758,1-Palmitoyl-2-Arachidonoyl-Gpc (16:0/20:4) Levels,Phenotype,1-Palmitoyl-2-Arachidonoyl-Gpc (16:0/20:4) Levels
53762,1-Palmitoyl-2-Eicosapentaenoyl-Gpc (16:0/20:5) Levels,Phenotype,1-Palmitoyl-2-Eicosapentaenoyl-Gpc (16:0/20:5) Levels
53764,1-Palmitoyl-2-Linoleoyl-Glycerol (16:0/18:2) Levels,Phenotype,1-Palmitoyl-2-Linoleoyl-Glycerol (16:0/18:2) Levels
53766,Hydroquinone Sulfate Levels,Phenotype,Hydroquinone Sulfate Levels
53769,Hypotaurine Levels,Phenotype,Hypotaurine Levels
53771,1-Palmitoyl-3-Linoleoyl-Glycerol (16:0/18:2) Levels,Phenotype,1-Palmitoyl-3-Linoleoyl-Glycerol (16:0/18:2) Levels
53773,1-Palmityl-2-Arachidonoyl-Gpc (O-16:0/20:4) Levels,Phenotype,1-Palmityl-2-Arachidonoyl-Gpc (O-16:0/20:4) Levels
53774,1-Stearoyl-2-Arachidonoyl-Gpc (18:0/20:4) Levels,Phenotype,1-Stearoyl-2-Arachidonoyl-Gpc (18:0/20:4) Levels
53776,1-Stearoyl-2-Docosahexaenoyl-Gpc (18:0/22:6) Levels,Phenotype,1-Stearoyl-2-Docosahexaenoyl-Gpc (18:0/22:6) Levels
53779,1-Stearoyl-2-Docosapentaenoyl-Gpc (18:0/22:5N6) Levels,Phenotype,1-Stearoyl-2-Docosapentaenoyl-Gpc (18:0/22:5N6) Levels
53781,1-Stearoyl-2-Linoleoyl-Gpc (18:0/18:2) Levels,Phenotype,1-Stearoyl-2-Linoleoyl-Gpc (18:0/18:2) Levels
53782,1-Stearoyl-2-Linoleoyl-Gpi (18:0/18:2) Levels,Phenotype,1-Stearoyl-2-Linoleoyl-Gpi (18:0/18:2) Levels
53784,1-Stearoyl-2-Oleoyl-Gpc (18:0/18:1) Levels,Phenotype,1-Stearoyl-2-Oleoyl-Gpc (18:0/18:1) Levels
53786,1-Stearoyl-Gpe (18:0) Levels,Phenotype,1-Stearoyl-Gpe (18:0) Levels
53788,2-Aminooctanoate Levels,Phenotype,2-Aminooctanoate Levels
53790,Indolelactate Levels,Phenotype,Indolelactate Levels
53792,Myo-Inositol Levels,Phenotype,Myo-Inositol Levels
53795,N2--N5-Diacetylornithine Levels,Phenotype,N2--N5-Diacetylornithine Levels
53797,N6-Carbamoylthreonyladenosine Levels,Phenotype,N6-Carbamoylthreonyladenosine Levels
53798,Mannitol/Sorbitol Levels,Phenotype,Mannitol/Sorbitol Levels
53801,Lactosyl-N-Palmitoyl-Sphingosine Levels,Phenotype,Lactosyl-N-Palmitoyl-Sphingosine Levels
53802,Indoleacetate Levels,Phenotype,Indoleacetate Levels
53803,Indoleacetylglutamine Levels,Phenotype,Indoleacetylglutamine Levels
53805,Indolin-2-One Levels,Phenotype,Indolin-2-One Levels
53806,Isoeugenol Sulfate Levels,Phenotype,Isoeugenol Sulfate Levels
53809,Isovalerylcarnitine Levels,Phenotype,Isovalerylcarnitine Levels
53810,Kynurenate Levels,Phenotype,Kynurenate Levels
53813,Interstitial Lung Diseases In Rheumatoid Arthritis,Phenotype,Interstitial Lung Diseases In Rheumatoid Arthritis
53815,N-Acetylarginine Levels,Phenotype,N-Acetylarginine Levels
53816,N-Acetyltryptophan Levels,Phenotype,N-Acetyltryptophan Levels
53817,N-Delta-Acetylornithine Levels,Phenotype,N-Delta-Acetylornithine Levels
53819,N-Acetylkynurenine (2) Levels,Phenotype,N-Acetylkynurenine (2) Levels
53820,N-Acetylleucine Levels,Phenotype,N-Acetylleucine Levels
53822,N-Acetylneuraminate Levels,Phenotype,N-Acetylneuraminate Levels
53823,N-Acetylcitrulline Levels,Phenotype,N-Acetylcitrulline Levels
53825,N-Acetylglycine Levels,Phenotype,N-Acetylglycine Levels
53827,Chronic Obstructive Pulmonary Disease Liability (Machine Learning-Based Score),Phenotype,Chronic Obstructive Pulmonary Disease Liability (Machine Learning-Based Score)
53833,Resistance To Covid-19 Infection (Exposed Negative Vs Positive),Phenotype,Resistance To Covid-19 Infection (Exposed Negative Vs Positive)
53835,Low-Density Lipoprotein Levels (Mtag),Phenotype,Low-Density Lipoprotein Levels (Mtag)
53852,Photoreceptor Cell Layer Thickness Phenotypes (Mtag),Phenotype,Photoreceptor Cell Layer Thickness Phenotypes (Mtag)
53861,Mitral Valve Annular Diameter (Left Ventricle Systole),Phenotype,Mitral Valve Annular Diameter (Left Ventricle Systole)
53882,Childhood Median Systolic Blood Pressure Percentile (0-3 Years Old),Phenotype,Childhood Median Systolic Blood Pressure Percentile (0-3 Years Old)
53885,Childhood Median Systolic Blood Pressure Percentile,Phenotype,Childhood Median Systolic Blood Pressure Percentile
53888,Childhood Median Systolic Blood Pressure Percentile (13-18 Years Old),Phenotype,Childhood Median Systolic Blood Pressure Percentile (13-18 Years Old)
53892,Age Of Onset Of Childhood Onset Asthma,Phenotype,Age Of Onset Of Childhood Onset Asthma
53895,Age Of Onset Of Adult Onset Asthma,Phenotype,Age Of Onset Of Adult Onset Asthma
53897,Bmi (Standard Gwa),Phenotype,Bmi (Standard Gwa)
53908,Triglyceride Levels (Mtag),Phenotype,Triglyceride Levels (Mtag)
53909,Coffee Intake (Weighted Gwa),Phenotype,Coffee Intake (Weighted Gwa)
53910,Depression/Anxiety (Standard Gwa),Phenotype,Depression/Anxiety (Standard Gwa)
53911,Diabetes (Standard Gwa),Phenotype,Diabetes (Standard Gwa)
53913,Diabetes (Weighted Gwa),Phenotype,Diabetes (Weighted Gwa)
53914,Coffee Intake (Standard Gwa),Phenotype,Coffee Intake (Standard Gwa)
53922,Plasma Myo-Inositol Levels,Phenotype,Plasma Myo-Inositol Levels
53924,Idiopathic Knee Osteoarthritis,Phenotype,Idiopathic Knee Osteoarthritis
53929,Age When Finished Full-Time Education (Standard Gwa),Phenotype,Age When Finished Full-Time Education (Standard Gwa)
53948,Age When Finished Full-Time Education (Weighted Gwa),Phenotype,Age When Finished Full-Time Education (Weighted Gwa)
53957,Fruit Intake (Standard Gwa),Phenotype,Fruit Intake (Standard Gwa)
53984,Migraine (Mtag),Phenotype,Migraine (Mtag)
53986,Cervical Artery Dissection (Mtag),Phenotype,Cervical Artery Dissection (Mtag)
53987,Migraine Without Aura (Mtag),Phenotype,Migraine Without Aura (Mtag)
54000,Height (Standard Gwa),Phenotype,Height (Standard Gwa)
54017,Gestational Age (Fetal Effect),Phenotype,Gestational Age (Fetal Effect)
54019,Multisyllabic Word Repetition,Phenotype,Multisyllabic Word Repetition
54021,Hearing Loss,Phenotype,Hearing Loss
54031,Attention Deficit Hyperactivity Disorder Or Autism Spectrum Disorder Or Intelligence (Pleiotropy),Phenotype,Attention Deficit Hyperactivity Disorder Or Autism Spectrum Disorder Or Intelligence (Pleiotropy)
54061,Impulse Control Disorders In Parkinson’S Disease,Phenotype,Impulse Control Disorders In Parkinson’S Disease
54065,3-Hydroxyhexanoate Levels,Phenotype,3-Hydroxyhexanoate Levels
54067,Myristoleoylcarnitine (C14:1) Levels,Phenotype,Myristoleoylcarnitine (C14:1) Levels
54069,Suberoylcarnitine (C8-Dc) Levels,Phenotype,Suberoylcarnitine (C8-Dc) Levels
54070,1-Oleoyl-2-Dihomo-Linolenoyl-Gpc (18:1/20:3) Levels,Phenotype,1-Oleoyl-2-Dihomo-Linolenoyl-Gpc (18:1/20:3) Levels
54071,Adipoylcarnitine (C6-Dc) Levels,Phenotype,Adipoylcarnitine (C6-Dc) Levels
54072,Nonanoylcarnitine (C9) Levels,Phenotype,Nonanoylcarnitine (C9) Levels
54073,1-Palmitoyl-2-Dihomo-Linolenoyl-Gpc (16:0/20:3N3 Or 6) Levels,Phenotype,1-Palmitoyl-2-Dihomo-Linolenoyl-Gpc (16:0/20:3N3 Or 6) Levels
54092,N-Acetylglucosaminylasparagine Levels,Phenotype,N-Acetylglucosaminylasparagine Levels
54094,Flavin Adenine Dinucleotide (Fad) Levels,Phenotype,Flavin Adenine Dinucleotide (Fad) Levels
54095,Succinylcarnitine (C4-Dc) Levels,Phenotype,Succinylcarnitine (C4-Dc) Levels
54097,Palmitoylcarnitine (C16) Levels,Phenotype,Palmitoylcarnitine (C16) Levels
54099,Propionylcarnitine (C3) Levels,Phenotype,Propionylcarnitine (C3) Levels
54100,Octanoylcarnitine (C8) Levels,Phenotype,Octanoylcarnitine (C8) Levels
54101,Decanoylcarnitine (C10) Levels,Phenotype,Decanoylcarnitine (C10) Levels
54102,Laurylcarnitine (C12) Levels,Phenotype,Laurylcarnitine (C12) Levels
54103,Oleoylcarnitine (C18:1) Levels,Phenotype,Oleoylcarnitine (C18:1) Levels
54104,Ascorbic Acid 2-Sulfate Levels,Phenotype,Ascorbic Acid 2-Sulfate Levels
54110,Carotene Diol (1) Levels,Phenotype,Carotene Diol (1) Levels
54112,Carotene Diol (2) Levels,Phenotype,Carotene Diol (2) Levels
54113,Carotene Diol (3) Levels,Phenotype,Carotene Diol (3) Levels
54114,Ascorbic Acid 3-Sulfate Levels,Phenotype,Ascorbic Acid 3-Sulfate Levels
54132,Alzheimer’S Disease Polygenic Risk Score (Upper Quantile Vs Lower Quantile),Phenotype,Alzheimer’S Disease Polygenic Risk Score (Upper Quantile Vs Lower Quantile)
54138,Dietary Macronutrient Intake (Multi-Trait Analysis),Phenotype,Dietary Macronutrient Intake (Multi-Trait Analysis)
54139,Widow'S Peak,Phenotype,Widow'S Peak
54140,Earlobe Attachment,Phenotype,Earlobe Attachment
54148,Late-Onset Alzheimer'S Disease In High Risk Polygenic Risk Score,Phenotype,Late-Onset Alzheimer'S Disease In High Risk Polygenic Risk Score
54151,Cftr Mutation F508Del Heterozygosity In Cystic Fibrosis,Phenotype,Cftr Mutation F508Del Heterozygosity In Cystic Fibrosis
54162,Depression-- Cognition And Memory (Multivariate Analysis),Phenotype,Depression-- Cognition And Memory (Multivariate Analysis)
54165,1-Oleoyl-2-Docosapentaenoyl-Gpc (18:1/22:5N3) Levels,Phenotype,1-Oleoyl-2-Docosapentaenoyl-Gpc (18:1/22:5N3) Levels
54167,Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc) Levels,Phenotype,Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc) Levels
54168,Docosapentaenoylcarnitine (C22:5N3) Levels,Phenotype,Docosapentaenoylcarnitine (C22:5N3) Levels
54169,N-Acetyl-2-Aminooctanoate Levels,Phenotype,N-Acetyl-2-Aminooctanoate Levels
54171,Dodecadienoate (12:2) Levels,Phenotype,Dodecadienoate (12:2) Levels
54173,Arachidonoylcarnitine (C20:4) Levels,Phenotype,Arachidonoylcarnitine (C20:4) Levels
54174,Eicosenoylcarnitine (C20:1) Levels,Phenotype,Eicosenoylcarnitine (C20:1) Levels
54175,Dihomo-Linoleoylcarnitine (C20:2) Levels,Phenotype,Dihomo-Linoleoylcarnitine (C20:2) Levels
54176,Dihomo-Linolenoylcarnitine (C20:3N3 Or 6) Levels,Phenotype,Dihomo-Linolenoylcarnitine (C20:3N3 Or 6) Levels
54177,Linolenoylcarnitine (C18:3) Levels,Phenotype,Linolenoylcarnitine (C18:3) Levels
54178,Cerotoylcarnitine (C26) Levels,Phenotype,Cerotoylcarnitine (C26) Levels
54179,Ximenoylcarnitine (C26:1) Levels,Phenotype,Ximenoylcarnitine (C26:1) Levels
54180,Nisinate (24:6N3) Levels,Phenotype,Nisinate (24:6N3) Levels
54182,Ceramide [N(26)S(19)] Levels,Phenotype,Ceramide [N(26)S(19)] Levels
54184,3Beta--7Alpha-Dihydroxy-5-Cholestenoate Levels,Phenotype,3Beta--7Alpha-Dihydroxy-5-Cholestenoate Levels
54186,Hexanoylglutamine Levels,Phenotype,Hexanoylglutamine Levels
54188,Androstenediol (3Beta--17Beta) Disulfate (1) Levels,Phenotype,Androstenediol (3Beta--17Beta) Disulfate (1) Levels
54189,Androstenediol (3Beta--17Beta) Disulfate (2) Levels,Phenotype,Androstenediol (3Beta--17Beta) Disulfate (2) Levels
54190,Androstenediol (3Alpha-- 17Alpha) Monosulfate (2) Levels,Phenotype,Androstenediol (3Alpha-- 17Alpha) Monosulfate (2) Levels
54191,Androstenediol (3Beta--17Beta) Monosulfate (2) Levels,Phenotype,Androstenediol (3Beta--17Beta) Monosulfate (2) Levels
54207,Covid-19 Or Hypertension (Pleiotropy),Phenotype,Covid-19 Or Hypertension (Pleiotropy)
54208,3-(3-Hydroxyphenyl)Propionate Levels,Phenotype,3-(3-Hydroxyphenyl)Propionate Levels
54209,3--4-Methyleneheptanoate Levels,Phenotype,3--4-Methyleneheptanoate Levels
54210,3-Formylindole Levels,Phenotype,3-Formylindole Levels
54212,3-Indoleglyoxylic Acid Levels,Phenotype,3-Indoleglyoxylic Acid Levels
54214,Phenylacetate Levels,Phenotype,Phenylacetate Levels
54218,Covid-19 Or Obesity (Pleiotropy),Phenotype,Covid-19 Or Obesity (Pleiotropy)
54220,Glutarylcarnitine (C5-Dc) Levels,Phenotype,Glutarylcarnitine (C5-Dc) Levels
54221,X-26054 Levels,Phenotype,X-26054 Levels
54223,X-24811 Levels,Phenotype,X-24811 Levels
54225,X-25371 Levels,Phenotype,X-25371 Levels
54226,Homoarginine Levels,Phenotype,Homoarginine Levels
54248,Trigger Finger,Phenotype,Trigger Finger
54252,Insomnia In Migraine With Aura,Phenotype,Insomnia In Migraine With Aura
54256,Alcohol Consumption (Drinks Per Month) (Ukb Data Field 1578-- 4424),Phenotype,Alcohol Consumption (Drinks Per Month) (Ukb Data Field 1578-- 4424)
54261,Lamb Or Mutton Consumption (Ukb Data Field 1379),Phenotype,Lamb Or Mutton Consumption (Ukb Data Field 1379)
54263,Drink Temperature,Phenotype,Drink Temperature
54268,Added Salt Consumption,Phenotype,Added Salt Consumption
54273,Cheese Consumption,Phenotype,Cheese Consumption
54280,Opioid Use Disorder (Mtag),Phenotype,Opioid Use Disorder (Mtag)
54302,Triglyceride Levels In Medium Hdl,Phenotype,Triglyceride Levels In Medium Hdl
54304,High-Density Lipoprotein 2 Cholesterol Levels,Phenotype,High-Density Lipoprotein 2 Cholesterol Levels
54320,Hdl Cholesterol Levels Adjusted For Adiponectin Levels,Phenotype,Hdl Cholesterol Levels Adjusted For Adiponectin Levels
54321,Methylmalonate (Mma) Levels,Phenotype,Methylmalonate (Mma) Levels
54324,3-Decenoylcarnitine Levels,Phenotype,3-Decenoylcarnitine Levels
54325,3-Hydroxydecanoylcarnitine Levels,Phenotype,3-Hydroxydecanoylcarnitine Levels
54326,Picolinoylglycine Levels,Phenotype,Picolinoylglycine Levels
54328,(2 Or 3)-Decenoate (10:1N7 Or N8) Levels,Phenotype,(2 Or 3)-Decenoate (10:1N7 Or N8) Levels
54330,Decadienedioic Acid (C10:2-Dc) Levels,Phenotype,Decadienedioic Acid (C10:2-Dc) Levels
54331,Gamma-Glutamyltryptophan Levels,Phenotype,Gamma-Glutamyltryptophan Levels
54332,Phenylalanylphenylalanine Levels,Phenotype,Phenylalanylphenylalanine Levels
54334,Isoleucylglycine Levels,Phenotype,Isoleucylglycine Levels
54335,Hypoxanthine Levels,Phenotype,Hypoxanthine Levels
54337,Phenylacetylglutamate Levels,Phenotype,Phenylacetylglutamate Levels
54338,4-Hydroxyphenylacetylglutamine Levels,Phenotype,4-Hydroxyphenylacetylglutamine Levels
54341,X-07765 Levels,Phenotype,X-07765 Levels
54343,X-12216 Levels,Phenotype,X-12216 Levels
54345,X-12689 Levels,Phenotype,X-12689 Levels
54346,X-12707 Levels,Phenotype,X-12707 Levels
54347,X-12822 Levels,Phenotype,X-12822 Levels
54358,Dried Fruit Consumption,Phenotype,Dried Fruit Consumption
54359,Spread Type: Butter And Margarine Spreads Vs Oil-Based Spreads (Ukb Data Field 1428),Phenotype,Spread Type: Butter And Margarine Spreads Vs Oil-Based Spreads (Ukb Data Field 1428)
54361,Spread Type: Flora Pro-Active/Benecol (Ukb Data Field 1428_2),Phenotype,Spread Type: Flora Pro-Active/Benecol (Ukb Data Field 1428_2)
54362,Cooked Vegetables Consumption,Phenotype,Cooked Vegetables Consumption
54364,Raw Vegetable Consumption,Phenotype,Raw Vegetable Consumption
54365,Fresh Fruit Consumption,Phenotype,Fresh Fruit Consumption
54366,Healthy Aging,Phenotype,Healthy Aging
54371,Principal Component-Derived Dietary Pattern 1,Phenotype,Principal Component-Derived Dietary Pattern 1
54372,Principal Component-Derived Dietary Pattern 13,Phenotype,Principal Component-Derived Dietary Pattern 13
54375,Principal Component-Derived Dietary Pattern 3,Phenotype,Principal Component-Derived Dietary Pattern 3
54379,Principal Component-Derived Dietary Pattern 5,Phenotype,Principal Component-Derived Dietary Pattern 5
54393,Glycerate Levels,Phenotype,Glycerate Levels
54395,N-Acetyl-D-Tryptophan Levels,Phenotype,N-Acetyl-D-Tryptophan Levels
54397,Right Ventricular End Systolic Volume,Phenotype,Right Ventricular End Systolic Volume
54398,Right Ventricular Stroke Volume,Phenotype,Right Ventricular Stroke Volume
54399,Right Ventricular End Diastolic Volume,Phenotype,Right Ventricular End Diastolic Volume
54401,Uterine Leiomyoma Or Er Positive Breast Cancer (Pleiotropy),Phenotype,Uterine Leiomyoma Or Er Positive Breast Cancer (Pleiotropy)
54404,Uterine Leiomyoma Or Breast Cancer (Pleiotropy),Phenotype,Uterine Leiomyoma Or Breast Cancer (Pleiotropy)
54412,Uterine Leiomyoma Or Er Negative Breast Cancer (Pleiotropy),Phenotype,Uterine Leiomyoma Or Er Negative Breast Cancer (Pleiotropy)
54415,X-23787 Levels,Phenotype,X-23787 Levels
54417,X-24328 Levels,Phenotype,X-24328 Levels
54419,X-13553 Levels,Phenotype,X-13553 Levels
54421,X-13729 Levels,Phenotype,X-13729 Levels
54422,X-13844 Levels,Phenotype,X-13844 Levels
54425,X-24422 Levels,Phenotype,X-24422 Levels
54426,X-24556 Levels,Phenotype,X-24556 Levels
54427,X-16087 Levels,Phenotype,X-16087 Levels
54428,X-21285 Levels,Phenotype,X-21285 Levels
54430,X-21470 Levels,Phenotype,X-21470 Levels
54435,Linoleoylcarnitine (C18:2) Levels,Phenotype,Linoleoylcarnitine (C18:2) Levels
54436,1-Dihomo-Linolenoyl-Gpe (20:3N3 Or 6) Levels,Phenotype,1-Dihomo-Linolenoyl-Gpe (20:3N3 Or 6) Levels
54437,Andro Steroid Monosulfate C19H28O6S (1) Levels,Phenotype,Andro Steroid Monosulfate C19H28O6S (1) Levels
54439,Cis-4-Decenoylcarnitine (C10:1) Levels,Phenotype,Cis-4-Decenoylcarnitine (C10:1) Levels
54440,16A-Hydroxy Dhea 3-Sulfate Levels,Phenotype,16A-Hydroxy Dhea 3-Sulfate Levels
54449,Insomnia In Chronic Migraine,Phenotype,Insomnia In Chronic Migraine
54452,Never Eat Wheat Vs No Wheat Restrictions (Ukb Data Field 6144),Phenotype,Never Eat Wheat Vs No Wheat Restrictions (Ukb Data Field 6144)
54453,Never Eat Sugar Vs No Eggs-- Dairy-- Wheat Or Sugar Restrictions (Ukb Data Field 6144),Phenotype,Never Eat Sugar Vs No Eggs-- Dairy-- Wheat Or Sugar Restrictions (Ukb Data Field 6144)
54454,Never Eat Sugar Vs No Sugar Restrictions (Ukb Data Field 6144),Phenotype,Never Eat Sugar Vs No Sugar Restrictions (Ukb Data Field 6144)
54456,Tea Intake (Ukb Data Field 1488),Phenotype,Tea Intake (Ukb Data Field 1488)
54458,Champagne Or White Wine Consumption (Glasses Per Month) (Ukb Data Field 1578-- 4418),Phenotype,Champagne Or White Wine Consumption (Glasses Per Month) (Ukb Data Field 1578-- 4418)
54460,Red Wine Consumption (Glasses Per Month) (Ukb Data Field 1578-- 4419),Phenotype,Red Wine Consumption (Glasses Per Month) (Ukb Data Field 1578-- 4419)
54461,Water Consumption (Glasses Per Day) (Ukb Data Field 1528),Phenotype,Water Consumption (Glasses Per Day) (Ukb Data Field 1528)
54464,Bread Type: White (Ukb Data Field 1448_1),Phenotype,Bread Type: White (Ukb Data Field 1448_1)
54466,Cereal Type: Other (E.G. Cornflakes-- Frosties) (Ukb Data Field 1468_5),Phenotype,Cereal Type: Other (E.G. Cornflakes-- Frosties) (Ukb Data Field 1468_5)
54468,Cereal Consumption (Bowls Per Week) (Ukb Data Field 1458),Phenotype,Cereal Consumption (Bowls Per Week) (Ukb Data Field 1458)
54469,Bread Consumption (Slices Per Week) (Ukb Data Field 1438),Phenotype,Bread Consumption (Slices Per Week) (Ukb Data Field 1438)
54474,Principal Component-Derived Dietary Pattern 36,Phenotype,Principal Component-Derived Dietary Pattern 36
54476,Principal Component-Derived Dietary Pattern 43,Phenotype,Principal Component-Derived Dietary Pattern 43
54477,Principal Component-Derived Dietary Pattern 44,Phenotype,Principal Component-Derived Dietary Pattern 44
54479,Principal Component-Derived Dietary Pattern 54,Phenotype,Principal Component-Derived Dietary Pattern 54
54514,Argininate Levels,Phenotype,Argininate Levels
54516,2-Oxoarginine Levels,Phenotype,2-Oxoarginine Levels
54520,Indoleacetoylcarnitine Levels,Phenotype,Indoleacetoylcarnitine Levels
54522,2-Ketocaprylate Levels,Phenotype,2-Ketocaprylate Levels
54523,Hydroxy-N6--N6--N6-Trimethyllysine Levels,Phenotype,Hydroxy-N6--N6--N6-Trimethyllysine Levels
54524,Picolinate Levels,Phenotype,Picolinate Levels
54525,N--N--N-Trimethyl-5-Aminovalerate Levels,Phenotype,N--N--N-Trimethyl-5-Aminovalerate Levels
54526,6-Bromotryptophan Levels,Phenotype,6-Bromotryptophan Levels
54532,Fructosyllysine Levels,Phenotype,Fructosyllysine Levels
54533,3-Methylglutarylcarnitine (2) Levels,Phenotype,3-Methylglutarylcarnitine (2) Levels
54535,Orbital Telorism,Phenotype,Orbital Telorism
54537,Oral Microbiome Alpha Diversity (Shannon Index) In Oral Squamous Cell Carcinoma,Phenotype,Oral Microbiome Alpha Diversity (Shannon Index) In Oral Squamous Cell Carcinoma
54539,Oral Microbiome Beta Diversity (Bray-Curtis) In Oral Squamous Cell Carcinoma,Phenotype,Oral Microbiome Beta Diversity (Bray-Curtis) In Oral Squamous Cell Carcinoma
54544,P-Cresol Glucuronide Levels,Phenotype,P-Cresol Glucuronide Levels
54546,4-Allylcatechol Sulfate Levels,Phenotype,4-Allylcatechol Sulfate Levels
54548,2-Hydroxyfluorene Sulfate Levels,Phenotype,2-Hydroxyfluorene Sulfate Levels
54550,3-Ethylcatechol Sulfate (1) Levels,Phenotype,3-Ethylcatechol Sulfate (1) Levels
54552,Salicylate Levels,Phenotype,Salicylate Levels
54556,S-Adenosylhomocysteine (Sah) Levels,Phenotype,S-Adenosylhomocysteine (Sah) Levels
54560,5-Methylthioadenosine (Mta) Levels,Phenotype,5-Methylthioadenosine (Mta) Levels
54562,2-Hydroxyphenylacetate Levels,Phenotype,2-Hydroxyphenylacetate Levels
54563,Phenylpyruvate Levels,Phenotype,Phenylpyruvate Levels
54602,Severe Covid-19 Infection,Phenotype,Severe Covid-19 Infection
54605,High-Density Lipoprotein Levels (Mtag),Phenotype,High-Density Lipoprotein Levels (Mtag)
54634,Minimum Measurement Of Hepatic Fat,Phenotype,Minimum Measurement Of Hepatic Fat
54636,Maximum Measurement Of Hepatic Fat,Phenotype,Maximum Measurement Of Hepatic Fat
54639,Medication Use For Hyperlipidemia (Number Of Purchases),Phenotype,Medication Use For Hyperlipidemia (Number Of Purchases)
54642,Medication Use For T2D (Number Of Purchases),Phenotype,Medication Use For T2D (Number Of Purchases)
54644,Years Ovulating,Phenotype,Years Ovulating
54671,Covid-19 Infection Or Rheumatoid Arthritis (Mtag),Phenotype,Covid-19 Infection Or Rheumatoid Arthritis (Mtag)
54673,Covid-19 Hospitalization Or Systemic Lupus Erythematosus (Mtag),Phenotype,Covid-19 Hospitalization Or Systemic Lupus Erythematosus (Mtag)
54676,Severe Covid-19 Or Systemic Lupus Erythematosus (Mtag),Phenotype,Severe Covid-19 Or Systemic Lupus Erythematosus (Mtag)
54684,Suicidal Thoughts And Behaviors,Phenotype,Suicidal Thoughts And Behaviors
54690,Body Composition (Mostest),Phenotype,Body Composition (Mostest)
54692,Bone Mineral Density At Right Trochanter (Model 2),Phenotype,Bone Mineral Density At Right Trochanter (Model 2)
54694,Bone Mineral Density At Left Trochanter (Model 2),Phenotype,Bone Mineral Density At Left Trochanter (Model 2)
54712,Covid-19 Infection Or Systemic Lupus Erythematosus (Mtag),Phenotype,Covid-19 Infection Or Systemic Lupus Erythematosus (Mtag)
54776,Systolic Blood Pressure X Low Social Support Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Low Social Support Interaction (2Df Test)
54782,Systolic Blood Pressure X Depressive Symptoms Interaction (2Df Test),Phenotype,Systolic Blood Pressure X Depressive Symptoms Interaction (2Df Test)
54783,Diastolic Blood Pressure X Depressive Symptoms Interaction (2Df Test),Phenotype,Diastolic Blood Pressure X Depressive Symptoms Interaction (2Df Test)
54785,Pulse Pressure X Anxiety Symptoms Interaction (2Df Test),Phenotype,Pulse Pressure X Anxiety Symptoms Interaction (2Df Test)
54787,Pulse Pressure X Low Social Support Interaction (2Df Test),Phenotype,Pulse Pressure X Low Social Support Interaction (2Df Test)
54788,Pulse Pressure X Anxiety Symptoms Interaction (1Df Test),Phenotype,Pulse Pressure X Anxiety Symptoms Interaction (1Df Test)
54797,Heart Failure (Multivariate Analysis),Phenotype,Heart Failure (Multivariate Analysis)
54802,Msln Plasma Levels,Phenotype,Msln Plasma Levels
54804,Haptoglobin Plasma Levels,Phenotype,Haptoglobin Plasma Levels
54805,Lp A Plasma Levels,Phenotype,Lp A Plasma Levels
54807,Early Onset Colorectal Cancer,Phenotype,Early Onset Colorectal Cancer
54808,Colorectal Cancer (Age Of Onset),Phenotype,Colorectal Cancer (Age Of Onset)
54810,Vegf Plasma Levels,Phenotype,Vegf Plasma Levels
54812,Irritable Bowel Syndrome (Mtag),Phenotype,Irritable Bowel Syndrome (Mtag)
54815,Half-Life Of Apixaban,Phenotype,Half-Life Of Apixaban
54817,Time To Peak Concentration Of Apixaban,Phenotype,Time To Peak Concentration Of Apixaban
54819,Anti-Xa Activity Of Apixaban,Phenotype,Anti-Xa Activity Of Apixaban
54822,Concentration Of Apixaban (At 12H),Phenotype,Concentration Of Apixaban (At 12H)
54860,Interleukin-12 Subunit Beta Levels,Phenotype,Interleukin-12 Subunit Beta Levels
54862,Tnf-Beta Levels,Phenotype,Tnf-Beta Levels
54864,Cub Domain-Containing Protein 1 Levels,Phenotype,Cub Domain-Containing Protein 1 Levels
54876,Thp Plasma Levels,Phenotype,Thp Plasma Levels
54877,Tn X Plasma Levels,Phenotype,Tn X Plasma Levels
54879,Change In Working Memory In Pediatric Cns Tumors Treated With Craniospinal Irradiation,Phenotype,Change In Working Memory In Pediatric Cns Tumors Treated With Craniospinal Irradiation
54882,Change In Intelligence Quotient In Pediatric Cns Tumors Treated With Craniospinal Irradiation,Phenotype,Change In Intelligence Quotient In Pediatric Cns Tumors Treated With Craniospinal Irradiation
54893,High Grade Prostate Cancer X Metformin Use Interaction (Simple Model),Phenotype,High Grade Prostate Cancer X Metformin Use Interaction (Simple Model)
54904,Nap Duration In Severe Depression,Phenotype,Nap Duration In Severe Depression
54907,Response To Antidepressants In Major Depressive Disorder,Phenotype,Response To Antidepressants In Major Depressive Disorder
54909,1--2-Dilinoleoyl-Gpc (18:2/18:2) Levels,Phenotype,1--2-Dilinoleoyl-Gpc (18:2/18:2) Levels
54912,1-(1-Enyl-Stearoyl)-2-Arachidonoyl-Gpc (P-18:0/20:4) Levels,Phenotype,1-(1-Enyl-Stearoyl)-2-Arachidonoyl-Gpc (P-18:0/20:4) Levels
54913,1-(1-Enyl-Stearoyl)-2-Docosahexaenoyl-Gpc (P-18:0/22:6) Levels,Phenotype,1-(1-Enyl-Stearoyl)-2-Docosahexaenoyl-Gpc (P-18:0/22:6) Levels
54914,1-(1-Enyl-Stearoyl)-2-Docosahexaenoyl-Gpe (P-18:0/22:6) Levels,Phenotype,1-(1-Enyl-Stearoyl)-2-Docosahexaenoyl-Gpe (P-18:0/22:6) Levels
54915,Phenol Sulfate Levels,Phenotype,Phenol Sulfate Levels
54916,1-(1-Enyl-Palmitoyl)-2-Arachidonoyl-Gpe (P-16:0/20:4) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Arachidonoyl-Gpe (P-16:0/20:4) Levels
54917,1-(1-Enyl-Palmitoyl)-2-Docosahexaenoyl-Gpc (P-16:0/22:6) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Docosahexaenoyl-Gpc (P-16:0/22:6) Levels
54918,1-(1-Enyl-Palmitoyl)-2-Docosahexaenoyl-Gpe (P-16:0/22:6) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Docosahexaenoyl-Gpe (P-16:0/22:6) Levels
54919,1-(1-Enyl-Palmitoyl)-2-Linoleoyl-Gpe (P-16:0/18:2) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Linoleoyl-Gpe (P-16:0/18:2) Levels
54921,1-(1-Enyl-Palmitoyl)-2-Myristoyl-Gpc (P-16:0/14:0) Levels,Phenotype,1-(1-Enyl-Palmitoyl)-2-Myristoyl-Gpc (P-16:0/14:0) Levels
54922,Pantothenate Levels,Phenotype,Pantothenate Levels
54923,P-Cresol Sulfate Levels,Phenotype,P-Cresol Sulfate Levels
54926,Body Surface Area,Phenotype,Body Surface Area
54935,Sphingomyelin (D18:1/20:1-- D18:2/20:0) Levels,Phenotype,Sphingomyelin (D18:1/20:1-- D18:2/20:0) Levels
54936,Suberate (Octanedioate) Levels,Phenotype,Suberate (Octanedioate) Levels
54939,Sarcosine (N-Methylglycine) Levels,Phenotype,Sarcosine (N-Methylglycine) Levels
54941,Spermidine Levels,Phenotype,Spermidine Levels
54943,Sphingomyelin (D18:1/20:0-- D16:1/22:0) Levels,Phenotype,Sphingomyelin (D18:1/20:0-- D16:1/22:0) Levels
54944,Sphingosine 1-Phosphate Levels,Phenotype,Sphingosine 1-Phosphate Levels
54946,Sphingomyelin (D18:2/24:1-- D18:1/24:2) Levels,Phenotype,Sphingomyelin (D18:2/24:1-- D18:1/24:2) Levels
54954,Theophylline Levels,Phenotype,Theophylline Levels
54956,Threonate Levels,Phenotype,Threonate Levels
54958,X-11429 Levels,Phenotype,X-11429 Levels
54960,X-11440 Levels,Phenotype,X-11440 Levels
54961,Vanillylmandelate (Vma) Levels,Phenotype,Vanillylmandelate (Vma) Levels
54962,X-02249 Levels,Phenotype,X-02249 Levels
54964,X-02269 Levels,Phenotype,X-02269 Levels
54965,X-09789 Levels,Phenotype,X-09789 Levels
54967,X-11308 Levels,Phenotype,X-11308 Levels
54969,X-11334 Levels,Phenotype,X-11334 Levels
54970,X-22379 Levels,Phenotype,X-22379 Levels
54972,X-21736 Levels,Phenotype,X-21736 Levels
54974,X-21792 Levels,Phenotype,X-21792 Levels
54975,Alcohol Dependence (Codominant Genetic Model),Phenotype,Alcohol Dependence (Codominant Genetic Model)
55010,Igg Antibody Levels In Response To Sars-Cov-2 Vaccination,Phenotype,Igg Antibody Levels In Response To Sars-Cov-2 Vaccination
55012,Total Antibody Levels In Response To Sars-Cov-2 Vaccination,Phenotype,Total Antibody Levels In Response To Sars-Cov-2 Vaccination
55014,Neutral Antibody Levels In Response To Sars-Cov-2 Vaccination,Phenotype,Neutral Antibody Levels In Response To Sars-Cov-2 Vaccination
55016,Maximum Habitual Alcohol Consumption (Mtag),Phenotype,Maximum Habitual Alcohol Consumption (Mtag)
55018,Opioid Addiction,Phenotype,Opioid Addiction
55028,Medication Use For Hypertension (Number Of Purchases),Phenotype,Medication Use For Hypertension (Number Of Purchases)
55034,Abdominal Subcutaneous Adipose Tissue Normalized,Phenotype,Abdominal Subcutaneous Adipose Tissue Normalized
55035,Posterior Thigh Muscle Volume,Phenotype,Posterior Thigh Muscle Volume
55036,Anterior Thigh Muscle Fat Infiltration Percentage,Phenotype,Anterior Thigh Muscle Fat Infiltration Percentage
55038,Abdominal Subcutaneous Adipose Tissue,Phenotype,Abdominal Subcutaneous Adipose Tissue
55039,Anterior Thigh Muscle Volume,Phenotype,Anterior Thigh Muscle Volume
55041,Posterior Thigh Muscle Fat Infiltration Percentage,Phenotype,Posterior Thigh Muscle Fat Infiltration Percentage
55075,Weight-To-Muscle Ratio,Phenotype,Weight-To-Muscle Ratio
55076,Abdominal Fat Ratio,Phenotype,Abdominal Fat Ratio
55095,Early-Onset Anorexia Nervosa,Phenotype,Early-Onset Anorexia Nervosa
55099,Ldl (Standard Gwa),Phenotype,Ldl (Standard Gwa)
55102,Bmi (Weighted Gwa),Phenotype,Bmi (Weighted Gwa)
55105,Cancer (Standard Gwa),Phenotype,Cancer (Standard Gwa)
55111,Brain Arteriolosclerosis,Phenotype,Brain Arteriolosclerosis
55113,Ldl (Weighted Gwa),Phenotype,Ldl (Weighted Gwa)
55122,Sleep Health Score,Phenotype,Sleep Health Score
55125,Male Infertility (Sertoli Cell-Only),Phenotype,Male Infertility (Sertoli Cell-Only)
55142,Early Neurological Instability After Acute Ischemic Stroke,Phenotype,Early Neurological Instability After Acute Ischemic Stroke
55173,Body Shape (Principal Component Analysis),Phenotype,Body Shape (Principal Component Analysis)
55175,Anti-Beta-Casein Igg Levels,Phenotype,Anti-Beta-Casein Igg Levels
55177,Anti-Feline Herpes Igg Levels,Phenotype,Anti-Feline Herpes Igg Levels
55178,Fibromuscular Dysplasia,Phenotype,Fibromuscular Dysplasia
55185,Opioid Analgesic Dose Requirement In Cancer Pain Treatment,Phenotype,Opioid Analgesic Dose Requirement In Cancer Pain Treatment
55259,Red Blood Cell Distribution Width Coefficient Of Variation,Phenotype,Red Blood Cell Distribution Width Coefficient Of Variation
55260,Disruptive Behavior (Multivariate Analysis),Phenotype,Disruptive Behavior (Multivariate Analysis)
55270,Common Executive Function,Phenotype,Common Executive Function
55309,Nodal Modulator 1 Levels,Phenotype,Nodal Modulator 1 Levels
55312,Low-Density Lipoprotein Receptor-Related Protein 11 Levels,Phenotype,Low-Density Lipoprotein Receptor-Related Protein 11 Levels
55316,Matrix Metalloproteinase-2 Levels,Phenotype,Matrix Metalloproteinase-2 Levels
55319,Serpin B6 Levels,Phenotype,Serpin B6 Levels
55322,Interleukin-4 Receptor Subunit Alpha Levels,Phenotype,Interleukin-4 Receptor Subunit Alpha Levels
55324,Serine Protease 27 Levels,Phenotype,Serine Protease 27 Levels
55328,Pulmonary Surfactant-Associated Protein D Levels,Phenotype,Pulmonary Surfactant-Associated Protein D Levels
55352,Early-Onset Ischemic Stroke,Phenotype,Early-Onset Ischemic Stroke
55362,Pulse Rate,Phenotype,Pulse Rate
55394,Afp Levels,Phenotype,Afp Levels
55400,Sialomucin Core Protein 24 Levels,Phenotype,Sialomucin Core Protein 24 Levels
55402,Cadherin-5 Levels,Phenotype,Cadherin-5 Levels
55404,Carbonic Anhydrase 5A--Mitochondrial Levels,Phenotype,Carbonic Anhydrase 5A--Mitochondrial Levels
55407,Carboxypeptidase A1 Levels,Phenotype,Carboxypeptidase A1 Levels
55408,Carboxypeptidase B Levels,Phenotype,Carboxypeptidase B Levels
55409,Cathepsin O Levels,Phenotype,Cathepsin O Levels
55413,Periodic Limb Movement In Sleep,Phenotype,Periodic Limb Movement In Sleep
55414,Periodic Limb Movement Index,Phenotype,Periodic Limb Movement Index
55415,Early Childhood Caries,Phenotype,Early Childhood Caries
55417,Hand Osteoarthritis,Phenotype,Hand Osteoarthritis
55445,Dental Development,Phenotype,Dental Development
55447,Oral Cancer,Phenotype,Oral Cancer
55457,Pediatric Steroid Sensitive Nephrotic Syndrome,Phenotype,Pediatric Steroid Sensitive Nephrotic Syndrome
55467,Personality Traits Or Cognitive Traits (Multivariate Analysis),Phenotype,Personality Traits Or Cognitive Traits (Multivariate Analysis)
55473,Multi-Trait Sex Score,Phenotype,Multi-Trait Sex Score
55487,Mood Disorder,Phenotype,Mood Disorder
55492,Noninflammatory Bullous Pemphigoid In Response To Dipeptidyl Peptidase-4 Inhibitors,Phenotype,Noninflammatory Bullous Pemphigoid In Response To Dipeptidyl Peptidase-4 Inhibitors
55494,Conventional Bullous Pemphigoid,Phenotype,Conventional Bullous Pemphigoid
55496,Bullous Pemphigoid (Except Dipeptidyl Peptidase-4 Inhibitor-Induced Noninflammatory),Phenotype,Bullous Pemphigoid (Except Dipeptidyl Peptidase-4 Inhibitor-Induced Noninflammatory)
55502,Total Cholesterol Levels (Mtag),Phenotype,Total Cholesterol Levels (Mtag)
55517,Neutrophil Perturbation Response (Side Fluorescence Standard Deviation Of Neutrophil 4 In Response To Colchicine Perturbation Measured By Wdf Dye),Phenotype,Neutrophil Perturbation Response (Side Fluorescence Standard Deviation Of Neutrophil 4 In Response To Colchicine Perturbation Measured By Wdf Dye)
55519,Breast Area Percent Density,Phenotype,Breast Area Percent Density
55534,Irritable Bowel Syndrome Or Major Depressive Disorder (Pleiotropy),Phenotype,Irritable Bowel Syndrome Or Major Depressive Disorder (Pleiotropy)
55537,Agrp Levels,Phenotype,Agrp Levels
55552,Aging (Eyeageacceleration),Phenotype,Aging (Eyeageacceleration)
55557,Multi-Trait Sum Score,Phenotype,Multi-Trait Sum Score
55560,Covid-19 With Respiratory Failure,Phenotype,Covid-19 With Respiratory Failure
55562,Covid-19 With Respiratory Failure Requiring Mechanical Ventilation,Phenotype,Covid-19 With Respiratory Failure Requiring Mechanical Ventilation
55592,Icd10 M54: Dorsalgia,Phenotype,Icd10 M54: Dorsalgia
55593,Icd10 M51: Intervertebral Disc Disorder,Phenotype,Icd10 M51: Intervertebral Disc Disorder
55620,Time To Osteonecrosis In Systemic Lupus Erythematosus,Phenotype,Time To Osteonecrosis In Systemic Lupus Erythematosus
55625,Persistence With Methotrexate Treatment At Three Years In Early Rheumatoid Arthritis,Phenotype,Persistence With Methotrexate Treatment At Three Years In Early Rheumatoid Arthritis
55628,Icd10 C22: Malignant Neoplasm Of Liver And Intrahepatic Bile Ducts,Phenotype,Icd10 C22: Malignant Neoplasm Of Liver And Intrahepatic Bile Ducts
55630,Icd10 C34: Malignant Neoplasm Of Bronchus And Lung,Phenotype,Icd10 C34: Malignant Neoplasm Of Bronchus And Lung
55632,Non-Insulin-Dependent Diabetes Mellitus (Union E11),Phenotype,Non-Insulin-Dependent Diabetes Mellitus (Union E11)
55633,Icd10 E14: Unspecified Diabetes Mellitus,Phenotype,Icd10 E14: Unspecified Diabetes Mellitus
55634,Icd10 H40: Glaucoma,Phenotype,Icd10 H40: Glaucoma
55636,Icd10 K74: Fibrosis And Cirrhosis Of Liver,Phenotype,Icd10 K74: Fibrosis And Cirrhosis Of Liver
55638,Icd10 K81: Cholecystitis,Phenotype,Icd10 K81: Cholecystitis
55640,Treatment Effectiveness Of Angiotensin Ii Receptor Blocker In Hypertension,Phenotype,Treatment Effectiveness Of Angiotensin Ii Receptor Blocker In Hypertension
55643,Treatment Effectiveness Of Beta Blocker In Hypertension,Phenotype,Treatment Effectiveness Of Beta Blocker In Hypertension
55645,Treatment Effectiveness Of Angiotensin Converting Enzyme Inhibitor In Hypertension,Phenotype,Treatment Effectiveness Of Angiotensin Converting Enzyme Inhibitor In Hypertension
55648,Treatment Effectiveness Of Alpha Blocker In Hypertension,Phenotype,Treatment Effectiveness Of Alpha Blocker In Hypertension
55650,Treatment Effectiveness Of Alpha-Beta Blocker In Hypertension,Phenotype,Treatment Effectiveness Of Alpha-Beta Blocker In Hypertension
55652,Treatment Effectiveness Of Calcium Channel Blocker-Dihydropyridine In Hypertension,Phenotype,Treatment Effectiveness Of Calcium Channel Blocker-Dihydropyridine In Hypertension
55655,Treatment Effectiveness Of Calcium Channel Blocker In Hypertension,Phenotype,Treatment Effectiveness Of Calcium Channel Blocker In Hypertension
55658,Treatment Effectiveness Of Calcium Channel Blocker-Benzothiazepine In Hypertension,Phenotype,Treatment Effectiveness Of Calcium Channel Blocker-Benzothiazepine In Hypertension
55677,Periodontitis / Loose Teeth (Mtag),Phenotype,Periodontitis / Loose Teeth (Mtag)
55693,Osteonecrosis In Systemic Lupus Erythematosus,Phenotype,Osteonecrosis In Systemic Lupus Erythematosus
55699,Raynauds Phenomenon Disease,Phenotype,Raynauds Phenomenon Disease
55700,Breast Dense Area,Phenotype,Breast Dense Area
55727,Brain Age Gap,Phenotype,Brain Age Gap
55734,Hearing Problems,Phenotype,Hearing Problems
55738,Treatment Effectiveness Of Anti-Hypertensive Diuretic In Hypertension,Phenotype,Treatment Effectiveness Of Anti-Hypertensive Diuretic In Hypertension
55741,Resistance To Antihypertensive Treatment In Hypertension,Phenotype,Resistance To Antihypertensive Treatment In Hypertension
55743,Csf1 Levels,Phenotype,Csf1 Levels
55745,Cxcl9 Levels,Phenotype,Cxcl9 Levels
55747,Breast Area,Phenotype,Breast Area
55757,Pierre Robin Sequence Endophenotypic Score,Phenotype,Pierre Robin Sequence Endophenotypic Score
55765,Inflammatory Bowel Disease Or Bipolar Disorder (Pleiotropy),Phenotype,Inflammatory Bowel Disease Or Bipolar Disorder (Pleiotropy)
55771,Mic-A Levels,Phenotype,Mic-A Levels
55778,Tie2 Levels,Phenotype,Tie2 Levels
55783,Gestational Duration,Phenotype,Gestational Duration
55799,Annual Healthcare Cost,Phenotype,Annual Healthcare Cost
55805,Male Puberty Timing (Late Vs. Average Onset Facial Hair),Phenotype,Male Puberty Timing (Late Vs. Average Onset Facial Hair)
55807,Male Puberty Timing (Early Vs. Average Onset Voice Breaking),Phenotype,Male Puberty Timing (Early Vs. Average Onset Voice Breaking)
55808,Male Puberty Timing (Late Vs. Average Onset Voice Breaking),Phenotype,Male Puberty Timing (Late Vs. Average Onset Voice Breaking)
55810,Male Puberty Timing (Age At Voice Breaking Mtag),Phenotype,Male Puberty Timing (Age At Voice Breaking Mtag)
55822,Spontaneous Dizygotic Twinning,Phenotype,Spontaneous Dizygotic Twinning
55846,Early Onset Non-Small Cell Lung Cancer,Phenotype,Early Onset Non-Small Cell Lung Cancer
55848,Migraine Or Glucose Levels,Phenotype,Migraine Or Glucose Levels
55849,Migraine Or Fasting Glucose Levels,Phenotype,Migraine Or Fasting Glucose Levels
55851,Headache Or Fasting Glucose Levels,Phenotype,Headache Or Fasting Glucose Levels
55853,Migraine Or Fasting Insulin Levels,Phenotype,Migraine Or Fasting Insulin Levels
55856,Headache Or Fasting Insulin Levels,Phenotype,Headache Or Fasting Insulin Levels
55857,Headache Or Hba1C Levels,Phenotype,Headache Or Hba1C Levels
55866,Cannabis Use Disorder,Phenotype,Cannabis Use Disorder
55869,Fracture Of Forearm,Phenotype,Fracture Of Forearm
55872,Thromboembolic Events In Sickle Cell Disease,Phenotype,Thromboembolic Events In Sickle Cell Disease
55882,Pain,Phenotype,Pain
55899,Gastroesophageal Reflux Disease Or Bipolar Disorder (Pleiotropy),Phenotype,Gastroesophageal Reflux Disease Or Bipolar Disorder (Pleiotropy)
55900,Covid-19 Severity,Phenotype,Covid-19 Severity
55910,Serum Sclerostin Levels,Phenotype,Serum Sclerostin Levels
55915,Male Puberty Timing (Early Vs. Average Onset Facial Hair),Phenotype,Male Puberty Timing (Early Vs. Average Onset Facial Hair)
55939,Childhood Wheezing (Pre-School Remitting),Phenotype,Childhood Wheezing (Pre-School Remitting)
55941,Childhood Wheezing (Late-Onset),Phenotype,Childhood Wheezing (Late-Onset)
55944,S-6-Hydroxywarfarin Levels,Phenotype,S-6-Hydroxywarfarin Levels
55952,R-6-Hydroxywarfarin Levels,Phenotype,R-6-Hydroxywarfarin Levels
55995,Morbidity In Covid-19 (Deceased Vs Asymptomatic),Phenotype,Morbidity In Covid-19 (Deceased Vs Asymptomatic)
55997,Covid-19 (Severe Vs Population) X Cardiometabolic Health Status Interaction (Joint Test),Phenotype,Covid-19 (Severe Vs Population) X Cardiometabolic Health Status Interaction (Joint Test)
55999,Covid-19 (Severe Vs Population) X Cardiometabolic Health Status Interaction,Phenotype,Covid-19 (Severe Vs Population) X Cardiometabolic Health Status Interaction
56001,Covid-19 (Severe Vs Population) X Sex Interaction (Joint Test),Phenotype,Covid-19 (Severe Vs Population) X Sex Interaction (Joint Test)
56003,Covid-19 (Severe Vs Population) X Sex Interaction,Phenotype,Covid-19 (Severe Vs Population) X Sex Interaction
56004,S-6-Hydroxywarfarin To S-Warfarin Ratio,Phenotype,S-6-Hydroxywarfarin To S-Warfarin Ratio
56006,S-Warfarin To R-Warfarin Ratio,Phenotype,S-Warfarin To R-Warfarin Ratio
56010,R-6-Hydroxywarfarin To R-Warfarin Ratio,Phenotype,R-6-Hydroxywarfarin To R-Warfarin Ratio
56017,Dhea-S-To-4-Androsten-3Beta--17Beta-Diol Disulfate 2 Ratio,Phenotype,Dhea-S-To-4-Androsten-3Beta--17Beta-Diol Disulfate 2 Ratio
56018,Docosapentaenoate N3 Dpa; 22:5N3-To-X-12627 Ratio,Phenotype,Docosapentaenoate N3 Dpa; 22:5N3-To-X-12627 Ratio
56019,Hexanoylcarnitine-To-Octanoylcarnitine Ratio,Phenotype,Hexanoylcarnitine-To-Octanoylcarnitine Ratio
56020,Linoleate 18:2N6-To-Dihomo-Linolenate 20:3N3 Or N6 Ratio,Phenotype,Linoleate 18:2N6-To-Dihomo-Linolenate 20:3N3 Or N6 Ratio
56021,Lysine-To-Glutaroyl Carnitine Ratio,Phenotype,Lysine-To-Glutaroyl Carnitine Ratio
56022,Phenyllactate-To-Phenylalanine Ratio,Phenotype,Phenyllactate-To-Phenylalanine Ratio
56024,X-11444-To-X-11470 Ratio,Phenotype,X-11444-To-X-11470 Ratio
56025,X-12798-To-Phenylalanine Ratio,Phenotype,X-12798-To-Phenylalanine Ratio
56026,4-Androsten-3Beta--17Beta-Diol Disulfate 2 Levels,Phenotype,4-Androsten-3Beta--17Beta-Diol Disulfate 2 Levels
56028,Cigarettes Smoked Per Day,Phenotype,Cigarettes Smoked Per Day
56041,Age Of Smoking Initiation,Phenotype,Age Of Smoking Initiation
56042,Visceral Adipose Tissue Volumes,Phenotype,Visceral Adipose Tissue Volumes
56043,Abdominal Adipose Tissue Volumes,Phenotype,Abdominal Adipose Tissue Volumes
56045,Gluteofemoral Adipose Tissue Volumes,Phenotype,Gluteofemoral Adipose Tissue Volumes
56049,Visceral Adipose Tissue Volumes (Adjusted For Bmi And Height),Phenotype,Visceral Adipose Tissue Volumes (Adjusted For Bmi And Height)
56052,Visceral Adipose Tissue Volumes To Gluteofemoral Adipose Tissue Volumes Ratio,Phenotype,Visceral Adipose Tissue Volumes To Gluteofemoral Adipose Tissue Volumes Ratio
56054,Abdominal Adipose Tissue Volumes To Gluteofemoral Adipose Tissue Volumes Ratio,Phenotype,Abdominal Adipose Tissue Volumes To Gluteofemoral Adipose Tissue Volumes Ratio
56056,Gluteofemoral Adipose Tissue Volumes (Adjusted For Bmi And Height),Phenotype,Gluteofemoral Adipose Tissue Volumes (Adjusted For Bmi And Height)
56057,Visceral Adipose Tissue Volumes To Abdominal Adipose Tissue Volumes Ratio,Phenotype,Visceral Adipose Tissue Volumes To Abdominal Adipose Tissue Volumes Ratio
56063,Abdominal Adipose Tissue Volumes (Adjusted For Bmi And Height),Phenotype,Abdominal Adipose Tissue Volumes (Adjusted For Bmi And Height)
56064,Colorectal Cancer X Menopausal Hormone Therapy Interaction,Phenotype,Colorectal Cancer X Menopausal Hormone Therapy Interaction
56067,Colorectal Cancer X Menopausal Hormone Therapy Interaction (2Df Test),Phenotype,Colorectal Cancer X Menopausal Hormone Therapy Interaction (2Df Test)
56069,Colorectal Cancer X Menopausal Hormone Therapy Interaction (3Df Test),Phenotype,Colorectal Cancer X Menopausal Hormone Therapy Interaction (3Df Test)
56070,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction,Phenotype,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction
56072,R-Warfarin Levels,Phenotype,R-Warfarin Levels
56083,Rs-10-Hydroxywarfarin To Rs-Warfarin Ratio,Phenotype,Rs-10-Hydroxywarfarin To Rs-Warfarin Ratio
56085,S-7-Hydroxywarfarin To S-Warfarin Ratio,Phenotype,S-7-Hydroxywarfarin To S-Warfarin Ratio
56089,Platelet Factor 4/Heparin Antibody Levels In Heparin Treatment,Phenotype,Platelet Factor 4/Heparin Antibody Levels In Heparin Treatment
56097,Opioid Use Disorder (Broad),Phenotype,Opioid Use Disorder (Broad)
56099,Rs-Warfarin Levels,Phenotype,Rs-Warfarin Levels
56101,Octadecadienylcarnitine Levels,Phenotype,Octadecadienylcarnitine Levels
56123,X-11550 Levels,Phenotype,X-11550 Levels
56124,X-12038 Levels,Phenotype,X-12038 Levels
56125,X-12244--N-Acetylcarnosine Levels,Phenotype,X-12244--N-Acetylcarnosine Levels
56126,X-03056--N-[3- 2-Oxopyrrolidin-1-Yl Propyl]Acetamide Levels,Phenotype,X-03056--N-[3- 2-Oxopyrrolidin-1-Yl Propyl]Acetamide Levels
56128,Glutaroyl Carnitine Levels,Phenotype,Glutaroyl Carnitine Levels
56129,Dihomo-Linolenate 20:3N3 Or N6 Levels,Phenotype,Dihomo-Linolenate 20:3N3 Or N6 Levels
56130,X-12556 Levels,Phenotype,X-12556 Levels
56132,X-12627 Levels,Phenotype,X-12627 Levels
56138,COVID-19,Phenotype,COVID-19
56141,Alanine Aminotransferase Level After Methotrexate Initiation In Rheumatoid Arthritis,Phenotype,Alanine Aminotransferase Level After Methotrexate Initiation In Rheumatoid Arthritis
56144,Alanine Aminotransferase Elevation After Methotrexate Initiation In Rheumatoid Arthritis (>1.5 × Uln),Phenotype,Alanine Aminotransferase Elevation After Methotrexate Initiation In Rheumatoid Arthritis (>1.5 × Uln)
56159,Rs-6-Hydroxywarfarin Levels,Phenotype,Rs-6-Hydroxywarfarin Levels
56166,S-7-Hydroxywarfarin Levels,Phenotype,S-7-Hydroxywarfarin Levels
56178,3-Phenylpropionate Hydrocinnamate Levels,Phenotype,3-Phenylpropionate Hydrocinnamate Levels
56181,Scyllo-Inositol Levels,Phenotype,Scyllo-Inositol Levels
56238,Covid-19 (Severe Vs Mild),Phenotype,Covid-19 (Severe Vs Mild)
56250,Adverse Response To Chemotherapy In Breast Cancer (Grade 3/4 Neutropenic Or Leukopenic Events),Phenotype,Adverse Response To Chemotherapy In Breast Cancer (Grade 3/4 Neutropenic Or Leukopenic Events)
56252,Alzheimer'S Disease In Non-Apoe E4 Carriers,Phenotype,Alzheimer'S Disease In Non-Apoe E4 Carriers
56268,Lifelong Premature Ejaculation,Phenotype,Lifelong Premature Ejaculation
56272,Dementia In Apoe E4+ Carriers,Phenotype,Dementia In Apoe E4+ Carriers
56273,Dementia In Non-Apoe E4 Carriers,Phenotype,Dementia In Non-Apoe E4 Carriers
56287,Colorectal Cancer X Estrogen Hormone Therapy Interaction,Phenotype,Colorectal Cancer X Estrogen Hormone Therapy Interaction
56290,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (3Df Test),Phenotype,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (3Df Test)
56301,Hla Risk Haplotype In Iga Deficiency (Homozygous Hla-Drb1*07:01 Hla-Dqb1*02:02),Phenotype,Hla Risk Haplotype In Iga Deficiency (Homozygous Hla-Drb1*07:01 Hla-Dqb1*02:02)
56303,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (2Df Test),Phenotype,Colorectal Cancer X Estrogen-Progesterone Hormone Therapy Interaction (2Df Test)
56304,S-Warfarin Levels,Phenotype,S-Warfarin Levels
56312,Rs-10-Hydroxywarfarin Levels,Phenotype,Rs-10-Hydroxywarfarin Levels
56423,Age-Related Macular Degeneration Or Covid-19 Infection (Mtag),Phenotype,Age-Related Macular Degeneration Or Covid-19 Infection (Mtag)
56425,Covid-19 Critical Illness Or Age-Related Macular Degeneration (Mtag),Phenotype,Covid-19 Critical Illness Or Age-Related Macular Degeneration (Mtag)
56426,Covid-19 Hospitalization Or Age-Related Macular Degeneration (Mtag),Phenotype,Covid-19 Hospitalization Or Age-Related Macular Degeneration (Mtag)
56467,Asthma Or Chronic Obstructive Pulmonary Disease (Pleiotropy),Phenotype,Asthma Or Chronic Obstructive Pulmonary Disease (Pleiotropy)
56484,Age-Related Macular Degeneration Or Covid-19 Hospitalization (Mtag),Phenotype,Age-Related Macular Degeneration Or Covid-19 Hospitalization (Mtag)
56485,Age-Related Macular Degeneration Or Covid-19 Critical Illness (Mtag),Phenotype,Age-Related Macular Degeneration Or Covid-19 Critical Illness (Mtag)
56500,Geographic Atrophy Within A Central 5 Mm Circle (Model 1),Phenotype,Geographic Atrophy Within A Central 5 Mm Circle (Model 1)
56502,Drusen Area Within A Central 5 Mm Circle (Model 1),Phenotype,Drusen Area Within A Central 5 Mm Circle (Model 1)
56506,Drusen Volume Within A Central 5 Mm Circle (Model 1),Phenotype,Drusen Volume Within A Central 5 Mm Circle (Model 1)
56509,Drusen Area Within A Central 3 Mm Circle (Model 1),Phenotype,Drusen Area Within A Central 3 Mm Circle (Model 1)
56510,Drusen Area Within A Central 5 Mm Circle (Model 2),Phenotype,Drusen Area Within A Central 5 Mm Circle (Model 2)
56519,Uterine Leiomyomata,Phenotype,Uterine Leiomyomata
56528,Juvenile Dermatomyositis,Phenotype,Juvenile Dermatomyositis
56568,Crohn'S Disease X Smoking Status (Never Vs Ever Smoking) Interaction,Phenotype,Crohn'S Disease X Smoking Status (Never Vs Ever Smoking) Interaction
56570,Ulcerative Colitis X Smoking Status (Never Vs Ever Smoking) Interaction,Phenotype,Ulcerative Colitis X Smoking Status (Never Vs Ever Smoking) Interaction
56571,Inflammatory Bowel Disease X Smoking Status (Never Vs Ever Smoking) Interaction,Phenotype,Inflammatory Bowel Disease X Smoking Status (Never Vs Ever Smoking) Interaction
56572,Crohn'S Disease X Smoking Status (Never Vs Current Smoking) Interaction,Phenotype,Crohn'S Disease X Smoking Status (Never Vs Current Smoking) Interaction
56575,Inflammatory Bowel Disease X Smoking Status (Never Vs Current Smoking) Interaction,Phenotype,Inflammatory Bowel Disease X Smoking Status (Never Vs Current Smoking) Interaction
56576,Crohn'S Disease X Smoking Status (Never Vs Former Smoking) Interaction,Phenotype,Crohn'S Disease X Smoking Status (Never Vs Former Smoking) Interaction
56578,Inflammatory Bowel Disease X Smoking Status (Never Vs Former Smoking) Interaction,Phenotype,Inflammatory Bowel Disease X Smoking Status (Never Vs Former Smoking) Interaction
56584,Bone Mineral Density Mean,Phenotype,Bone Mineral Density Mean
56592,Whole Body Fat Mass (Ukb Data Field 23100),Phenotype,Whole Body Fat Mass (Ukb Data Field 23100)
56625,Baseline Memory In Normal Cognition,Phenotype,Baseline Memory In Normal Cognition
56628,Whole Body Fat Free Mass (Ukb Data Field 23101),Phenotype,Whole Body Fat Free Mass (Ukb Data Field 23101)
56633,Baseline Memory In Normal Cognition X Sex Interaction,Phenotype,Baseline Memory In Normal Cognition X Sex Interaction
56636,Memory Decline In Impaired Cognition,Phenotype,Memory Decline In Impaired Cognition
56639,Memory Decline In Normal Cognition,Phenotype,Memory Decline In Normal Cognition
56681,Bone Mineral Density Variability,Phenotype,Bone Mineral Density Variability
56691,Memory Decline,Phenotype,Memory Decline
56695,Memory Decline In Impaired Cognition X Sex Interaction,Phenotype,Memory Decline In Impaired Cognition X Sex Interaction
56702,Memory Decline In Normal Cognition X Sex Interaction,Phenotype,Memory Decline In Normal Cognition X Sex Interaction
56758,Memory Decline X Sex Interaction,Phenotype,Memory Decline X Sex Interaction
56787,Gastroesophageal Reflux Disease (Ukb Data Field 20002_1138),Phenotype,Gastroesophageal Reflux Disease (Ukb Data Field 20002_1138)
56788,Gastritis And Duodenitis (Ukb Data Field 20002_1143),Phenotype,Gastritis And Duodenitis (Ukb Data Field 20002_1143)
56790,Icd10 K31.7: Polyp Of Stomach And Duodenum,Phenotype,Icd10 K31.7: Polyp Of Stomach And Duodenum
56792,Icd10 K70: Liver Fibrosis And Cirrhosis,Phenotype,Icd10 K70: Liver Fibrosis And Cirrhosis
56802,Diffuse Gastric Cancer In H. Pylori Positive Individuals,Phenotype,Diffuse Gastric Cancer In H. Pylori Positive Individuals
56807,Posterior Brain Arterial Diameters,Phenotype,Posterior Brain Arterial Diameters
56813,Icd10 K50-- K51: Inflammatory Bowel Disease,Phenotype,Icd10 K50-- K51: Inflammatory Bowel Disease
56814,Colorectal Polyp (Ukb Data Field 20002_1460),Phenotype,Colorectal Polyp (Ukb Data Field 20002_1460)
56820,Cancer Code-- Self-Reported: Small Intestinal Cancer (Ukb Data Field 20001_1019),Phenotype,Cancer Code-- Self-Reported: Small Intestinal Cancer (Ukb Data Field 20001_1019)
56821,Cholelithiasis (Ukb Data Field 20002_1162),Phenotype,Cholelithiasis (Ukb Data Field 20002_1162)
56824,Alpha-Fetoprotein Levels,Phenotype,Alpha-Fetoprotein Levels
56847,Bone Density T-Score,Phenotype,Bone Density T-Score
56856,Body Fat Rate,Phenotype,Body Fat Rate
56863,Ischemic Heart Disease (Phecode 411),Phenotype,Ischemic Heart Disease (Phecode 411)
56866,Bone Density Z-Score,Phenotype,Bone Density Z-Score
56895,Baseline Memory X Sex Interaction,Phenotype,Baseline Memory X Sex Interaction
56898,Baseline Memory In Impaired Cognition X Sex Interaction,Phenotype,Baseline Memory In Impaired Cognition X Sex Interaction
56909,Telomere Length (Principal Component 1),Phenotype,Telomere Length (Principal Component 1)
56924,Estimated Glomerular Filtration Rate (Creatinine-- Cystatin C),Phenotype,Estimated Glomerular Filtration Rate (Creatinine-- Cystatin C)
56931,Baseline Memory In Impaired Cognition,Phenotype,Baseline Memory In Impaired Cognition
56945,Baseline Memory,Phenotype,Baseline Memory
56951,Hip Shape Mode 1,Phenotype,Hip Shape Mode 1
56954,Hip Shape Mode 2,Phenotype,Hip Shape Mode 2
57030,Ease Of Skin Tanning,Phenotype,Ease Of Skin Tanning
57034,Ease Of Sunburn,Phenotype,Ease Of Sunburn
57036,Extensive White Matter Perivascular Space Burden,Phenotype,Extensive White Matter Perivascular Space Burden
57039,Underweight,Phenotype,Underweight
57042,Bifunctional Methylenetetrahydrofolate Dehydrogenase/Cyclohydrolase-- Mitochondrial Levels,Phenotype,Bifunctional Methylenetetrahydrofolate Dehydrogenase/Cyclohydrolase-- Mitochondrial Levels
57043,Statherin Levels,Phenotype,Statherin Levels
57045,Stromal Interaction Molecule 1 Levels,Phenotype,Stromal Interaction Molecule 1 Levels
57047,Serine/Threonine-Protein Kinase 16 Levels,Phenotype,Serine/Threonine-Protein Kinase 16 Levels
57049,Adenylyltransferase And Sulfurtransferase Mocs3 Levels,Phenotype,Adenylyltransferase And Sulfurtransferase Mocs3 Levels
57050,Matrix-Remodeling-Associated Protein 8 Levels,Phenotype,Matrix-Remodeling-Associated Protein 8 Levels
57051,Myeloblastin Levels,Phenotype,Myeloblastin Levels
57053,Myosin Light Chain 6B Levels,Phenotype,Myosin Light Chain 6B Levels
57054,Myelin Protein Zero-Like Protein 1 Levels,Phenotype,Myelin Protein Zero-Like Protein 1 Levels
57055,Melanoregulin Levels,Phenotype,Melanoregulin Levels
57056,Methenyltetrahydrofolate Synthase Domain-Containing Protein Levels,Phenotype,Methenyltetrahydrofolate Synthase Domain-Containing Protein Levels
57058,Serine/Threonine-Protein Kinase Pak 3 Levels,Phenotype,Serine/Threonine-Protein Kinase Pak 3 Levels
57060,Serine/Threonine-Protein Kinase Pak 5 Levels,Phenotype,Serine/Threonine-Protein Kinase Pak 5 Levels
57062,Mucin-16 Levels,Phenotype,Mucin-16 Levels
57065,Mitochondrial Ubiquitin Ligase Activator Of Nfkb 1 Levels,Phenotype,Mitochondrial Ubiquitin Ligase Activator Of Nfkb 1 Levels
57066,Neuroendocrine Protein 7B2 Levels,Phenotype,Neuroendocrine Protein 7B2 Levels
57069,E3 Ubiquitin-Protein Ligase Neurl1 Levels,Phenotype,E3 Ubiquitin-Protein Ligase Neurl1 Levels
57072,Magnesium Transporter Nipa4 Levels,Phenotype,Magnesium Transporter Nipa4 Levels
57073,Neutrophil Elastase Levels,Phenotype,Neutrophil Elastase Levels
57075,Nedd8-Activating Enzyme E1 Regulatory Subunit Levels,Phenotype,Nedd8-Activating Enzyme E1 Regulatory Subunit Levels
57077,Fc Receptor-Like Protein 1 Levels,Phenotype,Fc Receptor-Like Protein 1 Levels
57078,Zona Pellucida-Binding Protein 1 Levels,Phenotype,Zona Pellucida-Binding Protein 1 Levels
57079,Protein Zwilch Homolog Levels,Phenotype,Protein Zwilch Homolog Levels
57080,Inhibin Beta B Chain (Mixed) Levels,Phenotype,Inhibin Beta B Chain (Mixed) Levels
57086,Fatty Acid-Binding Protein 9 Levels,Phenotype,Fatty Acid-Binding Protein 9 Levels
57088,Iron-Sulfur Cluster Co-Chaperone Protein Hscb-- Mitochondrial Levels,Phenotype,Iron-Sulfur Cluster Co-Chaperone Protein Hscb-- Mitochondrial Levels
57089,Fibroblast Growth Factor 8 Isoform B Levels,Phenotype,Fibroblast Growth Factor 8 Isoform B Levels
57092,Poly(A) Rna Polymerase-- Mitochondrial Levels,Phenotype,Poly(A) Rna Polymerase-- Mitochondrial Levels
57093,Guanine Nucleotide-Binding Protein G(I)/G(S)/G(O) Subunit Gamma-11 Levels,Phenotype,Guanine Nucleotide-Binding Protein G(I)/G(S)/G(O) Subunit Gamma-11 Levels
57094,Guanylate-Binding Protein 6 Levels,Phenotype,Guanylate-Binding Protein 6 Levels
57095,Gtp Cyclohydrolase 1 Levels,Phenotype,Gtp Cyclohydrolase 1 Levels
57096,Melanocyte Protein Pmel Levels,Phenotype,Melanocyte Protein Pmel Levels
57099,Insomnia (Standard Gwa),Phenotype,Insomnia (Standard Gwa)
57101,Number Of Non-Cancer Illnesses (Standard Gwa),Phenotype,Number Of Non-Cancer Illnesses (Standard Gwa)
57103,Height (Weighted Gwa),Phenotype,Height (Weighted Gwa)
57106,Body Mass Index (Mtag),Phenotype,Body Mass Index (Mtag)
57120,Tnf Receptor-Associated Factor 1 Levels,Phenotype,Tnf Receptor-Associated Factor 1 Levels
57123,Triggering Receptor Expressed On Myeloid Cells 2 Levels,Phenotype,Triggering Receptor Expressed On Myeloid Cells 2 Levels
57125,Tryptophan 2--3-Dioxygenase Levels,Phenotype,Tryptophan 2--3-Dioxygenase Levels
57126,Thiopurine S-Methyltransferase Levels,Phenotype,Thiopurine S-Methyltransferase Levels
57127,Transferrin Receptor Protein 1 Levels,Phenotype,Transferrin Receptor Protein 1 Levels
57128,Trypsin-1 Levels,Phenotype,Trypsin-1 Levels
57130,Trypsin-2 Levels,Phenotype,Trypsin-2 Levels
57131,Tubulin Polymerization-Promoting Protein Family Member 2 Levels,Phenotype,Tubulin Polymerization-Promoting Protein Family Member 2 Levels
57136,Tapasin-Related Protein Levels,Phenotype,Tapasin-Related Protein Levels
57138,Troponin T-- Fast Skeletal Muscle Levels,Phenotype,Troponin T-- Fast Skeletal Muscle Levels
57139,Tom1-Like Protein 2 Levels,Phenotype,Tom1-Like Protein 2 Levels
57140,Tomm20-Like Protein 1 Levels,Phenotype,Tomm20-Like Protein 1 Levels
57141,Thioredoxin-Related Transmembrane Protein 2 Levels,Phenotype,Thioredoxin-Related Transmembrane Protein 2 Levels
57142,Protein Disulfide-Isomerase Tmx3 Levels,Phenotype,Protein Disulfide-Isomerase Tmx3 Levels
57144,Mitochondrial Import Inner Membrane Translocase Subunit Tim14 Levels,Phenotype,Mitochondrial Import Inner Membrane Translocase Subunit Tim14 Levels
57146,T-Cell Immunoglobulin And Mucin Domain-Containing Protein 4 Levels,Phenotype,T-Cell Immunoglobulin And Mucin Domain-Containing Protein 4 Levels
57148,Transcription Factor Ap-1 Levels,Phenotype,Transcription Factor Ap-1 Levels
57149,Tumor Necrosis Factor Alpha-Induced Protein 3 Levels,Phenotype,Tumor Necrosis Factor Alpha-Induced Protein 3 Levels
57151,Tumor Necrosis Factor Receptor Superfamily Member 21 Levels,Phenotype,Tumor Necrosis Factor Receptor Superfamily Member 21 Levels
57153,Tumor Necrosis Factor Receptor Superfamily Member 3 Levels,Phenotype,Tumor Necrosis Factor Receptor Superfamily Member 3 Levels
57154,Tumor Necrosis Factor Receptor Superfamily Member 8 Levels,Phenotype,Tumor Necrosis Factor Receptor Superfamily Member 8 Levels
57156,Tumor Necrosis Factor Ligand Superfamily Member 14 Levels,Phenotype,Tumor Necrosis Factor Ligand Superfamily Member 14 Levels
57157,Tumor Necrosis Factor Ligand Superfamily Member 18 Levels,Phenotype,Tumor Necrosis Factor Ligand Superfamily Member 18 Levels
57159,Trimeric Intracellular Cation Channel Type B Levels,Phenotype,Trimeric Intracellular Cation Channel Type B Levels
57160,Tumor Necrosis Factor Receptor Superfamily Member 17 Levels,Phenotype,Tumor Necrosis Factor Receptor Superfamily Member 17 Levels
57161,Chronotype X Daytime Light Exposure Interaction,Phenotype,Chronotype X Daytime Light Exposure Interaction
57163,Alanine--Trna Ligase-- Cytoplasmic Levels,Phenotype,Alanine--Trna Ligase-- Cytoplasmic Levels
57165,Paralemmin-1 Levels,Phenotype,Paralemmin-1 Levels
57166,Peptide Chain Release Factor 1-Like-- Mitochondrial Levels,Phenotype,Peptide Chain Release Factor 1-Like-- Mitochondrial Levels
57169,Proprotein Convertase Subtilisin/Kexin Type 7 Levels,Phenotype,Proprotein Convertase Subtilisin/Kexin Type 7 Levels
57171,Protein Canopy Homolog 3 Levels,Phenotype,Protein Canopy Homolog 3 Levels
57173,Phosphoenolpyruvate Carboxykinase-- Cytosolic [Gtp] Levels,Phenotype,Phosphoenolpyruvate Carboxykinase-- Cytosolic [Gtp] Levels
57174,Rbc Levels Of 15-Hete,Phenotype,Rbc Levels Of 15-Hete
57177,Beta-Defensin 113 Levels,Phenotype,Beta-Defensin 113 Levels
57179,Beta-Defensin 116 Levels,Phenotype,Beta-Defensin 116 Levels
57180,Beta-Defensin 132 Levels,Phenotype,Beta-Defensin 132 Levels
57181,Biglycan Levels,Phenotype,Biglycan Levels
57183,Rbc Levels Of 9--10-Dihome,Phenotype,Rbc Levels Of 9--10-Dihome
57185,Rbc Levels Of Acetyl-Carnitine,Phenotype,Rbc Levels Of Acetyl-Carnitine
57186,Rbc Levels Of Adp,Phenotype,Rbc Levels Of Adp
57188,Rbc Levels Of 2-Oxoglutaramate,Phenotype,Rbc Levels Of 2-Oxoglutaramate
57190,Rbc Levels Of 5-6-Dihydrothymine,Phenotype,Rbc Levels Of 5-6-Dihydrothymine
57192,Rbc Levels Of 8-Hete.1,Phenotype,Rbc Levels Of 8-Hete.1
57194,Rbc Levels Of 11-Hete.1,Phenotype,Rbc Levels Of 11-Hete.1
57198,Left Ventricular End Diastolic Mass,Phenotype,Left Ventricular End Diastolic Mass
57200,Left Ventricular End-Diastolic Volume,Phenotype,Left Ventricular End-Diastolic Volume
57201,Left Ventricular Ejection Fraction,Phenotype,Left Ventricular Ejection Fraction
57204,Right Ventricular Peak Ejection Rate,Phenotype,Right Ventricular Peak Ejection Rate
57213,Left Ventricular End Diastolic Mass End Diastolic Volume Ratio,Phenotype,Left Ventricular End Diastolic Mass End Diastolic Volume Ratio
57216,Systolic Blood Pressure (Standard Gwa),Phenotype,Systolic Blood Pressure (Standard Gwa)
57220,Smoking Status (Standard Gwa),Phenotype,Smoking Status (Standard Gwa)
57222,Nuclear Distribution Protein Nude Homolog 1 Levels,Phenotype,Nuclear Distribution Protein Nude Homolog 1 Levels
57224,Nucleoside Diphosphate Kinase-- Mitochondrial Levels,Phenotype,Nucleoside Diphosphate Kinase-- Mitochondrial Levels
57227,Protein Ndrg4 Levels,Phenotype,Protein Ndrg4 Levels
57231,Nadh Dehydrogenase [Ubiquinone] 1 Beta Subcomplex Subunit 11-- Mitochondrial Levels,Phenotype,Nadh Dehydrogenase [Ubiquinone] 1 Beta Subcomplex Subunit 11-- Mitochondrial Levels
57232,Tight Junction Protein Zo-1 Levels,Phenotype,Tight Junction Protein Zo-1 Levels
57235,U6 Snrna-Associated Sm-Like Protein Lsm4 Levels,Phenotype,U6 Snrna-Associated Sm-Like Protein Lsm4 Levels
57236,Neural Cell Adhesion Molecule 2 Levels,Phenotype,Neural Cell Adhesion Molecule 2 Levels
57238,Gamma-Aminobutyric Acid Receptor-Associated Protein-Like 2 Levels,Phenotype,Gamma-Aminobutyric Acid Receptor-Associated Protein-Like 2 Levels
57240,Nuclear Pore Membrane Glycoprotein 210-Like Levels,Phenotype,Nuclear Pore Membrane Glycoprotein 210-Like Levels
57242,Phosphatidylinositol 4-Phosphate 3-Kinase C2 Domain-Containing Subunit Alpha Levels,Phenotype,Phosphatidylinositol 4-Phosphate 3-Kinase C2 Domain-Containing Subunit Alpha Levels
57243,Receptor-Type Tyrosine-Protein Kinase Flt3 Levels,Phenotype,Receptor-Type Tyrosine-Protein Kinase Flt3 Levels
57244,G2/Mitotic-Specific Cyclin-B2 Levels,Phenotype,G2/Mitotic-Specific Cyclin-B2 Levels
57245,Galactose-3-O-Sulfotransferase 2 Levels,Phenotype,Galactose-3-O-Sulfotransferase 2 Levels
57247,Glycerol-3-Phosphate Dehydrogenase 1-Like Protein Levels,Phenotype,Glycerol-3-Phosphate Dehydrogenase 1-Like Protein Levels
57250,Frizzled-10 Levels,Phenotype,Frizzled-10 Levels
57251,Phospholipase A2 Levels,Phenotype,Phospholipase A2 Levels
57252,Prolyl 4-Hydroxylase Subunit Alpha-2 Levels,Phenotype,Prolyl 4-Hydroxylase Subunit Alpha-2 Levels
57254,Ferritin Light Chain Levels,Phenotype,Ferritin Light Chain Levels
57255,Pancreatic Triacylglycerol Lipase Levels,Phenotype,Pancreatic Triacylglycerol Lipase Levels
57258,Proto-Oncogene Tyrosine-Protein Kinase Ros Levels,Phenotype,Proto-Oncogene Tyrosine-Protein Kinase Ros Levels
57259,Peroxisome Proliferator-Activated Receptor Alpha Levels,Phenotype,Peroxisome Proliferator-Activated Receptor Alpha Levels
57261,Ph And Sec7 Domain-Containing Protein 1 Levels,Phenotype,Ph And Sec7 Domain-Containing Protein 1 Levels
57262,Pre-Mrna-Processing Factor 6 Levels,Phenotype,Pre-Mrna-Processing Factor 6 Levels
57263,Pr Domain Zinc Finger Protein 1 Levels,Phenotype,Pr Domain Zinc Finger Protein 1 Levels
57264,Prion-Like Protein Doppel Levels,Phenotype,Prion-Like Protein Doppel Levels
57266,Proteasome Subunit Alpha Type-2 Levels,Phenotype,Proteasome Subunit Alpha Type-2 Levels
57267,Proteasome Subunit Alpha Type-5 Levels,Phenotype,Proteasome Subunit Alpha Type-5 Levels
57269,Proteasome Subunit Alpha Type-7 Levels,Phenotype,Proteasome Subunit Alpha Type-7 Levels
57272,Proteasome Subunit Beta Type-2 Levels,Phenotype,Proteasome Subunit Beta Type-2 Levels
57276,Pro-Opiomelanocortin Levels,Phenotype,Pro-Opiomelanocortin Levels
57278,Prostasin Levels,Phenotype,Prostasin Levels
57289,Reaction Time (Standard Gwa),Phenotype,Reaction Time (Standard Gwa)
57290,Reaction Time (Weighted Gwa),Phenotype,Reaction Time (Weighted Gwa)
57291,Risk Taking (Standard Gwa),Phenotype,Risk Taking (Standard Gwa)
57293,Risk Taking (Weighted Gwa),Phenotype,Risk Taking (Weighted Gwa)
57294,Alcohol Frequency Weekly (Standard Gwa),Phenotype,Alcohol Frequency Weekly (Standard Gwa)
57306,Soluble Cd163 Levels,Phenotype,Soluble Cd163 Levels
57309,Neuronal Pentraxin-1 Levels,Phenotype,Neuronal Pentraxin-1 Levels
57311,Neurexophilin-1 Levels,Phenotype,Neurexophilin-1 Levels
57312,Ocia Domain-Containing Protein 1 Levels,Phenotype,Ocia Domain-Containing Protein 1 Levels
57313,Opticin Levels,Phenotype,Opticin Levels
57314,Oral Cancer-Overexpressed Protein 1 Levels,Phenotype,Oral Cancer-Overexpressed Protein 1 Levels
57315,Oncostatin-M Levels,Phenotype,Oncostatin-M Levels
57316,Arsenite Methyltransferase Levels,Phenotype,Arsenite Methyltransferase Levels
57317,Histone Chaperone Asf1A Levels,Phenotype,Histone Chaperone Asf1A Levels
57319,Atpase Family Aaa Domain-Containing Protein 1 Levels,Phenotype,Atpase Family Aaa Domain-Containing Protein 1 Levels
57320,Cyclic Amp-Dependent Transcription Factor Atf-6 Alpha Levels,Phenotype,Cyclic Amp-Dependent Transcription Factor Atf-6 Alpha Levels
57321,Armadillo Repeat-Containing Protein 5 Levels,Phenotype,Armadillo Repeat-Containing Protein 5 Levels
57324,Atp Synthase Subunit Beta-- Mitochondrial Levels,Phenotype,Atp Synthase Subunit Beta-- Mitochondrial Levels
57325,Atp-Dependent Rna Helicase A Levels,Phenotype,Atp-Dependent Rna Helicase A Levels
57326,Extracellular Tyrosine-Protein Kinase Pkdcc Levels,Phenotype,Extracellular Tyrosine-Protein Kinase Pkdcc Levels
57327,Plasmin Levels,Phenotype,Plasmin Levels
57330,1-Phosphatidylinositol 4--5-Bisphosphate Phosphodiesterase Gamma-1 Levels,Phenotype,1-Phosphatidylinositol 4--5-Bisphosphate Phosphodiesterase Gamma-1 Levels
57331,1-Phosphatidylinositol 4--5-Bisphosphate Phosphodiesterase Gamma-2 Levels,Phenotype,1-Phosphatidylinositol 4--5-Bisphosphate Phosphodiesterase Gamma-2 Levels
57333,Augurin Levels,Phenotype,Augurin Levels
57334,Aurora Kinase B Levels,Phenotype,Aurora Kinase B Levels
57345,Skin Phototype Score,Phenotype,Skin Phototype Score
57358,Skin Color (Fitzpatrick Scale),Phenotype,Skin Color (Fitzpatrick Scale)
57361,Primary Focal Segmental Glomerulosclerosis In Chronic Kidney Disease,Phenotype,Primary Focal Segmental Glomerulosclerosis In Chronic Kidney Disease
57369,Extrapulmonary Tuberculosis,Phenotype,Extrapulmonary Tuberculosis
57371,Transcription Initiation Factor Tfiid Subunit 10 Levels,Phenotype,Transcription Initiation Factor Tfiid Subunit 10 Levels
57372,Tropomyosin Beta Chain Levels,Phenotype,Tropomyosin Beta Chain Levels
57373,Histone-Lysine N-Methyltransferase Suv420H2 Levels,Phenotype,Histone-Lysine N-Methyltransferase Suv420H2 Levels
57374,T-Cell Surface Glycoprotein Cd1A Levels,Phenotype,T-Cell Surface Glycoprotein Cd1A Levels
57375,Sulfatase-Modifying Factor 2 Levels,Phenotype,Sulfatase-Modifying Factor 2 Levels
57377,Synaptotagmin-11 Levels,Phenotype,Synaptotagmin-11 Levels
57379,Syntaxin-7 Levels,Phenotype,Syntaxin-7 Levels
57381,Suppressor Of Fused Homolog Levels,Phenotype,Suppressor Of Fused Homolog Levels
57382,Tlr4 Interactor With Leucine Rich Repeats Levels,Phenotype,Tlr4 Interactor With Leucine Rich Repeats Levels
57384,Thymidine Kinase-- Cytosolic Levels,Phenotype,Thymidine Kinase-- Cytosolic Levels
57385,Thymidine Kinase 2-- Mitochondrial Levels,Phenotype,Thymidine Kinase 2-- Mitochondrial Levels
57387,Tachykinin-4 Levels,Phenotype,Tachykinin-4 Levels
57388,Transmembrane Protein 9 Levels,Phenotype,Transmembrane Protein 9 Levels
57389,Thyroid Peroxidase Levels,Phenotype,Thyroid Peroxidase Levels
57390,Transmembrane Protein C1Orf162 Levels,Phenotype,Transmembrane Protein C1Orf162 Levels
57391,Transmembrane Protein 185A Levels,Phenotype,Transmembrane Protein 185A Levels
57393,Ubiquitin D Levels,Phenotype,Ubiquitin D Levels
57394,Malignant Lymphoma (Non-Hodgkin Lymphoma-- Multiple Myeloma-- Or Hodgkin Lymphoma),Phenotype,Malignant Lymphoma (Non-Hodgkin Lymphoma-- Multiple Myeloma-- Or Hodgkin Lymphoma)
57397,Alanine Aminotransferase 1 Levels,Phenotype,Alanine Aminotransferase 1 Levels
57398,Anthrax Toxin Receptor 1 Levels,Phenotype,Anthrax Toxin Receptor 1 Levels
57399,Angiopoietin-1 Receptor-- Soluble Levels,Phenotype,Angiopoietin-1 Receptor-- Soluble Levels
57404,Cryptic Phenotype That Captures Alport Syndrome Severity,Phenotype,Cryptic Phenotype That Captures Alport Syndrome Severity
57405,Cryptic Phenotype That Captures Autosomal Dominant Polycystic Kidney Disease Severity,Phenotype,Cryptic Phenotype That Captures Autosomal Dominant Polycystic Kidney Disease Severity
57406,Systolic Blood Pressure (Weighted Gwa),Phenotype,Systolic Blood Pressure (Weighted Gwa)
57418,Alpha-1--3-Mannosyl-Glycoprotein 4-Beta-N-Acetylglucosaminyltransferase A Levels,Phenotype,Alpha-1--3-Mannosyl-Glycoprotein 4-Beta-N-Acetylglucosaminyltransferase A Levels
57419,Myc-Associated Zinc Finger Protein Levels,Phenotype,Myc-Associated Zinc Finger Protein Levels
57421,Mast Cell-Expressed Membrane Protein 1 Levels,Phenotype,Mast Cell-Expressed Membrane Protein 1 Levels
57422,Malonyl-Coa Decarboxylase-- Mitochondrial Levels,Phenotype,Malonyl-Coa Decarboxylase-- Mitochondrial Levels
57424,Homeobox Protein Mox-2 Levels,Phenotype,Homeobox Protein Mox-2 Levels
57426,Mical-Like Protein 2 Levels,Phenotype,Mical-Like Protein 2 Levels
57432,Matrix Metalloproteinase-9 Levels,Phenotype,Matrix Metalloproteinase-9 Levels
57434,Udp-Glucuronic Acid Decarboxylase 1 Levels,Phenotype,Udp-Glucuronic Acid Decarboxylase 1 Levels
57437,Valine--Trna Ligase Levels,Phenotype,Valine--Trna Ligase Levels
57438,Vesicle-Associated Membrane Protein 8 Levels,Phenotype,Vesicle-Associated Membrane Protein 8 Levels
57439,Urotensin-2 Levels,Phenotype,Urotensin-2 Levels
57442,Vascular Endothelial Growth Factor B Levels,Phenotype,Vascular Endothelial Growth Factor B Levels
57443,Vascular Endothelial Growth Factor Receptor 1 Levels,Phenotype,Vascular Endothelial Growth Factor Receptor 1 Levels
57444,Uncharacterized Protein C3Orf18 Levels,Phenotype,Uncharacterized Protein C3Orf18 Levels
57445,Uncharacterized Protein C4Orf32 Levels,Phenotype,Uncharacterized Protein C4Orf32 Levels
57446,Sleep Apnea (Mtag),Phenotype,Sleep Apnea (Mtag)
57448,Protein Disulfide-Isomerase A4 Levels,Phenotype,Protein Disulfide-Isomerase A4 Levels
57449,Apolipoprotein A-V Levels,Phenotype,Apolipoprotein A-V Levels
57450,Protein Delta Homolog 1 Levels,Phenotype,Protein Delta Homolog 1 Levels
57451,Protein Delta Homolog 2 Levels,Phenotype,Protein Delta Homolog 2 Levels
57452,Apolipoprotein C-Iii Levels,Phenotype,Apolipoprotein C-Iii Levels
57458,Er Membrane Protein Complex Subunit 4 Levels,Phenotype,Er Membrane Protein Complex Subunit 4 Levels
57459,Chymotrypsin-Like Elastase Family Member 2A Levels,Phenotype,Chymotrypsin-Like Elastase Family Member 2A Levels
57461,Histone-Lysine N-Methyltransferase Ehmt2 Levels,Phenotype,Histone-Lysine N-Methyltransferase Ehmt2 Levels
57462,Erythropoietin Levels,Phenotype,Erythropoietin Levels
57463,Epididymal-Specific Lipocalin-10 Levels,Phenotype,Epididymal-Specific Lipocalin-10 Levels
57464,Electron Transfer Flavoprotein Subunit Alpha-- Mitochondrial Levels,Phenotype,Electron Transfer Flavoprotein Subunit Alpha-- Mitochondrial Levels
57465,Dna Excision Repair Protein Ercc-1 Levels,Phenotype,Dna Excision Repair Protein Ercc-1 Levels
57467,Protein Fam177A1 Levels,Phenotype,Protein Fam177A1 Levels
57469,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 6 Levels,Phenotype,Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 6 Levels
57471,Ectonucleoside Triphosphate Diphosphohydrolase 1 Levels,Phenotype,Ectonucleoside Triphosphate Diphosphohydrolase 1 Levels
57472,Ectonucleoside Triphosphate Diphosphohydrolase 3 Levels,Phenotype,Ectonucleoside Triphosphate Diphosphohydrolase 3 Levels
57473,Endothelin-2 Levels,Phenotype,Endothelin-2 Levels
57476,Otu Domain-Containing Protein 5 Levels,Phenotype,Otu Domain-Containing Protein 5 Levels
57477,Activin Receptor Type-2A Levels,Phenotype,Activin Receptor Type-2A Levels
57478,Aspartoacylase Levels,Phenotype,Aspartoacylase Levels
57479,Acyl-Coenzyme A Thioesterase 13 Levels,Phenotype,Acyl-Coenzyme A Thioesterase 13 Levels
57481,Oxygen-Dependent Coproporphyrinogen-Iii Oxidase-- Mitochondrial Levels,Phenotype,Oxygen-Dependent Coproporphyrinogen-Iii Oxidase-- Mitochondrial Levels
57482,14-3-3 Protein Family Levels,Phenotype,14-3-3 Protein Family Levels
57484,5-Nucleotidase Levels,Phenotype,5-Nucleotidase Levels
57487,Amiloride-Sensitive Amine Oxidase [Copper-Containing] Levels,Phenotype,Amiloride-Sensitive Amine Oxidase [Copper-Containing] Levels
57489,Prorelaxin H2 Levels,Phenotype,Prorelaxin H2 Levels
57490,Prefoldin Subunit 3 Levels,Phenotype,Prefoldin Subunit 3 Levels
57491,Platelet Endothelial Cell Adhesion Molecule Levels,Phenotype,Platelet Endothelial Cell Adhesion Molecule Levels
57492,Prolyl Endopeptidase Fap Levels,Phenotype,Prolyl Endopeptidase Fap Levels
57493,Peptidyl-Prolyl Cis-Trans Isomerase G Levels,Phenotype,Peptidyl-Prolyl Cis-Trans Isomerase G Levels
57495,Peroxisomal 2--4-Dienoyl-Coa Reductase Levels,Phenotype,Peroxisomal 2--4-Dienoyl-Coa Reductase Levels
57514,Left Ventricle Sphericity Index,Phenotype,Left Ventricle Sphericity Index
57516,Left Ventricle Short Axis,Phenotype,Left Ventricle Short Axis
57519,Skin Color,Phenotype,Skin Color
57521,Overweight,Phenotype,Overweight
57523,Epstein-Barr Virus Seropositivity,Phenotype,Epstein-Barr Virus Seropositivity
57525,Colorectal Cancer X Cigarettes Per Day Interaction (1Df),Phenotype,Colorectal Cancer X Cigarettes Per Day Interaction (1Df)
57526,Colorectal Cancer X Cigarettes Per Day Interaction (3Df),Phenotype,Colorectal Cancer X Cigarettes Per Day Interaction (3Df)
57527,Pro-Fmrfamide-Related Neuropeptide Ff Levels,Phenotype,Pro-Fmrfamide-Related Neuropeptide Ff Levels
57528,Nkg2-E Type Ii Integral Membrane Protein Levels,Phenotype,Nkg2-E Type Ii Integral Membrane Protein Levels
57529,Nmra-Like Family Domain-Containing Protein 1 Levels,Phenotype,Nmra-Like Family Domain-Containing Protein 1 Levels
57532,Vitamin K-Dependent Protein S Levels,Phenotype,Vitamin K-Dependent Protein S Levels
57534,Noggin Levels,Phenotype,Noggin Levels
57535,B-Cell Lymphoma 6 Protein Levels,Phenotype,B-Cell Lymphoma 6 Protein Levels
57536,Breast Cancer Anti-Estrogen Resistance Protein 3 Levels,Phenotype,Breast Cancer Anti-Estrogen Resistance Protein 3 Levels
57539,Left Ventricular Stroke Volume,Phenotype,Left Ventricular Stroke Volume
57547,Inclusion Body Myositis,Phenotype,Inclusion Body Myositis
57548,Idiopathic Inflammatory Myopathy With Anti-Jo1 Positive,Phenotype,Idiopathic Inflammatory Myopathy With Anti-Jo1 Positive
57549,Thioredoxin Domain-Containing Protein 15 Levels,Phenotype,Thioredoxin Domain-Containing Protein 15 Levels
57551,Thioredoxin-Interacting Protein Levels,Phenotype,Thioredoxin-Interacting Protein Levels
57552,Trypsin-3 Levels,Phenotype,Trypsin-3 Levels
57557,Thrombospondin-Type Laminin G Domain And Ear Repeat-Containing Protein Levels,Phenotype,Thrombospondin-Type Laminin G Domain And Ear Repeat-Containing Protein Levels
57560,Tyrosine-Protein Kinase Receptor Tie-1-- Soluble Levels,Phenotype,Tyrosine-Protein Kinase Receptor Tie-1-- Soluble Levels
57562,Tyrosine-Protein Kinase Zap-70 Levels,Phenotype,Tyrosine-Protein Kinase Zap-70 Levels
57563,Alpha Angle,Phenotype,Alpha Angle
57565,Zinc Finger Protein 276 Levels,Phenotype,Zinc Finger Protein 276 Levels
57566,V-Set And Transmembrane Domain-Containing Protein 4 Levels,Phenotype,V-Set And Transmembrane Domain-Containing Protein 4 Levels
57567,Protein Wnt-11 Levels,Phenotype,Protein Wnt-11 Levels
57570,Wap Four-Disulfide Core Domain Protein 5 Levels,Phenotype,Wap Four-Disulfide Core Domain Protein 5 Levels
57571,Protein Wnt-5A Levels,Phenotype,Protein Wnt-5A Levels
57572,Ww Domain-Containing Oxidoreductase Levels,Phenotype,Ww Domain-Containing Oxidoreductase Levels
57575,Very Low-Density Lipoprotein Receptor Levels,Phenotype,Very Low-Density Lipoprotein Receptor Levels
57576,Vascular Non-Inflammatory Molecule 2 Levels,Phenotype,Vascular Non-Inflammatory Molecule 2 Levels
57581,Vesicular-- Overexpressed In Cancer-- Prosurvival Protein 1 Levels,Phenotype,Vesicular-- Overexpressed In Cancer-- Prosurvival Protein 1 Levels
57582,Vacuolar Protein Sorting-Associated Protein 28 Homolog Levels,Phenotype,Vacuolar Protein Sorting-Associated Protein 28 Homolog Levels
57584,Zinc Fingers And Homeoboxes Protein 3 Levels,Phenotype,Zinc Fingers And Homeoboxes Protein 3 Levels
57585,Afamin Levels,Phenotype,Afamin Levels
57593,25-Hydroxyvitamin D Levels (Skin Colour Stratified),Phenotype,25-Hydroxyvitamin D Levels (Skin Colour Stratified)
57594,25-Hydroxyvitamin D Levels,Phenotype,25-Hydroxyvitamin D Levels
57612,Soluble Transferrin Receptor Concentration,Phenotype,Soluble Transferrin Receptor Concentration
57616,Hepcidin Concentration,Phenotype,Hepcidin Concentration
57635,Hip Shape Mode 4,Phenotype,Hip Shape Mode 4
57640,Hip Shape Mode 3,Phenotype,Hip Shape Mode 3
57642,Hip Shape Mode 6,Phenotype,Hip Shape Mode 6
57652,Serum O-Methylascorbate Levels  X Sex Interaction,Phenotype,Serum O-Methylascorbate Levels  X Sex Interaction
57655,Serum Ascorbic Acid 2-Sulfate Levels X Sex Interaction,Phenotype,Serum Ascorbic Acid 2-Sulfate Levels X Sex Interaction
57672,Lactate Levels In Blood Donors,Phenotype,Lactate Levels In Blood Donors
57673,Phosphoenolpyruvate Levels In Blood Donors,Phenotype,Phosphoenolpyruvate Levels In Blood Donors
57708,FVC,Phenotype,FVC
57769,Pain Intensity In Opioid-Treated Advanced Cancer,Phenotype,Pain Intensity In Opioid-Treated Advanced Cancer
57810,Hip Shape Mode 8,Phenotype,Hip Shape Mode 8
57812,Hip Shape Mode 9,Phenotype,Hip Shape Mode 9
57821,Hip Shape Mode 10,Phenotype,Hip Shape Mode 10
57825,Fluid Intelligence,Phenotype,Fluid Intelligence
57842,2--3-Phospho-D-Glycerate Levels In Blood Donors,Phenotype,2--3-Phospho-D-Glycerate Levels In Blood Donors
57844,Atp Levels In Blood Donors,Phenotype,Atp Levels In Blood Donors
57845,D-Hexose-Phosphate Levels In Blood Donors,Phenotype,D-Hexose-Phosphate Levels In Blood Donors
57846,Serum 25-Hydroxyvitamin D Levels (Conditioned On Bmi),Phenotype,Serum 25-Hydroxyvitamin D Levels (Conditioned On Bmi)
57848,Adhesion G Protein-Coupled Receptor B3 Levels,Phenotype,Adhesion G Protein-Coupled Receptor B3 Levels
57850,Cadherin-15 Levels,Phenotype,Cadherin-15 Levels
57856,Epithelial Discoidin Domain-Containing Receptor 1 Levels,Phenotype,Epithelial Discoidin Domain-Containing Receptor 1 Levels
57858,Dipeptidase 1 Levels,Phenotype,Dipeptidase 1 Levels
57860,Dipeptidase 2 Levels,Phenotype,Dipeptidase 2 Levels
57907,Achondroplasia-Like Facial Shape Score,Phenotype,Achondroplasia-Like Facial Shape Score
57947,25-Hydroxyvitamin D Levels X Skin Colour (Very Fair Vs. Light Olive) Interaction,Phenotype,25-Hydroxyvitamin D Levels X Skin Colour (Very Fair Vs. Light Olive) Interaction
57948,Microalbumin Urine,Phenotype,Microalbumin Urine
57953,Telomere Length (Principal Component 2),Phenotype,Telomere Length (Principal Component 2)
57980,Nkg2D Ligand 2 Levels,Phenotype,Nkg2D Ligand 2 Levels
57986,Sparc-Related Modular Calcium-Binding Protein 2 Levels,Phenotype,Sparc-Related Modular Calcium-Binding Protein 2 Levels
57989,Interleukin-32 Levels,Phenotype,Interleukin-32 Levels
57992,Group 10 Secretory Phospholipase A2 Levels,Phenotype,Group 10 Secretory Phospholipase A2 Levels
57994,Tubulin Polymerization-Promoting Protein Family Member 3 Levels,Phenotype,Tubulin Polymerization-Promoting Protein Family Member 3 Levels
58000,Dihomo-Gamma-Linolenic Acid; Eicosatrienoic Acid Levels (305.2485_0.386),Phenotype,Dihomo-Gamma-Linolenic Acid; Eicosatrienoic Acid Levels (305.2485_0.386)
58001,Dihomo-Gamma-Linolenic Acid; Eicosatrienoic Acid Levels (305.2485_0.386) X Waist Circumference Interaction (2Df),Phenotype,Dihomo-Gamma-Linolenic Acid; Eicosatrienoic Acid Levels (305.2485_0.386) X Waist Circumference Interaction (2Df)
58018,Corpus Callosum Fractional Anisotropy (Body),Phenotype,Corpus Callosum Fractional Anisotropy (Body)
58022,Corpus Callosum Fractional Anisotropy (Mostest),Phenotype,Corpus Callosum Fractional Anisotropy (Mostest)
58026,Allergen Component Sensitization (Hevea Brasiliensis 8),Phenotype,Allergen Component Sensitization (Hevea Brasiliensis 8)
58050,Smoking Initiation (Mtag),Phenotype,Smoking Initiation (Mtag)
58055,Color Vision Defects (Tritan),Phenotype,Color Vision Defects (Tritan)
58067,Major Depressive Disorder Or Hospitalized Covid-19 (Pleiotropy),Phenotype,Major Depressive Disorder Or Hospitalized Covid-19 (Pleiotropy)
58068,Major Depressive Disorder Or Covid-19 Infection (Pleiotropy),Phenotype,Major Depressive Disorder Or Covid-19 Infection (Pleiotropy)
58072,Arthritis,Phenotype,Arthritis
58073,Cholesterol Levels,Phenotype,Cholesterol Levels
58079,Biliary Atresia,Phenotype,Biliary Atresia
58081,Metabolite Levels (Gamma-Glutamyllysine; Gamma-Glutamyl-Epsilon-Lysine),Phenotype,Metabolite Levels (Gamma-Glutamyllysine; Gamma-Glutamyl-Epsilon-Lysine)
58082,Metabolite Levels (Propyl 4-Hydroxybenzoate Sulfate),Phenotype,Metabolite Levels (Propyl 4-Hydroxybenzoate Sulfate)
58088,Metabolite Levels (Methyl-4-Hydroxybenzoate Sulfate),Phenotype,Metabolite Levels (Methyl-4-Hydroxybenzoate Sulfate)
58090,Metabolite Levels (Indoleacetoylcarnitine),Phenotype,Metabolite Levels (Indoleacetoylcarnitine)
58092,Metabolite Levels (1-Dihomo-Linolenylglycerol (Alpha-- Gamma); 1-Dihomo-Linolenylglycerol (20:3)),Phenotype,Metabolite Levels (1-Dihomo-Linolenylglycerol (Alpha-- Gamma); 1-Dihomo-Linolenylglycerol (20:3))
58093,Metabolite Levels (N-Acetylcarnosine),Phenotype,Metabolite Levels (N-Acetylcarnosine)
58095,Metabolite Levels (Butyrylcarnitine; Butyrylcarnitine (C4); C4 Carnitine; C4_Carnitine),Phenotype,Metabolite Levels (Butyrylcarnitine; Butyrylcarnitine (C4); C4 Carnitine; C4_Carnitine)
58096,Metabolite Levels (Cys-Gly-- Oxidized),Phenotype,Metabolite Levels (Cys-Gly-- Oxidized)
58099,Metabolite Levels (Linolenoylcarnitine (C18:3)),Phenotype,Metabolite Levels (Linolenoylcarnitine (C18:3))
58101,Metabolite Levels (Tyrosine),Phenotype,Metabolite Levels (Tyrosine)
58103,Metabolite Levels (4-Androsten-3Beta--17Beta-Diol Disulfate (2); Androstenediol (3Beta--17Beta) Disulfate (2)),Phenotype,Metabolite Levels (4-Androsten-3Beta--17Beta-Diol Disulfate (2); Androstenediol (3Beta--17Beta) Disulfate (2))
58124,Monocyte Side Fluorescence,Phenotype,Monocyte Side Fluorescence
58125,Basophil Forward Scatter Distribution Width,Phenotype,Basophil Forward Scatter Distribution Width
58126,Monocyte Side Scatter,Phenotype,Monocyte Side Scatter
58133,Pain (Pleiotropy),Phenotype,Pain (Pleiotropy)
58206,Metabolite Levels (Isobutyrylcarnitine; Isobutyrylcarnitine (C4)),Phenotype,Metabolite Levels (Isobutyrylcarnitine; Isobutyrylcarnitine (C4))
58207,Metabolite Levels (Kynurenine; Cmh_Kynurenine; Kynurenine),Phenotype,Metabolite Levels (Kynurenine; Cmh_Kynurenine; Kynurenine)
58208,Metabolite Levels (1-Palmitoyl-2-Docosahexaenoyl-Gpc (16:0/22:6); C38:6 Pc; C38_6_Pc),Phenotype,Metabolite Levels (1-Palmitoyl-2-Docosahexaenoyl-Gpc (16:0/22:6); C38:6 Pc; C38_6_Pc)
58209,Metabolite Levels (Ornithine),Phenotype,Metabolite Levels (Ornithine)
58210,Metabolite Levels (Arachidonoylcarnitine (C20:4)),Phenotype,Metabolite Levels (Arachidonoylcarnitine (C20:4))
58211,Metabolite Levels (Azelaoyltaurine),Phenotype,Metabolite Levels (Azelaoyltaurine)
58214,Metabolite Levels (Phenylacetate),Phenotype,Metabolite Levels (Phenylacetate)
58216,Metabolite Levels (Dihomo-Linolenoylcarnitine (C20:3N3 Or 6)),Phenotype,Metabolite Levels (Dihomo-Linolenoylcarnitine (C20:3N3 Or 6))
58217,Metabolite Levels (Dihomo-Linoleoylcarnitine (C20:2)),Phenotype,Metabolite Levels (Dihomo-Linoleoylcarnitine (C20:2))
58218,Metabolite Levels (Lysine),Phenotype,Metabolite Levels (Lysine)
58219,Metabolite Levels (Serotonin (5Ht); Serotonin),Phenotype,Metabolite Levels (Serotonin (5Ht); Serotonin)
58220,Metabolite Levels (Succinylcarnitine; Succinylcarnitine (C4-Dc)),Phenotype,Metabolite Levels (Succinylcarnitine; Succinylcarnitine (C4-Dc))
58221,Metabolite Levels (Cysteinylglycine Disulfide),Phenotype,Metabolite Levels (Cysteinylglycine Disulfide)
58223,Metabolite Levels (Guanosine),Phenotype,Metabolite Levels (Guanosine)
58226,Metabolite Levels (O-Cresol Sulfate),Phenotype,Metabolite Levels (O-Cresol Sulfate)
58227,Metabolite Levels (Oleoylcarnitine; Oleoylcarnitine (C18:1); C18:1 Carnitine; C18_1_Carnitine),Phenotype,Metabolite Levels (Oleoylcarnitine; Oleoylcarnitine (C18:1); C18:1 Carnitine; C18_1_Carnitine)
58228,Metabolite Levels (21-Hydroxypregnenolone Disulfate),Phenotype,Metabolite Levels (21-Hydroxypregnenolone Disulfate)
58229,Metabolite Levels (Indolepropionate; Indole-3-Propionate; Cmh_Indole_Pro; Indole_3_Propanoate),Phenotype,Metabolite Levels (Indolepropionate; Indole-3-Propionate; Cmh_Indole_Pro; Indole_3_Propanoate)
58230,Metabolite Levels (Inosine; Cmh_Inosine; Inosine),Phenotype,Metabolite Levels (Inosine; Cmh_Inosine; Inosine)
58233,Metabolite Levels (Phenyllactate (Pla); Phenyllactate),Phenotype,Metabolite Levels (Phenyllactate (Pla); Phenyllactate)
58235,Metabolite Levels (3-Phenylpropionate (Hydrocinnamate); Hydrocinnamate),Phenotype,Metabolite Levels (3-Phenylpropionate (Hydrocinnamate); Hydrocinnamate)
58236,Metabolite Levels (Propionylcarnitine; Propionylcarnitine (C3); C3 Carnitine; C3_Carnitine),Phenotype,Metabolite Levels (Propionylcarnitine; Propionylcarnitine (C3); C3 Carnitine; C3_Carnitine)
58237,Icd10 L50: Urticaria,Phenotype,Icd10 L50: Urticaria
58244,Common Variable Immunodeficiency,Phenotype,Common Variable Immunodeficiency
58259,Anterior Uveitis,Phenotype,Anterior Uveitis
58261,Crohn'S Disease X Sex Interaction (2Df),Phenotype,Crohn'S Disease X Sex Interaction (2Df)
58267,Erythema Nodosum In Behcet'S Disease,Phenotype,Erythema Nodosum In Behcet'S Disease
58268,Neurological Involvement In Behcet'S Disease,Phenotype,Neurological Involvement In Behcet'S Disease
58270,Absolute Neutrophil Count,Phenotype,Absolute Neutrophil Count
58298,Antipsychotic-Induced Triglycerides Change In Schizophrenia (6-Week),Phenotype,Antipsychotic-Induced Triglycerides Change In Schizophrenia (6-Week)
58300,Triglycerides Level In Antipsychotic-Treated Schizophrenia (6-Week),Phenotype,Triglycerides Level In Antipsychotic-Treated Schizophrenia (6-Week)
58310,Genetic Generalized Epilepsy,Phenotype,Genetic Generalized Epilepsy
58312,Red Blood Cell Haemoglobin Equivalent,Phenotype,Red Blood Cell Haemoglobin Equivalent
58314,Red Cell Distribution Width - Standard Deviation,Phenotype,Red Cell Distribution Width - Standard Deviation
58330,Reticulocyte Haemoglobin Equivalent,Phenotype,Reticulocyte Haemoglobin Equivalent
58332,Reticulocyte Production Index,Phenotype,Reticulocyte Production Index
58334,Low Fluorescent Percentage Of Reticulocytes,Phenotype,Low Fluorescent Percentage Of Reticulocytes
58335,Immature Granulocyte Percentage Of White Cells,Phenotype,Immature Granulocyte Percentage Of White Cells
58337,Neutrophil Forward Scatter Distribution Width,Phenotype,Neutrophil Forward Scatter Distribution Width
58339,Immature Granulocyte Count,Phenotype,Immature Granulocyte Count
58340,Neutrophil Side Scatter Distribution Width,Phenotype,Neutrophil Side Scatter Distribution Width
58341,Neutrophil Forward Scatter,Phenotype,Neutrophil Forward Scatter
58344,Neutrophil Side Fluorescence,Phenotype,Neutrophil Side Fluorescence
58347,Corpus Callosum Volume (Mostest),Phenotype,Corpus Callosum Volume (Mostest)
58355,Response To High-Intensity Interval Training In Physically Inactive (Maximal Oxygen Uptake),Phenotype,Response To High-Intensity Interval Training In Physically Inactive (Maximal Oxygen Uptake)
58360,Metabolite Levels (1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0)),Phenotype,Metabolite Levels (1-(1-Enyl-Palmitoyl)-2-Palmitoyl-Gpc (P-16:0/16:0))
58361,Metabolite Levels (Gamma-Glutamyl-Alpha-Lysine),Phenotype,Metabolite Levels (Gamma-Glutamyl-Alpha-Lysine)
58363,Metabolite Levels (Pterin),Phenotype,Metabolite Levels (Pterin)
58366,Metabolite Levels (N-Acetylglucosamine/N-Acetylgalactosamine),Phenotype,Metabolite Levels (N-Acetylglucosamine/N-Acetylgalactosamine)
58367,Metabolite Levels (N-Acetylglucosaminylasparagine),Phenotype,Metabolite Levels (N-Acetylglucosaminylasparagine)
58371,Metabolite Levels (12-Hete),Phenotype,Metabolite Levels (12-Hete)
58372,Metabolite Levels (Hexanoylglutamine),Phenotype,Metabolite Levels (Hexanoylglutamine)
58373,Metabolite Levels (3-Hydroxyhexanoate),Phenotype,Metabolite Levels (3-Hydroxyhexanoate)
58375,Metabolite Levels (Beta-Hydroxyisovalerate),Phenotype,Metabolite Levels (Beta-Hydroxyisovalerate)
58377,Metabolite Levels (Carnitine),Phenotype,Metabolite Levels (Carnitine)
58378,Metabolite Levels (Arginine),Phenotype,Metabolite Levels (Arginine)
58379,Metabolite Levels (Picolinate),Phenotype,Metabolite Levels (Picolinate)
58382,Metabolite Levels (Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc)),Phenotype,Metabolite Levels (Pimeloylcarnitine/3-Methyladipoylcarnitine (C7-Dc))
58383,Metabolite Levels (S-1-Pyrroline-5-Carboxylate),Phenotype,Metabolite Levels (S-1-Pyrroline-5-Carboxylate)
58385,Liver Thiopurine Methyltransferase Levels,Phenotype,Liver Thiopurine Methyltransferase Levels
58396,Iron Deficiency Anaemia,Phenotype,Iron Deficiency Anaemia
58401,End-Diastolic Bi-Ventricular Shape (Principal Component 5),Phenotype,End-Diastolic Bi-Ventricular Shape (Principal Component 5)
58402,End-Diastolic Bi-Ventricular Shape (Principal Component 9),Phenotype,End-Diastolic Bi-Ventricular Shape (Principal Component 9)
58404,End-Diastolic Bi-Ventricular Shape (Principal Component 1),Phenotype,End-Diastolic Bi-Ventricular Shape (Principal Component 1)
58406,End-Diastolic Bi-Ventricular Shape (Principal Component 3),Phenotype,End-Diastolic Bi-Ventricular Shape (Principal Component 3)
58407,End-Diastolic Bi-Ventricular Shape (Principal Component 4),Phenotype,End-Diastolic Bi-Ventricular Shape (Principal Component 4)
58410,Alcohol Use Frequency In Adolescence,Phenotype,Alcohol Use Frequency In Adolescence
58417,Platelet Forward Scatter Distribution Width,Phenotype,Platelet Forward Scatter Distribution Width
58418,High Fluorescence Immature Platelet Fraction,Phenotype,High Fluorescence Immature Platelet Fraction
58419,Platelet Side Fluorescence Distribution Width,Phenotype,Platelet Side Fluorescence Distribution Width
58422,Platelet Side Scatter Distribution Width,Phenotype,Platelet Side Scatter Distribution Width
58425,Reticulocyte Forward Scatter,Phenotype,Reticulocyte Forward Scatter
58427,Reticulocyte Side Fluorescence,Phenotype,Reticulocyte Side Fluorescence
58431,Medium Fluorescent Percentage Of Reticulocytes,Phenotype,Medium Fluorescent Percentage Of Reticulocytes
58432,High Fluorescent Percentage Of Reticulocytes,Phenotype,High Fluorescent Percentage Of Reticulocytes
58434,Neutrophil Side Scatter,Phenotype,Neutrophil Side Scatter
58435,Immature Reticulocyte Forward Scatter,Phenotype,Immature Reticulocyte Forward Scatter
58459,Reactive Lymphocyte Percentage Of White Cells,Phenotype,Reactive Lymphocyte Percentage Of White Cells
58461,Lymphocyte Side Scatter Distribution Width,Phenotype,Lymphocyte Side Scatter Distribution Width
58463,Lymphocyte Side Fluorescence Distribution Width,Phenotype,Lymphocyte Side Fluorescence Distribution Width
58465,Reactive Lymphocyte Count,Phenotype,Reactive Lymphocyte Count
58467,Reactive Percentage Of Lymphocytes,Phenotype,Reactive Percentage Of Lymphocytes
58469,Monocyte Side Fluorescence Distribution Width,Phenotype,Monocyte Side Fluorescence Distribution Width
58470,Lymphocyte Side Scatter,Phenotype,Lymphocyte Side Scatter
58473,Lymphocyte Forward Scatter,Phenotype,Lymphocyte Forward Scatter
58477,Lymphocyte Side Fluorescence,Phenotype,Lymphocyte Side Fluorescence
58485,Cannabis Use Disorder (Mtag),Phenotype,Cannabis Use Disorder (Mtag)
58534,Alcohol Use Disorder (Mtag),Phenotype,Alcohol Use Disorder (Mtag)
58537,Allergen Component Sensitization (Mercurialis Annua 1),Phenotype,Allergen Component Sensitization (Mercurialis Annua 1)
58538,Allergen Component Sensitization (Phleum Pratense 1),Phenotype,Allergen Component Sensitization (Phleum Pratense 1)
58548,Breast Cancer Or Critical Covid-19 (Pleiotropy),Phenotype,Breast Cancer Or Critical Covid-19 (Pleiotropy)
58550,Metabolite Levels (Xanthosine; Xanthosine),Phenotype,Metabolite Levels (Xanthosine; Xanthosine)
58551,Metabolite Levels (Carotene Diol (1)),Phenotype,Metabolite Levels (Carotene Diol (1))
58553,Metabolite Levels (Carotene Diol (2)),Phenotype,Metabolite Levels (Carotene Diol (2))
58554,Metabolite Levels (Cysteinylglycine),Phenotype,Metabolite Levels (Cysteinylglycine)
58555,Metabolite Levels (Imidazole Lactate; Imidazolelactate),Phenotype,Metabolite Levels (Imidazole Lactate; Imidazolelactate)
58557,Metabolite Levels (Prolylglycine; Pro-Gly),Phenotype,Metabolite Levels (Prolylglycine; Pro-Gly)
58559,Metabolite Levels (S-Adenosylhomocysteine (Sah); ___Adenosylhomocysteine; S_Ado_Homocysteine),Phenotype,Metabolite Levels (S-Adenosylhomocysteine (Sah); ___Adenosylhomocysteine; S_Ado_Homocysteine)
58561,Metabolite Levels (Indoleacetylglutamine),Phenotype,Metabolite Levels (Indoleacetylglutamine)
58562,Metabolite Levels (Indolebutyrate),Phenotype,Metabolite Levels (Indolebutyrate)
58564,Metabolite Levels (Linoleoylcarnitine; Linoleoylcarnitine (C18:2); C18:2 Carnitine; C18_2_Carnitine),Phenotype,Metabolite Levels (Linoleoylcarnitine; Linoleoylcarnitine (C18:2); C18:2 Carnitine; C18_2_Carnitine)
58565,Metabolite Levels (3-Methylglutarylcarnitine (2)),Phenotype,Metabolite Levels (3-Methylglutarylcarnitine (2))
58566,Metabolite Levels (N-6-Trimethyllysine; N6--N6--N6-Trimethyllysine; N6.N6.N6-Trimethyllysine),Phenotype,Metabolite Levels (N-6-Trimethyllysine; N6--N6--N6-Trimethyllysine; N6.N6.N6-Trimethyllysine)
58567,Metabolite Levels (N-Acetyltryptophan),Phenotype,Metabolite Levels (N-Acetyltryptophan)
58569,Metabolite Levels (N-Palmitoyltaurine),Phenotype,Metabolite Levels (N-Palmitoyltaurine)
58573,Basophil Side Fluorescence,Phenotype,Basophil Side Fluorescence
58577,Basophil Side Fluorescence Distribution Width,Phenotype,Basophil Side Fluorescence Distribution Width
58578,Eosinophil Forward Scatter Distribution Width,Phenotype,Eosinophil Forward Scatter Distribution Width
58581,Eosinophil Side Scatter,Phenotype,Eosinophil Side Scatter
58582,Eosinophil Side Fluorescence,Phenotype,Eosinophil Side Fluorescence
58583,Eosinophil Forward Scatter,Phenotype,Eosinophil Forward Scatter
58585,Eosinophil Side Scatter Distribution Width,Phenotype,Eosinophil Side Scatter Distribution Width
58589,Corpus Callosum Fractional Anisotropy (Splenium),Phenotype,Corpus Callosum Fractional Anisotropy (Splenium)
58591,Corpus Callosum Posterior Volume,Phenotype,Corpus Callosum Posterior Volume
58593,Corpus Callosum Volume,Phenotype,Corpus Callosum Volume
58599,Metabolite Levels (Glycine),Phenotype,Metabolite Levels (Glycine)
58601,Metabolite Levels (Dihomo-Linolenate (20:3N3 Or N6); Eicosatrienoate),Phenotype,Metabolite Levels (Dihomo-Linolenate (20:3N3 Or N6); Eicosatrienoate)
58602,Metabolite Levels (Glutarylcarnitine (C5); Glutarylcarnitine (C5-Dc); C5-Dc Carnitine; C5_Dc_Carnitine),Phenotype,Metabolite Levels (Glutarylcarnitine (C5); Glutarylcarnitine (C5-Dc); C5-Dc Carnitine; C5_Dc_Carnitine)
58603,Metabolite Levels (Docosapentaenoate (N3 Dpa; 22:5N3)),Phenotype,Metabolite Levels (Docosapentaenoate (N3 Dpa; 22:5N3))
58604,Il-6 Response To Bacterial Stimulus (Fla),Phenotype,Il-6 Response To Bacterial Stimulus (Fla)
58606,Il-6 Response To Bacterial Stimulus (Lpa),Phenotype,Il-6 Response To Bacterial Stimulus (Lpa)
58765,Asthma In Any Disease,Phenotype,Asthma In Any Disease
58769,Asthma In Gastrointestinal Disease,Phenotype,Asthma In Gastrointestinal Disease
58770,Asthma In Muscoskeletal Disease,Phenotype,Asthma In Muscoskeletal Disease
58771,Asthma In Cardiovascular Disease,Phenotype,Asthma In Cardiovascular Disease
58775,Triamcinolone Acetonide-Induced Ocular Hypertension,Phenotype,Triamcinolone Acetonide-Induced Ocular Hypertension
58778,Dyslexia,Phenotype,Dyslexia
58791,Opioid Addiction (Multi-Trait Analysis),Phenotype,Opioid Addiction (Multi-Trait Analysis)
58794,General Pain Factor,Phenotype,General Pain Factor
58802,Type 2 Diabetes Or Schizophrenia (Pleiotropy),Phenotype,Type 2 Diabetes Or Schizophrenia (Pleiotropy)
58813,Hoarding Symptoms,Phenotype,Hoarding Symptoms
58816,Congenital Solitary Functioning Kidney,Phenotype,Congenital Solitary Functioning Kidney
58820,Serum Neurofilament Light Levels,Phenotype,Serum Neurofilament Light Levels
58826,Hippocampal Subfield Left Ca3 Volume (Body),Phenotype,Hippocampal Subfield Left Ca3 Volume (Body)
58828,Hippocampal Subfield Left Ca1 Volume (Head),Phenotype,Hippocampal Subfield Left Ca1 Volume (Head)
58830,Hippocampal Subfield Left Ca4 Volume (Body),Phenotype,Hippocampal Subfield Left Ca4 Volume (Body)
58832,Hippocampal Left Gc-Ml-Dg Volume (Body),Phenotype,Hippocampal Left Gc-Ml-Dg Volume (Body)
58834,Hippocampal Subfield Left Ca4 Volume (Head),Phenotype,Hippocampal Subfield Left Ca4 Volume (Head)
58838,Orbitofrontal Area (Unadjusted For Global Measures),Phenotype,Orbitofrontal Area (Unadjusted For Global Measures)
58840,Occipital Area (Unadjusted For Global Measures),Phenotype,Occipital Area (Unadjusted For Global Measures)
58844,Hippocampal Subfield Right Ca1 Volume (Head),Phenotype,Hippocampal Subfield Right Ca1 Volume (Head)
58846,Right Molecular Layer Hippocampal Volume (Head),Phenotype,Right Molecular Layer Hippocampal Volume (Head)
58848,Right Presubiculum Volume (Body),Phenotype,Right Presubiculum Volume (Body)
58850,Right Presubiculum Volume (Head),Phenotype,Right Presubiculum Volume (Head)
58853,Right Subiculum Volume (Body),Phenotype,Right Subiculum Volume (Body)
58855,Right Subiculum Volume (Head),Phenotype,Right Subiculum Volume (Head)
58865,Occipital Thickness (Unadjusted For Global Measures),Phenotype,Occipital Thickness (Unadjusted For Global Measures)
58868,Superior Parietal Thickness (Unadjusted For Global Measures),Phenotype,Superior Parietal Thickness (Unadjusted For Global Measures)
58870,Perisylvian Thickness (Unadjusted For Global Measures),Phenotype,Perisylvian Thickness (Unadjusted For Global Measures)
58871,Right Hippocampal Volume (Body),Phenotype,Right Hippocampal Volume (Body)
58904,Triacylglycerol (52:4) Levels,Phenotype,Triacylglycerol (52:4) Levels
58906,Triacylglycerol (58:8) Levels,Phenotype,Triacylglycerol (58:8) Levels
58908,Inferior Parietal Area (Unadjusted For Global Measures),Phenotype,Inferior Parietal Area (Unadjusted For Global Measures)
58913,Motor Premotor Area (Unadjusted For Global Measures),Phenotype,Motor Premotor Area (Unadjusted For Global Measures)
58918,Dorsomedial Frontal Area (Unadjusted For Global Measures),Phenotype,Dorsomedial Frontal Area (Unadjusted For Global Measures)
58919,Hippocampal Subfield Right Ca4 Volume (Head),Phenotype,Hippocampal Subfield Right Ca4 Volume (Head)
58921,Hippocampal Right Gc-Ml-Dg Volume (Body),Phenotype,Hippocampal Right Gc-Ml-Dg Volume (Body)
58923,Hippocampal Right Gc-Ml-Dg Volume (Head),Phenotype,Hippocampal Right Gc-Ml-Dg Volume (Head)
58925,Hippocampal Subfield Right Ca4 Volume (Body),Phenotype,Hippocampal Subfield Right Ca4 Volume (Body)
58928,Right Hippocampal Volume (Fissure),Phenotype,Right Hippocampal Volume (Fissure)
58929,Right Hippocampal Volume (Head),Phenotype,Right Hippocampal Volume (Head)
58931,Inferior Parietal Thickness (Unadjusted For Global Measures),Phenotype,Inferior Parietal Thickness (Unadjusted For Global Measures)
58935,Post-Traumatic Stress Disorder In Combat Exposure,Phenotype,Post-Traumatic Stress Disorder In Combat Exposure
58937,Post-Traumatic Stress Disorder Symptom Severity (Total),Phenotype,Post-Traumatic Stress Disorder Symptom Severity (Total)
58947,O-Methylcatechol Sulfate Levels,Phenotype,O-Methylcatechol Sulfate Levels
58948,Palmitoyl Dihydrosphingomyelin (D18:0/16:0) Levels,Phenotype,Palmitoyl Dihydrosphingomyelin (D18:0/16:0) Levels
58949,Palmitoyl Sphingomyelin (D18:1/16:0) Levels,Phenotype,Palmitoyl Sphingomyelin (D18:1/16:0) Levels
58950,2-Oleoylglycerol (18:1) Levels,Phenotype,2-Oleoylglycerol (18:1) Levels
58952,3-(3-Hydroxyphenyl)Propionate Sulfate Levels,Phenotype,3-(3-Hydroxyphenyl)Propionate Sulfate Levels
58953,3-(4-Hydroxyphenyl)Lactate Levels,Phenotype,3-(4-Hydroxyphenyl)Lactate Levels
58957,3--7-Dimethylurate Levels,Phenotype,3--7-Dimethylurate Levels
58958,3-Hydroxyoctanoate Levels,Phenotype,3-Hydroxyoctanoate Levels
58960,3-Indoxyl Sulfate Levels,Phenotype,3-Indoxyl Sulfate Levels
58962,3-Methyl Catechol Sulfate (1) Levels,Phenotype,3-Methyl Catechol Sulfate (1) Levels
58963,X-23297 Levels,Phenotype,X-23297 Levels
58965,Orotidine Levels,Phenotype,Orotidine Levels
58967,Oxalate (Ethanedioate) Levels,Phenotype,Oxalate (Ethanedioate) Levels
58978,Phosphatidylcholine (16:0/22:5N3-- 18:1/20:4) Levels,Phenotype,Phosphatidylcholine (16:0/22:5N3-- 18:1/20:4) Levels
58979,1-Methylnicotinamide Levels,Phenotype,1-Methylnicotinamide Levels
58980,1-Myristoyl-2-Linoleoyl-Gpc (14:0/18:2) Levels,Phenotype,1-Myristoyl-2-Linoleoyl-Gpc (14:0/18:2) Levels
58981,Pregnenolone Sulfate Levels,Phenotype,Pregnenolone Sulfate Levels
58982,Proline Levels,Phenotype,Proline Levels
58984,Pipecolate Levels,Phenotype,Pipecolate Levels
58986,Pregn Steroid Monosulfate Levels,Phenotype,Pregn Steroid Monosulfate Levels
58988,1-Oleoyl-2-Linoleoyl-Glycerol (18:1/18:2) Levels,Phenotype,1-Oleoyl-2-Linoleoyl-Glycerol (18:1/18:2) Levels
58989,Pregnanediol-3-Glucuronide Levels,Phenotype,Pregnanediol-3-Glucuronide Levels
58991,Pregnen-Diol Disulfate Levels,Phenotype,Pregnen-Diol Disulfate Levels
58992,Pyridoxate Levels,Phenotype,Pyridoxate Levels
58994,Quinate Levels,Phenotype,Quinate Levels
58997,X-11564 Levels,Phenotype,X-11564 Levels
58998,X-11593 Levels,Phenotype,X-11593 Levels
59000,X-12681 Levels,Phenotype,X-12681 Levels
59002,X-12688 Levels,Phenotype,X-12688 Levels
59004,X-12714 Levels,Phenotype,X-12714 Levels
59006,X-12715 Levels,Phenotype,X-12715 Levels
59008,X-12170 Levels,Phenotype,X-12170 Levels
59010,X-12206 Levels,Phenotype,X-12206 Levels
59014,X-12221 Levels,Phenotype,X-12221 Levels
59015,X-12231 Levels,Phenotype,X-12231 Levels
59016,X-12339 Levels,Phenotype,X-12339 Levels
59018,X-12462 Levels,Phenotype,X-12462 Levels
59019,X-12511 Levels,Phenotype,X-12511 Levels
59022,X-12007 Levels,Phenotype,X-12007 Levels
59024,X-12117 Levels,Phenotype,X-12117 Levels
59025,X-12824 Levels,Phenotype,X-12824 Levels
59026,X-11452 Levels,Phenotype,X-11452 Levels
59028,Alcohol Dependence (Allelic Genetic Model),Phenotype,Alcohol Dependence (Allelic Genetic Model)
59030,Spielberger Trait Anxiety Inventory In Alcohol Dependence (Allelic Genetic Model),Phenotype,Spielberger Trait Anxiety Inventory In Alcohol Dependence (Allelic Genetic Model)
59031,Otosclerosis,Phenotype,Otosclerosis
59045,X-23369 Levels,Phenotype,X-23369 Levels
59047,X-23593 Levels,Phenotype,X-23593 Levels
59049,X-23997 Levels,Phenotype,X-23997 Levels
59051,X-24240 Levels,Phenotype,X-24240 Levels
59052,X-24452 Levels,Phenotype,X-24452 Levels
59053,X-24542 Levels,Phenotype,X-24542 Levels
59057,X-24544 Levels,Phenotype,X-24544 Levels
59059,X-24449 Levels,Phenotype,X-24449 Levels
59060,Refractive Error (Autorefraction Measured),Phenotype,Refractive Error (Autorefraction Measured)
59062,1-Dihomo-Linoleoyl-Gpc (20:2) Levels,Phenotype,1-Dihomo-Linoleoyl-Gpc (20:2) Levels
59063,1-Linoleoyl-Gpe (18:2) Levels,Phenotype,1-Linoleoyl-Gpe (18:2) Levels
59064,1-Margaroyl-2-Linoleoyl-Gpc (17:0/18:2) Levels,Phenotype,1-Margaroyl-2-Linoleoyl-Gpc (17:0/18:2) Levels
59066,1-Methylimidazoleacetate Levels,Phenotype,1-Methylimidazoleacetate Levels
59068,1-Linolenoyl-Gpc (18:3) Levels,Phenotype,1-Linolenoyl-Gpc (18:3) Levels
59070,1-Linoleoyl-2-Arachidonoyl-Gpc (18:2/20:4N6) Levels,Phenotype,1-Linoleoyl-2-Arachidonoyl-Gpc (18:2/20:4N6) Levels
59072,1-Linoleoyl-Gpc (18:2) Levels,Phenotype,1-Linoleoyl-Gpc (18:2) Levels
59073,1-Arachidonoyl-Gpa (20:4) Levels,Phenotype,1-Arachidonoyl-Gpa (20:4) Levels
59075,1-Arachidonoyl-Gpc (20:4N6) Levels,Phenotype,1-Arachidonoyl-Gpc (20:4N6) Levels
59076,1-Docosapentaenoyl-Gpc (22:5N3) Levels,Phenotype,1-Docosapentaenoyl-Gpc (22:5N3) Levels
59077,1-Docosapentaenoyl-Gpc (22:5N6) Levels,Phenotype,1-Docosapentaenoyl-Gpc (22:5N6) Levels
59079,1-Eicosapentaenoyl-Gpc (20:5) Levels,Phenotype,1-Eicosapentaenoyl-Gpc (20:5) Levels
59081,1-Eicosapentaenoyl-Gpe (20:5) Levels,Phenotype,1-Eicosapentaenoyl-Gpe (20:5) Levels
59083,1--5-Anhydroglucitol (1--5-Ag) Levels,Phenotype,1--5-Anhydroglucitol (1--5-Ag) Levels
59088,X-16071 Levels,Phenotype,X-16071 Levels
59090,X-16570 Levels,Phenotype,X-16570 Levels
59092,X-16649 Levels,Phenotype,X-16649 Levels
59095,X-14056 Levels,Phenotype,X-14056 Levels
59097,X-16944 Levels,Phenotype,X-16944 Levels
59098,X-17337 Levels,Phenotype,X-17337 Levels
59100,X-12846 Levels,Phenotype,X-12846 Levels
59102,X-13431 Levels,Phenotype,X-13431 Levels
59103,X-14939 Levels,Phenotype,X-14939 Levels
59104,X-15503 Levels,Phenotype,X-15503 Levels
59107,X-17677 Levels,Phenotype,X-17677 Levels
59108,X-18922 Levels,Phenotype,X-18922 Levels
59111,X-21258 Levels,Phenotype,X-21258 Levels
59112,X-21286 Levels,Phenotype,X-21286 Levels
59113,X-21312 Levels,Phenotype,X-21312 Levels
59114,X-21339 Levels,Phenotype,X-21339 Levels
59115,X-21343 Levels,Phenotype,X-21343 Levels
59120,X-21365 Levels,Phenotype,X-21365 Levels
59123,X-21467 Levels,Phenotype,X-21467 Levels
59125,X-21411 Levels,Phenotype,X-21411 Levels
59127,X-21441 Levels,Phenotype,X-21441 Levels
59129,Basal Cell Carcinoma (Mtag),Phenotype,Basal Cell Carcinoma (Mtag)
59133,Squamous Cell Carcinoma (Mtag),Phenotype,Squamous Cell Carcinoma (Mtag)
59135,Hiatus Hernia,Phenotype,Hiatus Hernia
59137,Hernia (Two Or More Subtypes),Phenotype,Hernia (Two Or More Subtypes)
59138,Back Pain,Phenotype,Back Pain
59140,Hernia (Any Subtypes),Phenotype,Hernia (Any Subtypes)
59141,Hernia,Phenotype,Hernia
59159,Dietary Approaches To Stop Hypertension (Dash) Diet,Phenotype,Dietary Approaches To Stop Hypertension (Dash) Diet
59173,Anteromedial Temporal Area (Unadjusted For Global Measures),Phenotype,Anteromedial Temporal Area (Unadjusted For Global Measures)
59174,Dorsolateral Prefrontal Area (Unadjusted For Global Measures),Phenotype,Dorsolateral Prefrontal Area (Unadjusted For Global Measures)
59176,Hippocampal Left Gc-Ml-Dg Volume (Head),Phenotype,Hippocampal Left Gc-Ml-Dg Volume (Head)
59178,Left Hippocampal Volume (Body),Phenotype,Left Hippocampal Volume (Body)
59179,Left Hippocampal Volume (Tail),Phenotype,Left Hippocampal Volume (Tail)
59182,Left Hippocampal Volume (Head),Phenotype,Left Hippocampal Volume (Head)
59185,Posterolateral Temporal Area (Unadjusted For Global Measures),Phenotype,Posterolateral Temporal Area (Unadjusted For Global Measures)
59188,Parsopercularis Area (Unadjusted For Global Measures),Phenotype,Parsopercularis Area (Unadjusted For Global Measures)
59189,Superior Temporal Area (Unadjusted For Global Measures),Phenotype,Superior Temporal Area (Unadjusted For Global Measures)
59192,Superior Parietal Area (Unadjusted For Global Measures),Phenotype,Superior Parietal Area (Unadjusted For Global Measures)
59193,Dorsolateral Prefrontal Thickness (Unadjusted For Global Measures),Phenotype,Dorsolateral Prefrontal Thickness (Unadjusted For Global Measures)
59195,Primary Aldosteronism,Phenotype,Primary Aldosteronism
59197,Ventromedial Occipital Thickness (Unadjusted For Global Measures),Phenotype,Ventromedial Occipital Thickness (Unadjusted For Global Measures)
59198,Temporal Pole Thickness (Unadjusted For Global Measures),Phenotype,Temporal Pole Thickness (Unadjusted For Global Measures)
59201,Ventral Frontal Thickness (Unadjusted For Global Measures),Phenotype,Ventral Frontal Thickness (Unadjusted For Global Measures)
59203,Vasculitis (Pleiotropy),Phenotype,Vasculitis (Pleiotropy)
59208,Phosphatidylinositol (16:0_18:1) Levels,Phenotype,Phosphatidylinositol (16:0_18:1) Levels
59243,Developmental Dysplasia Of The Hip,Phenotype,Developmental Dysplasia Of The Hip
59245,Left Subiculum Volume (Body),Phenotype,Left Subiculum Volume (Body)
59246,Left Subiculum Volume (Head),Phenotype,Left Subiculum Volume (Head)
59247,Precuneus Area (Unadjusted For Global Measures),Phenotype,Precuneus Area (Unadjusted For Global Measures)
59250,Left Molecular Layer Hippocampal Volume (Head),Phenotype,Left Molecular Layer Hippocampal Volume (Head)
59251,Left Parasubiculum Volume,Phenotype,Left Parasubiculum Volume
59254,Left Presubiculum Volume (Body),Phenotype,Left Presubiculum Volume (Body)
59256,Left Presubiculum Volume (Head),Phenotype,Left Presubiculum Volume (Head)
59260,Right Hippocampal Volume,Phenotype,Right Hippocampal Volume
59261,Right Hippocampal Volume (Tail),Phenotype,Right Hippocampal Volume (Tail)
59262,Medial Prefrontal Thickness (Unadjusted For Global Measures),Phenotype,Medial Prefrontal Thickness (Unadjusted For Global Measures)
59265,Middle Temporal Thickness (Unadjusted For Global Measures),Phenotype,Middle Temporal Thickness (Unadjusted For Global Measures)
59266,Motor Premotor Thickness (Unadjusted For Global Measures),Phenotype,Motor Premotor Thickness (Unadjusted For Global Measures)
59268,Right Molecular Layer Hippocampal Volume (Body),Phenotype,Right Molecular Layer Hippocampal Volume (Body)
59270,Cognitive Performance (Memory) (Longitudinal),Phenotype,Cognitive Performance (Memory) (Longitudinal)
59273,Cognitive Performance (Language) (Longitudinal),Phenotype,Cognitive Performance (Language) (Longitudinal)
59279,Cognitive Performance (Visuospatial Function) (Longitudinal),Phenotype,Cognitive Performance (Visuospatial Function) (Longitudinal)
59281,Post-Traumatic Stress Disorder Symptom Severity (Avoidance),Phenotype,Post-Traumatic Stress Disorder Symptom Severity (Avoidance)
59287,Genetically Independent Pain Phenotypes (Gip2),Phenotype,Genetically Independent Pain Phenotypes (Gip2)
59298,Tuberculosis X Mycobacterium Tuberculosis Lineage Interaction,Phenotype,Tuberculosis X Mycobacterium Tuberculosis Lineage Interaction
59300,Tuberculosis (Main Host Cluster) X Mycobacterium Tuberculosis Lineage Interaction,Phenotype,Tuberculosis (Main Host Cluster) X Mycobacterium Tuberculosis Lineage Interaction
59301,Diffuse Idiopathic Skeletal Hyperostosis Flow Score,Phenotype,Diffuse Idiopathic Skeletal Hyperostosis Flow Score
59308,Endometriosis (Stage 3 Or 4),Phenotype,Endometriosis (Stage 3 Or 4)
59309,Endometriosis (Mtag),Phenotype,Endometriosis (Mtag)
59331,Preterm Delivery,Phenotype,Preterm Delivery
59333,Nonalcoholic Fatty Liver Disease In Lean Individuals (Bmi <25),Phenotype,Nonalcoholic Fatty Liver Disease In Lean Individuals (Bmi <25)
59338,Docosanoid Osbond Acid-- All-Cis-4--7--10--13--16-Dpa-- Ffa Docosapentaenoic Acid Levels,Phenotype,Docosanoid Osbond Acid-- All-Cis-4--7--10--13--16-Dpa-- Ffa Docosapentaenoic Acid Levels
59339,Docosanoid 14S-Hdha-- Docosanoid 17R-Hdha Levels,Phenotype,Docosanoid 14S-Hdha-- Docosanoid 17R-Hdha Levels
59341,Eicosanoid 13-Hpode-- Eicosanoid 9-Hpode B Levels,Phenotype,Eicosanoid 13-Hpode-- Eicosanoid 9-Hpode B Levels
59343,Ffa Adrenic Acid A Levels,Phenotype,Ffa Adrenic Acid A Levels
59345,Ffa Docosahexaenoic Acid Levels,Phenotype,Ffa Docosahexaenoic Acid Levels
59346,Ffa Eicosapentaenoic Acid C Levels,Phenotype,Ffa Eicosapentaenoic Acid C Levels
59348,Sarcopenia In Chronic Obstructive Pulmonary Disease (Fat-Free Mass Index Defined),Phenotype,Sarcopenia In Chronic Obstructive Pulmonary Disease (Fat-Free Mass Index Defined)
59349,Fat-Free Mass Index In Chronic Obstructive Pulmonary Disease,Phenotype,Fat-Free Mass Index In Chronic Obstructive Pulmonary Disease
59350,Appendicular Skeletal Muscle Index In Chronic Obstructive Pulmonary Disease,Phenotype,Appendicular Skeletal Muscle Index In Chronic Obstructive Pulmonary Disease
59351,Hand Grip Strength In Chronic Obstructive Pulmonary Disease,Phenotype,Hand Grip Strength In Chronic Obstructive Pulmonary Disease
59353,Basal Metabolic Rate In Chronic Obstructive Pulmonary Disease,Phenotype,Basal Metabolic Rate In Chronic Obstructive Pulmonary Disease
59376,Body Mass Index Or Knee Osteoarthritis (Pleiotropy),Phenotype,Body Mass Index Or Knee Osteoarthritis (Pleiotropy)
59380,Body Mass Index Or Osteoarthritis (Pleiotropy),Phenotype,Body Mass Index Or Osteoarthritis (Pleiotropy)
59385,Body Mass Index Or Hip Osteoarthritis (Pleiotropy),Phenotype,Body Mass Index Or Hip Osteoarthritis (Pleiotropy)
59391,Lung Disease Severity In Cystic Fibrosis With Pancreatic Insufficiency,Phenotype,Lung Disease Severity In Cystic Fibrosis With Pancreatic Insufficiency
59400,Problematic Tobacco Use,Phenotype,Problematic Tobacco Use
59403,Substance Use Disorder (Pleiotropy),Phenotype,Substance Use Disorder (Pleiotropy)
59405,Addiction Risk Factors,Phenotype,Addiction Risk Factors
59447,Erosive Hand Osteoarthritis,Phenotype,Erosive Hand Osteoarthritis
59449,Cerebrospinal Fluid Amyloid Beta 42 Levels (12 Month Visit),Phenotype,Cerebrospinal Fluid Amyloid Beta 42 Levels (12 Month Visit)
59451,Amyloid (Pet Imaging) (24 Month Visit),Phenotype,Amyloid (Pet Imaging) (24 Month Visit)
59452,Cerebrospinal Fluid P-Tau Levels (24 Month Visit),Phenotype,Cerebrospinal Fluid P-Tau Levels (24 Month Visit)
59454,Functional Activities Questionnaire (Baseline),Phenotype,Functional Activities Questionnaire (Baseline)
59606,Butyrophilin-Like Protein 9 Levels,Phenotype,Butyrophilin-Like Protein 9 Levels
59608,S-Methylmethionine--Homocysteine S-Methyltransferase Bhmt2 Levels,Phenotype,S-Methylmethionine--Homocysteine S-Methyltransferase Bhmt2 Levels
59609,Baculoviral Iap Repeat-Containing Protein 5 Levels,Phenotype,Baculoviral Iap Repeat-Containing Protein 5 Levels
59610,Bone Morphogenetic Protein 3 Levels,Phenotype,Bone Morphogenetic Protein 3 Levels
59611,Bone Morphogenetic Protein 7 Levels,Phenotype,Bone Morphogenetic Protein 7 Levels
59612,Rbc Levels Of D-Rhamnose,Phenotype,Rbc Levels Of D-Rhamnose
59615,Rbc Levels Of L-Carnitine.1,Phenotype,Rbc Levels Of L-Carnitine.1
59616,Rbc Levels Of Lpc18:2,Phenotype,Rbc Levels Of Lpc18:2
59618,Rbc Levels Of Fumarate,Phenotype,Rbc Levels Of Fumarate
59620,Rbc Levels Of L-Carnitine,Phenotype,Rbc Levels Of L-Carnitine
59621,Rbc Levels Of Diphosphate,Phenotype,Rbc Levels Of Diphosphate
59623,Rbc Levels Of Dopamine,Phenotype,Rbc Levels Of Dopamine
59627,Rbc Levels Of Pyruvate (Um),Phenotype,Rbc Levels Of Pyruvate (Um)
59633,Dna-Directed Rna Polymerases I And Iii Subunit Rpac1 Levels,Phenotype,Dna-Directed Rna Polymerases I And Iii Subunit Rpac1 Levels
59634,Dna-Directed Rna Polymerase Iii Subunit Rpc9 Levels,Phenotype,Dna-Directed Rna Polymerase Iii Subunit Rpc9 Levels
59635,Rap Guanine Nucleotide Exchange Factor 5 Levels,Phenotype,Rap Guanine Nucleotide Exchange Factor 5 Levels
59640,Spatial Qrs-T Angle,Phenotype,Spatial Qrs-T Angle
59644,Kallikrein-6 Levels,Phenotype,Kallikrein-6 Levels
59646,Junctophilin-4 Levels,Phenotype,Junctophilin-4 Levels
59648,Killer Cell Immunoglobulin-Like Receptor 2Dl1 Levels,Phenotype,Killer Cell Immunoglobulin-Like Receptor 2Dl1 Levels
59649,Killer Cell Immunoglobulin-Like Receptor 2Dl2 Levels,Phenotype,Killer Cell Immunoglobulin-Like Receptor 2Dl2 Levels
59651,Integral Membrane Protein 2B Levels,Phenotype,Integral Membrane Protein 2B Levels
59652,Inactive Tyrosine-Protein Kinase 7 Levels,Phenotype,Inactive Tyrosine-Protein Kinase 7 Levels
59654,Adenylate Kinase 4-- Mitochondrial Levels,Phenotype,Adenylate Kinase 4-- Mitochondrial Levels
59655,Kallikrein-12 Levels,Phenotype,Kallikrein-12 Levels
59656,Frontal Qrs-T Angle,Phenotype,Frontal Qrs-T Angle
59663,Leucine-Rich Repeat-Containing Protein 74A Levels,Phenotype,Leucine-Rich Repeat-Containing Protein 74A Levels
59664,Leucine-Rich Repeat And Fibronectin Type Iii Domain-Containing Protein 1 Levels,Phenotype,Leucine-Rich Repeat And Fibronectin Type Iii Domain-Containing Protein 1 Levels
59665,Leucine-Rich Repeat-Containing Protein 25 Levels,Phenotype,Leucine-Rich Repeat-Containing Protein 25 Levels
59666,Leucine-Rich Repeat And Transmembrane Domain-Containing Protein 2 Levels,Phenotype,Leucine-Rich Repeat And Transmembrane Domain-Containing Protein 2 Levels
59667,Cadherin-11 Levels,Phenotype,Cadherin-11 Levels
59668,Cadherin-17 Levels,Phenotype,Cadherin-17 Levels
59683,Cytochrome C Oxidase Subunit 4 Isoform 2-- Mitochondrial Levels,Phenotype,Cytochrome C Oxidase Subunit 4 Isoform 2-- Mitochondrial Levels
59684,Collectin-10 Levels,Phenotype,Collectin-10 Levels
59689,Coagulation Factor Xa Levels,Phenotype,Coagulation Factor Xa Levels
59696,Glutathione S-Transferase A1 Levels,Phenotype,Glutathione S-Transferase A1 Levels
59697,Glutathione S-Transferase A4 Levels,Phenotype,Glutathione S-Transferase A4 Levels
59698,General Transcription Factor Ii-I Levels,Phenotype,General Transcription Factor Ii-I Levels
59700,Glycine N-Methyltransferase Levels,Phenotype,Glycine N-Methyltransferase Levels
59702,Gmp Reductase 2 Levels,Phenotype,Gmp Reductase 2 Levels
59705,Bpi Fold-Containing Family B Member 1 Levels,Phenotype,Bpi Fold-Containing Family B Member 1 Levels
59707,Growth Factor Receptor-Bound Protein 7 Levels,Phenotype,Growth Factor Receptor-Bound Protein 7 Levels
59708,Glutamate Receptor 4 Levels,Phenotype,Glutamate Receptor 4 Levels
59711,Granzyme B Levels,Phenotype,Granzyme B Levels
59713,Granzyme K Levels,Phenotype,Granzyme K Levels
59714,Scavenger Receptor Class A Member 3 Levels,Phenotype,Scavenger Receptor Class A Member 3 Levels
59715,Small Conductance Calcium-Activated Potassium Channel Protein 1 Levels,Phenotype,Small Conductance Calcium-Activated Potassium Channel Protein 1 Levels
59716,Secretogranin-1 Levels,Phenotype,Secretogranin-1 Levels
59718,Dna-Binding Protein Satb2 Levels,Phenotype,Dna-Binding Protein Satb2 Levels
59719,Soluble Calcium-Activated Nucleotidase 1 Levels,Phenotype,Soluble Calcium-Activated Nucleotidase 1 Levels
59720,Sperm Acrosome Membrane-Associated Protein 3 Levels,Phenotype,Sperm Acrosome Membrane-Associated Protein 3 Levels
59722,Interleukin-20 Receptor Subunit Alpha Levels,Phenotype,Interleukin-20 Receptor Subunit Alpha Levels
59723,Interleukin-20 Receptor Subunit Beta Levels,Phenotype,Interleukin-20 Receptor Subunit Beta Levels
59726,Interleukin-23 Levels,Phenotype,Interleukin-23 Levels
59727,Interleukin-36 Receptor Antagonist Protein Levels,Phenotype,Interleukin-36 Receptor Antagonist Protein Levels
59728,Interleukin-37 Levels,Phenotype,Interleukin-37 Levels
59729,Interleukin-5 Receptor Subunit Alpha Levels,Phenotype,Interleukin-5 Receptor Subunit Alpha Levels
59730,Vasomotor Rhinitis Or Allergic Rhinitis (Mtag),Phenotype,Vasomotor Rhinitis Or Allergic Rhinitis (Mtag)
59731,Chronic Rhinosinusitis (Mtag),Phenotype,Chronic Rhinosinusitis (Mtag)
59733,Nasal Polyposis (Mtag),Phenotype,Nasal Polyposis (Mtag)
59734,Nasal Septal Deviation (Mtag),Phenotype,Nasal Septal Deviation (Mtag)
59735,Chronic Inflammatory Sinonasal Disease,Phenotype,Chronic Inflammatory Sinonasal Disease
59737,Icd10 K04: Diseases Of Pulp And Periapical Tissues,Phenotype,Icd10 K04: Diseases Of Pulp And Periapical Tissues
59741,Swi/Snf Complex Subunit Smarcc1 Levels,Phenotype,Swi/Snf Complex Subunit Smarcc1 Levels
59750,Cd9 Antigen Levels,Phenotype,Cd9 Antigen Levels
59751,Cadherin-Related Family Member 5 Levels,Phenotype,Cadherin-Related Family Member 5 Levels
59752,Leukocyte Antigen Cd37 Levels,Phenotype,Leukocyte Antigen Cd37 Levels
59753,Cyclin-Dependent Kinase 4 Inhibitor C Levels,Phenotype,Cyclin-Dependent Kinase 4 Inhibitor C Levels
59758,C-C Motif Chemokine 28 Levels,Phenotype,C-C Motif Chemokine 28 Levels
59759,C-C Motif Chemokine 3-Like 1 Levels,Phenotype,C-C Motif Chemokine 3-Like 1 Levels
59760,Cd166 Antigen Levels,Phenotype,Cd166 Antigen Levels
59764,C-C Motif Chemokine 24 Levels,Phenotype,C-C Motif Chemokine 24 Levels
59765,Cervical Dysplasia,Phenotype,Cervical Dysplasia
59769,Potassium Voltage-Gated Channel Subfamily F Member 1 Levels,Phenotype,Potassium Voltage-Gated Channel Subfamily F Member 1 Levels
59770,Potassium Voltage-Gated Channel Subfamily G Member 4 Levels,Phenotype,Potassium Voltage-Gated Channel Subfamily G Member 4 Levels
59771,Ras-Related Protein Rab-35 Levels,Phenotype,Ras-Related Protein Rab-35 Levels
59772,Rab9 Effector Protein With Kelch Motifs Levels,Phenotype,Rab9 Effector Protein With Kelch Motifs Levels
59773,Rrna 2-O-Methyltransferase Fibrillarin Levels,Phenotype,Rrna 2-O-Methyltransferase Fibrillarin Levels
59774,Reticulon-4-Interacting Protein 1-- Mitochondrial Levels,Phenotype,Reticulon-4-Interacting Protein 1-- Mitochondrial Levels
59776,Protein Pet117 Homolog-- Mitochondrial Levels,Phenotype,Protein Pet117 Homolog-- Mitochondrial Levels
59778,Ras-Related Protein Rab-17 Levels,Phenotype,Ras-Related Protein Rab-17 Levels
59779,Ras-Related Protein Rab-26 Levels,Phenotype,Ras-Related Protein Rab-26 Levels
59781,Polycomb Protein Scmh1 Levels,Phenotype,Polycomb Protein Scmh1 Levels
59782,Sodium-Coupled Monocarboxylate Transporter 1 Levels,Phenotype,Sodium-Coupled Monocarboxylate Transporter 1 Levels
59783,Secreted And Transmembrane Protein 1 Levels,Phenotype,Secreted And Transmembrane Protein 1 Levels
59785,Stromal Cell-Derived Factor 2 Levels,Phenotype,Stromal Cell-Derived Factor 2 Levels
59786,Protein Sel-1 Homolog 2 Levels,Phenotype,Protein Sel-1 Homolog 2 Levels
59787,Advanced Metachronous Adenoma,Phenotype,Advanced Metachronous Adenoma
59792,Multiple Metachronous Adenoma,Phenotype,Multiple Metachronous Adenoma
59793,Sarcalumenin Levels,Phenotype,Sarcalumenin Levels
59795,Icd10 K05.30-31: Chronic Periodontitis,Phenotype,Icd10 K05.30-31: Chronic Periodontitis
59797,Spindlin-1 Levels,Phenotype,Spindlin-1 Levels
59798,Serine Protease Inhibitor Kazal-Type 14 Levels,Phenotype,Serine Protease Inhibitor Kazal-Type 14 Levels
59799,Sparc-Like Protein 1 Levels,Phenotype,Sparc-Like Protein 1 Levels
59800,Sodium/Potassium-Transporting Atpase Subunit Beta-1 Levels,Phenotype,Sodium/Potassium-Transporting Atpase Subunit Beta-1 Levels
59808,Spermatogenesis-Associated Protein 9 Levels,Phenotype,Spermatogenesis-Associated Protein 9 Levels
59810,Sorting Nexin-7 Levels,Phenotype,Sorting Nexin-7 Levels
59811,Sam Pointed Domain-Containing Ets Transcription Factor Levels,Phenotype,Sam Pointed Domain-Containing Ets Transcription Factor Levels
59813,Serine Protease 57 Levels,Phenotype,Serine Protease 57 Levels
59817,Low Affinity Immunoglobulin Epsilon Fc Receptor Levels,Phenotype,Low Affinity Immunoglobulin Epsilon Fc Receptor Levels
59819,Leukocyte-Associated Immunoglobulin-Like Receptor 1 Levels,Phenotype,Leukocyte-Associated Immunoglobulin-Like Receptor 1 Levels
59823,Layilin Levels,Phenotype,Layilin Levels
59824,Kv Channel-Interacting Protein 1 Levels,Phenotype,Kv Channel-Interacting Protein 1 Levels
59825,Left-Right Determination Factor 2 Levels,Phenotype,Left-Right Determination Factor 2 Levels
59827,Sulfotransferase 1A3 Levels,Phenotype,Sulfotransferase 1A3 Levels
59831,Sulfotransferase Family Cytosolic 2B Member 1 Levels,Phenotype,Sulfotransferase Family Cytosolic 2B Member 1 Levels
59832,Signal Transducer And Activator Of Transcription 5B Levels,Phenotype,Signal Transducer And Activator Of Transcription 5B Levels
59833,Stabilin-2 Levels,Phenotype,Stabilin-2 Levels
59843,Microtubule-Associated Proteins 1A/1B Light Chain 3B Levels,Phenotype,Microtubule-Associated Proteins 1A/1B Light Chain 3B Levels
59845,O-Acetyl-Adp-Ribose Deacetylase Macrod1 Levels,Phenotype,O-Acetyl-Adp-Ribose Deacetylase Macrod1 Levels
59846,Macrophage-Stimulating Protein Receptor Levels,Phenotype,Macrophage-Stimulating Protein Receptor Levels
59847,Endothelial Differentiation-Related Factor 1 Levels,Phenotype,Endothelial Differentiation-Related Factor 1 Levels
59848,Lymphokine-Activated Killer T-Cell-Originated Protein Kinase Levels,Phenotype,Lymphokine-Activated Killer T-Cell-Originated Protein Kinase Levels
59849,Isoform L-Vegf165 Levels,Phenotype,Isoform L-Vegf165 Levels
59850,Radiation-Inducible Immediate-Early Gene Iex-1 Levels,Phenotype,Radiation-Inducible Immediate-Early Gene Iex-1 Levels
59854,Heparan-Sulfate 6-O-Sulfotransferase 1 Levels,Phenotype,Heparan-Sulfate 6-O-Sulfotransferase 1 Levels
59855,Regulator Of G-Protein Signaling 19 Levels,Phenotype,Regulator Of G-Protein Signaling 19 Levels
59856,Regulator Of G-Protein Signaling 8 Levels,Phenotype,Regulator Of G-Protein Signaling 8 Levels
59857,Rhophilin-2 Levels,Phenotype,Rhophilin-2 Levels
59858,Hephaestin-Like Protein 1 Levels,Phenotype,Hephaestin-Like Protein 1 Levels
59859,Hexokinase-3 Levels,Phenotype,Hexokinase-3 Levels
59861,Sialate O-Acetylesterase Levels,Phenotype,Sialate O-Acetylesterase Levels
59863,Sh3 And Multiple Ankyrin Repeat Domains Protein 3 Levels,Phenotype,Sh3 And Multiple Ankyrin Repeat Domains Protein 3 Levels
59864,Methotrexate-Induced Liver Injury In Rheumatoid Arthritis,Phenotype,Methotrexate-Induced Liver Injury In Rheumatoid Arthritis
59866,C-C Motif Chemokine 1 Levels,Phenotype,C-C Motif Chemokine 1 Levels
59868,Chromobox Protein Homolog 5 Levels,Phenotype,Chromobox Protein Homolog 5 Levels
59869,Cytochrome B-C1 Complex Subunit 7 Levels,Phenotype,Cytochrome B-C1 Complex Subunit 7 Levels
59870,Cerebellin-1 Levels,Phenotype,Cerebellin-1 Levels
59875,Carboxypeptidase E Levels,Phenotype,Carboxypeptidase E Levels
59876,Carboxypeptidase M Levels,Phenotype,Carboxypeptidase M Levels
59877,17-Beta-Hydroxysteroid Dehydrogenase 14 Levels,Phenotype,17-Beta-Hydroxysteroid Dehydrogenase 14 Levels
59878,Atp-Dependent Rna Helicase Dhx8 Levels,Phenotype,Atp-Dependent Rna Helicase Dhx8 Levels
59879,Disks Large Homolog 3 Levels,Phenotype,Disks Large Homolog 3 Levels
59880,Delta-Like Protein 1 Levels,Phenotype,Delta-Like Protein 1 Levels
59882,Desmin Levels,Phenotype,Desmin Levels
59883,Desmoglein-1 Levels,Phenotype,Desmoglein-1 Levels
59884,Desmoglein-2 Levels,Phenotype,Desmoglein-2 Levels
59885,Differentially Expressed In Fdcp 6 Homolog Levels,Phenotype,Differentially Expressed In Fdcp 6 Homolog Levels
59887,Alzheimer Disease (Mtag),Phenotype,Alzheimer Disease (Mtag)
59896,Complement C3D Fragment Levels,Phenotype,Complement C3D Fragment Levels
59899,Complement Component C8 Levels,Phenotype,Complement Component C8 Levels
59900,Glutaredoxin-Like Protein C5Orf63 Levels,Phenotype,Glutaredoxin-Like Protein C5Orf63 Levels
59901,Rbc Levels Of Sphingosine 1-Phosphate,Phenotype,Rbc Levels Of Sphingosine 1-Phosphate
59904,Rbc Levels Of Threonine,Phenotype,Rbc Levels Of Threonine
59906,Rbc Levels Of Urate (Um),Phenotype,Rbc Levels Of Urate (Um)
59908,Rbc Levels Of Lps20:4,Phenotype,Rbc Levels Of Lps20:4
59909,Rbc Levels Of S-Adenosyl-L-Homocysteine,Phenotype,Rbc Levels Of S-Adenosyl-L-Homocysteine
59915,Relative Index Of Whole Blood Hyposectomy,Phenotype,Relative Index Of Whole Blood Hyposectomy
59923,Whole Blood Low Cut Reduction Viscosity,Phenotype,Whole Blood Low Cut Reduction Viscosity
59925,Plasma Viscosity,Phenotype,Plasma Viscosity
59927,Pharyngeal Disease,Phenotype,Pharyngeal Disease
59928,Sinonasal Disease,Phenotype,Sinonasal Disease
59930,3-Ketodihydrosphingosine Reductase Levels,Phenotype,3-Ketodihydrosphingosine Reductase Levels
59931,Keratin-- Type Ii Cytoskeletal 7 Levels,Phenotype,Keratin-- Type Ii Cytoskeletal 7 Levels
59937,Calcineurin Subunit B Type 2 Levels,Phenotype,Calcineurin Subunit B Type 2 Levels
59938,Calcium/Calmodulin-Dependent Protein Kinase Type 1D Levels,Phenotype,Calcium/Calmodulin-Dependent Protein Kinase Type 1D Levels
59939,Caspase-8 Levels,Phenotype,Caspase-8 Levels
59940,Catenin Beta-1 Levels,Phenotype,Catenin Beta-1 Levels
59945,Cullin-9 Levels,Phenotype,Cullin-9 Levels
59946,Cytochrome C Oxidase Subunit 7A1-- Mitochondrial Levels,Phenotype,Cytochrome C Oxidase Subunit 7A1-- Mitochondrial Levels
59948,C-X-C Motif Chemokine 10 Levels,Phenotype,C-X-C Motif Chemokine 10 Levels
59949,Cysteine And Glycine-Rich Protein 2 Levels,Phenotype,Cysteine And Glycine-Rich Protein 2 Levels
59951,D-Dopachrome Decarboxylase Levels,Phenotype,D-Dopachrome Decarboxylase Levels
59953,Atp-Dependent Rna Helicase Ddx19A Levels,Phenotype,Atp-Dependent Rna Helicase Ddx19A Levels
59954,Atp-Dependent Rna Helicase Ddx19B Levels,Phenotype,Atp-Dependent Rna Helicase Ddx19B Levels
59955,Probable Atp-Dependent Rna Helicase Ddx46 Levels,Phenotype,Probable Atp-Dependent Rna Helicase Ddx46 Levels
59956,C-X-C Motif Chemokine 17 Levels,Phenotype,C-X-C Motif Chemokine 17 Levels
59957,C-X-C Motif Chemokine 5 Levels,Phenotype,C-X-C Motif Chemokine 5 Levels
59958,Cystatin-8 Levels,Phenotype,Cystatin-8 Levels
59967,Cellular Retinoic Acid-Binding Protein 1 Levels,Phenotype,Cellular Retinoic Acid-Binding Protein 1 Levels
59968,Dna Repair Protein Rad51 Homolog 1 Levels,Phenotype,Dna Repair Protein Rad51 Homolog 1 Levels
59970,Ribosome Biogenesis Protein Tsr3 Homolog Levels,Phenotype,Ribosome Biogenesis Protein Tsr3 Homolog Levels
59971,Rac-Beta Serine/Threonine-Protein Kinase Levels,Phenotype,Rac-Beta Serine/Threonine-Protein Kinase Levels
59973,2-Deoxynucleoside 5-Phosphate N-Hydrolase 1 Levels,Phenotype,2-Deoxynucleoside 5-Phosphate N-Hydrolase 1 Levels
59975,Ribonucleoside-Diphosphate Reductase Subunit M2 Levels,Phenotype,Ribonucleoside-Diphosphate Reductase Subunit M2 Levels
59977,Retinoic Acid Early Transcript 1G Protein Levels,Phenotype,Retinoic Acid Early Transcript 1G Protein Levels
59978,Retinoblastoma-Associated Protein Levels,Phenotype,Retinoblastoma-Associated Protein Levels
59979,High Affinity Immunoglobulin Epsilon Receptor Subunit Alpha Levels,Phenotype,High Affinity Immunoglobulin Epsilon Receptor Subunit Alpha Levels
59981,Regenerating Islet-Derived Protein 3-Alpha Levels,Phenotype,Regenerating Islet-Derived Protein 3-Alpha Levels
59983,Ras-Related Protein Rab-27B Levels,Phenotype,Ras-Related Protein Rab-27B Levels
59985,Rna-Binding Protein 24 Levels,Phenotype,Rna-Binding Protein 24 Levels
59986,Surgical Knee Osteoarthritis,Phenotype,Surgical Knee Osteoarthritis
59989,Non-Surgical Knee Osteoarthritis,Phenotype,Non-Surgical Knee Osteoarthritis
59990,Serotransferrin Levels,Phenotype,Serotransferrin Levels
59991,Protein Set Levels,Phenotype,Protein Set Levels
59994,Surgical Hip Osteoarthritis,Phenotype,Surgical Hip Osteoarthritis
59996,Sperm-Associated Antigen 11B Levels,Phenotype,Sperm-Associated Antigen 11B Levels
59997,Sh3 Domain-Binding Glutamic Acid-Rich-Like Protein 2 Levels,Phenotype,Sh3 Domain-Binding Glutamic Acid-Rich-Like Protein 2 Levels
59998,Secreted Frizzled-Related Protein 3 Levels,Phenotype,Secreted Frizzled-Related Protein 3 Levels
59999,Non-Surgical Hip Osteoarthritis,Phenotype,Non-Surgical Hip Osteoarthritis
60000,Liver Carboxylesterase 1 Levels,Phenotype,Liver Carboxylesterase 1 Levels
60001,Leukotriene B4 Receptor 1 Levels,Phenotype,Leukotriene B4 Receptor 1 Levels
60009,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2 Levels,Phenotype,Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 2 Levels
60021,Complement Receptor Type 2 Levels,Phenotype,Complement Receptor Type 2 Levels
60026,Cysteine-Rich Pdz-Binding Protein Levels,Phenotype,Cysteine-Rich Pdz-Binding Protein Levels
60031,Age At Adiposity Rebound X Sex Interaction,Phenotype,Age At Adiposity Rebound X Sex Interaction
60033,Bmi At Adiposity Rebound X Sex Interaction,Phenotype,Bmi At Adiposity Rebound X Sex Interaction
60035,Bmi At 1.5 -2.5 Years Old Interval,Phenotype,Bmi At 1.5 -2.5 Years Old Interval
60039,Apnea Hypopnea Index,Phenotype,Apnea Hypopnea Index
60041,Apnea Hypopnea Index During Non-Rem Sleep,Phenotype,Apnea Hypopnea Index During Non-Rem Sleep
60042,Obstructive Sleep Apnea Trait (Percentage Of Blood Oxygen Below 90% Of Total Sleep Time),Phenotype,Obstructive Sleep Apnea Trait (Percentage Of Blood Oxygen Below 90% Of Total Sleep Time)
60043,Obstructive Sleep Apnea Trait (Oxygen Desaturation Index),Phenotype,Obstructive Sleep Apnea Trait (Oxygen Desaturation Index)
60044,Obstructive Sleep Apnea Trait (Percentage Of Wake Time During Sleep Period Time),Phenotype,Obstructive Sleep Apnea Trait (Percentage Of Wake Time During Sleep Period Time)
60052,Heterogeneous Nuclear Ribonucleoprotein Q Levels,Phenotype,Heterogeneous Nuclear Ribonucleoprotein Q Levels
60053,Glycoprotein Hormone Alpha-2 Levels,Phenotype,Glycoprotein Hormone Alpha-2 Levels
60055,Heme Oxygenase 1 Levels,Phenotype,Heme Oxygenase 1 Levels
60056,Hepacam Family Member 2 Levels,Phenotype,Hepacam Family Member 2 Levels
60058,Hematological And Neurological Expressed 1 Protein Levels,Phenotype,Hematological And Neurological Expressed 1 Protein Levels
60063,Kin Of Irre-Like Protein 2 Levels,Phenotype,Kin Of Irre-Like Protein 2 Levels
60065,Insulin Receptor Levels,Phenotype,Insulin Receptor Levels
60071,Cytochrome C Oxidase Assembly Factor 3 Homolog-- Mitochondrial Levels,Phenotype,Cytochrome C Oxidase Assembly Factor 3 Homolog-- Mitochondrial Levels
60072,Coagulation Factor X Levels,Phenotype,Coagulation Factor X Levels
60074,C-Type Lectin Domain Family 4 Member D Levels,Phenotype,C-Type Lectin Domain Family 4 Member D Levels
60075,Calcium-Activated Potassium Channel Subunit Beta-3 Levels,Phenotype,Calcium-Activated Potassium Channel Subunit Beta-3 Levels
60076,C-Type Lectin Domain Family 4 Member A Levels,Phenotype,C-Type Lectin Domain Family 4 Member A Levels
60077,Collagen Alpha-1(Ix) Chain Levels,Phenotype,Collagen Alpha-1(Ix) Chain Levels
60079,Collagen Alpha-1(X) Chain Levels,Phenotype,Collagen Alpha-1(X) Chain Levels
60085,Endothelin-Converting Enzyme 1 Levels,Phenotype,Endothelin-Converting Enzyme 1 Levels
60087,Enoyl-Coa Delta Isomerase 2-- Mitochondrial Levels,Phenotype,Enoyl-Coa Delta Isomerase 2-- Mitochondrial Levels
60089,Histone-Lysine N-Methyltransferase-- H3 Lysine-79 Specific Levels,Phenotype,Histone-Lysine N-Methyltransferase-- H3 Lysine-79 Specific Levels
60091,Disintegrin And Metalloproteinase Domain-Containing Protein 10 Levels,Phenotype,Disintegrin And Metalloproteinase Domain-Containing Protein 10 Levels
60092,Dipeptidyl Peptidase 4 Levels,Phenotype,Dipeptidyl Peptidase 4 Levels
60093,Diphosphomevalonate Decarboxylase Levels,Phenotype,Diphosphomevalonate Decarboxylase Levels
60096,Dnaj Homolog Subfamily B Member 9 Levels,Phenotype,Dnaj Homolog Subfamily B Member 9 Levels
60101,Dipeptidyl Peptidase 1 Levels,Phenotype,Dipeptidyl Peptidase 1 Levels
60106,Non-Alcoholic Fatty Liver Disease Or Type 2 Diabetes,Phenotype,Non-Alcoholic Fatty Liver Disease Or Type 2 Diabetes
60116,Preeclampsia Or Other Maternal Hypertension (Maternal Genotype Effect),Phenotype,Preeclampsia Or Other Maternal Hypertension (Maternal Genotype Effect)
60120,Aortic Stenosis,Phenotype,Aortic Stenosis
60122,Cholesteryl Esters To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23596),Phenotype,Cholesteryl Esters To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23596)
60123,Triglycerides To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23598),Phenotype,Triglycerides To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23598)
60124,Free Cholesterol To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23597),Phenotype,Free Cholesterol To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23597)
60126,Phospholipids To Total Lipids In Small Vldl Percentage (Ukb Data Field 23599),Phenotype,Phospholipids To Total Lipids In Small Vldl Percentage (Ukb Data Field 23599)
60127,Cholesteryl Esters To Total Lipids In Idl Percentage (Ukb Data Field 23611),Phenotype,Cholesteryl Esters To Total Lipids In Idl Percentage (Ukb Data Field 23611)
60128,Free Cholesterol To Total Lipids In Idl Percentage (Ukb Data Field 23612),Phenotype,Free Cholesterol To Total Lipids In Idl Percentage (Ukb Data Field 23612)
60129,Cholesterol To Total Lipids In Idl Percentage (Ukb Data Field 23610),Phenotype,Cholesterol To Total Lipids In Idl Percentage (Ukb Data Field 23610)
60130,Phospholipids To Total Lipids In Idl Percentage (Ukb Data Field 23609),Phenotype,Phospholipids To Total Lipids In Idl Percentage (Ukb Data Field 23609)
60135,Cholesterol To Total Lipids In Small Ldl Percentage (Ukb Data Field 23625),Phenotype,Cholesterol To Total Lipids In Small Ldl Percentage (Ukb Data Field 23625)
60136,Cholesteryl Esters To Total Lipids In Small Ldl Percentage (Ukb Data Field 23626),Phenotype,Cholesteryl Esters To Total Lipids In Small Ldl Percentage (Ukb Data Field 23626)
60138,Free Cholesterol To Total Lipids In Small Ldl Percentage (Ukb Data Field 23627),Phenotype,Free Cholesterol To Total Lipids In Small Ldl Percentage (Ukb Data Field 23627)
60139,Triglycerides To Total Lipids In Small Ldl Percentage (Ukb Data Field 23628),Phenotype,Triglycerides To Total Lipids In Small Ldl Percentage (Ukb Data Field 23628)
60140,Margaroylcarnitine (C17) Levels,Phenotype,Margaroylcarnitine (C17) Levels
60142,Phenylacetylcarnitine Levels,Phenotype,Phenylacetylcarnitine Levels
60143,Carnitine C18:2 Levels,Phenotype,Carnitine C18:2 Levels
60144,Carboxyethyl-Gaba Levels,Phenotype,Carboxyethyl-Gaba Levels
60145,Prolylglycine Levels,Phenotype,Prolylglycine Levels
60147,Cholesterol To Total Lipids In Large Hdl Percentage (Ukb Data Field 23635),Phenotype,Cholesterol To Total Lipids In Large Hdl Percentage (Ukb Data Field 23635)
60148,Cholesteryl Esters To Total Lipids In Large Hdl Percentage (Ukb Data Field 23636),Phenotype,Cholesteryl Esters To Total Lipids In Large Hdl Percentage (Ukb Data Field 23636)
60150,Phospholipids To Total Lipids In Large Hdl Percentage (Ukb Data Field 23634),Phenotype,Phospholipids To Total Lipids In Large Hdl Percentage (Ukb Data Field 23634)
60151,Gamma-Glutamylcitrulline Levels,Phenotype,Gamma-Glutamylcitrulline Levels
60153,3-Amino-2-Piperidone Levels,Phenotype,3-Amino-2-Piperidone Levels
60156,Cis 3--4-Methyleneheptanoate Levels,Phenotype,Cis 3--4-Methyleneheptanoate Levels
60157,Vanillic Acid Glycine Levels,Phenotype,Vanillic Acid Glycine Levels
60158,N-Succinyl-Phenylalanine Levels,Phenotype,N-Succinyl-Phenylalanine Levels
60160,Cis-3--4-Methyleneheptanoylcarnitine Levels,Phenotype,Cis-3--4-Methyleneheptanoylcarnitine Levels
60163,Free Cholesterol To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23642),Phenotype,Free Cholesterol To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23642)
60164,Cholesteryl Esters To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23641),Phenotype,Cholesteryl Esters To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23641)
60167,Microscopic Colitis,Phenotype,Microscopic Colitis
60168,Creatinine Levels (Ukb Data Field 23478),Phenotype,Creatinine Levels (Ukb Data Field 23478)
60171,Concentration Of Chylomicrons And Extremely Large Vldl Particles (Ukb Data Field 23481),Phenotype,Concentration Of Chylomicrons And Extremely Large Vldl Particles (Ukb Data Field 23481)
60173,3-Hydroxybutyrate Levels (Ukb Data Field 23474),Phenotype,3-Hydroxybutyrate Levels (Ukb Data Field 23474)
60174,Acetoacetate Levels (Ukb Data Field 23476),Phenotype,Acetoacetate Levels (Ukb Data Field 23476)
60176,Glycoprotein Acetyls Levels (Ukb Data Field 23480),Phenotype,Glycoprotein Acetyls Levels (Ukb Data Field 23480)
60180,Phospholipids In Very Large Vldl (Ukb Data Field 23490),Phenotype,Phospholipids In Very Large Vldl (Ukb Data Field 23490)
60182,Cholesteryl Esters In Very Large Vldl (Ukb Data Field 23492),Phenotype,Cholesteryl Esters In Very Large Vldl (Ukb Data Field 23492)
60183,Free Cholesterol In Very Large Vldl (Ukb Data Field 23493),Phenotype,Free Cholesterol In Very Large Vldl (Ukb Data Field 23493)
60184,Total Lipids In Very Large Vldl (Ukb Data Field 23489),Phenotype,Total Lipids In Very Large Vldl (Ukb Data Field 23489)
60185,Cholesterol In Very Large Vldl (Ukb Data Field 23491),Phenotype,Cholesterol In Very Large Vldl (Ukb Data Field 23491)
60186,Glycine Levels (Ukb Data Field 23462),Phenotype,Glycine Levels (Ukb Data Field 23462)
60188,Tyrosine Levels (Ukb Data Field 23469),Phenotype,Tyrosine Levels (Ukb Data Field 23469)
60190,Glucose Levels (Ukb Data Field 23470),Phenotype,Glucose Levels (Ukb Data Field 23470)
60192,Lactate Levels (Ukb Data Field 23471),Phenotype,Lactate Levels (Ukb Data Field 23471)
60193,Total Concentration Of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine) (Ukb Data Field 23464),Phenotype,Total Concentration Of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine) (Ukb Data Field 23464)
60194,Isoleucine Levels (Ukb Data Field 23465),Phenotype,Isoleucine Levels (Ukb Data Field 23465)
60195,Leucine Levels (Ukb Data Field 23466),Phenotype,Leucine Levels (Ukb Data Field 23466)
60196,Valine Levels (Ukb Data Field 23467),Phenotype,Valine Levels (Ukb Data Field 23467)
60199,Alanine Levels (Ukb Data Field 23460),Phenotype,Alanine Levels (Ukb Data Field 23460)
60200,Pyruvate Levels (Ukb Data Field 23472),Phenotype,Pyruvate Levels (Ukb Data Field 23472)
60201,Citrate Levels (Ukb Data Field 23473),Phenotype,Citrate Levels (Ukb Data Field 23473)
60204,Glutamine Levels (Ukb Data Field 23461),Phenotype,Glutamine Levels (Ukb Data Field 23461)
60205,Triglycerides In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23487),Phenotype,Triglycerides In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23487)
60207,Concentration Of Very Large Vldl Particles (Ukb Data Field 23488),Phenotype,Concentration Of Very Large Vldl Particles (Ukb Data Field 23488)
60208,Free Cholesterol In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23486),Phenotype,Free Cholesterol In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23486)
60209,Phospholipids In Large Vldl (Ukb Data Field 23497),Phenotype,Phospholipids In Large Vldl (Ukb Data Field 23497)
60210,Cholesteryl Esters In Large Vldl (Ukb Data Field 23499),Phenotype,Cholesteryl Esters In Large Vldl (Ukb Data Field 23499)
60211,Cholesterol In Large Vldl (Ukb Data Field 23498),Phenotype,Cholesterol In Large Vldl (Ukb Data Field 23498)
60212,Concentration Of Very Small Vldl Particles (Ukb Data Field 23516),Phenotype,Concentration Of Very Small Vldl Particles (Ukb Data Field 23516)
60213,Triglycerides In Small Vldl (Ukb Data Field 23515),Phenotype,Triglycerides In Small Vldl (Ukb Data Field 23515)
60214,Total Lipids In Very Small Vldl (Ukb Data Field 23517),Phenotype,Total Lipids In Very Small Vldl (Ukb Data Field 23517)
60215,Cholesterol In Very Small Vldl (Ukb Data Field 23519),Phenotype,Cholesterol In Very Small Vldl (Ukb Data Field 23519)
60216,Phospholipids In Very Small Vldl (Ukb Data Field 23518),Phenotype,Phospholipids In Very Small Vldl (Ukb Data Field 23518)
60217,Concentration Of Large Ldl Particles (Ukb Data Field 23530),Phenotype,Concentration Of Large Ldl Particles (Ukb Data Field 23530)
60218,Cholesterol In Large Ldl (Ukb Data Field 23533),Phenotype,Cholesterol In Large Ldl (Ukb Data Field 23533)
60219,Phospholipids In Large Ldl (Ukb Data Field 23532),Phenotype,Phospholipids In Large Ldl (Ukb Data Field 23532)
60221,Cholesteryl Esters In Large Ldl (Ukb Data Field 23534),Phenotype,Cholesteryl Esters In Large Ldl (Ukb Data Field 23534)
60222,Total Lipids In Large Ldl (Ukb Data Field 23531),Phenotype,Total Lipids In Large Ldl (Ukb Data Field 23531)
60223,Triglycerides In Idl (Ukb Data Field 23529),Phenotype,Triglycerides In Idl (Ukb Data Field 23529)
60225,Concentration Of Very Large Hdl Particles (Ukb Data Field 23551),Phenotype,Concentration Of Very Large Hdl Particles (Ukb Data Field 23551)
60227,Total Lipids In Very Large Hdl (Ukb Data Field 23552),Phenotype,Total Lipids In Very Large Hdl (Ukb Data Field 23552)
60228,Phospholipids In Very Large Hdl (Ukb Data Field 23553),Phenotype,Phospholipids In Very Large Hdl (Ukb Data Field 23553)
60230,Triglycerides In Small Ldl (Ukb Data Field 23550),Phenotype,Triglycerides In Small Ldl (Ukb Data Field 23550)
60234,Cholesterol In Large Hdl (Ukb Data Field 23561),Phenotype,Cholesterol In Large Hdl (Ukb Data Field 23561)
60235,Cholesteryl Esters In Large Hdl (Ukb Data Field 23562),Phenotype,Cholesteryl Esters In Large Hdl (Ukb Data Field 23562)
60237,Total Lipids In Medium Hdl (Ukb Data Field 23566),Phenotype,Total Lipids In Medium Hdl (Ukb Data Field 23566)
60238,Cholesterol In Medium Hdl (Ukb Data Field 23568),Phenotype,Cholesterol In Medium Hdl (Ukb Data Field 23568)
60239,Cholesteryl Esters In Medium Hdl (Ukb Data Field 23569),Phenotype,Cholesteryl Esters In Medium Hdl (Ukb Data Field 23569)
60240,Phospholipids In Medium Hdl (Ukb Data Field 23567),Phenotype,Phospholipids In Medium Hdl (Ukb Data Field 23567)
60241,Cholesteryl Esters To Total Lipids In Large Vldl Percentage (Ukb Data Field 23591),Phenotype,Cholesteryl Esters To Total Lipids In Large Vldl Percentage (Ukb Data Field 23591)
60242,Triglycerides To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23588),Phenotype,Triglycerides To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23588)
60243,Cholesterol To Total Lipids In Large Vldl Percentage (Ukb Data Field 23590),Phenotype,Cholesterol To Total Lipids In Large Vldl Percentage (Ukb Data Field 23590)
60244,Phospholipids To Total Lipids In Large Vldl Percentage (Ukb Data Field 23589),Phenotype,Phospholipids To Total Lipids In Large Vldl Percentage (Ukb Data Field 23589)
60245,Phospholipids To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23584),Phenotype,Phospholipids To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23584)
60246,Cholesterol To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23585),Phenotype,Cholesterol To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23585)
60247,Cholesteryl Esters To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23586),Phenotype,Cholesteryl Esters To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23586)
60248,Mitochondrial Dna Copy Number (Raw),Phenotype,Mitochondrial Dna Copy Number (Raw)
60255,Triglycerides To Total Lipids In Small Vldl Percentage (Ukb Data Field 23603),Phenotype,Triglycerides To Total Lipids In Small Vldl Percentage (Ukb Data Field 23603)
60256,Free Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23602),Phenotype,Free Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23602)
60257,Cholesterol To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23605),Phenotype,Cholesterol To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23605)
60258,Phospholipids To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23604),Phenotype,Phospholipids To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23604)
60260,Phospholipids To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23619),Phenotype,Phospholipids To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23619)
60261,Cholesteryl Esters To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23621),Phenotype,Cholesteryl Esters To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23621)
60262,Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23620),Phenotype,Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23620)
60264,X-24241 Levels,Phenotype,X-24241 Levels
60265,Triglycerides To Total Lipids In Large Ldl Percentage (Ukb Data Field 23618),Phenotype,Triglycerides To Total Lipids In Large Ldl Percentage (Ukb Data Field 23618)
60267,X-25109 Levels,Phenotype,X-25109 Levels
60269,X-24947 Levels,Phenotype,X-24947 Levels
60270,X-24949 Levels,Phenotype,X-24949 Levels
60271,X-24518 Levels,Phenotype,X-24518 Levels
60272,X-24531 Levels,Phenotype,X-24531 Levels
60275,Thymol Sulfate Levels,Phenotype,Thymol Sulfate Levels
60276,Free Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23632),Phenotype,Free Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23632)
60277,Cholesteryl Esters To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23631),Phenotype,Cholesteryl Esters To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23631)
60278,Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23630),Phenotype,Cholesterol To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23630)
60282,Free Cholesterol To Total Lipids In Large Hdl Percentage (Ukb Data Field 23637),Phenotype,Free Cholesterol To Total Lipids In Large Hdl Percentage (Ukb Data Field 23637)
60287,3-Hydroxyoctanoylcarnitine (1) Levels,Phenotype,3-Hydroxyoctanoylcarnitine (1) Levels
60288,3-Hydroxyoctanoylcarnitine (2) Levels,Phenotype,3-Hydroxyoctanoylcarnitine (2) Levels
60293,Triglycerides To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23643),Phenotype,Triglycerides To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23643)
60294,Phospholipids To Total Lipids In Small Hdl Percentage (Ukb Data Field 23644),Phenotype,Phospholipids To Total Lipids In Small Hdl Percentage (Ukb Data Field 23644)
60297,Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23600),Phenotype,Cholesterol To Total Lipids In Small Vldl Percentage (Ukb Data Field 23600)
60298,Cholesteryl Esters To Total Lipids In Small Vldl Percentage (Ukb Data Field 23601),Phenotype,Cholesteryl Esters To Total Lipids In Small Vldl Percentage (Ukb Data Field 23601)
60301,Cholesteryl Esters To Total Lipids In Large Ldl Percentage (Ukb Data Field 23616),Phenotype,Cholesteryl Esters To Total Lipids In Large Ldl Percentage (Ukb Data Field 23616)
60302,Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23615),Phenotype,Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23615)
60304,Triglycerides To Total Lipids In Idl Percentage (Ukb Data Field 23613),Phenotype,Triglycerides To Total Lipids In Idl Percentage (Ukb Data Field 23613)
60305,Phospholipids To Total Lipids In Large Ldl Percentage (Ukb Data Field 23614),Phenotype,Phospholipids To Total Lipids In Large Ldl Percentage (Ukb Data Field 23614)
60306,Free Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23617),Phenotype,Free Cholesterol To Total Lipids In Large Ldl Percentage (Ukb Data Field 23617)
60312,X-12839 Levels,Phenotype,X-12839 Levels
60317,X-21829 Levels,Phenotype,X-21829 Levels
60318,Phospholipids To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23629),Phenotype,Phospholipids To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23629)
60319,Stearoylcarnitine (C18) Levels,Phenotype,Stearoylcarnitine (C18) Levels
60321,Indolebutyrate Levels,Phenotype,Indolebutyrate Levels
60325,Hydroxy-Cmpf Levels,Phenotype,Hydroxy-Cmpf Levels
60327,Glycine Conjugate Of C10H12O2 Levels,Phenotype,Glycine Conjugate Of C10H12O2 Levels
60329,Cholesterol To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23640),Phenotype,Cholesterol To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23640)
60330,Response To Bnt162B2 Vaccine (Anti-Sars-Cov-2 Spike Antibody Levels At Two Months After First Dose),Phenotype,Response To Bnt162B2 Vaccine (Anti-Sars-Cov-2 Spike Antibody Levels At Two Months After First Dose)
60332,Response To Bnt162B2 Vaccine (Anti-Sars-Cov-2 Spike Antibody Levels At Four Months After First Dose),Phenotype,Response To Bnt162B2 Vaccine (Anti-Sars-Cov-2 Spike Antibody Levels At Four Months After First Dose)
60335,Response To Bnt162B2 Vaccine (Percentage Decrease Of Anti-Sars-Cov-2 Spike Antibody Levels From Two To Four Months After First Dose),Phenotype,Response To Bnt162B2 Vaccine (Percentage Decrease Of Anti-Sars-Cov-2 Spike Antibody Levels From Two To Four Months After First Dose)
60338,Free Cholesterol To Total Lipids In Large Vldl Percentage (Ukb Data Field 23592),Phenotype,Free Cholesterol To Total Lipids In Large Vldl Percentage (Ukb Data Field 23592)
60341,Cholesterol To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23595),Phenotype,Cholesterol To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23595)
60342,Triglycerides To Total Lipids In Large Vldl Percentage (Ukb Data Field 23593),Phenotype,Triglycerides To Total Lipids In Large Vldl Percentage (Ukb Data Field 23593)
60344,Phospholipids To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23594),Phenotype,Phospholipids To Total Lipids In Medium Vldl Percentage (Ukb Data Field 23594)
60345,Free Cholesterol To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23607),Phenotype,Free Cholesterol To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23607)
60347,Cholesteryl Esters To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23606),Phenotype,Cholesteryl Esters To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23606)
60348,Triglycerides To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23608),Phenotype,Triglycerides To Total Lipids In Very Small Vldl Percentage (Ukb Data Field 23608)
60349,Phospholipids To Total Lipids In Small Ldl Percentage (Ukb Data Field 23624),Phenotype,Phospholipids To Total Lipids In Small Ldl Percentage (Ukb Data Field 23624)
60350,Triglycerides To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23623),Phenotype,Triglycerides To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23623)
60351,1-Palmitoyl-2-Arachidonoyl-Gpc (16:0/20:4N6) Levels,Phenotype,1-Palmitoyl-2-Arachidonoyl-Gpc (16:0/20:4N6) Levels
60352,Butyrylcarnitine (C4) Levels,Phenotype,Butyrylcarnitine (C4) Levels
60353,Free Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23622),Phenotype,Free Cholesterol To Total Lipids In Medium Ldl Percentage (Ukb Data Field 23622)
60355,Cysteinylglycine Disulfide Levels,Phenotype,Cysteinylglycine Disulfide Levels
60356,Succinylcarnitine (C4Dc) Levels,Phenotype,Succinylcarnitine (C4Dc) Levels
60357,5Alpha-Androstan-3Alpha--17Alpha-Diol Monosulfate Levels,Phenotype,5Alpha-Androstan-3Alpha--17Alpha-Diol Monosulfate Levels
60358,Triglycerides To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23633),Phenotype,Triglycerides To Total Lipids In Very Large Hdl Percentage (Ukb Data Field 23633)
60361,Methylsuccinoylcarnitine Levels,Phenotype,Methylsuccinoylcarnitine Levels
60362,Furaneol Sulfate Levels,Phenotype,Furaneol Sulfate Levels
60363,Lactosyl-N-Nervonoyl-Sphingosine (D18:1/24:1) Levels,Phenotype,Lactosyl-N-Nervonoyl-Sphingosine (D18:1/24:1) Levels
60364,Phospholipids To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23639),Phenotype,Phospholipids To Total Lipids In Medium Hdl Percentage (Ukb Data Field 23639)
60365,Triglycerides To Total Lipids In Large Hdl Percentage (Ukb Data Field 23638),Phenotype,Triglycerides To Total Lipids In Large Hdl Percentage (Ukb Data Field 23638)
60368,Cholesteryl Esters To Total Lipids In Small Hdl Percentage (Ukb Data Field 23646),Phenotype,Cholesteryl Esters To Total Lipids In Small Hdl Percentage (Ukb Data Field 23646)
60370,Free Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23647),Phenotype,Free Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23647)
60371,Triglycerides To Total Lipids In Small Hdl Percentage (Ukb Data Field 23648),Phenotype,Triglycerides To Total Lipids In Small Hdl Percentage (Ukb Data Field 23648)
60372,Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23645),Phenotype,Cholesterol To Total Lipids In Small Hdl Percentage (Ukb Data Field 23645)
60384,Color Vision Defects (Deutan-Protan),Phenotype,Color Vision Defects (Deutan-Protan)
60417,Immature Platelet Fraction,Phenotype,Immature Platelet Fraction
60419,Immature Platelet Count,Phenotype,Immature Platelet Count
60427,Hearing Difficulty,Phenotype,Hearing Difficulty
60428,Hearing Difficulty With Background Noise,Phenotype,Hearing Difficulty With Background Noise
60429,Hearing Difficulty And Hearing Difficulty With Background Noise,Phenotype,Hearing Difficulty And Hearing Difficulty With Background Noise
60430,Fornix White Matter Microstructure (Isotropic Or Free Water Volume Fraction),Phenotype,Fornix White Matter Microstructure (Isotropic Or Free Water Volume Fraction)
60458,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (4-Week),Phenotype,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (4-Week)
60460,Antipsychotic-Induced Hdl-Cholesterol Change In Schizophrenia (6-Week),Phenotype,Antipsychotic-Induced Hdl-Cholesterol Change In Schizophrenia (6-Week)
60463,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (6-Week),Phenotype,Hdl-Cholesterol Level In Antipsychotic-Treated Schizophrenia (6-Week)
60470,Alcohol Use Frequency,Phenotype,Alcohol Use Frequency
60526,Platelet Side Scatter,Phenotype,Platelet Side Scatter
60528,Left Ventricular End Systole Anterolateral Wall Thickness,Phenotype,Left Ventricular End Systole Anterolateral Wall Thickness
60529,Left Ventricular End Systole Inferoseptal Wall Thickness,Phenotype,Left Ventricular End Systole Inferoseptal Wall Thickness
60530,Left Ventricular End Systole Inferolateral Wall Thickness,Phenotype,Left Ventricular End Systole Inferolateral Wall Thickness
60531,Left Ventricular End Diastole Inferior Wall Thickness,Phenotype,Left Ventricular End Diastole Inferior Wall Thickness
60532,Left Ventricular End Diastole Anterolateral Wall Thickness,Phenotype,Left Ventricular End Diastole Anterolateral Wall Thickness
60534,Platelet Side Fluorescence,Phenotype,Platelet Side Fluorescence
60535,Facial Morphology (D497),Phenotype,Facial Morphology (D497)
60537,Facial Morphology (D99),Phenotype,Facial Morphology (D99)
60539,Gastroparesis,Phenotype,Gastroparesis
60541,Plasma Oxylipin Levels (Pc2),Phenotype,Plasma Oxylipin Levels (Pc2)
60543,Plasma Oxylipin Levels (Pc1),Phenotype,Plasma Oxylipin Levels (Pc1)
60553,Phenotypic Age Acceleration,Phenotype,Phenotypic Age Acceleration
60557,Alcohol Use Frequency In Adulthood,Phenotype,Alcohol Use Frequency In Adulthood
60564,Alcohol Use Frequency In Early Adulthood,Phenotype,Alcohol Use Frequency In Early Adulthood
60578,Red Blood Cell Side Fluorescence,Phenotype,Red Blood Cell Side Fluorescence
60582,Red Blood Cell Side Scatter,Phenotype,Red Blood Cell Side Scatter
60585,Red Blood Cell Forward Scatter,Phenotype,Red Blood Cell Forward Scatter
60586,Platelet Large Cell Ratio,Phenotype,Platelet Large Cell Ratio
60589,Peptic Ulcer Disease,Phenotype,Peptic Ulcer Disease
60592,Duodenal Ulcer,Phenotype,Duodenal Ulcer
60619,Facial Morphology (D10),Phenotype,Facial Morphology (D10)
60621,Facial Morphology (D120),Phenotype,Facial Morphology (D120)
60623,Platelet Forward Scatter,Phenotype,Platelet Forward Scatter
60629,Red Blood Cell Forward Scatter Distribution Width,Phenotype,Red Blood Cell Forward Scatter Distribution Width
60631,Hyper-Haemoglobinised Percentage Of Red Cells,Phenotype,Hyper-Haemoglobinised Percentage Of Red Cells
60633,Macrocytic Percentage Of Red Cells,Phenotype,Macrocytic Percentage Of Red Cells
60637,Microcytic Percentage Of Red Cells,Phenotype,Microcytic Percentage Of Red Cells
60638,Red Blood Cell Side Fluorescence Distribution Width,Phenotype,Red Blood Cell Side Fluorescence Distribution Width
60644,Fornix White Matter Microstructure (Intra-Cellular Volume Fraction),Phenotype,Fornix White Matter Microstructure (Intra-Cellular Volume Fraction)
60645,Fornix White Matter Microstructure (Diffusion Tensor Mode),Phenotype,Fornix White Matter Microstructure (Diffusion Tensor Mode)
60646,Hearing Aid Use,Phenotype,Hearing Aid Use
60648,Neonatal Circulating Complement Component 3 (C3) Protein Concentration,Phenotype,Neonatal Circulating Complement Component 3 (C3) Protein Concentration
60650,Neonatal Circulating Complement Component 4 (C4) Protein Concentration,Phenotype,Neonatal Circulating Complement Component 4 (C4) Protein Concentration
60661,Cranial Vault Shape (Segment 1),Phenotype,Cranial Vault Shape (Segment 1)
60663,Cranial Vault Shape (Segment 3),Phenotype,Cranial Vault Shape (Segment 3)
60672,Cranial Vault Shape (Segment 11),Phenotype,Cranial Vault Shape (Segment 11)
60677,Ulcerative Colitis X Sex Interaction (2Df),Phenotype,Ulcerative Colitis X Sex Interaction (2Df)
60681,Inflammatory Bowel Disease X Sex Interaction (2Df),Phenotype,Inflammatory Bowel Disease X Sex Interaction (2Df)
60682,Solar Lentigines (Non-Facial),Phenotype,Solar Lentigines (Non-Facial)
60696,Mercury Levels In Pregnancy,Phenotype,Mercury Levels In Pregnancy
60710,Lymphatic Filariasis,Phenotype,Lymphatic Filariasis
60713,Lymphatic Filariasis With Lymphedema,Phenotype,Lymphatic Filariasis With Lymphedema
60715,Delta Of The Haemoglobin Equivalents,Phenotype,Delta Of The Haemoglobin Equivalents
60717,Delta Of The Red Cell Haemoglobins,Phenotype,Delta Of The Red Cell Haemoglobins
60736,Chemoradiation-Induced Hearing Loss In Nasopharyngeal Carcinoma,Phenotype,Chemoradiation-Induced Hearing Loss In Nasopharyngeal Carcinoma
60774,Systemic Lupus Erythematosus (Mtag),Phenotype,Systemic Lupus Erythematosus (Mtag)
60782,Anxiety X Caesarean-Section Interaction,Phenotype,Anxiety X Caesarean-Section Interaction
60784,Self-Harm X Caesarean-Section Interaction,Phenotype,Self-Harm X Caesarean-Section Interaction
60786,Free Androgen Index,Phenotype,Free Androgen Index
60824,Neurocognitive Measure (Immediate Recall) In Obsessive-Compulsive Disorder,Phenotype,Neurocognitive Measure (Immediate Recall) In Obsessive-Compulsive Disorder
60826,Neurocognitive Measure (Delayed Recall) In Obsessive-Compulsive Disorder,Phenotype,Neurocognitive Measure (Delayed Recall) In Obsessive-Compulsive Disorder
60828,Neurocognitive Measure (Copy Organization) In Obsessive-Compulsive Disorder,Phenotype,Neurocognitive Measure (Copy Organization) In Obsessive-Compulsive Disorder
60853,Interventricular Septum Cross-Sectional Area,Phenotype,Interventricular Septum Cross-Sectional Area
60871,Median Relapse-Independent Longitudinal Age-Related Multiple Sclerosis Severity Score In Relapse-Onset Multiple Sclerosis,Phenotype,Median Relapse-Independent Longitudinal Age-Related Multiple Sclerosis Severity Score In Relapse-Onset Multiple Sclerosis
60873,Median Relapse-Independent Longitudinal Multiple Sclerosis Severity Scale Score In Relapse-Onset Multiple Sclerosis,Phenotype,Median Relapse-Independent Longitudinal Multiple Sclerosis Severity Scale Score In Relapse-Onset Multiple Sclerosis
60875,Multiple Sclerosis (Age Of Onset),Phenotype,Multiple Sclerosis (Age Of Onset)
60893,Alcohol Withdrawal Factor Score,Phenotype,Alcohol Withdrawal Factor Score
60929,Hip Width To Body Height Ratio,Phenotype,Hip Width To Body Height Ratio
60931,Shoulder Width To Body Height Ratio,Phenotype,Shoulder Width To Body Height Ratio
60935,Torso Length To Body Height Ratio,Phenotype,Torso Length To Body Height Ratio
60937,Tibiofemoral Angle,Phenotype,Tibiofemoral Angle
60941,Femur Length To Body Height Ratio,Phenotype,Femur Length To Body Height Ratio
60943,Icd10 127.0 Pulmonary Arterial Hypertension,Phenotype,Icd10 127.0 Pulmonary Arterial Hypertension
60958,Vitamin D Levels Or Covid-19 (Mtag),Phenotype,Vitamin D Levels Or Covid-19 (Mtag)
60985,Pelvic Organ Prolapse X Maximum Birth Weight Interaction,Phenotype,Pelvic Organ Prolapse X Maximum Birth Weight Interaction
60990,Pelvic Organ Prolapse X Age Interaction,Phenotype,Pelvic Organ Prolapse X Age Interaction
60993,Red Meat Related Metabolomic Signature,Phenotype,Red Meat Related Metabolomic Signature
61001,Preeclampsia Or Eclampsia,Phenotype,Preeclampsia Or Eclampsia
61049,Forearm Length To Body Height Ratio,Phenotype,Forearm Length To Body Height Ratio
61085,Bola-Like Protein 2 Levels,Phenotype,Bola-Like Protein 2 Levels
61087,Complement C1Q Tumor Necrosis Factor-Related Protein 5 Levels,Phenotype,Complement C1Q Tumor Necrosis Factor-Related Protein 5 Levels
61088,Complement C1Q And Tumor Necrosis Factor-Related Protein 9A Levels,Phenotype,Complement C1Q And Tumor Necrosis Factor-Related Protein 9A Levels
61090,Butyrophilin Subfamily 3 Member A3 Levels,Phenotype,Butyrophilin Subfamily 3 Member A3 Levels
61095,Protein Btg2 Levels,Phenotype,Protein Btg2 Levels
61097,Glypican-3 Levels,Phenotype,Glypican-3 Levels
61102,Insulin Growth Factor-Like Family Member 3 Levels,Phenotype,Insulin Growth Factor-Like Family Member 3 Levels
61103,Interferon Alpha-5 Levels,Phenotype,Interferon Alpha-5 Levels
61105,Icos Ligand Levels,Phenotype,Icos Ligand Levels
61106,Insulin-Like Growth Factor I Levels,Phenotype,Insulin-Like Growth Factor I Levels
61108,Insulin-Like Growth Factor-Binding Protein Complex Acid Labile Subunit Levels,Phenotype,Insulin-Like Growth Factor-Binding Protein Complex Acid Labile Subunit Levels
61110,Insulin-Like Growth Factor-Binding Protein 3 Levels,Phenotype,Insulin-Like Growth Factor-Binding Protein 3 Levels
61111,Interleukin-10 Receptor Subunit Beta Levels,Phenotype,Interleukin-10 Receptor Subunit Beta Levels
61112,Immunoglobulin Lambda-Like Polypeptide 1 Levels,Phenotype,Immunoglobulin Lambda-Like Polypeptide 1 Levels
61114,Immunoglobulin M Levels,Phenotype,Immunoglobulin M Levels
61116,Icd10 J33: Nasal Polyps,Phenotype,Icd10 J33: Nasal Polyps
61117,Icd10 J35: Chronic Diseases Of Tonsils And Adenoids,Phenotype,Icd10 J35: Chronic Diseases Of Tonsils And Adenoids
61118,Somatoliberin Levels,Phenotype,Somatoliberin Levels
61119,S-Methyl-5-Thioadenosine Phosphorylase Levels,Phenotype,S-Methyl-5-Thioadenosine Phosphorylase Levels
61123,Stromal Membrane-Associated Protein 1 Levels,Phenotype,Stromal Membrane-Associated Protein 1 Levels
61130,Casein Kinase Ii Subunit Alpha Levels,Phenotype,Casein Kinase Ii Subunit Alpha Levels
61131,Ceruloplasmin Levels,Phenotype,Ceruloplasmin Levels
61132,Chitinase-3-Like Protein 2 Levels,Phenotype,Chitinase-3-Like Protein 2 Levels
61133,Chordin Levels,Phenotype,Chordin Levels
61134,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 19 Levels,Phenotype,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 19 Levels
61135,Ccaat/Enhancer-Binding Protein Beta Levels,Phenotype,Ccaat/Enhancer-Binding Protein Beta Levels
61136,Carbohydrate Sulfotransferase 4 Levels,Phenotype,Carbohydrate Sulfotransferase 4 Levels
61138,Chymotrypsinogen B Levels,Phenotype,Chymotrypsinogen B Levels
61144,Mitogen-Activated Protein Kinase 13 Levels,Phenotype,Mitogen-Activated Protein Kinase 13 Levels
61147,Melanoma-Associated Antigen 5 Levels,Phenotype,Melanoma-Associated Antigen 5 Levels
61148,Mast/Stem Cell Growth Factor Receptor Kit Levels,Phenotype,Mast/Stem Cell Growth Factor Receptor Kit Levels
61149,Left Ventricular Mass Indexed By Body Surface Area,Phenotype,Left Ventricular Mass Indexed By Body Surface Area
61151,Left Ventricular Mass,Phenotype,Left Ventricular Mass
61171,Triglycerides In Large Vldl (Ukb Data Field 23501),Phenotype,Triglycerides In Large Vldl (Ukb Data Field 23501)
61172,Concentration Of Medium Vldl Particles (Ukb Data Field 23502),Phenotype,Concentration Of Medium Vldl Particles (Ukb Data Field 23502)
61175,Breast Cancer (Luminal A),Phenotype,Breast Cancer (Luminal A)
61178,Total Lipids In Medium Vldl (Ukb Data Field 23503),Phenotype,Total Lipids In Medium Vldl (Ukb Data Field 23503)
61179,Cholesterol In Medium Vldl (Ukb Data Field 23505),Phenotype,Cholesterol In Medium Vldl (Ukb Data Field 23505)
61180,Phospholipids In Medium Vldl (Ukb Data Field 23504),Phenotype,Phospholipids In Medium Vldl (Ukb Data Field 23504)
61181,Cholesterol In Small Vldl (Ukb Data Field 23512),Phenotype,Cholesterol In Small Vldl (Ukb Data Field 23512)
61182,Cholesteryl Esters In Small Vldl (Ukb Data Field 23513),Phenotype,Cholesteryl Esters In Small Vldl (Ukb Data Field 23513)
61183,Free Cholesterol In Small Vldl (Ukb Data Field 23514),Phenotype,Free Cholesterol In Small Vldl (Ukb Data Field 23514)
61184,Total Lipids In Small Vldl (Ukb Data Field 23510),Phenotype,Total Lipids In Small Vldl (Ukb Data Field 23510)
61185,Phospholipids In Small Vldl (Ukb Data Field 23511),Phenotype,Phospholipids In Small Vldl (Ukb Data Field 23511)
61186,Cholesteryl Esters In Idl (Ukb Data Field 23527),Phenotype,Cholesteryl Esters In Idl (Ukb Data Field 23527)
61187,Cholesterol In Idl (Ukb Data Field 23526),Phenotype,Cholesterol In Idl (Ukb Data Field 23526)
61188,Free Cholesterol In Idl (Ukb Data Field 23528),Phenotype,Free Cholesterol In Idl (Ukb Data Field 23528)
61189,Phospholipids In Idl (Ukb Data Field 23525),Phenotype,Phospholipids In Idl (Ukb Data Field 23525)
61190,Total Lipids In Idl (Ukb Data Field 23524),Phenotype,Total Lipids In Idl (Ukb Data Field 23524)
61191,Total Lipids In Medium Ldl (Ukb Data Field 23538),Phenotype,Total Lipids In Medium Ldl (Ukb Data Field 23538)
61193,Triglycerides In Large Ldl (Ukb Data Field 23536),Phenotype,Triglycerides In Large Ldl (Ukb Data Field 23536)
61194,Free Cholesterol In Large Ldl (Ukb Data Field 23535),Phenotype,Free Cholesterol In Large Ldl (Ukb Data Field 23535)
61195,Cholesterol In Medium Ldl (Ukb Data Field 23540),Phenotype,Cholesterol In Medium Ldl (Ukb Data Field 23540)
61196,Phospholipids In Medium Ldl (Ukb Data Field 23539),Phenotype,Phospholipids In Medium Ldl (Ukb Data Field 23539)
61197,Concentration Of Medium Ldl Particles (Ukb Data Field 23537),Phenotype,Concentration Of Medium Ldl Particles (Ukb Data Field 23537)
61198,Total Lipids In Small Ldl (Ukb Data Field 23545),Phenotype,Total Lipids In Small Ldl (Ukb Data Field 23545)
61199,Free Cholesterol In Small Ldl (Ukb Data Field 23549),Phenotype,Free Cholesterol In Small Ldl (Ukb Data Field 23549)
61200,Cholesterol In Small Ldl (Ukb Data Field 23547),Phenotype,Cholesterol In Small Ldl (Ukb Data Field 23547)
61201,Phospholipids In Small Ldl (Ukb Data Field 23546),Phenotype,Phospholipids In Small Ldl (Ukb Data Field 23546)
61203,Cholesteryl Esters In Small Ldl (Ukb Data Field 23548),Phenotype,Cholesteryl Esters In Small Ldl (Ukb Data Field 23548)
61204,Concentration Of Large Hdl Particles (Ukb Data Field 23558),Phenotype,Concentration Of Large Hdl Particles (Ukb Data Field 23558)
61205,Phospholipids In Large Hdl (Ukb Data Field 23560),Phenotype,Phospholipids In Large Hdl (Ukb Data Field 23560)
61206,Total Lipids In Large Hdl (Ukb Data Field 23559),Phenotype,Total Lipids In Large Hdl (Ukb Data Field 23559)
61207,Free Cholesterol In Large Hdl (Ukb Data Field 23563),Phenotype,Free Cholesterol In Large Hdl (Ukb Data Field 23563)
61208,Concentration Of Medium Hdl Particles (Ukb Data Field 23565),Phenotype,Concentration Of Medium Hdl Particles (Ukb Data Field 23565)
61209,Movement Related Adverse Drug Reaction To Aripiprazole In Schizophrenia,Phenotype,Movement Related Adverse Drug Reaction To Aripiprazole In Schizophrenia
61211,Cholesteryl Esters To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23581),Phenotype,Cholesteryl Esters To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23581)
61212,Free Cholesterol To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23582),Phenotype,Free Cholesterol To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23582)
61213,Phospholipids To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23579),Phenotype,Phospholipids To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23579)
61214,Cholesterol To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23580),Phenotype,Cholesterol To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23580)
61215,Cholesterol In Small Hdl (Ukb Data Field 23575),Phenotype,Cholesterol In Small Hdl (Ukb Data Field 23575)
61216,Phospholipids In Small Hdl (Ukb Data Field 23574),Phenotype,Phospholipids In Small Hdl (Ukb Data Field 23574)
61217,Cholesteryl Esters In Small Hdl (Ukb Data Field 23576),Phenotype,Cholesteryl Esters In Small Hdl (Ukb Data Field 23576)
61218,Free Cholesterol In Small Hdl (Ukb Data Field 23577),Phenotype,Free Cholesterol In Small Hdl (Ukb Data Field 23577)
61220,Triglycerides In Small Hdl (Ukb Data Field 23578),Phenotype,Triglycerides In Small Hdl (Ukb Data Field 23578)
61221,Descending Aorta Strain,Phenotype,Descending Aorta Strain
61224,Vascular Endothelial Function,Phenotype,Vascular Endothelial Function
61246,Phospholipids In Ldl (Ukb Data Field 23413),Phenotype,Phospholipids In Ldl (Ukb Data Field 23413)
61248,Phospholipids In Vldl (Ukb Data Field 23412),Phenotype,Phospholipids In Vldl (Ukb Data Field 23412)
61249,Phospholipids In Hdl (Ukb Data Field 23414),Phenotype,Phospholipids In Hdl (Ukb Data Field 23414)
61250,Average Diameter For Hdl Particles (Ukb Data Field 23433),Phenotype,Average Diameter For Hdl Particles (Ukb Data Field 23433)
61251,Phosphoglycerides Levels (Ukb Data Field 23434),Phenotype,Phosphoglycerides Levels (Ukb Data Field 23434)
61252,Triglycerides To Phosphoglycerides Ratio (Ukb Data Field 23435),Phenotype,Triglycerides To Phosphoglycerides Ratio (Ukb Data Field 23435)
61253,Monounsaturated Fatty Acids Levels (Ukb Data Field 23447),Phenotype,Monounsaturated Fatty Acids Levels (Ukb Data Field 23447)
61254,Saturated Fatty Acids Levels (Ukb Data Field 23448),Phenotype,Saturated Fatty Acids Levels (Ukb Data Field 23448)
61255,Linoleic Acid Levels (Ukb Data Field 23449),Phenotype,Linoleic Acid Levels (Ukb Data Field 23449)
61256,Docosahexaenoic Acid Levels (Ukb Data Field 23450),Phenotype,Docosahexaenoic Acid Levels (Ukb Data Field 23450)
61270,Descending Aorta Diameter,Phenotype,Descending Aorta Diameter
61271,Headache Or Migraine,Phenotype,Headache Or Migraine
61297,Total Lipids In Lipoprotein Particles (Ukb Data Field 23423),Phenotype,Total Lipids In Lipoprotein Particles (Ukb Data Field 23423)
61298,Free Cholesterol In Ldl (Ukb Data Field 23421),Phenotype,Free Cholesterol In Ldl (Ukb Data Field 23421)
61299,Free Cholesterol In Vldl (Ukb Data Field 23420),Phenotype,Free Cholesterol In Vldl (Ukb Data Field 23420)
61300,Free Cholesterol In Hdl (Ukb Data Field 23422),Phenotype,Free Cholesterol In Hdl (Ukb Data Field 23422)
61301,Total Lipids In Vldl (Ukb Data Field 23424),Phenotype,Total Lipids In Vldl (Ukb Data Field 23424)
61302,Total Lipids In Ldl (Ukb Data Field 23425),Phenotype,Total Lipids In Ldl (Ukb Data Field 23425)
61303,Total Lipids In Hdl (Ukb Data Field 23426),Phenotype,Total Lipids In Hdl (Ukb Data Field 23426)
61304,Omega-3 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23451),Phenotype,Omega-3 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23451)
61305,Polyunsaturated Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23453),Phenotype,Polyunsaturated Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23453)
61306,Omega-6 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23452),Phenotype,Omega-6 Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23452)
61307,Saturated Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23455),Phenotype,Saturated Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23455)
61308,Linoleic Acid To Total Fatty Acids Percentage (Ukb Data Field 23456),Phenotype,Linoleic Acid To Total Fatty Acids Percentage (Ukb Data Field 23456)
61309,Occupational Creativity,Phenotype,Occupational Creativity
61310,Total Lipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23482),Phenotype,Total Lipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23482)
61311,Cholesterol In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23484),Phenotype,Cholesterol In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23484)
61312,Cholesteryl Esters In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23485),Phenotype,Cholesteryl Esters In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23485)
61313,Phospholipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23483),Phenotype,Phospholipids In Chylomicrons And Extremely Large Vldl (Ukb Data Field 23483)
61318,Concentration Of Large Vldl Particles (Ukb Data Field 23495),Phenotype,Concentration Of Large Vldl Particles (Ukb Data Field 23495)
61319,Triglycerides In Very Large Vldl (Ukb Data Field 23494),Phenotype,Triglycerides In Very Large Vldl (Ukb Data Field 23494)
61320,Total Lipids In Large Vldl (Ukb Data Field 23496),Phenotype,Total Lipids In Large Vldl (Ukb Data Field 23496)
61321,Free Cholesterol In Large Vldl (Ukb Data Field 23500),Phenotype,Free Cholesterol In Large Vldl (Ukb Data Field 23500)
61322,Free Cholesterol In Medium Vldl (Ukb Data Field 23507),Phenotype,Free Cholesterol In Medium Vldl (Ukb Data Field 23507)
61323,Concentration Of Small Vldl Particles (Ukb Data Field 23509),Phenotype,Concentration Of Small Vldl Particles (Ukb Data Field 23509)
61324,Triglycerides In Medium Vldl (Ukb Data Field 23508),Phenotype,Triglycerides In Medium Vldl (Ukb Data Field 23508)
61325,Cholesteryl Esters In Medium Vldl (Ukb Data Field 23506),Phenotype,Cholesteryl Esters In Medium Vldl (Ukb Data Field 23506)
61326,Free Cholesterol In Very Small Vldl (Ukb Data Field 23521),Phenotype,Free Cholesterol In Very Small Vldl (Ukb Data Field 23521)
61327,Concentration Of Idl Particles (Ukb Data Field 23523),Phenotype,Concentration Of Idl Particles (Ukb Data Field 23523)
61328,Triglycerides In Very Small Vldl (Ukb Data Field 23522),Phenotype,Triglycerides In Very Small Vldl (Ukb Data Field 23522)
61329,Cholesteryl Esters In Very Small Vldl (Ukb Data Field 23520),Phenotype,Cholesteryl Esters In Very Small Vldl (Ukb Data Field 23520)
61330,Triglycerides In Medium Ldl (Ukb Data Field 23543),Phenotype,Triglycerides In Medium Ldl (Ukb Data Field 23543)
61331,Cholesteryl Esters In Medium Ldl (Ukb Data Field 23541),Phenotype,Cholesteryl Esters In Medium Ldl (Ukb Data Field 23541)
61332,Free Cholesterol In Medium Ldl (Ukb Data Field 23542),Phenotype,Free Cholesterol In Medium Ldl (Ukb Data Field 23542)
61333,Concentration Of Small Ldl Particles (Ukb Data Field 23544),Phenotype,Concentration Of Small Ldl Particles (Ukb Data Field 23544)
61337,Systemic Sclerosis Complicated With Interstitial Lung Disease,Phenotype,Systemic Sclerosis Complicated With Interstitial Lung Disease
61338,Triglycerides In Very Large Hdl (Ukb Data Field 23557),Phenotype,Triglycerides In Very Large Hdl (Ukb Data Field 23557)
61339,Cholesteryl Esters In Very Large Hdl (Ukb Data Field 23555),Phenotype,Cholesteryl Esters In Very Large Hdl (Ukb Data Field 23555)
61340,Cholesterol In Very Large Hdl (Ukb Data Field 23554),Phenotype,Cholesterol In Very Large Hdl (Ukb Data Field 23554)
61341,Free Cholesterol In Very Large Hdl (Ukb Data Field 23556),Phenotype,Free Cholesterol In Very Large Hdl (Ukb Data Field 23556)
61342,Triglycerides In Medium Hdl (Ukb Data Field 23571),Phenotype,Triglycerides In Medium Hdl (Ukb Data Field 23571)
61343,Concentration Of Small Hdl Particles (Ukb Data Field 23572),Phenotype,Concentration Of Small Hdl Particles (Ukb Data Field 23572)
61344,Total Lipids In Small Hdl (Ukb Data Field 23573),Phenotype,Total Lipids In Small Hdl (Ukb Data Field 23573)
61347,Free Cholesterol In Medium Hdl (Ukb Data Field 23570),Phenotype,Free Cholesterol In Medium Hdl (Ukb Data Field 23570)
61348,Triglycerides To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23583),Phenotype,Triglycerides To Total Lipids In Chylomicrons And Extremely Large Vldl Percentage (Ukb Data Field 23583)
61349,Free Cholesterol To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23587),Phenotype,Free Cholesterol To Total Lipids In Very Large Vldl Percentage (Ukb Data Field 23587)
61351,Gall Stone Disease Or Coronary Artery Disease,Phenotype,Gall Stone Disease Or Coronary Artery Disease
61362,Adverse Response To Chemotherapy In Colorectal Cancer (Folfox) (Stomatitis),Phenotype,Adverse Response To Chemotherapy In Colorectal Cancer (Folfox) (Stomatitis)
61364,Adverse Response To Chemotherapy In Colorectal Cancer (Folfox) (Neutropenia),Phenotype,Adverse Response To Chemotherapy In Colorectal Cancer (Folfox) (Neutropenia)
61366,Time To Levodopa-Induced-Dyskinesia Onset In Parkinson'S Disease,Phenotype,Time To Levodopa-Induced-Dyskinesia Onset In Parkinson'S Disease
61368,Age At Menarche Or Uterine Leiomyomata (Pleiotropy),Phenotype,Age At Menarche Or Uterine Leiomyomata (Pleiotropy)
61369,Age At Natural Menopause Or Uterine Leiomyomata (Pleiotropy),Phenotype,Age At Natural Menopause Or Uterine Leiomyomata (Pleiotropy)
61370,Age At First Birth Or Uterine Leiomyomata (Pleiotropy),Phenotype,Age At First Birth Or Uterine Leiomyomata (Pleiotropy)
61371,Hypothyroidism Or Rheumatoid Arthritis (Pleiotropy),Phenotype,Hypothyroidism Or Rheumatoid Arthritis (Pleiotropy)
61483,Postmenopausal Breast Cancer,Phenotype,Postmenopausal Breast Cancer
61517,Skull Bone Mineral Density,Phenotype,Skull Bone Mineral Density
61536,Mono-(2-Ethyl-5-Carboxypentyl) Phthalate Levels (Mtag),Phenotype,Mono-(2-Ethyl-5-Carboxypentyl) Phthalate Levels (Mtag)
61571,Nonsyndromic Biliary Atresia,Phenotype,Nonsyndromic Biliary Atresia
61576,Hospitalized Covid-19 Or Bmi (Pleiotropy),Phenotype,Hospitalized Covid-19 Or Bmi (Pleiotropy)
61682,Skin Luminance,Phenotype,Skin Luminance
61686,Skin Yellow/Blue Component,Phenotype,Skin Yellow/Blue Component
61688,Femoral Neck Width,Phenotype,Femoral Neck Width
61689,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 60),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 60)
61690,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 62),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 62)
61691,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 71),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 71)
61692,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 80),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 80)
61694,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 4),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 4)
61695,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 42),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 42)
61697,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 44),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 44)
61698,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 10),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 10)
61700,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 22),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 22)
61701,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 28),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 28)
61703,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 39),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 39)
61704,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 7),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 7)
61706,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 11),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 11)
61708,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 16),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 16)
61710,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 24),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 24)
61712,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 117),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 117)
61715,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 121),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 121)
61716,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 125),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 125)
61717,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 2),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 2)
61718,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 8),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 8)
61719,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 114),Phenotype,T1 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 114)
61721,Pcsk9 Levels In Statin-Naive Individuals,Phenotype,Pcsk9 Levels In Statin-Naive Individuals
61838,Vegetarianism,Phenotype,Vegetarianism
61844,Uterine Cancer,Phenotype,Uterine Cancer
61858,Pma Induced Il5 Level Without Bcg Vaccination,Phenotype,Pma Induced Il5 Level Without Bcg Vaccination
61860,Pma Induced Tnfa Level Without Bcg Vaccination,Phenotype,Pma Induced Tnfa Level Without Bcg Vaccination
61862,Preeclampsia In Pregnancy,Phenotype,Preeclampsia In Pregnancy
61892,Facial Trait (Forehead Height),Phenotype,Facial Trait (Forehead Height)
61895,Clonal Hematopoiesis (Overall),Phenotype,Clonal Hematopoiesis (Overall)
61896,Clonal Hematopoiesis (Dnmt3A Mutation),Phenotype,Clonal Hematopoiesis (Dnmt3A Mutation)
61898,Steroid-Dependent/Frequent Relapse Nephrotic Syndrome,Phenotype,Steroid-Dependent/Frequent Relapse Nephrotic Syndrome
61905,Dti Tbss Md Fornix,Phenotype,Dti Tbss Md Fornix
61909,Body Fat Percentage (Adjusted For Testosterone And Shbg),Phenotype,Body Fat Percentage (Adjusted For Testosterone And Shbg)
61915,T1 Freesurfer Dk Rh Cuneus Volume,Phenotype,T1 Freesurfer Dk Rh Cuneus Volume
61916,T1 Freesurfer Pial Lh Pericalcarine Area,Phenotype,T1 Freesurfer Pial Lh Pericalcarine Area
61918,T1 Freesurfer Pial Rh Cuneus Area,Phenotype,T1 Freesurfer Pial Rh Cuneus Area
61919,T1 First Volume Brstem,Phenotype,T1 First Volume Brstem
61920,T1 Freesurfer Dk Lh Cuneus Volume,Phenotype,T1 Freesurfer Dk Lh Cuneus Volume
61921,T1 Freesurfer Dk Rh Cuneus Area,Phenotype,T1 Freesurfer Dk Rh Cuneus Area
61922,T1 Freesurfer Dk Rh Lateraloccipital Area,Phenotype,T1 Freesurfer Dk Rh Lateraloccipital Area
61923,T1 Freesurfer Dk Rh Lingual Area,Phenotype,T1 Freesurfer Dk Rh Lingual Area
61924,T1 Freesurfer Dk Rh Pericalcarine Area,Phenotype,T1 Freesurfer Dk Rh Pericalcarine Area
61925,T1 Cat Volume R Postcentralgyrus,Phenotype,T1 Cat Volume R Postcentralgyrus
61927,T1 Cat Volume R Supramarginalgyrusanteriordivision,Phenotype,T1 Cat Volume R Supramarginalgyrusanteriordivision
61928,T1 Cat Volume L X,Phenotype,T1 Cat Volume L X
61932,Short Sleep Duration (<5 Hours),Phenotype,Short Sleep Duration (<5 Hours)
61961,Left-Hemisphere Visual Network To Left-Hemisphere Limbic Network White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Visual Network To Left-Hemisphere Limbic Network White-Matter Structural Connectivity
62066,T1 Freesurfer Dk Lh Pericalcarine Area,Phenotype,T1 Freesurfer Dk Lh Pericalcarine Area
62067,T1 Cat Volume L Middletemporalgyrusanteriordivision,Phenotype,T1 Cat Volume L Middletemporalgyrusanteriordivision
62068,T1 Freesurfer Ba Rh V1 Exvivo Area,Phenotype,T1 Freesurfer Ba Rh V1 Exvivo Area
62069,T1 Freesurfer Ba Rh V2 Exvivo Area,Phenotype,T1 Freesurfer Ba Rh V2 Exvivo Area
62070,T1 Freesurfer Ba Lh V1 Exvivo Area,Phenotype,T1 Freesurfer Ba Lh V1 Exvivo Area
62071,Dti Autoptx Md Ilf L Tract,Phenotype,Dti Autoptx Md Ilf L Tract
62073,Long Sleep Duration (>=10 Hours),Phenotype,Long Sleep Duration (>=10 Hours)
62076,T1 Freesurfer Dkt Rh Rostralanteriorcingulate Thickness,Phenotype,T1 Freesurfer Dkt Rh Rostralanteriorcingulate Thickness
62078,T1 Freesurfer Dkt Rh Cuneus Volume,Phenotype,T1 Freesurfer Dkt Rh Cuneus Volume
62079,Rest Ukbbica Net100 0810,Phenotype,Rest Ukbbica Net100 0810
62081,Dti Tbss L2 Fornix,Phenotype,Dti Tbss L2 Fornix
62082,Dti Tbss L2 Corticospinal Tract R,Phenotype,Dti Tbss L2 Corticospinal Tract R
62084,Dti Tbss Fa Posterior Thalamic Radiation L,Phenotype,Dti Tbss Fa Posterior Thalamic Radiation L
62086,Dti Tbss L1 Fornix,Phenotype,Dti Tbss L1 Fornix
62087,Dti Tbss L1 Superior Corona Radiata L,Phenotype,Dti Tbss L1 Superior Corona Radiata L
62171,Dti Tbss L3 Fornix,Phenotype,Dti Tbss L3 Fornix
62172,Dti Tbss L3 Superior Corona Radiata R,Phenotype,Dti Tbss L3 Superior Corona Radiata R
62260,Right-Hemisphere Visual Network To Right-Hemisphere Salience/Ventral Attention Network White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Visual Network To Right-Hemisphere Salience/Ventral Attention Network White-Matter Structural Connectivity
62262,Right-Hemisphere Visual Network To Right-Hemisphere Control Network White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Visual Network To Right-Hemisphere Control Network White-Matter Structural Connectivity
62263,Right-Hemisphere Visual Network To Pallidum White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Visual Network To Pallidum White-Matter Structural Connectivity
62265,Left-Hemisphere Control Network To Accumbens White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Control Network To Accumbens White-Matter Structural Connectivity
62267,Left-Hemisphere Default Mode Network To Right-Hemisphere Visual Network White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Default Mode Network To Right-Hemisphere Visual Network White-Matter Structural Connectivity
62268,Left-Hemisphere Control Network To Right-Hemisphere Visual Network White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Control Network To Right-Hemisphere Visual Network White-Matter Structural Connectivity
62270,Right-Hemisphere Visual Network To Right-Hemisphere Visual Network White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Visual Network To Right-Hemisphere Visual Network White-Matter Structural Connectivity
62271,Left-Hemisphere Limbic Network To Thalamus White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Limbic Network To Thalamus White-Matter Structural Connectivity
62273,Left-Hemisphere Limbic Network To Putamen White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Limbic Network To Putamen White-Matter Structural Connectivity
62274,Left-Hemisphere Control Network To Thalamus White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Control Network To Thalamus White-Matter Structural Connectivity
62275,Left-Hemisphere Control Network To Putamen White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Control Network To Putamen White-Matter Structural Connectivity
62277,Left-Hemisphere Visual Network To Right-Hemisphere Control Network White-Matter Structural Connectivity,Phenotype,Left-Hemisphere Visual Network To Right-Hemisphere Control Network White-Matter Structural Connectivity
62291,Right-Hemisphere Somatomotor Network To Amygdala White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Somatomotor Network To Amygdala White-Matter Structural Connectivity
62293,Right-Hemisphere Dorsal Attention Network To Hippocampus White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Dorsal Attention Network To Hippocampus White-Matter Structural Connectivity
62295,Right-Hemisphere Limbic Network To Thalamus White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Limbic Network To Thalamus White-Matter Structural Connectivity
62296,Right-Hemisphere Limbic Network To Caudate White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Limbic Network To Caudate White-Matter Structural Connectivity
62297,Right-Hemisphere Limbic Network To Putamen White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Limbic Network To Putamen White-Matter Structural Connectivity
62298,Right-Hemisphere Control Network To Right-Hemisphere Control Network White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Control Network To Right-Hemisphere Control Network White-Matter Structural Connectivity
62300,Right-Hemisphere Control Network To Thalamus White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Control Network To Thalamus White-Matter Structural Connectivity
62301,Right-Hemisphere Control Network To Putamen White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Control Network To Putamen White-Matter Structural Connectivity
62303,Right-Hemisphere Control Network To Hippocampus White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Control Network To Hippocampus White-Matter Structural Connectivity
62304,Right-Hemisphere Default Mode Network To Hippocampus White-Matter Structural Connectivity,Phenotype,Right-Hemisphere Default Mode Network To Hippocampus White-Matter Structural Connectivity
62376,T1 Freesurfer A2009S Rh S Calcarine Area,Phenotype,T1 Freesurfer A2009S Rh S Calcarine Area
62377,T1 Freesurfer A2009S Rh S Circular Insula Ant Area,Phenotype,T1 Freesurfer A2009S Rh S Circular Insula Ant Area
62378,T1 Freesurfer A2009S Rh G Cuneus Volume,Phenotype,T1 Freesurfer A2009S Rh G Cuneus Volume
62379,T1 Freesurfer A2009S Rh G Pariet Inf-Supramar Volume,Phenotype,T1 Freesurfer A2009S Rh G Pariet Inf-Supramar Volume
62383,T1 Freesurfer A2009S Rh S Calcarine Volume,Phenotype,T1 Freesurfer A2009S Rh S Calcarine Volume
62384,T1 Freesurfer A2009S Lh G Cuneus Volume,Phenotype,T1 Freesurfer A2009S Lh G Cuneus Volume
62385,T1 Freesurfer A2009S Lh G Parietal Sup Volume,Phenotype,T1 Freesurfer A2009S Lh G Parietal Sup Volume
62386,T1 Freesurfer A2009S Rh G Cuneus Area,Phenotype,T1 Freesurfer A2009S Rh G Cuneus Area
62387,T1 Freesurfer A2009S Lh G Cuneus Area,Phenotype,T1 Freesurfer A2009S Lh G Cuneus Area
62389,T1 Freesurfer Pial Rh Pericalcarine Area,Phenotype,T1 Freesurfer Pial Rh Pericalcarine Area
62390,T1 Freesurfer Aseg 4Th-Ventricle,Phenotype,T1 Freesurfer Aseg 4Th-Ventricle
62391,T1 Freesurfer Dkt Lh Pericalcarine Area,Phenotype,T1 Freesurfer Dkt Lh Pericalcarine Area
62392,T1 Freesurfer Pial Rh Supramarginal Area,Phenotype,T1 Freesurfer Pial Rh Supramarginal Area
62393,T1 Freesurfer Dkt Lh Cuneus Volume,Phenotype,T1 Freesurfer Dkt Lh Cuneus Volume
62394,T1 Freesurfer Dkt Rh Cuneus Area,Phenotype,T1 Freesurfer Dkt Rh Cuneus Area
62395,T1 Freesurfer Dkt Rh Lateraloccipital Area,Phenotype,T1 Freesurfer Dkt Rh Lateraloccipital Area
62396,T1 Freesurfer Dkt Rh Lingual Area,Phenotype,T1 Freesurfer Dkt Rh Lingual Area
62397,T1 Freesurfer Dkt Rh Pericalcarine Area,Phenotype,T1 Freesurfer Dkt Rh Pericalcarine Area
62448,Drug-Induced Liver Injury (Japanese Traditional Medicines),Phenotype,Drug-Induced Liver Injury (Japanese Traditional Medicines)
62474,(Z)-4-Hydroxytamoxifen To Tamoxifen Ratio In Tamoxifen-Treated Hormone-Receptor-Positive Breast Cancer,Phenotype,(Z)-4-Hydroxytamoxifen To Tamoxifen Ratio In Tamoxifen-Treated Hormone-Receptor-Positive Breast Cancer
62476,Ascending Aorta Strain,Phenotype,Ascending Aorta Strain
62478,Tinnitus-Related Distress,Phenotype,Tinnitus-Related Distress
62488,Response To Metfomin (Fasting Glucose Levels Adjusted For Baseline Glucose Levels),Phenotype,Response To Metfomin (Fasting Glucose Levels Adjusted For Baseline Glucose Levels)
62490,Total Phospholipids In Lipoprotein Particles (Ukb Data Field 23411),Phenotype,Total Phospholipids In Lipoprotein Particles (Ukb Data Field 23411)
62491,Triglycerides In Hdl (Ukb Data Field 23410),Phenotype,Triglycerides In Hdl (Ukb Data Field 23410)
62492,Triglycerides In Vldl (Ukb Data Field 23408),Phenotype,Triglycerides In Vldl (Ukb Data Field 23408)
62493,Triglycerides In Ldl (Ukb Data Field 23409),Phenotype,Triglycerides In Ldl (Ukb Data Field 23409)
62494,Average Diameter For Ldl Particles (Ukb Data Field 23432),Phenotype,Average Diameter For Ldl Particles (Ukb Data Field 23432)
62495,Average Diameter For Vldl Particles (Ukb Data Field 23431),Phenotype,Average Diameter For Vldl Particles (Ukb Data Field 23431)
62496,Infliximab Persistence In Crohn'S Disease,Phenotype,Infliximab Persistence In Crohn'S Disease
62498,Omega-3 Fatty Acids Levels (Ukb Data Field 23444),Phenotype,Omega-3 Fatty Acids Levels (Ukb Data Field 23444)
62499,Degree Of Unsaturation (Ukb Data Field 23443),Phenotype,Degree Of Unsaturation (Ukb Data Field 23443)
62501,Polyunsaturated Fatty Acids Levels (Ukb Data Field 23446),Phenotype,Polyunsaturated Fatty Acids Levels (Ukb Data Field 23446)
62502,Omega-6 Fatty Acids Levels (Ukb Data Field 23445),Phenotype,Omega-6 Fatty Acids Levels (Ukb Data Field 23445)
62503,Heart Rate Variability (Corrected Root Mean Square Of Successive Differences),Phenotype,Heart Rate Variability (Corrected Root Mean Square Of Successive Differences)
62504,Heart Rate Variability (Root Mean Square Of Successive Differences),Phenotype,Heart Rate Variability (Root Mean Square Of Successive Differences)
62505,Heart Rate Variability (Corrected Standard Deviation Of Normal-To-Normal Intervals),Phenotype,Heart Rate Variability (Corrected Standard Deviation Of Normal-To-Normal Intervals)
62506,Heart Rate Variability (Standard Deviation Of Normal-To-Normal Intervals),Phenotype,Heart Rate Variability (Standard Deviation Of Normal-To-Normal Intervals)
62516,Alzheimer'S Disease Or Related Dementias (Adjusted For Apoe E4 Dosage),Phenotype,Alzheimer'S Disease Or Related Dementias (Adjusted For Apoe E4 Dosage)
62518,Alzheimer'S Disease-- Proxy Alzheimer'S Disease Or Related Dementias,Phenotype,Alzheimer'S Disease-- Proxy Alzheimer'S Disease Or Related Dementias
62524,Alzheimer'S Disease-- Proxy Alzheimer'S Disease Or Related Dementias (Adjusted For Apoe E4 Dosage),Phenotype,Alzheimer'S Disease-- Proxy Alzheimer'S Disease Or Related Dementias (Adjusted For Apoe E4 Dosage)
62533,Insulin Resistance,Phenotype,Insulin Resistance
62535,Clinical Ldl Cholesterol Levels (Ukb Data Field 23404),Phenotype,Clinical Ldl Cholesterol Levels (Ukb Data Field 23404)
62536,Ldl Cholesterol Levels (Ukb Data Field 23405),Phenotype,Ldl Cholesterol Levels (Ukb Data Field 23405)
62537,Hdl Cholesterol Levels (Ukb Data Field 23406),Phenotype,Hdl Cholesterol Levels (Ukb Data Field 23406)
62538,Total Triglycerides Levels (Ukb Data Field 23407),Phenotype,Total Triglycerides Levels (Ukb Data Field 23407)
62539,Total Esterified Cholesterol Levels (Ukb Data Field 23415),Phenotype,Total Esterified Cholesterol Levels (Ukb Data Field 23415)
62540,Cholesteryl Esters In Hdl (Ukb Data Field 23418),Phenotype,Cholesteryl Esters In Hdl (Ukb Data Field 23418)
62541,Cholesteryl Esters In Ldl (Ukb Data Field 23417),Phenotype,Cholesteryl Esters In Ldl (Ukb Data Field 23417)
62542,Cholesteryl Esters In Vldl (Ukb Data Field 23416),Phenotype,Cholesteryl Esters In Vldl (Ukb Data Field 23416)
62543,Total Free Cholesterol Levels (Ukb Data Field 23419),Phenotype,Total Free Cholesterol Levels (Ukb Data Field 23419)
62544,Apolipoprotein A1 Levels (Ukb Data Field 23440),Phenotype,Apolipoprotein A1 Levels (Ukb Data Field 23440)
62545,Apolipoprotein B To Apolipoprotein A1 Ratio (Ukb Data Field 23441),Phenotype,Apolipoprotein B To Apolipoprotein A1 Ratio (Ukb Data Field 23441)
62547,Apolipoprotein B Levels (Ukb Data Field 23439),Phenotype,Apolipoprotein B Levels (Ukb Data Field 23439)
62548,Total Fatty Acids Levels (Ukb Data Field 23442),Phenotype,Total Fatty Acids Levels (Ukb Data Field 23442)
62553,Primary Sclerosing Cholangitis (Mtag),Phenotype,Primary Sclerosing Cholangitis (Mtag)
62570,Concentration Of Ldl Particles (Ukb Data Field 23429),Phenotype,Concentration Of Ldl Particles (Ukb Data Field 23429)
62571,Concentration Of Vldl Particles (Ukb Data Field 23428),Phenotype,Concentration Of Vldl Particles (Ukb Data Field 23428)
62572,Total Concentration Of Lipoprotein Particles (Ukb Data Field 23427),Phenotype,Total Concentration Of Lipoprotein Particles (Ukb Data Field 23427)
62573,Concentration Of Hdl Particles (Ukb Data Field 23430),Phenotype,Concentration Of Hdl Particles (Ukb Data Field 23430)
62584,Total Cholesterol Levels (Ukb Data Field 23400),Phenotype,Total Cholesterol Levels (Ukb Data Field 23400)
62585,Vldl Cholesterol Levels (Ukb Data Field 23403),Phenotype,Vldl Cholesterol Levels (Ukb Data Field 23403)
62586,Total Cholesterol Minus Hdl-C Levels (Ukb Data Field 23401),Phenotype,Total Cholesterol Minus Hdl-C Levels (Ukb Data Field 23401)
62587,Remnant Cholesterol (Non-Hdl-- Non-Ldl -Cholesterol) Levels (Ukb Data Field 23402),Phenotype,Remnant Cholesterol (Non-Hdl-- Non-Ldl -Cholesterol) Levels (Ukb Data Field 23402)
62595,Phosphatidylcholines Levels (Ukb Data Field 23437),Phenotype,Phosphatidylcholines Levels (Ukb Data Field 23437)
62596,Sphingomyelins Levels (Ukb Data Field 23438),Phenotype,Sphingomyelins Levels (Ukb Data Field 23438)
62597,Total Cholines Levels (Ukb Data Field 23436),Phenotype,Total Cholines Levels (Ukb Data Field 23436)
62598,Docosahexaenoic Acid To Total Fatty Acids Percentage (Ukb Data Field 23457),Phenotype,Docosahexaenoic Acid To Total Fatty Acids Percentage (Ukb Data Field 23457)
62599,Polyunsaturated Fatty Acids To Monounsaturated Fatty Acids Ratio (Ukb Data Field 23458),Phenotype,Polyunsaturated Fatty Acids To Monounsaturated Fatty Acids Ratio (Ukb Data Field 23458)
62600,Monounsaturated Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23454),Phenotype,Monounsaturated Fatty Acids To Total Fatty Acids Percentage (Ukb Data Field 23454)
62602,Omega-6 Fatty Acids To Omega-3 Fatty Acids Ratio (Ukb Data Field 23459),Phenotype,Omega-6 Fatty Acids To Omega-3 Fatty Acids Ratio (Ukb Data Field 23459)
62603,Age At Dementia Onset In Psen1 E280A Mutation Carriers,Phenotype,Age At Dementia Onset In Psen1 E280A Mutation Carriers
62610,Serum Levels Of Protein Igf1,Phenotype,Serum Levels Of Protein Igf1
62611,Serum Levels Of Protein Igfbp3,Phenotype,Serum Levels Of Protein Igfbp3
62612,Igf-1 And Igfbp-3 Levels (Bivariate Analysis),Phenotype,Igf-1 And Igfbp-3 Levels (Bivariate Analysis)
62616,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 76),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 76)
62617,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 79),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 79)
62619,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 81),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 81)
62620,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 82),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 82)
62621,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 85),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 85)
62622,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 105),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 105)
62623,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 108),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 108)
62624,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 109),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 109)
62626,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 112),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 112)
62628,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 52),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 52)
62630,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 100),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 100)
62631,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 101),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 101)
62632,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 122),Phenotype,T2 Brain Mris Unsupervised Deep Learning Derived Imaging Phenotypes (Dimension 122)
62636,Response To Bnt162B2 Vaccine (Anti-Sars-Cov-2 Spike Antibody Levels After Second Dose),Phenotype,Response To Bnt162B2 Vaccine (Anti-Sars-Cov-2 Spike Antibody Levels After Second Dose)
62780,Speech-In-Noise Perception,Phenotype,Speech-In-Noise Perception
62901,Il6 Expression At 6 Weeks In Pbmc Upon Bbmix 10-5 Stimulation In Lyme Borreliosis,Phenotype,Il6 Expression At 6 Weeks In Pbmc Upon Bbmix 10-5 Stimulation In Lyme Borreliosis
62903,Il6 Expression At 6 Weeks In Whole Blood Upon Bbmix Moi30 Stimulation In Lyme Borreliosis,Phenotype,Il6 Expression At 6 Weeks In Whole Blood Upon Bbmix Moi30 Stimulation In Lyme Borreliosis
62928,High-Density Lipoprotein Levels,Phenotype,High-Density Lipoprotein Levels
62936,Anti-N-Methyl-D-Aspartate Receptor Encephalitis,Phenotype,Anti-N-Methyl-D-Aspartate Receptor Encephalitis
62939,B-Cell Lymphoblastic Leukemia Or Hypothyroidism (Pleiotropy),Phenotype,B-Cell Lymphoblastic Leukemia Or Hypothyroidism (Pleiotropy)
62941,B-Cell Lymphoblastic Leukemia Or Primary Biliary Cholangitis (Pleiotropy),Phenotype,B-Cell Lymphoblastic Leukemia Or Primary Biliary Cholangitis (Pleiotropy)
62942,B-Cell Lymphoblastic Leukemia Or Inflammatory Bowel Disease (Pleiotropy),Phenotype,B-Cell Lymphoblastic Leukemia Or Inflammatory Bowel Disease (Pleiotropy)
62944,B-Cell Lymphoblastic Leukemia Or Crohn'S Disease (Pleiotropy),Phenotype,B-Cell Lymphoblastic Leukemia Or Crohn'S Disease (Pleiotropy)
62955,B-Cell Lymphoblastic Leukemia Or Rheumatoid Arthritis (Pleiotropy),Phenotype,B-Cell Lymphoblastic Leukemia Or Rheumatoid Arthritis (Pleiotropy)
62956,B-Cell Lymphoblastic Leukemia Or Multiple Sclerosis (Pleiotropy),Phenotype,B-Cell Lymphoblastic Leukemia Or Multiple Sclerosis (Pleiotropy)
62958,Pancreatic Cancer X Smoking Interaction,Phenotype,Pancreatic Cancer X Smoking Interaction
62962,Attention Deficit Hyperactivity Disorder Or Risk-Taking Behavior (Pleiotropy),Phenotype,Attention Deficit Hyperactivity Disorder Or Risk-Taking Behavior (Pleiotropy)
62969,Obsessive-Compulsive Symptoms,Phenotype,Obsessive-Compulsive Symptoms
62972,Current Medication Use (Ukb Data Field 20003),Phenotype,Current Medication Use (Ukb Data Field 20003)
62976,Age At First Sexual Intercourse Or Uterine Leiomyoma (Pleiotropy),Phenotype,Age At First Sexual Intercourse Or Uterine Leiomyoma (Pleiotropy)
62977,Lifetime Number Of Sexual Partners Or Uterine Leiomyoma (Pleiotropy),Phenotype,Lifetime Number Of Sexual Partners Or Uterine Leiomyoma (Pleiotropy)
62980,Left Atrial Maximum Volume,Phenotype,Left Atrial Maximum Volume
62983,Left Atrial Minimum Volume,Phenotype,Left Atrial Minimum Volume
62985,Left Atrial Stroke Volume,Phenotype,Left Atrial Stroke Volume
62987,Left Atrial Maximum Volume Bsa Indexed,Phenotype,Left Atrial Maximum Volume Bsa Indexed
62989,Knee Extension Strength,Phenotype,Knee Extension Strength
62998,Left Atrial Minimum Volume Bsa Indexed,Phenotype,Left Atrial Minimum Volume Bsa Indexed
62999,Left Atrial Stroke Volume Bsa Indexed,Phenotype,Left Atrial Stroke Volume Bsa Indexed
63027,Neuroticism General Factor,Phenotype,Neuroticism General Factor
63039,Neuroticism Group Factors (Worry),Phenotype,Neuroticism Group Factors (Worry)
63043,Kidney Stone Disease,Phenotype,Kidney Stone Disease
63055,Pregnancy Loss In Nulliparas,Phenotype,Pregnancy Loss In Nulliparas
63075,Gestational Length In Nulliparas,Phenotype,Gestational Length In Nulliparas
63082,Progression-Free Survival In Glioma,Phenotype,Progression-Free Survival In Glioma
63084,Apo-Ciii0C Levels,Phenotype,Apo-Ciii0C Levels
63086,Apo-Ciii1 Levels,Phenotype,Apo-Ciii1 Levels
63088,Apo-Ciii1/Apo-Ciii2 Ratio,Phenotype,Apo-Ciii1/Apo-Ciii2 Ratio
63090,Ecg Cardiac Mri Latent Space,Phenotype,Ecg Cardiac Mri Latent Space
63096,Ecg Latent Space,Phenotype,Ecg Latent Space
63116,Late-Onset Alzheimer'S Disease (Adjusted For Apoe),Phenotype,Late-Onset Alzheimer'S Disease (Adjusted For Apoe)
63154,Oral Lichen Planus,Phenotype,Oral Lichen Planus
63157,Non-Oral Lichen Planus,Phenotype,Non-Oral Lichen Planus
63166,T-Cell Receptor Clonality In Colorectal Cancer,Phenotype,T-Cell Receptor Clonality In Colorectal Cancer
63168,Preeclampsia In Nulliparas,Phenotype,Preeclampsia In Nulliparas
63171,Gestational Diabetes In Nulliparas,Phenotype,Gestational Diabetes In Nulliparas
63186,Cardiac Mri Latent Space,Phenotype,Cardiac Mri Latent Space
63204,Leukocyte Telomere Length Or Covid-19 Infection (Mtag),Phenotype,Leukocyte Telomere Length Or Covid-19 Infection (Mtag)
63207,Leukocyte Telomere Length Or Covid-19 Hospitalization (Mtag),Phenotype,Leukocyte Telomere Length Or Covid-19 Hospitalization (Mtag)
63210,Leukocyte Telomere Length Or Severe Covid-19 Infection (Mtag),Phenotype,Leukocyte Telomere Length Or Severe Covid-19 Infection (Mtag)
63228,Icd10 L43: Lichen Planus,Phenotype,Icd10 L43: Lichen Planus
63229,Dry Skin (Generalised),Phenotype,Dry Skin (Generalised)
63363,Hepatitis B Virus Antibody Levels,Phenotype,Hepatitis B Virus Antibody Levels
63369,Urine Red Blood Cell Levels,Phenotype,Urine Red Blood Cell Levels
63373,Number Of Sexual Partners In Opposite-Sex Sexual Behavior,Phenotype,Number Of Sexual Partners In Opposite-Sex Sexual Behavior
63377,Il6 Expression At 6 Weeks In Whole Blood Upon Lps Stimulation In Lyme Borreliosis,Phenotype,Il6 Expression At 6 Weeks In Whole Blood Upon Lps Stimulation In Lyme Borreliosis
63382,Myeloproliferative Neoplasms (Mtag),Phenotype,Myeloproliferative Neoplasms (Mtag)
63714,Total_GRS,Phenotype,Total_GRS
63977,Lipodystrophy1,Phenotype,Lipodystrophy1
63978,ALPNeg,Phenotype,ALPNeg
63979,Lipodystrophy2,Phenotype,Lipodystrophy2
63980,HyperInsulin,Phenotype,HyperInsulin
63981,BetaCell_2,Phenotype,BetaCell_2
63982,BetaCell_1,Phenotype,BetaCell_1
63984,Diastolic Blood Pressue,Phenotype,Diastolic Blood Pressue
63985,Apolipoprotein A (Apoa),Phenotype,Apolipoprotein A (Apoa)
63987,Systolic Blood Pressue,Phenotype,Systolic Blood Pressue
63989,Pulse Pressure Measurement,Phenotype,Pulse Pressure Measurement
63992,Type 2 Diabetes Mellitus_2024,Phenotype,Type 2 Diabetes Mellitus_2024
64037,CRP,Phenotype,CRP
64123,alcohol_consumption,Phenotype,alcohol_consumption
64265,Insulin-Like Growth Factor 1 (Igf1),Phenotype,Insulin-Like Growth Factor 1 (Igf1)
64345,Fasting Glucose Hm3,Phenotype,Fasting Glucose Hm3
64351,Age,Phenotype,Age
64390,fibrinogen,Phenotype,fibrinogen
65837,Interleukin 1 (Il-1),Phenotype,Interleukin 1 (Il-1)
65962,Fasting Insulin Hm3,Phenotype,Fasting Insulin Hm3
68663,Interleukin 6 (Il-6),Phenotype,Interleukin 6 (Il-6)
68799,EduAttain,Phenotype,EduAttain
83122,Apolipoprotein B (Apob),Phenotype,Apolipoprotein B (Apob)
